Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cellular potassium ion homeostasis (GO:0030007),-0.890649487467711,-2.379038420722185,0.0,0.0008921614553295467,0.001,6/13,5.31%,KCNMA1;SLC12A2;ATP1B1;ATP1A2;KCNJ2;ATP1B2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.6385257735469028,-2.1740480540916662,0.0,0.011152018191619331,0.022,11/38,6.42%,BIN1;CACNB2;CTNNA3;ANK2;CACNA1C;SCN1B;JUP;KCNJ2;TRPM4;KCNJ3;AKAP9
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.4780789596054295,-2.1275879705863994,0.0,0.015464131892378807,0.046,39/159,9.00%,CADM1;TENM2;PTPRD;PTPRM;ADGRL3;LRRC4C;IL1RAPL1;PTPRT;SDK1;ITGAM;ACVR1;NTNG1;ROBO2;KIRREL3;ROBO1;TENM3;NLGN1;CNTN6;CDH23;TGFBR2;CNTN2;CDH11;GRID2;CNTN4;UNC5D;ATP2C1;CDH9;IGSF11;MAG;LRRC4B;ITGB2;CD164;CDH8;CDH2;CDH6;CDH12;BSG;TGFB2;CLDN11
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.8142470903392055,-2.1023436671428417,0.0,0.019627552017250024,0.077,7/12,11.24%,BIN1;CTNNA3;CACNA1C;RYR2;JUP;TRPM4;DLG1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.6193763399149389,-2.099295255895071,0.0,0.016415770778063655,0.08,16/32,11.50%,DLG2;MEF2C;GRIN2A;NLGN1;GRIA4;GRIN2B;GRIA1;GRIA2;NEFL;OPRM1;RELN;GRIN1;GRIA3;DLG1;ACTN2;CAMK2A
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.7164724878783062,-2.091787926750687,0.0,0.014720664012937517,0.085,11/18,14.95%,GRIK1;UNC13C;GRIA2;GRID2;GRIK2;SLC17A6;CDH8;GRIK5;GRID1;GRIK3;SLC1A4
prerank,regulation of T cell proliferation (GO:0042129),0.726385333347342,2.086612121441272,0.0,0.0,0.0,15/61,4.33%,GPNMB;LGALS3;ARG1;LILRB1;ANXA1;NCK2;CEBPB;FOXP3;TFRC;IL6;CD28;CD46;CD274;PLA2G2D;TNFRSF1B
prerank,triglyceride catabolic process (GO:0019433),0.8781812422254703,2.07058608104248,0.0,0.0,0.0,3/19,1.44%,FABP4;LIPG;FABP5
prerank,cholesterol transport (GO:0030301),0.7391816447448329,2.009591755630172,0.0,0.0027505875224721767,0.006,13/45,9.77%,CD36;CEL;SOAT1;ABCA1;APOE;LIMA1;LIPG;NPC1;ABCG1;SERAC1;STARD5;RELCH;VPS4A
prerank,acylglycerol catabolic process (GO:0046464),0.7681053210195088,1.996642076031565,0.0,0.0030944109627811986,0.01,4/30,1.78%,FABP4;LIPG;FABP5;MGLL
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.543641157906201,-1.9905053056026045,0.0,0.050470848044357204,0.293,23/46,17.32%,GRM5;MEF2C;OPHN1;NRXN1;SYT1;NLGN1;GRM1;GRM8;GRIK1;ATP1A2;RELN;TSHZ3;GRM3;CDH2;CACNG4;HOMER1;NLGN3;GRIK3;CACNG3;CCR2;GRM7;CACNG2;TNF
prerank,cholesterol efflux (GO:0033344),0.8344358600652687,1.9791013390121417,0.0,0.0049510575404499175,0.021,5/20,1.98%,SOAT1;ABCA1;APOE;NPC1;ABCG1
prerank,intestinal lipid absorption (GO:0098856),0.9199295340760785,1.9624932666490311,0.0,0.007907939127107506,0.039,3/11,0.71%,CD36;CEL;LIMA1
prerank,fatty acid transport (GO:0015908),0.8441800659930437,1.9579473785760524,0.0,0.007514998052468625,0.044,8/17,8.02%,FABP4;CD36;PPARG;APOE;FABP5;SLC27A4;SLC27A3;SLC27A1
prerank,positive regulation of synapse assembly (GO:0051965),-0.5999360898115343,-1.940838436838887,0.0,0.08408621716480977,0.476,10/27,10.47%,PTPRD;IL1RAPL1;NRXN1;NLGN1;GRID2;LRRC4B;CUX2;SYNDIG1;AGRN;NLGN3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.7589374948281596,1.919757500441488,0.0,0.018953267147034842,0.12,6/27,2.82%,CD36;PPARG;ABCA1;PRKCH;ABCG1;NR1H3
prerank,vacuolar acidification (GO:0007035),0.7917400131788587,1.9191686245355029,0.0,0.01707656420201476,0.122,15/21,15.74%,ATP6V0D2;DMXL2;TCIRG1;ATP6V0D1;PPT1;TMEM199;CLN5;CLN3;ATP6V0A1;ATP6V0E1;SLC11A1;ATP6V1H;ATP6AP2;DMXL1;GRN
prerank,iron ion transport (GO:0006826),0.7009475600684161,1.917462383369133,0.0,0.016503525134833056,0.128,23/47,17.17%,ATP6V0D2;ATP6V1A;STEAP3;ABCB7;TFRC;ATP6V1E1;SLC11A2;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;HEPH;ATP6V0A1;SLC39A14;ATP6V0E1;RAB11B;ATP6V0C;ATP6V0B;SLC11A1;ATP6V1H;MELTF;ATP6V1F;FTH1
prerank,intracellular pH reduction (GO:0051452),0.7249620932448193,1.913613601437389,0.0,0.01640975510565787,0.138,20/33,16.69%,ATP6V0D2;DMXL2;ATP6V1A;RAB20;ATP6V1E1;RAB7A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B;SLC11A1;ATP6V1H;DMXL1;GPR89A;GPR89B;ATP6V1F
prerank,regulation of neuron projection development (GO:0010975),-0.4051571104026719,-1.9122342955794438,0.0,0.10200379305934483,0.576,45/163,9.54%,TANC2;CSMD3;RTN4RL1;ARSB;CAMK1D;RIT2;LRRC4C;IL1RAPL1;CTNNA2;SPOCK1;NTNG1;TWF2;TENM3;DCC;DISC1;NTRK3;SETX;ITGA6;EPHA3;TOX;PTPRO;ABI2;MBOAT1;PLPPR5;KNDC1;MAGI2;SCN1B;RELN;FUT9;MAG;ARHGAP44;CDK5R1;NTRK2;SIPA1L1;ATP1B2;PRKD1;PAK1;SRCIN1;CDH2;MARK1;ULK4;MARK2;SEMA3A;DAB2IP;SERPINI1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.8240160801824147,1.9008642772119524,0.0,0.019426024377459748,0.173,4/15,1.86%,PPARG;OSBPL8;PLIN2;PLIN3
prerank,reverse cholesterol transport (GO:0043691),0.8702398313674926,1.8994269834298394,0.0,0.018645809647527732,0.181,4/13,1.98%,ABCA1;APOE;LIPG;ABCG1
prerank,long-chain fatty acid transport (GO:0015909),0.7464920879203538,1.8972913389196406,0.0,0.01834543642220282,0.193,11/30,9.93%,FABP4;CD36;PPARG;APOE;FABP5;PRKAG2;ABCD1;SLC27A4;SLC27A1;CPT1A;SLC25A20
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6193646941585825,-1.8956346838172338,0.0,0.11321528868131946,0.652,14/25,16.03%,ATP1B1;ANK2;ANK3;WNK3;ATP1B2;AKAP9;NDUFA4;TCAF1;GLRX;WNK2;ACTN2;WNK1;COX17;STAC
prerank,secretory granule organization (GO:0033363),0.9178595571822953,1.8926994004875048,0.0,0.019460406721490648,0.217,3/10,0.64%,LYST;ABCA1;DTNBP1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5369836628447462,-1.8891531989589365,0.0,0.11062802046086377,0.672,8/37,5.61%,CADM1;TENM2;PTPRD;IL1RAPL1;TENM3;NLGN1;GRID2;CD164
prerank,positive regulation of nervous system development (GO:0051962),-0.508247298566338,-1.886014388093324,0.007194244604316547,0.10534939851683062,0.683,13/42,10.47%,CX3CR1;PTPRD;IL1RAPL1;NUMB;NRXN1;NLGN1;OPRM1;GRID2;LRRC4B;CUX2;SYNDIG1;NAP1L1;NLGN3
prerank,transferrin transport (GO:0033572),0.7241097478696723,1.8824184093369243,0.0,0.023079148430743105,0.265,15/33,13.91%,ATP6V0D2;ATP6V1A;STEAP3;TFRC;ATP6V1E1;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;RAB11B;ATP6V0C;ATP6V0B;ATP6V1H
prerank,positive regulation of leukocyte migration (GO:0002687),0.7305754439855207,1.8798771398386762,0.0,0.02342044375752044,0.275,7/27,10.25%,F7;LGALS3;VEGFA;IL6;ADAM8;IL6R;ADAM17
prerank,insulin receptor signaling pathway (GO:0008286),0.6505372544960184,1.8729790684694867,0.0,0.025958669743331164,0.304,30/69,14.52%,ATP6V0D2;NAMPT;GRB2;ATP6V1A;PDK4;BAIAP2;AP3S1;ATP6V1E1;SOS1;ATP6V1C1;TCIRG1;ATP6V0D1;FOXO4;IRS2;PIK3CA;APC;ATP6V1B2;ATP6V0A1;SLC39A14;SH2B2;GSK3B;FOXO1;APPL1;ATP6V0E1;GPLD1;ATP6V0C;ATP6V0B;ATP6V1H;SHC1;PHIP
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.47984000360987533,-1.872194778942062,0.0,0.11584373358432883,0.753,26/57,16.54%,DLG2;MEF2C;GRIN2A;NLGN1;GRIA4;GRIN2B;GRIA1;GRIA2;DLGAP1;NEFL;DLGAP2;OPRM1;RELN;GRIN1;AKAP9;GRIA3;CACNG4;SHISA6;DLG1;GSG1L;ACTN2;CAMK2A;DLG3;CACNG3;CACNG2;SHISA7
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.7597147307236185,-1.871279385584082,0.0030581039755351682,0.10846134264077774,0.756,5/11,8.69%,ACVR1;TGFBR2;TGFBR1;SMAD7;TGFB2
prerank,positive regulation of cholesterol transport (GO:0032376),0.747461795184033,1.8603169081406343,0.0,0.032084155771994534,0.384,12/27,12.33%,PPARG;EEPD1;APOE;LIPG;LRP1;NR1H3;RXRA;PLTP;ABCA3;SIRT1;LPCAT3;TREM2
prerank,cellular response to insulin stimulus (GO:0032869),0.6118264019692725,1.8590091469609134,0.0,0.03151141830432187,0.395,42/124,14.52%,ATP6V0D2;PPARG;MYO5A;DENND4C;NAMPT;GRB2;LPIN3;ATP6V1A;PDK4;RAB8B;BAIAP2;AP3S1;ATP6V1E1;SOS1;PDPK1;ATP6V1C1;TCIRG1;ATP6V0D1;ENPP1;FOXO4;SLC27A4;IRS2;APC;ATP6V1B2;RAB31;SLC27A1;ATP6V0A1;SLC39A14;RAB12;SH2B2;GSK3B;RAB10;FOXO1;EPRS1;APPL1;ATP6V0E1;GPLD1;ATP6V0C;ATP6V0B;ATP6V1H;SHC1;PHIP
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.6373294597656182,-1.8583649171431054,0.006734006734006734,0.11764635724278952,0.808,7/17,19.77%,SNTA1;ANK2;SCN1B;NOS1AP;AKAP9;CACNA2D1;SCN4B
prerank,negative regulation of T cell proliferation (GO:0042130),0.7385081806650742,1.8565481824203327,0.0,0.031680874142759885,0.41,7/28,4.18%,GPNMB;ARG1;LILRB1;CEBPB;FOXP3;CD274;PLA2G2D
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.858208813260433,1.8564911420703254,0.0,0.030334604438173263,0.412,4/12,2.82%,PPARG;ABCA1;ABCG1;NR1H3
prerank,positive regulation of cholesterol efflux (GO:0010875),0.7716045401471149,1.851831424448142,0.0,0.031661654198891685,0.435,10/21,12.33%,PPARG;EEPD1;APOE;LRP1;NR1H3;RXRA;PLTP;ABCA3;SIRT1;TREM2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.7854602215899845,1.8512035612450537,0.0,0.030858153767734733,0.437,7/18,7.16%,ANXA1;BCL2L11;AQP1;UBE2L3;NR3C1;HNRNPU;ZFP36L2
prerank,response to glucocorticoid (GO:0051384),0.736365036271384,1.8473390338914348,0.0,0.03205809757441321,0.463,8/26,7.16%,ANXA1;BCL2L11;ADAM9;IL6;UBE2L3;NR3C1;HNRNPU;ZFP36L2
prerank,regulation of cholesterol efflux (GO:0010874),0.7288341789437675,1.8434052962953449,0.0,0.03372114510723101,0.491,12/30,12.33%,PPARG;EEPD1;APOE;LRP1;NR1H3;RXRA;PLTP;ABCA3;ABCA2;LAMTOR1;SIRT1;TREM2
prerank,negative regulation of lipid storage (GO:0010888),0.7869352005130578,1.8419598959453938,0.0,0.03392391277715684,0.504,6/19,2.98%,PPARG;OSBPL8;ABCA1;ABCG1;NR1H3;IL6
prerank,phagosome maturation (GO:0090382),0.7148732181203673,1.8410174952447609,0.0,0.03374381478461402,0.517,18/35,13.91%,ATP6V0D2;PIKFYVE;ATP6V1A;MREG;RAB20;ATP6V1E1;RAB7A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;RAB31;ATP6V0A1;ATP6V0E1;RAB43;ATP6V0C;ATP6V0B;ATP6V1H
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.7102161746381375,1.837598904815901,0.0012690355329949238,0.03478544737471278,0.543,8/31,4.18%,GPNMB;CD300A;ARG1;LILRB1;CEBPB;FOXP3;CD274;PLA2G2D
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7403080894577247,1.8362583124629182,0.0012953367875647669,0.034485491062994915,0.551,8/24,12.65%,CCBE1;HPSE;IL6;ATF4;SULF2;BRCA1;RORA;SULF1
prerank,phagosome acidification (GO:0090383),0.7330297823659079,1.836009473062337,0.0012787723785166241,0.033472875575891244,0.553,14/26,13.91%,ATP6V0D2;ATP6V1A;RAB20;ATP6V1E1;RAB7A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B;ATP6V1H
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7209686341453482,-1.8348495537800498,0.0029498525073746312,0.14051542921440358,0.887,6/12,8.00%,SYT1;RIMS1;UNC13C;RIMS2;SYT7;SYT2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.745360182297725,1.8340391794115294,0.0,0.033683952667774505,0.564,8/22,7.28%,SASH1;XDH;VEGFA;GADD45B;GADD45G;RELL1;GADD45A;MFHAS1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7228317327253231,-1.8330459435448443,0.0033444816053511705,0.13555606112448346,0.891,7/12,12.13%,ATP1B1;ANK3;WNK3;ATP1B2;GLRX;WNK2;WNK1
prerank,neutrophil activation involved in immune response (GO:0002283),0.5746117567496586,1.8323067327804856,0.0,0.03403852059059318,0.579,147/428,16.10%,ANPEP;PSAP;LGALS3;CD36;IQGAP2;HPSE;IQGAP1;CTSB;ADGRE5;SDCBP;IDH1;CTSD;CLEC12A;CD300A;SYK;FTL;IGF2R;VAT1;ARG1;FRK;CPPED1;GALNS;ADGRG3;FABP5;LILRB3;DIAPH1;LAMP1;ATG7;GYG1;HK3;ANO6;PLEKHO2;CLEC4D;RAB7A;CD44;CYB5R3;GLA;PRKCD;CTSA;OSTF1;PYGL;DYNC1H1;PSMD1;SNAP29;GNS;CD63;ARHGAP9;PGRMC1;TCIRG1;CD93;APAF1;ATP8B4;TNFRSF1B;DNAJC5;RNASE3;IMPDH2;C3AR1;EEF1A1;AMPD3;CD53;ADAM8;ANXA2;NRAS;DDOST;RAB37;MANBA;PTAFR;DOK3;HSPA1B;CYBB;ARSA;PTGES2;CYBA;KCNAB2;RAB31;CAT;TIMP2;CTSS;LAMP2;CTSZ;SIRPA;TICAM2;CTSH;AGA;PAFAH1B2;TYROBP;HP;VAPA;HRNR;HUWE1;ATP6V0A1;QSOX1;LAMTOR1;PLAU;XRCC5;DERA;COTL1;ROCK1;RAP2B;FAF2;MOSPD2;LTA4H;RAB10;DNASE1L1;NHLRC3;RAB18;MAGT1;OLFM4;PSMD14;COMMD9;PGM1;BST2;GM2A;HMOX2;STXBP3;RAB24;PSMD12;VPS35L;FUCA1;DOCK2;BRI3;GLIPR1;MGST1;CRACR2A;LAMTOR3;CAP1;ATP6V0C;FGR;PPIE;SLC11A1;AGL;HSPA1A;ARL8A;DEGS1;SLPI;CREG1;GUSB;PRDX6;NCSTN;ATP6AP2;SLC44A2;DNAJC13;STK11IP;GRN;TOM1;RAB44;BST1
prerank,toll-like receptor signaling pathway (GO:0002224),0.6240593017317744,1.8320101060200213,0.0,0.033280086531087986,0.58,31/84,16.64%,SFTPA1;SFTPA2;CD36;CTSB;RFTN1;TLR8;CTSL;MAP3K1;MAPKAPK3;IRAK2;TNIP1;RIPK1;LY96;NR1H4;IRAK3;RPS27A;UBC;CTSS;TICAM2;UNC93B1;EPG5;BIRC3;TAB2;S100A1;BTK;TRAF3;LBP;MYD88;HSPD1;TLR1;TRIL
prerank,acute inflammatory response (GO:0002526),0.7508711861030107,1.8293031789589256,0.0,0.033861697107005685,0.594,7/23,9.55%,SIGIRR;CEBPB;ANO6;IL6;HPR;HP;IL6R
prerank,neutrophil mediated immunity (GO:0002446),0.5723480857750226,1.825629420399326,0.0,0.0353565104451111,0.621,149/432,16.10%,ANPEP;PSAP;LGALS3;CD36;IQGAP2;HPSE;IQGAP1;CTSB;ADGRE5;SDCBP;IDH1;CTSD;CLEC12A;CD300A;FTL;IGF2R;VAT1;ARG1;FRK;CPPED1;GALNS;ADGRG3;FABP5;LILRB3;DIAPH1;LAMP1;ATG7;GYG1;HK3;ANO6;PLEKHO2;CLEC4D;RAB7A;CD44;CYB5R3;GLA;IL6;PRKCD;CTSA;OSTF1;PYGL;DYNC1H1;PSMD1;SNAP29;GNS;CD63;ARHGAP9;PGRMC1;TCIRG1;CD93;APAF1;ATP8B4;TNFRSF1B;DNAJC5;RNASE3;IMPDH2;C3AR1;EEF1A1;AMPD3;CD53;ADAM8;ANXA2;NRAS;DDOST;RAB37;MANBA;PTAFR;DOK3;HSPA1B;CYBB;ARSA;PTGES2;CYBA;KCNAB2;RAB31;CAT;TIMP2;CTSS;LAMP2;CTSZ;SIRPA;TICAM2;CTSH;AGA;PAFAH1B2;TYROBP;HP;VAPA;HRNR;HUWE1;ATP6V0A1;QSOX1;LAMTOR1;PLAU;XRCC5;DERA;COTL1;ROCK1;RAP2B;FAF2;MOSPD2;ADAM17;LTA4H;RAB10;DNASE1L1;KMT2E;NHLRC3;RAB18;MAGT1;OLFM4;PSMD14;COMMD9;PGM1;BST2;GM2A;HMOX2;STXBP3;RAB24;PSMD12;VPS35L;FUCA1;DOCK2;BRI3;GLIPR1;MGST1;CRACR2A;LAMTOR3;CAP1;ATP6V0C;FGR;PPIE;SLC11A1;AGL;HSPA1A;ARL8A;DEGS1;SLPI;CREG1;GUSB;PRDX6;NCSTN;ATP6AP2;SLC44A2;DNAJC13;STK11IP;GRN;TOM1;RAB44;BST1
prerank,neutrophil degranulation (GO:0043312),0.5720686713318409,1.8244227407544888,0.0,0.03512574606400279,0.626,146/425,16.10%,ANPEP;PSAP;LGALS3;CD36;IQGAP2;HPSE;IQGAP1;CTSB;ADGRE5;SDCBP;IDH1;CTSD;CLEC12A;CD300A;FTL;IGF2R;VAT1;ARG1;FRK;CPPED1;GALNS;ADGRG3;FABP5;LILRB3;DIAPH1;LAMP1;ATG7;GYG1;HK3;ANO6;PLEKHO2;CLEC4D;RAB7A;CD44;CYB5R3;GLA;PRKCD;CTSA;OSTF1;PYGL;DYNC1H1;PSMD1;SNAP29;GNS;CD63;ARHGAP9;PGRMC1;TCIRG1;CD93;APAF1;ATP8B4;TNFRSF1B;DNAJC5;RNASE3;IMPDH2;C3AR1;EEF1A1;AMPD3;CD53;ADAM8;ANXA2;NRAS;DDOST;RAB37;MANBA;PTAFR;DOK3;HSPA1B;CYBB;ARSA;PTGES2;CYBA;KCNAB2;RAB31;CAT;TIMP2;CTSS;LAMP2;CTSZ;SIRPA;TICAM2;CTSH;AGA;PAFAH1B2;TYROBP;HP;VAPA;HRNR;HUWE1;ATP6V0A1;QSOX1;LAMTOR1;PLAU;XRCC5;DERA;COTL1;ROCK1;RAP2B;FAF2;MOSPD2;LTA4H;RAB10;DNASE1L1;NHLRC3;RAB18;MAGT1;OLFM4;PSMD14;COMMD9;PGM1;BST2;GM2A;HMOX2;STXBP3;RAB24;PSMD12;VPS35L;FUCA1;DOCK2;BRI3;GLIPR1;MGST1;CRACR2A;LAMTOR3;CAP1;ATP6V0C;FGR;PPIE;SLC11A1;AGL;HSPA1A;ARL8A;DEGS1;SLPI;CREG1;GUSB;PRDX6;NCSTN;ATP6AP2;SLC44A2;DNAJC13;STK11IP;GRN;TOM1;RAB44;BST1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5225614951304872,-1.823829716511616,0.005291005291005291,0.14130846161914098,0.917,18/37,7.14%,GRM5;GRIN2A;GRIA4;GRM1;GRIN2B;GRM8;PLCB1;GRIK1;GRIA2;GRIN3A;GRID2;GRIK2;CDK5R1;GRIN1;FMR1;GRM3;GRIA3;HOMER1
prerank,regulation of cation channel activity (GO:2001257),-0.441648571091926,-1.8237545218281845,0.0,0.13396508589764192,0.917,37/89,16.54%,FGF14;DLG2;CACNB2;MEF2C;GRIN2A;NLGN1;GRIA4;GRIN2B;GRIA1;GRIA2;ANK2;NEFL;ANK3;OPRM1;CACNB4;FGF12;RELN;KCNAB1;GRIN1;FGF13;GRIA3;CACNG4;JPH1;HOMER1;SHISA6;PRKACA;DLG1;GSG1L;ACTN2;CAMK2A;SELENON;DLG3;CACNG3;STAC;CACNB1;CACNG2;SHISA7
prerank,membrane repolarization (GO:0086009),-0.6547389746845944,-1.821396807301399,0.006779661016949152,0.1306124370602456,0.92,4/15,5.31%,ATP1B1;ATP1A2;KCNJ2;ATP1B2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7294859945030048,1.819927801059589,0.0,0.0372957952882576,0.656,9/26,12.65%,CCBE1;HPSE;IL6;ATF4;SULF2;BRCA1;RORA;SARS1;SULF1
prerank,"wound healing, spreading of cells (GO:0044319)",0.7397233769868432,1.8188916447725623,0.0,0.0368684519839059,0.664,10/24,10.92%,ARHGAP24;MMP12;MRTFA;CD44;LCP1;ITGA5;CD151;ACVRL1;ADAM17;CCN1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.60683453059247,-1.815522443877693,0.003663003663003663,0.13263466969232593,0.931,7/19,7.07%,MEF2C;ERBB4;BMPR1A;FGFR2;TGFBR1;FGF2;ZFPM2
prerank,sterol homeostasis (GO:0055092),0.6364770963275673,1.8145752262392358,0.0,0.03973739411371522,0.709,16/65,11.94%,SOAT1;ABCA1;GRAMD1B;APOE;LIMA1;LIPG;NPC1;ABCG1;NR1H3;ABCD1;FGFR4;ACSM3;ABCA2;LAMTOR1;SIRT1;RORA
prerank,response to lipid (GO:0033993),0.6013152249571914,1.8113678542169023,0.0,0.04161102221496018,0.733,36/105,17.41%,CD36;PPARG;ANXA1;CTNNB1;ABCG1;MAPKAPK3;SPP1;FOXO3;RXRA;LY96;RARA;FGFR4;STAT5B;IRAK3;GPX3;SOX9;ABCA2;FOXP1;CTSH;HNRNPA0;ESR1;ADAM17;FOXO1;LIAS;STRN3;PPARD;TAB2;SLC11A1;ERBIN;SLPI;ASXL1;LBP;SCD;OTUD5;IFNAR1;ACER2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5845127400164968,-1.8067622864841435,0.0,0.13767673367471867,0.953,10/24,8.82%,ACVR1;ROBO2;ROBO1;BMPR1A;TGFBR2;FGFR2;ENG;ZFPM2;TGFB2;PARVA
prerank,regulation of synapse assembly (GO:0051963),-0.4961242223344629,-1.8067455486267145,0.0,0.13172957836083218,0.954,14/46,11.57%,PTPRD;MEF2C;IL1RAPL1;NRXN1;ROBO2;NLGN1;GRID2;LRRC4B;SLIT1;IL1RAPL2;CUX2;SYNDIG1;NLGN3;LRFN5
prerank,synapse organization (GO:0050808),-0.3955866573000779,-1.804588773084264,0.0,0.12902885047703566,0.957,29/125,8.61%,CX3CR1;GRM5;PTPRD;CACNB2;ADGRL3;LRRC4C;SDK1;GPM6A;NRXN1;ARHGAP39;NTNG1;KIRREL3;NLGN1;DNM3;RYK;UNC13C;CTNND2;MAPT;CNTN2;ANK3;CACNB4;LRRC4B;FARP1;CDH2;PPFIA4;SEMA3E;REST;DNER;AGRN
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.6425675419743397,1.8033256384381862,0.0,0.046858223150686724,0.772,19/56,16.53%,SFTPA1;SFTPA2;CD36;CTSB;TLR8;CTSL;MAPKAPK3;IRAK2;LY96;RPS27A;UBC;CTSS;UNC93B1;TAB2;S100A1;TRAF3;LBP;MYD88;TLR1
prerank,secondary alcohol metabolic process (GO:1902652),0.668919950869205,1.8027577393866874,0.0,0.046080336895369625,0.773,7/42,3.66%,SOAT1;ABCA1;IDH1;APOE;ABCG1;OSBPL1A;RXRA
prerank,triglyceride metabolic process (GO:0006641),0.6528024288012181,1.7972347549791372,0.0,0.04995598304308132,0.811,6/48,1.54%,FABP4;APOE;LIPG;LPIN3;FABP5;GPAT2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5774603294218089,-1.7966651538752008,0.0,0.1343952016308429,0.966,9/25,12.20%,MEF2C;GRIN2A;GRIN2B;GRID2;GRIN1;ARRB2;GLRA1;NLGN3;GRIN2D
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.7202121281341595,1.7955546309436694,0.0013157894736842105,0.05072541822692438,0.819,9/26,7.95%,IQGAP1;PDPK1;EEF1A1;STAT5B;DUSP3;PTPN12;ZFP36L2;SOX9;SNAI2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.49531916625774064,-1.7949649775091945,0.006369426751592357,0.13145655905259587,0.967,15/44,13.99%,KCNMA1;ATP1B1;ANK2;WNK3;KCNJ2;ATP1B2;KCNJ3;NOS1AP;AKAP9;GABBR1;KCNJ9;WNK2;ACTN2;WNK1;KCNN2
prerank,sensory perception of taste (GO:0050909),0.854847063478414,1.789322976505844,0.0030911901081916537,0.055116392366059315,0.841,2/10,1.08%,CD36;TAS1R3
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.5703675949966931,-1.7889955812919403,0.004366812227074236,0.13352683114765546,0.97,9/25,6.42%,CTNNA3;ANK2;CACNA1C;RYR2;JUP;TRPM4;FGF13;NOS1AP;AKAP9
prerank,negative regulation of leukocyte activation (GO:0002695),0.7937985300258367,1.7852733264599834,0.0014367816091954023,0.05791596121120271,0.855,4/15,2.82%,CD300LF;CD300A;CD84;NR1H3
prerank,cholesterol homeostasis (GO:0042632),0.6274101742464641,1.7830058345698991,0.0,0.058922742082958654,0.865,15/64,11.94%,SOAT1;ABCA1;GRAMD1B;APOE;LIMA1;LIPG;NPC1;ABCG1;NR1H3;FGFR4;ACSM3;ABCA2;LAMTOR1;SIRT1;RORA
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.816470633222111,1.7821684987127198,0.00291970802919708,0.0585412033162892,0.869,4/13,0.68%,CD36;PPARG;ABCA1;SYK
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.668855098005925,-1.7793914087198823,0.0,0.14102523576030618,0.977,5/14,11.43%,ATP1B1;ANK2;ATP1B2;AKAP9;ACTN2
prerank,negative regulation of T cell activation (GO:0050868),0.6723897470978482,1.7792242976247918,0.0,0.06040290199348899,0.882,9/35,5.64%,GPNMB;LGALS3;ARG1;LILRB1;CEBPB;FOXP3;CD274;PLA2G2D;DUSP3
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7939263733226612,1.7783943658928132,0.0,0.06012865223757192,0.884,4/15,5.17%,APOE;LIPG;ABCG1;PLTP
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.6649316670575269,-1.7774057395790057,0.010033444816053512,0.1388080167740315,0.979,7/14,17.94%,ATP1B1;ANK3;WNK3;GLRX;WNK2;WNK1;SLC9A1
prerank,response to alcohol (GO:0097305),-0.5477170390111368,-1.7744632037897083,0.004807692307692308,0.13777946741805963,0.982,9/27,12.47%,GRIN2A;GRIN2B;CCR5;TGFBR2;GRIN3A;TGFBR1;GRIN1;GLRA1;SMAD2
prerank,cell-cell junction organization (GO:0045216),-0.41864405248594017,-1.7735835066554015,0.0,0.13454370334405258,0.982,16/79,8.69%,CADM1;CADM2;SDK1;CSF1R;SMAD3;CTNND1;TLN2;CTNND2;CDH11;CDH9;JUP;CDH8;CDH2;CDH6;CDH12;TGFB2
prerank,Rac protein signal transduction (GO:0016601),-0.6105355479650038,-1.7723230377065355,0.006779661016949152,0.13217929561616815,0.983,12/18,25.31%,ELMO1;TIAM1;ABI2;AIF1;NCKAP1;DBNL;HACD3;CYFIP1;RHOG;HACE1;RHOH;RAC1
prerank,regulation of platelet activation (GO:0010543),0.7419882013898332,1.7696926189457924,0.0,0.0688704798895918,0.912,4/21,3.72%,APOE;SYK;TEC;PDGFA
prerank,myoblast differentiation (GO:0045445),0.7813435856411837,1.7668460584680412,0.004437869822485207,0.07109360532729384,0.918,5/14,8.03%,EPAS1;MBNL1;IGF1;DDX5;RB1
prerank,cellular component disassembly (GO:0022411),0.6317106556444829,1.7666384024913706,0.001142857142857143,0.07006357661408293,0.918,15/53,7.98%,MMP12;TIMP1;TLL2;CTSL;FLOT1;CD44;LCP1;KIF9;WASHC1;MMP14;ADAM8;CAPG;CAPN2;TIMP2;CTSS
prerank,organic acid transport (GO:0015849),0.5928553437284106,1.7641681166060055,0.0,0.07218416845905959,0.928,30/94,13.46%,LRRC8D;SLC6A6;SLC7A2;SLC51A;SLC36A2;SLC43A2;SLC1A5;SLC7A4;SLC7A7;RXRA;SLC16A10;SLC16A1;SLC27A4;SLC38A1;SLC26A1;STARD5;SLC27A3;ABCC4;NR1H4;ABCC3;FOLR2;FOLR1;SLC27A1;SLC25A32;NCOA1;PPARD;SLC7A11;SLC23A2;SLC23A1;ATP8B1
prerank,negative regulation of cell development (GO:0010721),0.7043671767178294,1.763978421168378,0.0012836970474967907,0.07111619480534646,0.928,9/25,11.89%,LILRB1;HOOK3;FBXW7;IL6;APPL2;SORL1;IGF1;GSK3B;NOTCH1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.7698127360265301,1.7625566022037091,0.0,0.0716057554369895,0.936,6/15,7.16%,ANXA1;BCL2L11;UBE2L3;NR3C1;HNRNPU;ZFP36L2
prerank,vasodilation (GO:0042311),-0.664844757635694,-1.7605997032235092,0.003134796238244514,0.1435839239168249,0.988,6/13,25.76%,KCNMA1;SOD2;ADRB1;KLF2;NOS1;ADRB2
prerank,peptidyl-arginine modification (GO:0018195),-0.640664094323479,-1.7591657715579423,0.003067484662576687,0.14117143028449883,0.988,7/15,22.63%,PADI2;PRMT1;ART3;PRMT7;PARK7;PRMT8;KRTCAP2
prerank,regulation of vasculature development (GO:1901342),0.7097848327901136,1.758859703692905,0.0,0.07474603032511135,0.944,6/26,9.13%,GPNMB;PLXND1;CTNNB1;IL6;HMOX1;VASH2
prerank,regulation of mast cell activation (GO:0033003),0.842077095834036,1.7557479683793937,0.0030165912518853697,0.07706307075672046,0.949,2/10,1.73%,CD300LF;CD84
prerank,water transport (GO:0006833),0.8171679521965137,1.7543106414019294,0.004291845493562232,0.07780724454193169,0.954,1/12,1.89%,AQP1
prerank,phospholipid homeostasis (GO:0055091),0.8442766191467699,1.753852361874125,0.0,0.07707281512763225,0.954,3/11,1.98%,ABCA1;LIPG;ABCG1
prerank,negative regulation of defense response (GO:0031348),0.5979372540436269,1.7524724595834318,0.0,0.07772627966727827,0.955,24/77,14.38%,PPARG;APOE;NR1H3;RNF26;PRKCD;AOAH;MAPK7;NR1H4;IRAK3;PROC;METRNL;MFHAS1;RB1;SIRPA;MEFV;PTGER4;NLRC3;TRAFD1;PPARD;RORA;LPCAT3;TNFAIP3;TNFAIP8L2;ACOD1
prerank,amino acid transport (GO:0006865),0.6318777246770223,1.7495809465476395,0.0,0.08055292030097087,0.962,12/49,7.51%,SLC6A6;SLC7A2;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC7A4;SLC7A7;SLC16A10;SLC38A1;SLC38A7
prerank,extracellular matrix disassembly (GO:0022617),0.6270606921438648,1.7485157389510797,0.002306805074971165,0.08066420244124947,0.965,15/53,7.98%,MMP12;TIMP1;TLL2;CTSL;FLOT1;CD44;LCP1;KIF9;WASHC1;MMP14;ADAM8;CAPG;CAPN2;TIMP2;CTSS
prerank,cellular response to amino acid starvation (GO:0034198),0.6150908853730821,1.746641427175962,0.0,0.08153376167574256,0.969,26/71,13.91%,ATP6V0D2;TFEB;ATP6V1A;CEBPB;ATP6V1E1;CDKN1A;ATP6V1C1;FAS;TCIRG1;ATP6V0D1;SESN2;SH3GLB1;FLCN;EIF2AK4;ATF4;ATP6V1B2;LAMTOR1;MIOS;ATP6V0E1;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;CASTOR1;NPRL3;ATP6V1H
prerank,natural killer cell mediated immunity (GO:0002228),0.7732473404191645,1.7464348617151928,0.002861230329041488,0.08064222509066153,0.969,7/15,17.75%,LYST;PLEKHM2;SLAMF7;ARL8B;ULBP1;KLRD1;KIF5B
prerank,smooth muscle contraction (GO:0006939),0.7689190997796914,1.7461612904416248,0.004166666666666667,0.0798542769350551,0.97,6/14,12.20%,TPCN2;EDNRA;ADRA1A;SLC8A1;ROCK1;MYLK
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.6651028660812949,-1.7435317792562752,0.014164305949008499,0.15849885512111772,0.996,4/13,5.80%,CACNB2;ANK2;CACNA1C;KCNJ3
prerank,lipid catabolic process (GO:0016042),0.757292927348683,1.7409333714200386,0.0014124293785310734,0.08620361520336055,0.976,6/18,11.54%,CEL;LIPG;PPT1;ACADL;MT3;PLAAT3
prerank,potassium ion transmembrane transport (GO:0071805),-0.4046709896777794,-1.7407922389072097,0.0,0.15818518248245822,0.997,33/135,13.99%,SLC24A3;SLC9A9;KCND2;SLC12A2;HCN1;ATP1B1;SLC12A6;KCNH7;SLC24A2;KCNC2;KCNB2;SLC1A3;ATP1A2;KCNH1;KCNAB1;KCNK2;KCNC1;KCNJ2;KCNK6;ATP1B2;KCNJ3;KCNC3;NALCN;KCNJ9;SLC24A4;KCNQ2;HCN2;HPN;KCNH8;PKD2;SLC12A4;PKD2L1;KCNN2
prerank,axonal fasciculation (GO:0007413),-0.6799872037029093,-1.7367879651020715,0.0136986301369863,0.15979335039105147,0.997,5/12,5.76%,SEMA5A;EPHA3;CNTN4;CDK5R1;MEGF8
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7195722949627531,1.73648299653516,0.0027472527472527475,0.09126270013419911,0.981,9/21,11.91%,CD300A;ELF2;PRKCH;LPXN;STAP1;FOXP1;CD22;CBFB;PRKCB
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.4442848522701412,-1.734462474288622,0.0,0.1583821362540295,0.997,18/59,13.74%,CADM1;PTPRM;PTPRT;SDK1;ROBO2;KIRREL3;ROBO1;TENM3;CNTN6;CNTN2;CNTN4;IGSF11;CDH2;BSG;IGSF9;NEXN;CELSR2;PKD1
prerank,response to amino acid starvation (GO:1990928),0.6082717768957678,1.734200868912959,0.0,0.0927733877222401,0.985,26/72,13.91%,ATP6V0D2;TFEB;ATP6V1A;CEBPB;ATP6V1E1;CDKN1A;ATP6V1C1;FAS;TCIRG1;ATP6V0D1;SESN2;SH3GLB1;FLCN;EIF2AK4;ATF4;ATP6V1B2;LAMTOR1;MIOS;ATP6V0E1;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;CASTOR1;NPRL3;ATP6V1H
prerank,regulation of protein-containing complex assembly (GO:0043254),0.5738954736959678,1.7334231793644674,0.0,0.09246913510846162,0.985,18/110,5.04%,LGALS3;CD36;FNIP2;ABCA1;FBLIM1;APOE;SYK;BCL2L11;VEGFA;FNIP1;TFRC;TFIP11;KIF9;SH3GLB1;RAF1;AIDA;MTLN;SORL1
prerank,neutral amino acid transport (GO:0015804),0.6748689585817406,1.730508748939372,0.003870967741935484,0.0950385292920855,0.987,7/28,5.28%,SLC6A6;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC38A1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.5128931103471941,-1.7302501443008462,0.0,0.16045180635080616,0.997,13/34,13.84%,MEF2C;GRIN2A;GRIN2B;GRID2;GABRA2;GRIN1;ARRB2;GABRA3;GLRA1;GABRG3;NLGN3;GRIN2D;GABRA4
prerank,cellular response to increased oxygen levels (GO:0036295),0.799038310543995,1.7301071722635957,0.004524886877828055,0.09434421003876742,0.987,6/11,10.58%,ATP6V1A;ATG7;FAS;ATP6V0D1;TMEM199;FOXO1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.5801822574520644,1.7299347509724183,0.0010893246187363835,0.09333412525577885,0.988,18/90,10.41%,EPAS1;FABP4;CD36;CXCR4;SYK;FABP5;VEGFA;CEBPB;GADD45G;DYNC1H1;APPL2;SIRT6;ACADL;APC;KDM3A;KSR2;TRPV2;PTH2R
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.7994539781695397,1.729598496430444,0.0,0.09254351719357637,0.988,5/12,12.62%,CTSB;CTSL;CTSS;CTSH;GAS2L1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5679144013807338,-1.7275422111714207,0.015151515151515152,0.16054445388655192,0.999,5/21,6.42%,SNTA1;ANK2;SCN1B;NOS1AP;AKAP9
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.7032979976497724,1.7251619153257314,0.004021447721179625,0.09750108928342162,0.99,10/24,11.89%,NFE2L2;VEGFA;CEBPB;ATF3;SESN2;MAPK7;ATF4;DDIT3;MT3;NOTCH1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5821549274365191,1.723037517451087,0.0010893246187363835,0.09926227374116312,0.99,27/88,14.85%,LGALS3;FNIP2;SDCBP;SYK;SYNPO2L;BCL2L11;VEGFA;FLOT1;FNIP1;TFRC;RAB7A;SH3GLB1;MTLN;HAS3;STAM;CHMP2A;PDCD6IP;TPR;VPS4A;GSK3B;PFN1;SDC4;SYNPO;BAX;PFN2;CX3CL1;SNF8
prerank,positive regulation of proteolysis (GO:0045862),0.6226865311055704,1.7224791919307854,0.0,0.09854508758395508,0.99,17/55,13.02%,CCBE1;APOE;ADAM9;TNIP1;TANK;SNX9;TNFRSF1B;FGFR4;ADAM8;TBC1D10A;NLRC4;CTSH;CYFIP2;SNX33;STUB1;RHBDD1;GPLD1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7599473430633481,1.7205770189048335,0.009873060648801129,0.10043126213381004,0.992,6/14,8.64%,TLR8;LILRB1;PIBF1;THBS1;IRAK3;MEFV
prerank,positive regulation of blood coagulation (GO:0030194),0.743995936416383,1.7194898169310355,0.004201680672268907,0.10081333049160912,0.993,4/17,7.33%,HPSE;ANO6;THBS1;ST3GAL4
prerank,positive regulation of protein maturation (GO:1903319),0.8012841154776417,1.7172279893729159,0.00904977375565611,0.10245938521208858,0.995,4/11,11.90%,CCBE1;ADAM8;NLRC4;RHBDD1
prerank,cGMP-mediated signaling (GO:0019934),0.79627351131652,1.7171291333467944,0.001451378809869376,0.10141114301602447,0.995,4/13,1.89%,CD36;HTR2B;APOE;AQP1
prerank,excitatory postsynaptic potential (GO:0060079),-0.5841905991611513,-1.7143897394444352,0.0,0.17569052659343315,0.999,6/19,5.92%,MEF2C;GRIN2A;GRIN2B;GRID2;GRIN1;ARRB2
prerank,response to hydrogen peroxide (GO:0042542),0.6338122247823132,1.7131091071352613,0.0011961722488038277,0.10614202422937435,0.998,18/45,13.61%,NFE2L2;ANXA1;AQP1;ADAM9;IL6;PRKCD;RIPK1;MAPK7;PPIF;STK24;HMOX1;CAT;SIRPA;HP;PLEKHA1;SIRT1;RELA;TNFAIP3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.791611041484523,1.7127067251942452,0.001524390243902439,0.10546784031479252,0.998,2/12,0.46%,F7;CBLB
prerank,positive chemotaxis (GO:0050918),0.7442601330494782,1.710338006984344,0.0014619883040935672,0.10820730413772528,0.998,3/17,1.73%,GPNMB;LGALS3;VEGFA
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.6505866905091968,1.7091934954035604,0.0,0.10864021124369029,0.998,13/34,14.38%,CD300LF;CD300A;RAB7B;LY96;IRAK3;MFHAS1;GPR108;NFKBIL1;TICAM2;NLRP2B;TREM2;TNFAIP3;ACOD1
prerank,regulation of steroid metabolic process (GO:0019218),0.7041076727296482,1.707655966765483,0.003963011889035667,0.11002350089888706,0.999,12/23,15.34%,APOE;ABCG1;NR1H4;ACADL;ACADVL;ABCA2;NR5A1;LAMTOR1;STUB1;RORA;DGKQ;PANK2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5873533024385564,-1.707515853461443,0.021052631578947368,0.18321172743374617,0.999,6/17,8.24%,CTNNA2;FCHSD2;ABI2;NCKAP1;PICK1;ARFIP2
prerank,membrane raft organization (GO:0031579),0.7623194137150507,1.7041413783743822,0.00425531914893617,0.1141298467598505,0.999,6/15,5.78%,RFTN1;FLOT1;NPC1;PPT1;CLN3;ANXA2
prerank,negative regulation of blood coagulation (GO:0030195),0.6396763497713156,1.7036881469405099,0.003708281829419036,0.11360080995198991,1.0,7/38,9.75%,F7;APOE;F11;PDGFA;F10;PROC;PLAU
prerank,sodium ion export across plasma membrane (GO:0036376),-0.646673765438385,-1.70243441759645,0.010169491525423728,0.18673146739455623,0.999,3/13,5.31%,ATP1B1;ATP1A2;ATP1B2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6852714477159533,1.7019501562262398,0.005427408412483039,0.11383578497879697,1.0,8/23,10.25%,SDCBP;ZEB2;CITED2;THBS1;CREBBP;FLCN;HIPK2;ADAM17
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6852714477159533,1.7019501562262398,0.005427408412483039,0.11383578497879697,1.0,8/23,10.25%,SDCBP;ZEB2;CITED2;THBS1;CREBBP;FLCN;HIPK2;ADAM17
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5816747998548084,-1.7018553673664865,0.017241379310344827,0.18340000826035793,0.999,8/19,14.52%,DLG2;PARD3B;PARD3;SYNJ2BP;PATJ;MARK2;DLG1;DLG3
prerank,ceramide transport (GO:0035627),0.8012116897464605,1.7008586657738456,0.007692307692307693,0.11452684052467371,1.0,4/12,8.19%,PSAP;CERT1;PLTP;ABCA2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.8152948908377345,1.7004271559977344,0.004559270516717325,0.1139275606082024,1.0,6/10,12.33%,CD300A;ANO6;APPL2;RAB31;STAP1;TREM2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.605651979899309,-1.6980049680945388,0.025089605734767026,0.18489550516451894,0.999,10/17,14.97%,CACNB2;ANK2;CACNA1C;ATP1A2;SCN1B;KCNJ2;TRPM4;CACNA1G;HCN2;CACNA2D1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.47686374520767766,-1.6978434037808743,0.010869565217391304,0.18114756506039054,0.999,25/38,37.96%,KCNMA1;ANK2;KCNJ2;KCNJ3;NOS1AP;GABBR1;KCNJ9;DLG1;ACTN2;KCNN2;KCNJ6;ADRA2A;KCNMB4;GNB1;KCNJ12;KCNJ16;FHL1;KCNJ10;KCNN1;GNG2;AKAP6;KCNQ1;KCNMB2;KCNN3;KCNJ15
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6617552483256843,1.695580230606128,0.005108556832694764,0.12112095108928676,1.0,6/30,4.04%,SYK;PIBF1;IL6;CD28;CD46;CD274
prerank,central nervous system neuron differentiation (GO:0021953),-0.5074147283319829,-1.6934383037285012,0.0,0.18416490297036725,0.999,11/33,4.96%,OPHN1;MDGA2;SPOCK1;RYK;MAPT;TOX;GRID2;KNDC1;FAIM2;NTRK2;MAP2
prerank,vasoconstriction (GO:0042310),0.8084126258641035,1.6934260935744563,0.011922503725782414,0.12350499895310925,1.0,3/11,5.02%,HTR2B;EDNRA;SLC8A1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.6977316321074781,1.691676385784189,0.005242463958060288,0.12495833158731022,1.0,4/22,3.72%,GPNMB;RAP2A;VEGFA;PDGFA
prerank,negative regulation of reproductive process (GO:2000242),0.7270275428775176,1.690048191923576,0.005649717514124294,0.1265624717492159,1.0,5/17,12.65%,TIMP1;WEE2;IGF1;WDR77;SULF1
prerank,transition metal ion homeostasis (GO:0055076),0.6615818893603519,1.6894993072915339,0.0050062578222778474,0.12614461016643763,1.0,11/28,13.66%,FTL;ABCB7;HMOX1;XIAP;HEPH;PICALM;SLC39A14;MT3;HMOX2;PRKN;SLC11A1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.5260925111198873,-1.688988183811835,0.013043478260869565,0.18763270607399524,0.999,10/27,11.24%,CTNNA3;ANK2;CACNA1C;RYR2;JUP;TRPM4;FGF13;AKAP9;PDE4B;DLG1
prerank,positive regulation of hemostasis (GO:1900048),0.8089001446879764,1.6887485467470094,0.010752688172043012,0.12489042645784916,1.0,3/10,7.33%,HPSE;THBS1;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.8089001446879764,1.6887485467470094,0.010752688172043012,0.12489042645784916,1.0,3/10,7.33%,HPSE;THBS1;ST3GAL4
prerank,receptor metabolic process (GO:0043112),0.6081567209633001,1.6880812400809868,0.0011467889908256881,0.12462408243834643,1.0,17/53,13.62%,CD36;SYK;GRB2;PHETA2;LILRB1;TFRC;LRP1;KIF16B;UVRAG;SH3GLB1;RAB31;PICALM;ITGB1;SNX25;ARFGEF2;RAB11B;PLEKHJ1
prerank,regulation of vacuole organization (GO:0044088),0.7157839101469733,1.6878377384361603,0.005449591280653951,0.12378655096537468,1.0,11/20,16.67%,MTM1;PIKFYVE;MTMR3;TBC1D12;ANXA2;SCARB2;RAB1B;ENO3;NPRL3;UBQLN2;NPRL2
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.35698127835197235,-1.6858711293796267,0.0,0.18840993346428872,1.0,57/224,11.24%,GRM5;DLG2;KCND2;CACNB2;RIT2;GRIN2A;GABRB3;NRXN1;SYT1;NLGN1;RPS6KA1;CACNA1E;GRIA4;GRM1;GRIN2B;SLC12A6;CAMKK2;DTNA;GRIA1;GRIK1;UNC13C;GRIA2;HTR2C;MBP;DLGAP1;NOVA1;AMPH;GLRB;SLC1A3;GLRA3;CACNB4;CHRM3;SYN2;CHRM2;GRIK2;GABRA2;GRIN1;SYNJ2BP;HCRTR2;GABRB1;SNAP25;GRM3;KIF5A;SLC1A2;AKAP9;GRIA3;HOMER1;GABRA3;GLRA1;GABRG3;SLC6A1;SLC1A1;NLGN3;HTR1F;KCNQ2;PRKACA;DLG1
prerank,regulation of immune response (GO:0050776),0.5565730726500264,1.6836912594923696,0.0,0.12981504631240348,1.0,36/135,13.45%,CD300LF;CD300A;SYK;ICAM2;CD200R1;SLAMF7;LILRB1;FOXP3;IFITM1;CLEC2D;FCRLB;ITGA4;CD3D;APPL2;COL1A1;ADCY7;RNF135;TKFC;GPR108;XIAP;DENND1B;FOXP1;CD22;TYROBP;ITGB1;TREML1;BIRC3;ULBP1;APPL1;IL15;CD300LD;TREM2;COL3A1;TRAF3;FGR;N4BP1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.7302417782312295,1.6830745132204588,0.011065006915629323,0.1295387871310424,1.0,8/16,11.53%,NCOR1;APPL2;ACADL;ACADVL;SOX9;BRCA1;ERLIN1;WDTC1
prerank,lipid homeostasis (GO:0055088),0.6003365450671296,1.6828239124865474,0.0034562211981566822,0.1287471431054298,1.0,13/57,8.19%,PPARG;ABCA1;APOE;LIPG;ABCG1;FBXW7;RBP1;NR1H3;ABCD1;IRS2;ZBTB20;ABHD4;ABCA2
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4017376800849451,-1.678911704651176,0.0,0.19586512590304864,1.0,36/107,11.89%,CX3CR1;NRG3;GRM5;SLC12A2;MEF2C;OPHN1;LRRC4C;SYT1;NLGN1;RIMS1;GRM1;GRM8;GRIK1;DLGAP1;DLGAP2;RIMS2;GRID2;ATP1A2;GRIK2;SNCAIP;RELN;FMR1;GRM3;AKAP9;CDH2;GRIK5;HOMER1;CNTNAP4;BCR;LRP8;SLC4A8;GRID1;NLGN3;NMU;CAMK2A;GRIK3
prerank,mesonephric tubule development (GO:0072164),-0.6077065202417733,-1.6783691597810517,0.009966777408637873,0.19298676814108934,1.0,6/15,13.74%,SALL1;ROBO2;FGFR2;PKD2;NPNT;PKD1
prerank,phosphate ion homeostasis (GO:0055062),0.8257920628433053,1.678122441094145,0.010558069381598794,0.1357453865748356,1.0,4/10,11.35%,TFAP2B;ENPP1;FGFR4;XPR1
prerank,cellular iron ion homeostasis (GO:0006879),0.5983394449928375,1.677706624450813,0.0011494252873563218,0.13522865104640078,1.0,17/55,14.67%,FLVCR1;FTL;ATP6V1A;ABCB7;TFRC;SLC11A2;ATP6V0D1;TMEM199;NUBP1;HMOX1;FRRS1;HEPH;SLC39A14;GLRX3;HMOX2;SLC11A1;CUL1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6947206242528854,1.6768737380442962,0.003947368421052632,0.1354091315750365,1.0,10/22,13.02%,APOE;TIMP1;ADAM9;SNX9;TNFRSF1B;ADAM8;TIMP2;SNX33;ROCK1;GPLD1
prerank,peptide metabolic process (GO:0006518),0.5739710209616027,1.6765754657816396,0.0,0.13462107142668295,1.0,23/75,17.56%,ANPEP;CPQ;TPP1;NPEPPS;GSTM1;NAT8;NLN;RHD;CPXM1;CLN5;GSR;HPGDS;BACE1;DNPEP;LTA4H;HM13;SPCS2;GSTA4;CPM;LNPEP;PARL;ACE;OPLAH
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7174650130690166,1.6750476670238181,0.0041265474552957355,0.13620096737696033,1.0,4/18,2.62%,GPR137B;LILRB1;LILRB3;FBXW7
prerank,regulation of blood coagulation (GO:0030193),0.656122701022212,1.6746819391482466,0.002531645569620253,0.13547572800716845,1.0,5/27,7.33%,HPSE;APOE;THBS1;PROC;ST3GAL4
prerank,acute-phase response (GO:0006953),0.7846934033652601,1.6746018245640895,0.01032448377581121,0.134431895308682,1.0,5/12,15.53%,SIGIRR;CEBPB;IL6;IL6R;LBP
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6717488119639734,1.6736269515861903,0.002699055330634278,0.1349309228667601,1.0,13/27,16.53%,CD36;MAP3K1;IRAK2;TNIP1;LY96;IRAK3;RPS27A;UBC;TAB2;BTK;MYD88;HSPD1;TLR1
prerank,cardiac cell development (GO:0055006),0.7765679651235108,1.672554055278514,0.013953488372093023,0.1355478673491963,1.0,4/11,11.89%,ALPK3;VEGFA;SLC8A1;NOTCH1
prerank,regulation of glucose import (GO:0046324),0.6492987223140438,1.6718802100491224,0.006321112515802781,0.13566973977689395,1.0,7/30,5.81%,OSBPL8;PRKAG2;ENPP1;APPL2;PID1;IGF1;IRS2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5630167160606966,-1.6711295662019197,0.004048582995951417,0.2012681929321329,1.0,7/20,5.31%,KCNMA1;SLC12A2;ATP1B1;LACC1;ATP1A2;KCNJ2;ATP1B2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.795543055915571,1.6707340057244275,0.013677811550151976,0.13666092553731102,1.0,2/11,1.98%,PLA2G7;ABCG1
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5983077138937171,-1.67048308611171,0.007194244604316547,0.19859850660335832,1.0,8/17,17.03%,NLGN1;RAB27A;SCAMP5;SYT4;SLC4A8;CACNA1G;STX1A;CACNA1I
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6935585230781306,1.6689881598444953,0.007978723404255319,0.13875479812881278,1.0,6/22,8.59%,LGALS3;CD300A;DGKZ;DUSP3;LPXN;CD22
prerank,neutrophil activation (GO:0042119),0.764916777511105,1.6682311890377715,0.011799410029498525,0.1388901010950013,1.0,5/12,12.24%,SYK;PRKCD;TYROBP;KMT2E;IL15
prerank,cellular response to starvation (GO:0009267),0.5437211968427159,1.6674744664926784,0.0,0.139135811693456,1.0,43/147,13.91%,ATP6V0D2;MTMR3;TFEB;ATP6V1A;ATG7;CEBPB;FNIP1;PDK4;CPEB4;PRKAG2;ATP6V1E1;CDKN1A;FOXO3;ATP6V1C1;FAS;TCIRG1;ATP6V0D1;SESN2;SH3GLB1;SIK1;STK24;FLCN;EIF2AK4;ATF4;ATP6V1B2;LAMP2;BMPR2;LAMTOR1;FOXO1;SIRT1;ATG5;XPR1;GAS2L1;MIOS;WRN;ATP6V0E1;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;CASTOR1;NPRL3;ATP6V1H
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.7019123076045941,1.6662911455294729,0.013513513513513514,0.1403143459901119,1.0,9/20,11.53%,FBXW7;SIK1;ACADL;ACADVL;BRCA1;SLC27A1;ABCA2;ERLIN1;WDTC1
prerank,response to laminar fluid shear stress (GO:0034616),0.7944723363410715,1.6660545837621077,0.01794453507340946,0.13956390160510684,1.0,4/10,5.24%,ABCA1;NFE2L2;MAP2K5;MAPK7
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6584268672419799,1.664597675566412,0.008928571428571428,0.14108315774844224,1.0,6/26,7.23%,CD36;PIKFYVE;ABCB7;ABCD1;SPHK2;CYBA
prerank,response to thyroid hormone (GO:0097066),0.7558984259874162,1.6633204124805119,0.004373177842565598,0.14209132616087974,1.0,5/13,12.62%,CTSB;CTSL;CTSS;CTSH;GAS2L1
prerank,glutathione derivative metabolic process (GO:1901685),0.6825073366135211,1.6624110726403643,0.009929078014184398,0.14145996569322156,1.0,8/20,15.25%,MGST2;GSTM1;AKR1A1;HPGDS;ESD;MGST1;GSTO2;GSTA4
prerank,glutathione derivative biosynthetic process (GO:1901687),0.6825073366135211,1.6624110726403643,0.009929078014184398,0.14145996569322156,1.0,8/20,15.25%,MGST2;GSTM1;AKR1A1;HPGDS;ESD;MGST1;GSTO2;GSTA4
prerank,carboxylic acid transport (GO:0046942),0.5884775564189308,1.6620872399985098,0.002352941176470588,0.14087756153042763,1.0,10/55,5.69%,PSAP;SLC6A6;SLC36A2;SLC36A4;SLC38A6;SLC1A5;SLC16A1;CLN3;SLC38A1;SLC17A5
prerank,sterol metabolic process (GO:0016125),0.587195638410448,1.6594278647119252,0.0033821871476888386,0.14470635203116172,1.0,8/60,3.66%,LIPA;SOAT1;ABCA1;APOE;ABCG1;OSBPL1A;PRKAG2;RXRA
prerank,lipid transport (GO:0006869),0.563339849489999,1.6590599457489423,0.0010741138560687433,0.14421244424461543,1.0,29/97,13.98%,CD36;OSBPL8;ABCA1;APOE;SLC51A;FABP5;ABCG1;CERT1;ABCD1;RXRA;SLC27A4;CLN3;PLTP;STARD5;SLC27A3;ABCC4;NR1H4;ABCC3;ABCA3;SLC27A1;ABCA2;NCOA1;PITPNA;ABCA6;PPARD;GM2A;PITPNC1;ATP8B1;PRELID3A
prerank,positive regulation of protein processing (GO:0010954),0.6971081697634097,1.6589214895962,0.012413793103448275,0.14342234997262623,1.0,6/19,12.31%,CCBE1;ADAM8;NLRC4;RHBDD1;LPCAT3;MYH9
prerank,regulation of exosomal secretion (GO:1903541),0.7017643904716662,1.6584772459456671,0.014844804318488529,0.14310460544800435,1.0,10/19,14.85%,SDCBP;RAB7A;STAM;CHMP2A;PDCD6IP;VPS4A;CHMP6;SDC4;PRKN;SNF8
prerank,cytosolic transport (GO:0016482),0.5563662259444946,1.6581364942621208,0.0,0.1427208476116336,1.0,44/108,19.25%,TMEM87B;PHETA2;PIKFYVE;LAMP1;HOOK3;RIC1;RAB7A;EEA1;WASHC1;KIF16B;SNX5;CLN5;WDR91;CLN3;STX8;VTI1B;GAK;TBC1D10A;TBC1D23;STX5;VPS54;KLHL20;SNX16;VTI1A;DENND2A;VPS52;VPS13C;VPS51;AP1G1;SPAG9;EPS15;VAMP3;PLEKHJ1;STX6;SNF8;TMEM87A;RAB29;ERC1;UBE2O;VPS29;AP4M1;BAIAP3;ANKRD27;VPS13A
prerank,potassium ion transport (GO:0006813),-0.39084705568663347,-1.6575769365213484,0.0,0.21590307218975024,1.0,26/120,11.82%,KCNMA1;SLC24A3;SLC9A9;KCND2;HCN1;KCNH7;SLC24A2;KCNC2;KCNB2;SLC1A3;ATP1A2;KCNH1;KCNAB1;KCNK2;KCNC1;KCNJ2;KCNK6;KCNJ3;KCNC3;NALCN;SLC24A4;KCNQ2;HCN2;HPN;KCNH8;PKD2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.6807519327321676,1.656877441845845,0.009971509971509971,0.14371819804917121,1.0,10/20,16.62%,NFE2L2;VEGFA;RUNX2;SESN2;ATF4;CARF;MT3;NOTCH1;RELA;CREB3
prerank,lipoprotein localization (GO:0044872),0.7841135109175446,1.6563738196827529,0.008902077151335312,0.14352172751185177,1.0,5/11,11.91%,CD36;PPARG;LRP1;VMP1;PRKCB
prerank,chloride transmembrane transport (GO:1902476),-0.4613273280133626,-1.6563374322107034,0.0,0.21419985486593934,1.0,20/48,13.84%,SLC12A2;GABRB3;SLC12A6;ANO4;GLRB;SLC1A3;ANO3;GLRA3;GABRA2;GABRB1;GABRA3;GLRA1;GABRG3;SLC6A1;SLC4A8;SLC1A1;LRRC8A;CLCN3;SLC12A4;GABRA4
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5007455342850641,-1.6553686223658728,0.020100502512562814,0.21180868836797,1.0,14/29,13.99%,SNTA1;KCNIP4;DPP10;DPP6;FGF12;KCNAB1;WNK3;KCNIP3;HOMER1;DLG1;WNK1;ATP2B4;KCNIP1;KCNN2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.805974347891318,1.6548986854136327,0.007692307692307693,0.14527566691683969,1.0,2/10,0.58%,ABCA1;APOE
prerank,positive regulation of exosomal secretion (GO:1903543),0.7400460373746116,1.6544892891041516,0.01293103448275862,0.14498652451786673,1.0,8/15,14.85%,SDCBP;RAB7A;STAM;CHMP2A;PDCD6IP;VPS4A;SDC4;SNF8
prerank,lipoprotein transport (GO:0042953),0.7952946527718503,1.6522145987788175,0.011940298507462687,0.14816767786493504,1.0,5/10,11.91%,CD36;PPARG;LRP1;VMP1;PRKCB
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6750255123371418,1.6514338382012137,0.006802721088435374,0.14846396538949502,1.0,12/22,15.53%,RAB7B;FLOT1;NR1H3;APPL2;NINJ1;MFHAS1;TICAM2;APPL1;TREM2;TNFAIP3;ACOD1;LBP
prerank,intracellular sterol transport (GO:0032366),0.7703350527531795,1.6506304459636716,0.011461318051575931,0.14903998695134565,1.0,6/13,9.77%,ABCA1;NPC1;ABCG1;SERAC1;RELCH;VPS4A
prerank,neuropeptide signaling pathway (GO:0007218),-0.42173266641351,-1.6493710885891606,0.006711409395973154,0.21840738504681564,1.0,15/58,14.84%,SORCS3;GLRB;OPRM1;GLRA3;SORCS1;HCRTR2;GPR37;PPY;GLRA1;CYSLTR1;ADCYAP1;NMU;GPR149;GPR84;RAPGEF2
prerank,lysosome localization (GO:0032418),0.6181995962870827,1.6470953365342842,0.0012285012285012285,0.15461665904198812,1.0,11/37,12.45%,PLEKHM1;PLEKHM2;TFEB;FLCN;HPS6;BORCS5;VPS33A;LAMTOR1;ARL8B;MYH9;SPAG9
prerank,iron ion homeostasis (GO:0055072),0.5837532625189106,1.6459858521293187,0.0011441647597254005,0.15547941558945624,1.0,17/58,14.67%,FLVCR1;FTL;ATP6V1A;ABCB7;TFRC;SLC11A2;ATP6V0D1;TMEM199;NUBP1;HMOX1;FRRS1;HEPH;PICALM;GLRX3;HMOX2;SLC11A1;CUL1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.7620206352058975,1.6426769637098735,0.01809954751131222,0.16044850034676128,1.0,7/12,11.53%,PIBF1;ACADL;ACADVL;BRCA1;SIRT1;ERLIN1;WDTC1
prerank,platelet degranulation (GO:0002576),0.5461008608017125,1.64173717461023,0.0010526315789473684,0.16114907795610536,1.0,26/118,11.60%,PSAP;CD36;VWF;TIMP1;VEGFA;HGF;APLP2;CD63;PDGFA;LHFPL2;ANXA5;IGF1;ACTN1;THBS1;VTI1B;ABCC4;OLA1;TLN1;LAMP2;F13A1;QSOX1;ITIH3;WDR1;APP;CTSW;GTPBP2
prerank,response to chemokine (GO:1990868),-0.6375918440414575,-1.6416964563279173,0.016233766233766232,0.22768575623772322,1.0,6/13,14.48%,DOCK8;SLC12A2;SH2B3;RIPOR2;WNK1;RHOA
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.48521438086055596,-1.6404516409122865,0.02072538860103627,0.2259890330491538,1.0,10/31,8.84%,TANC2;NLGN1;ABI2;RELN;ARHGAP44;CDK5R1;SIPA1L1;CUX2;SRCIN1;LRP8
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5688436915434133,-1.638637934761235,0.016722408026755852,0.2256871094831976,1.0,11/18,19.40%,PLCB1;RGS10;OPRM1;CHRM3;GNA15;CHRM2;CDK5R1;AGRN;GRK2;GNA11;RGS8
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.636808693699384,-1.6383068024606537,0.015723270440251572,0.22268934948930616,1.0,6/13,17.03%,SYT1;SCAMP5;SYT4;CACNA1G;STX1A;CACNA1I
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6876975724741192,1.6380853844563668,0.010596026490066225,0.16695393040683826,1.0,10/20,12.05%,TXN;ANO6;P2RX4;PSTPIP1;C3AR1;ENTPD1;MEFV;NT5E;APP;SUGT1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.6214569444136264,-1.6373949885656862,0.034375,0.22053655587710694,1.0,9/13,34.71%,TRIM11;TRIM13;TRIM8;PML;TRIM5;TRIM32;TRIM35;TRIM28;CHMP3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6934426888259062,-1.636374536438449,0.019886363636363636,0.21876365336398151,1.0,3/10,10.88%,ANK3;KCNAB1;KCNRG
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6613623461244637,1.6363257737055366,0.00909090909090909,0.16934020734053315,1.0,8/24,9.80%,CDKN1A;NIBAN2;ZRANB3;ACVRL1;RTEL1;DACH1;BMPR2;XRCC5
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6254731074580042,-1.634497502402529,0.030303030303030304,0.21896987719244557,1.0,6/13,7.07%,MEF2C;ERBB4;BMPR1A;FGFR2;FGF2;ZFPM2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5250856473398033,1.6332805756978823,0.0,0.17411219017248875,1.0,41/151,15.61%,CDO1;PLPP3;B4GALT5;APOE;SPTLC2;ARG1;MGST2;MOCOS;LPIN3;SAMD8;SGPL1;GSTM1;AKR1A1;CERT1;TNIP1;RHD;LCMT2;SGMS2;HACD4;ARG2;CERS6;SPHK2;ST3GAL4;SPTSSA;SLC27A1;HPGDS;VAPA;CSNK2A2;ESD;PCYT1A;ELOVL1;ALDH3A2;LPCAT3;MGST1;DEGS1;GSTO2;GOLPH3;SLC25A15;GSTA4;SLC44A2;PRKD3
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5962699999356017,1.6329743318150365,0.008264462809917356,0.1735766733894321,1.0,12/47,8.66%,CD36;XDH;SYK;GRB2;PRKCD;CDKN1A;RIPK1;PID1;THBS1;GADD45A;CYBA;TYROBP
prerank,regulation of trophoblast cell migration (GO:1901163),0.7428201825102762,1.631906197577743,0.00904977375565611,0.17450092116418509,1.0,5/14,11.99%,TIMP1;VEGFA;YTHDF3;AGO2;ACVR1B
prerank,negative regulation of cytokine production (GO:0001818),0.5224466188739114,1.62998380858782,0.0,0.17744774216975695,1.0,44/163,15.15%,GPNMB;ANXA4;TLR8;CD200R1;LILRB1;ANXA1;CD84;SIGIRR;PIBF1;FOXP3;IKBKE;IL6;ATP2B1;ABCD1;CD274;APPL2;HOMER3;RARA;MAP2K5;TRIM25;THBS1;NPLOC4;ADCY7;NR1H4;IRAK3;RNF135;SIRPA;MEFV;TYROBP;DDIT3;PTGER4;MAVS;NLRC3;TAX1BP1;SARS1;TREM2;GAS6;N4BP1;TNFAIP3;SLC11A1;ACOD1;JAK3;CX3CL1;ARRB1
prerank,epithelial cell differentiation (GO:0030855),0.5481306149966284,1.6284745147277506,0.001088139281828074,0.17924046677478925,1.0,13/88,10.39%,LGALS3;PPARG;ANXA4;CTSB;ANXA1;VEGFA;TPP1;TST;ACADVL;CPT1A;FSTL1;FZD7;RAB10
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5723183150567894,1.6282784106066421,0.001098901098901099,0.17836872436351445,1.0,40/71,25.10%,CTSB;CTSL;FBXL17;LONP1;SOCS6;CAPN2;RPS27A;UBC;CTSS;CTSZ;PDCD6IP;CTSH;RSPRY1;VPS4A;DDB1;ZER1;HM13;STUB1;CTSW;RHBDD1;OMA1;CHFR;TNFAIP3;PRKN;RNF123;ATE1;DDI2;ATXN3;PSMA6;CUL4B;LGMN;USP9X;CLPX;VCP;MALT1;ISG15;CASP8;PRPF19;CTSK;CTSO
prerank,regulation of cholesterol storage (GO:0010885),0.7199085371461063,1.6271713574721254,0.01276595744680851,0.17965344000252872,1.0,4/15,2.82%,PPARG;ABCA1;ABCG1;NR1H3
prerank,energy reserve metabolic process (GO:0006112),0.6826288366552428,1.6271192216412655,0.015514809590973202,0.17855294134363792,1.0,8/19,12.60%,PRKAG2;PYGL;PID1;GBE1;GFPT1;GSK3B;MT3;UGP2
prerank,negative regulation of cellular metabolic process (GO:0031324),0.6165442293891561,1.6254830675026024,0.007308160779537149,0.18065562215609535,1.0,12/37,13.63%,SDCBP;APOE;OPTN;NCOR1;ATXN2;TRAT1;BRCA1;ABCA2;RIN3;MT3;ANKRD13D;PRKN
prerank,B cell receptor signaling pathway (GO:0050853),0.6296473537644386,1.6248583805595724,0.011194029850746268,0.18077522053130854,1.0,12/32,14.42%,CD38;RFTN1;SYK;VAV3;TEC;MS4A1;BLNK;PLEKHA1;SH2B2;PRKCB;BTK;BAX
prerank,receptor internalization (GO:0031623),0.5999176971737765,1.6224899877082077,0.0071090047393364926,0.1846065688570177,1.0,10/44,9.78%,CD36;SYK;GRB2;LILRB1;TFRC;LRP1;LMBRD1;RAB31;PICALM;ITGB1
prerank,positive regulation of lipid transport (GO:0032370),0.7557234147276661,1.6218420328513432,0.01749271137026239,0.18487783104770317,1.0,4/12,7.78%,APOE;LRP1;SPP1;ABCA3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6237665716998914,1.6208690750746686,0.01125,0.18588803350516186,1.0,13/33,13.61%,NFE2L2;ANXA1;AQP1;IL6;PRKCD;RIPK1;MAPK7;PPIF;SIRPA;PLEKHA1;SIRT1;RELA;TNFAIP3
prerank,snRNA metabolic process (GO:0016073),0.6968961564540805,1.6200510366020862,0.017591339648173207,0.1863566568429369,1.0,10/17,17.20%,INTS9;INTS6;INTS1;INTS8;MEPCE;INTS5;INTS7;INTS2;MTREX;RBM7
prerank,cellular lipid catabolic process (GO:0044242),0.6387671333732703,1.61956655081613,0.009079118028534372,0.1862030982488653,1.0,9/27,11.17%,CEL;MGST2;LIPG;LPIN3;AOAH;ACADL;PLBD2;PPARD;MT3
prerank,amyloid precursor protein catabolic process (GO:0042987),0.7407076321197092,1.6192640178595168,0.008733624454148471,0.18559374418230817,1.0,11/14,23.21%,ABCG1;CLN3;DYRK1A;BACE1;ADAM17;ADAM19;NCSTN;ADAM10;APH1B;PSEN2;ABCA7
prerank,regulation of lysosomal lumen pH (GO:0035751),0.762348364630429,1.618545542830787,0.012968299711815562,0.18608749653197243,1.0,8/12,15.74%,TMEM165;PPT1;TMEM199;CLN5;CLN3;VPS33A;ATP6AP2;GRN
prerank,positive regulation of metabolic process (GO:0009893),0.5374607269583704,1.6179044800125881,0.001081081081081081,0.1863968743527152,1.0,19/103,10.41%,EPAS1;FABP4;CD36;CXCR4;SYK;FABP5;VEGFA;CEBPB;GADD45G;DYNC1H1;FASN;APPL2;SIRT6;ACADL;APC;KDM3A;KSR2;TRPV2;PTH2R
prerank,regulation of fatty acid metabolic process (GO:0019217),0.7098868740172999,1.6172842381854653,0.005578800557880056,0.18672776828169246,1.0,6/17,11.10%,PPARG;PDK4;PRKAG2;NCOR1;EIF6;PPARD
prerank,lipoprotein biosynthetic process (GO:0042158),0.7618446837959412,1.615237702439466,0.017991004497751123,0.19001695936493002,1.0,3/11,5.36%,APOE;ATG7;ATG10
prerank,chemical synaptic transmission (GO:0007268),-0.3306178971587242,-1.615231304553914,0.0,0.24946206847099242,1.0,72/284,11.24%,GRM5;DLG2;KCND2;CACNB2;RIT2;GRIN2A;GABRB3;NRXN1;SYT1;NLGN1;RPS6KA1;CACNA1E;GRIA4;RIMS1;GRM1;GRIN2B;SLC12A6;FCHSD2;CAMKK2;DTNA;GRIA1;GRIK1;UNC13C;GRIA2;HTR2C;MBP;DLGAP1;NOVA1;DLGAP2;AMPH;GLRB;SLC1A3;GLRA3;CACNB4;GRID2;CHRM3;SYN2;CHRM2;GRIK2;GABRA2;PTPRN2;LIN7A;GRIN1;SYNJ2BP;SLC17A6;HCRTR2;GABRB1;SNAP25;GRM3;KIF5A;CDH8;SLC1A2;AKAP9;GRIK5;GRIA3;HOMER1;NSG1;SHISA6;GABRA3;GLRA1;GABRG3;PDLIM4;SLC6A1;RIC3;GRID1;SLC1A1;KIF1B;NLGN3;HTR1F;KCNQ2;PRKACA;DLG1
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6868454001661175,1.6131399298147389,0.012640449438202247,0.19342881618257746,1.0,6/18,10.36%,F7;IL6;SLC8B1;IL6R;ADAM17;PTK2B
prerank,blood vessel morphogenesis (GO:0048514),0.5736151832591976,1.6125965655859877,0.006857142857142857,0.193543599736363,1.0,5/54,1.73%,CCBE1;APLNR;SYK;STRA6;VEGFA
prerank,microglial cell activation (GO:0001774),-0.5165885448602869,-1.612181751486927,0.02032520325203252,0.2517787767722444,1.0,7/21,8.09%,CX3CR1;ITGAM;MAPT;IFNGR1;AIF1;ITGB2;CLU
prerank,amino acid transmembrane transport (GO:0003333),0.5909430285547601,1.6104419800992174,0.0035087719298245615,0.19704171364200757,1.0,9/45,7.51%,LRRC8D;SLC6A6;SLC36A2;SLC36A4;SLC38A6;SLC7A7;SLC38A1;MFSD12;SLC38A7
prerank,cardiac muscle cell development (GO:0055013),0.6818736887987008,1.609913692643459,0.011126564673157162,0.19708450774856442,1.0,5/20,6.79%,ALPK3;VEGFA;MYL2;SLC8A1;PDLIM5
prerank,regulation of organelle assembly (GO:1902115),0.5515301731048747,1.6079122354568935,0.0043859649122807015,0.2006850628544548,1.0,27/72,16.67%,PIKFYVE;MTMR3;TBC1D22A;PLK2;TBC1D1;TBC1D2;KIF9;TBC1D12;ATXN2;STAM;TBC1D10A;TBC1D2B;RAB1B;MSN;PDCD6IP;TBC1D22B;ATG5;TBC1D24;TBC1D15;CEP76;NPRL3;IFT140;VPS11;UBQLN2;ALMS1;RABGAP1;NPRL2
prerank,defense response to bacterium (GO:0042742),0.5330236132158018,1.6067768142277292,0.0010741138560687433,0.20220458773656122,1.0,25/105,15.74%,LYST;SYK;OPTN;MPEG1;CEBPB;AQP1;IL6;STAB2;PRKCD;ANKRD17;LYZL4;RNASE3;GBP6;NLRC4;IL6R;MAVS;ADAM17;DROSHA;TREM2;FGR;SLC11A1;SLPI;SHC1;LBP;MYD88
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7110164371685069,1.6067518868610866,0.02245508982035928,0.20106432869860758,1.0,2/15,1.73%,F7;VEGFA
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5823127027388081,1.606301360883367,0.011682242990654205,0.2009807926485447,1.0,14/45,15.42%,IQGAP1;REPS2;GRB2;NCK2;SOS1;PDPK1;KIF16B;PIK3CA;SOX9;ADAM17;PTK2B;ERBIN;SHC1;CBL
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6752178332763011,1.6049711073754973,0.014844804318488529,0.2029730874873995,1.0,8/20,13.94%,EPAS1;ZMIZ1;WASHC1;HSPA1B;DCUN1D5;DCUN1D3;PRKN;HSPA1A
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.678787469010071,1.604149009395422,0.012328767123287671,0.2037628123058968,1.0,3/19,3.68%,CCBE1;XDH;CD63
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.7492271360069137,1.6027604981590367,0.013100436681222707,0.205745911386292,1.0,3/12,2.77%,GCNT2;FLOT1;CD44
prerank,glycoprotein catabolic process (GO:0006516),0.6879510888613386,1.6007127855262075,0.018156424581005588,0.20917749258255025,1.0,6/17,12.93%,MMP12;CTSL;MANBA;EDEM2;OGA;FBXO6
prerank,receptor clustering (GO:0043113),-0.4898617504675853,-1.599985916118695,0.00851063829787234,0.27193613792149257,1.0,10/27,11.24%,DLG2;NRXN1;NLGN1;MAGI2;SYNJ2BP;ITGB2;ITGB1BP1;PICK1;AGRN;DLG1
prerank,cellular protein catabolic process (GO:0044257),0.5699228898743294,1.5990387341852725,0.004561003420752566,0.2119409271287936,1.0,34/59,27.13%,CTSB;CTSL;RAB7A;TCIRG1;RIPK1;LONP1;HTRA2;CAPN2;AFG1L;CTSS;CTSZ;CTSH;RSPRY1;RAB12;CTSW;AP2B1;PRKN;RNF123;BNIP3;MYLIP;PSMA6;LGMN;CLPX;MALT1;SIAH2;AP2S1;CASP8;CTSK;CTSO;CLTC;UBE2G1;AP2A2;AP2A1;MAGEC2
prerank,positive regulation of wound healing (GO:0090303),0.6026138210669345,1.5987233806839185,0.0170316301703163,0.21146880012130015,1.0,8/36,12.20%,HPSE;PLPP3;ANXA1;THBS1;ST3GAL4;RREB1;ITGB1;MYLK
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.45441157583338077,-1.598180509230929,0.004975124378109453,0.27120396239878025,1.0,8/35,7.69%,NLGN1;CDH23;CDH11;ATP2C1;CDH9;CDH8;CDH6;CDH12
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.7668274148606535,1.5977439800870537,0.009036144578313253,0.21252898534319584,1.0,3/10,4.62%,PPARG;RXRA;RARA
prerank,superoxide anion generation (GO:0042554),0.7278525009098454,1.5962150417833336,0.02092675635276532,0.21496414527187238,1.0,6/13,16.77%,CYBB;CYBA;NCF2;NCF4;TAFA4;NCF1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5570895752885808,-1.5958617314218522,0.045774647887323945,0.271604978705108,1.0,7/16,35.28%,CLDN11;CLDN12;CLDN10;CLDN14;CLDN18;CLDN1;CLDN5
prerank,membrane depolarization during action potential (GO:0086010),-0.49709610951390987,-1.5947251941262721,0.00847457627118644,0.26991707572813056,1.0,13/26,21.29%,SCN2A;CACNA1C;ATP1A2;SCN1B;KCNJ2;SCN9A;CACNA1G;HCN2;YWHAH;SCN8A;CACNA1I;SCN4B;SCN1A
prerank,leukocyte cell-cell adhesion (GO:0007159),0.6389044404840518,1.594331990610527,0.019867549668874173,0.21842666260117966,1.0,8/24,10.12%,SYK;TNIP1;ITGA4;CERCAM;MSN;NT5E;ITGB1;ROCK1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5885897289562634,1.5941197158751441,0.006045949214026602,0.21771391416710575,1.0,12/44,7.84%,VEGFA;AQP1;FNIP1;DNAJB6;CD44;HGF;MAP2K5;RAF1;PCID2;THBS1;SH3RF1;XIAP
prerank,regulation of postsynapse organization (GO:0099175),-0.4907188781823291,-1.5929018559944181,0.0136986301369863,0.27004847657024345,1.0,8/28,7.14%,TANC2;IL1RAPL1;ABI2;ARHGAP44;CDK5R1;SIPA1L1;SRCIN1;HOMER1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.5419024344978461,1.592577957964572,0.001092896174863388,0.22004700179777414,1.0,28/86,20.47%,EPAS1;NFE2L2;VEGFA;ATF3;PSMD1;BACH1;MAPK7;CREBBP;ATF4;HMOX1;RPS27A;UBC;DDIT3;EGLN3;PSMF1;PSMD14;PSMD12;LIMD1;HSPA1A;PSME2;INO80;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6
prerank,cardiac muscle cell action potential (GO:0086001),-0.4891975177738499,-1.5920537562906085,0.009708737864077669,0.26797060601328854,1.0,9/30,11.03%,ATP1B1;ANK2;CACNA1C;ATP1A2;SCN1B;FGF12;KCNJ2;CACNA1G;HCN2
prerank,sulfur amino acid metabolic process (GO:0000096),0.649260442354616,1.5918553050379443,0.015915119363395226,0.22052162763385288,1.0,3/24,3.71%,CDO1;MSRA;TST
prerank,regulation of small molecule metabolic process (GO:0062012),0.6287672892842093,1.5910908374778059,0.014012738853503185,0.22114723680676296,1.0,11/28,15.34%,APOE;PDK4;NR1H4;ACADL;ACADVL;FOXK1;SIRT1;RORA;DGKQ;PRKN;PANK2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7054561589848736,1.5886363174915328,0.018571428571428572,0.22580327165327033,1.0,4/16,7.09%,APLNR;VEGFA;THBS1;HMOX1
prerank,cellular response to oxygen levels (GO:0071453),0.7570662994378718,1.588332986657929,0.01875,0.22530731657169983,1.0,4/10,4.28%,ATP6V1A;CPEB4;ATP6V0D1;TMEM199
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.6319365151662839,1.588297053515529,0.017632241813602016,0.22421311773939087,1.0,10/30,13.14%,CD300LF;IKBKE;TANK;RIPK1;LY96;RPS27A;UBC;TICAM2;BIRC3;TRAF3
prerank,regulation of autophagy (GO:0010506),0.5083149830990572,1.5882221586026508,0.0,0.22324510554414054,1.0,74/216,19.53%,ATP6V0D2;PSAP;HTR2B;TPCN2;GPR137B;OPTN;MTMR3;TFEB;ERN1;ATP6V1A;PRKAG2;ATP6V1E1;FBXW7;PLK2;HGF;ABL2;FOXO3;ATP6V1C1;CTSA;WASHC1;ATP6V0D1;DAPK1;SNX5;SH3GLB1;HTRA2;EEF1A1;FLCN;ATP6V1B2;DCAF12;MEFV;CSNK2A2;ATP6V0A1;DDIT3;LAMTOR1;ROCK1;GSK3B;FOXK1;FOXO1;MT3;TAB2;FZD5;TREM2;ATP6V0E1;ATG13;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;VDAC1;PRKN;ZKSCAN3;ATP6V1H;MCL1;UBQLN2;USP36;EXOC4;BNIP3;RUBCN;NPRL2;PIP4K2A;ACER2;KEAP1;DRAM2;TRIM14;EXOC7;EXOC1;VPS29;CASP3;RHEB;EIF4G3;EIF4G2;PIK3CB;TLK2;ATP6V1G2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.5242135872189981,-1.5869758011915993,0.026022304832713755,0.2735391464819988,1.0,6/21,5.94%,ST3GAL6;B3GALT1;ST8SIA6;FUT9;ST3GAL2;ST6GALNAC5
prerank,alanine transport (GO:0032328),0.7787735397815417,1.5868539948694085,0.01664145234493192,0.22535997874907565,1.0,3/10,1.64%,SLC6A6;SLC36A2;SLC36A4
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6277788756045133,-1.5856055251316397,0.05309734513274336,0.2727120556696533,1.0,3/11,5.80%,ATP1B1;KCNJ2;KCNJ3
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5646367495592431,1.5848515421128675,0.011350737797956867,0.22912142045011852,1.0,19/55,17.49%,XDH;GRB2;PIKFYVE;MPV17;CDKN1A;COQ7;RIPK1;PID1;THBS1;GADD45A;SPHK2;EIF6;BRCA1;MT3;PRKN;ACOD1;BST1;PARL;ARF4
prerank,long-chain fatty acid import into cell (GO:0044539),0.7562522428073518,1.5846651595381713,0.024077046548956663,0.22843307039656133,1.0,4/10,12.33%,CD36;SLC27A4;SLC27A1;SLC2A1
prerank,glycogen metabolic process (GO:0005977),0.6237029212304966,1.5842787374736051,0.023591087811271297,0.22819543918623766,1.0,9/27,13.88%,GYG1;PRKAG2;PYGL;GBE1;NHLRC1;GSK3B;PGM1;UGP2;AGL
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.4397758252453383,-1.5835147684493776,0.0189873417721519,0.2736318660926075,1.0,26/41,37.96%,KCNMA1;ANK2;ANK3;KCNJ2;KCNJ3;NOS1AP;GABBR1;KCNJ9;ACTN2;KCNN2;STAC;KCNJ6;NOS1;KCNMB4;GNB1;KCNJ12;KCNJ16;KCNJ10;KCNN1;GNG2;AKAP6;KCNQ1;PDZK1;KCNMB2;KCNN3;KCNJ15
prerank,regulation of histone deacetylation (GO:0031063),0.7197047468151143,1.583310134180514,0.031484257871064465,0.22924162039737828,1.0,4/13,6.98%,APLNR;FOXP3;SPHK2;NIPBL
prerank,regulation of mast cell degranulation (GO:0043304),0.7145531698535246,1.5818947363067166,0.03170028818443804,0.23134027941407817,1.0,7/14,13.44%,CD300A;SYK;GAB2;CD84;SPHK2;FES;FGR
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.6320959180239437,1.581591254083099,0.020202020202020204,0.23096515022881164,1.0,10/29,13.14%,CD300LF;IKBKE;TANK;RIPK1;LY96;RPS27A;UBC;TICAM2;BIRC3;TRAF3
prerank,organonitrogen compound catabolic process (GO:1901565),0.560361894150301,1.5797456729876598,0.005707762557077625,0.23413852696049006,1.0,13/57,10.32%,ANPEP;PLA2G7;CPQ;TPP1;SGPL1;NPEPPS;TST;PPT1;CLN5;RENBP;NAGK;LTA4H;GGACT
prerank,regulation of interleukin-10 production (GO:0032653),0.5754743219072512,1.5793361002448356,0.018050541516245487,0.23386766220898375,1.0,8/44,4.04%,SYK;LILRB1;PIBF1;FOXP3;IL6;CD28;CD46;CD274
prerank,response to ethanol (GO:0045471),-0.5731150878387513,-1.5792257034131207,0.028846153846153848,0.27830741819674853,1.0,5/14,8.54%,GRIN2A;GRIN2B;GRIN3A;GRIN1;GLRA1
prerank,regulation of fatty acid oxidation (GO:0046320),0.7057941978957881,1.5792010725915144,0.022191400832177532,0.23298271083090802,1.0,8/16,12.40%,PDK4;PRKAG2;ABCD1;APPL2;ACADL;ACADVL;SOX9;LONP2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5598085902165185,1.5779566318142388,0.007075471698113208,0.23497925381039492,1.0,9/51,10.25%,F7;PLA2G7;VEGFA;ANO6;IL6;THBS1;IL6R;MOSPD2;ADAM17
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5919322119414113,1.5776962258145286,0.015606242496998799,0.2344773229044752,1.0,11/36,13.94%,CD300LF;CXCR4;RIPK1;UBE2K;HSPA1B;TICAM2;MAVS;ADAM17;GAS6;PRKN;HSPA1A
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6905512847892948,1.5769652673021815,0.02664796633941094,0.2350833199744568,1.0,2/16,0.58%,CD36;APOE
prerank,response to fatty acid (GO:0070542),0.688824278573344,1.5753348176955055,0.03070175438596491,0.23797493832817315,1.0,8/17,12.56%,CD36;PDK4;FOXO3;PID1;NR1H4;SOX9;FOXO1;KCNK4
prerank,peptide cross-linking (GO:0018149),0.6276113429963548,1.5738310161925564,0.02610966057441253,0.24043370931727379,1.0,6/25,15.27%,ANXA1;TGM2;THBS1;F13A1;COL3A1;CD247
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5415009255453584,-1.5735146335449506,0.02702702702702703,0.2862447890119019,1.0,9/17,22.78%,ATP1B1;CACNA1C;ATP1A2;RYR2;ATP1B2;PRKACA;FKBP1B;GJC1;GJD3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4183702218111436,-1.5733538671868985,0.0,0.2828380572742183,1.0,15/54,13.99%,BIN1;KCNMA1;KCNIP4;DPP10;DPP6;KCNAB1;KCNJ2;KCNIP3;KCNJ3;NOS1AP;GABBR1;KCNJ9;DLG1;KCNIP1;KCNN2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.658836507142259,1.5722027175676532,0.014627659574468085,0.24327604886255433,1.0,8/21,14.61%,CTNNB1;APC;DVL1;GSK3B;FZD5;FZD2;PPP1CA;LRP6
prerank,serine family amino acid metabolic process (GO:0009069),0.6991745221408047,1.571594308899825,0.01849217638691323,0.2437724882249234,1.0,5/16,12.16%,CDO1;BAAT;SEPHS2;GLYAT;SARS1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6701434028866912,1.5704645221910607,0.01928374655647383,0.2453005843410513,1.0,5/19,13.37%,SYK;ZMIZ1;MMP14;BTK;GAS6
prerank,early endosome to late endosome transport (GO:0045022),0.6538346959579953,1.569793617991078,0.02631578947368421,0.24596599960568502,1.0,7/20,9.45%,HOOK3;RAB7A;EEA1;KIF16B;WDR91;STX8;SNX16
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.546271679091671,1.5696404814596567,0.007583965330444204,0.24515927364618184,1.0,31/80,18.49%,TMEM87B;RAB7B;PHETA2;PIKFYVE;SNX8;RIC1;RAB7A;WASHC1;SNX5;CLN5;VTI1B;TBC1D10A;TBC1D23;STX5;VPS54;VTI1A;DENND2A;VPS52;VPS51;SPAG9;VAMP3;PLEKHJ1;TRAPPC10;STX6;TMEM87A;RAB29;ERC1;UBE2O;SNX3;VPS29;BAIAP3
prerank,negative regulation of chemokine production (GO:0032682),0.701620930830526,1.569251405273722,0.027941176470588237,0.2450085835642091,1.0,5/14,8.64%,SIGIRR;IL6;MAP2K5;SIRPA;MEFV
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.6152103610837939,1.5678412384819185,0.02681992337164751,0.24742088792929667,1.0,13/30,15.08%,MICALL2;NPEPPS;FBXW7;SH3GLB1;HTRA2;UBE2L3;HUWE1;CSNK2A2;ARIH2;FZD5;ATG13;VPS11;USP36
prerank,positive regulation of protein polymerization (GO:0032273),-0.4050774788453091,-1.567229633623256,0.008130081300813009,0.2907655821565802,1.0,17/65,7.80%,NAV3;BIN1;EVL;FCHSD2;PRKCE;VASP;MAPT;FER;HCK;CDK5R1;NCKAP1;NCK1;HSP90AA1;PAK1;AKAP9;TPPP;CARMIL1
prerank,positive regulation of protein catabolic process (GO:0045732),0.5383240271479166,1.5667642854688573,0.002157497303128371,0.248988177704918,1.0,30/84,17.29%,APOE;ATG7;WWP1;TIPARP;RAB7A;PLK2;ADAM9;SNX9;TNFRSF1B;SORL1;ADAM8;STX5;APC;MSN;NEDD4L;WWP2;HUWE1;SNX33;DDB1;GSK3B;OAZ2;FOXO1;GPLD1;TNFAIP3;PRKN;VPS11;SNF8;SH3D19;OAZ1;CSNK2A1
prerank,alcohol catabolic process (GO:0046164),0.7641511937968717,1.566210828758533,0.016051364365971106,0.2491025037957196,1.0,6/10,17.70%,CEL;APOE;MT3;CYP46A1;SNX17;CYP27A1
prerank,melanocyte differentiation (GO:0030318),0.7225538699292885,1.56585497272611,0.033690658499234305,0.24892174417737106,1.0,5/11,7.95%,LRMDA;MITF;MREG;ENPP1;HPS6
prerank,regulation of protein autophosphorylation (GO:0031952),0.5979811091306362,1.5650431654291777,0.018541409147095178,0.24994205013794554,1.0,5/36,4.24%,GPNMB;RAP2A;VEGFA;PDGFA;ENPP1
prerank,regulation of interleukin-1 production (GO:0032652),0.6915868074612401,1.5641621951022588,0.04096045197740113,0.2509147062166285,1.0,5/15,13.37%,ANXA1;SIRPA;FOXP1;MEFV;GAS6
prerank,synaptic membrane adhesion (GO:0099560),-0.5923784458477895,-1.5641235608347197,0.03819444444444445,0.2928966057846901,1.0,4/14,5.18%,PTPRD;LRRC4C;NTNG1;LRRC4B
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.7008540246712611,1.5634962343651013,0.015647226173541962,0.25139831245857885,1.0,8/15,16.09%,APOE;ADAM9;SNX9;TNFRSF1B;ADAM8;SNX33;GPLD1;SH3D19
prerank,protein targeting to lysosome (GO:0006622),0.6541694617621305,1.562796243574099,0.02029769959404601,0.2519673807354544,1.0,12/20,21.68%,RAB7A;SORL1;SCARB2;NCOA4;LAMP2;SNX16;VPS4A;M6PR;AP4M1;NAGPA;GGA3;ZFYVE16
prerank,pentose-phosphate shunt (GO:0006098),0.7379919184002333,1.562617548793233,0.027906976744186046,0.2513631943267424,1.0,6/11,20.16%,PGD;TALDO1;SHPK;DERA;RPIA;RBKS
prerank,cholesterol metabolic process (GO:0008203),0.546411576877551,1.5618051410534177,0.00904977375565611,0.2523960990293943,1.0,17/68,15.79%,CEL;SOAT1;ABCA1;APOE;ABCG1;OSBPL1A;RXRA;MVD;PLPP6;IDI1;PPARD;MT3;CYP46A1;INSIG2;PMVK;SNX17;ACAA2
prerank,regulation of p38MAPK cascade (GO:1900744),0.5967864468344437,1.5610418530026786,0.0186799501867995,0.25294826023965283,1.0,8/35,7.28%,SASH1;XDH;VEGFA;GADD45B;GADD45G;RELL1;GADD45A;MFHAS1
prerank,neuronal action potential (GO:0019228),-0.5129947012207794,-1.5610174341719325,0.046875,0.2953054417140799,1.0,9/22,25.85%,SCN2A;ANK3;SCN9A;CACNA1G;MYH14;SCN8A;CACNA1I;SCN1A;KCNMB4
prerank,Golgi localization (GO:0051645),0.7410566623263862,1.5604494804717417,0.025602409638554216,0.25332353530443924,1.0,3/11,4.23%,ARHGAP21;HOOK3;UVRAG
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5674222662672304,1.5600197205206907,0.018779342723004695,0.253279156203248,1.0,10/46,8.06%,DDHD1;GPAT2;AGPAT4;PLD2;PLA2G2D;DGKZ;DGKA;GPD1L;SLC27A1;ABHD4
prerank,fluid transport (GO:0042044),0.7266571346500864,1.5594196959929065,0.026988636363636364,0.25360816037972395,1.0,1/12,1.89%,AQP1
prerank,negative regulation of inflammatory response (GO:0050728),0.49889868790841985,1.5591837820779164,0.0010214504596527069,0.25309072656773984,1.0,45/182,15.74%,PPARG;APOE;SYK;CD200R1;GPR15;PTGDR;NR1H3;PLK2;IL6;HTR6;PRKCD;RHBDF2;TNFRSF1B;AOAH;IGF1;MAPK7;GPR83;ADCY7;NR1H4;PTGER2;PROC;METRNL;MFHAS1;GPR176;RB1;SIRPA;MEFV;PTGER4;VIPR1;NLRC3;ADAM17;PTH2R;PPARD;RORA;LPCAT3;MYH9;TREM2;FGR;TNFAIP3;TNFAIP8L2;ACOD1;ADCY8;ADCY3;CD247;GRN
prerank,positive regulation of endocytosis (GO:0045807),0.5711566810938804,1.5588408273711047,0.011668611435239206,0.25281520127041135,1.0,12/45,8.00%,APOE;FLOT1;ANO6;LRP1;CD151;PPT1;APPL2;CLN3;RAB21;RAB31;STAP1;NEDD4L
prerank,negative regulation of immune effector process (GO:0002698),0.7231405803304858,1.5585679863893043,0.028148148148148148,0.25241487368942084,1.0,3/13,1.46%,LGALS3;CD300A;LILRB1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6072098676214974,1.5584146936621883,0.020671834625323,0.25175114218837447,1.0,15/30,20.41%,ACD;CDKN1A;NIBAN2;TENT4B;HNRNPU;ACVRL1;DACH1;TERF1;NAT10;BMPR2;TEN1;STN1;EXOSC10;GNL3L;CERS1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.5786307606534568,1.5572898782368936,0.014563106796116505,0.25351648708759383,1.0,16/40,19.68%,SLC36A2;SLC36A4;SLC38A6;SLC7A7;SLC16A1;SLC38A1;SLC38A7;SLC27A1;SLC7A11;SLC23A2;SLC23A1;SLC38A9;SLC36A1;ABCC1;SLC19A1;SLC7A8
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.6966457220346947,1.556844299884447,0.02318840579710145,0.2535847360731346,1.0,6/15,15.74%,CD36;MEFV;NLRP2B;NLRC3;TREM2;MYD88
prerank,positive regulation of cell communication (GO:0010647),-0.48045711881858444,-1.556457002063846,0.01809954751131222,0.30095217092525106,1.0,11/28,20.41%,SYT1;RIMS1;RIMS2;ANK3;GRIK2;CD80;HOMER1;NMU;TNF;CDKN2AIP;SOX11
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.5877955400671737,1.5543207525608698,0.0171990171990172,0.25901068153980694,1.0,17/38,18.02%,MICALL2;NPEPPS;FBXW7;SH3GLB1;HTRA2;UBE2L3;HUWE1;CSNK2A2;ARIH2;BAG4;FZD5;ATG13;PRKN;VPS11;USP36;PARL;TOMM7
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6390205444480384,1.552711550660792,0.02925531914893617,0.2620201374720505,1.0,4/21,5.64%,GPNMB;LGALS3;PIBF1;DUSP3
prerank,positive regulation of lyase activity (GO:0051349),-0.5717564138901386,-1.55131149191893,0.046511627906976744,0.3072690043620532,1.0,6/14,25.20%,ORAI1;CACNA1C;AKAP5;PARK7;ISCU;NOS1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6165643970960791,1.5508880574311341,0.02284263959390863,0.26544202537814515,1.0,8/31,12.04%,GPNMB;CDKN1A;PTEN;APC;RB1;BRD7;DCUN1D3;CDK2AP2
prerank,positive regulation of calcium ion import (GO:0090280),0.7184123642401817,1.5507881182360335,0.03597122302158273,0.2645324653823722,1.0,2/12,6.26%,LGALS3;SPHK2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.5205760631372089,-1.550678671037205,0.02681992337164751,0.3049705241468167,1.0,10/19,21.63%,PTPRD;IL1RAPL1;RELN;CUX2;LRP8;CDKL3;DBNL;SS18L2;CUL7;DBN1
prerank,adherens junction organization (GO:0034332),-0.4104130502891067,-1.5502229069145737,0.0,0.3021908289457997,1.0,11/48,7.69%,CADM1;CADM2;CTNND1;CDH11;CDH9;JUP;CDH8;CDH2;CDH6;SMAD7;CDH12
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6029292660787948,1.5496029574242332,0.02732919254658385,0.2665099847505129,1.0,8/33,12.04%,GPNMB;CDKN1A;PTEN;APC;RB1;BRD7;DCUN1D3;CDK2AP2
prerank,positive regulation of bone resorption (GO:0045780),0.731372085965765,1.5480671882557513,0.030791788856304986,0.2693142784118851,1.0,4/11,5.73%,SYK;PLEKHM1;SPP1;ADAM8
prerank,regulation of protein processing (GO:0070613),0.6506618271506237,1.5454359157936275,0.028225806451612902,0.2750065259018542,1.0,4/21,7.30%,CCBE1;CLN3;ADAM8;NLRC4
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5291222586163884,-1.5451621739233559,0.029197080291970802,0.30897833471552577,1.0,9/19,20.41%,GRM5;RYR2;TRPM2;PRKACA;PRNP;FIS1;PTPRJ;FKBP1B;ADGRL1
prerank,negative regulation of type I interferon production (GO:0032480),0.5658619640235402,1.5447352258168385,0.027710843373493974,0.2756149372241882,1.0,19/40,24.55%,LILRB1;IKBKE;TRIM25;NPLOC4;RNF135;REL;SIRPA;MAVS;NLRC3;TAX1BP1;RELB;TNFAIP3;ACOD1;OTUD5;TBK1;RNF125;ISG15;DHX58;GPATCH3
prerank,peptide catabolic process (GO:0043171),0.6364090846400446,1.5427365070017474,0.031746031746031744,0.2799168767573581,1.0,6/23,10.31%,ANPEP;CPQ;TPP1;NPEPPS;CTSH;LTA4H
prerank,regulation of brown fat cell differentiation (GO:0090335),0.6668913819791822,1.5423980355171059,0.03672316384180791,0.2796101150383083,1.0,7/16,10.59%,PIM1;FLCN;HNRNPU;METRNL;RREB1;FTO;SIRT1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5383626426024462,-1.5414722293247811,0.02962962962962963,0.3130051046094684,1.0,9/18,16.45%,NRXN1;NLGN1;RELN;TSHZ3;CACNG4;NLGN3;CACNG3;CCR2;CACNG2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5601050989839287,1.5411212991356422,0.018094089264173704,0.2817069565287116,1.0,21/46,24.07%,PPARG;CTNNB1;ID2;IL6;IGF1;THBS1;HMOX1;FOXP1;IL6R;XRCC5;RBPMS2;TNFAIP3;CX3CL1;APOD;TCF7L2;HES5;PRKDC;IGFBP3;MFN2;PDGFRB;OGN
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.671923632152836,1.5410952693947924,0.02586206896551724,0.28062812367701667,1.0,5/16,11.20%,LYST;PLEKHM2;SLAMF7;ARL8B;ULBP1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.7241474423707155,1.5409731228055183,0.023494860499265784,0.2798170988717413,1.0,3/12,10.02%,PPARG;NCOR1;ESR1
prerank,positive regulation of cellular component organization (GO:0051130),0.5126310542902808,1.540813057831291,0.005291005291005291,0.27903385849767565,1.0,19/107,8.03%,LGALS3;FNIP2;APOE;SYK;PLEKHM2;BCL2L11;VEGFA;FLOT1;ABCB7;FNIP1;TFRC;LRP1;CD151;SH3GLB1;MTLN;HAS3;ASAP1;NEDD4L;RB1
prerank,regulation of macroautophagy (GO:0016241),0.5174393512365634,1.5406877837112118,0.010626992561105207,0.27816439009784566,1.0,38/105,19.60%,ATP6V0D2;ERN1;ATP6V1A;TBC1D25;PRKAG2;ATP6V1E1;ATP6V1C1;WAC;ATP6V0D1;SNX5;SESN2;SH3GLB1;CLN3;PIK3CA;ATP6V1B2;EPM2A;PAFAH1B2;ATP6V0A1;QSOX1;LAMTOR1;SIRT1;ATP6V0E1;ATG13;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;ATP6V1H;UBQLN2;USP36;EXOC4;BNIP3;EXOC7;EXOC1;CASP3;RHEB;ATP6V1G2;TBK1
prerank,protein-containing complex disassembly (GO:0032984),0.5530711484796964,1.5402889031910416,0.019450800915331808,0.2780651108655295,1.0,19/54,14.89%,CTNNB1;SNAP29;TECPR1;UVRAG;CLN3;VTI1B;APC;RPL23;LAMP2;DVL1;VPS33A;VPS4A;GSK3B;EPG5;FZD5;FZD2;PPP1CA;LRP6;SNX14
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6117294763974174,1.5384292097269638,0.0327653997378768,0.2819171250828555,1.0,9/26,14.77%,EYA1;MAP2K5;HTRA2;MAPK7;HSPA1B;SNAI2;HSPA1A;GDNF;MCL1
prerank,negative regulation of interferon-beta production (GO:0032688),0.7376664649799484,1.5374023887193606,0.04313099041533546,0.2833715157475922,1.0,5/10,12.23%,LILRB1;REL;SIRPA;NLRC3;RELB
prerank,smooth muscle cell differentiation (GO:0051145),0.7218122519595898,1.5363890547087073,0.026865671641791045,0.2849053584835375,1.0,3/12,0.87%,APLNR;MRTFA;MRTFB
prerank,regulation of glycogen metabolic process (GO:0070873),-0.6068595338821379,-1.5363149758151697,0.05263157894736842,0.31988043452906656,1.0,6/12,29.00%,RUBCNL;PPP1R3B;PPP1R3F;KHK;PPP1R3C;PPP1R3E
prerank,defense response to Gram-negative bacterium (GO:0050829),0.5685266255107837,1.536291448331524,0.018028846153846152,0.28402154168919325,1.0,12/42,17.91%,OPTN;MPEG1;AQP1;IL6;RNASE3;IL6R;DROSHA;TREM2;SLC11A1;LBP;TNFRSF14;DEFA6
prerank,positive regulation of interleukin-17 production (GO:0032740),0.6341123102464351,1.53629072587864,0.03062583222370173,0.28290231009267364,1.0,8/22,19.58%,RFTN1;IL6;LY9;NR1H4;IL15;MYD88;ZBTB7B;OSM
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6305893509122051,1.536095305838838,0.032722513089005235,0.28232406899184276,1.0,4/23,4.49%,PPARG;ARG1;NR1H3;IFNGR2
prerank,regulation of keratinocyte migration (GO:0051547),0.7135501135718214,1.535774230451337,0.03293413173652695,0.2819746316453703,1.0,3/12,4.72%,IQSEC1;ADAM9;PTEN
prerank,regulation of protein neddylation (GO:2000434),0.7505953996510488,1.5351384418606546,0.03538461538461538,0.28254164979851004,1.0,6/10,16.63%,EPAS1;COPS9;DCUN1D5;DCUN1D3;DCUN1D4;DCUN1D1
prerank,establishment of protein localization to membrane (GO:0090150),0.5275902695472132,1.5343333231237157,0.0077951002227171495,0.2834520891724085,1.0,23/66,17.79%,RFTN1;SDCBP;PIKFYVE;ZDHHC14;ZDHHC19;NPC1;SYNE3;GRIN3B;RAB3GAP2;YIF1B;MICALL1;ZDHHC12;ZDHHC18;NACA;RAB10;RAB11B;RABGEF1;ZDHHC24;BID;NCF1;ZDHHC4;SEC63;ICMT
prerank,negative regulation of mitochondrion organization (GO:0010823),0.5944616527450391,1.5338833396300118,0.016270337922403004,0.28363016316929646,1.0,13/33,15.79%,VAT1;SLC35F6;TFRC;HGF;IGF1;PPIF;FLCN;HUWE1;OMA1;PRKN;HSPA1A;BNIP3;ACAA2
prerank,vasculature development (GO:0001944),0.6835353124642332,1.5332747940830194,0.039160839160839164,0.28409983710950704,1.0,6/16,9.37%,APLNR;STRA6;FBXW7;PIK3CA;ACVRL1;BMPR2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5293411276976655,1.5331847765808853,0.004530011325028313,0.2832985209736931,1.0,23/74,20.47%,EPAS1;NFE2L2;VEGFA;PSMD1;CITED2;BACH1;CREBBP;RPS27A;UBC;EGLN3;PSMF1;PSMD14;NOTCH1;PSMD12;LIMD1;PSME2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5163891290792197,-1.5327079352127155,0.0299625468164794,0.3239648754307897,1.0,7/18,5.89%,NRXN1;NLGN1;RIMS1;RIMS2;RELN;GRIN1;CUX2
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.48506006279665836,-1.5327049904123757,0.036585365853658534,0.3203751786088402,1.0,10/24,15.79%,HDGFL3;MAPT;STMN3;FGF13;TPPP;STMN4;STMN2;KIF18A;TPPP3;STMN1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.7436415788734001,1.5326650880163835,0.03484848484848485,0.2836065481242439,1.0,5/10,13.63%,AOC3;ETFBKMT;HP;MT3;PRKN
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5854510382319491,-1.531237068388184,0.05572755417956656,0.3200310591903559,1.0,2/13,3.51%,CYRIB;STX7
prerank,negative regulation of response to external stimulus (GO:0032102),0.5076035317670146,1.5311491406404953,0.004268943436499467,0.2865186519922868,1.0,29/105,14.38%,PPARG;APOE;SIGIRR;NR1H3;RNF26;PRKCD;AOAH;PTEN;MAPK7;DUSP3;NR1H4;IRAK3;PROC;METRNL;MFHAS1;RB1;SIRPA;NFKBIL1;MEFV;PTGER4;NLRC3;TRAFD1;PPARD;RORA;LPCAT3;TNFAIP3;TNFAIP8L2;INPP5F;ACOD1
prerank,inhibitory synapse assembly (GO:1904862),-0.6073154266803596,-1.5311097295975422,0.05014749262536873,0.316717316641989,1.0,4/11,5.31%,GABRB3;GABRA2;LGI2;FGF13
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.703245513696883,1.5303151464207412,0.04081632653061224,0.2877327956158502,1.0,4/13,5.49%,PLXNA1;PLXNC1;PLXND1;NRP2
prerank,intermediate filament organization (GO:0045109),0.6485494383886661,1.530282500008347,0.04016620498614958,0.2867487492177244,1.0,3/17,2.65%,MTM1;VIM;DNAJB6
prerank,cellular glucan metabolic process (GO:0006073),0.7196772012745659,1.5302750376730339,0.04451510333863275,0.28567021561219225,1.0,5/11,12.60%,PRKAG2;PYGL;GBE1;GSK3B;UGP2
prerank,negative regulation of anoikis (GO:2000811),0.6885664599146292,1.529685554326262,0.045845272206303724,0.28608063775985115,1.0,7/14,14.77%,PDK4;ITGA5;PIK3CA;SNAI2;ITGB1;NOTCH1;MCL1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.597224556946442,1.5288795163393483,0.03713188220230474,0.28718469139109737,1.0,12/29,16.59%,GRB2;TGM2;NOTCH2;IGF1;IRS2;VAV1;NOTCH1;RAPGEF1;RASGEF1A;ERBIN;SHC1;LRRC59
prerank,endosome organization (GO:0007032),0.5671200248954597,1.528350236582835,0.02609727164887307,0.2874932691486191,1.0,19/41,19.18%,PHETA2;HOOK3;SNX10;CORO1C;RNF26;EEA1;LAMTOR1;SNX33;PI4K2A;ARFGEF2;PLEKHJ1;SQSTM1;VPS11;DNAJC13;USP8;RAB22A;SNX3;ALS2CL;WASHC5
prerank,protein localization to lysosome (GO:0061462),0.6095822399013284,1.5280216623848717,0.038560411311053984,0.2873707219580587,1.0,17/28,24.59%,RAB7A;SORL1;GLMP;RNF128;LMBRD1;SCARB2;NCOA4;SNX16;VPS4A;M6PR;RTN4;AP4M1;NAGPA;GGA3;ZFYVE16;KPTN;ATP13A2
prerank,protein processing (GO:0016485),0.5124127394447371,1.5273196846985357,0.0021141649048625794,0.2881612477542178,1.0,47/102,25.50%,F7;CD5L;CTSL;PCSK4;KLK3;TMPRSS4;CPXM1;CLN5;MMP14;CLN3;HTRA2;FAM111A;PITRM1;CTSS;CTSH;HPR;HP;BACE1;ADAM17;HM13;MYRFL;LONP2;OMA1;SPCS2;ADAM19;NCSTN;CPM;PARL;CASP2;DDI2;AFG3L2;TYSND1;OGT;LGMN;ADAM10;APH1B;FURIN;XPNPEP3;PSEN2;PCSK7;SPRTN;SRGN;KLK1;ZMPSTE24;FXN;RCE1;SPPL3
prerank,positive regulation of neuron projection development (GO:0010976),-0.38278002208820194,-1.5261634133851398,0.011627906976744186,0.3229624468292958,1.0,24/85,9.54%,ARSB;CAMK1D;RIT2;TWF2;TENM3;NTRK3;SETX;ITGA6;EPHA3;TOX;PLPPR5;MAGI2;SCN1B;RELN;FUT9;NTRK2;ATP1B2;CUX2;PRKD1;VLDLR;MARK2;LRP8;DAB2IP;SERPINI1
prerank,cell differentiation in hindbrain (GO:0021533),-0.6239212919456033,-1.526049004650308,0.05309734513274336,0.3197639531011463,1.0,4/11,3.92%,OPHN1;GRID2;KNDC1;FAIM2
prerank,potassium ion homeostasis (GO:0055075),-0.5050261286922115,-1.5260219286260783,0.04054054054054054,0.31645436379199715,1.0,7/23,5.31%,KCNMA1;SLC12A2;ATP1B1;SLC12A6;ATP1A2;KCNJ2;ATP1B2
prerank,triglyceride homeostasis (GO:0070328),0.6123096633687187,1.525807649532461,0.02967741935483871,0.2910778569958904,1.0,6/26,11.94%,APOE;NR1H3;MTLN;NR1H4;SIRT1;RORA
prerank,response to interleukin-6 (GO:0070741),-0.6384493260622827,-1.524953800852763,0.057803468208092484,0.3150259272162601,1.0,3/10,0.56%,SELPLG;ST3GAL6;PTPRT
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5252254908160299,1.5246058371384617,0.003329633740288568,0.29305217895672314,1.0,23/74,14.77%,LGALS3;EYA1;FAS;BIRC6;RIPK1;MAP2K5;IGF1;MAPK7;THBS1;HSPA1B;HMOX1;SH3RF1;BRCA1;SNAI2;GSK3B;ARHGEF2;RNF34;RELA;TNFAIP3;HSPA1A;GDNF;PHIP;MCL1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5039567930952181,1.524509198116297,0.005291005291005291,0.2921991754153907,1.0,23/113,12.34%,LGALS3;CD36;FNIP2;ABCA1;SYK;BCL2L11;VEGFA;FNIP1;TFRC;LCP1;SH3GLB1;GTF2H5;MTLN;ASAP1;CAPG;IL5;TERF1;DDB1;ESR1;GSK3B;PIEZO1;STUB1;CUL4A
prerank,regulation of tissue remodeling (GO:0034103),0.6527641900913903,1.5243070089230484,0.03462603878116344,0.2917164923074834,1.0,1/18,0.01%,GPNMB
prerank,cellular response to fluid shear stress (GO:0071498),0.6972075575965864,1.5231163139893062,0.05359877488514548,0.29374234469038374,1.0,4/12,5.24%,MTSS1;NFE2L2;MAP2K5;MAPK7
prerank,regulation of hemopoiesis (GO:1903706),0.7482465606697355,1.5226678534731874,0.032210834553440704,0.29372058510953797,1.0,5/10,11.91%,LGALS3;CREBBP;CBFB;MAFB;PRKCB
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6636898242249921,1.5226178782868127,0.04781420765027322,0.29277628669310546,1.0,3/17,5.64%,LGALS3;DGKZ;DUSP3
prerank,phagosome-lysosome fusion (GO:0090385),0.7440393974236594,1.5212413501670108,0.037993920972644375,0.2953667584932962,1.0,6/10,9.66%,RAB7B;PIKFYVE;RAB20;RAB7A;CLN3;ARL8B
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7281847116527441,1.5201859026225821,0.053763440860215055,0.29710813706183664,1.0,3/10,15.74%,CD36;TREM2;MYD88
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.693070706448756,1.5197794532097497,0.040345821325648415,0.2970931350261584,1.0,4/13,4.59%,CBLB;IPO5;KPNA4;KPNA2
prerank,receptor-mediated endocytosis (GO:0006898),0.5007402003363725,1.519570085945619,0.005219206680584551,0.296656779540608,1.0,35/132,14.61%,CD36;TPCN2;APOE;SYK;IGF2R;GRB2;PIKFYVE;CTSL;LILRB1;TFRC;LRP1;STAB2;SNX9;PPT1;SORL1;CLN3;GAK;LMBRD1;SCARB2;RAB31;MICALL1;FOLR1;HPR;HP;PICALM;ITGB1;FCHO1;M6PR;AP1G2;AP1G1;EPS15;AP2B1;INPP5F;RABEPK;LRP6
prerank,proteolysis (GO:0006508),0.4836391439884734,1.5180840217777145,0.0,0.29953898119722,1.0,77/252,22.83%,F7;ANPEP;MMP12;CTSB;ADAM33;CTSD;CAPN15;TINAGL1;CTSL;CPQ;PCSK4;TPP1;KLK3;NPEPPS;TMPRSS4;HGF;NLN;CTSA;CNDP2;CPXM1;MMP14;LONP1;CLN3;HTRA2;FAM111A;PITRM1;PROC;CAPN2;CTSS;CTSZ;CTSH;VASH2;BACE1;RSPRY1;PLAU;ADAM17;HM13;CTSW;PGPEP1;LONP2;ATG4B;UBA3;FBXO6;FBXW2;CAPN7;RNF123;TMPRSS5;ADAM19;NCSTN;CASP6;CPM;LNPEP;PARL;ACE;SENP1;CASP2;CASP3;APEH;PRCP;RNPEPL1;DDI2;LAP3;UFSP2;AFG3L2;TYSND1;PSMA6;OGT;LGMN;ADAM10;MMP19;CLPX;DPP3;APH1B;FURIN;XPNPEP3;MALT1;PSEN2
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.6239277988835512,-1.516449434206922,0.060526315789473685,0.3291799843942729,1.0,3/10,10.33%,WHRN;PLS1;ADGRV1
prerank,protein neddylation (GO:0045116),0.6934056926142518,1.5151365762296902,0.05349182763744428,0.3064494652761428,1.0,8/13,17.29%,DCUN1D5;DCUN1D3;UBA3;DCUN1D4;UBE2F;RNF7;DCUN1D1;UBE2M
prerank,inflammatory response (GO:0006954),0.48557242296209757,1.5150725347411826,0.0,0.3055675960303831,1.0,43/195,14.82%,CDO1;ADGRE5;CXCR4;AOC3;HRH1;ANXA1;PTGDR;MGLL;CEBPB;IL36G;CD44;IL6;XCR1;IL10RB;PLA2G2D;PARP4;C3AR1;THBS1;ADAM8;PTGER2;CYBB;REL;CYBA;MFHAS1;NLRC4;FOLR2;BLNK;MEFV;HPR;HP;HNRNPA0;PTGER4;NFATC3;LIAS;SIGLEC1;RELB;AFAP1L2;RELA;SLC11A1;TRAF3IP2;ADCY8;NRROS;CX3CL1
prerank,synapse assembly (GO:0007416),-0.3809449207631903,-1.5136257630463041,0.0,0.3315927433563613,1.0,16/67,6.52%,ADGRL3;GABRB3;SDK1;GPM6A;NRXN1;KIRREL3;NLGN1;DNM3;RYK;LRRTM3;GRID2;GABRA2;LGI2;FGF13;FARP1;CDH2
prerank,regulation of cholesterol esterification (GO:0010872),0.7348196403732254,1.5134939982628945,0.04309063893016345,0.3087413001593283,1.0,4/10,9.57%,APOE;ABCG1;ABCA2;LAMTOR1
prerank,glycogen biosynthetic process (GO:0005978),0.7044869840813927,1.5127118493704326,0.0380517503805175,0.3087353534269592,1.0,5/12,12.60%,GYG1;GBE1;NHLRC1;PGM1;UGP2
prerank,glucan biosynthetic process (GO:0009250),0.7044869840813927,1.5127118493704326,0.0380517503805175,0.3087353534269592,1.0,5/12,12.60%,GYG1;GBE1;NHLRC1;PGM1;UGP2
prerank,positive regulation of protein deacetylation (GO:0090312),0.6732610583912745,1.512037763257443,0.0456490727532097,0.309567325163548,1.0,3/14,6.98%,APLNR;DYRK1A;NIPBL
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6566671567950864,1.511557065283713,0.04794520547945205,0.3097537719503172,1.0,11/18,22.83%,APOE;ABCG1;CLN3;BACE1;ADAM17;ADAM19;NCSTN;ADAM10;APH1B;LDLRAP1;PSEN2
prerank,phosphatidic acid metabolic process (GO:0046473),0.546966890538066,1.5113905193831736,0.02927400468384075,0.30913308777950965,1.0,10/48,8.06%,DDHD1;GPAT2;AGPAT4;PLD2;PLA2G2D;DGKZ;DGKA;GPD1L;SLC27A1;ABHD4
prerank,chloride transport (GO:0006821),-0.3736644388127854,-1.5113383426463793,0.0,0.3329744809391052,1.0,24/74,14.65%,SLC12A2;GABRB3;SLC12A6;ANO4;GLRB;SLC1A3;ANO3;GLRA3;GABRA2;GABRB1;TTYH1;GABRA3;GLRA1;GABRG3;SLC4A10;SLC6A1;SLC4A8;SLC1A1;LRRC8A;CLCN3;CLCN6;SLC12A4;GABRA4;CLCN2
prerank,regulation of response to biotic stimulus (GO:0002831),0.6009645351381805,1.5103455251562372,0.033854166666666664,0.31099008631023867,1.0,19/28,24.88%,CD36;APPL2;RNF135;TKFC;XIAP;FOXP1;BIRC3;APPL1;TREM2;TRAF3;FGR;N4BP1;CX3CL1;BIRC2;FCGR2B;TIRAP;CASP8;DHX58;ZMPSTE24
prerank,organic hydroxy compound transport (GO:0015850),0.5782470854336224,1.5086248654073802,0.04049079754601227,0.3148118555353608,1.0,9/36,9.35%,STRA6;SLC51A;RXRA;SLC16A1;STARD5;ABCC4;NR1H4;ABCC3;NCOA1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.55812177897515,-1.50845735613165,0.058419243986254296,0.3356311394949754,1.0,7/15,15.84%,GRM5;GRM1;GRM8;GRM3;HOMER1;GRIK3;GRM7
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.6679245263837488,1.5082966182804503,0.04,0.3145878141681065,1.0,2/16,0.58%,HTR2B;APOE
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6262223011756236,1.5080663766498184,0.034974093264248704,0.314107439750533,1.0,5/23,8.15%,IRX3;HOPX;ID2;MYL2;MYBPC3
prerank,intracellular cholesterol transport (GO:0032367),0.6882406680111276,1.5075992231759792,0.04310344827586207,0.31431681776100034,1.0,6/15,9.77%,ABCA1;NPC1;ABCG1;SERAC1;RELCH;VPS4A
prerank,positive regulation of vasoconstriction (GO:0045907),0.6797945056426018,1.507543951048646,0.04454022988505747,0.31338103223186503,1.0,2/13,1.52%,ADRA1D;ADRA1A
prerank,T cell activation involved in immune response (GO:0002286),0.6903620125143903,1.5072894304491637,0.039647577092511016,0.31302851508920854,1.0,4/12,13.66%,LILRB1;LCP1;EIF2AK4;SLC11A1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6772773107241244,1.5061694213749603,0.05308464849354376,0.3151106983461885,1.0,3/14,6.34%,AK8;ENPP1;ITPA
prerank,zymogen activation (GO:0031638),0.5673870565277533,1.5051043362391128,0.022946859903381644,0.31707119828174535,1.0,12/39,9.75%,CD5L;CTSL;KLK3;F11;MMP14;TBC1D10A;NLRC4;CTSH;HPR;HP;CYFIP2;PLAU
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.5400117126296026,-1.5045027446032764,0.04823151125401929,0.34086750890803835,1.0,9/16,13.96%,ST6GALNAC3;ST8SIA6;ST3GAL5;ST6GALNAC5;ST6GALNAC4;ST8SIA1;ST8SIA5;ST8SIA3;ST6GALNAC6
prerank,ureteric bud development (GO:0001657),-0.5397653166644116,-1.5036875074198288,0.04363636363636364,0.3391438065583121,1.0,12/17,36.11%,SALL1;ROBO2;FGFR2;PKD2;NPNT;FOXC1;FOXJ1;BMP2;BMP4;LHX1;BMP7;SLIT2
prerank,muscle cell development (GO:0055001),0.5822185275274576,1.5031175183518566,0.04725415070242656,0.321469147839266,1.0,5/30,5.08%,MYOF;ALPK3;VEGFA;SLC8A1;IGF1
prerank,NAD biosynthetic process (GO:0009435),0.6326387157704477,1.5022656262282534,0.03523035230352303,0.3226777237744314,1.0,3/20,6.98%,NAMPT;KYNU;NMNAT1
prerank,positive regulation of DNA binding (GO:0043388),0.5859959504287842,1.502056557173427,0.03850931677018633,0.32219006944477835,1.0,5/31,8.03%,PPARG;TXN;NIBAN2;IGF1;RB1
prerank,regulation of B cell differentiation (GO:0045577),0.6538095559580899,1.501833652122488,0.03626220362622036,0.32177076476548055,1.0,5/17,12.78%,SYK;ID2;MMP14;ZFP36L2;BTK
prerank,regulation of interleukin-4 production (GO:0032673),0.6276440719607946,1.5017534070772451,0.04046997389033943,0.3209238883938708,1.0,6/21,9.53%,SYK;CEBPB;FOXP3;CD28;RARA;DDIT3
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6481647457305018,1.5017515778223993,0.04806408544726302,0.31986813783917467,1.0,3/16,8.59%,LGALS3;TNFRSF1B;CD22
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6273576142328204,1.5009236347224115,0.04223433242506812,0.32009398647785836,1.0,8/21,14.77%,EYA1;MAP2K5;MAPK7;HSPA1B;SNAI2;HSPA1A;GDNF;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6273576142328204,1.5009236347224115,0.04223433242506812,0.32009398647785836,1.0,8/21,14.77%,EYA1;MAP2K5;MAPK7;HSPA1B;SNAI2;HSPA1A;GDNF;MCL1
prerank,fatty acid metabolic process (GO:0006631),0.49755701171382344,1.5006494400726493,0.01050420168067227,0.31978613684977075,1.0,18/115,9.10%,CD36;PPARG;CEL;BAAT;LIPG;LPIN3;GPAT2;SGPL1;FASN;AOAH;SLC27A4;PON3;ACSM3;SLC27A3;GPX4;CRAT;CPT1A;NDUFAB1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.5808689482581381,1.4997710576305288,0.030690537084398978,0.3211266134643881,1.0,13/30,19.10%,DNAJB13;CHCHD4;GAK;HSPA1B;DNAJB5;DNAJB14;HSPA1A;UGGT1;HSPA13;DNAJC18;HSPE1;CCT2;BAG1
prerank,protein heterooligomerization (GO:0051291),-0.5201510672774788,-1.4997279590883261,0.05423728813559322,0.34416643947635145,1.0,8/17,21.94%,GRIN2B;KCNC2;GRIN1;TMEM120A;PKD2;PKD1;MAT2A;NUDT21
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.7089528596258243,1.4996961457786997,0.04769475357710652,0.3202748835774675,1.0,7/11,21.03%,VCPIP1;LPCAT3;ATL2;ATL1;MOSPD3;RTN4;ARL6IP1
prerank,positive regulation of organelle organization (GO:0010638),0.582608146254459,1.498056911888238,0.032133676092544985,0.3240752900870009,1.0,10/32,12.33%,ANXA1;FYCO1;SORBS3;UVRAG;HTRA2;ANXA2;RAB3GAP2;GSK3B;SHCBP1L;TREM2
prerank,regulation of neuron differentiation (GO:0045664),-0.3649451530928181,-1.4976953163170101,0.010416666666666666,0.3450262858976381,1.0,10/76,4.41%,ZFHX3;BIN1;MEF2C;BRINP3;NLGN1;ZEB1;TIAM1;CNTN4;CDK5R1;VWC2
prerank,RNA metabolic process (GO:0016070),0.48777834032360934,1.497672978527757,0.004210526315789474,0.3240680108935888,1.0,43/127,15.47%,APOBEC1;RBMS1;DHX8;POLR2A;ATXN1;WTAP;TFIP11;HNRNPH2;MPHOSPH10;RBM39;ATXN2;RNASE3;AGO2;NUFIP1;RNASEL;HNRNPUL1;THOC1;HNRNPU;RBPMS;POLR2L;TENT2;HNRNPA0;WDR74;POLR2G;DKC1;AGO3;FTO;POLR2I;NCBP2;DROSHA;HNRNPM;GTF2F2;SND1;DEDD2;DDX20;SIDT2;RNASEH2A;MRPL44;HNRNPD;RNASEH1;MTREX;ADARB1;PCBP1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.5026938654926868,1.497595921688397,0.008639308855291577,0.3232647885534382,1.0,33/94,18.23%,FNIP2;BCL2L11;ERN1;CEBPB;IKBKE;PRKCD;CDKN1A;APAF1;TNFRSF1B;E2F1;HTRA2;CUL3;GSKIP;MLLT11;STK24;DDX5;ATF4;PRODH;BRCA1;TOPORS;HIPK2;DDIT3;CUL4A;BAX;CUL1;MCL1;QRICH1;BNIP3;TRAF2;RRP8;BBC3;C1QBP;CASP2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.45018866676586017,-1.497312100785736,0.039301310043668124,0.34253052141619056,1.0,7/30,4.62%,SNTA1;ANK2;CACNA1C;RYR2;SCN1B;FGF12;KCNJ2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5044101367232172,1.4972565388114363,0.010638297872340425,0.323141137976587,1.0,32/91,20.67%,FLVCR1;FTL;ATP6V1A;ABCB7;TFRC;SLC11A2;ATP6V0D1;TMEM199;NUBP1;HMOX1;FRRS1;HEPH;SLC39A14;GLRX3;MT3;APP;HMOX2;SLC11A1;SLC39A12;CUL1;ATP7A;SLC31A2;FTH1;SLC30A1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,positive regulation of T cell proliferation (GO:0042102),0.5266597014804547,1.4972415281878024,0.03608847497089639,0.32218453311845524,1.0,9/55,5.08%,SYK;ANXA1;NCK2;TFRC;IL6;CD28;CD46;CD274;IGF1
prerank,neuron migration (GO:0001764),-0.40534463087064815,-1.496849615136228,0.006756756756756757,0.3403680118257251,1.0,16/48,9.06%,ADGRL3;MEF2C;GPM6A;SPOCK1;DISC1;AUTS2;RELN;CDK5R1;NTRK2;FGF13;ASTN2;MARK1;TUBB2A;DNER;MARK2;SEMA3A
prerank,sterol transport (GO:0015918),0.6411503092530871,1.4964513684841803,0.03415300546448088,0.32317213430829544,1.0,2/19,1.84%,CD36;NPC1
prerank,sphingolipid metabolic process (GO:0006665),0.49372789425225,1.496099396710722,0.006389776357827476,0.32313836723824024,1.0,39/108,20.51%,PSAP;PLPP3;SPTLC2;CERK;SAMD8;SGPL1;GALC;CERT1;GLA;CTSA;ESYT1;PPT1;SGMS2;HACD4;HEXA;CERS6;SPHK2;ARSA;SPTSSA;ABCA2;VAPA;ELOVL1;GM2A;ALDH3A2;DEGS1;PRKD3;ESYT2;SUMF1;NEU1;ACER2;SGMS1;CERKL;PPP2CA;NSMAF;ASAH1;SGPP2;PPP2R1A;CERS1;ARV1
prerank,positive regulation of secretion (GO:0051047),0.6972439535542129,1.4955522652899464,0.056439942112879886,0.32358464343184445,1.0,3/11,13.02%,AQP1;TRH;GPLD1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.5158916538893489,-1.4953773336458653,0.05501618122977346,0.34015531524882414,1.0,10/18,11.83%,CAMK1D;RPS6KA5;EPHA5;RELN;PRKD1;CD200;LRP8;LPAR5;ADCY1;PRKD2
prerank,endocytic recycling (GO:0032456),0.5404801729428379,1.4951867202572813,0.021889400921658985,0.3235595496614086,1.0,22/50,20.14%,MICALL2;SNX27;DENND1A;RAB7A;WASHC1;MICALL1;DENND1B;EIPR1;VPS52;VPS51;VPS35L;RAB11B;EPS15;ARL4C;STX6;SNF8;SNX17;SNX3;VPS29;ANKRD27;ANKRD50;RAB13
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5686916437046585,1.4936155466713361,0.0322180916976456,0.3265219853032832,1.0,7/35,7.85%,CD36;HTR2B;APOE;AQP1;PDE7B;MAPK7;SOX9
prerank,oligosaccharide metabolic process (GO:0009311),-0.4139022161843339,-1.4933825102572083,0.0213903743315508,0.3412600174177675,1.0,16/46,13.96%,ST3GAL6;B3GALT1;ST6GALNAC3;ST8SIA6;FUT9;MAN2B2;ST3GAL2;ST6GALNAC5;ST6GALNAC4;ST8SIA1;ST8SIA5;ST6GAL2;ST8SIA3;GAL3ST4;B4GALT1;ST6GALNAC6
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5449430342439506,1.493312893211352,0.018604651162790697,0.3263326353267813,1.0,13/47,12.29%,FBXW7;GLA;SIK1;ACADL;ACADVL;BRCA1;SNAI2;SLC27A1;ABCA2;SIRPA;ERLIN1;WDTC1;PGP
prerank,protein transport (GO:0015031),0.46947804401806886,1.4932205206121558,0.0,0.3255836068006284,1.0,92/332,16.85%,ATP6V0D2;CD36;PPARG;ABCA1;APOE;TLK1;OPTN;STX3;SNX8;ATP6V1A;STEAP3;ACD;ABCG1;RAB8B;TBC1D22A;SNX27;RIC1;TBC1D25;TFRC;RAB20;ATP6V1E1;RAB7A;LRP1;TBC1D1;TBC1D2;ATP6V1C1;CTSA;ARRDC4;TCIRG1;SNX9;ATP6V0D1;TBC1D12;PPT1;RAB21;STX8;TBC1D10A;COG7;STX5;RAB3GAP2;CHMP2A;TANGO6;ATP6V1B2;VMP1;TBC1D2B;RAB31;KIF3A;RAB1B;LAMP2;TICAM2;RAB28;VPS33A;UNC93B1;STX11;ATP6V0A1;SNX33;RAB12;SIL1;TBC1D22B;RAB10;ARHGEF2;RAB18;TBC1D15;WLS;PRKCB;STXBP3;RAB24;MYH9;AP3D1;ATP6V0E1;RAB43;RAB11B;MACF1;ATP6V0C;ATP6V0B;ATP6V1H;ARL4C;STX6;SLC10A7;AP3B1;GOLPH3;GOLPH3L;GOLGA4;SNX17;TOM1;TBC1D9;NEURL1B;RABGAP1;ZDHHC17;RAB29;ATP6V1F;GGA2;RAB22A
prerank,O-glycan processing (GO:0016266),0.528597073731614,1.4928859880024679,0.029308323563892145,0.3255750915472002,1.0,7/54,7.77%,B4GALT5;B3GNT8;GALNT3;GALNT6;GALNT9;ST3GAL4;GXYLT2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5406752803443601,1.4921305570138885,0.024390243902439025,0.3267550623793956,1.0,15/50,13.37%,VEGFA;AQP1;FNIP1;DNAJB6;CD44;HGF;MAP2K5;RAF1;THBS1;SH3RF1;XIAP;PAK2;MT3;RNF34;GAS6
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.599147368144413,-1.491640246990024,0.06289308176100629,0.3416159877164155,1.0,5/11,16.42%,BIN1;CACNB2;NOS1AP;CACNA2D1;CACNB1
prerank,response to insulin (GO:0032868),0.5074980458995243,1.4911543042266613,0.011995637949836423,0.32849295985289034,1.0,30/80,22.59%,PPARG;MYO5A;DENND4C;LPIN3;RAB8B;PDPK1;ENPP1;IRS2;EIF6;RAB31;SLC27A1;SLC39A14;RAB12;RAB10;FOXO1;SIRT1;EPRS1;GPLD1;INSIG2;EPM2AIP1;ZBTB7B;CPEB2;RAB13;VAMP2;GCK;OGT;TBC1D4;PKM;PRKDC;SYAP1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.5784413700832615,-1.490665215479003,0.08176100628930817,0.34035148464953724,1.0,5/11,31.82%,MEF2C;TGFB2;TGFB1;GREM1;EFNB2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6518108854338843,1.4897317751142132,0.054285714285714284,0.33139485965192556,1.0,2/15,1.26%,CD36;PRKCH
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.5105407226268643,1.48875661335348,0.015418502202643172,0.33320934622711307,1.0,20/80,13.37%,CTSD;SYK;VEGFA;AQP1;FNIP1;DNAJB6;CD44;HGF;DAPK1;MAP2K5;RAF1;HTRA2;THBS1;SH3RF1;XIAP;CYCS;SIRT1;MT3;SOX2;GAS6
prerank,regulation of RNA splicing (GO:0043484),0.5170897622090536,1.4876526072452523,0.013559322033898305,0.3353291029217556,1.0,25/69,18.30%,HNRNPLL;ERN1;AHNAK;POLR2A;HNRNPH2;MBNL1;SRPK2;CELF1;RBM39;AHNAK2;DYRK1A;SF1;GRSF1;PTBP3;LARP7;SRSF3;PTBP2;PQBP1;RPS26;HSPA1A;PRX;MBNL2;SRPK1;RBM22;CLK3
prerank,sodium-independent organic anion transport (GO:0043252),-0.5957403763321969,-1.4875285595615815,0.06976744186046512,0.34373936000070915,1.0,6/10,23.40%,SLCO2B1;SLCO1B1;SLC16A2;SLCO5A1;SLCO4A1;MFSD10
prerank,nitrogen compound transport (GO:0071705),0.4860196553842789,1.4868315691940859,0.007172131147540984,0.336707241397672,1.0,43/141,21.63%,LRRC8D;SLC6A6;SLC7A2;FLVCR1;SLC18A1;SLC36A2;SLC43A2;AQP1;CERT1;RAB7A;SLC1A5;SLC7A4;SLC7A7;ARRDC4;SLC16A10;PPT1;SLC38A1;CHMP2A;SCARB2;KIF3A;SLC15A3;SLC6A8;SLC7A11;MYH9;SLC23A1;SLC52A1;SLC11A1;SLC44A2;TOM1;SLC7A1;SLC36A1;ABCC1;SLC6A4;LRP2;SLC19A2;SLC7A8;CALCRL;VAMP2;TMEM30A;ARRDC3;CHMP2B;NDC1;SLC22A5
prerank,connective tissue development (GO:0061448),0.5523840532659087,1.486417180621145,0.0414572864321608,0.33682223068150996,1.0,14/35,20.92%,NAMPT;SPTLC2;CD44;SULF2;SOX9;ARID5B;TRIP11;SULF1;SH3PXD2B;ATP7A;COL11A2;SOX8;HES5;ZBTB16
prerank,positive regulation of lipid storage (GO:0010884),0.6138769772541937,1.4861131893896882,0.053691275167785234,0.3365414897556079,1.0,3/21,2.44%,PLIN2;PLIN3;IKBKE
prerank,response to copper ion (GO:0046688),0.6290019744769687,1.4852079099747286,0.04794520547945205,0.33807533752058305,1.0,11/20,20.67%,AQP1;MT3;ATP5F1D;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6366433336714981,1.4851893585503686,0.06732117812061711,0.3371256350428209,1.0,9/16,18.44%,ABCD1;APPL2;ADCY7;SIRPA;MEFV;NLRC3;TREM2;APOD;CUEDC2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5770906096340221,1.4848249904783462,0.037758830694275276,0.33715720089556067,1.0,5/33,5.80%,LGALS3;CD300A;DGKZ;DUSP3;TRAT1
prerank,nuclear migration (GO:0007097),0.6791903439024679,1.484790015832857,0.041176470588235294,0.336265519639166,1.0,3/13,5.00%,HOOK3;DYNC1H1;SYNE3
prerank,negative regulation of immune response (GO:0050777),0.47831374975876856,1.4847646147443492,0.002066115702479339,0.3353421189775669,1.0,33/154,15.27%,LGALS3;CD300A;SYK;GPR15;LILRB1;PTGDR;FOXP3;PLK2;FCRLB;RNF26;IL6;HTR6;RHBDF2;GPR83;ADCY7;IRAK3;PTGER2;GPR176;PTGER4;VIPR1;NLRC3;ADAM17;PTH2R;TRAFD1;MYH9;TREM2;COL3A1;FGR;TNFAIP3;ACOD1;ADCY8;ADCY3;CD247
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5304669792405524,1.484095419237026,0.023310023310023312,0.3362162183998565,1.0,14/48,14.77%,FNIP2;BCL2L11;IKBKE;TNFRSF1B;E2F1;HTRA2;BRCA1;HIPK1;TOPORS;HIPK2;SIRT1;DYRK2;BAX;MCL1
prerank,regulation of cellular metabolic process (GO:0031323),0.5501601070652227,1.4837239675090832,0.026497695852534562,0.33621020698789367,1.0,17/45,17.49%,FLOT1;PDK4;ABCG1;MPV17;COQ7;FASN;KIF16B;PID1;EIF6;ABCA2;LAMTOR1;STUB1;RNF34;PRKN;PANK2;PARL;ARF4
prerank,B cell differentiation (GO:0030183),0.533420972378345,1.4830073079943102,0.03348729792147806,0.33729385568594267,1.0,12/46,17.63%,ADGRG3;FNIP1;TPD52;ITGA4;MS4A1;BLNK;ITGB1;ADAM17;DCAF1;JAK3;KLF6;ZBTB7A
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5914114528676906,1.4828707192675912,0.04521276595744681,0.33668656084982646,1.0,2/25,0.46%,PPARG;CBLB
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6732209690212752,1.4818720516742756,0.06358381502890173,0.3384318019353266,1.0,3/13,2.99%,NFE2L2;TXN;HGF
prerank,regulation of cell communication (GO:0010646),0.564371729514488,1.4811891606759,0.022900763358778626,0.3393324994313386,1.0,5/35,5.02%,MTCH1;ANXA1;MGLL;CDC42SE2;SLC8A1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6219818992122114,1.4804923306807183,0.043758043758043756,0.3404003301041859,1.0,7/21,11.17%,HTR2B;IGF1;ZFP36L2;SOX9;CTSH;PTGER4;MT3
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5874706206822835,1.4801321392374283,0.03346203346203346,0.34037615792066056,1.0,10/26,12.33%,CD36;FLOT1;APPL2;IRAK3;GPR108;NFKBIL1;NLRP2B;BIRC3;APPL1;TREM2
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6448554333180199,1.4798776543050138,0.051075268817204304,0.34006343528103616,1.0,4/17,4.62%,SYK;CEBPB;CD28;RARA
prerank,monocarboxylic acid metabolic process (GO:0032787),0.4903435011774116,1.47915129238949,0.008403361344537815,0.3410238779360407,1.0,27/117,15.95%,CD36;PPARG;BAAT;GPAT2;NPC1;SGPL1;AMACR;KYNU;MTHFS;FASN;PDZD11;SLC16A1;AOAH;SLC27A4;IGF1;GLYAT;CPT1A;GRHPR;MCCC1;PPARD;SLC6A8;MTHFD1L;HAGH;VDAC1;ME2;PANK2;ALDH1A2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4544583155402389,-1.4779795469948904,0.05078125,0.36087134295352186,1.0,8/26,14.51%,NAV3;MAPT;CDK5R1;PAK1;AKAP9;NUMA1;STMN2;MAPRE1
prerank,angiogenesis involved in wound healing (GO:0060055),0.6967130637495939,1.4777471760201828,0.04236006051437216,0.34402375483511516,1.0,2/11,1.73%,HPSE;VEGFA
prerank,positive regulation of integrin activation (GO:0033625),-0.6119627790690183,-1.4774626405494422,0.06528189910979229,0.3587673335542471,1.0,3/11,11.64%,P2RY12;FERMT2;RAP1B
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6180470829496236,1.4768451181419637,0.04632152588555858,0.345557463151043,1.0,5/22,5.24%,GCNT2;FLOT1;CD44;MAP2K5;MAPK7
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5535441678624049,1.4767066924941386,0.03579952267303103,0.3449807480274109,1.0,12/40,17.91%,MPEG1;IL6;STAB2;RNASE3;GBP6;ADAM17;DROSHA;FGR;LBP;MYD88;TNFRSF14;DEFA6
prerank,granulocyte chemotaxis (GO:0071621),0.5281317884405955,1.4756068157734963,0.022222222222222223,0.34705715904503187,1.0,4/55,1.55%,LGALS3;SYK;PIKFYVE;ANXA1
prerank,response to X-ray (GO:0010165),0.6613841131881222,1.4752478455335065,0.06204906204906205,0.3471858168184051,1.0,6/14,15.39%,XRRA1;ANXA1;NIPBL;XRCC4;XRCC5;BRCC3
prerank,cellular response to unfolded protein (GO:0034620),0.5830866583080341,1.4741858759128526,0.04336399474375821,0.34946803884620964,1.0,10/26,16.55%,OPTN;ERN1;HSPA1B;RHBDD1;PRKN;HSPA1A;BAX;HSPA13;HSPD1;PTPN1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.48760506705966883,1.4740744781064612,0.012752391073326248,0.34877508558184855,1.0,35/109,19.69%,SYK;GRB2;VAV3;MAP3K1;GAB2;TEC;SOS1;PDPK1;PSMD1;JUN;PIK3CA;VAV1;MAP2K4;PPP3CA;PPP3R1;PAK2;PSMF1;NFATC3;PSMD14;TAB2;PSMD12;BTK;RELA;SHC1;PSME2;CUL1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PIK3CB;PSMA2;PSMD11;LAT2
prerank,positive regulation of programmed cell death (GO:0043068),0.4639359888519745,1.4737591713187013,0.0010090817356205853,0.34874832038299386,1.0,80/272,18.60%,MTCH1;ABR;CTSD;MAP3K20;SYK;VAV3;LILRB1;RPS6KA2;BCL2L11;CTNNB1;ATG7;TGM2;GADD45B;ANO6;GADD45G;SOS1;IL6;FOXO3;FAS;JUN;APAF1;DAPK1;RIPK1;GNA13;SLC27A4;E2F1;HTRA2;GADD45A;AIFM2;MELK;MLLT11;SPHK2;STK3;APC;FLCN;CTNNBL1;ATF4;RPS27A;UBC;NLRC4;TNFAIP8;AKAP13;VAV1;ING3;NLRP2B;ITGB1;FOXO1;SIRT1;ARHGEF2;ING4;STPG1;DCUN1D3;DDX20;OMA1;GPLD1;BCLAF1;MCF2;SOS2;BAX;SQSTM1;FGD3;LATS1;NCSTN;QRICH1;BNIP3;HSPD1;BID;IFIT2;ADAMTSL4;CCAR1;UTP11;PRR7;SHQ1;C1QBP;ITSN1;CASP2;CASP3;STK4;CRADD;HTT
prerank,epithelium development (GO:0060429),0.4879861419259678,1.4726046550014418,0.005319148936170213,0.35113236692680927,1.0,15/107,9.86%,LGALS3;PPARG;ANXA4;CTSB;VEGFA;TPP1;TST;DAG1;ACADVL;SOX9;SNAI2;CPT1A;DVL1;RIPK4;PAX8
prerank,Fc receptor signaling pathway (GO:0038093),0.48641633090467684,1.4722496558493205,0.012779552715654952,0.3512651781611343,1.0,35/110,19.69%,SYK;GRB2;VAV3;MAP3K1;GAB2;TEC;SOS1;PDPK1;PSMD1;JUN;PIK3CA;VAV1;MAP2K4;PPP3CA;PPP3R1;PAK2;PSMF1;NFATC3;PSMD14;TAB2;PSMD12;BTK;RELA;SHC1;PSME2;CUL1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PIK3CB;PSMA2;PSMD11;LAT2
prerank,positive regulation of transporter activity (GO:0032411),0.6847912647621182,1.4719826554531474,0.06020558002936858,0.35102533073757947,1.0,3/13,3.66%,SGK1;NR1H3;RXRA
prerank,transport along microtubule (GO:0010970),0.6763478001555849,1.471811016146718,0.04700854700854701,0.35048550236309967,1.0,4/13,11.47%,ARHGAP21;SPG11;BORCS5;APP
prerank,regulation of autophagosome assembly (GO:2000785),0.5625438847910981,1.4712873559637598,0.045454545454545456,0.35102350764725804,1.0,13/33,17.73%,MTM1;PIKFYVE;MTMR3;TBC1D12;SH3GLB1;RAB3GAP2;RAB1B;NPRL3;UBQLN2;NPRL2;PIP4K2A;TMEM39A;PHF23
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4934927802039491,-1.4705421189936272,0.041666666666666664,0.37052091318050334,1.0,12/20,26.97%,PRKCE;MTDH;HCK;IL18;TNF;CD14;LYN;CCL3;IL1B;CCL5;TGFB1;TICAM1
prerank,regulation of receptor recycling (GO:0001919),0.6456310045360347,1.4694949810434124,0.059782608695652176,0.3552147526707687,1.0,8/16,16.65%,OPTN;KIF16B;ANXA2;TRAT1;LAMTOR1;VAMP3;INPP5F;RAB29
prerank,negative regulation of histone modification (GO:0031057),0.6636182018021894,1.469143668002595,0.06082036775106082,0.3552280350923085,1.0,4/14,7.94%,FOXP3;TAF7;SPHK2;BRCA1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6037750177690642,1.4689069032185336,0.04533333333333334,0.3550148932910807,1.0,4/22,11.10%,PPARG;APOE;ZBTB20;PPARD
prerank,plasma membrane organization (GO:0007009),0.516279197601915,1.4675366948491015,0.02252252252252252,0.3579116295861718,1.0,18/61,14.26%,MYOF;CXCR4;PLSCR4;ANO6;ABCD1;BIN3;SNX9;AHNAK2;CLN3;FER1L6;MICALL1;A4GALT;ARL8B;EPB41L3;SNX33;MYH9;DEGS1;WHAMM
prerank,positive regulation of cellular metabolic process (GO:0031325),0.49860319995345626,1.4667757991255883,0.00966702470461869,0.3590770437658256,1.0,25/98,16.96%,PPARG;XDH;APOE;GRB2;VEGFA;NR1H3;CDKN1A;FASN;CD63;IL10RB;RIPK1;PID1;THBS1;GADD45A;ANXA2;RAB1B;PAX8;PPARD;MT3;VAMP3;INPP5F;ACOD1;ARRB1;RAB29;IFNAR1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5845987880732826,1.4660773529731965,0.03636363636363636,0.3602331954146799,1.0,14/25,26.73%,DNAJB13;GAK;HSPA1B;DNAJB5;DNAJB14;HSPA1A;HSPA13;DNAJC18;HSPE1;BAG1;HSPA9;ST13;ERO1A;DNAJB12
prerank,cardiac muscle cell differentiation (GO:0055007),0.6115933822563591,1.4657581899437073,0.054945054945054944,0.3600879892614425,1.0,6/21,7.99%,ALPK3;IRX3;VEGFA;SLC8A1;SIK1;AKAP13
prerank,negative regulation of histone acetylation (GO:0035067),0.6860470268298084,1.4656987802517298,0.058646616541353384,0.3592399181832616,1.0,6/11,22.85%,TAF7;BRCA1;SIRT1;NOC2L;SIN3A;CTBP1
prerank,regulation of inflammatory response (GO:0050727),0.46937488810127664,1.4654132172604193,0.0030581039755351682,0.3591433109772175,1.0,45/190,16.10%,PPARG;PLA2G7;APOE;MGST2;CD200R1;ANXA1;MGLL;NR1H3;IL6;PRKCD;TNIP1;RIPK1;TNFRSF1B;CELF1;SHPK;AOAH;NINJ1;MAPK7;NR1H4;PROC;METRNL;MFHAS1;XIAP;RB1;SIRPA;FOXP1;MEFV;PTGER4;NLRC3;BIRC3;PPARD;APP;RORA;LPCAT3;IL15;RELA;VAMP3;TNFAIP3;TNFAIP8L2;CASP12;ACOD1;CX3CL1;MYD88;GRN;BST1
prerank,purine-containing compound catabolic process (GO:0072523),0.6703631086521868,1.4645208965388194,0.05597579425113464,0.3607195050119464,1.0,4/13,9.11%,XDH;ITPA;NT5C2;NT5E
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3819527532267687,-1.4644011811945667,0.023622047244094488,0.38092966764862085,1.0,19/63,10.66%,SLC12A2;GABRB3;SLC12A6;ANO4;GLRB;SLC1A3;ANO3;GLRA3;GABRA2;GABRB1;SLC25A14;GABRA3;GLRA1;GABRG3;SLC6A1;SLC4A8;SLC1A1;LRRC8A;CLCN3
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5969153615574377,1.4639631094883552,0.055415617128463476,0.36139020206089767,1.0,8/26,19.23%,HTR2B;APOE;POR;S100A1;GDNF;ATP7A;GCH1;PIK3CB
prerank,regulation of cytokine production (GO:0001817),0.4806977611985645,1.4632737728433636,0.012526096033402923,0.3623982920232777,1.0,24/126,13.66%,GPNMB;HTR2B;ANXA1;FLOT1;FOXP3;RNF26;IL6;CD28;ATP2B1;PLD3;TNFRSF1B;IGF2BP3;SNAI2;SIRPA;FOXP1;PTGER4;IL15;TREM2;AFAP1L2;TRAF3;FGR;N4BP1;POLA1;SLC11A1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.45535933165716325,-1.4619719332866252,0.046413502109704644,0.3825757523487727,1.0,12/28,23.22%,ITGAM;ANK3;ITGB2;ITGB1BP1;TCAF1;PRNP;GDI1;FIS1;AKT2;MIEF2;CIB1;C2CD5
prerank,DNA modification (GO:0006304),0.6085446665836554,1.4613905992939744,0.05241935483870968,0.367147679097553,1.0,8/22,11.06%,ACD;MUTYH;PARP2;PARP3;NEIL1;EXOSC3;TERF1;MBD4
prerank,cellular response to topologically incorrect protein (GO:0035967),0.5641150979977844,1.461367739687363,0.05216284987277354,0.3662220083112559,1.0,12/31,16.55%,OPTN;ERN1;HSPA1B;STUB1;RHBDD1;DNAJB14;PRKN;HSPA1A;BAX;HSPA13;DNAJC18;PTPN1
prerank,ceramide metabolic process (GO:0006672),0.5296239604411811,1.4613232639288756,0.037825059101654845,0.36534013302513507,1.0,18/49,20.41%,PLPP3;SPTLC2;CERK;SAMD8;SGPL1;SGMS2;CERS6;SPTSSA;ABCA2;DEGS1;TLCD3B;ACER2;SGMS1;PPP2CA;NSMAF;ASAH1;PPP2R1A;CERS1
prerank,T cell activation (GO:0042110),0.5052170688692645,1.4603182486443744,0.026136363636363635,0.3671287701785475,1.0,18/69,17.11%,KIF13B;NCK2;FOXP3;CD44;LCP1;CD28;DDOST;EIF2AK4;LFNG;MSN;PPP3CA;NLRC3;CTPS1;GPR89A;GPR89B;HSPD1;RAB29;CHD7
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5195105524145293,-1.4602571945206575,0.07961783439490445,0.38343116769052066,1.0,6/16,7.07%,MEF2C;ERBB4;BMPR1A;FGFR2;FGF2;ZFPM2
prerank,positive regulation of developmental growth (GO:0048639),-0.39217315940170056,-1.4601698500694673,0.020689655172413793,0.38033296482116535,1.0,13/49,8.61%,SYT1;TWF2;RIMS1;PLCB1;MAPT;GHR;RIMS2;SMURF1;LIMK1;MAP3K13;SYT2;SYT4;AGRN
prerank,neuron projection fasciculation (GO:0106030),-0.603111357929377,-1.4586762715520731,0.109375,0.38037566048403254,1.0,3/10,4.40%,SEMA5A;CNTN4;CDK5R1
prerank,regulation of interleukin-17 production (GO:0032660),0.567679145873375,1.4572070747810142,0.04887218045112782,0.3752290455706178,1.0,10/31,19.58%,RFTN1;FOXP3;IL6;LY9;NR1H4;DDIT3;IL15;MYD88;ZBTB7B;OSM
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6875273872727997,1.4571116429896194,0.06184012066365008,0.37450899470972165,1.0,3/11,10.59%,TMEM106A;TAF7;SIRT1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5815093784023324,1.4570338203737652,0.05102040816326531,0.37369950265417196,1.0,9/27,9.37%,HGF;CDKN1A;NIBAN2;PDGFA;PARP4;FGFR4;ACVRL1;DACH1;BMPR2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5906914783505358,1.456939444978638,0.04773869346733668,0.3729845928392103,1.0,9/26,11.53%,PDK4;PRKAG2;NR1H3;EIF6;ACADL;ACADVL;BRCA1;ERLIN1;WDTC1
prerank,metanephric mesenchyme development (GO:0072075),-0.6018912822848157,-1.4566039660348076,0.07878787878787878,0.3815551504080638,1.0,5/10,20.46%,PAX2;BASP1;STAT1;PKD2;WNT4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.46247004780711215,-1.4558105776318808,0.06614785992217899,0.38017137849790705,1.0,10/23,18.68%,HACD2;ELOVL7;ACOT7;FAR2;ACSL6;ACSL4;ELOVL6;TECR;DGAT1;ACSBG1
prerank,acylglycerol homeostasis (GO:0055090),0.6126458279895907,1.4556618308260005,0.06032171581769437,0.37558344841820224,1.0,4/20,11.94%,APOE;NR1H3;MTLN;RORA
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4589404811837999,1.4556457320906553,0.0,0.3746713882358505,1.0,57/308,14.15%,EPAS1;FABP4;CD36;HTR2B;B4GALT5;ABCA1;SDCBP;APOE;CXCR4;SYK;PRKCH;FABP5;GCNT2;ADRA1D;ADRA1A;CTNNB1;VEGFA;FLOT1;CEBPB;TFRC;GADD45G;LRP1;IL6;CD28;NIBAN2;DYNC1H1;APPL2;SORL1;COL1A1;AGO2;SIRT6;ACADL;APC;KDM3A;RREB1;SOX9;SLC27A1;KSR2;NCOA3;TRPV2;BMPR2;PTGER4;PAX8;ROCK1;PTH2R;CFL1;SIRT1;ACVR1B;IL15;TREM2;KMT5B;OMA1;GAS6;FGR;SLC11A1;IL4R;GDNF
prerank,sphingosine metabolic process (GO:0006670),0.6247029642307257,1.4551302004301199,0.05785123966942149,0.37528418989582474,1.0,4/17,8.19%,PLPP3;SPTLC2;SPHK2;ABCA2
prerank,negative regulation of platelet activation (GO:0010544),0.6400145908287685,1.4543559021526562,0.05578800557880056,0.3766815906635937,1.0,3/16,3.72%,APOE;PRKCD;PDGFA
prerank,positive regulation of dendrite development (GO:1900006),-0.599439225000062,-1.4542791674864748,0.07780979827089338,0.3803532919229539,1.0,9/10,36.28%,VLDLR;LRP8;DAB2IP;PACSIN1;BMP5;PTN;ZDHHC15;BMP7;COBL
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5790051693838403,1.4539265762339744,0.05229591836734694,0.37688089401496383,1.0,8/26,19.18%,SPTLC2;CYB5R3;ARG2;SPHK2;ABCA2;ACER2;GCH1;ASAH1
prerank,DNA dealkylation (GO:0035510),0.7029820382548366,1.4537793265311607,0.0625,0.37535312423361034,1.0,6/10,21.78%,ASCC2;ASCC1;FTO;ALKBH1;ALKBH5;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7029820382548366,1.4537793265311607,0.0625,0.37535312423361034,1.0,6/10,21.78%,ASCC2;ASCC1;FTO;ALKBH1;ALKBH5;MGMT
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6146830902753653,1.4533438937669232,0.061391541609822645,0.3746187973085138,1.0,6/19,10.93%,POLR2A;ACD;POLR2L;TERF1;POLR2G;POLR2I
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6146830902753653,1.4533438937669232,0.061391541609822645,0.3746187973085138,1.0,6/19,10.93%,POLR2A;ACD;POLR2L;TERF1;POLR2G;POLR2I
prerank,phagolysosome assembly (GO:0001845),0.6926575222351455,1.453319222867101,0.05934718100890208,0.37373874491389386,1.0,6/12,9.66%,RAB7B;PIKFYVE;RAB20;RAB7A;CLN3;ARL8B
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6111162794944495,-1.4532929235960792,0.07608695652173914,0.37912509844406556,1.0,6/10,31.29%,GLI3;LAG3;IRF1;FOXJ1;BMP4;ZC3H8
prerank,electron transport chain (GO:0022900),0.6405264225650973,1.4528908972960524,0.058992805755395686,0.3740967397710765,1.0,6/15,10.61%,ETFRF1;POR;UQCRFS1;ENOX2;SDHB;SDHA
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7011322843338093,1.4526359403582985,0.08536585365853659,0.3738483304563164,1.0,3/10,4.15%,NFE2L2;TXN;RIPK1
prerank,regulation of viral genome replication (GO:0045069),0.5175695555372481,1.4525690380677874,0.03758542141230068,0.37309339426209864,1.0,21/56,17.55%,IFITM1;CD28;TNIP1;SRPK2;FAM111A;RNASEL;RAD23A;ZC3HAV1;IFITM2;PPIH;MAVS;DDB1;CNOT7;PKN2;BST2;N4BP1;PPIE;SLPI;ADARB1;TMEM39A;SRPK1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.563472304075875,1.4521747230794253,0.05176767676767677,0.37329201097816767,1.0,13/31,21.08%,FBXW7;ARRDC4;PTEN;UBE2L3;TOPORS;DCUN1D5;DCUN1D3;DCUN1D4;DCUN1D1;UBE2S;CDC14B;RAB1A;ARRDC3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5959604800150904,-1.4519644790804955,0.07262569832402235,0.37899594210434834,1.0,8/11,18.96%,PLCB1;GHR;GIGYF1;IRS1;IGF1R;GIGYF2;TSC2;EIF2AK3
prerank,regulation of DNA metabolic process (GO:0051052),0.538299411056192,1.4513726310854618,0.04767580452920143,0.3746421245491703,1.0,20/44,19.36%,MPV17;ALYREF;PDGFA;KPNA2;HELB;THOC1;WDR18;POLH;XRCC5;WDR70;NBN;IL7R;SIRT7;KDM1B;HNRNPD;MPHOSPH8;CDT1;UBE2V1;RADX;HDAC8
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5247105186319104,-1.4509864007666413,0.08450704225352113,0.37791959247759593,1.0,4/15,5.31%,SLC12A2;ATP1B1;ATP1A2;ATP1B2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.6592317186041001,1.4507871056201818,0.07828655834564253,0.3754105785084043,1.0,6/13,13.44%,SYK;LAMP1;GAB2;SPHK2;AP1G1;FGR
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.688692521833654,1.4507227213863496,0.0832072617246596,0.37460960058989,1.0,4/11,9.53%,CEBPB;ATF3;ATF4;DDIT3
prerank,positive regulation of cell killing (GO:0031343),0.6625568776500033,1.4507181704649283,0.06666666666666667,0.3736821123923649,1.0,3/13,9.80%,SYK;CYBA;FZD7
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.7023071110069371,1.449840585712317,0.07239819004524888,0.37530672760459133,1.0,4/10,6.37%,SIGIRR;MAP2K5;MAPK7;IRAK3
prerank,sulfur compound transport (GO:0072348),0.5685551360978452,1.4490133007986308,0.06555269922879177,0.3766685384796006,1.0,5/27,8.02%,SLC26A11;LRRC8D;SLC6A6;SLC26A1;SLC27A1
prerank,positive regulation of transport (GO:0051050),0.4928941451000046,1.448399027367405,0.03556034482758621,0.37756997013874977,1.0,22/85,14.42%,APOE;SGK1;ANXA1;FLOT1;LRP1;NR1H3;DYNC1H1;RXRA;CD151;MERTK;ANXA2;CYBA;NEDD4L;SIRPA;GSK3B;IL15;TREM2;DOCK2;GPLD1;GAS6;SLC11A1;BAX
prerank,negative regulation of autophagy (GO:0010507),0.5212502273069258,1.4483166364947482,0.045714285714285714,0.3768563419651776,1.0,18/54,19.38%,HTR2B;ATG7;HGF;CTSA;WASHC1;PIK3CA;QSOX1;FOXK1;MT3;TAB2;TREM2;ZKSCAN3;MCL1;USP36;RUBCN;EIF4G3;EIF4G2;TLK2
prerank,cardiac muscle cell contraction (GO:0086003),-0.48299598221096685,-1.4483020272690372,0.07829181494661921,0.38080424784982814,1.0,9/19,21.29%,CACNA1C;SCN1B;FGF12;KCNJ2;CACNA1G;CACNA2D1;GSN;SCN4B;SCN1A
prerank,cellular response to interleukin-2 (GO:0071352),0.6969129183206684,1.4477297935683662,0.05646359583952452,0.3766358573593611,1.0,5/11,14.65%,SYK;STAT5B;PTK2B;SHC1;JAK3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6969129183206684,1.4477297935683662,0.05646359583952452,0.3766358573593611,1.0,5/11,14.65%,SYK;STAT5B;PTK2B;SHC1;JAK3
prerank,brain development (GO:0007420),-0.32883965171879065,-1.4464748671712064,0.0,0.38143765906680094,1.0,32/136,11.46%,ZFHX3;CX3CR1;CNTNAP2;ADGRL3;GRIN2A;CTNNA2;PHF8;ROBO2;PTCH1;GRIN2B;NFIB;TGFBR2;EML1;CNTN4;RELN;CDK5R1;GRIN1;PBX3;ARNT2;CDH2;POU6F1;ADGRG1;BBS2;MEIS3;PAX2;QARS1;UFM1;EPHA7;MEIS1;SOX6;IER3IP1;NDUFS4
prerank,pinocytosis (GO:0006907),0.701713140288411,1.4454338540465324,0.0794392523364486,0.3824804847246618,1.0,5/10,12.44%,MAPKAPK3;SNX5;PPT1;SNX33;DOCK2
prerank,regulation of anoikis (GO:2000209),0.6173666280764415,1.4447325841515426,0.07330567081604426,0.3834638088129379,1.0,8/19,14.77%,PDK4;ITGA5;SIK1;PIK3CA;SNAI2;ITGB1;NOTCH1;MCL1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5619735624146702,1.4446617293182704,0.048051948051948054,0.3827061267962463,1.0,3/29,2.36%,LGALS3;PLA2G7;ANO6
prerank,purine nucleotide catabolic process (GO:0006195),0.6562995054277239,1.4444407011951583,0.07819548872180451,0.3824590076385617,1.0,4/13,9.11%,XDH;ITPA;NT5C2;NT5E
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.51473878812251,1.4431122596665535,0.03468208092485549,0.38534562528880445,1.0,32/59,26.83%,TLR8;IRAK2;TANK;RIPK1;LY96;REL;RPS27A;UBC;NFKBIL1;TICAM2;NLRC3;ROCK1;BIRC3;TAB2;RELB;RELA;TRAF2;ERC1;BIRC2;CARD11;TBK1;AZI2;BCL3;BCL10;TRAF6;PRDX4;TAB1;FAIM;TLR9;MAP3K7;TAB3;RNF31
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6085987560872629,1.4430495975091462,0.06490066225165562,0.38458383587391226,1.0,6/22,10.26%,LGALS3;MGAT5;STYXL1;BOD1;ROCK1;GSK3B
prerank,regulation of autophagosome maturation (GO:1901096),0.6539288642176284,1.4429602731744275,0.08345323741007195,0.3839016241268083,1.0,7/13,17.73%,FYCO1;TBC1D25;UVRAG;CLN3;RUBCN;TMEM39A;PHF23
prerank,myoblast fusion (GO:0007520),-0.5545069004843297,-1.4425476849875742,0.1027190332326284,0.3873374718404185,1.0,4/12,10.09%,ADGRB3;KCNH1;JAM2;ADAMTS5
prerank,apoptotic cell clearance (GO:0043277),0.5634392552198724,1.4422999410197566,0.05935483870967742,0.38485443859274593,1.0,9/30,13.37%,ANXA1;TGM2;LRP1;NR1H3;RARA;THBS1;TYROBP;TREM2;GAS6
prerank,regulation of metal ion transport (GO:0010959),-0.5106240601347388,-1.442237918187839,0.10472972972972973,0.38499187390565787,1.0,7/16,14.97%,ANK2;ORAI1;EPB41;BCL2;DLG1;IL16;CACNA2D1
prerank,placenta development (GO:0001890),0.6733626961591564,1.441397206224672,0.058383233532934134,0.3865045081577244,1.0,1/12,0.13%,PPARG
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5034109346854329,1.4413095631497481,0.03156708004509583,0.38584518983117,1.0,19/66,15.64%,GPNMB;ANXA1;ID2;CDKN1A;ANKRD17;APPL2;PTEN;E2F1;APC;RB1;BRD7;ADAM17;KMT2E;DCUN1D3;CDK2AP2;APPL1;PSME2;INO80;CDC73
prerank,cilium-dependent cell motility (GO:0060285),-0.47311577911406183,-1.4412628670731737,0.07352941176470588,0.38386962310660144,1.0,16/22,41.61%,RFX3;CCDC39;CFAP44;CFAP54;DNAH8;EFHC2;EFHC1;DNAH2;RSPH9;DRC1;GAS8;DNAAF2;DNAH17;CCDC65;DNAH1;TEKT5
prerank,negative regulation of receptor binding (GO:1900121),-0.5913849534884178,-1.4411444548746934,0.10584958217270195,0.38116406360216837,1.0,4/10,25.39%,ADAM15;HFE;ATP2A2;ATP2A3
prerank,regulation of fibroblast proliferation (GO:0048145),0.5354396781716295,1.4407839405642622,0.041617122473246136,0.3863957922117513,1.0,13/45,17.17%,CD300A;CTNNB1;AQP1;CDKN1A;PDGFA;B4GALT7;E2F1;IGF1;NLRC3;S100A6;GAS6;CDC73;FTH1
prerank,positive regulation of cell projection organization (GO:0031346),-0.34227845859494027,-1.4407636104690442,0.0,0.3791348245205372,1.0,27/115,6.14%,PTPRD;ARSB;CAMK1D;RIT2;PLXNA4;IL1RAPL1;TWF2;ROBO2;ROBO1;TENM3;NTRK3;SETX;ITGA6;EPHA3;TOX;TIAM1;ARHGDIA;PLPPR5;MAGI2;SCN1B;RELN;FUT9;NTRK2;ATP1B2;MAP3K13;CUX2;PRKD1
prerank,cellular response to chemical stress (GO:0062197),0.47962782276676275,1.4402699366452942,0.021528525296017224,0.3869112606481844,1.0,23/96,11.17%,LRRC8D;MSRA;PRDX1;NFE2L2;ATG7;TXNRD1;FOXO3;FAS;SESN2;LONP1;HTRA2;PIK3CA;HSPA1B;CYBB;GPX3;ATF4;CYBA;NCF2;CAT;GSR;CYCS;FOXO1;MT3
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.48734993582090175,-1.4399604094754002,0.0625,0.3779477659972379,1.0,7/20,13.96%,ST3GAL6;B3GALT1;FUT9;ST3GAL2;ST6GALNAC5;B4GALT1;ST6GALNAC6
prerank,AMP metabolic process (GO:0046033),0.6682171743336502,1.4398329390825229,0.0639269406392694,0.38730713961129276,1.0,4/13,9.11%,XDH;ADSL;AMPD3;NT5E
prerank,regulation of dendritic spine development (GO:0060998),-0.48566858567809545,-1.4396789840188937,0.07936507936507936,0.37582634201822573,1.0,5/19,5.49%,TANC2;MEF2C;NLGN1;GRIN3A;FMR1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.42865408564538354,-1.4387371737415302,0.05853658536585366,0.3749589381665764,1.0,13/31,20.63%,SYT1;SCAMP5;SYT7;REST;SYT2;SYT4;SYT6;CACNA1G;STX1A;CACNA1I;SYT3;SYT12;SYT11
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5926068574080586,1.4383034192802682,0.06657789613848203,0.39069610286064427,1.0,12/24,15.74%,CTNNB1;FBXW7;FOXO3;TFAP2B;SRPK2;ATF4;TYROBP;BACE1;DDIT3;BAX;MCL1;GRN
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.44637974015331827,-1.4380517190301116,0.03619909502262444,0.37363852949415427,1.0,9/26,10.47%,NRXN1;NLGN1;RIMS1;RIMS2;RELN;GRIN1;CUX2;MTMR2;NLGN3
prerank,activin receptor signaling pathway (GO:0032924),-0.5154345180251131,-1.438049389966999,0.06309148264984227,0.37091775308511177,1.0,4/15,4.29%,ACVR1;SMAD3;ACVR2B;TGFBR1
prerank,positive regulation of viral process (GO:0048524),0.511199231652915,1.4373732795614063,0.037122969837587005,0.3925017315683501,1.0,22/60,17.55%,MDFIC;POLR2A;RAB7A;CD28;SRPK2;KPNA2;POLR2L;RAD23A;VPS4A;PPIH;DDB1;POLR2G;CNOT7;PKN2;POLR2I;GTF2F2;CTDP1;PPIE;ADARB1;TMEM39A;NELFE;SRPK1
prerank,adipose tissue development (GO:0060612),0.6737068643452239,1.4371559247936847,0.07669172932330827,0.39223823309440686,1.0,4/11,13.34%,NAMPT;SPTLC2;ARID5B;SH3PXD2B
prerank,negative regulation of endocytosis (GO:0045806),0.5805856437079681,1.4370513625202,0.05511811023622047,0.3916009152620114,1.0,7/24,13.05%,LGALS3;CD300A;LILRB1;NR1H3;PICALM;SNX33;MCTP1
prerank,regulation of acrosome reaction (GO:0060046),-0.623193266970113,-1.4369629801285062,0.055401662049861494,0.37040862741381425,1.0,2/10,8.54%,PLCB1;GLRA1
prerank,regulation of mitochondrial fusion (GO:0010635),0.6886496555954202,1.43677319437907,0.0791476407914764,0.39159438398689805,1.0,7/11,15.64%,VAT1;TFRC;PID1;HUWE1;OMA1;PRKN;BNIP3
prerank,fatty acid transmembrane transport (GO:1902001),0.6223776699973597,1.436406460849768,0.07250341997264022,0.39173278083436774,1.0,7/19,12.33%,CD36;PRKAG2;ABCD1;SLC27A1;CPT1A;SLC25A20;SLC2A1
prerank,regulation of B cell apoptotic process (GO:0002902),0.6566088613027935,1.436131797390426,0.08181818181818182,0.3917063669806569,1.0,5/12,18.52%,FNIP1;IRS2;FOXP1;BTK;NOC2L
prerank,cellular response to copper ion (GO:0071280),0.6311198320158355,1.434737909862947,0.0754985754985755,0.39476960078893475,1.0,10/16,20.67%,AQP1;MT3;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,positive regulation of apoptotic process (GO:0043065),0.4512615958961138,1.4346675959453834,0.001006036217303823,0.3940265395223706,1.0,86/293,18.60%,MTCH1;ABR;CTSD;MAP3K20;VAV3;LILRB1;RPS6KA2;BCL2L11;CTNNB1;ATG7;TGM2;GADD45B;ANO6;GADD45G;SOS1;IL6;FOXO3;FAS;TFAP2B;JUN;APAF1;SRPK2;DAPK1;RIPK1;GNA13;SLC27A4;E2F1;HTRA2;GADD45A;AIFM2;MELK;MLLT11;SIK1;SPHK2;STK3;APC;FLCN;CTNNBL1;ATF4;RPS27A;UBC;NLRC4;TNFAIP8;AKAP13;VAV1;ING3;DLC1;BACE1;DDIT3;NLRP2B;ITGB1;FOXO1;SIRT1;ARHGEF2;ING4;STPG1;DCUN1D3;DDX20;OMA1;GPLD1;BCLAF1;MCF2;SOS2;BAX;SQSTM1;FGD3;LATS1;NCSTN;QRICH1;BNIP3;GRN;HSPD1;BID;IFIT2;ADAMTSL4;CCAR1;UTP11;PRR7;SHQ1;C1QBP;ITSN1;CASP2;CASP3;STK4;CRADD;HTT
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5887882664942033,1.434427973197813,0.06951871657754011,0.3938611035347497,1.0,7/23,13.37%,LILRB1;FOXP3;CD274;RARA;NR1H4;DDIT3;GAS6
prerank,lysosome organization (GO:0007040),0.544851386911054,1.433967038715804,0.05818181818181818,0.3942789234271234,1.0,12/36,13.77%,ABCA1;TPCN2;TFEB;TPP1;HOOK3;TMEM165;CLN5;CLN3;VPS33A;LAMTOR1;CLVS2;ZKSCAN3
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4446742223360637,-1.4333552824515592,0.061946902654867256,0.3750800800471082,1.0,8/27,8.86%,SYT1;RIMS1;RIMS2;VAMP7;SYT7;SYT2;SYT4;SYT6
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5671259426016417,-1.4330041696995228,0.07462686567164178,0.3730573125460499,1.0,6/11,18.38%,CSNK1E;CSNK1D;RSPO3;WNT5B;NKD1;DAB2
prerank,regulation of biosynthetic process (GO:0009889),0.6749938568583131,1.4328663690689705,0.08321167883211679,0.396660870692286,1.0,2/11,6.26%,PIKFYVE;SPHK2
prerank,amyloid fibril formation (GO:1990000),0.5191778577485117,1.4328107294730466,0.035046728971962614,0.39587685979899173,1.0,22/51,22.83%,CD36;MFGE8;NAT8;RIPK1;SORL1;RPS27A;UBC;CALB1;BACE1;APP;TSPAN15;PRKN;NCSTN;GGA2;CALCA;ADAM10;GGA3;USP9X;APH1B;FKBP1A;FURIN;SIAH2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5692933405999577,1.4326834655331258,0.07068062827225131,0.39533028031438083,1.0,8/25,15.04%,SDCBP;ATXN2;ABCA2;PICALM;RIN3;ANKRD13D;APP;UBQLN2
prerank,myelin maintenance (GO:0043217),0.6879480806803929,1.4307725350969747,0.08487654320987655,0.4001527798863631,1.0,6/10,14.94%,CXCR4;ABCD1;PTEN;EPB41L3;DEGS1;PRX
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6845572588008223,1.4305864556202856,0.07851851851851852,0.39976431363669596,1.0,2/11,2.06%,ANXA1;FOXP3
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6836649381270281,1.4296869303170132,0.08549618320610687,0.4014358042512902,1.0,2/10,2.89%,IQSEC1;ADAM9
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.44581367130755695,-1.429127951868484,0.04672897196261682,0.37864344545979234,1.0,11/27,16.52%,IL1RAPL1;CTNNA2;NTNG1;DISC1;MBOAT1;MARK1;HOMER1;ULK4;NCS1;NDEL1;BRSK1
prerank,entry into host (GO:0044409),0.6405913477659573,1.4290214241541652,0.08368794326241134,0.40248592714896897,1.0,3/13,1.59%,CXCR4;GRB2;CTNNB1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.501777701263332,1.428915678629493,0.0359955005624297,0.40183510982887544,1.0,17/65,15.79%,EPAS1;VEGFA;AQP1;NPEPPS;CPEB4;LMNA;ADAM8;HMOX1;HIPK2;EGLN3;SIRT1;MT3;STUB1;RORA;SUV39H2;BNIP3;ACAA2
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.4574275616685297,-1.4285830708405742,0.05405405405405406,0.37689423508668196,1.0,11/24,23.22%,ITGAM;ANK3;ITGB2;ITGB1BP1;TCAF1;PRNP;FIS1;AKT2;MIEF2;CIB1;C2CD5
prerank,superoxide metabolic process (GO:0006801),0.5647915994303718,1.42810520775843,0.06847545219638243,0.40335005201727003,1.0,12/29,16.77%,PRDX1;CYBB;CYBA;NCF2;MT3;CYB5R4;NCF4;SH3PXD2B;NRROS;TAFA4;ATP7A;NCF1
prerank,positive regulation of exocytosis (GO:0045921),0.5412282604991359,1.4275761424612867,0.05745721271393643,0.404035223893622,1.0,10/35,14.85%,SDCBP;RAB7A;STAM;CHMP2A;STXBP5;PDCD6IP;VPS4A;SDC4;CLASP1;SNF8
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5197631268108053,1.4275188586193195,0.0399529964747356,0.4033025297248661,1.0,8/45,11.76%,CD36;TLR8;IL6;TMEM106A;NLRC4;TYROBP;APP;FZD5
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6096960834008779,1.427144953860055,0.0792507204610951,0.4034819212812689,1.0,3/17,4.62%,ANXA4;ANXA1;MAP2K5
prerank,somite development (GO:0061053),-0.5780603247096754,-1.4265230334074013,0.12034383954154727,0.37860087940712034,1.0,7/11,37.44%,PTCH1;SMO;SOX11;MTHFD1;MEOX2;SHH;SFRP2
prerank,negative regulation of programmed cell death (GO:0043069),0.44785334080733935,1.4264907096641373,0.001,0.40438817481496336,1.0,96/355,18.72%,HTR2B;ARHGAP10;ANXA4;CD38;ANXA1;CTNNB1;VEGFA;AQP1;TFRC;RAB7A;CD44;PLK2;NAT8;IL6;HGF;CD28;NIBAN2;FAS;TFAP2B;BIRC6;RIPK1;PPT1;ANXA5;NOTCH2;CITED2;RAF1;PIM1;IGF1;CLN3;PCID2;PPIF;THBS1;BABAM2;AIFM2;NR1H4;PROC;GPX4;HSPA1B;RPS27A;UBC;CAT;TNFAIP8;BFAR;SH3RF1;XIAP;SOX9;KLHL20;CTSH;TOPORS;COPS5;FSTL1;PIM3;GSK3B;PTK2B;CFL1;POU3F3;FOXO1;SIRT1;BIRC3;PAK2;BAG4;MT3;TAX1BP1;RHBDD1;TREM2;ZFAND6;ATAD3A;RELA;GAS6;VDAC1;HSPA1A;GDNF;SHC1;PHIP;SQSTM1;GOLPH3;MCL1;CX3CL1;RPL10;CBL;BNIP3;MYD88;HSPD1;MIEN1;TMBIM4;BID;ERC1;UBE2O;ARF4;TEK;HMGN5;BIRC2;CASP2;CASP3;SOX8;LRP2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6078212763349927,1.4262858402222716,0.07744565217391304,0.40401447187637807,1.0,5/20,7.73%,ANO6;IL6;ITGA4;THBS1;PIAS4
prerank,regulation of T cell activation (GO:0050863),0.5214810386276265,1.4260429953185376,0.05665024630541872,0.40382297489367575,1.0,5/42,8.22%,GPNMB;LGALS3;TNFRSF1B;DUSP3;SIRPA
prerank,lipoprotein catabolic process (GO:0042159),0.6861604142109541,1.4258468923388525,0.09852941176470588,0.4034639430603129,1.0,4/11,9.85%,CTSD;APOE;PPT1;ABHD10
prerank,regulation of interleukin-8 production (GO:0032677),0.4898682500901022,1.4251016446841085,0.037037037037037035,0.4046607422165521,1.0,17/69,16.53%,ANXA4;SYK;TLR8;ANXA1;IL6;RIPK1;MAP2K5;HSPA1B;DDIT3;MAVS;AFAP1L2;RELA;HSPA1A;ARRB1;LBP;MYD88;TLR1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.638420467073703,1.424319147151128,0.06789250353606789,0.406117573016749,1.0,9/15,22.21%,IQGAP2;ARPC2;WASHC1;ACTR3;WHAMM;ARPC1A;ARPC4;ARPC5L;ARPC5
prerank,integrated stress response signaling (GO:0140467),0.6493381881541378,1.4240221276551361,0.08608321377331421,0.40607174492442916,1.0,8/14,22.65%,NFE2L2;EIF2AK4;ATF4;DDIT3;OMA1;QRICH1;EIF2S1;HERPUD1
prerank,lytic vacuole organization (GO:0080171),0.5518078700983583,1.4237641885914234,0.05941845764854614,0.4058638690427154,1.0,7/32,5.15%,ABCA1;TPCN2;TFEB;TPP1;HOOK3;CLN5;CLN3
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5293247295528836,-1.4234539896348448,0.08524590163934426,0.38251422397254314,1.0,4/15,13.99%,ATP1B1;KCNJ2;KCNJ3;KCNN2
prerank,wound healing (GO:0042060),0.5060333569377493,1.4234374016805735,0.03518728717366629,0.40601077053962337,1.0,15/62,13.66%,MYOF;HPSE;MMP12;PDGFA;RAF1;AHNAK2;IGF1;HMOX1;PPP3CA;ARL8B;FZD7;MYH9;COL3A1;MACF1;SLC11A1
prerank,protein maturation (GO:0051604),0.48001457680206394,1.4233191166932513,0.02925243770314193,0.40545321509944726,1.0,42/95,25.57%,F7;PCSK4;TMPRSS4;CPXM1;MMP14;SORL1;CLN3;TSPAN17;PITRM1;CTSS;NDUFAB1;BACE1;GLRX3;ADAM17;STUB1;LONP2;NAA10;TSPAN15;CIAO2B;ADAM19;NCSTN;CPM;HSPD1;CIAO2A;CASP2;DDI2;AFG3L2;TYSND1;OGT;ADAM10;APH1B;NAA15;FURIN;XPNPEP3;PSEN2;PCSK7;GCSH;SRGN;TSPAN5;TSPAN33;CIAO1;TSPAN14
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6346964906810906,1.4231822512065038,0.08689248895434462,0.40499945386686304,1.0,3/15,5.22%,GRB2;SOS1;ZFYVE27
prerank,ganglioside metabolic process (GO:0001573),-0.46189733163303587,-1.422231051806294,0.06040268456375839,0.3826080547462932,1.0,8/20,13.96%,HEXB;ST6GALNAC3;ST8SIA6;ST3GAL5;ST6GALNAC5;ST6GALNAC4;ST8SIA3;ST6GALNAC6
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.5607254283105784,1.4215250829292478,0.07255936675461741,0.409013589797636,1.0,9/26,18.05%,SIGIRR;RNF26;IRAK3;NFKBIL1;NLRC3;TRAFD1;TNFAIP3;ACOD1;C1QBP
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5341999457883192,1.4213345015840035,0.0413625304136253,0.4086914627139908,1.0,10/38,13.61%,LGALS3;FAS;RIPK1;THBS1;HMOX1;BRCA1;GSK3B;ARHGEF2;RNF34;TNFAIP3
prerank,regulation of protein localization to cell surface (GO:2000008),0.545770689952764,1.4200583654602346,0.06682867557715674,0.4115383614588408,1.0,11/33,12.95%,CTNNB1;STX3;RANGRF;GPD1L;KCNAB2;NEDD4L;ABCA2;TYROBP;PICALM;SNX33;RAB11B
prerank,regulation of interleukin-12 production (GO:0032655),0.5143074490167705,1.4181168677744431,0.04431137724550898,0.4163146572072731,1.0,16/47,22.19%,SYK;TLR8;LILRB1;PIBF1;THBS1;IRAK3;FOXP1;MEFV;JAK3;HSPD1;LTB;C1QBP;SCIMP;CD47;SLAMF1;TIRAP
prerank,myotube differentiation (GO:0014902),-0.495085049893722,-1.4180449592588118,0.08029197080291971,0.38910460842167266,1.0,5/17,4.15%,MEF2C;ADGRB3;MYEF2;KCNH1;JAM2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5965738105951116,1.4167807526785139,0.08464849354375897,0.4196012157625602,1.0,8/18,17.48%,MDFIC;FLCN;MFHAS1;POLR1A;GSK3B;LATS1;CTNNA1;APOD
prerank,monocyte chemotaxis (GO:0002548),0.5464492291829317,1.4165379252038897,0.06496815286624204,0.4194539946920635,1.0,9/32,19.46%,LGALS3;ANXA1;IL6;FOLR2;IL6R;CX3CL1;CCL7;CALCA;CCL25
prerank,membrane depolarization (GO:0051899),-0.42371833051182695,-1.4160984214776793,0.05365853658536585,0.3906635423000516,1.0,11/32,17.03%,CACNA1E;SCN2A;CACNB4;SCN1B;CACNG4;SCN9A;CACNA1G;YWHAH;SCN8A;CACNG2;CACNA1I
prerank,negative regulation of biosynthetic process (GO:0009890),0.6170095354419532,1.4153145750541205,0.08380681818181818,0.42248344254851133,1.0,3/16,3.44%,ABCB7;IL6;ABCD1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.6531345952008093,1.4147897112713783,0.09221902017291066,0.42312224522292596,1.0,1/13,0.52%,NAMPT
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.6061805436952448,1.414411293025047,0.07387140902872777,0.423342955677648,1.0,9/20,20.09%,SLC8B1;MICU2;MICU1;PMPCA;LETM1;SMDT1;PMPCB;PARL;AFG3L2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6616136348573298,1.4140395744189043,0.10225563909774436,0.42359197987311825,1.0,4/11,7.63%,PRKCD;GSKIP;STK24;PRODH
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.6271828775022685,1.4133618131237444,0.08464849354375897,0.4248399283483741,1.0,10/15,21.03%,REEP4;ZFYVE27;RTN3;RAB10;RAB18;ATL2;ATL1;RTN4;TMEM170A;ARL6IP1
prerank,amide biosynthetic process (GO:0043604),0.508535896090682,1.4133141434720504,0.06783625730994151,0.4240509028938246,1.0,17/47,22.96%,SPTLC2;ARG1;SAMD8;RHD;SGMS2;ARG2;CERS6;SPTSSA;DEGS1;SLC25A15;TLCD3B;SGMS1;PAM;ASAH1;CERS1;FURIN;CERS2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6474958230673087,1.412984049009142,0.10906298003072197,0.424155810711809,1.0,5/13,13.30%,PPARG;SOX9;NFATC3;PPARD;RELA
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.45625685393875204,1.4117649271288328,0.011282051282051283,0.42696619951102194,1.0,26/150,10.02%,F7;OSBPL8;HPSE;GDF15;PIK3R5;GRB2;GCNT2;GAB2;TXN;HGF;CD28;PDPK1;PDGFA;P2RX4;F10;FGFR4;THBS1;ADAM8;TRAT1;IRS2;PIK3CA;MFHAS1;VAV1;STRN;ITGB1;ESR1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6489206085437347,1.4116146025063003,0.10283159463487332,0.4265074082091684,1.0,3/12,5.70%,B4GALT5;PTEN;B4GALT6
prerank,regulation of macrophage migration (GO:1905521),-0.5817757320085071,-1.4113348452232126,0.09375,0.3982355555637556,1.0,5/10,6.62%,CX3CR1;P2RY12;CSF1;MTUS1;CD200
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5139633036254355,1.410227015513501,0.05548854041013269,0.4297363224562389,1.0,12/48,13.37%,PPARG;ARG1;SIGIRR;NR1H3;IL6;YTHDF3;IRAK3;STAP1;NLRP2B;CNOT7;TREM2;GAS6
prerank,regulation of synapse maturation (GO:0090128),-0.5791754703803238,-1.409097596670015,0.0927536231884058,0.40008351759872246,1.0,5/10,24.26%,NRXN1;RELN;DAB2IP;ADGRL1;YWHAZ
prerank,positive regulation of lipid localization (GO:1905954),0.6620539363674979,1.4083083919514228,0.10822510822510822,0.43473035792672754,1.0,2/11,2.65%,IKBKE;LRP1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6361516573830095,1.4081815044944272,0.1027900146842878,0.43417596107469275,1.0,5/13,9.87%,STX3;RANGRF;GPD1L;TYROBP;SNX33
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.47772021549537846,1.406691476910781,0.030735455543358946,0.43782270742134405,1.0,19/76,15.15%,ANXA4;FOXP3;IRAK2;MAP2K5;RWDD3;NFKBIB;IRAK3;NWD1;NFKBIL1;DDIT3;NLRP2B;NLRC3;SIRT1;TAX1BP1;TRAF3;TNFAIP3;ERBIN;ACOD1;ARRB1
prerank,intestinal absorption (GO:0050892),0.6347014388184387,1.4055606248625236,0.08638360175695461,0.44030117925829854,1.0,1/13,0.12%,CD36
prerank,negative regulation of phagocytosis (GO:0050765),0.6137740505616704,1.4053017527410776,0.07365439093484419,0.44021569803284305,1.0,7/17,20.76%,CD300LF;CD300A;SIRPA;APPL1;SNX3;FCGR2B;CD47
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5445923159551245,1.405025665382016,0.06826801517067003,0.4400910774386094,1.0,7/33,9.32%,HTR2B;PIK3R5;PTEN;IGF1;PIK3CA;PIK3C2G;PLEKHA1
prerank,cellular senescence (GO:0090398),0.5550823400335358,1.4049793624013847,0.07733333333333334,0.4392946688457852,1.0,4/27,3.13%,NSMCE2;ID2;PRKCD;CDKN1A
prerank,negative regulation of cell death (GO:0060548),0.4748790974771435,1.4047806384885841,0.034972677595628415,0.4389824049304813,1.0,21/88,16.20%,GPNMB;HTR2B;CD200R1;SPEF1;CCN5;TNFRSF1B;SORL1;HTRA2;CHMP2A;HSPA1B;GSK3B;ATG5;NENF;CCN1;MT3;DUS2;PRKN;HSPA1A;BNIP3;INPP5A;TRAF2
prerank,purine nucleotide metabolic process (GO:0006163),0.5622431369298057,1.404549523743528,0.07482993197278912,0.4387652313991743,1.0,6/24,9.11%,XDH;ADSL;PPAT;ITPA;NT5C2;NT5E
prerank,cell junction assembly (GO:0034329),-0.33096613138437847,-1.4043111059577518,0.028169014084507043,0.40759288248185666,1.0,23/100,8.46%,ADGRL3;OPHN1;SDK1;GPM6A;NRXN1;KIRREL3;NLGN1;DNM3;CTNND1;RYK;TLN2;ITGA6;CTNND2;VASP;CDH11;CDH9;CDH8;FARP1;CDH2;CDH6;CDH12;SH3BP1;DNER
prerank,vesicle organization (GO:0016050),0.5146377957126826,1.403917376159147,0.06129807692307692,0.4397806455233678,1.0,23/46,23.95%,PHETA2;HOOK3;SNX10;RNF26;LAMTOR1;SNX33;PI4K2A;ARFGEF2;EPS15;PLEKHJ1;SQSTM1;VPS11;WASL;DNAJC13;USP8;RAB22A;ALS2CL;WASHC5;CHMP2B;ZFYVE16;PI4K2B;SRGN;HOOK1
prerank,sodium ion transmembrane transport (GO:0035725),-0.3457073339664095,-1.4036185787103372,0.022727272727272728,0.40632341353952484,1.0,19/84,11.82%,SLC24A3;SLC9A9;SLC12A2;HCN1;ATP1B1;SLC24A2;SCN2A;ATP1A2;SCN1B;TRPM4;ATP1B2;SLC6A15;NALCN;SLC6A1;SLC4A8;SCN9A;SLC24A4;HCN2;PKD2
prerank,digestive tract morphogenesis (GO:0048546),0.6269044102441732,1.4034686300587138,0.09261939218523878,0.4403227366632064,1.0,4/14,10.80%,STRA6;ID2;NIPBL;RBPMS2
prerank,protein catabolic process (GO:0030163),0.49465342024583087,1.4029285745349642,0.04499437570303712,0.4410770786002974,1.0,15/59,13.63%,CTSD;APOE;TPP1;RIPK1;PPT1;CLN5;HTRA2;SOCS6;MANBA;LAMP2;DDB1;RAB12;OGA;FBXO6;PRKN
prerank,potassium ion import across plasma membrane (GO:1990573),-0.39484926406742965,-1.4029264890312638,0.030864197530864196,0.40499434485354413,1.0,13/41,20.02%,SLC12A2;ATP1B1;SLC12A6;ATP1A2;KCNJ2;ATP1B2;KCNJ3;KCNJ9;HCN2;SLC12A4;KCNK9;ABCC9;KCNJ6
prerank,negative regulation of leukocyte migration (GO:0002686),0.6764574350866965,1.4023030252892126,0.08792846497764531,0.44209639671332274,1.0,3/10,7.09%,CD300A;CD200R1;HMOX1
prerank,regulation of apoptotic process (GO:0042981),0.43541644131077434,1.4006872040167464,0.0,0.44621665029828966,1.0,180/676,18.72%,MTCH1;HTR2B;ARHGAP10;ANXA4;ABR;CD38;CTSB;CTSD;SGK1;MAP3K20;VAV3;LILRB1;RPS6KA2;ANXA1;BCL2L11;CTNNB1;STEAP3;ATG7;VEGFA;AQP1;TGM2;GADD45B;ANO6;TFRC;GADD45G;CD44;PLK2;NAT8;SOS1;IL6;HGF;CD28;FOXO3;NIBAN2;FAS;TFAP2B;BIRC6;JUN;APAF1;DAPK1;RIPK1;PPT1;ANXA5;NOTCH2;GNA13;CITED2;RAF1;SLC27A4;OSGIN1;E2F1;PIM1;IGF1;CLN3;HTRA2;PCID2;ACTN1;PPIF;THBS1;GADD45A;BABAM2;AIFM2;MELK;MLLT11;NR1H4;SPHK2;STK3;CREBBP;HS1BP3;APC;PROC;FLCN;CTNNBL1;HSPA1B;ATF4;RPS27A;UBC;ANP32B;NLRC4;CAT;TNFAIP8;BFAR;USP42;NF2;SH3RF1;XIAP;SOX9;AKAP13;VAV1;ING3;KLHL20;FBXO11;CTSH;TOPORS;COPS5;FSTL1;NLRP2B;EGLN3;ITGB1;PAX8;PIM3;GSK3B;PTK2B;CFL1;POU3F3;FOXO1;SIRT1;BIRC3;PAK2;ARHGEF2;BAG4;ING4;MT3;OLFM4;STPG1;DCUN1D3;TAX1BP1;RHBDD1;DDX20;ZFAND6;OMA1;WRN;GPLD1;BCLAF1;ATAD3A;RELA;GAS6;VDAC1;PRKN;MCF2;HSPA1A;SOS2;GDNF;BAX;SHC1;PHIP;SQSTM1;JAK3;GOLPH3;FGD3;MCL1;CX3CL1;RPL10;LATS1;NCSTN;USP36;CASP6;QRICH1;RTN4;CBL;BNIP3;MYD88;HSPD1;MIEN1;TMBIM4;BID;TRAF2;IFIT2;ADAMTSL4;CCAR1;UTP11;ERC1;UBE2O;GAS1;PRR7;ACER2;ARF4;TEK;ZBTB7A;SHQ1;HMGN5;BIRC2;C1QBP;ITSN1;CASP2;CASP3;STK4;CRADD;HTT;SOX8;LRP2
prerank,epiboly involved in wound healing (GO:0090505),0.6151085110501258,1.4006035279724067,0.10260115606936417,0.4455198102454353,1.0,4/16,3.78%,MRTFA;CD44;LCP1;CD151
prerank,positive regulation of histone deacetylation (GO:0031065),0.6369815600310388,1.400584671483256,0.10510510510510511,0.4446303241111254,1.0,3/12,6.98%,APLNR;VEGFA;NIPBL
prerank,positive regulation of phagocytosis (GO:0050766),0.5057606513343154,1.4002585227189854,0.06235294117647059,0.4447609957821961,1.0,13/47,13.66%,CD300LF;ANO6;APPL2;MERTK;CYBA;RAB31;STAP1;SIRPA;IL15;TREM2;DOCK2;GAS6;SLC11A1
prerank,phospholipid biosynthetic process (GO:0008654),0.5331990824543882,1.4002200388501127,0.04955527318932656,0.4439516740627499,1.0,8/36,8.56%,GPAT2;SAMD8;AGPAT4;SGMS2;CLN3;MVD;SPHK2;IDI1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4671548798095528,1.3999253158508569,0.028421052631578948,0.44402982098989313,1.0,21/102,15.56%,PPARG;MYO5A;DENND4C;LPIN3;RAB8B;PDPK1;PRKCD;ENPP1;ADCY7;IRS2;RAB31;SLC39A14;RAB12;RAB10;FOXO1;EPRS1;GPLD1;RELA;ADCY8;ADCY3;INSIG2
prerank,plasma membrane repair (GO:0001778),0.6468302960106326,1.3989684224411787,0.10581222056631892,0.4461109138009561,1.0,4/13,12.31%,MYOF;AHNAK2;ARL8B;MYH9
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6098844183986437,1.3988442926098525,0.09831460674157304,0.44557391121119516,1.0,5/17,8.42%,CD36;SASH1;SIGIRR;LY96;NFKBIL1
prerank,glycosphingolipid metabolic process (GO:0006687),0.5115345259178743,1.3983927896900852,0.07301980198019802,0.44607483356339284,1.0,15/42,16.70%,PSAP;CERK;GALC;GLA;CTSA;ESYT1;B4GALT6;HEXA;ARSA;ABCA2;A4GALT;GM2A;ESYT2;SUMF1;NEU1
prerank,actomyosin structure organization (GO:0031032),-0.33946287002347786,-1.3982271384197835,0.010526315789473684,0.41202698322605075,1.0,13/75,5.85%,EPB41L2;FRMD5;SORBS1;F11R;CAPN3;MYO18A;PHACTR1;CIT;EPB41;CDC42BPA;TMOD2;EPB41L4B;FRMD3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5172658852255345,1.398069432710349,0.06356968215158924,0.44619033913367634,1.0,14/43,15.53%,LILRB1;CD274;RARA;IGF1;ARG2;NR1H4;IRAK3;SIRPA;NFKBIL1;NLRC3;GAS6;TNFAIP3;CX3CL1;LBP
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5791834280861431,1.398035483688032,0.08133333333333333,0.44537747076537887,1.0,11/21,25.66%,PRKCH;TRAT1;STAP1;FOXP1;PRKCB;RELA;RAB29;CARD11;PTPRC;BCL10;SLC39A10
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6489045260740245,1.397645962375706,0.11782032400589101,0.4456985366072112,1.0,6/11,14.63%,SORL1;RAB21;MSN;EIPR1;PRKN;VPS11
prerank,retinol metabolic process (GO:0042572),0.6199086024590887,1.3975042093668775,0.10183875530410184,0.4451952207609495,1.0,2/14,5.07%,DHRS3;RDH12
prerank,liver development (GO:0001889),0.5405420119122005,1.3971671988997665,0.06939281288723669,0.44541031226932853,1.0,6/32,9.12%,ANXA1;CEBPB;IL6;CCDC40;CITED2;ARID5B
prerank,neuron maturation (GO:0042551),0.6042466624043561,1.396921800480857,0.08472222222222223,0.44526183762214416,1.0,4/18,5.70%,MTCH1;B4GALT5;CLN5;B4GALT6
prerank,ERBB signaling pathway (GO:0038127),0.48930515172882366,1.3965700465397597,0.061659192825112105,0.4454278000894294,1.0,17/64,15.42%,IQGAP1;REPS2;GRB2;NCK2;SOS1;PDPK1;KIF16B;PIK3CA;PTPN12;SOX9;ADAM17;PTK2B;NRG4;STUB1;ERBIN;SHC1;CBL
prerank,melanosome organization (GO:0032438),0.5556426052326325,1.3963501693543054,0.08224543080939947,0.4452381312217101,1.0,9/26,18.69%,LYST;DTNBP1;PIKFYVE;AP1G1;AP3D1;AP3B1;TRAPPC6A;RAB29;AP1M1
prerank,regulation of dendrite development (GO:0050773),-0.40029974316391675,-1.3959626996114183,0.060109289617486336,0.4143278904137262,1.0,9/37,9.38%,CSMD3;CAMK1D;ADGRB3;DCC;KNDC1;VLDLR;MARK1;LRP8;DAB2IP
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5970750995908385,1.3959227868980462,0.09246088193456614,0.44556600574252697,1.0,2/18,5.64%,GPNMB;DUSP3
prerank,regulation of MAP kinase activity (GO:0043405),0.47144890151613356,1.3957904611348855,0.036519871106337275,0.4450253744712707,1.0,11/92,6.37%,HTR2B;PIK3R5;APOE;CD300A;VEGFA;PRKCD;PDGFA;SORL1;ADAM8;PPEF2;IRAK3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6268426644762118,1.3953693946434,0.10526315789473684,0.44550593674149885,1.0,4/13,15.64%,BCL2L11;VDAC2;BAX;BNIP3
prerank,carbohydrate homeostasis (GO:0033500),0.4915120346161248,1.3951318560949295,0.045707915273132664,0.44533213299640073,1.0,9/67,5.34%,PPARG;PDK4;IL6;PYGL;TFAP2B;SLC8B1;APPL2;TENT4B;FGFR4
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5589154573380201,1.3949986305655824,0.06064516129032258,0.4447745499482921,1.0,9/26,16.77%,CBLB;NCK2;FBXW7;ADAM17;CHMP6;APP;SHC1;CBL;NCF1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3430218623429223,-1.3944186517169108,0.0,0.41490112377109484,1.0,26/75,19.19%,MEF2C;OPHN1;CTNNA2;NTNG1;DCC;MEF2A;RYK;BTBD3;ANK3;CNTN4;FGFR2;PARD3;MAP2;FARP1;SPTBN4;PAX2;RAB8A;KLF7;CELSR2;BRSK1;SLITRK5;SLITRK3;ADGRB1;ABITRAM;S100B;LMTK2
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5521504486536906,1.3943627723087468,0.0759493670886076,0.4458654238645755,1.0,10/28,10.59%,MITF;PDK4;PRKAG2;TNFRSF1B;FGFR4;MFSD12;NR1H4;EIF6;SIRPA;SIRT1
prerank,proteoglycan metabolic process (GO:0006029),0.5676179534511632,1.3943182160276129,0.09472259810554803,0.4451031199444815,1.0,7/26,12.65%,HPSE;XYLT1;B4GALT7;IGF1;SULF2;BMPR2;SULF1
prerank,central nervous system development (GO:0007417),-0.2803116915225538,-1.3939975177430763,0.0,0.41311650568708413,1.0,55/250,12.20%,ZFHX3;CX3CR1;CNTNAP2;ADGRL3;GRIN2A;ITGAM;SPOCK1;ADAM23;DCLK1;PHF8;ROBO2;CNTN6;PTCH1;MARCKS;GRIN2B;NFIB;TGFBR2;GRIK1;MBP;EML1;SMO;CNTN4;ANKLE2;RELN;CDK5R1;NCKAP1;GRIN1;PBX3;ARNT2;IL1RAPL2;TPPP;CDH2;POU6F1;MYRF;ADGRG1;MEIS3;ATN1;MAL;QARS1;DNER;UFM1;SZT2;EPHA7;SERPINI1;MEIS1;SOX6;ADAM22;SH3GL3;IER3IP1;HAPLN2;NDUFS4;SNTG2;PKD2;RPS6KA6;GRIN2D
prerank,carnitine metabolic process (GO:0009437),0.6387791936667128,1.3927974960976812,0.11509715994020926,0.44885396734366056,1.0,4/12,8.37%,TMLHE;ACADL;CRAT;CPT1A
prerank,regulation of embryonic development (GO:0045995),0.5370586598397675,1.392494409515014,0.06870229007633588,0.4488741469171574,1.0,8/34,13.75%,B4GALT5;TRIP12;NIBAN2;DAG1;WDPCP;NIPBL;CFL1;CLASP1
prerank,snRNA 3'-end processing (GO:0034472),0.5811266101082218,1.391963373513508,0.08516483516483517,0.4496289643598323,1.0,10/19,13.46%,TOE1;INTS6;EXOSC3;EXOSC9;INTS1;INTS8;EXOSC8;INTS5;INTS7;INTS2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4562564856972403,1.3917491147573855,0.019668737060041408,0.4494289802095621,1.0,28/132,11.47%,APOE;OPTN;TFEB;PLK2;ADAM9;PRKCD;FOXO3;ABCD1;SNX9;DAPK1;TNFRSF1B;SH3GLB1;MTLN;IGF1;ADAM8;IRS2;FLCN;ZBTB20;MSN;MEFV;ZC3HAV1;SNX33;ROCK1;CNOT7;GRSF1;GSK3B;FOXO1;APP
prerank,sulfation (GO:0051923),-0.561664119263948,-1.3915547354465585,0.09366391184573003,0.4159859055792619,1.0,6/11,35.35%,UST;HS3ST5;SULT1A1;SULT4A1;SULT6B1;SULT2B1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5866594245584006,1.3913385189815082,0.09472259810554803,0.44984540713680266,1.0,6/18,12.93%,AOAH;MANBA;DERA;OGA;FUCA1;FBXO6
prerank,regulation of cholesterol transport (GO:0032374),0.5944989490241314,1.3900893794447142,0.08575380359612725,0.45290702150718265,1.0,5/20,9.57%,LIPG;LRP1;NR1H3;ABCA2;LAMTOR1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4878125298878171,1.3892780307269346,0.05327413984461709,0.4545352649063231,1.0,24/68,20.90%,MMAB;MTHFS;CYB5R3;PDZD11;ENPP1;LMBRD1;ACP5;FOLR2;SLC25A32;CYB5A;MCCC1;SLC2A1;MTHFD1L;SLC23A2;SLC23A1;SLC52A1;GSTO2;PANK2;MTRR;ABCC1;SLC19A1;SLC19A2;GSTO1;BTD
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6527963803465248,1.3887510104176668,0.09711684370257967,0.45533639245718494,1.0,3/11,7.63%,CORO1C;CD44;RREB1
prerank,ovarian follicle development (GO:0001541),0.625272585743821,1.3877886859957145,0.10075187969924812,0.45741259253299626,1.0,2/13,1.88%,VEGFA;CEBPB
prerank,regulation of interleukin-6 production (GO:0032675),0.4634057898529354,1.3875746373475546,0.03739316239316239,0.4572037614499868,1.0,26/96,16.53%,SYK;RAB7B;TLR8;CD200R1;IL6;TMEM106A;SPHK2;IRAK3;CYBA;SIRPA;TYROBP;IL6R;MAVS;NLRC3;ARHGEF2;APP;TREM2;AFAP1L2;GAS6;TNFAIP3;CX3CL1;ARRB1;LBP;MYD88;HSPD1;TLR1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.6076956107631991,1.3872746387063302,0.1012311901504788,0.4572657012364506,1.0,7/18,12.24%,MMP14;CLN3;STX8;VTI1B;ABCA2;VPS4A;APPL1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6035458097163965,1.3870322754233386,0.10748299319727891,0.4571464398368396,1.0,5/17,12.13%,APOE;ABCG1;ABCA2;ERLIN1;LPCAT3
prerank,sulfur compound biosynthetic process (GO:0044272),0.4546656329804399,1.3865988897351411,0.039572192513368985,0.4576958907712128,1.0,26/104,15.25%,CDO1;B4GALT5;MGST2;PAPSS2;GSTM1;AKR1A1;DSE;CNDP2;UGDH;SLC26A1;B4GALT6;ST3GAL4;LUM;HPGDS;SLC35B3;PAPSS1;ESD;B4GALT3;LIAS;GGTA1;MGST1;HAGH;B4GALT2;SLC10A7;GSTO2;GSTA4
prerank,neurotrophin signaling pathway (GO:0038179),0.5735628714682498,1.3859906974570586,0.08602150537634409,0.4587499302285488,1.0,7/21,18.32%,GRB2;SOS1;KIDINS220;ZFYVE27;RAPGEF1;FRS2;CASP3
prerank,cellular response to hormone stimulus (GO:0032870),0.47929278339965764,1.3859096632848749,0.06172839506172839,0.458158727026203,1.0,15/69,12.62%,CTSB;CTSL;RARA;UBE2L3;STAT5B;NR3C1;SLC5A5;NCOA4;CTSS;CTSH;NCOA3;NCOA1;PAX8;BCAS3;GAS2L1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4888003128773901,1.3853836027285074,0.05956471935853379,0.4589025423553543,1.0,20/59,15.31%,CTNNB1;MITF;CEBPB;RUNX2;IL6;CDKN1A;JUN;MED12;PTEN;MED15;SOX9;CBFB;TNRC6B;AGO3;MED16;MED26;BCLAF1;RELA;BAX;CDK8
prerank,prostanoid biosynthetic process (GO:0046457),-0.5098851601605162,-1.3850095535439175,0.09666666666666666,0.4276220200858348,1.0,7/15,27.74%,PTGS1;PLA2G4A;CD74;PNPLA8;PTGDS;PTGIS;PRXL2B
prerank,microtubule polymerization (GO:0046785),-0.4136427270293246,-1.3842230111545555,0.08071748878923767,0.426587841527573,1.0,7/28,6.59%,TUBGCP5;HDGFL3;MAPT;FGF13;AKAP9;TPPP;CSNK1D
prerank,monocarboxylic acid transport (GO:0015718),0.49932106849152286,1.383977737421364,0.06390532544378698,0.4624212871575461,1.0,13/51,13.46%,CD36;SLC51A;RXRA;SLC16A1;SLC27A4;STARD5;ABCC4;NR1H4;ABCC3;SLC27A1;NCOA1;SLC6A8;ATP8B1
prerank,regulation of neuroinflammatory response (GO:0150077),0.5881950307544979,1.383886108635313,0.0758988015978695,0.46181450289691994,1.0,4/19,5.08%,CD200R1;IL6;TNFRSF1B;IGF1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.4940336780992224,1.3832872249367494,0.05263157894736842,0.4627751102742413,1.0,8/51,11.76%,CD36;TLR8;IL6;TMEM106A;NLRC4;TYROBP;APP;FZD5
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5188685308119824,1.3830504599677764,0.08443908323281062,0.4627322364100601,1.0,5/41,4.74%,PLPP3;GCNT2;FLOT1;CD44;CITED2
prerank,positive regulation of TOR signaling (GO:0032008),0.5186771423079565,1.3823356957023694,0.07888349514563107,0.4640786525522776,1.0,13/40,14.72%,GPR137B;FNIP1;HTR6;SIK3;PIK3CA;FLCN;LAMTOR1;TREM2;MIOS;SLC38A9;LAMTOR3;GAS6;GOLPH3
prerank,phasic smooth muscle contraction (GO:0014821),0.6608941506581579,1.3820848190037325,0.1069182389937107,0.4639545614655597,1.0,1/10,0.14%,HTR2B
prerank,regulation of calcium ion import (GO:0090279),0.5735941231467724,1.3820277746558058,0.11068211068211069,0.4632305652916101,1.0,3/21,6.26%,LGALS3;CTNNB1;SPHK2
prerank,macrophage chemotaxis (GO:0048246),0.6685005719745408,1.3816386279867257,0.1238390092879257,0.4635643739837287,1.0,2/10,6.87%,LGALS3;CKLF
prerank,negative regulation of apoptotic process (GO:0043066),0.4334656080661883,1.3813132354683146,0.0,0.4636400263461406,1.0,105/444,16.14%,HTR2B;ARHGAP10;ANXA4;CD38;APOE;PRKCH;ANXA1;CTNNB1;VEGFA;AQP1;FNIP1;PDK4;CPEB4;TFRC;DNAJB6;CD44;PLK2;NAT8;IL6;HGF;CD28;ITGA5;PRKCD;NIBAN2;FAS;TFAP2B;BIRC6;RIPK1;PPT1;ANXA5;NOTCH2;MAP2K5;CITED2;RAF1;PIM1;IGF1;CLN3;PCID2;PPIF;THBS1;MERTK;BABAM2;ADAM8;NR1H4;PIK3CA;PROC;HSPA1B;RPS27A;UBC;CAT;TNFAIP8;BFAR;SH3RF1;XIAP;SOX9;SNAI2;RB1;KLHL20;CTSH;TOPORS;COPS5;CSNK2A2;FSTL1;ITGB1;PIM3;GSK3B;PTK2B;CFL1;POU3F3;FOXO1;SIRT1;BIRC3;PAK2;BAG4;MT3;TAX1BP1;NOTCH1;RHBDD1;TREM2;ZFAND6;MAZ;HCLS1;ATAD3A;RELA;GAS6;VDAC1;PRKN;HSPA1A;GDNF;SHC1;PHIP;SQSTM1;GOLPH3;MCL1;CX3CL1;RPL10;CBL;PRKCG;BNIP3;MYD88;GRN;HSPD1;MIEN1;TMBIM4;BID
prerank,regulation of organelle organization (GO:0033043),0.47607600696999347,1.3808176450829086,0.04500548847420417,0.4644454455491237,1.0,20/80,14.72%,MYO5A;MTM1;DIAPH1;ZEB2;SPEF1;TBC1D25;RAB33B;CLN3;STX5;CAPN2;SCARB2;MSN;MAVS;PAK2;CPLANE2;SIRT7;PRKN;SQSTM1;VPS11;GOLPH3
prerank,cellular response to acid chemical (GO:0071229),0.5405378260519156,1.3808042208062752,0.07652399481193256,0.4636068384112266,1.0,8/27,13.12%,VEGFA;IPO5;CPEB4;SESN2;CAPN2;LAMTOR1;SLC38A9;LAMTOR3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6639228632584541,1.380739173547582,0.1232876712328767,0.4629410387065931,1.0,4/10,11.91%,ENPP1;APPL2;PID1;PRKCB
prerank,regulation of multicellular organismal development (GO:2000026),0.5518215639519026,1.380566283182203,0.09505208333333333,0.4626086004245387,1.0,3/25,6.98%,HPSE;TRIP12;NIPBL
prerank,nucleotide catabolic process (GO:0009166),0.6116539909268366,1.380494657425357,0.09635036496350365,0.46193359082376473,1.0,5/16,9.82%,XDH;ITPA;NT5C2;NT5E;DERA
prerank,regulation of phosphate metabolic process (GO:0019220),-0.4980704602515476,-1.37951810116733,0.11447811447811448,0.43437110856357297,1.0,6/16,23.02%,SMG6;SIRT2;TIGAR;SMG7;IGBP1;SMG5
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.47109163091018513,1.3792793700878465,0.04756756756756757,0.46484024331252655,1.0,34/76,24.93%,FBXW7;TNIP1;TANK;UBE2L3;RWDD3;CUL3;PIAS4;XIAP;BRCA1;HUWE1;DCUN1D5;BIRC3;STUB1;DCUN1D3;NSMCE3;DCUN1D4;CENPX;DCUN1D1;CRY1;PHF23;BIRC2;MYCBP2;WFS1;PAXIP1;PIAS1;HSPBP1;FKBP1A;MALT1;SPRTN;BCL10;TRAF6;FBXO4;NDFIP1;DCUN1D2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.5872742417409101,1.378463032758039,0.08762169680111266,0.4663910136661628,1.0,9/19,19.82%,UGDH;RENBP;GFPT1;NAGK;SLC35D1;UGP2;GNPDA1;NANS;PMM2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.6598699698582046,1.377658990460765,0.12037037037037036,0.4680016500314176,1.0,4/10,13.94%,DNAJB6;SORL1;HSPA1B;HSPA1A
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.58789563875063,1.3774395256735006,0.10138888888888889,0.4677476907665711,1.0,5/18,10.25%,PPARG;PDPK1;ITGA4;SIRT6;ADAM17
prerank,cellular amide metabolic process (GO:0043603),0.4599650818872082,1.3774318722839,0.026624068157614485,0.46689042224381144,1.0,31/102,20.90%,PLPP3;BAAT;CERK;SGPL1;MTHFS;NLN;PDZD11;CPXM1;ACSM3;ATF4;GLYAT;FOLR2;ABHD4;ABCA2;PLAAT1;SLC25A32;DNPEP;MCCC1;PLAAT3;MTHFD1L;ACOT9;PANK2;CPM;MTRR;SLC19A1;PPP2CA;NSMAF;ACOT2;PPP2R1A;ACOT6;BTD
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.546991334563844,1.3770419557629845,0.09287531806615776,0.46725797618130344,1.0,9/25,22.14%,LYST;CHMP2A;CHMP6;CHMP5;TMEM50A;CHMP7;LEPROTL1;CHMP2B;VCP
prerank,snRNA transcription (GO:0009301),0.4721563017038522,1.3768077341775973,0.048314606741573035,0.46719278675432785,1.0,23/70,14.20%,POLR2A;GTF2B;INTS9;TAF5;POLR2L;RPAP2;INTS6;SNAPC1;INTS1;POLR2G;INTS13;INTS8;CDK7;POLR2I;NCBP2;GTF2F2;INTS5;INTS7;ICE2;INTS2;POU2F1;USPL1;GTF2A1
prerank,regulation of dendrite extension (GO:1903859),-0.46243271594375845,-1.3767926642863122,0.09398496240601503,0.43749159564141427,1.0,10/18,23.00%,SYT1;RIMS1;RIMS2;SMURF1;SYT2;SYT4;SYT3;UNC13A;RASAL1;CPNE5
prerank,T cell migration (GO:0072678),-0.5250910603821892,-1.3765781011583722,0.11343283582089553,0.4352921826586586,1.0,4/13,7.38%,SLC12A2;GPR183;S1PR1;CXCL16
prerank,sensory perception of chemical stimulus (GO:0007606),0.6115021766499351,1.3764084665720975,0.11363636363636363,0.46756798425252327,1.0,1/15,0.12%,CD36
prerank,regulation of cholesterol metabolic process (GO:0090181),0.5879012210814594,1.3763048725302456,0.10013351134846461,0.4670058283206249,1.0,7/20,13.22%,APOE;NR1H4;ACADL;ACADVL;ABCA2;LPCAT3;DGKQ
prerank,protein localization to chromosome (GO:0034502),0.5218940250366393,1.375886275373294,0.0832313341493268,0.4675020067134168,1.0,13/34,18.57%,ACD;TPP1;MCM9;PARP3;RB1;BOD1;XRCC4;XRCC5;ESR1;TNKS;CHMP7;TNKS2;RAD21
prerank,positive regulation of catabolic process (GO:0009896),0.48005279437171544,1.375618840594389,0.06504961411245866,0.46748061902916654,1.0,20/65,17.29%,ATG7;WWP1;TIPARP;RAB7A;PLK2;SORL1;STX5;APC;NEDD4L;WWP2;HUWE1;DDB1;GSK3B;OAZ2;FOXO1;TNFAIP3;PRKN;SNF8;OAZ1;CSNK2A1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4731857963392418,1.3756001028333837,0.05585980284775466,0.4666709856583301,1.0,13/75,10.59%,HTR2B;APLNR;VEGFA;PDPK1;ITGA4;NRP2;SIRT6;NRAS;HMOX1;VASH2;BMPR2;ADAM17;SIRT1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.48980702025970974,1.3755469150598398,0.06285072951739619,0.4659780939896947,1.0,21/63,19.38%,HTR2B;TIMP1;RIC1;HGF;WASHC1;SORL1;TIMP2;HP;ROCK1;FOXK1;MT3;TAB2;TREM2;GPLD1;ZKSCAN3;MCL1;RUBCN;NELL1;EIF4G3;EIF4G2;TLK2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6064628505251962,1.3750419522112416,0.11273792093704246,0.4666352805813113,1.0,5/15,10.19%,TENT4B;AGO2;TNRC6B;POLR2G;CNOT7
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5845555795050934,1.3744597634203555,0.10082872928176796,0.467529980648339,1.0,5/18,10.02%,IL6;RIPK1;NCOR1;DDX5;ESR1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6556457981607352,1.3741497657515245,0.1062874251497006,0.46755587947690325,1.0,3/12,8.74%,CD300A;ELF2;CBFB
prerank,neurotransmitter transport (GO:0006836),-0.3352284589813534,-1.373707171492079,0.024096385542168676,0.43861503303244503,1.0,15/73,6.71%,NRXN1;SYT1;CASK;RIMS1;SLC1A3;ATP1A2;SYN2;GABRA2;PTPRN2;LIN7A;SLC17A6;SNAP25;SLC6A15;SLC1A2;PPFIA4
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5743834817391927,1.3732510330548375,0.1051930758988016,0.46940746154204055,1.0,5/21,12.13%,OSBPL8;PLA2G2D;PLA2G4F;PLAAT3;LPCAT3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6387786542889178,1.3718649385922999,0.11782945736434108,0.472700865926494,1.0,4/12,16.55%,BCL2L11;ERN1;BAX;PTPN1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.549274244220742,1.3718534929604678,0.09498680738786279,0.47188266861946476,1.0,3/26,3.86%,CD36;TMEM106A;P2RX4
prerank,positive regulation of immune effector process (GO:0002699),0.5414695579741614,1.371308508009871,0.09529860228716645,0.47271854248788325,1.0,4/27,4.47%,LILRB1;CD46;ANKRD17;APPL2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6243068363575841,1.3712808219046446,0.12816691505216096,0.4702406166154232,1.0,3/12,8.03%,NSMCE2;CUL3;RB1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6243068363575841,1.3712808219046446,0.12816691505216096,0.4702406166154232,1.0,3/12,8.03%,NSMCE2;CUL3;RB1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6243068363575841,1.3712808219046446,0.12816691505216096,0.4702406166154232,1.0,3/12,8.03%,NSMCE2;CUL3;RB1
prerank,Golgi to lysosome transport (GO:0090160),0.6510661523880252,1.3710333398188164,0.11919504643962849,0.4701999274310394,1.0,5/11,18.27%,LAMP1;CLN3;GAK;AP1G1;AP4M1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5177417884289368,1.3709744714605843,0.08521303258145363,0.46954718100288345,1.0,13/37,18.44%,IL6;ABCD1;PLD3;APPL2;ADCY7;SIRPA;MEFV;NLRC3;APPL1;TREM2;MYD88;APOD;CUEDC2
prerank,regulation of Golgi organization (GO:1903358),0.5833044694182035,1.3707090911749977,0.12285714285714286,0.46947640172608585,1.0,3/17,6.52%,MYO5A;RAB33B;STX5
prerank,second-messenger-mediated signaling (GO:0019932),0.46850138850452494,1.3704850714455135,0.041065482796892344,0.4693467237186142,1.0,9/82,3.93%,CD36;HTR2B;TPCN2;APOE;CXCR4;HRH1;PDPK1;P2RX4;XCR1
prerank,regulated exocytosis (GO:0045055),0.4444183140126662,1.369582761217707,0.012295081967213115,0.4712859859361411,1.0,34/173,13.37%,PSAP;CD36;VWF;TIMP1;VEGFA;HGF;APLP2;CD63;PDGFA;LHFPL2;ANXA5;DNAJC5;IGF1;ACTN1;THBS1;VTI1B;ABCC4;OLA1;RAB31;TLN1;LAMP2;F13A1;QSOX1;ITIH3;ARHGAP17;SYT17;RAB10;WDR1;APP;CTSW;GTPBP2;MYH9;RAB11B;GAS6
prerank,bile acid metabolic process (GO:0008206),0.539514130210432,1.369207419131797,0.08408796895213454,0.4716084917520157,1.0,4/27,2.13%,BAAT;NPC1;AMACR;OSBPL1A
prerank,axonal transport of mitochondrion (GO:0019896),-0.5542724936999239,-1.3684636106195285,0.11173184357541899,0.44803369085052513,1.0,3/11,9.71%,MAPT;NEFL;SPAST
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4583591540318685,1.3684010096798986,0.046413502109704644,0.47327572352740344,1.0,29/108,18.54%,MTCH1;PPARG;CTSD;XDH;SYK;ST18;FAS;APAF1;DAPK1;RIPK1;HTRA2;ANP32B;NLRC4;DLC1;EGLN3;CYCS;SIRT1;CASP12;BAX;HSPD1;BID;TRAF2;HSPE1;PRR7;ACER2;BBC3;SENP1;CASP2;CRADD
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.46378511012180507,-1.3680608215156544,0.11191335740072202,0.4462429388384696,1.0,5/20,3.74%,ATP1B1;ANK2;CACNA1C;ATP1A2;RYR2
prerank,cellular macromolecule catabolic process (GO:0044265),0.490119283093829,1.3675011610027907,0.08064516129032258,0.4753811783528153,1.0,16/49,15.02%,RIPK1;RNASE3;HTRA2;MANBA;DFFB;RAB12;DNASE1L1;OGA;SND1;FBXO6;PRKN;SIDT2;RNASEH2A;HNRNPD;RNASEH1;MTREX
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.6380014419197139,1.3673265162557238,0.09956076134699854,0.47508826785236447,1.0,5/12,10.36%,IL6;NOTCH2;DOCK10;LFNG;PTK2B
prerank,regulation of cellular catabolic process (GO:0031329),0.4764767754990257,1.3670908388807896,0.05073280721533258,0.47501402896395495,1.0,19/62,17.98%,PSAP;TPCN2;GPR137B;MTMR3;ABL2;ABCD1;DAPK1;WDR91;SCARB2;DCAF12;DDIT3;ROCK1;LONP2;PRKN;PIP4K2A;ACER2;KEAP1;DRAM2;VPS29
prerank,response to interferon-alpha (GO:0035455),0.5952253721021193,1.3667741455633327,0.11461318051575932,0.4752047664902555,1.0,8/16,16.96%,IFITM1;IFNAR2;KLHL20;IFITM2;TPR;BST2;GAS6;IFNAR1
prerank,regulation of leukocyte migration (GO:0002685),0.5925585422016083,1.3664800670861477,0.11363636363636363,0.4752873092745291,1.0,3/16,7.09%,ANXA1;VEGFA;HMOX1
prerank,neutrophil chemotaxis (GO:0030593),0.4932051923184928,1.3660978153721235,0.0650887573964497,0.4755187329772286,1.0,3/53,1.15%,LGALS3;SYK;PIKFYVE
prerank,cellular defense response (GO:0006968),0.5099203600525205,1.365792387394312,0.09282178217821782,0.47560951220437025,1.0,14/40,16.77%,CD5L;VEZF1;TCIRG1;LY96;TRAT1;LSP1;NCF2;ZNF148;TYROBP;ITGB1;PTK2B;RELA;LBP;NCF1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.47481307138876105,1.3654895653847987,0.05790645879732739,0.47565465291397696,1.0,7/66,5.73%,HTR2B;PIK3R5;SASH1;VEGFA;TAOK3;PDGFA;ADAM8
prerank,regulation of innate immune response (GO:0045088),0.48386078738791,1.3654504947941122,0.07377049180327869,0.47493598527823194,1.0,22/57,20.24%,TLR8;APPL2;ADAM8;IFNAR2;RNASEL;IRAK3;RNF135;TKFC;XIAP;NLRC3;TRAFD1;BIRC3;APPL1;TREM2;FGR;N4BP1;TNFAIP3;ACOD1;PTPN1;BIRC2;FCGR2B;POLR3C
prerank,natural killer cell activation (GO:0030101),0.560198247185397,1.3650546716786562,0.10512129380053908,0.47532717515912404,1.0,3/23,2.24%,PRDX1;SLAMF7;SNX27
prerank,central nervous system myelination (GO:0022010),0.6283452490924729,1.3649528683710976,0.1328358208955224,0.4748261819660655,1.0,4/11,8.19%,B4GALT5;PTEN;B4GALT6;ABCA2
prerank,negative regulation of cellular component organization (GO:0051129),0.4663026793848374,1.364287736416701,0.05263157894736842,0.4761414611462716,1.0,15/74,10.26%,LGALS3;LILRB1;VEGFA;DNAJB6;TFIP11;RAF1;AIDA;SORL1;NR1H4;IRAK3;HSPA1B;RTEL1;XRCC5;SNX33;GSK3B
prerank,actin nucleation (GO:0045010),0.5637605772853542,1.3641719411444193,0.10918774966711052,0.4757000955159127,1.0,9/21,22.21%,IQGAP2;ARPC2;WASHC1;ACTR3;WHAMM;ARPC1A;ARPC4;ARPC5L;ARPC5
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6032148214434389,1.3634231304236921,0.10043041606886657,0.47733038115791987,1.0,6/16,13.63%,PDK4;SCARB2;FOXK1;SIRT1;RORA;PRKN
prerank,regulation of protein metabolic process (GO:0051246),0.5076700278999072,1.3625293236582143,0.07628128724672228,0.4793167369970509,1.0,20/44,23.21%,APOE;MAP2K5;MAPK7;NEDD4L;MTPN;CHMP6;APP;TRAF3;SNF8;PARL;ACE;WFS1;SPOP;GSAP;VPS35;FKBP1A;FURIN;PLAUR;FAF1;ABCA7
prerank,regulation of DNA binding (GO:0051101),0.5042719619004812,1.3624904788510448,0.07015457788347206,0.47860401655369583,1.0,6/44,6.69%,PPARG;TXN;JUN;E2F1;IGF1;DOT1L
prerank,negative regulation of receptor internalization (GO:0002091),0.6311172656108823,1.3623587059834272,0.12998522895125553,0.47820248954703126,1.0,5/12,15.04%,SDCBP;ATXN2;RIN3;ANKRD13D;UBQLN2
prerank,organelle transport along microtubule (GO:0072384),0.5251543313185953,1.3619837524322345,0.09950859950859951,0.47858975862994024,1.0,10/31,19.76%,ARHGAP21;CLN3;PEX14;UXT;BORCS5;NDE1;KIF5B;PAFAH1B1;HTT;RAB1A
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4855471278879593,1.3619000005536996,0.0979020979020979,0.47801180107128316,1.0,6/53,5.96%,HTR2B;HRH1;ANXA1;HTR6;XCR1;CNR2
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4702677415709219,-1.3618827484067813,0.09057971014492754,0.4575659627854916,1.0,6/18,8.69%,ACVR1;BMPR1A;TGFBR2;ENG;MDM4;TGFB2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6630677433113952,1.3613956811945325,0.13740458015267176,0.4787833132005796,1.0,2/10,4.04%,FOXP3;CD274
prerank,regulation of lymphocyte activation (GO:0051249),-0.5424179601452467,-1.3612732350973773,0.11940298507462686,0.456113537324108,1.0,1/12,0.04%,PAG1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.3715713335828331,-1.3611606138493932,0.04216867469879518,0.4536322371259556,1.0,10/44,4.77%,BIN1;EVL;FCHSD2;SPIRE1;PRKCE;VASP;FER;HCK;NCKAP1;NCK1
prerank,membrane fusion (GO:0061025),0.5277853180103059,1.3609906243205387,0.074719800747198,0.4791746772154155,1.0,12/33,20.45%,MYOF;SNAP29;VTI1B;RABEP1;VAPA;HUWE1;STX11;VAMP3;RABIF;GCA;VAMP2;SNAP23
prerank,generation of neurons (GO:0048699),-0.28876144374210966,-1.360858497274822,0.0,0.45162374262392135,1.0,32/190,9.06%,CX3CR1;PTPRD;ADGRL3;MEF2C;OPHN1;IL1RAPL1;GPM6A;SPOCK1;TAFA1;DISC1;AUTS2;RYK;MAPT;FZD3;EML1;MYEF2;CIT;RELN;FUT9;MYT1L;CDK5R1;NTRK2;FGF13;ASTN2;ACSL4;MARK1;MAP2K1;TUBB2A;DNER;MARK2;TGFB2;SEMA3A
prerank,glycolipid metabolic process (GO:0006664),0.49735122968740286,1.3605434654072945,0.08674101610904585,0.4797451617185959,1.0,12/47,8.19%,PSAP;CERK;PGAP3;GALC;GLA;CTSA;ESYT1;HEXA;PGAP1;ARSA;ST3GAL4;ABCA2
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5684821962082143,1.3604570349272254,0.10789473684210527,0.47924336542813223,1.0,9/20,20.60%,SDCBP;FLOT1;RIPK1;PDCD6IP;BIRC3;STUB1;BIRC2;ASAH1;OGT
prerank,positive regulation of glucose import (GO:0046326),0.5657790660809818,1.3602483701415975,0.11484593837535013,0.47904126499547633,1.0,3/21,5.81%,OSBPL8;IGF1;IRS2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5718591088671291,1.3589552454454434,0.10911602209944751,0.48219477315079373,1.0,9/19,18.74%,ACD;TENT4B;HNRNPU;TERF1;NAT10;TEN1;STN1;EXOSC10;GNL3L
prerank,regulation of glucose metabolic process (GO:0010906),0.516869969116292,1.3588538843605253,0.097708082026538,0.48166325326970716,1.0,12/34,13.63%,PDK4;ZNF692;GNMT;SDHAF3;IRS2;FOXK1;SIRT1;RORA;SIRT7;GPLD1;DGKQ;PRKN
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.46919707822327433,1.3579939179720746,0.0622876557191393,0.48353855116030964,1.0,19/67,12.85%,VAV3;NCK2;VEGFA;MAPKAPK3;BAIAP2;ABI1;NRP2;PIK3CA;CYBB;CYBA;NCF2;VAV1;CYFIP2;ROCK1;PTK2B;PAK2;SULF1;DOCK1;NCF4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5941081492723722,1.3578305823582173,0.11505681818181818,0.4831764232705348,1.0,5/16,8.88%,ADSL;IMPDH2;PPAT;AMPD3;LHPP
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5215421504554748,1.3575502179527408,0.0821078431372549,0.4832490901186742,1.0,6/37,5.08%,PPARG;ERN1;CDKN1A;JUN;PTEN;IGF1
prerank,response to nitric oxide (GO:0071731),0.6213690480604454,1.357305282453613,0.12700729927007298,0.48315221728013646,1.0,4/13,11.17%,TXN;AQP1;FOXO1;MT3
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6360046398082727,1.3569280389060012,0.13501483679525222,0.48348603179792654,1.0,4/12,17.56%,MGST2;CNDP2;HAGH;OPLAH
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5674382115950012,1.356629143557667,0.11328671328671329,0.48355780891744576,1.0,6/20,8.88%,ADSL;IMPDH2;PPAT;AMPD3;NT5C2;LHPP
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.5760824562180721,1.3565165089508453,0.10419485791610285,0.48306672418811075,1.0,8/21,20.17%,TGM2;SLC8B1;MICU2;MICU1;LETM1;SMDT1;AFG3L2;BCAP31
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4503488435295379,-1.3558555082877841,0.09448818897637795,0.4602660948045131,1.0,8/22,14.84%,NTRK3;ACAP2;MAPT;MAGI2;NTRK2;EHD1;STMN2;RAPGEF2
prerank,urogenital system development (GO:0001655),0.6372551740298699,1.3554231766983025,0.11879699248120301,0.48565956618157735,1.0,3/11,9.86%,ANXA1;SOX9;PAX8
prerank,regulation of necroptotic process (GO:0060544),0.5536965941365293,1.3552352875096367,0.1011826544021025,0.4854088946353368,1.0,7/23,11.49%,SDCBP;FLOT1;RIPK1;PDCD6IP;BIRC3;ARHGEF2;STUB1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.44295068859530656,1.3550369249622656,0.03008298755186722,0.48520571227126963,1.0,31/136,15.15%,ANXA4;ADGRG3;SIGIRR;FOXP3;IRAK2;ID2;MAP2K5;PIM1;RWDD3;SIK1;IRAK3;BHLHE40;NWD1;PEX14;EIF2AK4;RB1;WWP2;NFKBIL1;DDIT3;NLRP2B;ESR1;NLRC3;SIRT1;TAX1BP1;TBX6;TRAF3;GAS6;TNFAIP3;ERBIN;ACOD1;ARRB1
prerank,sphingosine biosynthetic process (GO:0046512),0.6446375593998895,1.3548606385571265,0.12293853073463268,0.48415219359187484,1.0,5/11,19.18%,SPTLC2;SPHK2;ABCA2;ACER2;ASAH1
prerank,sphingoid biosynthetic process (GO:0046520),0.6446375593998895,1.3548606385571265,0.12293853073463268,0.48415219359187484,1.0,5/11,19.18%,SPTLC2;SPHK2;ABCA2;ACER2;ASAH1
prerank,T cell homeostasis (GO:0043029),0.6553426654348278,1.3546230485522808,0.1339421613394216,0.48410684218950617,1.0,3/10,14.65%,FOXP3;FAS;JAK3
prerank,cellular response to mechanical stimulus (GO:0071260),0.4996747027153353,1.3546150035618885,0.09154929577464789,0.4833202187807552,1.0,17/46,18.54%,TLR8;MAP3K1;AQP1;FAS;GADD45A;SOX9;MAP2K4;PTGER4;PIEZO1;PIEZO2;KCNK4;MAP3K2;BNIP3;MYD88;LTBR;CASP2;CRADD
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5646387334240354,1.3544027610140812,0.13509933774834437,0.48321471745490224,1.0,4/20,8.03%,NIBAN2;GTF2B;IGF1;RB1
prerank,regulation of cardiac conduction (GO:1903779),-0.3496302923596457,-1.3535499573710958,0.04929577464788732,0.4626613657059271,1.0,14/54,12.40%,ATP1B1;RYR3;ANK2;ITPR2;TRPC1;ASPH;ATP1A2;RYR2;ATP1B2;ATP2B3;PRKACA;ATP2B2;ATP2B4;AGT
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.5005449141084134,1.3532185605586327,0.10121951219512196,0.48616121290381825,1.0,13/41,15.53%,LILRB1;RARA;IGF1;ARG2;NR1H4;IRAK3;SIRPA;NFKBIL1;NLRC3;GAS6;TNFAIP3;CX3CL1;LBP
prerank,positive regulation of neuron differentiation (GO:0045666),-0.35858219359603993,-1.3530333270704356,0.06593406593406594,0.4611852285829107,1.0,13/40,23.56%,MEF2C;BRINP3;ZEB1;VWC2;REST;RHOA;HOXD3;BRINP1;ECT2;NBL1;SOX11;TRIM32;MMD
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.550805415552413,1.3527677926026735,0.10430247718383312,0.4867224960889802,1.0,15/24,26.97%,IRAK2;RPS27A;UBC;TAB2;RNF34;TNFAIP3;UBE2V1;AAMP;IRAK1;TRAF6;CASP8;TAB1;MAP3K7;TAB3;CYLD
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6349418671323283,1.3525233210072136,0.12345679012345678,0.48666304159998214,1.0,4/12,8.88%,ADSL;IMPDH2;PPAT;LHPP
prerank,eosinophil migration (GO:0072677),0.6171660472187067,1.3519297358997242,0.12735166425470332,0.4869559490051792,1.0,1/14,0.11%,LGALS3
prerank,eosinophil chemotaxis (GO:0048245),0.6171660472187067,1.3519297358997242,0.12735166425470332,0.4869559490051792,1.0,1/14,0.11%,LGALS3
prerank,regulation of cell junction assembly (GO:1901888),0.5374912082648968,1.3519191905327914,0.10411311053984576,0.48618557156565867,1.0,8/27,12.80%,APLNR;PRKCH;FLOT1;PDLIM5;SNAI2;CBFB;ROCK1;RAPGEF1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4867962388491377,-1.3518520412985284,0.1267605633802817,0.46130935643695914,1.0,4/17,10.88%,ANK3;KCNAB1;NOS1AP;KCNRG
prerank,regulation of biomineral tissue development (GO:0070167),0.5435208194428287,1.3517148485610038,0.09922680412371133,0.48604439736689686,1.0,7/26,13.37%,CEBPB;ENPP1;SGMS2;SOX9;ROCK1;NOTCH1;GAS6
prerank,RNA polyadenylation (GO:0043631),0.5408470607996946,1.35164604184226,0.11439588688946016,0.4846728791131926,1.0,9/26,15.64%,CPSF1;TENT4B;CSTF3;WDR33;TENT2;GRSF1;APP;SSU72;CDC73
prerank,mRNA polyadenylation (GO:0006378),0.5408470607996946,1.35164604184226,0.11439588688946016,0.4846728791131926,1.0,9/26,15.64%,CPSF1;TENT4B;CSTF3;WDR33;TENT2;GRSF1;APP;SSU72;CDC73
prerank,membrane repolarization during action potential (GO:0086011),-0.5238197335911522,-1.3515598062577203,0.14666666666666667,0.459242672813227,1.0,2/13,4.62%,ATP1B1;KCNJ2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5580969297395219,1.3513794150060305,0.12158469945355191,0.4846781284313058,1.0,8/21,20.34%,HK3;PGD;TALDO1;SHPK;DERA;RPIA;RBKS;GCK
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.46885293401222244,1.3513558557636973,0.05875706214689266,0.4839699129619651,1.0,10/63,5.81%,CD38;VAV3;ANXA1;NCK2;TFRC;IL6;CD28;CD46;CD274;IRS2
prerank,RNA catabolic process (GO:0006401),0.48839357014407436,1.3511302065338664,0.07879490150637311,0.48395613104826063,1.0,23/46,25.91%,ERN1;RNASE3;HSPA1B;ZFP36L2;AGO3;SND1;HSPA1A;SIDT2;RNASEH2A;HNRNPD;RNASEH1;RNH1;MTREX;AGO4;EXOSC7;RNASEH2B;LSM5;PABPC4;ZC3H12D;XRN2;LSM6;ZFP36;RIDA
prerank,postsynaptic membrane organization (GO:0001941),0.5829310488641353,1.3508970245381449,0.12588401697312587,0.4838820152032943,1.0,2/17,0.58%,CEL;APOE
prerank,activation of protein kinase B activity (GO:0032148),0.5333175015180294,1.3502332197809201,0.1084967320261438,0.4850757098528601,1.0,7/29,15.51%,OSBPL8;TXN;PDPK1;IGF1;MT3;GAS6;MAPKAP1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5715753246013846,1.3501855266897462,0.11854951185495119,0.48441323512659706,1.0,4/19,5.81%,PRKCD;ABCD1;MTLN;IRS2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4700859542623306,1.3497753015680216,0.06181015452538632,0.4848377841188699,1.0,22/73,18.54%,MTCH1;PPARG;XDH;FAS;APAF1;RIPK1;ANP32B;NLRC4;DLC1;EGLN3;CYCS;CASP12;BAX;HSPD1;BID;TRAF2;HSPE1;ACER2;BBC3;SENP1;CASP2;CRADD
prerank,membrane lipid biosynthetic process (GO:0046467),0.47567084769522,1.3496605241995023,0.07586206896551724,0.4843861279149048,1.0,18/58,17.43%,PLPP3;SPTLC2;SAMD8;SGPL1;CERT1;SGMS2;HACD4;CERS6;SPHK2;ST3GAL4;SPTSSA;VAPA;ELOVL1;ALDH3A2;DEGS1;PRKD3;ACER2;SGMS1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6152964835721733,1.349186444718002,0.13063063063063063,0.4849973448999065,1.0,4/13,13.00%,ATG7;ATG10;UBA3;UBA5
prerank,response to estradiol (GO:0032355),0.520351743394554,1.348652508871862,0.12020460358056266,0.485849096881503,1.0,8/31,12.68%,ANXA1;CTNNB1;STAT5B;LCOR;NCOA3;ESR1;STRN3;FAM210B
prerank,P-body assembly (GO:0033962),0.625173225682934,1.3483520253446841,0.1366906474820144,0.4860099104593246,1.0,6/12,16.07%,DYNC1H1;DDX6;ATXN2;PATL1;LIMD1;EDC3
prerank,positive regulation of dendrite extension (GO:1903861),-0.46244713293309203,-1.3483011086586556,0.11313868613138686,0.46415336971702037,1.0,10/17,23.00%,SYT1;RIMS1;RIMS2;SMURF1;SYT2;SYT4;SYT3;UNC13A;RASAL1;CPNE5
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.46456933416310425,1.3482274997432366,0.06787330316742081,0.4856105978804384,1.0,22/69,14.20%,POLR2A;GTF2B;INTS9;TAF5;POLR2L;RPAP2;INTS6;SNAPC1;INTS1;POLR2G;INTS13;INTS8;CDK7;POLR2I;NCBP2;GTF2F2;INTS5;INTS7;ICE2;INTS2;POU2F1;GTF2A1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.550825752224557,1.348200235977309,0.13020134228187918,0.48490510765005435,1.0,8/21,15.06%,ADAM9;DAG1;BACE1;ADAM17;HM13;MYH9;ADAM19;NCSTN
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6398925173655221,1.3479416941160447,0.1276923076923077,0.484896673396584,1.0,5/11,11.89%,P2RX4;LMNA;GLRX3;FOXO1;NOTCH1
prerank,cellular response to reactive oxygen species (GO:0034614),0.48261858863988166,1.347939273745738,0.08036739380022963,0.48412207807166935,1.0,16/59,13.61%,NFE2L2;ANXA1;AQP1;MPV17;IL6;PRKCD;JUN;RIPK1;MAPK7;PPIF;SIRPA;PLEKHA1;SIRT1;ERCC6L2;RELA;TNFAIP3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.468309963483104,1.347625999837916,0.07175398633257403,0.4842481717194437,1.0,22/67,20.47%,CD36;PSMD1;CYBB;CYBA;NCF2;PSMF1;PSMD14;PSMD12;NCF4;VAMP3;PSME2;NCF1;PSMB10;PSMD5;PSMD8;PSMA3;TAPBP;PSMA2;PSMD11;ITGAV;SNAP23;PSMA6
prerank,regulation of pseudopodium assembly (GO:0031272),0.6489782643159674,1.3467997523214477,0.13538461538461538,0.4852698892041005,1.0,2/10,6.54%,WASHC1;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6489782643159674,1.3467997523214477,0.13538461538461538,0.4852698892041005,1.0,2/10,6.54%,WASHC1;APC
prerank,long-term memory (GO:0007616),0.5788427399332867,1.3466678934811103,0.11312849162011174,0.4848827370864702,1.0,4/19,8.38%,APOE;SGK1;EIF2AK4;CALB1
prerank,regulation of osteoclast differentiation (GO:0045670),0.5093594038052648,1.3466023857002933,0.10893512851897184,0.4843464233756702,1.0,4/33,5.29%,GPR137B;LILRB3;CEBPB;PRXL2A
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5831728911166287,1.3464386891742737,0.11823361823361823,0.4840451933410001,1.0,5/17,12.33%,NFE2L2;HTRA2;MAPK7;SIRT1;TREM2
prerank,regulation of primary metabolic process (GO:0080090),0.44171244327665,1.346360389240205,0.046413502109704644,0.48352656273297323,1.0,39/126,20.52%,PSAP;PPARG;APOE;ID2;FASN;PSMD1;RXRA;NCOR1;FGFR4;MVD;IRS2;CREBBP;IDI1;TBL1XR1;NCOA1;OAZ2;PSMF1;PPARD;PSMD14;PSMD12;PSME2;AZIN1;PMVK;SCD;SC5D;OAZ1;PSMB10;PSMD5;NFYC;PSMD8;PSMA3;NCOA6;HMGCR;NCOA2;PSMA2;PSMD11;SREBF1;PSMA6;SIN3A
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6022772027340079,1.345823024743077,0.11904761904761904,0.48440546965897074,1.0,2/15,2.82%,PPARG;NR1H3
prerank,cellular response to ketone (GO:1901655),0.5104519457341644,1.3455003018367764,0.11166253101736973,0.48465947745620125,1.0,12/35,14.72%,AQP1;SPP1;NR3C1;SPHK2;PTGER2;NCOA4;MSN;PTGER4;ACOD1;ADCY8;ADCY3;GOLPH3
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.45321315931649636,1.3454150331659143,0.04333694474539545,0.48413584012871713,1.0,22/93,16.77%,SDCBP;SASH1;XDH;VEGFA;GADD45B;GADD45G;RELL1;TAOK3;RIPK1;GADD45A;MFHAS1;SH3RF1;HIPK2;FZD7;PTK2B;APP;TRAF1;TRAF3;TRAF5;TRAF2;LTBR;NCF1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4998306163087475,-1.345265546915287,0.12987012987012986,0.4684810769323941,1.0,4/16,10.16%,MEF2C;PLCB1;RIPOR2;LRRC8A
prerank,regulation of store-operated calcium entry (GO:2001256),0.65773198327118,1.3449514503802993,0.1288244766505636,0.48477971599702957,1.0,3/10,4.59%,CD84;SLC8B1;HOMER3
prerank,diterpenoid metabolic process (GO:0016101),0.4871748499333589,1.3447641734535662,0.08130081300813008,0.4846067442266526,1.0,6/55,5.07%,APOE;STRA6;DHRS3;LRP1;RBP1;RDH12
prerank,dopaminergic neuron differentiation (GO:0071542),0.5681571133478888,1.3447243886677052,0.12734584450402145,0.4840000955035548,1.0,2/19,1.73%,CTNNB1;VEGFA
prerank,activation of phospholipase C activity (GO:0007202),0.5260006830979698,1.344263630877399,0.12066752246469833,0.484636330287582,1.0,5/29,5.05%,HTR2B;EDNRA;ADRA1A;GNAQ;LPAR2
prerank,cellular protein metabolic process (GO:0044267),0.42113084923512667,1.3440336207035004,0.002,0.48458668776121605,1.0,95/396,17.38%,SFTPA1;SFTPA2;MFGE8;APOE;MSRA;TIMP1;RPL3L;KLK3;ITIH2;SPP1;IL6;MSRB1;ABL2;TNIP1;APLP2;FAM20C;RIPK1;D2HGDH;CLN5;PARP4;B4GALT7;IGF2BP3;GNMT;IGF1;HTRA2;UBE2L3;EEF1A1;AGO2;RPL18A;RPS14;MRPL11;MANBA;RPS11;PIGH;PROC;CSF2RB;RPS27A;MRPL23;RPL17;RPL23;DARS1;PPP4R2;ABCA3;WWP2;FBXO11;CTSH;RPL36A;EIF4EBP2;COPS5;MRPS7;QSOX1;FSTL1;RPL22;RPS21;RAB12;RRBP1;ADAM17;LTA4H;MRPL32;CCN1;MRPL36;HM13;IGFALS;APP;SARS1;STK38;RPL10A;CSF2RA;MRPL28;OMA1;UBA3;FBXW2;DHPS;GAS6;RPS26;PRKN;SPCS2;MRPS21;SRBD1;SERPINC1;MCRS1;NUCB1;MRPL35;RPL15;RPL10;NCSTN;RPSA;CDC34;MELTF;PARL;MRPL43;RPL7;UBE2M;RPL26;TTF1
prerank,regulation of protein kinase B signaling (GO:0051896),0.4310203450673574,1.3435528566950503,0.023445463812436288,0.48539675848523745,1.0,33/193,10.59%,F7;OSBPL8;HPSE;GDF15;PIK3R5;XDH;GRB2;GCNT2;GAB2;TXN;HGF;CD28;PDPK1;PDGFA;P2RX4;PTEN;F10;FGFR4;THBS1;DAG1;ADAM8;TRAT1;IRS2;PIK3CA;FLCN;MFHAS1;VAV1;STRN;PLEKHA1;DDIT3;ITGB1;ESR1;SIRT1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.590554568435197,1.3434616735957123,0.13031161473087818,0.48493863290341205,1.0,3/17,4.72%,PPARG;CDKN1A;PTEN
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5844145823473029,1.3434380326740742,0.13583815028901733,0.4842464857594552,1.0,7/16,19.77%,LILRB1;FOXP3;CD274;TYROBP;JAK3;TNFRSF21;FCGR2B
prerank,negative regulation of axon extension (GO:0030517),-0.40537261744843556,-1.343340897252285,0.08181818181818182,0.47017412741887066,1.0,10/30,11.90%,SEMA5A;MAG;RNF6;MAP2;SEMA4G;SEMA3E;DIP2B;SEMA3A;CDKL3;SEMA6A
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6286795012803207,1.3428939631870376,0.14328358208955225,0.4851284775608616,1.0,4/11,13.37%,LILRB1;MERTK;HCLS1;GAS6
prerank,negative regulation of neuron death (GO:1901215),0.45760062302862575,1.3427780403687388,0.048034934497816595,0.4846904585288815,1.0,21/93,16.20%,GPNMB;APOE;CD200R1;CPEB4;PPT1;TNFRSF1B;SORL1;CLN3;HTRA2;ADAM8;ATF4;GSK3B;PTK2B;NENF;MT3;PRKN;GDNF;PRKCG;GRN;INPP5A;TRAF2
prerank,membrane lipid catabolic process (GO:0046466),0.648757942753174,1.3426384180467577,0.13513513513513514,0.4843223456203385,1.0,3/10,4.22%,MGST2;SGPL1;PPT1
prerank,protein import into nucleus (GO:0006606),0.4743649602844505,1.342465450132155,0.08775981524249422,0.4840667931258109,1.0,13/66,12.24%,MMP12;CBLB;SYK;IPO5;KPNA4;E2F3;APPL2;KPNA2;RPL23;TPR;NUP50;TNPO1;APPL1
prerank,t-circle formation (GO:0090656),0.6393633447431941,1.3423616139828083,0.13496932515337423,0.4821513741004454,1.0,3/10,12.79%,TERF1;NBN;WRN
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6393633447431941,1.3423616139828083,0.13496932515337423,0.4821513741004454,1.0,3/10,12.79%,TERF1;NBN;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6393633447431941,1.3423616139828083,0.13496932515337423,0.4821513741004454,1.0,3/10,12.79%,TERF1;NBN;WRN
prerank,muscle contraction (GO:0006936),0.4449988428363873,1.3421382857068347,0.03444676409185804,0.48207632219966146,1.0,16/126,12.20%,MYOF;TPCN2;EDNRA;ADRA1A;VIM;SORBS3;MYL2;SLC8A1;KLHL41;TLN1;MYBPC3;TPM3;ROCK1;TPM4;SLC6A8;MYLK
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.6268610560681637,1.3419392729491804,0.13221884498480244,0.48192410040312905,1.0,1/11,1.08%,TAS1R3
prerank,regulation of cell death (GO:0010941),0.45515962423471523,1.341489275870529,0.05984766050054407,0.4825751245346469,1.0,27/94,18.26%,CD36;HTR2B;SPEF1;CCN5;LRP1;TNFRSF1B;CELF1;APC;CHMP2A;HSPA1B;PRODH;CTSZ;HPR;HP;SNCG;ATG5;CCN1;MT3;OLFM4;DUS2;PRKN;HSPA1A;BNIP3;RAB29;PRR7;ACER2;CCN2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5876557348874933,1.3413613512899187,0.12482662968099861,0.4814403446560022,1.0,4/15,10.19%,AGO2;ZFP36L2;TNRC6B;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5876557348874933,1.3413613512899187,0.12482662968099861,0.4814403446560022,1.0,4/15,10.19%,AGO2;ZFP36L2;TNRC6B;CNOT7
prerank,positive regulation of organelle assembly (GO:1902117),0.48792228428998313,1.341211871384975,0.08595641646489104,0.4811377305361818,1.0,15/44,18.60%,SDCBP;LCP1;DYNC1H1;SH3GLB1;ASAP1;CAPG;RAB3GAP2;PDCD6IP;IL5;CNOT6L;SDC4;CNOT6;CCP110;PIP4K2A;HTT
prerank,endomembrane system organization (GO:0010256),0.43206004701383316,1.3411878037367495,0.028659160696008188,0.4804801946312387,1.0,53/178,19.76%,MYOF;ARHGAP21;OPTN;PLEKHM2;PHETA2;HOOK3;SNX10;REEP4;RNF26;ATP8B4;NPLOC4;GAK;COG7;VMP1;FER1L6;TICAM2;VAPA;HUWE1;A4GALT;LAMTOR1;VPS4A;SNX33;BCAS3;TRIP11;PI4K2A;VPS51;AP3D1;ARFGEF2;LEMD3;RAB43;ATL2;DYM;ATP8B1;PLEKHJ1;CLASP1;ATL1;SQSTM1;VPS11;GOLPH3;GOLPH3L;DNAJC13;USP8;RAB2A;RAB29;RAB22A;COG2;TMEM170A;ALS2CL;HTT;ARFGEF1;WASHC5;SEC31A;RAB1A
prerank,regulation of gluconeogenesis (GO:0006111),0.5358784897334967,1.3411110750422317,0.1175,0.4799983920759659,1.0,12/27,20.60%,ZNF692;GNMT;SDHAF3;SIK1;DDB1;SIRT1;PGP;SIRT7;DGKQ;CRY1;GCK;OGT
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6565924846685118,1.3405932333208823,0.135258358662614,0.4807980104266777,1.0,6/10,22.65%,NFE2L2;ATF4;DDIT3;QRICH1;EIF2S1;HERPUD1
prerank,positive regulation of cell death (GO:0010942),0.4759619324537774,1.3405642563182796,0.08191126279863481,0.48017518213783567,1.0,13/59,11.17%,CD36;SLC6A6;LRP1;RIPK1;CELF1;APC;PRODH;TYROBP;HPR;HP;PICALM;GSK3B;MT3
prerank,RNA stabilization (GO:0043489),0.5065265210386826,1.3404047101742458,0.12747524752475248,0.4799858326034869,1.0,11/33,17.12%,TRDMT1;E2F1;TENT5A;HNRNPU;TENT2;DKC1;SLC11A1;TENT5D;GDNF;THRAP3;TAF15
prerank,positive regulation of fat cell differentiation (GO:0045600),0.48315030927228575,1.3402662133154766,0.10082063305978899,0.4797037085288863,1.0,8/47,7.63%,PPARG;CEBPB;ID2;ASXL2;PIM1;HNRNPU;METRNL;RREB1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.5566156163695707,-1.338966525757198,0.17366946778711484,0.47749182789258376,1.0,6/10,44.35%,SAG;GNB1;PDE6G;PDE6B;PDE6A;CNGB1
prerank,modified amino acid transport (GO:0072337),0.587568183009525,1.3387602506747653,0.12609970674486803,0.4834628774556117,1.0,6/15,18.76%,FOLR2;FOLR1;SLC25A32;SLC6A8;MGST1;SLC19A1
prerank,iron ion transmembrane transport (GO:0034755),0.6293757597274681,1.33869654757012,0.1582089552238806,0.4829375064244311,1.0,3/10,9.95%,ABCB7;SLC11A2;SLC39A14
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5267173518482826,-1.338284339925044,0.1504424778761062,0.4762646928797215,1.0,3/11,11.13%,P3H2;P4HTM;CRTAP
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4451794282631465,-1.3372025775015812,0.1288135593220339,0.4760771783739645,1.0,15/20,33.30%,PLCB1;RGS10;CHRM3;CHRM2;CDK5R1;AGRN;GRK2;GNA11;RGS8;LYPD1;CHRNA7;GNB1;LY6G6D;CHRNB2;LY6H
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.4309900559555414,1.3363130795259197,0.021538461538461538,0.4893985946867091,1.0,37/182,11.89%,SDCBP;APLNR;APOBEC1;XDH;APOE;OPTN;VEGFA;TIPARP;FBXW7;ID2;CD28;CD46;NOTCH2;CELF1;ATXN2;CITED2;IGF1;AGO2;TRAT1;FLCN;REL;RB1;WWP2;ZNF148;FOXP1;ACVRL1;PICALM;TNRC6B;CNPY2;ESR1;CNOT7;RIN3;AGO3;SIRT1;ANKRD13D;APP;NOTCH1
prerank,macroautophagy (GO:0016236),0.44090462975897,1.3361677313942317,0.055150884495317375,0.4891009575589951,1.0,45/118,23.39%,PLEKHM1;MTMR3;ATG7;PRKAG2;SNAP29;TCIRG1;TECPR1;UVRAG;CLN3;ATG10;VTI1B;STAM;CHMP2A;TOMM20;AMBRA1;LAMP2;VPS33A;CSNK2A2;ARL8B;VPS4A;EPG5;ATG5;FUNDC1;CHMP6;ATG4B;ATG13;VDAC1;PRKN;SQSTM1;SNF8;SNX14;STAM2;PIP4K2A;CSNK2A1;TOMM7;TOMM22;ACBD5;PLAA;VPS36;CHMP2B;VPS37B;VCP;MFN2;MTERF3;KLHL3
prerank,regulation of protein kinase C signaling (GO:0090036),0.5898392405495426,1.3361529526465667,0.1475177304964539,0.4884212704831755,1.0,4/14,6.26%,ADRA1A;VEGFA;GPD1L;SPHK2
prerank,glutathione biosynthetic process (GO:0006750),0.6360156571889,1.3359716184649253,0.15781710914454278,0.488215408956467,1.0,4/11,17.56%,MGST2;CNDP2;HAGH;OPLAH
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.5561826619358767,-1.335940823178208,0.1524390243902439,0.4763205648385123,1.0,5/10,14.97%,CACNB2;NOS1AP;PDE4B;NIPSNAP2;CACNA2D1
prerank,negative regulation of response to wounding (GO:1903035),-0.4567259884935027,-1.3353784877475463,0.1357142857142857,0.47486518956419693,1.0,5/19,16.94%,RTN4RL1;CASK;FGF2;GIT1;CRK
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.6021076185024179,1.3353765641868467,0.1416058394160584,0.4893387572954503,1.0,4/13,7.63%,PIM1;HNRNPU;METRNL;RREB1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5371323128196211,1.3353300739642466,0.11214953271028037,0.48877089682809094,1.0,11/24,18.74%,ACD;TENT4B;HNRNPU;TERF1;NAT10;TEN1;STN1;TNKS;EXOSC10;TNKS2;GNL3L
prerank,activation of GTPase activity (GO:0090630),0.44873670514542013,1.3347673023552091,0.07601713062098502,0.48971509367728955,1.0,16/89,11.46%,ARHGAP24;ABR;TBC1D22A;CORO1C;TBC1D25;TBC1D1;TBC1D2;TBC1D12;RALGAPA2;SLC27A4;TBC1D10A;TBC1D2B;TBC1D22B;CCDC125;BCAS3;TBC1D15
prerank,glycosaminoglycan metabolic process (GO:0030203),0.47879618059511025,1.3345806201554993,0.09291521486643438,0.48955144729456135,1.0,16/54,14.88%,HPSE;GCNT2;XYLT1;NDST1;GNS;EXT1;UGDH;B4GALT7;HEXA;HS2ST1;IDUA;FUCA1;SGSH;SDC4;HS3ST2;GUSB
prerank,positive regulation of catalytic activity (GO:0043085),0.5028617080655768,1.3344480397561715,0.13242574257425743,0.4892077026846759,1.0,12/37,15.41%,ABL2;CHTOP;FGFR4;XRCC4;XRCC5;MT3;BCAS3;WRN;SSBP1;PHACTR4;NCSTN;ATP7A
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.624726699683802,1.334327348569876,0.15327380952380953,0.48883594259793434,1.0,2/12,2.39%,IQGAP1;MYO1E
prerank,neutrophil migration (GO:1990266),0.47659493664679914,1.3342602650280013,0.0811764705882353,0.48830812049509514,1.0,3/58,1.15%,LGALS3;SYK;PIKFYVE
prerank,positive regulation of actin nucleation (GO:0051127),-0.5324971793846944,-1.3340774697639344,0.14912280701754385,0.4752880461285947,1.0,5/11,17.41%,FCHSD2;ABI2;NCKAP1;CYFIP1;GSN
prerank,calcium ion transport (GO:0006816),-0.29955454493666017,-1.3334622632039514,0.0,0.47409653684354564,1.0,35/113,15.95%,SLC24A3;TRPM3;CACNB2;CACNA1E;RYR3;CCR5;CDH23;SLC24A2;ANK2;ORAI1;TRPC1;CACNA1C;GRIN3A;RYR2;ATP2C1;TRPM4;CRACR2B;RAMP1;NALCN;TRPC7;TRPM2;TRPC4;MCOLN1;SLC24A4;CACNA1G;CAMK2A;PKD2;ATP2B2;ATP2B4;PKD1;CACNA2D1;CACNG3;TRPM6;ORAI2;CCR1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5424861751682161,-1.333386551797705,0.146875,0.4717556876008517,1.0,3/11,8.69%,BMPR1A;ZFPM2;TGFB2
prerank,glycoprotein biosynthetic process (GO:0009101),0.45557234940229385,1.3331174424867611,0.07513812154696133,0.4910057737885446,1.0,14/79,7.33%,B4GALT5;B3GNT8;GCNT2;NPC1;XYLT1;TMEM106A;TNIP1;B4GALT7;IGF1;DDOST;COG7;DAD1;B3GALNT2;ST3GAL4
prerank,thyroid hormone generation (GO:0006590),0.6511245613776594,1.3325431248373085,0.14592933947772657,0.49192614789346145,1.0,2/10,5.98%,CPQ;SLC5A5
prerank,glucose homeostasis (GO:0042593),0.4569728865329623,1.332274755072571,0.07057546145494029,0.49204020602197135,1.0,14/83,12.00%,PPARG;LRRC8D;PDK4;HK3;IL6;PYGL;TFAP2B;SLC8B1;APPL2;FGFR4;FOXK1;FOXO1;SIRT1;CYB5R4
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6098523483106892,1.3321468268638401,0.1432791728212703,0.4916852164366234,1.0,2/13,4.30%,IDH1;D2HGDH
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.47099331916893267,1.3316766297962037,0.07781649245063879,0.49235365188181335,1.0,23/61,22.88%,PDK4;PRKAG2;PSMD1;FGFR4;NR1H4;OAZ2;SIRT1;PSMF1;PSMD14;PSMD12;PSME2;AZIN1;PANK2;OAZ1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3737759867217987,-1.331271010938167,0.08433734939759036,0.4741694238067616,1.0,16/41,14.97%,GRIN2A;RYR3;GRIN2B;SLC24A2;HTR2C;ITPR2;RYR2;GRIN1;FGF2;TRPM2;PKD2;GRIN2D;ATP2B4;HTR2A;CHERP;CACNA2D1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5921851443029393,1.330964758296741,0.13991769547325103,0.49366593037120504,1.0,8/16,20.78%,STAM;CHMP6;SNF8;CHMP5;TMEM50A;CHMP7;LEPROTL1;VPS36
prerank,regulation of potassium ion transport (GO:0043266),-0.4044136012566184,-1.3307092614019431,0.1,0.4729886988308623,1.0,11/31,13.99%,KCNIP4;ANK2;DPP10;ANK3;DPP6;KCNAB1;KCNIP3;DLG1;ACTN2;KCNIP1;KCNN2
prerank,regulation of extracellular matrix organization (GO:1903053),0.5917295453003049,1.3300171262485372,0.14693295292439373,0.4959016323160439,1.0,5/15,11.89%,RIC1;LRP1;FGFR4;RB1;NOTCH1
prerank,myeloid leukocyte differentiation (GO:0002573),0.4601598124530658,1.3298810241946566,0.07216494845360824,0.49558680526191534,1.0,14/65,12.33%,PPARG;GAB2;VEGFA;SNX10;CDKN1A;RXRA;RARA;E2F1;FOXP1;TYROBP;SIRT1;IL15;MYH9;TREM2
prerank,leukocyte tethering or rolling (GO:0050901),-0.465676669573318,-1.3296219576004915,0.11191335740072202,0.47294997319709187,1.0,4/17,5.38%,CX3CR1;SELPLG;JAM2;ADD2
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6311616719992793,1.329513383264707,0.13803680981595093,0.4959851389609354,1.0,3/11,7.46%,PRDX1;GPX3;CAT
prerank,regulation of mitotic spindle assembly (GO:1901673),0.5643011944189453,1.3292464235996446,0.1396957123098202,0.4960094182765911,1.0,8/19,17.04%,CHMP2A;HSPA1B;HNRNPU;EML3;PDCD6IP;TPR;HSPA1A;CHMP5
prerank,regulation of presynapse assembly (GO:1905606),-0.45016180696612923,-1.3289931217790736,0.15057915057915058,0.46945066220780046,1.0,4/18,5.61%,PTPRD;IL1RAPL1;LRRC4B;IL1RAPL2
prerank,regulation of presynapse organization (GO:0099174),-0.45016180696612923,-1.3289931217790736,0.15057915057915058,0.46945066220780046,1.0,4/18,5.61%,PTPRD;IL1RAPL1;LRRC4B;IL1RAPL2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5146174525207644,1.328164588746961,0.12376237623762376,0.49862056048063985,1.0,10/32,11.47%,SAMD8;PRKCD;FOXO3;ATXN2;NR1H4;PUM3;PICALM;ROCK1;MTPN;APP
prerank,regulation of receptor internalization (GO:0002090),0.5008054483781998,1.3281523929600834,0.11721611721611722,0.4979333020468354,1.0,7/35,11.29%,SDCBP;VEGFA;FLOT1;CD63;ATXN2;RIN3;ANKRD13D
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6047707163125638,1.3277195110783966,0.14437689969604864,0.4984531671619626,1.0,4/13,13.37%,LAMP1;TYROBP;AP1G1;GAS6
prerank,protein acylation (GO:0043543),0.5023666759304876,1.3276069362357432,0.11477411477411477,0.4980461919018954,1.0,15/38,21.77%,ZDHHC14;ZDHHC16;GTF2B;CREBBP;ZDHHC12;ZDHHC18;NAT10;FOXO1;ING4;NAA10;ZDHHC17;NAT9;CLOCK;NAA80;KAT2A
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5825653686461894,1.3275734607888243,0.1329639889196676,0.49742395000504924,1.0,3/16,6.69%,GPR137B;SIK3;FLCN
prerank,regulation of lipid metabolic process (GO:0019216),0.4520501119026354,1.3263388766554565,0.0770065075921909,0.50035999231272,1.0,32/88,23.76%,PSAP;PPARG;PRKAG2;ID2;FASN;RXRA;NCOR1;FGFR4;MVD;IRS2;CREBBP;IDI1;TBL1XR1;NCOA1;PPARD;RORA;PANK2;PMVK;SCD;SC5D;NFYC;NCOA6;HMGCR;NCOA2;SREBF1;SIN3A;DISP3;ADIPOR1;CERS2;ABCA7;EDF1;MBOAT7
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5497822084442225,1.3261295072490447,0.1388888888888889,0.5002898970865343,1.0,6/21,9.53%,NCK2;PTEN;GADD45A;GPD1L;CNKSR3;NLRP2B
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5966751446178183,1.325582300471229,0.16114457831325302,0.5012262076207521,1.0,3/13,8.19%,SOAT1;IGF1;ABCA2
prerank,snRNA processing (GO:0016180),0.5725151117756222,1.3255817233673788,0.13121546961325967,0.5005065029627667,1.0,8/16,13.46%,TOE1;INTS9;INTS6;INTS1;INTS8;INTS5;INTS7;INTS2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5495738280242429,1.3250613103834754,0.14323962516733602,0.5013953518065067,1.0,2/21,1.42%,CEL;LPIN3
prerank,receptor recycling (GO:0001881),0.635019241100526,1.3249086024802008,0.14909638554216867,0.5011332699949715,1.0,5/10,13.62%,PHETA2;SORL1;ARFGEF2;RAB11B;PLEKHJ1
prerank,negative regulation of mRNA processing (GO:0050686),-0.48910138285623816,-1.3244603252312086,0.12323943661971831,0.47722230055839676,1.0,8/15,30.89%,SRSF6;RBMX;PCBP4;SRSF12;SRSF9;SRSF4;SAP18;SRSF7
prerank,amide transport (GO:0042886),0.5347837682017956,1.3244021245223234,0.13914174252275682,0.5019625195021573,1.0,6/26,8.91%,CERT1;PLTP;FOLR2;FOLR1;SLC27A1;SLC25A32
prerank,neuron projection extension (GO:1990138),0.5082275580938428,1.3242119254498486,0.12229299363057325,0.5018272809574706,1.0,7/32,6.97%,IQGAP1;CTNNB1;ALCAM;SPG11;NRP2;TNN;EIF2AK4
prerank,positive regulation of interleukin-8 production (GO:0032757),0.47923364575408695,1.3232648834905103,0.0947867298578199,0.5038128370826461,1.0,13/49,16.53%,SYK;TLR8;IL6;RIPK1;HSPA1B;DDIT3;MAVS;AFAP1L2;RELA;HSPA1A;LBP;MYD88;TLR1
prerank,retrograde axonal transport (GO:0008090),-0.49849523401191115,-1.322848485242123,0.1423728813559322,0.47831470691279965,1.0,4/16,5.93%,DLG2;DST;NEFL;KIF5A
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5580471845395993,1.3227427081355343,0.12585499316005472,0.5046788580506286,1.0,6/19,11.47%,TMEM106A;MAP2K5;MAPK7;PAX8;MTPN;APP
prerank,nucleic acid metabolic process (GO:0090304),0.45504034398091703,1.3223694342065377,0.08779931584948689,0.5050090445906448,1.0,21/69,15.86%,POLR2A;WTAP;HNRNPH2;ENPP1;KPNA2;ATXN2;HNRNPU;POLR2L;NT5E;HNRNPA0;WDR74;POLR2G;DNASE1L1;POLR2I;NCBP2;HNRNPM;GTF2F2;WRN;HNRNPD;PCBP1;DNASE2
prerank,regulation of microtubule polymerization (GO:0031113),-0.3690977008702724,-1.32230500969283,0.08629441624365482,0.47706600349417205,1.0,11/40,15.79%,NAV3;MAPT;CDK5R1;MAP2;TUBB4A;PAK1;AKAP9;NUMA1;STMN2;MAPRE1;STMN1
prerank,import into cell (GO:0098657),0.48435205024051337,1.3219898999243835,0.11814859926918392,0.5054204572542624,1.0,15/41,19.68%,LRRC8D;SLC6A6;SLC11A2;SLC38A1;SLC27A1;LRRC8C;SLC39A14;TREM2;SLC12A7;NEURL1B;SLC7A1;SLC36A1;LRP2;SLC19A1;SLC7A8
prerank,regulation of RNA metabolic process (GO:0051252),0.46922885485958815,1.3215877762645762,0.09739524348810873,0.5060079850933132,1.0,17/59,15.86%,HNRNPLL;MITF;AHNAK;HNRNPH2;MBNL1;TNFRSF1B;CELF1;IGF2BP3;AHNAK2;GRSF1;PTBP3;PTBP2;PQBP1;PRX;USP36;PCBP1;MBNL2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.45674735478239603,1.3212003000443677,0.09009009009009009,0.5063758474947807,1.0,23/70,20.47%,CD36;PSMD1;CYBB;CYBA;NCF2;PSMF1;PSMD14;PSMD12;NCF4;VAMP3;PSME2;LNPEP;NCF1;PSMB10;PSMD5;PSMD8;PSMA3;TAPBP;PSMA2;PSMD11;ITGAV;SNAP23;PSMA6
prerank,protein targeting to membrane (GO:0006612),0.4484779207952836,1.3211037684709688,0.07616974972796518,0.5059274263780041,1.0,29/83,21.96%,SDCBP;PIKFYVE;ZDHHC14;ZDHHC19;RAB8B;ABCD1;YIF1B;PEX14;MICALL1;ZDHHC12;GET3;ZDHHC18;NACA;SIL1;ALDH3A2;PXMP2;GDAP1;RABGEF1;ZDHHC24;NCF1;ZDHHC4;SGTA;SEC63;ICMT;ACBD5;SLC25A17;ARL6IP1;VPS37B;PXMP4
prerank,lipid modification (GO:0030258),0.49896048033324986,1.3207162827814032,0.10962241169305725,0.5064169130239841,1.0,8/37,13.22%,PLPP3;PLA2G7;DGKZ;DGKA;PLPP6;PLPP5;LPCAT3;DGKQ
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5222628350367878,1.3194760363081055,0.13324538258575197,0.5093001259896138,1.0,10/28,17.63%,FBXW7;NIBAN2;MMP14;RITA1;LFNG;WWP2;TSPAN15;ARRB1;EGFL7;ZBTB7A
prerank,regulation of programmed cell death (GO:0043067),0.42904154837293285,1.3194642057727282,0.047471620227038186,0.5086152510832551,1.0,47/161,20.22%,CTSB;SGK1;BCL2L11;STEAP3;TGM2;FAS;APAF1;DAPK1;RIPK1;RAF1;OSGIN1;ACTN1;AIFM2;CREBBP;HS1BP3;ANP32B;NLRC4;USP42;NF2;SOX9;FBXO11;PAX8;SIRT1;BIRC3;OLFM4;OMA1;WRN;PRKN;BAX;JAK3;USP36;CASP6;RTN4;BNIP3;BID;TRAF2;GAS1;ACER2;ZBTB7A;BIRC2;CASP2;CRADD;ASAH1;BCL3;AKT1S1;AMIGO2;WFS1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5950714606487169,1.3191898211041968,0.15080527086383602,0.5086892012290313,1.0,4/14,8.88%,ADSL;IMPDH2;PPAT;LHPP
prerank,glucose metabolic process (GO:0006006),0.46982288679532386,1.3191175194966567,0.08493771234428087,0.5081899042903381,1.0,19/58,22.69%,SORD;TPI1;AKR1A1;TFAP2B;SLC25A1;IRS2;ATF4;ENO3;SLC39A14;PPARD;PGM1;OMA1;CRY1;APOD;GAPDHS;MDH1;GALM;SLC37A4;SLC25A13
prerank,heart morphogenesis (GO:0003007),0.47181740283395146,1.3190110913010957,0.10153482880755609,0.5078006619414579,1.0,8/50,8.84%,HTR2B;SYNPO2L;VEGFA;NIPBL;SOX9;MYBPC3;DLC1;ACVRL1
prerank,positive regulation of cytokine production (GO:0001819),0.417009850972645,1.3189748573857836,0.011033099297893681,0.5072041920448698,1.0,53/292,13.94%,CCBE1;HTR2B;HPSE;RFTN1;SYK;RAB7B;TLR8;LILRB1;ANXA1;CTNNB1;FLOT1;CEBPB;PIBF1;IL6;CD28;CD46;TMEM106A;LY9;CD274;RIPK1;RARA;SORL1;NR1H4;SPHK2;CREBBP;HSPA1B;ATF4;HMOX1;SULF2;CYBA;POLR2L;BRCA1;FOXP1;TYROBP;DDIT3;IL6R;XRCC5;PTGER4;MAVS;ADAM17;ARHGEF2;APP;FZD5;RORA;PQBP1;APPL1;IL15;AFAP1L2;SULF1;RELA;FGR;SLC11A1;HSPA1A
prerank,response to interferon-beta (GO:0035456),0.5458673026126442,1.3188739767094846,0.13667117726657646,0.5067740814709412,1.0,9/22,16.15%,IKBKE;IFITM1;HTRA2;IFNAR2;UBE2K;IFITM2;BST2;ACOD1;CDC34
prerank,regulation of lipid storage (GO:0010883),0.5475247068592791,1.3184637891448432,0.14705882352941177,0.5073146118436013,1.0,5/22,10.59%,IKBKE;FBXW7;IL6;FTO;SIRT1
prerank,blood vessel diameter maintenance (GO:0097746),0.5086134489187312,1.3183256179017033,0.11330049261083744,0.5070152025688801,1.0,2/34,1.12%,HTR2B;EDNRA
prerank,amyloid-beta metabolic process (GO:0050435),0.5775487207601963,1.3180110074550273,0.1327683615819209,0.507254661799844,1.0,9/16,23.21%,NAT8;DYRK1A;BACE1;NCSTN;ACE;APEH;APH1B;PSEN2;ABCA7
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.6306045527490829,1.3179179598928805,0.15407407407407409,0.5068814674442106,1.0,4/11,12.53%,SOAT1;AGO2;ABCA2;ITM2C
prerank,positive regulation of cell motility (GO:2000147),0.42396853180813976,1.3176829540942416,0.030211480362537766,0.506875131670702,1.0,36/205,12.52%,GPNMB;F7;SDCBP;NEDD9;GCNT2;VEGFA;RUFY3;ARHGEF39;ADAM9;MGAT5;HGF;WASHC1;PDGFA;CD151;SEMA4B;MMP14;IGF1;F10;COL1A1;THBS1;APC;CFAP20;GTSE1;SNAI2;CTSH;PPP3CA;PLAU;ITGB1;ADAM17;RHOD;PTK2B;CCN1;NOTCH1;MYLK;SPAG9;MAZ
prerank,cellular respiration (GO:0045333),0.48246466481424016,1.316718968372846,0.10570071258907364,0.5090993680655689,1.0,14/41,16.72%,ETFRF1;LYRM7;UQCRFS1;MTLN;MTFR1L;NDUFS8;SDHAF4;CYCS;SDHB;SDHA;ATP5F1D;NDUFS1;SIRT3;COX15
prerank,mononuclear cell differentiation (GO:1903131),0.5349769427219014,1.3160139356327485,0.14188267394270124,0.5105391823697646,1.0,7/24,13.37%,PPARG;LILRB1;VEGFA;RELB;MYH9;TREM2;GAS6
prerank,protein import (GO:0017038),0.4507413234543618,1.315968745635381,0.084070796460177,0.5099477833581653,1.0,18/84,12.77%,MMP12;APOE;SYK;IPO5;RAB8B;E2F3;ABCD1;APPL2;PEX14;LAMP2;TPR;SNX33;NUP50;TNPO1;ALDH3A2;PXMP2;APPL1;GDAP1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5565795553494272,1.3156175391728675,0.1474269819193324,0.5102568118710573,1.0,9/20,18.38%,CELF1;AGO2;EIF6;TNRC6B;CNOT7;AGO3;LIMD1;CNOT6;AGO4
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.632943313436876,1.3155292685690017,0.14724919093851133,0.5098227269941307,1.0,4/10,12.10%,ACD;TFIP11;RTEL1;DCLRE1B
prerank,dendrite morphogenesis (GO:0048813),-0.385877470992429,-1.314912926396545,0.0847457627118644,0.49126824550017595,1.0,23/35,32.83%,CTNNA2;MEF2A;PHACTR1;CTNND2;BTBD3;MAP2;FARP1;KLF7;CELSR2;ABITRAM;TAOK2;MAPK8IP2;DIP2A;PAK3;MAP6;DCDC2;SHANK1;CHRNA7;WNT7A;PTN;EPHB3;SHANK3;SDC2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5830181968221135,1.3145370177119309,0.14469914040114612,0.5121043849338698,1.0,8/15,19.92%,ANP32B;GTSE1;TPR;GSK3B;GAS6;CAMK1;RBM22;TCF7L2
prerank,integrin-mediated signaling pathway (GO:0007229),0.4616475985507965,1.3141478029214992,0.06900328587075576,0.512457471716455,1.0,19/73,16.18%,PLPP3;SYK;NEDD9;TEC;PRAM1;ADAM9;ITGA5;CUL3;ITGB1;PTK2B;ITGA10;FBLN1;MYH9;DOCK1;COL3A1;FGR;ERBIN;LAMA3;NRP1
prerank,positive regulation of macroautophagy (GO:0016239),0.4691013813624941,1.313785343485023,0.11471610660486674,0.5128947153706913,1.0,12/48,10.59%,OPTN;SPTLC2;FYCO1;WAC;UVRAG;SESN2;SH3GLB1;RAB3GAP2;VPS13D;EPM2A;PAFAH1B2;SIRT1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4901970478386268,1.3137843297861214,0.10778443113772455,0.5121944402272738,1.0,13/43,15.85%,ERN1;ID2;IL6;JUN;IGF1;THBS1;HMOX1;FOXP1;IL6R;RBPMS2;HTR1B;CX3CL1;DNMT1
prerank,response to estrogen (GO:0043627),0.5065984442026253,1.3137764440678938,0.127129750982962,0.5115158950355433,1.0,7/31,11.32%,RARA;CITED2;TRIM25;NCOA4;BRCA1;ESR1;BCAS3
prerank,mesenchymal cell differentiation (GO:0048762),0.4712247234644798,1.3135272862625527,0.10957324106113034,0.5116050402606978,1.0,11/51,11.89%,HTR2B;CTNNB1;HGF;HNRNPAB;FBXL17;DDX5;SOX9;SNAI2;ROCK1;GSK3B;NOTCH1
prerank,response to steroid hormone (GO:0048545),0.5095657457286373,1.313064830280041,0.12595419847328243,0.5122654128313037,1.0,7/31,8.19%,NR1H3;CATSPERB;UBE2L3;THBS1;NR3C1;CATSPER2;ABCA2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.47339411062520453,1.3129869085539962,0.10532407407407407,0.511789645574741,1.0,18/52,18.02%,MICALL2;NPEPPS;FBXW7;SH3GLB1;E2F1;HTRA2;UBE2L3;HUWE1;CSNK2A2;ARIH2;PPP3R1;FZD5;ATG13;VPS11;USP36;BID;BBC3;TOMM7
prerank,positive regulation of cyclase activity (GO:0031281),-0.48077422683514404,-1.3129724017464668,0.1488673139158576,0.49321430362787577,1.0,2/14,2.42%,ORAI1;CACNA1C
prerank,axon development (GO:0061564),-0.3213068465933218,-1.3120827008451592,0.011235955056179775,0.49302389648525097,1.0,26/78,19.19%,RTN4RL1;SEMA5A;CTNNA2;NTNG1;DCC;RYK;MAPT;ANK3;CNTN4;FGFR2;PARD3;CDK5R1;SPTBN4;PAX2;MARK2;RAB8A;KLF7;SVBP;GRM7;BRSK1;SLITRK5;SLITRK3;DHFR;ADGRB1;S100B;LMTK2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.45701412779639017,1.3120199497917862,0.0940649496080627,0.5140648258510633,1.0,16/66,15.74%,CD36;TLR8;IL6;TMEM106A;IGF1;NLRC4;SIRPA;FOXP1;MEFV;TYROBP;NLRP2B;APP;FZD5;TNFAIP3;CX3CL1;MYD88
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4508289038780824,1.3114974714981762,0.09121245828698554,0.5148414068884518,1.0,18/78,12.72%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;MMP14;PID1;CLN3;STAC2;STX8;VTI1B;PICALM;VPS4A;ITGB1;APPL1;TREM2;ITGA3
prerank,calcium import into the mitochondrion (GO:0036444),0.6311983334089766,1.3114107063767988,0.17443609022556392,0.5143907406438758,1.0,6/10,28.09%,MICU2;MICU1;SMDT1;AFG3L2;SLC25A23;MICU3
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5139163294667284,1.3103494532454112,0.11292346298619825,0.5169558271069128,1.0,6/32,9.48%,APOE;PDK4;PRKAG2;EIF6;ZBTB20;NR5A1
prerank,response to exogenous dsRNA (GO:0043330),0.553818454962726,1.3095423974835751,0.12952646239554316,0.5187553951345787,1.0,5/18,12.11%,RFTN1;FLOT1;IRAK3;MAVS;PQBP1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5274759199894213,1.3094560013917846,0.12857142857142856,0.5182998597032366,1.0,7/27,13.37%,AQP1;CDKN1A;PDGFA;E2F1;IGF1;S100A6;GAS6
prerank,negative regulation of protein transport (GO:0051224),0.5288019929816675,1.309436292543239,0.1364221364221364,0.5176599203722725,1.0,5/25,8.27%,APOE;SERGEF;RHBDF2;WWP2;PKDCC
prerank,regulation of kinase activity (GO:0043549),-0.32194564166467365,-1.3093739203321455,0.024096385542168676,0.49691128692679787,1.0,28/89,19.19%,ERBB4;EPHA5;CSF1R;NTRK3;CAMKK2;EPHA6;RYK;MAPT;EPHA3;FGFR2;NTRK2;FLT3;TSPYL2;EGFR;VAC14;IGF1R;RAD50;EPHA7;LDB1;LDB2;ERBB3;RBL1;CD74;ANKRD54;TYRO3;FGFR3;ECT2;LMTK2
prerank,negative regulation by host of viral process (GO:0044793),0.6276016889116556,1.309200098263603,0.18628912071535023,0.517706105103791,1.0,3/10,13.63%,EIF2AK4;VAPA;PRKN
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.4935809729105286,-1.3088380577378635,0.13028169014084506,0.4956632764246032,1.0,8/14,30.89%,SRSF6;RBMX;PCBP4;SRSF12;SRSF9;SRSF4;SAP18;SRSF7
prerank,positive regulation of cell junction assembly (GO:1901890),-0.33827518071389917,-1.308513168356725,0.07563025210084033,0.4939032716044731,1.0,15/56,12.74%,CNTNAP2;PTPRD;IL1RAPL1;NRXN1;NLGN1;GRID2;LRRC4B;CUX2;PPM1F;SYNDIG1;FERMT2;NLGN3;NPHP1;AGT;LIMS1
prerank,membrane protein proteolysis (GO:0033619),0.48896825545584016,1.3082372731384917,0.13242574257425743,0.5199543055954223,1.0,17/37,23.92%,ADAM9;DAG1;CTSH;BACE1;ADAM17;HM13;RHBDD1;MYH9;RELA;ADAM19;NCSTN;PARL;AFG3L2;ADAM10;APH1B;PSEN2;TRAF6
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4331104535026406,1.308061442933849,0.07807486631016043,0.519810997365094,1.0,39/105,26.33%,SYK;ICAM2;CLEC4D;PDPK1;PRKCD;PSMD1;RAF1;NRAS;CREBBP;TYROBP;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELB;RELA;PSME2;CUL1;KLRD1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;MALT1;PSME3;BCL10;TRAF6;HRAS;PSMC5;TAB1;MAP3K7;PSMC1;TAB3
prerank,negative regulation of viral genome replication (GO:0045071),0.48734730256296993,1.307745461246845,0.13925570228091236,0.5200817736194182,1.0,13/40,17.55%,IFITM1;TNIP1;SRPK2;FAM111A;RNASEL;ZC3HAV1;IFITM2;MAVS;BST2;N4BP1;SLPI;MPHOSPH8;SRPK1
prerank,cellular response to lectin (GO:1990858),0.43312703469146496,1.307319092658656,0.07914438502673797,0.5199358060389595,1.0,39/104,26.33%,SYK;ICAM2;CLEC4D;PDPK1;PRKCD;PSMD1;RAF1;NRAS;CREBBP;TYROBP;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELB;RELA;PSME2;CUL1;KLRD1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;MALT1;PSME3;BCL10;TRAF6;HRAS;PSMC5;TAB1;MAP3K7;PSMC1;TAB3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.43312703469146496,1.307319092658656,0.07914438502673797,0.5199358060389595,1.0,39/104,26.33%,SYK;ICAM2;CLEC4D;PDPK1;PRKCD;PSMD1;RAF1;NRAS;CREBBP;TYROBP;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELB;RELA;PSME2;CUL1;KLRD1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;MALT1;PSME3;BCL10;TRAF6;HRAS;PSMC5;TAB1;MAP3K7;PSMC1;TAB3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.44705738590829663,1.3062860460891133,0.0962800875273523,0.5222337000189717,1.0,35/80,24.93%,FBXW7;ARRDC4;UBE2L3;SPSB4;CUL3;XIAP;BRCA1;TOPORS;HUWE1;DCUN1D5;BIRC3;STUB1;DCUN1D3;NSMCE3;DCUN1D4;CENPX;DCUN1D1;CRY1;PHF23;BIRC2;MYCBP2;WFS1;PAXIP1;ARRDC3;PEF1;FANCM;HSPBP1;FKBP1A;MALT1;SPRTN;BCL10;TRAF6;FBXO4;NDFIP1;DCUN1D2
prerank,regulation of integrin activation (GO:0033623),0.589077248445038,1.305814352582597,0.16165951359084407,0.5230148278422848,1.0,3/15,10.70%,FBLIM1;PTGER4;PIEZO1
prerank,negative regulation of secretion by cell (GO:1903531),0.4969192233620676,1.3055436946781447,0.13636363636363635,0.523138855855321,1.0,13/38,19.58%,APOE;LILRB1;ANXA1;SERGEF;RHBDF2;TNFRSF1B;TRH;NOTCH1;VAMP3;HTR1B;HMGCR;SLC30A1;OSM
prerank,sphingoid metabolic process (GO:0046519),0.601321560586374,1.3054719604135263,0.15501519756838905,0.5226524841244364,1.0,2/12,6.26%,PLPP3;SPHK2
prerank,sensory perception (GO:0007600),-0.36077487175916767,-1.3054498827771552,0.06382978723404255,0.49854874285270395,1.0,9/45,10.33%,WHRN;PCDH15;CDH23;OPRM1;MYO7A;TMEM150C;GNAL;SCN9A;ADGRV1
prerank,cellular zinc ion homeostasis (GO:0006882),0.5165859826199384,1.3053820798277196,0.1326530612244898,0.5222526775980308,1.0,17/26,29.02%,SLC39A14;MT3;SLC39A12;SLC30A1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;ATP13A2;SLC39A10;SLC30A9;SLC39A13;SLC30A5
prerank,L-glutamate transmembrane transport (GO:0015813),-0.5252155348759208,-1.3047832468597163,0.15497076023391812,0.49758196829257784,1.0,8/10,32.45%,SLC1A3;SLC1A2;SLC1A1;ARL6IP5;PRAF2;SLC1A6;SLC25A18;SLC25A12
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5049005029572702,1.3040937680135287,0.14875,0.5254922379067632,1.0,7/33,11.89%,PPARG;APOE;MAP2K5;THBS1;GADD45A;ACVRL1;NOTCH1
prerank,protein autoprocessing (GO:0016540),0.5676386518328854,1.303782297825115,0.1469387755102041,0.5257028397483429,1.0,5/17,12.75%,CTSL;HTRA2;FAM111A;MYRFL;OMA1
prerank,regulation of angiogenesis (GO:0045765),0.41920940785154787,1.3036838868137839,0.038696537678207736,0.5253060543975535,1.0,30/192,12.65%,GPNMB;PPARG;APLNR;SASH1;PLXND1;CTNNB1;VEGFA;AQP1;KLK3;IL6;PDPK1;NIBAN2;RHOJ;CEMIP2;NINJ1;FOXO4;THBS1;AGO2;HMOX1;BRCA1;HIPK1;CTSH;VASH2;HIPK2;ITGB1;ROCK1;SIRT1;PRKCB;SARS1;SULF1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5410426181524011,1.303658289081063,0.15568022440392706,0.5246887058885565,1.0,5/19,8.86%,PAPSS2;ENPP1;SLC26A1;SLC35B3;PAPSS1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5164344868475041,1.3032624983510988,0.1548731642189586,0.5252219550443511,1.0,3/26,5.81%,OSBPL8;IGF1;IRS2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4488233993894888,-1.302932844263034,0.13127413127413126,0.49924825043337273,1.0,4/18,5.38%,CX3CR1;SELPLG;JAM2;ADD2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6121843226276752,1.3026023810117162,0.19631901840490798,0.5264851004881156,1.0,3/11,6.40%,IL6;RIPK1;DDX5
prerank,neuromuscular process (GO:0050905),0.5700599403920241,1.3023661224467198,0.17329545454545456,0.5265649175450764,1.0,7/16,18.90%,STRA6;TPP1;CLN3;UBA5;MYCBP2;PAFAH1B1;GCH1
prerank,monocyte differentiation (GO:0030224),0.6298838602935557,1.3015987582752937,0.16323296354992076,0.5281495453419205,1.0,2/10,1.73%,PPARG;VEGFA
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5728573741165192,1.3006022272666375,0.17318435754189945,0.5298649466624433,1.0,6/16,11.32%,CORO1C;PTEN;THBS1;DLC1;ACVRL1;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5728573741165192,1.3006022272666375,0.17318435754189945,0.5298649466624433,1.0,6/16,11.32%,CORO1C;PTEN;THBS1;DLC1;ACVRL1;BCAS3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4434122487476641,1.300444212479937,0.08505997818974918,0.5296213804870518,1.0,24/87,20.47%,GPNMB;CDKN1A;PSMD1;PTEN;APC;ZFP36L2;RB1;BRD7;PSMF1;PSMD14;DCUN1D3;CDK2AP2;PSMD12;PSME2;CUL1;CDC73;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;PSMA2;PSMD11;PSMA6
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5219752184211038,1.2999167041519135,0.16087516087516088,0.5304559475240078,1.0,10/24,16.72%,LYRM7;PID1;MTLN;ACADVL;SDHAF4;GFPT1;CYCS;MT3;NDUFS1;COX15
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5710483803008108,1.299873452995008,0.1567489114658926,0.5299175394109065,1.0,2/15,5.28%,PAOX;SAT1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4696604850942295,1.2995289699916175,0.11251435132032148,0.5302729515836151,1.0,11/54,10.98%,PPARG;APOE;VEGFA;PDPK1;P2RX4;THBS1;GADD45A;ACVRL1;ADAM17;SIRT1;ATP5F1A
prerank,regulation of acute inflammatory response (GO:0002673),0.560966714210824,1.29950927388629,0.15954415954415954,0.5296404590514036,1.0,3/18,5.73%,IL6;PLA2G2D;ADAM8
prerank,vesicle transport along actin filament (GO:0030050),0.5456305875505224,1.2992912720931524,0.16292134831460675,0.5296128799510974,1.0,4/19,9.52%,MYO5A;MYO1E;MYO19;MYO1F
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.5111271287480321,1.2992502587745545,0.13298565840938723,0.5290501378396724,1.0,7/27,17.60%,AK8;TXNRD1;GSR;CTPS1;AK2;CTPS2;RRM1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4579291947250528,1.2991241206605564,0.11174458380843785,0.5288111956777856,1.0,17/60,15.31%,CTNNB1;CEBPB;RUNX2;IL6;CDKN1A;MED12;PTEN;MED15;SOX9;CBFB;TNRC6B;AGO3;MED16;MED26;RELA;BAX;CDK8
prerank,cellular response to chemokine (GO:1990869),-0.3577309703285152,-1.297762285150404,0.08695652173913043,0.5088616458390717,1.0,9/46,15.95%,DOCK8;SLC12A2;SH2B3;RIPOR2;CCL4;WNK1;RHOA;CCR2;CCR1
prerank,hexose metabolic process (GO:0019318),0.48887235342604923,1.29761762531097,0.14182692307692307,0.532595475072185,1.0,18/39,26.11%,SORD;AKR1A1;TFAP2B;IRS2;GALK2;PPARD;PGM1;FUCA1;OMA1;APOD;SLC35A2;PMM2;GALM;SLC37A4;HK1;GALT;CHST15;BRAT1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5135332837591707,1.2975444942274907,0.1548223350253807,0.5320993701264487,1.0,8/27,15.15%,CD200R1;IRAK3;SIRPA;NLRC3;GAS6;TNFAIP3;CX3CL1;ARRB1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.40660401648992256,1.2975305355241322,0.006,0.5314640794818722,1.0,78/390,13.51%,ATP6V0D2;MTSS1;GDF15;SDCBP;NAMPT;SYK;GALNT3;GRB2;FRK;NEDD9;VAV3;NCK2;ARPC2;ATP6V1A;VEGFA;POLR2A;PDK4;MAPKAPK3;BAIAP2;AP3S1;ATP6V1E1;SOS1;HGF;ATP6V1C1;PDGFA;KIF16B;TCIRG1;COL4A6;ATP6V0D1;ABI1;ANKS1B;FOXO4;IGF1;ZFYVE27;FGFR4;NRP2;COL1A1;MERTK;IRS2;PIK3CA;APC;CYBB;ATP6V1B2;SULF2;CYBA;NCF2;POLR2L;STAP1;VAV1;ACTR3;BLNK;ATP6V0A1;CYFIP2;SLC39A14;SH2B2;ROCK1;POLR2G;GSK3B;PTK2B;FOXO1;PAK2;FES;POLR2I;NCBP2;HNRNPM;ROR1;GTF2F2;APPL1;SULF1;DOCK1;RAPGEF1;NCF4;ATP6V0E1;GPLD1;ATP6V0C;ATP6V0B;FGR;AP2B1
prerank,glutathione metabolic process (GO:0006749),0.4852634779045687,1.2974631612735958,0.14516129032258066,0.5309947751465746,1.0,9/38,17.56%,MGST2;GSTM1;NAT8;CNDP2;GSR;HPGDS;HAGH;GSTA4;OPLAH
prerank,positive regulation of phospholipase C activity (GO:0010863),0.47718175632245985,1.297217379494598,0.13189448441247004,0.531039084280755,1.0,6/40,5.05%,HTR2B;EDNRA;ADRA1A;GNAQ;ABL2;LPAR2
prerank,response to cytokine (GO:0034097),0.4246589643736765,1.2961759353807487,0.07142857142857142,0.5334274085005198,1.0,37/141,15.95%,CXCR4;TIMP1;ANXA1;SIGIRR;MAPKAPK3;IRAK2;IKBKE;KYNU;IFITM1;ADAM9;CD274;RIPK1;PID1;IFNAR2;DDOST;IRAK3;PTPN12;NUB1;REL;TIMP2;KLHL20;MEFV;MAP4K3;IFITM2;IL6R;APP;BST2;RELB;HCLS1;COL3A1;RELA;SLC11A1;JAK3;MCL1;YTHDC2;MYD88;ALDH1A2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5687998452749761,1.2956235629923472,0.1607898448519041,0.5344400429026415,1.0,4/15,13.02%,PPARG;IRS2;PPARD;GPLD1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4202024722892952,-1.2956230663991775,0.116,0.511510274396074,1.0,7/24,8.61%,TENM2;GPM6A;NLGN1;PLPPR5;RIPOR2;FMR1;AGRN
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4973811785242258,1.2944713801288872,0.14039408866995073,0.5371009516214992,1.0,10/33,15.64%,FBXW7;ID2;CDKN1A;APPL2;PTEN;E2F1;APPL1;PSME2;INO80;CDC73
prerank,lamellipodium assembly (GO:0030032),-0.39556729353069103,-1.2940691808636384,0.0958904109589041,0.5128013485021259,1.0,9/26,9.92%,P2RY12;ABLIM1;SPATA13;PTPRO;SRGAP2;S1PR1;CARMIL1;ARFIP2;ARHGEF6
prerank,phospholipid transport (GO:0015914),0.4688913645187615,1.2936714992479375,0.12600229095074456,0.5387925710223261,1.0,12/52,13.98%,OSBPL8;ABCA1;APOE;ABCG1;ATP8B4;PLTP;SCARB2;ABCA3;PITPNA;PITPNC1;ATP8B1;PRELID3A
prerank,primary alcohol metabolic process (GO:0034308),0.5211378455453584,1.2932568171747687,0.1484375,0.5393913621811445,1.0,5/25,14.45%,DHRS3;RDH12;IGF1;ALDH3A2;GDE1
prerank,cellular response to hypoxia (GO:0071456),0.4262347102519344,1.2928594311704307,0.07660020986358866,0.5398893088516609,1.0,33/126,19.67%,EPAS1;VEGFA;AQP1;NPEPPS;PSMD1;LMNA;BACH1;ADAM8;CREBBP;HMOX1;RPS27A;UBC;HIPK2;EGLN3;SIRT1;PSMF1;MT3;PSMD14;STUB1;RORA;PSMD12;LIMD1;SUV39H2;PSME2;BNIP3;ACAA2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;CPEB2;PSMD11
prerank,regulation of JNK cascade (GO:0046328),0.43141816339225164,1.2926277008326865,0.08441558441558442,0.5398940467366313,1.0,26/101,16.77%,SDCBP;RAP2A;GADD45B;GADD45G;TAOK3;RIPK1;NCOR1;AIDA;GADD45A;DUSP3;MFHAS1;SH3RF1;SIRPA;COPS5;HIPK2;FZD7;PTK2B;APP;TRAF1;TRAF3;PRKN;FKTN;TRAF5;TRAF2;LTBR;NCF1
prerank,zinc ion homeostasis (GO:0055069),0.5053519762172403,1.2925158734814888,0.14358322744599747,0.5395210509627603,1.0,18/28,29.02%,SLC39A14;MT3;PRKN;SLC39A12;SLC30A1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X;ATP13A2;SLC39A10;SLC30A9;SLC39A13;SLC30A5
prerank,replicative senescence (GO:0090399),-0.5026292283026571,-1.2925094642322188,0.15584415584415584,0.5141318584783323,1.0,8/12,40.78%,ATM;ATR;CHEK2;ROMO1;CDKN2A;CHEK1;TERT;PLA2R1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.5815686724589738,1.2923423023851228,0.16524216524216523,0.5393653277262036,1.0,3/14,11.40%,ERN1;CPSF1;NCBP2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.5692851536095055,1.2921085606533935,0.17690058479532164,0.5394115539220543,1.0,6/15,16.60%,FLOT1;ADAM9;CD53;TYROBP;TREM2;CAMK1
prerank,actin filament-based transport (GO:0099515),0.5325171295920553,1.291742086846463,0.16550764951321278,0.539802362734858,1.0,4/21,9.52%,MYO5A;MYO1E;MYO19;MYO1F
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.5535438102766034,1.2915722672466694,0.14464534075104313,0.5396284806109698,1.0,3/17,7.99%,ADRA1D;ADRA1A;AKAP13
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6176761430679404,1.2914342749964576,0.20801232665639446,0.5393854888652475,1.0,5/10,22.85%,TAF7;BRCA1;SIRT1;NOC2L;CTBP1
prerank,regulation of actin filament polymerization (GO:0030833),-0.317452381497835,-1.291397648328771,0.04424778761061947,0.5141220459994957,1.0,14/69,7.80%,SSH2;BIN1;TWF2;EVL;FCHSD2;PRKCE;VASP;CYRIB;FER;HCK;NCKAP1;NCK1;SSH3;CARMIL1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.528394109671561,1.2913085069525119,0.15424164524421594,0.5390500594965338,1.0,7/25,15.36%,ARHGAP24;PRKCD;ODF2L;STAP1;CAPZB;PFN2;CCP110
prerank,protein localization to Golgi apparatus (GO:0034067),0.506852076522546,1.291291163131084,0.13212435233160622,0.53842619855144,1.0,10/27,19.36%,OPTN;RAB33B;SORL1;GAK;COG7;VPS13D;VPS13C;GOLPH3;VPS13A;ARL5B
prerank,positive regulation of cell migration (GO:0030335),0.4123505770329128,1.2910869129008957,0.023092369477911646,0.5383804442393235,1.0,56/253,16.52%,GPNMB;F7;SDCBP;NEDD9;GCNT2;VEGFA;KIF20B;RUFY3;ARHGEF39;ADAM9;MGAT5;HGF;WASHC1;PDGFA;CD151;SEMA4B;DOCK5;MMP14;IGF1;F10;COL1A1;THBS1;AGO2;APC;NIPBL;GTSE1;RREB1;SOX9;SNAI2;CTSH;PPP3CA;BMPR2;PLAU;ITGB1;ADAM17;RHOD;PTK2B;ARHGEF2;CCN1;NOTCH1;ACVR1B;PFN1;MYLK;SPAG9;MAZ;DOCK1;FGR;CAPN7;CLASP1;RTN4;GRN;CCL7;MIEN1;SEMA3B;NRP1;CCAR1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5105447587922792,1.2909049124784735,0.15104166666666666,0.5382473266324249,1.0,7/26,13.63%,NFE2L2;TXN;HTRA2;MAPK7;ATF4;SIRT1;PRKN
prerank,bile acid and bile salt transport (GO:0015721),0.5255576708779663,1.2907635504208557,0.17345597897503284,0.5379698007190671,1.0,8/24,13.46%,SLC51A;RXRA;STARD5;ABCC4;NR1H4;ABCC3;NCOA1;ATP8B1
prerank,membrane organization (GO:0061024),0.4135747100924785,1.2905527847382448,0.036290322580645164,0.5379287030631772,1.0,73/227,20.73%,MYOF;MTCH1;REPS2;IGF2R;GRB2;ARPC2;NPC1;CORO1C;TFRC;CERT1;REEP4;SNAP29;SNX9;CD3D;PPT1;SH3GLB1;CLN3;GRIN3B;VTI1B;STAM;GAK;CHMP2A;SCARB2;SH3KBP1;RPS27A;UBC;RABEP1;FER1L6;ACTR3;PDCD6IP;TRIP10;VAPA;HUWE1;STX11;PICALM;A4GALT;VPS4A;FCHO1;CHMP6;M6PR;LPCAT3;AP3D1;IL7R;LEMD3;EPS15;AP2B1;VAMP3;OCRL;STAM2;WASL;ARRB1;MOSPD3;CBL;GAPVD1;RABIF;ARPC1A;CHMP5;NEMP1;CHMP7;SNX3;TMEM170A;ITSN1;FCHO2;LRP2;SYNJ2;AZIN2;GCA;AGFG1;ARPC4;ACTG1;VAMP2;SNAP23;TOR1A
prerank,cellular response to fatty acid (GO:0071398),0.6018466570674372,1.2905302952080804,0.18397626112759644,0.5373323019624902,1.0,4/12,12.56%,PDK4;PID1;NR1H4;KCNK4
prerank,response to organic cyclic compound (GO:0014070),0.46598971925640104,1.290312952788418,0.11935110081112399,0.5373102978564257,1.0,10/52,11.10%,ANXA1;CTNNB1;TIPARP;KYNU;SPP1;FGFR4;STAT5B;ABCA2;ESR1;STRN3
prerank,regulation of mitochondrion organization (GO:0010821),0.4692202964804573,1.289953874276294,0.13849765258215962,0.5376672036144151,1.0,18/47,16.47%,FBXW7;PID1;HTRA2;MYO19;FLCN;CSNK2A2;INF2;GSK3B;FZD5;TREM2;OMA1;SIRT7;VDAC1;PRKN;SQSTM1;GOLPH3;USP36;PARL
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.5687393226518206,1.2898262978463169,0.18607954545454544,0.5373791915821823,1.0,3/15,3.02%,VEGFA;ITGA5;PDPK1
prerank,glycine metabolic process (GO:0006544),0.5993744279872198,1.2897867873278523,0.1873156342182891,0.5368214163466757,1.0,6/12,25.91%,BAAT;GLYAT;GCSH;SHMT2;AMT;RIDA
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.4323962464813571,-1.2896167663759919,0.12173913043478261,0.515712213558138,1.0,6/22,6.54%,PPM1E;DUSP6;PPP5C;PPM1F;DUSP7;PPP2CB
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.5301111593180279,1.2891407016948062,0.1523809523809524,0.5380940246382153,1.0,8/22,22.66%,ERCC6;ALYREF;TCERG1;THOC1;CDC73;CDK13;CCNT1;SUPT4H1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.47486273407182855,1.288762431592804,0.14993954050785974,0.5385566026829933,1.0,10/43,13.30%,PPARG;FOXO3;JUN;NR3C1;DDX5;KLF5;SOX9;NFATC3;PPARD;RELA
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5438227335757335,1.2885328930230022,0.15789473684210525,0.5385989894647826,1.0,9/22,21.83%,STAM;MVB12B;RNF115;VPS4A;UBAP1;SNF8;PLAA;VPS36;VPS37B
prerank,positive regulation of protein metabolic process (GO:0051247),0.4311706487545882,1.2885319772015993,0.07983193277310924,0.5379304444229575,1.0,25/110,13.63%,APOE;ATG7;WWP1;TIPARP;RAB7A;NR1H3;PLK2;MAP2K5;SORL1;MAPK7;STX5;APC;RAB1B;NEDD4L;WWP2;ABCA2;HUWE1;DDB1;GSK3B;MTPN;OAZ2;FOXO1;APP;TNFAIP3;PRKN
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.47938620400630566,1.2881403311834703,0.15289765721331688,0.5384622328339848,1.0,10/38,13.61%,TNIP1;TANK;RIPK1;NR1H4;ESR1;NLRC3;SIRT1;RORA;TREM2;TNFAIP3
prerank,lipid oxidation (GO:0034440),0.5973244861779535,1.287679433734805,0.17629629629629628,0.5392097807810202,1.0,1/12,0.37%,PLA2G7
prerank,regulation of endocytosis (GO:0030100),0.4551057245817088,1.2873765887008637,0.10236220472440945,0.5394743729242725,1.0,17/61,16.55%,LGALS3;APOE;LILRB1;FLOT1;LRP1;ABL2;CD151;NEDD4L;CD22;PICALM;SNX33;ROCK1;MCTP1;STON1;SNX17;RUBCN;PTPN1
prerank,positive regulation of transmembrane transport (GO:0034764),0.5862360993646342,1.2873418788788882,0.19519519519519518,0.5388939114951303,1.0,7/13,25.47%,ANO6;ACSL5;AZIN1;CA2;AZIN2;BRAF;C3
prerank,blood circulation (GO:0008015),0.46054813859726,1.2868524643474315,0.14020857473928158,0.539686771538559,1.0,6/49,10.12%,MYOF;CYB5R3;MYL2;C3AR1;ACVRL1;ROCK1
prerank,protein modification by small protein conjugation (GO:0032446),0.4084249934724887,1.2867385891110477,0.01002004008016032,0.5393349969016958,1.0,125/361,23.82%,EPAS1;EYA1;FBXO32;NSMCE2;NFE2L2;ATG7;WWP1;FBXW7;RNF26;WAC;ARRDC4;BIRC6;UBE2Q2;TRIM17;FBXL17;BRAP;UHRF2;UBE2L3;TSPAN17;ZNRF3;ATG10;SPSB4;CUL3;UBE2K;FBXL3;KLHL41;RNF135;SUMO2;DET1;PEX14;NUB1;CNOT4;RPS27A;UBC;PIAS4;BRCA1;NEDD4L;KLHL20;WWP2;FBXO11;EIPR1;MEFV;TOPORS;SPSB2;HUWE1;VCPIP1;TRIM7;PCNP;TPR;ARIH2;RLIM;DDB1;DCUN1D5;NUP50;SIRT1;MIB2;FBXO9;LZTR1;CAND2;KLHL24;STUB1;DCUN1D3;TRIM41;CUL4A;RNF34;UBA3;CHFR;UBA5;DCUN1D4;PRKN;UBE2F;VPS11;CUL1;ARRB1;CBL;CDC73;NUP98;CDC34;RNF7;DCUN1D1;TMEM129;UBE2M;KEAP1;GAN;TRIM14;MYLIP;MYCBP2;AMFR;TRPC4AP;TNFAIP1;NFX1;RNF43;UBE2S;FBXO7;NUP88;CBLL1;PIAS2;UBE2R2;DTX1;BCL11A;CUL4B;MKRN1;FBXO45;DTX2;PIAS1;NUP188;USP9X;NDC1;NUP43;UBE2H;VCP;PRKDC;UBR3;KCTD10;RNF168;NUP54;RANBP2;RNF138;ARIH1;UBE2D3;KLHL3;BCL10;EGR2;ISG15;MIB1
prerank,DNA geometric change (GO:0032392),0.5179238135198696,1.28651705268962,0.168848167539267,0.5393211080494842,1.0,6/24,12.79%,ANXA1;MCM9;ZRANB3;RTEL1;NBN;WRN
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5412527395101244,1.286075134724865,0.18376068376068377,0.5399562255891839,1.0,5/19,15.92%,HRH1;PPP3CA;PPP3R1;NFATC3;INPP5A
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5509265498791055,1.2852957601719996,0.1651006711409396,0.5416314326195488,1.0,8/18,23.13%,APOE;RNF128;MSN;ABCA2;VPS11;VPS35;FAF1;EZR
prerank,protein palmitoylation (GO:0018345),0.5037995386586454,1.2852195046818355,0.13909774436090225,0.5411925093459944,1.0,8/30,17.11%,ZDHHC14;ZDHHC19;ZDHHC16;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC17;ZDHHC4
prerank,myeloid cell differentiation (GO:0030099),0.46008563143914455,1.284993242388629,0.13333333333333333,0.5411509956619429,1.0,19/47,23.28%,FLVCR1;RPS14;MFHAS1;HIPK2;TET2;KMT2E;HCLS1;UBA5;JAK3;ACIN1;CASP3;NCOA6;ZBTB16;CEBPA;SNRK;TIRAP;JAK2;SLC25A38;HSPA9
prerank,positive regulation of biosynthetic process (GO:0009891),0.4781530540292902,1.2846159696440291,0.13842482100238662,0.5416107289694464,1.0,6/40,10.43%,CD36;APOE;VIM;CYBA;ZBTB20;MTPN
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5545362109079967,1.2843277605245342,0.18361581920903955,0.5417639465349863,1.0,1/18,0.05%,DDHD1
prerank,response to histamine (GO:0034776),0.6166088839607715,1.2842363002408799,0.20276497695852536,0.5413447334009063,1.0,2/10,1.52%,HRH1;DIAPH1
prerank,protein localization to microtubule organizing center (GO:1905508),0.5633553137776998,1.2841312290381635,0.17902097902097902,0.5410112395533095,1.0,3/15,2.21%,HOOK3;PIBF1;SNX10
prerank,sphingolipid biosynthetic process (GO:0030148),0.43932392110114793,1.2841098110360742,0.1161504424778761,0.5404045975148365,1.0,23/71,20.41%,PLPP3;SPTLC2;SAMD8;SGPL1;CERT1;SGMS2;HACD4;B4GALT6;CERS6;SPHK2;SPTSSA;VAPA;A4GALT;ELOVL1;ALDH3A2;DEGS1;PRKD3;TLCD3B;ACER2;SGMS1;ASAH1;SGPP2;CERS1
prerank,sulfate transport (GO:0008272),0.5731055516542073,1.2837952196956133,0.1791907514450867,0.5406795930901581,1.0,2/14,5.29%,SLC26A11;SLC26A1
prerank,primary miRNA processing (GO:0031053),-0.5383232835011595,-1.2833750279050837,0.19321148825065274,0.5283474050193714,1.0,5/10,12.47%,SMAD3;DGCR8;METTL3;SMAD1;SMAD2
prerank,positive regulation of immune system process (GO:0002684),0.5619345653155183,1.2833352718319218,0.18361581920903955,0.5414249426445713,1.0,2/16,1.73%,ANXA1;VEGFA
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4304002743248296,-1.282377797727459,0.1568627450980392,0.5281468363914439,1.0,14/21,41.77%,SMO;ARMC9;TTC23;ULK3;PDCL;TEDC2;DCDC2;GAS8;KIF7;SFRP1;SHH;STK36;TEDC1;EVC
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5005739823845834,1.281926471733681,0.14823815309842042,0.5450955857815314,1.0,5/32,9.30%,APLNR;PDPK1;P2RX4;P2RX3;TRPC3
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4208474390194928,1.2812868506918556,0.07610993657505286,0.546382769487522,1.0,12/110,6.49%,ADGRE5;ABCA1;ADGRG3;ADRA1D;ADRA1A;GNAQ;GNA13;LPAR2;ADCY7;CNR2;ADGRE1;PTGER2
prerank,regulation of cellular component size (GO:0032535),0.5019194431912606,1.2806649356040634,0.14866581956797967,0.5475438480124141,1.0,11/30,16.85%,VAV3;PTEN;PEX11A;MSN;VAV1;PICALM;RIN3;MTPN;RAP1GAP2;PPP1CA;RAB22A
prerank,protein targeting (GO:0006605),0.42148608357806033,1.2802098832740039,0.08919202518363065,0.5482371286683952,1.0,35/118,19.17%,SDCBP;KIF13B;PIKFYVE;ZDHHC14;ZDHHC19;TIMM22;ZFAND2A;HOMER3;SORL1;PITRM1;YIF1B;TOMM20;TIMM17A;MICALL1;LAMP2;ZDHHC12;ZDHHC18;NACA;TIMM17B;ZFAND6;LONP2;GDAP1;SPCS2;ZFAND2B;RABGEF1;ZDHHC24;TOMM34;NCF1;ZDHHC4;SEC63;ICMT;TOMM7;AP4M1;TOMM22;FBXO7
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5105718530221328,1.2797481324086608,0.15256410256410258,0.5489149569762671,1.0,4/26,10.57%,GPR137B;LILRB3;RARA;MAFB
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4957054288804549,1.2791940337414534,0.15510718789407313,0.5497886842587942,1.0,5/33,6.88%,PPARG;FOXO3;JUN;NR3C1;KLF5
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4195433778812226,1.2790872386035739,0.07430340557275542,0.5494602439469195,1.0,26/140,10.80%,ARHGAP24;ARHGAP21;ARHGAP10;ABR;ARHGAP19;ARHGAP15;VAV3;TGM2;SOS1;RHOJ;ARAP2;ARHGAP9;ARHGAP31;MYO9B;GNA13;FLCN;ARAP1;AKAP13;VAV1;TRIP10;DLC1;ARHGAP18;ARHGAP17;RHOD;FAM13B;ARHGEF2
prerank,positive regulation of viral genome replication (GO:0045070),0.49801320215022604,1.2783552172679395,0.16229712858926343,0.55104088038431,1.0,11/29,17.55%,CD28;SRPK2;RAD23A;PPIH;DDB1;CNOT7;PKN2;PPIE;ADARB1;TMEM39A;SRPK1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.458320304254002,1.2782174946063587,0.1410693970420933,0.5507839738443098,1.0,16/54,17.90%,SYK;RIPK1;UBE2K;HSPA1B;HIPK1;NLRP2B;ADAM17;BIRC3;TRAF1;TAX1BP1;GAS6;TNFAIP3;PRKN;HSPA1A;TRAF2;BIRC2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.42564919500957715,-1.2775378610536743,0.14736842105263157,0.537677379829721,1.0,7/20,18.45%,CCND3;EGFR;PKD2;PKD1;RGCC;TTBK1;PSMD10
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.38064206508628917,-1.2772057591170949,0.12682926829268293,0.5359828275242312,1.0,4/29,3.51%,CADM1;ITGAM;CYRIB;STX7
prerank,protein tetramerization (GO:0051262),-0.31914379393369385,-1.2771554579076443,0.07766990291262135,0.5335753785585708,1.0,20/67,16.74%,HCN1;RYR3;GRIN2B;ACACA;KCNC1;KCNJ2;GRIN1;TRPM4;HOMER1;KCNC3;TRPM2;SOD2;MCOLN1;APIP;PKD2;PKD1;PKD2L1;ALDOA;GBP5;OSBPL2
prerank,actin crosslink formation (GO:0051764),0.6005304247939741,1.27674616094485,0.19054878048780488,0.5545689604471937,1.0,3/12,3.00%,GAS2L3;BAIAP2;LCP1
prerank,cellular response to oxidative stress (GO:0034599),0.4195791147549906,1.276583435745166,0.09233997901364113,0.5543742872325261,1.0,27/118,13.94%,MSRA;PRDX1;NFE2L2;TXNRD1;MPV17;PRKCD;FOXO3;JUN;DAPK1;SESN2;LONP1;HTRA2;HSPA1B;CYBB;GPX3;ATF4;HMOX1;CYBA;NCF2;CAT;GSR;CYCS;FOXO1;MT3;NCF4;ERCC6L2;HSPA1A
prerank,autophagosome maturation (GO:0097352),0.4954691303884234,1.2764435582449127,0.16,0.5541366391504664,1.0,9/32,10.44%,SNAP29;TECPR1;UVRAG;CLN3;VTI1B;VMP1;LAMP2;VPS33A;EPG5
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.46140669598510564,1.2761680961752966,0.1451990632318501,0.5543086791718561,1.0,14/48,17.86%,PAPSS2;ADSL;IMPDH2;COASY;SLC26A1;AMPD3;ADCY7;SLC35B3;PAPSS1;ADCY8;ADCY3;PANK2;NPR2;ADSS1
prerank,embryonic heart tube development (GO:0035050),-0.47709176360024685,-1.275928116422764,0.16049382716049382,0.5338877583757589,1.0,3/14,5.76%,ACVR1;RYR2;MEGF8
prerank,regulation of cell migration (GO:0030334),0.4033372745012992,1.2757236725375205,0.018036072144288578,0.5550573351470384,1.0,75/382,13.09%,GPNMB;F7;PLXNA1;SDCBP;SASH1;SGK1;PLXNC1;PLXND1;NEDD9;ADGRG3;GCNT2;ANXA1;MITF;RAP2A;VEGFA;RUFY3;CORO1C;ARHGEF39;IFITM1;ADAM9;MGAT5;HGF;FOXO3;WASHC1;PDGFA;CD151;SEMA4B;LMNA;APPL2;MMP14;PTEN;CITED2;YTHDF3;OSGIN1;SORL1;IGF1;CLN3;F10;COL1A1;ZMYND8;THBS1;DAG1;DUSP3;GNA12;STK24;APC;FLCN;DOCK10;GTSE1;NF2;SNAI2;CTSH;DLC1;ACVRL1;DACH1;PPP3CA;PLAU;ITGB1;ROCK1;RAP2B;ADAM17;RHOD;PTK2B;CCN1;BST2;NOTCH1;MYLK;APPL1;SPAG9;MAZ;SULF1;ARID2;MACF1;MCTP1;PODN
prerank,response to unfolded protein (GO:0006986),0.47172852307103563,1.2755615563263907,0.13592233009708737,0.5548221964618293,1.0,16/48,19.26%,OPTN;ERN1;HSPA1B;DNAJB5;DDIT3;RHBDD1;PRKN;HSPA1A;BAX;HSPA13;HSPD1;PTPN1;HSPA4;HSPE1;HSPA4L;DNAJA1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5038589792842716,-1.2755417900965418,0.19941348973607037,0.5322842721904291,1.0,5/12,14.48%,DOCK8;JAM2;AIF1;PYCARD;RHOA
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5837298384456221,1.275528916378401,0.19732937685459942,0.5542800328274698,1.0,3/14,5.58%,ANO6;ITGA4;THBS1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.41782782582909644,1.275306776905028,0.07684319833852545,0.5542586028442816,1.0,18/140,10.02%,CD36;CXCR4;EDNRA;ADRA1D;ADRA1A;PTGDR;ABL2;P2RX4;XCR1;GPR157;C3AR1;SLC8A1;LPAR2;PTGER2;P2RX3;TRPC3;PTGER4;ESR1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5546181915355551,1.2749362064396135,0.18169209431345354,0.5547535753992473,1.0,5/17,11.06%,ACD;MUTYH;NEIL1;TERF1;MBD4
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6113912218204807,1.2742904172192024,0.19552238805970149,0.5560154304543903,1.0,1/10,0.55%,XDH
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4129112474789393,1.2742415800355436,0.06735751295336788,0.5555076233387555,1.0,19/142,10.02%,CD36;CXCR4;EDNRA;ADRA1D;ADRA1A;PTGDR;ABL2;ATP2B1;XCR1;SLC8B1;C3AR1;SLC8A1;LPAR2;CLN3;PTGER2;CALB1;TRPC3;PTGER4;ESR1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5885960270913526,1.2738857280484475,0.20028612303290416,0.5559391721033818,1.0,4/12,22.37%,IRX3;SRI;CALM2;PDE4D
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.4204454554640373,1.273692982265938,0.08851422550052687,0.5558987259800593,1.0,27/118,14.52%,GPNMB;KIF13B;PLXND1;CTNNB1;RAP2A;RUFY3;ZMYM6;IL6;PID1;DAG1;MYO19;PDLIM5;HMOX1;LFNG;NEDD4L;VASH2;CAPZB;INF2;TNIK;GSK3B;CFL1;PAK2;TNFAIP3;CLASP1;GDNF;RNH1;PHIP
prerank,negative regulation of cell activation (GO:0050866),0.5625462177933647,1.2730337129177767,0.19627507163323782,0.5571997773551476,1.0,3/14,12.33%,APOE;PDGFA;TREM2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5447778629041653,1.2729379728106596,0.18518518518518517,0.5568508154980671,1.0,4/18,7.09%,ANXA1;VEGFA;RHOJ;HMOX1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.5145022528571467,-1.2726951195941119,0.19756838905775076,0.5367135925457743,1.0,7/11,17.86%,TRIM37;MDM1;CENATAC;RBM14;TMEM67;CCNF;NPM1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5725511562808885,1.2719744947841314,0.1829436038514443,0.5590996881856363,1.0,9/15,25.47%,FBXW7;NR1H3;SIK1;SLC27A1;GPLD1;SREBF1;NR1H2;CTDNEP1;C3
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.31908537055163105,-1.2719611762476126,0.07608695652173914,0.5360451376441334,1.0,22/75,20.02%,SLC9A9;SLC12A2;ATP1B1;SLC12A6;SLC24A2;ATP1A2;KCNJ2;TRPM4;ATP1B2;KCNJ3;TRPM2;KCNJ9;SLC6A1;HCN2;ATP2B4;SLC12A4;CACNA2D1;KCNK9;SLC39A8;SLC9A1;ABCC9;KCNJ6
prerank,negative regulation of catabolic process (GO:0009895),-0.3398633672124105,-1.2718646640242033,0.09271523178807947,0.5338399489862723,1.0,18/47,23.87%,PDE3B;FMN2;CST3;BANP;CBFA2T3;EGFR;MDM4;APOC1;SIRT2;GIT1;CYP51A1;TNF;ADGRB1;TIGAR;AGAP2;PFKFB1;IL1B;ADRA2A
prerank,negative regulation of immune system process (GO:0002683),0.5580760159370328,1.2718108062644533,0.18067226890756302,0.5589092122752128,1.0,5/16,12.97%,FOXP3;FCRLB;HMOX1;SOX9;COL3A1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.564505102760032,1.2713495176485214,0.18219749652294853,0.5596567761149238,1.0,7/16,19.90%,NIPBL;RB1;SMC1A;BOD1;RAD21;SGO1;PDS5A
prerank,embryonic hemopoiesis (GO:0035162),-0.5017618755087501,-1.2700613966696779,0.17088607594936708,0.5358672047216828,1.0,5/12,9.13%,TGFBR2;KITLG;SH2B3;TAL1;THOC5
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.4297950790666656,-1.2699780832073322,0.15018315018315018,0.5336585403433955,1.0,5/19,8.69%,ACVR1;BMPR1A;TGFBR2;MDM4;TGFB2
prerank,post-translational protein modification (GO:0043687),0.4000614773855709,1.2696916889381706,0.019076305220883535,0.5639512223483799,1.0,89/332,21.31%,EPAS1;MFGE8;FBXO32;APOE;TIMP1;CCDC8;GPS1;ITIH2;FBXW7;SPP1;IL6;APLP2;PSMD1;FAM20C;SPSB4;CUL3;FBXW10;SOCS6;FBXL3;DCAF13;KLHL41;PROC;NUB1;BTBD1;RAB1B;WSB2;KLHL20;FBXO11;SPSB2;COPS5;QSOX1;FSTL1;DDB1;FBXO9;ATG5;CCN1;PSMF1;ASB4;PSMD14;APP;DCUN1D3;ASB8;WDTC1;RHBDD1;PSMD12;CUL4A;COPS7A;UBA3;FBXO6;RAB11B;FBXW2;GAS6;RBBP7;UBE2F;SERPINC1;PSME2;CUL1;NUCB1;SUMF1;RNF7;MELTF;RAB2A;LRRC41;DCUN1D1;UBE2M;PSMB10;KEAP1;PSMD5;GAN;DCAF10;ICMT;PSMD8;PSMA3;FBXO31;FBXO7;PSMA2;PSMD11;RAB1A;DCAF7;SHISA5;RAB13;WFS1;DDA1;PSMA6;ANO8;CUL4B;ZBTB16;FBXL4;ADAM10
prerank,regulation of AMPA receptor activity (GO:2000311),-0.40613050643553367,-1.2682956472939793,0.1072961373390558,0.5353897225799568,1.0,17/25,29.74%,MEF2C;NLGN1;RELN;CACNG4;SHISA6;NLGN3;GSG1L;CACNG3;CACNG2;SHISA7;MAPK8IP2;CACNG7;ADRB2;CNIH3;CACNG5;SHANK1;SHISA8
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6180468624896877,1.267974566384421,0.20094936708860758,0.5685226003073927,1.0,4/10,15.41%,ZEB2;MFSD12;APPL1;ATP7A
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5137352214877129,1.2678083978880763,0.17724867724867724,0.5683377169831788,1.0,5/23,10.70%,NIBAN2;MMP14;IGF1;MAML1;PIEZO1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5170984593959224,1.2675452327474659,0.16191709844559585,0.5684651367638198,1.0,5/24,10.12%,PRKCH;CTSL;NCOA3;CBFB;ROCK1
prerank,modification-dependent protein catabolic process (GO:0019941),0.40698583489669327,1.2672979600111764,0.05989847715736041,0.56851226056239,1.0,78/193,24.76%,RNF149;TRIP12;BIRC6;RNF19A;RNF130;TRIM25;WDR91;LONP1;UBE2L3;ZNRF3;ANAPC1;SPSB4;CUL3;NPLOC4;UBE2K;RNF128;NUB1;CNOT4;RPS27A;UBC;KCTD21;BFAR;NEDD4L;FBXO11;RNF146;TOPORS;SPSB2;ARIH2;RLIM;DDB1;PSMF1;PSMD14;STUB1;RNF34;CHFR;PRKN;SQSTM1;UBQLN2;ARRB1;ANAPC10;CBL;PCYOX1;CDC34;RNF7;KEAP1;MYLIP;AMFR;TRPC4AP;RNF43;UBE2S;FBXO7;ATXN3;ANAPC15;PSMD11;UBE2R2;RNF19B;FBXO45;FBXL4;TAF1;UBE2H;UBR3;KCTD10;RNF125;HERPUD1;UBE4A;RNF168;SIAH2;ARIH1;KLHL3;UBE4B;ISG15;MIB1;PTTG1;NDFIP1;RNF150;TTC3;UBE2E1;ANAPC7
prerank,cellular response to UV-A (GO:0071492),0.6043627787228019,1.2672052026234935,0.18636363636363637,0.5681585499433263,1.0,1/11,0.97%,TIMP1
prerank,signal peptide processing (GO:0006465),0.5968355917060161,1.2669107780305127,0.19969512195121952,0.5683848882163637,1.0,6/11,25.50%,CLN5;HM13;SPCS2;PARL;FURIN;SPPL3
prerank,regulation of cell cycle (GO:0051726),0.40318528395162845,1.2666876188102065,0.05226130653266332,0.5683824202046219,1.0,62/271,14.61%,IQGAP1;SDCBP;MAP3K20;LILRB1;RPS6KA2;ERN1;KIF20B;GADD45B;GADD45G;ID2;CDKN1A;LIN37;ANKRD17;RUNX3;JUN;SRPK2;NOTCH2;FBXL17;RARA;CITED2;FOXO4;UHRF2;HTRA2;THBS1;GADD45A;APBB2;FBXL3;SIK1;APC;NUDT6;HNRNPU;RPL23;NF2;XIAP;SOX9;BRCA1;RB1;PPP1R9B;RAD23A;CSNK2A2;HIPK2;NLRP2B;PIM3;INTS13;SIRT1;BIRC3;CDK7;ING4;NBN;DCUN1D3;CDC123;NOTCH1;SND1;AFAP1L2;GAS2L1;SOX2;HBP1;PHACTR4;JUNB;WHAMM;UHMK1;LRP6
prerank,negative regulation of catalytic activity (GO:0043086),0.5179773542048973,1.2664990714375133,0.18386243386243387,0.5683015420936559,1.0,7/24,11.89%,TIMP1;CLN3;HP;NOSIP;SIRT1;MT3;NOTCH1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.49199197903578057,1.2662971490425927,0.16216216216216217,0.5682774874187945,1.0,6/32,7.09%,ANXA1;VEGFA;RHOJ;MAP2K5;THBS1;HMOX1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.53899831361459,1.2662464903277457,0.1936813186813187,0.5677407626769959,1.0,4/19,7.46%,PRDX1;GPX3;CYBA;CAT
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6156616041732192,1.2660792346413365,0.1924812030075188,0.5675971996765793,1.0,5/10,13.22%,ZNF692;GNMT;SDHAF3;SIRT7;DGKQ
prerank,Rap protein signal transduction (GO:0032486),0.6060405986852505,1.2658392979699031,0.20610687022900764,0.567653300470429,1.0,4/10,12.80%,RAP2A;PLK2;RAP2B;RAPGEF1
prerank,macromolecule catabolic process (GO:0009057),0.509615729550525,1.265022685696497,0.16326530612244897,0.5694699666474567,1.0,6/26,4.48%,TPP1;KIF16B;PPT1;UVRAG;CLN5;SH3GLB1
prerank,regulation of mRNA stability (GO:0043488),0.40709768455120837,1.264797614596019,0.07826982492276004,0.5694782383579687,1.0,43/145,21.01%,SAMD4A;VIM;PRKCD;PSMD1;CELF1;IGF2BP3;YTHDF3;E2F1;PCID2;TENT5A;HNRNPU;RPS27A;UBC;ZFP36L2;EXOSC3;EXOSC9;SERBP1;ROCK1;FTO;PSMF1;PSMD14;TNPO1;PUM2;EXOSC8;PSMD12;SLC11A1;HSPA1A;TENT5D;GDNF;HNRNPD;PSME2;THRAP3;EXOSC1;TAF15;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;XPO1;PSMA6;EXOSC7
prerank,regulation of fibrinolysis (GO:0051917),0.5784120611465022,1.2646548022931514,0.19111111111111112,0.5692675128386075,1.0,2/13,5.58%,F11;THBS1
prerank,negative regulation of cell population proliferation (GO:0008285),0.40033776329874454,1.2645335811138207,0.018036072144288578,0.5689640489252792,1.0,67/351,16.18%,GPNMB;PPARG;MTSS1;CD300A;ADAMTS8;FRK;RPS6KA2;ADRA1A;CTNNB1;NCK2;FOXP3;ST18;IFITM1;E2F3;IL6;CDKN1A;NIBAN2;TFAP2B;RUNX3;LMNA;APPL2;B4GALT7;CELF1;ABI1;PTEN;RAF1;FOXO4;E2F1;TNN;APC;FLCN;NUDT6;HSPA1B;HMOX1;NF2;SOX9;TES;MCC;BNIPL;P3H3;DLC1;STRN;ACVRL1;BRD7;BMPR2;NLRC3;CNOT7;PTK2B;ING4;FBLN1;APP;NOTCH1;TREM2;ARID2;GPLD1;PODN;SOX2;TNFAIP3;TENM1;HSPA1A;SPEG;FKTN;ADARB1;SMYD2;CDC73;ALDH1A2;NELL1
prerank,secondary palate development (GO:0062009),-0.48169229018904686,-1.2644472707787262,0.19607843137254902,0.542197058868002,1.0,7/14,29.95%,TGFBR2;TGFB2;SMAD2;SMAD4;WNT5A;LEF1;WNT7A
prerank,ether lipid metabolic process (GO:0046485),0.5555539875968862,1.2644315409215283,0.19881305637982197,0.5686230848702344,1.0,5/14,11.54%,PLA2G7;NCEH1;PEX7;PEDS1;PLAAT3
prerank,regulation of DNA recombination (GO:0000018),0.48942503553493577,1.2640846057842476,0.1797752808988764,0.5690103044266065,1.0,8/32,12.70%,ALYREF;ZRANB3;KPNA2;SIRT6;THOC1;PPP4R2;RTEL1;IL7R
prerank,actin polymerization or depolymerization (GO:0008154),0.4571467566983186,1.2637153603357303,0.15807962529274006,0.5695205014359389,1.0,19/50,19.63%,VILL;DIAPH1;MICALL2;MSRB1;ABI1;PSTPIP1;CAPG;SVIL;CFL1;WDR1;PSTPIP2;MICAL2;WASL;DSTN;WASHC3;FLII;WASHC5;CFL2;MICAL1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.42676121266401607,1.2636422252547888,0.12555066079295155,0.569102744842018,1.0,21/86,13.22%,VEGFA;TEC;CD44;IL6;HGF;ITGA5;PRKCD;PDGFA;IGF1;IL5;IL6R;RAP2B;CNOT7;PTK2B;PAK2;ARHGEF2;APP;IL15;TREM2;HCLS1;DGKQ
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5270475920284011,1.2635495714080098,0.17438692098092642,0.5687192240570529,1.0,4/20,10.49%,ADRA1D;ADRA1A;AKAP13;LMBRD2
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5076439539895822,1.2627472894920628,0.1859557867360208,0.5705016053514212,1.0,15/26,26.97%,IRAK2;RPS27A;UBC;TAB2;TNFAIP3;UBE2V1;AAMP;ALPK1;IRAK1;TRAF6;CASP8;TAB1;MAP3K7;TAB3;CYLD
prerank,positive regulation of RNA metabolic process (GO:0051254),0.46189830056005776,1.2624049854254922,0.17204301075268819,0.5709093378485709,1.0,11/45,13.94%,HNRNPLL;ERN1;POLR2A;IL6;RIPK1;DDX5;DYRK1A;GRSF1;SIRT7;RELA;HSPA1A
prerank,regulation of smooth muscle cell migration (GO:0014910),0.527584105374521,1.262348823790495,0.20357634112792297,0.5704291406839884,1.0,7/20,16.74%,LRP1;PDGFA;SORL1;IGF1;PLAU;NRP1;ACE
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.41258415893762573,1.2622504438156623,0.09824198552223372,0.5700316635268292,1.0,32/138,12.94%,PPARG;POLR2A;NR1H3;E2F3;RXRA;NCOR1;NOTCH2;RARA;GTF2H5;GTF2B;TAF7;MAML1;NR3C1;MAML2;NR1H4;CREBBP;TAF5;POLR2L;TBL1XR1;NR5A1;NR2C1;ESR1;POLR2G;CDK7;MED26;POLR2I;PPARD;NOTCH1;RORA;GTF2F2;MAZ;NRBF2
prerank,stress granule assembly (GO:0034063),0.5244909892083671,1.2620238141275897,0.1958904109589041,0.570039178126911,1.0,5/20,4.89%,DYNC1H1;UBAP2L;DDX6;ATXN2;YTHDF3
prerank,membrane assembly (GO:0071709),0.47902403782351843,1.2615982512295418,0.16066838046272494,0.5706237796351542,1.0,9/34,9.77%,CEL;RFTN1;FLOT1;PTEN;ANXA2;GAK;CHMP2A;PICALM;VPS4A
prerank,proton transmembrane transport (GO:1902600),0.47972695342314503,1.2612976647920633,0.15920398009950248,0.5708852261712495,1.0,10/36,17.24%,SLC36A2;ATP6V1A;ATP6V0D1;NNT;ATP6V0E1;ATP6V0C;ATP6V1H;ATP6V1F;COX15;SLC36A1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.40372146392015545,-1.2611821820336595,0.15547703180212014,0.5476751132999236,1.0,5/24,6.90%,MEF2C;CTNNA2;MEF2A;CDH2;CDON
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5810469958444442,1.2602436381771365,0.18778625954198475,0.5734398020362188,1.0,4/13,10.59%,CD44;DYRK1A;SNAI2;SIRT1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5561339881247708,1.2601567521700747,0.21726618705035972,0.5723861420304408,1.0,4/15,14.70%,DTNBP1;AP3S1;AP3D1;AP3B1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5561339881247708,1.2601567521700747,0.21726618705035972,0.5723861420304408,1.0,4/15,14.70%,DTNBP1;AP3S1;AP3D1;AP3B1
prerank,lamellipodium organization (GO:0097581),-0.37753623542457276,-1.2600612802221427,0.10050251256281408,0.5481256769817301,1.0,9/29,9.92%,P2RY12;ABLIM1;SPATA13;PTPRO;SNX2;S1PR1;CARMIL1;ARFIP2;ARHGEF6
prerank,positive regulation of chemotaxis (GO:0050921),0.4631346542542626,1.2599374642286716,0.15625,0.5724061817136488,1.0,10/43,12.33%,F7;STX3;VEGFA;IL6;P2RX4;THBS1;DSCAM;IL6R;ADAM17;TREM2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4405514615510007,1.259653321891933,0.15730337078651685,0.5725926176539082,1.0,20/62,20.92%,LGALS3;THBS1;EIF6;CREBBP;CNOT4;CBFB;TNRC6B;PTK2B;AGO3;MAFB;KMT2E;FES;PRKCB;CDC73;AGO4;KMT2A;PURB;RBM15;SIN3A;ZBTB16
prerank,regulation of spindle assembly (GO:0090169),0.5095643328424775,1.2593388499662954,0.1782437745740498,0.5729214673368153,1.0,9/25,17.04%,DYNC1H1;CHMP2A;HSPA1B;HNRNPU;EML3;PDCD6IP;TPR;HSPA1A;CHMP5
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6092852720638974,1.259321160649888,0.20532915360501566,0.5723385561587608,1.0,6/10,25.36%,SOX9;PKDCC;ACVRL1;ZBTB16;BMPR1B;SOX5
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5693559148136125,1.259319645889115,0.21021897810218979,0.5717020625540616,1.0,4/13,10.25%,PDPK1;ITGA4;SIRT6;ADAM17
prerank,protein ubiquitination (GO:0016567),0.39581102244257566,1.2592073840069613,0.009,0.5714147218258845,1.0,160/471,23.99%,EPAS1;FBXO32;SASH1;TRIP12;NFE2L2;CTNNB1;ZNRF1;WWP1;NPEPPS;FBXW7;RNF26;WAC;PSMD1;ARRDC4;BIRC6;UBE2Q2;RNF19A;TRIM17;FBXL17;BRAP;TRIM25;UHRF2;UBE2L3;TSPAN17;ZNRF3;SPSB4;CUL3;FBXW10;RNF10;UBE2K;FBXL3;KLHL41;RNF135;DET1;PEX14;NUB1;CNOT4;RPS27A;UBC;NHLRC1;BFAR;SH3RF1;LONRF1;BRCA1;NEDD4L;KLHL20;WWP2;FBXO11;RNF115;RNF146;EIPR1;MEFV;CBFB;TOPORS;SPSB2;HUWE1;VCPIP1;TRIM7;PCNP;ARIH2;RLIM;DDB1;SIRT1;MIB2;FBXO9;NHLRC3;PSMF1;ASB4;LZTR1;UNKL;PSMD14;CAND2;KLHL24;STUB1;RUSC1;TRIM41;PSMD12;CUL4A;RNF34;CHFR;FBXO6;FBXW2;PRKN;PSME2;VPS11;CUL1;FBXO28;TNKS;ARRB1;CBL;CDC73;LNPEP;CDC34;RNF7;TRAF2;BLMH;TMEM129;UBE2O;PSMB10;KEAP1;PSMD5;GAN;TRIM14;UBE2V1;BIRC2;MYLIP;TNKS2;PSMD8;MYCBP2;AMFR;PSMA3;TRPC4AP;TNFAIP1;FBXO31;NFX1;RNF43;UBE2S;FBXO7;PSMA2;CBLL1;PSMD11;PELI2;UBE2R2;DTX1;DDA1;RNF19B;PSMA6;SPOP;CUL4B;MKRN1;FBXO45;FBXL4;DTX2;TAF1;USP9X;UBE2H;VCP;PSMB3;PRKDC;UBR3;KCTD10;RNF141;RNF125;KLHL12;IRF2BP1;UBE4A;RNF168;OBI1;SIAH2;PSME3;RNF138;ARIH1;UBE2D3;KLHL3;UBE4B;BCL10;ISG15;MIB1;TRAF6;FBXO4
prerank,gliogenesis (GO:0042063),-0.4627217653889663,-1.2590914025210642,0.18666666666666668,0.5480488342659049,1.0,6/15,8.69%,NFIB;RELN;METTL3;CDH2;PAX2;TGFB2
prerank,positive regulation of MAPK cascade (GO:0043410),0.40052116414319133,1.2587645859633279,0.04843592330978809,0.5721245356805876,1.0,21/245,5.73%,GPNMB;CD36;HTR2B;IQGAP1;GDF15;PIK3R5;APOE;GCNT2;ADRA1D;ADRA1A;VEGFA;FBXW7;CD44;TAOK3;IL6;TMEM106A;PDGFA;NOTCH2;IGF1;FGFR4;ADAM8
prerank,protein oxidation (GO:0018158),0.5955071326243015,1.2587352602837072,0.2,0.5715579616920351,1.0,2/11,15.68%,CHCHD4;SUMF1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.590896482577119,1.2585011476731667,0.20430107526881722,0.5716055004510651,1.0,2/12,7.23%,CD36;CYBA
prerank,inositol phosphate metabolic process (GO:0043647),-0.3386618934275656,-1.257929656432848,0.09146341463414634,0.548497704642958,1.0,13/46,11.08%,INPP4B;INPP5D;PLCB1;IP6K2;IMPA1;PPIP5K1;PLCH1;FGF2;ITPK1;PLD4;ITPKC;NUDT3;MINPP1
prerank,glycoprotein metabolic process (GO:0009100),0.44405542560888833,1.2577983065600264,0.15321637426900586,0.5730955967113038,1.0,12/53,12.93%,HPSE;B4GALT5;MAN1C1;TNIP1;B4GALT7;MAN2A1;MANBA;ST3GAL4;AGA;OGA;MAN2A2;FBXO6
prerank,regulation of hydrolase activity (GO:0051336),0.439512162460296,1.2574994519140459,0.12597547380156077,0.5733373826825938,1.0,17/71,14.73%,PLXNA1;GPR137B;PLXNC1;PLXND1;ARHGAP15;FGD6;VAV3;ARHGAP9;ADAP1;RAB3GAP2;SCARB2;VAV1;TBC1D15;FGD5;WRN;OCRL;FGD3
prerank,cellular response to glucose starvation (GO:0042149),0.4706598558664319,1.2572107568083108,0.18335343787696018,0.5735635588942047,1.0,8/41,6.99%,MTMR3;CPEB4;PRKAG2;FOXO3;SESN2;SH3GLB1;SIK1;ATF4
prerank,phospholipid dephosphorylation (GO:0046839),0.4680136336085446,1.2569664031731562,0.1791767554479419,0.5736688313282626,1.0,8/37,13.76%,PLPP3;MTM1;MTMR3;PTEN;PLPP6;PLPP5;OCRL;INPP5F
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5386501472736553,1.2567185710188007,0.2,0.5737599914431287,1.0,3/17,10.22%,PLA2G7;ANO6;MOSPD2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4820498249960069,1.256348670115709,0.16585365853658537,0.5742448235167924,1.0,3/36,2.92%,HTR2B;APOE;GLA
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4931234103500737,1.2560895046553162,0.19225806451612903,0.5743339816375428,1.0,9/28,14.59%,APOE;EIF2AK4;CALB1;TYROBP;GSK3B;APP;CYP46A1;ADCY8;SQSTM1
prerank,regulation of translational initiation (GO:0006446),0.4340478925077151,1.255983486340609,0.14852607709750568,0.5740011325474544,1.0,21/63,18.86%,NCK2;CEBPB;EIF1;ATF3;YTHDF3;AGO2;EIF2AK4;ATF4;EIF4EBP2;TPR;EIF3B;EIF5;POLR2G;NCBP2;CDC123;UHMK1;ALKBH1;EIF3H;EIF2B2;EIF4G3;EIF4G2
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5397471802121733,1.2552335716579481,0.20516499282639886,0.575589218941168,1.0,6/16,21.74%,PYGL;AOAH;AGL;PHKG2;MGAM;PYGB
prerank,protein targeting to peroxisome (GO:0006625),0.49069729337064755,1.2551894918883983,0.17654476670870115,0.5750567779841412,1.0,9/29,12.77%,RAB8B;ABCD1;PEX7;PEX14;ALDH3A2;PXMP2;ZFAND6;LONP2;GDAP1
prerank,cellular response to ionizing radiation (GO:0071479),0.45923184941107803,1.254957368983079,0.15845070422535212,0.5751342971072986,1.0,16/47,20.59%,MAP3K20;GRB2;CDKN1A;TANK;GADD45A;NIPBL;XRCC5;SIRT1;WRN;INTS7;INO80;RPL26;CLOCK;TLK2;EEF1D;TNKS1BP1
prerank,protein lipidation (GO:0006497),0.44418587917243846,1.2549538497938224,0.14562002275312855,0.5745071690499268,1.0,14/59,16.35%,ZDHHC14;ATG7;PGAP3;DPM2;ZDHHC16;ATG10;PIGH;ZDHHC12;ZDHHC18;ATG5;PIGC;GPLD1;PIGQ;ZDHHC17
prerank,regulation of defense response (GO:0031347),0.4303927260748824,1.2546786613523977,0.14410480349344978,0.5746550373511558,1.0,23/76,17.90%,APOE;ANXA1;MGLL;APPL2;CELF1;SHPK;RNF135;TKFC;XIAP;FOXP1;BIRC3;APPL1;TREM2;TRAF3;RELA;FGR;N4BP1;CASP12;MYD88;GRN;BST1;NLRP6;BIRC2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3777257370404554,-1.2545338586503318,0.1572052401746725,0.5542287750934214,1.0,7/31,7.03%,MEF2C;CTNNA2;MEF2A;FGFR2;CDH2;CDON;HDAC9
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6093543539408373,1.254475069051527,0.20955315870570107,0.5746148292159424,1.0,1/10,0.52%,NAMPT
prerank,muscle cell differentiation (GO:0042692),0.4868776737673356,1.2543119587140408,0.16666666666666666,0.5744317681163772,1.0,4/32,4.98%,MRTFA;MRTFB;NINJ1;MTLN
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4103394873322308,1.254221271183655,0.11239495798319328,0.5740674914477883,1.0,22/117,15.27%,SYK;GPR15;PTGDR;PLK2;IL6;HTR6;RHBDF2;PLA2G2D;GPR83;ADCY7;PTGER2;GPR176;PTGER4;VIPR1;ADAM17;PTH2R;MYH9;TREM2;FGR;ADCY8;ADCY3;CD247
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5345771679524369,1.2538084453184257,0.20299727520435967,0.5746556205325073,1.0,6/18,19.77%,BCL2L11;ERN1;DDIT3;BAX;ATXN3;FCGR2B
prerank,positive regulation of angiogenesis (GO:0045766),0.4144513818827276,1.2536218257166334,0.10759493670886076,0.5745187110404771,1.0,20/108,12.09%,APLNR;SASH1;VEGFA;AQP1;ITGA5;PDPK1;NINJ1;THBS1;AGO2;SIRT6;HMOX1;BRCA1;HIPK1;CTSH;VASH2;HIPK2;ITGB1;SIRT1;PRKCB;S100A1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.41361028623000134,1.2532701648842115,0.10253699788583509,0.574951347883378,1.0,28/112,15.53%,SYK;LILRB1;IL6;TMEM106A;RIPK1;LY96;RARA;IGF1;THBS1;ARG2;NR1H4;SPHK2;IRAK3;CYBA;SIRPA;FOXP1;NFKBIL1;TYROBP;MAVS;NLRC3;ARHGEF2;APP;FZD5;ARFGEF2;GAS6;TNFAIP3;CX3CL1;LBP
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4575479545707082,1.2531644226960128,0.1646919431279621,0.5746449665212431,1.0,10/48,10.98%,ANXA1;VEGFA;PDPK1;RHOJ;P2RX4;THBS1;HMOX1;ADAM17;SIRT1;ATP5F1A
prerank,positive regulation of B cell activation (GO:0050871),0.45446670954917845,1.2526554683191014,0.15456674473067916,0.5755808867268368,1.0,8/50,7.14%,CD38;SYK;VAV3;TFRC;IL6;MMP14;IRS2;SH3KBP1
prerank,multivesicular body assembly (GO:0036258),0.4926166618994038,1.2519579692719685,0.1880559085133418,0.5768994214521036,1.0,12/30,21.83%,STAM;CHMP2A;PDCD6IP;VPS4A;CHMP6;SNF8;STAM2;CHMP5;CHMP7;VPS36;CHMP2B;VPS37B
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4321695388408487,1.251932616027607,0.15299334811529933,0.5763425429470168,1.0,16/68,16.53%,SYK;RAB7B;TLR8;IL6;TMEM106A;SPHK2;CYBA;TYROBP;IL6R;MAVS;ARHGEF2;APP;LBP;MYD88;HSPD1;TLR1
prerank,fat cell differentiation (GO:0045444),0.4444383556810649,1.251282253693891,0.15034965034965034,0.5775939414882634,1.0,8/57,10.59%,PPARG;OSBPL8;TFAP2B;PID1;METRNL;MAFB;FOXO1;SIRT1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5176885680981655,1.2511738260983176,0.2160737812911726,0.577291997258596,1.0,4/22,6.54%,IPO5;CDKN1A;PTEN;APC
prerank,response to progesterone (GO:0032570),0.5342068043031006,1.251133643189954,0.19549929676511954,0.5767873577722941,1.0,6/18,17.67%,NR1H3;CATSPERB;THBS1;CATSPER2;ACOD1;CATSPER3
prerank,defense response to protozoan (GO:0042832),0.5754119279503723,1.2509612982999145,0.23273273273273273,0.576719432534187,1.0,4/12,15.74%,LYST;GBP6;SLC11A1;MYD88
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3451976651207904,-1.250749670316425,0.11242603550295859,0.5605395641991793,1.0,12/39,13.58%,FGF14;PRKCE;ANK3;SCN1B;FGF12;WNK3;FGF13;PTPN3;GLRX;WNK2;WNK1;YWHAH
prerank,cellular response to nutrient levels (GO:0031669),0.4361908915262122,1.2501011234069292,0.1534216335540839,0.5786007401216092,1.0,12/62,12.79%,TFEB;ATG7;FNIP1;PDK4;STK24;FLCN;LAMP2;BMPR2;FOXO1;SIRT1;GAS2L1;WRN
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.569573134277138,1.2495818657701454,0.2198473282442748,0.5795545714226394,1.0,5/12,19.66%,NCOR1;FOXP1;SIRT1;ZBTB7A;PIAS2
prerank,retinoid metabolic process (GO:0001523),0.4388600539892744,1.2487982679366663,0.14590347923681257,0.5812779566795627,1.0,6/71,5.07%,APOE;STRA6;DHRS3;LRP1;RBP1;RDH12
prerank,negative regulation of DNA recombination (GO:0045910),0.46216153770191143,1.2487953603897664,0.16767189384800965,0.5806526215331216,1.0,10/43,10.93%,POLR2A;ACD;ZRANB3;HELB;PARP3;POLR2L;RTEL1;TERF1;POLR2G;POLR2I
prerank,fatty acid catabolic process (GO:0009062),0.43262760674682266,1.2486554064646187,0.15453527435610304,0.5804708663396053,1.0,19/67,19.80%,CEL;LPIN3;ABCD1;HADHA;SLC27A4;MTLN;ACADL;ACADVL;AIG1;PPARD;ALDH3A2;MCEE;ECHDC1;EHHADH;ACAA2;ACAD10;NUDT7;ACBD5;SLC25A17
prerank,skeletal system development (GO:0001501),0.40153994791684977,1.2485350947686646,0.10134436401240951,0.5802009343580824,1.0,30/148,17.11%,PRDX1;TRPS1;HAPLN4;XYLT1;TGM2;PAPSS2;CD44;EXT1;RAB33B;MMP14;IGF1;COL1A1;SULF2;SOX9;AKAP13;PKDCC;PAPSS1;PTGER4;TRIP11;PLS3;SULF1;SH3PXD2B;DYM;GDF10;SLC10A7;ATP7A;WWOX;COL11A2;BPNT2;CHD7
prerank,positive regulation of T cell activation (GO:0050870),0.43028099272338444,1.2479796302543862,0.15523059617547807,0.5812564847366244,1.0,8/62,4.04%,ZMIZ1;ANXA1;NCK2;TFRC;IL6;CD28;CD46;CD274
prerank,cellular response to interleukin-15 (GO:0071350),0.5692547718597384,1.247926139891774,0.20845481049562684,0.580152325912286,1.0,5/13,14.65%,GRB2;STAT5B;IL15;SHC1;JAK3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5692547718597384,1.247926139891774,0.20845481049562684,0.580152325912286,1.0,5/13,14.65%,GRB2;STAT5B;IL15;SHC1;JAK3
prerank,protein localization to nucleus (GO:0034504),0.419768293035248,1.2475365051800755,0.11159263271939328,0.5806921155549022,1.0,19/102,12.79%,MMP12;SYK;PIKFYVE;IPO5;E2F3;LMNA;APPL2;COL1A1;HNRNPU;DVL1;TOPORS;TPR;INTS13;NUP50;SUPT7L;TNPO1;NOL8;APPL1;WRN
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4609436515559404,1.2467210873400199,0.17339667458432304,0.5825287180345713,1.0,11/43,15.42%,CBLB;GRB2;RAB7A;DUSP3;STAM;SH3KBP1;RNF115;CHMP6;EPS15;STAM2;CBL
prerank,protein polyubiquitination (GO:0000209),0.3948437857901999,1.246599367516217,0.03927492447129909,0.5822917297353615,1.0,120/297,26.32%,FBXO32;SASH1;TRIP12;CTNNB1;ZNRF1;WWP1;NPEPPS;FBXW7;RNF26;PSMD1;UBE2Q2;RNF19A;FBXL17;UBE2L3;ANAPC1;CUL3;FBXW10;UBE2K;FBXL3;RNF135;RPS27A;UBC;NHLRC1;BFAR;LONRF1;BRCA1;NEDD4L;KLHL20;WWP2;FBXO11;RNF115;RNF146;CBFB;TOPORS;HUWE1;ARIH2;RLIM;MIB2;FBXO9;NHLRC3;PSMF1;UNKL;PSMD14;STUB1;RUSC1;TRAF1;PSMD12;RNF34;CHFR;FBXO6;FBXW2;TRAF3;TNFAIP3;PRKN;HECTD1;TRAF3IP2;PSME2;CUL1;FBXO28;TNKS;TRAF5;ANAPC10;LNPEP;CDC34;TRAF2;BLMH;TMEM129;UBE2O;PSMB10;PSMD5;TRIM14;UBE2V1;BIRC2;MYLIP;TNKS2;PSMD8;AMFR;PSMA3;FBXO31;UBE2S;FBXO7;PSMA2;PSMD11;PELI2;UBE2R2;DDA1;RNF19B;PSMA6;SPOP;MKRN1;FBXL4;TAF1;UBE2H;PSMB3;RNF125;IRF2BP1;UBE4A;RNF168;SIAH2;PSME3;ARIH1;UBE2D3;KLHL3;UBE4B;TRAF6;FBXO4;TTC3;UBE2J2;PRPF19;UBE2E1;ANAPC7;PSMC5;UBR5;FBXW8;FZR1;FBXO30;UBE2G1;FBXL12;PSMC1;RC3H1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.39914198272336193,1.2465239584470142,0.07164480322906155,0.5818594180274304,1.0,54/208,18.29%,HTR2B;LITAF;OPTN;TFRC;IKBKE;PLK2;PDPK1;TMEM106A;TNIP1;ANKRD17;TANK;RIPK1;TRIM25;NR1H4;SPHK2;REL;HMOX1;AKAP13;TICAM2;VAPA;MAVS;ESR1;NLRC3;SIRT1;MIB2;BIRC3;TAB2;BST2;TRAF1;WLS;PRKCB;RORA;ROR1;TREM2;ZFAND6;TRAF3;RELA;TNFAIP3;GOLT1B;PRKN;TRAF3IP2;SQSTM1;CX3CL1;TRAF5;SLC44A2;MYD88;GPR89A;TRAF2;ZDHHC17;LTBR;TRIM14;UBE2V1;BIRC2;CARD11
prerank,regulation of response to external stimulus (GO:0032101),0.4132587890716375,1.2460257682112537,0.10388247639034627,0.5827195989233063,1.0,28/121,16.80%,CD36;CXCR4;ANXA1;MGLL;P2RX4;PPEF1;APPL2;CELF1;SHPK;STK24;RNF135;TKFC;CAMKMT;XIAP;FOXP1;BIRC3;APPL1;TREM2;TRAF3;RELA;FGR;N4BP1;CASP12;CX3CL1;MYD88;GRN;BST1;NLRP6
prerank,response to amyloid-beta (GO:1904645),0.45204254718017356,1.2458948989885694,0.17447306791569087,0.5824898322666525,1.0,8/44,12.33%,CD36;MMP12;LRP1;ITGA4;IGF1;GSK3B;APP;TREM2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5792025271280493,1.2458668490758107,0.2374631268436578,0.581946682204075,1.0,8/12,23.25%,APOE;ABCA2;PICALM;ROCK1;RANBP9;FKBP1A;ABCA7;TMED10
prerank,carboxylic acid catabolic process (GO:0046395),0.579879684455907,1.2452833169522457,0.20783132530120482,0.5830167175518886,1.0,4/12,14.52%,RENBP;PON3;NAGK;GNPDA1
prerank,regulation of protein kinase activity (GO:0045859),0.4160757271609133,1.2443622912956092,0.11534391534391535,0.5851148202796241,1.0,23/106,13.44%,IQGAP1;DTNBP1;GNAQ;PRKAG2;PDPK1;CDKN1A;SNX9;UVRAG;TAF7;GSKIP;CACUL1;RB1;DVL1;CEP85;XRCC5;RAP2B;PTK2B;SIRT1;PAK2;CCN1;TAB2;GAS6;FGR
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3858551523248628,-1.2438693699896566,0.15517241379310345,0.5752999903301462,1.0,6/27,7.55%,P2RY12;IRS1;FGF2;FLT3;PRKD1;ATG14
prerank,icosanoid biosynthetic process (GO:0046456),0.6150224780237987,1.2437547902681008,0.2323076923076923,0.5863007758059271,1.0,2/10,10.31%,MGST2;LTA4H
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5562888486032391,1.243135778916147,0.22271386430678466,0.587459895938105,1.0,8/14,26.83%,ACD;TPP1;XRCC5;TNKS;TNKS2;TERF2IP;BRCA2;TINF2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4157711508037057,1.2427014691105813,0.14456521739130435,0.5881245198099643,1.0,31/88,20.45%,MYO5A;DTNBP1;FTL;KIF16B;CLINT1;SORL1;CHMP2A;RABEP1;KLHL20;RAB10;VPS13C;APP;AP1G2;VPS35L;AP1G1;ARFGEF2;CLVS2;EPS15;ARL3;EXOC4;ARRB1;SH3D19;RABIF;FTH1;EXOC1;AP4M1;AP1M1;GOPC;VPS13A;VAMP2;SNAP23
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5382743740121948,1.2426430005594393,0.20165745856353592,0.5876647873733103,1.0,1/19,0.58%,APOE
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4452008778699434,1.2415481935924446,0.16037735849056603,0.5902211879931051,1.0,8/52,5.48%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;CLN3;STAC2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4210553362272409,1.2414436045486237,0.13480662983425415,0.5898822615290663,1.0,17/86,12.65%,GDF15;SDCBP;ZEB2;CITED2;THBS1;CREBBP;FLCN;RBPMS;ACVR2A;ACVRL1;HIPK2;BMPR2;ADAM17;CCN1;NOTCH1;ACVR1B;SULF1
prerank,response to muramyl dipeptide (GO:0032495),0.5812082518953816,1.2413390199219403,0.2072463768115942,0.5895660265020315,1.0,5/12,17.04%,VIM;ARHGEF2;TRIM41;ERBIN;CHMP5
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5451616154107122,1.2409498690494825,0.2017167381974249,0.5901085598377828,1.0,6/17,13.63%,CD44;DYRK1A;SNAI2;SIRT1;RNF34;PRKN
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4454898054230432,-1.2409295483548428,0.19795221843003413,0.5803936952832118,1.0,6/17,18.45%,CCND3;EGFR;PKD2;PKD1;RGCC;PSMD10
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5832863511661979,1.2406395394468854,0.23583460949464014,0.5904471536665807,1.0,2/11,3.44%,ABCB7;ABCD1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5888504141790647,1.24063099611947,0.22796352583586627,0.5898488214740941,1.0,5/11,17.41%,ST18;FAS;HTRA2;CAAP1;PRR7
prerank,organophosphate ester transport (GO:0015748),0.5036718564066025,1.2404582138776363,0.1932555123216602,0.5897439763535078,1.0,7/24,13.98%,OSBPL8;PLTP;ABCA3;PITPNA;EPG5;PITPNC1;PRELID3A
prerank,androgen receptor signaling pathway (GO:0030521),0.5919867587479446,1.240029263478128,0.22629969418960244,0.5904053074884418,1.0,3/11,7.28%,ZMIZ1;DDX5;KDM3A
prerank,positive regulation of RNA splicing (GO:0033120),0.4905069455399055,1.239887911989669,0.1981747066492829,0.5901854875747651,1.0,10/29,19.65%,HNRNPLL;ERN1;POLR2A;DYRK1A;HSPA1A;PRDX6;NUP98;THRAP3;RBM22;NCL
prerank,extracellular transport (GO:0006858),0.577811084744551,1.2397164055376753,0.21764705882352942,0.5900751673142809,1.0,3/12,12.50%,CCDC40;WWP2;SPAG17
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.37099401107107943,-1.239675560968071,0.15481171548117154,0.5811756001581595,1.0,8/28,14.51%,NAV3;MAPT;CDK5R1;PAK1;AKAP9;NUMA1;GIT1;MAPRE1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5543282623533956,1.2394700050023033,0.21242774566473988,0.5902014359663226,1.0,2/14,6.98%,AK8;NMNAT1
prerank,regulation of nuclear division (GO:0051783),0.5212225540469622,1.2392887263643666,0.21380243572395127,0.5901022121144234,1.0,2/20,2.06%,CCDC8;KIF20B
prerank,regulation of intracellular protein transport (GO:0033157),0.4772060990089895,1.2385121013212221,0.18592964824120603,0.5918400623300379,1.0,12/32,16.75%,KIF20B;RUFY3;LCP1;TPR;OAZ2;BCAS3;SIRT7;TENM1;UHMK1;PTPN1;RAB29;OAZ1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.42571563294221376,1.2384915354592059,0.1404867256637168,0.5912648461529756,1.0,21/73,20.59%,FNIP2;VEGFA;TXN;FNIP1;TFRC;CD44;IL6;RAF1;APP;HCLS1;GAS6;TENM1;PFN2;LATS1;CAMK1;SH2D3C;STK4;BCAR3;OSM;TBK1;TNKS1BP1
prerank,telomere maintenance via recombination (GO:0000722),0.5766403266217273,1.2383000989263953,0.234375,0.5912689402949545,1.0,2/11,4.72%,NSMCE2;TEP1
prerank,regulation of developmental growth (GO:0048638),0.4898742703330969,1.238233365948073,0.18604651162790697,0.590832050604054,1.0,7/29,14.94%,APOE;IGF1;STAT5B;NIPBL;GSK3B;APP;LATS1
prerank,negative regulation of cell communication (GO:0010648),-0.4058068495328618,-1.2382033127548229,0.1889763779527559,0.5825122109069356,1.0,5/21,12.21%,ACVR1;UBASH3B;OPRM1;GLRA1;ERBB3
prerank,neuron differentiation (GO:0030182),-0.2738475526766701,-1.2381232547796692,0.0,0.5802189255321752,1.0,20/165,4.89%,ATP8A2;TENM2;PTPRD;MEF2C;OPHN1;IL1RAPL1;EPHA5;SPOCK1;TENM3;RYK;RORB;FZD3;MYEF2;MYO7A;FUT9;MYT1L;TGFBR1;CDK5R1;PBX3;NTRK2
prerank,ethanol metabolic process (GO:0006067),-0.4936955874933622,-1.2375857577180331,0.2054380664652568,0.5792148552658519,1.0,5/12,24.60%,ACSS1;ACSS2;ALDH1A1;SULT1A1;ADH5
prerank,purine-containing compound salvage (GO:0043101),-0.481315118907447,-1.23754865008407,0.18950437317784258,0.5768222434036624,1.0,5/12,11.95%,GMPR2;PNP;AMPD2;DCK;GMPR
prerank,acidic amino acid transport (GO:0015800),0.5357413858813826,1.2375201509621518,0.20781032078103207,0.5922869263171842,1.0,2/17,0.69%,LRRC8D;SLC6A6
prerank,regulation of sprouting angiogenesis (GO:1903670),0.47726353127308474,1.2371788966547896,0.207663782447466,0.5927126876844172,1.0,6/33,5.58%,VEGFA;ITGA5;PDPK1;RHOJ;CEMIP2;THBS1
prerank,innate immune response (GO:0045087),0.3980355494327641,1.2371168457458188,0.08080808080808081,0.5922864593808386,1.0,52/217,17.91%,PPARG;SYK;TLR8;FRK;CLEC4D;KYNU;IFITM1;MSRB1;ANKRD17;SRPK2;TRIM17;RNASE3;TRIM25;ANKHD1;RNF135;CYBB;NUB1;REL;CYBA;NCF2;MFHAS1;TKFC;AKAP1;MEFV;TYROBP;IFITM2;MAVS;PTK2B;TREML1;FES;APP;BST2;RELB;TREM2;BTK;MFAP4;CYBC1;ATAD3A;RELA;FGR;SLC11A1;SLPI;NRROS;KLRD1;LBP;MYD88;NCF1;CAPZA1;MASP1;SRPK1;TRIM14;DEFA6
prerank,regulation of blood circulation (GO:1903522),-0.3585424309518537,-1.2370735294675201,0.12631578947368421,0.5756331559450426,1.0,22/34,37.45%,CELF2;ECE1;AGT;KCNG2;ADORA3;TPM1;FXYD1;KCNMB4;PER2;TMIGD3;DMPK;KCNJ12;AGER;CACNA1H;BDKRB2;KCNQ1;PLN;KCNIP2;CAMK2D;KCNMB2;TBX2;DES
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5904464687552085,1.2370075039725776,0.24397590361445784,0.591988438142612,1.0,2/10,8.66%,LILRB1;TYROBP
prerank,oogenesis (GO:0048477),-0.4635095109866253,-1.2367516327311354,0.20327868852459016,0.5739496741400224,1.0,8/15,38.43%,FMN2;METTL3;IHO1;TRIP13;PIWIL2;PTN;HORMAD1;NANOS1
prerank,female gonad development (GO:0008585),0.5178574955801359,1.2361672183496433,0.19549929676511954,0.5938488282157465,1.0,3/19,9.48%,VEGFA;CEBPB;NR5A1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5273706917484597,1.2358993337814432,0.22160664819944598,0.5941086011009047,1.0,6/18,16.14%,SLC35F6;GSK3B;HSPA1A;BAX;ACAA2;BID
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.3640255290474955,-1.2358202370364055,0.15454545454545454,0.5738847304295025,1.0,11/31,21.98%,TGFBR2;FGFR2;TGFBR1;MEGF8;HOXD4;HOXD3;HOXC9;HOXA9;SOX11;HOXB9;DSCAML1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.49221630828235663,1.2358161145415216,0.2109479305740988,0.5937300200276896,1.0,9/26,20.35%,B4GALT5;TPI1;TNIP1;ST3GAL4;GOLPH3;GK5;RRM1;ALG6;GK
prerank,negative regulation of axonogenesis (GO:0050771),-0.3901776114075604,-1.2351619455047957,0.16216216216216217,0.5731820054577261,1.0,14/27,16.87%,DCC;ARHGDIA;MAG;RNF6;MAP2;FGF13;DIP2B;EFNB3;CDKL3;LINGO1;ULK2;GDI1;RHOA;OMG
prerank,positive regulation of viral transcription (GO:0050434),0.5016142113608739,1.2351595015839307,0.2073490813648294,0.5950165480057897,1.0,7/25,13.49%,MDFIC;POLR2A;POLR2L;POLR2G;POLR2I;GTF2F2;CTDP1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.6013293735767125,1.2351226775586293,0.22327044025157233,0.5944907637913411,1.0,7/10,27.28%,NPLOC4;TKFC;C1QBP;RNF125;DHX58;GPATCH3;RIOK3
prerank,aggrephagy (GO:0035973),0.484490745821009,1.2346954145659201,0.1969309462915601,0.5951959026813958,1.0,12/27,20.02%,VIM;DYNC1H1;RPS27A;UBC;ATG5;WDFY3;PRKN;SQSTM1;UBE2V1;ARL13B;ACBD5;IFT88
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4762543285381063,1.2344993684195453,0.20654911838790932,0.5951755127918796,1.0,8/32,11.32%,MMP12;CORO1C;PTEN;THBS1;NF2;DLC1;ACVRL1;BCAS3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.39676198686890696,1.2344338452627281,0.07676767676767676,0.5947753187694277,1.0,63/234,18.84%,CD36;PPARG;PLPP3;RAB7B;PRKCH;CTNNB1;VEGFA;FLOT1;IRAK2;TFRC;IKBKE;IL6;RIPK1;PTEN;TRIM25;ADAM8;NFKBIB;CRTC1;IRAK3;STK3;HSPA1B;RPS27A;UBC;NLRC4;COPS5;ARID5B;HIPK2;RIPK4;DDIT3;MAVS;ESR1;MTPN;ARHGEF2;APP;TAB2;TRAF1;TRIM41;PRKCB;ROR1;HCLS1;FZD2;BTK;PPRC1;BUD31;RELA;HSPA1A;ADCY8;LRP6;CX3CL1;TRAF5;PPARGC1B;MYD88;NHLH2;TRAF2;SLCO3A1;ERC1;SMARCB1;ZBTB7A;TRIM14;UBE2V1;CARD11;CRTC3;CLOCK
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.42747373957686574,1.2344156797816221,0.15883668903803133,0.594196382129493,1.0,34/77,25.29%,LGALS3;SLC35F6;HGF;BIRC6;RIPK1;IGF1;PPIF;THBS1;SH3RF1;RB1;CSNK2A2;MAZ;RELA;PRKN;HSPA1A;PHIP;MCL1;CX3CL1;ACAA2;CAAP1;NDUFS3;CSNK2A1;NOC2L;HTT;TCF7L2;ITGAV;PLAUR;HERPUD1;SIAH2;PSME3;NDUFA13;BCL2L1;GPX1;FXN
prerank,regulation of protein sumoylation (GO:0033233),0.5394652980419605,1.234329869883858,0.2225237449118046,0.5938546223158573,1.0,4/17,7.73%,ZMIZ1;CTNNB1;RWDD3;PIAS4
prerank,regulation of protein catabolic process (GO:0042176),0.41328047502141474,1.2342707391037258,0.148109243697479,0.5934250357007637,1.0,28/99,17.81%,ATG7;WWP1;TIPARP;RAB7A;PLK2;CTSA;WDR91;SORL1;EEF1A1;IRAK3;STX5;APC;NEDD4L;WWP2;HUWE1;DDB1;GSK3B;OAZ2;FOXO1;CHMP6;TNFAIP3;PRKN;SNF8;AZIN1;PRKCG;OAZ1;CSNK2A1;SNX3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5602432002170379,1.2340500388146085,0.23520485584218512,0.5934907604515175,1.0,4/13,10.19%,AGO2;TNRC6B;POLR2G;CNOT7
prerank,organophosphate biosynthetic process (GO:0090407),0.46191617831433024,1.233948859971209,0.1980319803198032,0.5931795275726433,1.0,6/37,7.25%,MOCOS;GPAT2;TPI1;AGPAT4;ITPKB;IPPK
prerank,heart trabecula morphogenesis (GO:0061384),-0.43162137152265856,-1.2333478351140683,0.1891891891891892,0.575291727772272,1.0,5/18,8.69%,BMPR1A;TGFBR1;ENG;S1PR1;TGFB2
prerank,respiratory electron transport chain (GO:0022904),0.5518619752253395,1.233345299134006,0.215007215007215,0.5944033814348572,1.0,9/14,25.82%,ETFRF1;UQCRFS1;SDHB;SDHA;ETFA;SLC25A13;GPD2;SLC25A22;NDUFA5
prerank,positive regulation of autophagy (GO:0010508),0.4211653388505471,1.2332348735638319,0.1401766004415011,0.5941343407883326,1.0,25/81,19.60%,OPTN;TFEB;PLK2;FOXO3;WAC;DAPK1;SESN2;SH3GLB1;FLCN;EIF2AK4;EPM2A;PAFAH1B2;MEFV;ROCK1;GSK3B;FOXO1;SIRT1;PRKN;BNIP3;NPRL2;TRIM14;HTT;FBXO7;PIK3CB;TBK1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.448003495848148,1.2332325420155652,0.17301038062283736,0.593530519750738,1.0,10/52,8.57%,TATDN2;ERN1;TPP1;CXXC1;ATP6V0D1;LMNA;YIF1A;ACADVL;TLN1;GFPT1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5458539420253036,1.2330709050626698,0.21685082872928177,0.593409222009933,1.0,7/15,22.14%,ATF3;PPIF;GSTO2;CPEB2;MKNK2;GSTO1;VCP
prerank,rRNA 3'-end processing (GO:0031125),0.6011256565861905,1.2329035180508099,0.23919753086419754,0.5932595802206849,1.0,7/10,21.01%,EXOSC3;EXOSC9;RPS21;ERI1;EXOSC8;EXOSC10;EXOSC7
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.4514395924565204,1.232897369099722,0.17349397590361446,0.592668035548802,1.0,10/44,10.56%,CELF1;YTHDF3;AGO2;ZFP36L2;ZC3HAV1;TNRC6B;ROCK1;POLR2G;CNOT7;FTO
prerank,protein localization to vacuole (GO:0072665),0.5714199236593389,1.2328574991534542,0.22931785195936139,0.592188670664871,1.0,4/13,6.78%,SH3GLB1;GLMP;RNF128;LMBRD1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5370805221769351,1.23281069921292,0.21835883171070933,0.5917377366490179,1.0,3/17,10.64%,CEBPB;SOX9;MAFG
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.560039488099093,1.2323961635181737,0.23055162659123055,0.5923814208242004,1.0,6/14,15.74%,CD200R1;TNFRSF1B;IGF1;TREM2;CX3CL1;GRN
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3414246347185613,-1.232379191775214,0.1201923076923077,0.5753515908187474,1.0,13/37,15.79%,MAPT;EPHA3;PRKAA2;STMN3;TRIM36;TPPP;MARK2;STMN4;BICD1;MAP6D1;STMN2;MAPRE1;STMN1
prerank,synaptic vesicle cycle (GO:0099504),-0.36173496666397886,-1.2320396461171597,0.155,0.5738072804802586,1.0,10/30,16.85%,NLGN1;RIMS1;SLC17A6;SNAP25;SYT7;SYNDIG1;STX1A;CPLX1;BRSK1;CPLX2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.4718334252280864,1.232031282151374,0.20901126408010012,0.5927740878038672,1.0,3/35,0.58%,PPARG;XDH;APOE
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5430244811466903,1.2317919618395503,0.21794871794871795,0.5928523022431302,1.0,8/16,26.45%,MUS81;MSH4;EME1;CENPX;RMI1;FANCM;ERCC4;HFM1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5333712259087157,1.2317684061327454,0.21621621621621623,0.5923205174825806,1.0,5/18,13.63%,NFE2L2;HTRA2;MAPK7;SIRT1;PRKN
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4146417252864384,1.2315735883305348,0.146524064171123,0.5922740396339135,1.0,25/93,19.60%,FNIP2;NCK2;VEGFA;TXN;FNIP1;TFRC;CD44;IL6;PTEN;RAF1;GPD1L;CNKSR3;NLRP2B;APP;HCLS1;GAS6;TENM1;PFN2;LATS1;CAMK1;SH2D3C;STK4;BCAR3;OSM;TBK1
prerank,response to muscle stretch (GO:0035994),0.5493947056723123,1.2315236103313214,0.21787709497206703,0.5918068836133291,1.0,3/15,6.41%,CTNNB1;SLC8A1;PIK3CA
prerank,small GTPase mediated signal transduction (GO:0007264),0.41191490661726576,1.231425709090869,0.13197424892703863,0.5915157335435944,1.0,29/103,16.19%,ABR;GRB2;PLK2;SOS1;CDKN1A;PLD2;RGL1;JUN;RGL2;ARHGAP31;BRAP;IGF1;NRAS;RREB1;RB1;KSR2;RGS19;ARHGAP18;RRAD;CCNA2;RAB18;RIT1;ARL3;RRAS;SHC1;NUCB1;DNMT1;USP8;CCDC88C
prerank,carbohydrate derivative transport (GO:1901264),0.5313163911578523,1.2313583081034731,0.21635883905013192,0.5910953245706563,1.0,6/18,15.53%,ABCG1;CLN3;PLTP;SLC15A3;SLC10A7;LBP
prerank,cellular response to lipid (GO:0071396),0.3945251557429592,1.2312480885752526,0.09416581371545547,0.5908264090502123,1.0,48/191,15.74%,LILRB1;AQP1;PDK4;VIM;SPP1;IL36G;NR1H3;ADAM9;IL6;ABL2;CD274;TNFRSF1B;LY96;SHPK;PID1;HTRA2;UBE2L3;NR3C1;NFKBIB;NR1H4;SPHK2;NCOA4;STAP1;MSN;SOX9;LCOR;SIRPA;NFKBIL1;TICAM2;NCOA3;FZD7;ESR1;PTK2B;FES;TRIM41;RORA;KCNK4;FAM210B;MGST1;GPLD1;RELA;TNFAIP3;ACOD1;ADCY8;ADCY3;LBP;CDC73;MYD88
prerank,microtubule anchoring (GO:0034453),0.5659091119197003,1.2309957111311596,0.24005891016200295,0.5909279882862518,1.0,4/12,13.75%,SAXO2;DAG1;PEX14;CLASP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4866326419348393,1.230239623093944,0.20948616600790515,0.5925212354677696,1.0,10/26,19.66%,NCOR1;BRCA1;FOXP1;SIRT1;STRN3;VPS11;CRY1;ZBTB7A;CLOCK;PIAS2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5198298939068999,1.2293167432957777,0.21584699453551912,0.5947057380472303,1.0,10/20,23.92%,ADAM9;ADAM17;HM13;RHBDD1;RELA;NCSTN;ADAM10;APH1B;PSEN2;TRAF6
prerank,cell projection assembly (GO:0030031),0.4981515706141703,1.2292680586667681,0.2413793103448276,0.5942248424400176,1.0,4/22,6.27%,RHOJ;PDGFA;CAPG;PARVB
prerank,regulation of Ras protein signal transduction (GO:0046578),0.41882367991899205,1.2290971617418769,0.16304347826086957,0.5941185781510967,1.0,23/85,16.59%,DENND4C;GRB2;DENND1A;MYO9B;NOTCH2;RAF1;IGF1;IRS2;FLCN;AKAP13;VAV1;DLC1;ARHGAP17;ARHGEF2;LZTR1;NOTCH1;RAPGEF1;RASGEF1A;ERBIN;SHC1;SQSTM1;MAPKAP1;LRRC59
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3672384757129863,-1.2283027871519425,0.16666666666666666,0.5806539210131239,1.0,8/31,8.69%,BMPR1A;FGFR2;RYR2;TGFBR1;ENG;ZFPM2;SMAD7;TGFB2
prerank,axonogenesis (GO:0007409),-0.2595150095111913,-1.228089909439603,0.0,0.578815338940893,1.0,57/237,12.35%,UNC5C;OPHN1;SEMA5A;RPS6KA5;EPHA5;CTNNA2;NRXN1;NTNG1;ROBO2;ROBO1;NRXN3;DCC;CNTN6;NCAM1;EVL;AUTS2;EPHA6;SIAH1;RYK;DAB1;VASP;CNTN2;EPHA3;PTPRO;ENAH;ANK3;CNTN4;UNC5D;FGFR2;DOK6;PARD3;SCN1B;RELN;CDK5R1;HSP90AA1;SLIT1;TUBB3;SEMA4G;KIF5A;VLDLR;SEMA3E;SPTBN4;BSG;PAX2;RAP1GAP;SEMA3A;EPHA7;EFNB3;RAB8A;NLGN3;PRKCA;KLF7;IGSF9;NEXN;SEMA6A;ULK2;GFRA2
prerank,sympathetic nervous system development (GO:0048485),0.5375035064685034,1.2279755165987902,0.21982758620689655,0.5967866841694451,1.0,5/15,16.18%,CTNNB1;TFAP2B;NRP2;GDNF;NRP1
prerank,regulation of multicellular organism growth (GO:0040014),0.543214373022681,1.2277502227755293,0.2411764705882353,0.5968338652329789,1.0,4/15,11.47%,GDF15;IGF1;STAT5B;APP
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.41482165998670284,-1.2268476756760929,0.2170212765957447,0.5795116666287946,1.0,5/22,7.53%,SSH2;TWF2;CYRIB;TMSB4X;SSH3
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.294735604269907,-1.2267013138487795,0.10975609756097561,0.5775331020951584,1.0,18/86,8.09%,NAV3;BIN1;SEMA5A;EVL;FCHSD2;PRKCE;VASP;MAPT;FER;HCK;LIMK1;CDK5R1;NCKAP1;NCK1;PAK1;AKAP9;CARMIL1;CLU
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.4806748329292423,1.225837705327179,0.21065989847715735,0.6017529364319508,1.0,9/30,16.20%,FAS;RIPK1;HMOX1;BRCA1;GSK3B;ARHGEF2;RNF34;TNFAIP3;TRAF2
prerank,carboxylic acid metabolic process (GO:0019752),0.47534623265343434,1.225645558120521,0.19119496855345913,0.6016841095168628,1.0,11/33,14.57%,CYB5R3;GNMT;PON3;GLYAT;GRHPR;CYB5A;LIAS;SLC2A1;SLC23A2;SLC23A1;GSTO2
prerank,protein localization to centrosome (GO:0071539),0.5194664768638743,1.2252881875538126,0.23505434782608695,0.6021125149389988,1.0,3/17,2.21%,HOOK3;PIBF1;SNX10
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.41633362031795484,-1.2252121280657828,0.16206896551724137,0.5788755289003635,1.0,7/18,18.68%,HACD2;ELOVL7;ACSL6;ACSL4;ELOVL6;TECR;ACSBG1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5129123439270827,1.2248180164856872,0.22533333333333333,0.6029218187940111,1.0,6/18,17.63%,NCOR1;ESR1;PTBP3;PTBP2;RPS26;SHQ1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5867875110491753,1.2247697632164511,0.22533136966126657,0.6024665181000427,1.0,4/11,12.33%,P2RX4;TRAT1;P2RX3;TREM2
prerank,positive regulation of vasculature development (GO:1904018),0.4090415043384141,1.2247295577390094,0.14668094218415417,0.6019842513427338,1.0,17/94,11.91%,APLNR;SASH1;VEGFA;AQP1;PDPK1;NINJ1;THBS1;AGO2;HMOX1;BRCA1;HIPK1;CTSH;VASH2;HIPK2;ITGB1;SIRT1;PRKCB
prerank,phosphatidylserine metabolic process (GO:0006658),0.47578681953959867,1.2246112415780452,0.22,0.601767005521097,1.0,6/32,12.13%,OSBPL8;PLA2G2D;SLC27A1;PLA2G4F;PLAAT3;LPCAT3
prerank,transport across blood-brain barrier (GO:0150104),0.4151714450971913,1.22441869383552,0.15777777777777777,0.6017542208534927,1.0,15/83,8.19%,CD36;SLC6A6;SLC7A2;FABP5;TFRC;LRP1;SLC1A5;SLC16A1;SLC27A4;SLC38A1;SLC5A5;ABCC4;ABCC3;SLC27A1;ABCA2
prerank,DNA damage checkpoint signaling (GO:0000077),0.4874034122446228,1.2240633555288503,0.191969887076537,0.6022499909841652,1.0,8/28,13.24%,MAP3K20;ERCC6;BRIP1;E2F1;DOT1L;NBN;FBXO6;INTS7
prerank,negative regulation of protein polymerization (GO:0032272),-0.3877369678174468,-1.2239221392611181,0.16071428571428573,0.5798653742867511,1.0,10/27,15.79%,SSH2;TWF2;CYRIB;MAP2;TUBB4A;SSH3;HIP1R;STMN2;MAPRE1;STMN1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.49516346213436996,1.22349421580491,0.18908122503328895,0.6033844281131979,1.0,2/25,3.86%,CD36;P2RX4
prerank,ketone body metabolic process (GO:1902224),0.5854427902848871,1.2233652023896253,0.21921921921921922,0.6031543248838568,1.0,3/10,12.19%,ACSS3;AACS;HMGCL
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.47720489948768235,1.2229076236026128,0.22,0.6039068856381832,1.0,8/30,14.01%,DPM2;MGAT5;MCFD2;NUDT14;DDOST;DAD1;MAGT1;UGGT1
prerank,regulation of fibroblast migration (GO:0010762),0.5116104874866361,1.2225482349490895,0.21796565389696168,0.6043923927795585,1.0,7/20,12.24%,CORO1C;APPL2;CLN3;THBS1;GNA12;ITGB1;APPL1
prerank,hexose biosynthetic process (GO:0019319),0.4513116871469056,1.2221431877679674,0.1966824644549763,0.6049404422701044,1.0,15/42,25.99%,SORD;TPI1;SLC25A1;ATF4;ENO3;SLC39A14;PGM1;CRY1;GAPDHS;MDH1;SLC37A4;SLC25A13;GOT1;PGK1;CHST15
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5254401420103779,1.2218096078271787,0.24166666666666667,0.605266375006383,1.0,9/18,24.55%,ANKRD17;NPLOC4;BIRC3;PUM2;BIRC2;C1QBP;RNF125;DHX58;GPATCH3
prerank,retinal metabolic process (GO:0042574),-0.4749556292631136,-1.2216822899528939,0.2111801242236025,0.5832872769434465,1.0,8/12,42.57%,BCO2;RDH11;DHRS13;ABCA4;CYP1B1;ALDH1A3;RDH10;ALDH8A1
prerank,amino acid import across plasma membrane (GO:0089718),0.4935574332514965,1.2215948448981637,0.22356091030789826,0.6053074706617001,1.0,3/24,3.08%,SLC6A6;SLC7A2;SLC1A5
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5056188466333431,1.2215121854536541,0.2098273572377158,0.6049522369350069,1.0,5/24,8.84%,TRPS1;SOX9;SNAI2;PKDCC;ACVRL1
prerank,error-free translesion synthesis (GO:0070987),0.4949621477864311,1.2211468631772784,0.21834625322997417,0.6054383899658777,1.0,5/22,9.33%,RFC3;NPLOC4;RPS27A;UBC;POLH
prerank,L-amino acid transport (GO:0015807),0.48005841022552465,1.2210779557247764,0.19870967741935483,0.6050511132528994,1.0,3/28,1.64%,SLC7A2;SLC36A2;SLC36A4
prerank,response to lipopolysaccharide (GO:0032496),0.3980110113812557,1.2207556580824321,0.13900414937759337,0.6054242031863551,1.0,35/138,17.04%,LILRB1;MAPKAPK3;VIM;IL36G;NR1H3;ADAM9;IL6;CD274;TNFRSF1B;LY96;SHPK;NFKBIB;IRAK3;STAP1;SIRPA;FOXP1;NFKBIL1;TICAM2;HNRNPA0;ADAM17;LIAS;TAB2;TRIM41;RELA;TNFAIP3;SLC11A1;ERBIN;SLPI;ACOD1;LBP;CDC73;MYD88;OTUD5;IFNAR1;CHMP5
prerank,negative regulation of gene expression (GO:0010629),0.3860144060081176,1.2205379736374933,0.06733668341708543,0.6054924057373413,1.0,56/302,13.94%,GPNMB;APLNR;XDH;APOE;SAMD4A;ERN1;VEGFA;TIPARP;FOXP3;DNMT3A;FBXW7;ID2;CD28;CD46;ATP2B1;DAPK1;DDX6;NCOR1;NOTCH2;CELF1;IGF2BP3;CITED2;IGF1;AGO2;SMYD5;EED;FLCN;HSPA1B;REL;ZFP36L2;RB1;WWP2;EPC1;ZNF148;FOXP1;ACVRL1;PICALM;TNRC6B;PTGER4;CNPY2;ESR1;CNOT7;AGO3;SIRT1;PTBP3;APP;EPRS1;NOTCH1;PTBP2;DGKQ;N4BP1;RPS26;PRKN;SLC11A1;RBBP7;HSPA1A
prerank,regulation of protein localization (GO:0032880),0.4348051855609371,1.2200983936375611,0.19117647058823528,0.6061986644030469,1.0,11/58,9.77%,CTSD;PLEKHM2;FBXW7;DNAJB6;TRIM17;TRIM25;WDPCP;DVL1;PICALM;TPR;VPS4A
prerank,proteasomal protein catabolic process (GO:0010498),0.3920731635153936,1.2192612762966317,0.11291963377416073,0.6079715512776933,1.0,69/201,23.40%,NFE2L2;CTNNB1;ZNRF1;WWP1;FBXW7;PSMD1;ZFAND2A;FBXL17;SPSB4;CUL3;SOCS6;UBE2K;NHLRC1;BFAR;NEDD4L;KLHL20;WWP2;RAD23A;TOPORS;SPSB2;HUWE1;TBL1XR1;PCNP;DDIT3;DDB1;SIRT1;NHLRC3;PSMF1;PSMD14;STUB1;RHBDD1;PSMD12;CUL4A;RNF34;PRKN;ZFAND2B;PSME2;ARRB1;ATE1;CDC34;KCTD5;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;PPP2R5C;TNFAIP1;AGAP3;CLOCK;DDI2;PSMA2;ATXN3;PSMD11;BRSK2;PLAA;PSMA6;SPOP;CUL4B;FBXO45;KCTD2;VCP;PSMB3;KCTD10;FAF1;SIAH2;PSME3;UBE2D3;UBE4B
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.42932319527783347,1.2187685945169142,0.18376550169109357,0.6088271318269664,1.0,14/66,13.24%,MTSS1;XDH;APOE;FBXW7;RUNX3;THBS1;SOX9;MCC;SNAI2;WDR77;NLRC3;ATP5F1A;SULF1;SOX2
prerank,chromosome condensation (GO:0030261),0.4647984197366119,1.218584457708128,0.2286401925391095,0.6087529108290217,1.0,13/36,20.68%,NCAPG2;NCAPG;INCENP;RB1;DFFB;CSNK2A2;SMC2;CSNK2A1;ACIN1;PHF13;MCPH1;NCAPD2;NCAPH
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3846841092418024,1.2181628652668754,0.05315947843530592,0.6093813285403207,1.0,116/341,23.40%,RNF149;TRIP12;NFE2L2;CTNNB1;ZNRF1;WWP1;FBXW7;PSMD1;BIRC6;RNF19A;RNF130;ZFAND2A;FBXL17;TRIM25;WDR91;UBE2L3;ZNRF3;ANAPC1;SPSB4;CUL3;NPLOC4;UBE2K;MVB12B;RNF128;NUB1;CNOT4;NHLRC1;KCTD21;BFAR;NEDD4L;KLHL20;WWP2;FBXO11;RNF115;RAD23A;RNF146;TOPORS;SPSB2;HUWE1;TBL1XR1;PCNP;DDIT3;ARIH2;VPS4A;RLIM;DDB1;SIRT1;NHLRC3;PSMF1;PSMD14;STUB1;UBAP1;PSMD12;CUL4A;RNF34;CHFR;TNFAIP3;PRKN;ZFAND2B;PSME2;SQSTM1;UBQLN2;ARRB1;ANAPC10;CBL;ATE1;CDC34;RNF7;KCTD5;PSMB10;KEAP1;PSMD5;BIRC2;MYLIP;PSMD8;AMFR;PSMA3;TRPC4AP;PPP2R5C;TNFAIP1;AGAP3;CLOCK;RNF43;UBE2S;FBXO7;PSMA2;ATXN3;ANAPC15;PSMD11;UBE2R2;PLAA;RNF19B;PSMA6;SPOP;FBXO45;FBXL4;TAF1;USP9X;VPS37B;KCTD2;UBE2H;VCP;PSMB3;UBR3;KCTD10;RNF125;HERPUD1;UBE4A;FAF1;RNF168;SIAH2;PSME3;ARIH1;UBE2D3;KLHL3;UBE4B
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5399816505027246,1.2172075396260387,0.24104683195592286,0.6115688657317843,1.0,3/15,6.37%,LILRB1;FOXP3;IRAK3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5003271004486828,1.2166711950213407,0.23138297872340424,0.6119434856517645,1.0,6/22,17.11%,ZDHHC14;ZDHHC19;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5003271004486828,1.2166711950213407,0.23138297872340424,0.6119434856517645,1.0,6/22,17.11%,ZDHHC14;ZDHHC19;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC4
prerank,Notch signaling involved in heart development (GO:0061314),0.5754200232923676,1.2153453699753611,0.24279210925644917,0.6152604512143335,1.0,3/11,11.89%,NOTCH2;SNAI2;NOTCH1
prerank,peptidyl-asparagine modification (GO:0018196),0.47170794016869,1.2150410526216058,0.23661270236612703,0.6155258848322857,1.0,8/31,14.01%,DPM2;MGAT5;MCFD2;NUDT14;DDOST;DAD1;MAGT1;UGGT1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5326375097865722,1.2146759063964518,0.24283765347885403,0.6160222524078741,1.0,4/16,12.33%,APOE;LRP1;ROCK1;TREM2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.48197265140266804,-1.2146319169155702,0.22424242424242424,0.5982977465272792,1.0,2/12,1.95%,MEF2C;DOCK4
prerank,negative regulation of nervous system development (GO:0051961),0.5189431928410182,1.2146120877433702,0.23943661971830985,0.6155796779322188,1.0,4/17,5.04%,HOOK3;IL6;APPL2;SORL1
prerank,keratan sulfate catabolic process (GO:0042340),0.5794219722119571,1.2144197352152426,0.2669826224328594,0.6155768675064139,1.0,4/11,7.91%,GALNS;GNS;HEXA;LUM
prerank,steroid metabolic process (GO:0008202),0.41963416169835527,1.214146707385444,0.19079685746352412,0.6158138693642212,1.0,4/72,1.88%,LIPA;BAAT;NPC1;AMACR
prerank,ventricular septum morphogenesis (GO:0060412),-0.3735301161006431,-1.2139733293868047,0.1694915254237288,0.597574008093461,1.0,9/27,8.69%,ACVR1;ROBO2;ROBO1;BMPR1A;TGFBR2;TGFBR1;ZFPM2;SMAD7;TGFB2
prerank,mRNA splice site selection (GO:0006376),-0.3698069884078671,-1.2139291149090083,0.16037735849056603,0.5953018117151108,1.0,14/30,19.17%,LUC7L2;SETX;SF3A1;SLU7;SRSF6;SRSF5;CELF2;SNRPC;CELF5;SF3A2;SRSF12;CELF4;SRSF1;SRSF9
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4898475108095232,1.213912516019133,0.23096774193548386,0.6159561849111609,1.0,9/26,15.13%,SYNPO2L;PTGER4;ROCK1;PFN1;SYNPO;PRKN;PFN2;CX3CL1;ALMS1
prerank,immunoglobulin mediated immune response (GO:0016064),0.5778617339289374,1.2136778822781773,0.24477611940298508,0.6160271227650135,1.0,1/10,0.91%,TLR8
prerank,regulation of B cell proliferation (GO:0030888),0.44534814843161963,1.2133197708709018,0.1990521327014218,0.6164550858650961,1.0,7/44,8.66%,CD38;CD300A;VAV3;TFRC;IRS2;CD22;TYROBP
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.47339940159478505,1.2132618420454224,0.21994884910485935,0.6160356543062394,1.0,9/29,17.12%,DHX34;E2F1;TENT5A;HNRNPU;SLC11A1;TENT5D;GDNF;THRAP3;TAF15
prerank,regulation of cellular component biogenesis (GO:0044087),0.454183153446562,1.2130486820621116,0.2033898305084746,0.61604240398633,1.0,9/39,16.20%,CD36;APOE;MSN;ROCK1;NOTCH1;RAPGEF1;VPS11;LATS1;TRAF2
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5016968555833714,1.21250234120467,0.23149394347240915,0.6170496867733161,1.0,6/24,13.54%,PLA2G2D;SERAC1;ABCA3;SLC27A1;PLA2G4F;CDS2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4603627974295349,1.2124659676057112,0.20625,0.6165551556486409,1.0,17/36,27.77%,TAOK3;NCOR1;AIDA;DUSP3;SIRPA;FOXO1;TREM2;PRKN;FKTN;DUSP10;EZR;MEN1;FOXM1;PPIA;CYLD;PER1;PTPN22
prerank,signal transduction in response to DNA damage (GO:0042770),0.4468800218644097,1.2116539969172144,0.19953051643192488,0.6183266322868601,1.0,16/49,20.44%,MAP3K20;GRB2;ERCC6;SESN2;BRIP1;E2F1;GADD45A;DOT1L;NBN;FBXO6;INTS7;BID;ACER2;CLOCK;BCL3;PAXIP1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.49212116556911145,1.210992871862589,0.24005305039787797,0.6196013372447934,1.0,6/24,14.94%,APOE;NUB1;PTK2B;PSMD14;PSME2;LATS1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.416132302826619,1.2109925130675108,0.19209659714599342,0.6190044188081414,1.0,14/70,13.02%,PLA2G7;LPIN3;NR1H3;PLA2G2D;ABCA3;SLC27A1;ABHD4;PLAAT1;CSNK2A2;PLA2G4F;PCYT1A;PLAAT3;LPCAT3;GPLD1
prerank,Golgi organization (GO:0007030),0.40001828778196435,1.2107906224039668,0.15657620041753653,0.6189874243695394,1.0,30/112,16.90%,ARHGAP21;OPTN;PLEKHM2;ATP8B4;VTI1B;NPLOC4;GAK;COG7;STX5;VMP1;TICAM2;HUWE1;VCPIP1;VTI1A;BET1;BCAS3;TRIP11;PI4K2A;VPS51;RAB43;ATL2;DYM;ATP8B1;CLASP1;STX6;GOLPH3;GOLPH3L;RAB2A;RAB29;COG2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4101191002650959,1.210649970420112,0.18398268398268397,0.6187641685483644,1.0,25/92,17.88%,SASH1;IQSEC1;VEGFA;ADAM9;DOCK5;NRP2;THBS1;RREB1;SOX9;FOXP1;CTSH;BMPR2;PTK2B;BCAS3;PFN1;DOCK1;GPLD1;CAPN7;CLASP1;RRAS;RTN4;GRN;NRP1;TEK;AAMP
prerank,mesenchyme morphogenesis (GO:0072132),-0.42129085263885657,-1.210317574419827,0.2049469964664311,0.602208982347444,1.0,6/17,12.47%,ACVR1;BMPR1A;ENG;MDM4;TGFB2;SMAD2
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5212197353313223,1.2102470666402378,0.24200278164116829,0.6194608464154342,1.0,6/18,16.36%,POR;ABL2;PDP1;GDNF;ATP7A;SIRT3
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.33222905465659475,-1.2102387408922406,0.1340782122905028,0.6000453151959361,1.0,7/41,8.69%,MEF2C;BMPR1A;TGFBR2;FGFR2;ENG;SMAD7;TGFB2
prerank,regulation of mRNA catabolic process (GO:0061013),0.39739625814072516,1.2101376752560347,0.14526315789473684,0.619190049820931,1.0,34/121,21.01%,SAMD4A;VIM;PRKCD;PSMD1;IGF2BP3;YTHDF3;PCID2;RPS27A;UBC;ZFP36L2;ZC3HAV1;EXOSC3;EXOSC9;SERBP1;CNOT7;PSMF1;PSMD14;TNPO1;PUM2;EXOSC8;PSMD12;HSPA1A;HNRNPD;PSME2;EXOSC1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;XPO1;PSMA6;EXOSC7
prerank,regulation of isotype switching (GO:0045191),0.5351178696171778,1.2090888853654094,0.2611190817790531,0.6217580465286806,1.0,6/14,20.44%,TFRC;PARP3;KMT5B;SHLD1;SHLD2;PAXIP1
prerank,detection of calcium ion (GO:0005513),-0.46597080995200524,-1.2087666164351296,0.219435736677116,0.6013063248749928,1.0,2/13,3.74%,SYT1;RYR2
prerank,action potential (GO:0001508),-0.339342297769702,-1.2085895365927979,0.12727272727272726,0.5993547626915263,1.0,12/44,18.07%,KCND2;SCN2A;ANK3;GNA15;KCNJ2;SCN9A;CACNA1G;MYH14;YWHAH;SCN8A;CACNA1I;GNA11
prerank,regulation of urine volume (GO:0035809),0.5842941340987577,1.208562444956415,0.2723146747352496,0.6227215543063571,1.0,1/10,3.48%,TFAP2B
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.38948394237375417,-1.2084440415323052,0.1990521327014218,0.5973871447542426,1.0,7/26,11.43%,ATP1B1;ANK2;KCNAB1;ATP1B2;AKAP9;DLG1;ACTN2
prerank,bile acid biosynthetic process (GO:0006699),0.48548166719547314,1.2081161099547302,0.22894736842105262,0.6234226360741961,1.0,3/24,2.13%,BAAT;AMACR;OSBPL1A
prerank,bone development (GO:0060348),0.44969420986067477,1.2074842504977863,0.21071428571428572,0.624675584655137,1.0,10/39,14.61%,TGM2;SULF2;AKAP13;PTGER4;PLS3;SULF1;SH3PXD2B;DYM;SLC10A7;LRP6
prerank,RNA interference (GO:0016246),0.5208903749618919,1.2071351016645249,0.240981240981241,0.625136035533551,1.0,7/17,22.39%,CELF1;AGO2;AGO3;DROSHA;MRPL44;AGO4;TSNAX
prerank,response to ketone (GO:1901654),0.48620301700005797,1.2071207412723324,0.23553162853297444,0.6245976010997736,1.0,4/24,6.89%,NR1H3;CATSPERB;THBS1;CATSPER2
prerank,phosphorylation (GO:0016310),0.38174439929948994,1.2070063160992321,0.06006006006006006,0.6242961826296662,1.0,73/384,13.58%,HTR2B;FNIP2;SGK1;MAP3K20;MAK;SYK;TLK1;FRK;PRKCH;MAP3K1;CERK;ERN1;TEC;PDK4;PRKAG2;IKBKE;PLK2;TAOK3;PDPK1;PRKCD;PPP4R1;RUNX3;BIRC6;SIK3;FAM20C;SRPK2;DAPK1;SHPK;RARA;DGKZ;MAPK6;PIM1;MAML1;PKN3;DGKA;MERTK;RNASEL;MELK;SIK1;SPHK2;IRAK3;STK24;STK3;PIK3CA;DYRK1A;EIF2AK4;TKFC;TOP1;BRD2;ACVR2A;HIPK1;MAP4K3;ACVRL1;HIPK2;BMPR2;TNIK;PIM3;ROCK1;GSK3B;PTK2B;PAK2;PKN2;CDK7;APP;PRKCB;ACVR1B;STK38;BTK;DGKQ;DYRK2;GAS6;FGR;LIMD1
prerank,negative regulation of phosphorylation (GO:0042326),0.41221406968184376,1.2065005920464045,0.185226019845645,0.6251633556343422,1.0,14/85,11.33%,PLPP3;XDH;CORO1C;CDKN1A;NCOR1;PTEN;PID1;IRS2;HNRNPU;STAP1;SIRPA;ROCK1;SIRT1;FBLN1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3780732191648566,1.206299901674117,0.03003003003003003,0.6251956545681558,1.0,102/509,16.46%,F7;OSBPL8;HTR2B;HPSE;IQGAP1;GDF15;PIK3R5;SASH1;VWF;LITAF;GRB2;GCNT2;ADRA1D;ADRA1A;BCL2L11;GAB2;VEGFA;TXN;FNIP1;TGM2;TFRC;IKBKE;PLK2;IL6;HGF;CD28;PDPK1;HTR6;TMEM106A;ANKRD17;PDGFA;P2RX4;RIPK1;TRIM25;IGF1;F10;FGFR4;THBS1;ADAM8;TRAT1;IRS2;SPHK2;PIK3CA;FLCN;REL;HMOX1;P2RX3;MFHAS1;RPL23;SOX9;AKAP13;VAV1;TICAM2;STRN;VAPA;STYXL1;DDIT3;LAMTOR1;ITGB1;MAVS;ESR1;ROCK1;SIRT1;MIB2;BIRC3;NRG4;APP;TAB2;BST2;WLS;PRKCB;ROR1;PUM2;TREM2;MAZ;HCLS1;MIOS;BCLAF1;SLC38A9;LAMTOR3;SOX2;RELA;GAS6;FGR;GOLT1B;PRKN;BAX;TRAF3IP2;SHC1;GOLPH3;CX3CL1;TRAF5;SLC44A2;RTN4;CBL;MYD88;FRS2;GPR89A;BID;TRAF2;ZDHHC17;LTBR
prerank,regulation of membrane depolarization (GO:0003254),0.5200520018926564,1.2057435387553315,0.26458036984352773,0.6262672062988468,1.0,4/18,8.00%,ABCD1;RANGRF;GPD1L;NEDD4L
prerank,protein-containing complex subunit organization (GO:0043933),0.3970091089160408,1.205722952497609,0.17091295116772823,0.6257282951896294,1.0,39/109,21.60%,REPS2;MITF;SKAP2;FAS;SNX9;CAPG;LPXN;CREBBP;APC;DET1;PEX14;DARS1;SOX9;PICALM;TPR;PPIH;PTK2B;TUBGCP4;TRAF1;EPRS1;SLC2A1;VAMP3;WASL;MNAT1;CD247;NUP98;FANCA;TRAF2;KPNA3;CAPZA1;RANBP9;TAPBP;KMT2A;AFG3L2;VAMP2;PPP2R1A;HES5;WIPF1;NDC1
prerank,cellular response to alcohol (GO:0097306),0.4470549642422948,1.2051567119887896,0.20386007237635706,0.6268090517588101,1.0,14/42,15.71%,GRAMD1B;CTNNB1;ADCY7;SPHK2;PTGER2;BRCA1;GRAMD1C;PTGER4;GPLD1;ADCY8;ADCY3;LRP6;GOLPH3;CTNNA1
prerank,regulation of protein localization to nucleus (GO:1900180),0.43945140392898324,1.2048935160513539,0.22666666666666666,0.6269511257871507,1.0,10/43,15.71%,TFRC;BYSL;SESN2;FLCN;MFHAS1;GTSE1;TPR;GSK3B;LATS1;CTNNA1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5717752415216626,1.2044171250470137,0.2674591381872214,0.6277141571791777,1.0,4/11,14.52%,RENBP;GFPT1;NAGK;GNPDA1
prerank,erythrocyte differentiation (GO:0030218),0.4415084161663247,1.2043232934081078,0.21844660194174756,0.627382796118771,1.0,12/44,18.32%,FLVCR1;VEGFA;ID2;RPS14;MFHAS1;HIPK2;KMT2E;HCLS1;UBA5;JAK3;ACIN1;CASP3
prerank,positive regulation of JNK cascade (GO:0046330),0.4172340805556006,1.2036918229010782,0.1857304643261608,0.6286324143705985,1.0,18/70,16.77%,SDCBP;GADD45B;GADD45G;TAOK3;RIPK1;GADD45A;MFHAS1;SH3RF1;HIPK2;FZD7;PTK2B;APP;TRAF1;TRAF3;TRAF5;TRAF2;LTBR;NCF1
prerank,macrophage migration (GO:1905517),0.5525573048525071,1.2028871365229405,0.26521739130434785,0.6304387509677596,1.0,3/13,6.87%,LGALS3;P2RX4;CKLF
prerank,granulocyte differentiation (GO:0030851),0.5150609474996789,1.202212096072947,0.24822695035460993,0.6318524452992934,1.0,4/18,4.96%,CDKN1A;RXRA;RARA;E2F1
prerank,receptor catabolic process (GO:0032801),0.4867160029517188,1.2009164815237494,0.2503209242618742,0.6351261488167206,1.0,13/24,27.02%,KIF16B;UVRAG;SH3GLB1;ZNRF3;SNX25;AP2B1;MYLIP;RNF43;LGMN;AP2S1;CLTC;AP2A2;AP2A1
prerank,icosanoid secretion (GO:0032309),0.5631882956777838,1.2009100534144856,0.24300441826215022,0.6345484979013937,1.0,4/12,22.02%,ANXA1;ABCC4;ACE;DRD2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4208888629840456,1.2008594372679804,0.20296465222348917,0.6341068109337991,1.0,16/61,16.59%,GRB2;SYNPO2L;NOTCH2;IGF1;IRS2;AKAP13;VAV1;NOTCH1;RAPGEF1;RASGEF1A;COL3A1;LPAR6;ERBIN;SHC1;ARRB1;LRRC59
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.471653731289009,1.2003858919960202,0.22745098039215686,0.6349262092962237,1.0,8/27,13.58%,IL6;RIPK1;DDX6;AGO2;DDX5;TNRC6B;PUM2;LIMD1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3925207251915567,1.2002383626788877,0.1650893796004206,0.6347494021973178,1.0,21/116,15.27%,SYK;GPR15;PTGDR;PLK2;IL6;HTR6;RHBDF2;GPR83;ADCY7;PTGER2;GPR176;PTGER4;VIPR1;ADAM17;PTH2R;MYH9;TREM2;FGR;ADCY8;ADCY3;CD247
prerank,genitalia development (GO:0048806),0.5520894777142026,1.2000109343514276,0.27111111111111114,0.6348390190688177,1.0,1/12,1.11%,STRA6
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5483601963351381,1.199797379874574,0.25755395683453236,0.6348453316466508,1.0,5/14,16.55%,BCL2L11;BFAR;COPS5;BAX;PTPN1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.5656051230107116,1.199573335762983,0.28549141965678626,0.6348873668618609,1.0,6/11,19.18%,FGFR4;NR1H4;NR5A1;SIRT1;DGKQ;ASAH1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.4194923092040509,-1.199484534218245,0.21611721611721613,0.6174448868907849,1.0,6/20,19.73%,PJA2;AKAP12;ADGRV1;AKAP5;PRKAR2B;TCIM
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5113737895723955,1.1992753026922625,0.26345609065155806,0.6352139667863721,1.0,4/18,13.02%,SPG21;C3AR1;SH2B2;GPLD1
prerank,mitotic chromosome condensation (GO:0007076),0.48399927688091404,1.198652176883722,0.23536895674300254,0.6364393598039451,1.0,10/26,20.68%,NCAPG2;NCAPG;RB1;CSNK2A2;SMC2;CSNK2A1;PHF13;MCPH1;NCAPD2;NCAPH
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4557969919671564,1.1985205302440516,0.23478260869565218,0.6362524994733644,1.0,10/33,16.22%,RAB7B;FOXO3;STAT5B;HSPA1B;ACVR2A;FES;ACVR1B;FAM210B;HSPA1A;BRD1
prerank,protein localization to chromatin (GO:0071168),0.4979208283057446,1.198121927411096,0.24821683309557774,0.6368472880432072,1.0,8/18,22.54%,MCM9;NIPBL;ESR1;CHMP7;RAD21;SGF29;RUVBL2;WAPL
prerank,establishment of protein localization to organelle (GO:0072594),0.4135683060699357,1.1979181067917284,0.20227272727272727,0.6368651518233251,1.0,12/72,12.24%,MMP12;SYK;LAMP1;IPO5;E2F3;APPL2;TSPAN17;LAMP2;TPR;NUP50;TNPO1;APPL1
prerank,purine ribonucleotide transport (GO:0015868),0.5191739900244718,1.1975842745078218,0.2476060191518468,0.6372277661785384,1.0,7/16,19.80%,LRRC8D;ABCC4;LRRC8C;SLC25A42;SLC17A9;SLC19A1;SLC25A17
prerank,chemical homeostasis (GO:0048878),0.42474404220327716,1.19713664873721,0.20642201834862386,0.637930330985118,1.0,9/61,8.06%,PPARG;FBXW7;RBP1;NR1H3;TENT4B;IRS2;ZBTB20;NEDD4L;ABHD4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4829748526185026,-1.1965656734693202,0.23546511627906977,0.6226391352106082,1.0,4/11,17.09%,GTF2H2;ARRB2;GRK2;SAG
prerank,aorta development (GO:0035904),0.5477997621157098,1.196380729969125,0.24242424242424243,0.63961225360647,1.0,3/14,3.48%,APLNR;LRP1;TFAP2B
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.475213199569931,1.1959183249301197,0.2601307189542484,0.640398452751177,1.0,9/28,20.17%,ERN1;CEBPB;ATF4;DDIT3;BAX;QRICH1;TRAF2;BBC3;BRSK2
prerank,response to ionizing radiation (GO:0010212),0.41558781922910704,1.195742600368773,0.20449438202247192,0.640327780963418,1.0,16/70,15.39%,EYA1;GRB2;XRRA1;ANXA1;CDKN1A;TANK;GADD45A;BABAM2;BRCA1;XRCC4;SIRT1;INIP;DCUN1D3;INTS7;INO80;BRCC3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5803567836631448,1.1956229099269093,0.27246376811594203,0.6401042881304574,1.0,3/10,8.74%,RUNX3;SH3RF1;CBFB
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4924859225824402,-1.1953947960926938,0.27492447129909364,0.6232193846204548,1.0,3/10,11.43%,SEMA5A;CARMIL1;ACTN2
prerank,establishment of melanosome localization (GO:0032401),0.5019184083998015,1.1952872989688172,0.24929577464788732,0.6405287433190285,1.0,2/19,2.08%,MYO5A;MREG
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5668873724228878,1.19518603274469,0.254601226993865,0.640257768994175,1.0,3/11,9.18%,RFTN1;RIPK1;UNC93B1
prerank,response to molecule of bacterial origin (GO:0002237),0.41061148983922285,1.1950162797537065,0.21951219512195122,0.6401655625978456,1.0,23/69,23.10%,MAPKAPK3;IL6;LY96;IRAK3;FOXP1;HNRNPA0;ADAM17;LIAS;TAB2;FZD5;TNFAIP3;SLC11A1;ERBIN;SLPI;ACOD1;LBP;OTUD5;IFNAR1;GCH1;FCGR2B;TIRAP;JAK2;IRAK1
prerank,regulation of ruffle assembly (GO:1900027),0.49342268122144245,1.1947155454154288,0.25780189959294436,0.6404754475110489,1.0,4/23,7.70%,ARHGAP24;PLEKHM1;P2RX4;STAP1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.46284318753521514,-1.1946504162271827,0.2287390029325513,0.6227218593337757,1.0,6/13,31.26%,GTPBP1;RAB23;MFN1;ENTPD7;EFL1;AK4
prerank,negative regulation of JNK cascade (GO:0046329),0.46357661647049453,1.19412362903706,0.22857142857142856,0.6416630329190763,1.0,9/31,20.08%,TAOK3;NCOR1;AIDA;DUSP3;SIRPA;PRKN;FKTN;DNAJA1;DUSP10
prerank,muscle filament sliding (GO:0030049),0.4530432025000167,1.1939325726047978,0.22102747909199522,0.6410122648192237,1.0,5/38,10.90%,VIM;MYL2;MYBPC3;TPM3;TPM4
prerank,actin-myosin filament sliding (GO:0033275),0.4530432025000167,1.1939325726047978,0.22102747909199522,0.6410122648192237,1.0,5/38,10.90%,VIM;MYL2;MYBPC3;TPM3;TPM4
prerank,maintenance of blood-brain barrier (GO:0035633),-0.35501249225038045,-1.193877652770286,0.18357487922705315,0.6223609346094297,1.0,5/30,4.34%,SLC12A2;F11R;MBP;JAM2;WNK3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.4090054913695475,1.1938720696145138,0.18946188340807174,0.6405905150326412,1.0,18/72,15.09%,POLR2A;ERCC6;GPS1;RFC3;GTF2H5;RPS27A;UBC;POLR2L;ISY1;COPS5;DDB1;POLR2G;CDK7;POLR2I;CUL4A;COPS7A;PPIE;MNAT1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5775976680405027,1.1938615359846212,0.2686804451510334,0.6400330223906908,1.0,1/10,0.37%,PLA2G7
prerank,positive regulation of intracellular transport (GO:0032388),0.445651468840527,1.1938376230736376,0.22972972972972974,0.639504021598686,1.0,12/38,16.75%,KIF20B;RUFY3;DYNC1H1;SORL1;PGAP1;EIPR1;TPR;OAZ2;BCAS3;TENM1;RAB29;OAZ1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3739637864663517,1.1936853761763726,0.0920920920920921,0.6393573515781653,1.0,66/306,15.04%,B4GALT5;APOE;RBMS1;RPL3L;POLR2A;TNIP1;MCM9;EXT1;RFC3;IGF2BP3;BRIP1;E2F1;FAM111A;EEF1A1;AGO2;NFKBIB;RPL18A;RPS14;MRPL11;RPS11;HELB;RPS27A;ST3GAL4;MRPL23;RPL17;RPL23;DARS1;POLR2L;TOP1;BRCA1;EPC1;TAF1B;RPL36A;EIF4EBP2;TOPORS;COPS5;MRPS7;PAX8;RPL22;RPS21;RRBP1;POLR2G;POLL;MRPL32;POLR2I;MRPL36;DBF4;ING4;NBN;GTPBP2;SARS1;RPL10A;MRPL28;WRN;DHPS;RPS26;POLA1;RNASEH2A;MRPS21;SRBD1;GOLPH3;MRPL35;RPL15;RPL10;PWP1;ORC1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.38282851082004615,1.193342117707695,0.140973630831643,0.6397574122501622,1.0,40/172,18.20%,DDHD1;PIK3R5;MTM1;PIKFYVE;MTMR3;LPIN3;GPAT2;AGPAT4;PLD2;PLA2G2D;DGKZ;INPP4A;PTEN;CLN3;DGKA;GPD1L;FIG4;PIK3CA;PIK3C2G;SLC27A1;ABHD4;CSNK2A2;PLEKHA1;TAMM41;PCYT1A;PI4K2A;LPCAT3;DGKQ;CDS2;OCRL;INPP5F;GPD1;SLC44A2;GPAT3;PIP4K2A;DGKG;CSNK2A1;PTDSS1;ETNPPL;PITPNM1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.5031234395483863,1.1929508480357722,0.25100671140939596,0.6403163725218779,1.0,7/20,17.56%,MGST2;MTHFS;CNDP2;SLC27A1;HAGH;PTDSS1;OPLAH
prerank,lymphocyte differentiation (GO:0030098),0.40902223245625,1.1928224661796965,0.2119205298013245,0.6401325573198587,1.0,16/68,17.63%,ADGRG3;TPD52;ITGA4;MS4A1;LFNG;BLNK;ITGB1;ADAM17;RELB;DCAF1;JAK3;GPR89A;GPR89B;KLF6;CHD7;ZBTB7A
prerank,regulation of response to oxidative stress (GO:1902882),0.559786060205239,1.192797945805347,0.27575757575757576,0.6396228544572942,1.0,4/11,13.63%,ABCD1;AIFM2;MCTP1;PRKN
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5539648518615605,1.192397325595454,0.286144578313253,0.6402519968489808,1.0,5/11,15.83%,TENT4B;EXOSC3;DKC1;LARP7;EXOSC10
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3721039658384954,1.1921556155735304,0.043,0.6403614326424791,1.0,119/532,18.42%,CD300LF;CD36;SYK;GRB2;TIMP1;ANXA1;BCL2L11;STX3;GAB2;VEGFA;TEC;ST18;IRAK2;VIM;IL17RE;IFITM1;IL36G;CD44;SOS1;IL6;HGF;LCP1;TALDO1;ABL2;PRKCD;CDKN1A;FOXO3;PSMD1;IL10RB;RIPK1;TNFRSF1B;APPL2;IFNGR2;TRIM25;PIM1;STAT5B;SOCS6;ANXA2;IRS2;IFNAR2;RNASEL;MAOA;IRAK3;PIK3CA;PTAFR;CSF2RB;HMOX1;RPS27A;UBC;MSN;SLC27A1;F13A1;VAV1;MAP3K8;IRF2;IL20RB;IFITM2;IL5;IL6R;ITGB1;IL3RA;ADAM17;PTK2B;PITPNA;CFL1;FOXO1;SIRT1;BIRC3;PAK2;PSMF1;BAG4;MT3;PSMD14;NUMBL;TAB2;BST2;TRAF1;RORA;PSMD12;APPL1;IL15;CSF2RA;IL7R;RAPGEF1;TRAF3;SOX2;RELA;POU2F1;JUNB;IL4R;TRAF3IP2;SHC1;PSME2;SQSTM1;JAK3;CUL1;MCL1;CX3CL1;TRAF5;CBL;LBP;MYD88;CCL7;TRAF2;LTB;LTBR;IFIT2;BRWD1;CAPZA1;IFNAR1;HNRNPDL;TNFRSF14;PSMB10;PSMD5;UBE2V1;BIRC2;PSMD8;CASP3;PSMA3
prerank,mRNA catabolic process (GO:0006402),0.43790532477984784,1.1920073935826012,0.22424242424242424,0.6402374832844945,1.0,22/44,27.00%,DHX34;ERN1;DDX5;HSPA1B;ZFP36L2;EXOSC9;AGO3;NBDY;HSPA1A;RNH1;EXOSC10;THRAP3;AGO4;LSM5;ZC3H12D;XRN2;LSM6;ZFP36;RIDA;RC3H1;EXOSC4;TUT7
prerank,protein import into peroxisome membrane (GO:0045046),0.4913214267702063,1.1919827976126804,0.2733333333333333,0.6397276628853578,1.0,12/22,27.24%,RAB8B;ABCD1;PEX14;ALDH3A2;PXMP2;GDAP1;ACBD5;SLC25A17;PXMP4;ABCD2;PEX3;ABCD3
prerank,protein targeting to mitochondrion (GO:0006626),0.4267694292621747,1.1917867157714173,0.21303841676367868,0.6397190193031931,1.0,21/52,23.52%,CHCHD4;TIMM22;IMMP2L;PITRM1;TOMM20;TIMM17A;PMPCA;TIMM17B;GDAP1;HSPD1;PMPCB;TOMM34;HSPA4;TOMM7;TOMM22;FBXO7;BCAP31;MFN2;AIFM1;AIP;NDUFA13
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.4135481942231686,1.1916859322599807,0.19106145251396647,0.639417828945606,1.0,14/69,12.63%,SYK;IL6;TMEM106A;RIPK1;LY96;THBS1;SPHK2;CYBA;TYROBP;MAVS;ARHGEF2;APP;FZD5;ARFGEF2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.48785660350639604,1.1916142586251706,0.2522639068564036,0.6390609747927956,1.0,7/23,12.64%,GPS1;RPS27A;UBC;COPS5;DDB1;CUL4A;COPS7A
prerank,gene expression (GO:0010467),0.372765428202066,1.1915200632039897,0.07707707707707707,0.6387618641952324,1.0,88/348,17.05%,APOBEC1;RBMS1;RPL3L;DHX8;POLR2A;ATXN1;ALYREF;TNIP1;TFIP11;CPSF1;MPHOSPH10;RBM39;IGF2BP3;E2F1;CHTOP;SORL1;TSPAN17;EEF1A1;AGO2;NUFIP1;NFKBIB;RNASEL;RPL18A;HNRNPUL1;RPS14;MRPL11;RPS11;THOC1;HNRNPU;RPS27A;MRPL23;RPL17;RPL23;DARS1;RBPMS;POLR2L;WDR33;EPC1;TAF1B;RPL36A;EIF4EBP2;TOPORS;COPS5;MRPS7;TPR;PAX8;RPL22;RPS21;RRBP1;POLR2G;DKC1;NUP50;MRPL32;POLR2I;MRPL36;NCBP2;STUB1;DROSHA;SRSF3;THOC2;SARS1;DEDD2;RPL10A;DDX20;MRPL28;DHPS;TSPAN15;RPS26;UPF2;MRPS21;MRPL44;SRBD1;HNRNPD;GOLPH3;MRPL35;RPL15;RPL10;PWP1;ADARB1;RPSA;DDX39A;NUP98;HSPD1;EIF4A3;SYNCRIP;DHX38;MRPL43;RPL7
prerank,pigment granule transport (GO:0051904),0.5025133852239482,1.1914551013430332,0.24289772727272727,0.6378186422523899,1.0,2/18,2.08%,MYO5A;MREG
prerank,melanosome transport (GO:0032402),0.5025133852239482,1.1914551013430332,0.24289772727272727,0.6378186422523899,1.0,2/18,2.08%,MYO5A;MREG
prerank,sphingolipid catabolic process (GO:0030149),0.5259432728926511,1.1912430620388472,0.2682926829268293,0.6378808490646819,1.0,3/15,4.22%,SGPL1;GLA;PPT1
prerank,cobalamin metabolic process (GO:0009235),0.5089116423305311,1.1909661226746504,0.2513812154696133,0.6380828353837681,1.0,4/17,18.34%,MMAB;LMBRD1;MTRR;ABCC1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4986466770683807,1.190811054226513,0.2695883134130146,0.6379741770872203,1.0,4/21,10.64%,CTSL;CBFB;ROCK1;MAFG
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.31830203962061343,-1.1905070091953722,0.16783216783216784,0.628790644567833,1.0,14/52,9.80%,RBFOX1;RBFOX2;NOVA1;KHDRBS2;SRSF6;RBFOX3;SRRM4;KHDRBS3;FMR1;KHDRBS1;RBM8A;REST;RBMX;CELF2
prerank,negative regulation of heart contraction (GO:0045822),-0.4749373088656894,-1.1904781966122275,0.24404761904761904,0.626506864407366,1.0,5/11,18.41%,ATP1A2;SPTBN4;GRK2;PIK3CG;FKBP1B
prerank,regulation of Wnt signaling pathway (GO:0030111),0.39518710644989385,1.1904524750621408,0.1980728051391863,0.638468026565251,1.0,30/108,19.02%,MDFIC;CTNNB1;FOXP3;GNAQ;LRP1;GSKIP;SULF2;FOLR1;CBFB;FZD7;ESR1;APP;WLS;APCDD1;SULF1;ITGA3;MACF1;ATP6V0C;TNFAIP3;PRKN;PPP1CA;KREMEN1;ATP6AP2;DEPDC1B;CDC73;WWOX;CSNK2A1;SNX3;PPP2CA;RNF43
prerank,intracellular protein transport (GO:0006886),0.37684249422871224,1.1904451578665505,0.07028112449799197,0.6379174239251246,1.0,89/304,22.22%,MMP12;KIF13B;SYK;TLK1;STX3;SNX8;ACD;IPO5;TBC1D22A;SNX27;RIC1;TBC1D25;RAB20;RAB7A;TBC1D1;E2F3;TBC1D2;CTSA;RANGRF;SNX9;TBC1D12;APPL2;HOMER3;SORL1;RAB21;STX8;STAM;TBC1D10A;COG7;STX5;RAB3GAP2;TBC1D2B;RAB31;RAB1B;LAMP2;TECPR2;TICAM2;RAB28;VPS33A;UNC93B1;STX11;TPR;SIL1;TBC1D22B;NUP50;ARHGEF2;RAB18;TBC1D15;TNPO1;WLS;STXBP3;RAB24;APPL1;AP3D1;RAB43;ARL4C;STX6;AP3B1;SNF8;SNX17;TBC1D9;RABGAP1;RAB29;GGA2;RAB22A;ARF4;VPS29;AP4M1;ARF5;STXBP2;NUP88;ARL5B;SEC31A;XPO1;RAB1A;SGSM2;VPS36;CSE1L;NUP188;GGA3;PREB;RPGR;PPP1R10;TBC1D4;DNAJC27;GIPC1;RPAIN;VPS35;SNX13
prerank,organelle organization (GO:0006996),0.3747205929727882,1.1902830710065704,0.05805805805805806,0.6378268641172669,1.0,100/388,18.60%,ARHGAP21;ARHGAP10;APOE;OPTN;PLEKHM2;PIKFYVE;PALLD;FGD6;NEDD9;DIAPH1;MREG;RAB7A;ZMYM6;ABCD1;KIF9;PLD2;ATP8B4;PEX11A;YTHDF3;SYNE3;LONP1;NPLOC4;GAK;PEX7;WDPCP;COG7;CHMP2A;POLG2;PEX14;SH3KBP1;VMP1;RAB31;VPS13D;KIF3A;ABCA3;AFG1L;HPS6;KLHL20;GABPB1;PDCD6IP;TICAM2;VAPA;HUWE1;CAPZB;TNIK;VPS4A;CYCS;FAF2;CFL1;RAB18;VPS13C;BCAS3;CHMP6;TRIP11;PLAAT3;SPRYD3;PI4K2A;CFAP410;VPS51;LONP2;MICAL2;FGD5;POLRMT;PPRC1;RAB43;ATL2;ATAD3A;SSBP1;DYM;ATP8B1;EPS15;LIMD1;TNFAIP3;PRKN;CLASP1;MAST4;ATL1;PHIP;VPS11;GOLPH3;FGD3;WASL;GOLPH3L;ATP7A;TWNK;CCL7;SH3D19;SIRT3;RAB2A;RAB29;BRWD1;COG2;CHMP5;TFB2M;CHMP7;GABPA;KIF5C;RANBP9;TMEM135;HTT
prerank,negative regulation of MAP kinase activity (GO:0043407),0.44054163652252554,1.1901763540521741,0.22526817640047675,0.6375507841072761,1.0,6/44,6.37%,APOE;CD300A;PRKCD;AIDA;SORL1;IRAK3
prerank,negative regulation of B cell activation (GO:0050869),0.48489482258493644,1.1900489854829632,0.24897400820793433,0.6373744518350185,1.0,7/21,19.77%,CD300A;ID2;PARP3;TYROBP;TNFAIP3;TNFRSF21;FCGR2B
prerank,positive regulation of phospholipid transport (GO:2001140),0.582032619848025,1.1899117093270364,0.28678678678678676,0.6372178981263583,1.0,2/10,7.78%,APOE;ABCA3
prerank,positive regulation of cell population proliferation (GO:0008284),0.3712717639424226,1.189814698193006,0.047,0.6369005161157018,1.0,75/423,14.86%,HTR2B;HPSE;CDCA7L;SDCBP;NAMPT;TIMP1;SLC35F6;PRKCH;GCNT2;ADRA1D;STX3;GAB2;VEGFA;AQP1;KIF20B;KDM4C;ID2;IL6;CDKN1A;TFAP2B;PDGFA;TCIRG1;SRPK2;RARA;PTEN;PID1;E2F1;CHTOP;PIM1;IGF1;FGFR4;MVD;CUL3;THBS1;IRS2;COPS9;SIRT6;DOT1L;HNRNPU;CACUL1;HMOX1;RPL23;FOLR2;SOX9;FOXP1;CTSH;CNOT6L;IL6R;VIPR1;WDR77;CNOT7;ADAM17;PTK2B;POU3F3;SIRT1;RBPMS2;CCN1;BST2;CDC123;NOTCH1;TBX6;IL15;MAZ;S100A6;HCLS1;IL7R;DHPS;RELA;GAS6;DERL2;GDNF;SHC1;PHIP;CX3CL1;CNOT6
prerank,regulation of protein modification process (GO:0031399),0.42918206669545583,1.1893569785343563,0.23140495867768596,0.6376956561586556,1.0,13/50,16.19%,FNIP2;ATG7;FNIP1;CORO1C;SESN2;ATG10;FLCN;ABCA2;PUM3;MT3;PHIP;FKTN;CCDC88C
prerank,acylglycerol metabolic process (GO:0006639),0.4475834852335342,1.1893533423353964,0.24171779141104294,0.6371316383328569,1.0,9/37,17.90%,APOE;MGLL;DGKZ;DGKA;PLAAT3;DGKQ;DGKG;GK5;LYPLA2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4310823935731526,-1.1893465967721035,0.22039473684210525,0.6270346373346141,1.0,4/16,3.74%,ANK2;CACNA1C;ATP1A2;RYR2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.38707140028595255,1.1892038679431987,0.14887063655030802,0.6370349620896186,1.0,54/158,24.46%,HTR2B;LITAF;TFRC;IKBKE;PLK2;TMEM106A;ANKRD17;RIPK1;TRIM25;REL;HMOX1;AKAP13;TICAM2;VAPA;MAVS;MIB2;BIRC3;TAB2;BST2;WLS;PRKCB;ROR1;RELA;GOLT1B;PRKN;TRAF3IP2;CX3CL1;TRAF5;SLC44A2;MYD88;GPR89A;TRAF2;ZDHHC17;LTBR;TRIM14;UBE2V1;BIRC2;CARD11;TBK1;PELI2;SHISA5;EEF1D;TIRAP;FKBP1A;MALT1;ALPK1;IRAK1;BCL10;FLNA;TRAF6;TFG;NDFIP1;TERF2IP;CASP8
prerank,tetrapyrrole metabolic process (GO:0033013),0.49937060564912833,1.1889331887399475,0.24931880108991825,0.6372060137046587,1.0,4/18,18.34%,MMAB;LMBRD1;MTRR;ABCC1
prerank,neurogenesis (GO:0022008),0.44202571948164443,1.1881357707374423,0.21505376344086022,0.638874649920482,1.0,8/43,11.70%,CXCR4;ANXA1;ERCC6;CLN5;RITA1;BTBD1;WDR62;THOC2
prerank,regulation of fat cell differentiation (GO:0045598),0.4082344675035359,1.1880218515911347,0.2028985507246377,0.638667082649522,1.0,13/74,11.94%,PPARG;CEBPB;ID2;IL6;ASXL2;ENPP1;E2F1;ZFP36L2;FTO;FOXO1;SIRT1;PPARD;RORA
prerank,innate immune response in mucosa (GO:0002227),0.5773602828947153,1.1877915066043117,0.27217125382262997,0.6387423668710388,1.0,2/10,17.91%,RNASE3;DEFA6
prerank,diol biosynthetic process (GO:0034312),0.5288446052537479,1.1877077165833358,0.2552891396332863,0.6383881972527018,1.0,6/15,19.18%,SPTLC2;SPHK2;ABCA2;ACER2;GCH1;ASAH1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4730196170504099,1.1868607377289493,0.25559947299077734,0.6403152824394392,1.0,6/28,4.97%,PRKCD;ENPP1;APPL2;PID1;SLC27A4;PTPRE
prerank,positive regulation of nervous system process (GO:0031646),-0.40858408336111574,-1.1867530213027777,0.22137404580152673,0.6314121770525355,1.0,9/18,14.58%,RIMS1;RIMS2;PARD3;TPPP;MYRF;CST7;TENM4;ATPSCKMT;DICER1
prerank,regulation of macrophage activation (GO:0043030),0.4634922628853006,1.1866942387013548,0.2490170380078637,0.6402567536906109,1.0,6/30,7.28%,GPR137B;NR1H3;IL6;SHPK;THBS1;MFHAS1
prerank,positive regulation of ERAD pathway (GO:1904294),0.5417663634336555,1.1863908651022375,0.28088235294117647,0.6405357343956481,1.0,8/13,27.95%,NFE2L2;UBQLN2;SGTA;ATXN3;BCAP31;HERPUD1;RNFT1;RNF185
prerank,regulation of protein export from nucleus (GO:0046825),0.4860212127535272,1.1862285902003926,0.24142480211081793,0.6404276472171674,1.0,10/23,19.92%,ANP32B;GTSE1;TPR;GSK3B;SIRT7;GAS6;UHMK1;CAMK1;RBM22;TCF7L2
prerank,nucleotide-excision repair (GO:0006289),0.392984059500544,1.1861028873799349,0.18211206896551724,0.6402373806646614,1.0,22/101,13.60%,POLR2A;ERCC6;GPS1;RFC3;GTF2H5;BRIP1;RPS27A;UBC;POLR2L;RAD23A;ISY1;COPS5;DDB1;POLR2G;SIRT1;POLL;CDK7;POLR2I;CUL4A;COPS7A;PPIE;POLA1
prerank,response to organophosphorus (GO:0046683),0.5268531768805561,1.1859094705074968,0.2703488372093023,0.6402157054881799,1.0,4/16,13.22%,P2RX4;RFC3;TRPC3;DGKQ
prerank,exit from mitosis (GO:0010458),0.5520346284269737,1.1858771774099957,0.2734375,0.6397454841848407,1.0,7/12,23.55%,CHMP2A;SIRT7;CTDP1;CLASP1;CHMP7;UBE2S;EPS8
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4138566858912971,1.1856679900595315,0.21380846325167038,0.6397772254025595,1.0,15/75,14.94%,APOE;CD300A;IPO5;PRKCD;PTEN;SLC8A1;SORL1;GADD45A;IRAK3;APC;RB1;SIRT1;STK38;LRP6;LATS1
prerank,cellular component assembly (GO:0022607),0.3747754639875441,1.1847073275989648,0.12399193548387097,0.6420323628713702,1.0,71/253,21.03%,FBLIM1;LIMA1;REPS2;NEDD9;MITF;ACD;DNAJB13;SPEF1;BAIAP2;SKAP2;LCP1;FAS;RHOJ;PDGFA;CCDC40;SNX9;YTHDF3;HAS3;ZFYVE27;CAPG;LPXN;PARVB;CREBBP;APC;DET1;PEX14;VMP1;DARS1;ABCA3;SOX9;RTN3;DVL1;VCPIP1;PICALM;QSOX1;PPIH;RHOD;PTK2B;TOGARAM1;PLS3;TUBGCP4;TRAF1;EPRS1;SLC2A1;SPAG17;GAS6;VAMP3;WASL;MNAT1;CD247;RTN4;NLGN2;FANCA;TRAF2;MYO9A;KPNA3;CAPZA1;RANBP9;NOC2L;RAD21;TAPBP;CORO1B;KMT2A;MICAL1;AFG3L2;ACTG1;VAMP2;PPP2R1A;PAWR;HES5;ARL6IP1
prerank,protein K48-linked ubiquitination (GO:0070936),0.42544516957008255,1.184687820538811,0.21914648212226068,0.6415271575877586,1.0,23/54,25.99%,ZNRF1;UBE2Q2;CUL3;UBE2K;BFAR;NEDD4L;RNF115;RNF146;TOPORS;ARIH2;RNF34;TNFAIP3;PRKN;CDC34;AMFR;UBE2R2;UBE2H;UBE2D3;KLHL3;TTC3;UBE2E1;UBR5;UBE2G1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.4028041013385297,1.184594299481275,0.20238095238095238,0.6412240399930191,1.0,20/84,17.88%,PLPP3;SASH1;VEGFA;PDPK1;P2RX4;NRP2;THBS1;FOXP1;BMPR2;ADAM17;PTK2B;SIRT1;ATP5F1A;BCAS3;GPLD1;RRAS;GRN;NRP1;TEK;AAMP
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4705028756606012,1.1842726815206628,0.2595520421607378,0.6415299699114099,1.0,9/26,16.53%,FLOT1;NR1H3;NINJ1;CYBA;MFHAS1;TICAM2;RTN4;LBP;TLR1
prerank,neurotransmitter uptake (GO:0001504),-0.44619835610690517,-1.1842164001045616,0.25748502994011974,0.635673390493981,1.0,3/12,5.23%,SLC1A3;ATP1A2;SNAP25
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4690349991490392,-1.1840212342732,0.24362606232294617,0.6338707271296802,1.0,5/12,23.37%,CD80;IL18;CARD9;RASGRP1;IL1B
prerank,mitochondrial protein processing (GO:0034982),0.5584546772187549,1.1837676421996133,0.2808641975308642,0.6424051685799191,1.0,5/11,20.09%,IMMP2L;PMPCA;OMA1;PMPCB;AFG3L2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.4082386040995239,1.1829392837213488,0.19200887902330743,0.644205878516324,1.0,15/73,12.63%,SYK;IL6;TMEM106A;RIPK1;LY96;THBS1;ADAM8;SPHK2;CYBA;TYROBP;MAVS;ARHGEF2;APP;FZD5;ARFGEF2
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5456507245717742,1.1828500287362163,0.2767203513909224,0.6439096360159898,1.0,5/13,22.37%,IRX3;SLC8A1;SRI;CALM2;PDE4D
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5342368976203726,1.1826979491041738,0.276218611521418,0.6437942855005986,1.0,2/13,7.63%,ARG1;PRODH
prerank,cellular response to zinc ion (GO:0071294),0.5283093014085566,1.1826922968389026,0.2657856093979442,0.6432453585298138,1.0,10/15,20.67%,P2RX4;MT3;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,vitamin transport (GO:0051180),0.46471842966187216,1.1824577753882215,0.2518610421836228,0.6433642311032962,1.0,8/29,19.48%,FOLR2;FOLR1;SLC27A1;SLC25A32;SLC23A1;SLC52A1;SLC19A1;SLC19A2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5201279093846497,1.1823507716981907,0.2727272727272727,0.6431158690620169,1.0,2/15,5.83%,AK8;ENTPD1
prerank,positive regulation of binding (GO:0051099),0.3986984689401723,1.18220226692471,0.19803063457330417,0.6429808437231881,1.0,12/84,11.47%,PPARG;APOE;FLOT1;TXN;LRP1;CLN5;RARA;IGF1;STK3;HIPK2;GSK3B;APP
prerank,mitochondrion morphogenesis (GO:0070584),0.5607984587849705,1.181594435224199,0.2709284627092846,0.6441590811731839,1.0,2/11,4.84%,MTM1;PID1
prerank,glucose import (GO:0046323),0.5462744180096598,1.1815097452258219,0.29333333333333333,0.6438142006980887,1.0,3/13,12.33%,SLC27A4;SLC27A1;SLC2A1
prerank,polyol metabolic process (GO:0019751),-0.3201687495392007,-1.1814211612945993,0.16875,0.6380579532420799,1.0,12/46,11.08%,INPP4B;INPP5D;PLCB1;IP6K2;IMPA1;PPIP5K1;PLCH1;ITPK1;PLD4;ITPKC;NUDT3;MINPP1
prerank,cellular response to cytokine stimulus (GO:0071345),0.36837433720448404,1.181356781467456,0.07707707707707707,0.6436627039868613,1.0,84/416,14.82%,CD36;CXCR4;SYK;GRB2;TIMP1;NFE2L2;ANXA1;BCL2L11;STX3;GAB2;VEGFA;TEC;SIGIRR;IRAK2;VIM;IL36G;SOS1;IL6;HGF;ABL2;CDKN1A;FOXO3;TANK;DAPK1;IL10RB;RIPK1;TNFRSF1B;IFNGR2;SHPK;PID1;PIM1;HTRA2;STAT5B;SOCS6;IFNAR2;UBE2K;MAOA;IRAK3;PIK3CA;PTAFR;CSF2RB;PTPN12;HNRNPU;GBP6;HMOX1;RPS27A;UBC;ZFP36L2;SOX9;BRCA1;F13A1;VAV1;SIRPA;IL20RB;IFITM2;IL5;TPR;IL6R;ITGB1;IL3RA;GSK3B;FOXO1;SIRT1;ARHGEF2;BAG4;NUMBL;EPRS1;RORA;CSF2RA;ZFAND6;HCLS1;RAPGEF1;SOX2;RELA;GAS6;POU2F1;JUNB;IL4R;ERBIN;ACOD1;SHC1;JAK3;MCL1;CX3CL1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5144150244797763,1.1812603995622883,0.27311522048364156,0.643372862218042,1.0,4/17,6.69%,NCOR1;PID1;PPIF;FLCN
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5693782524359614,1.1811156151608224,0.27786032689450224,0.6432606833409056,1.0,2/11,2.06%,LILRB1;FOXP3
prerank,adenine nucleotide transport (GO:0051503),0.5079241803680707,1.1808638478189735,0.25895316804407714,0.6434164509040049,1.0,7/17,19.80%,LRRC8D;ABCC4;LRRC8C;SLC25A42;SLC17A9;SLC19A1;SLC25A17
prerank,respiratory tube development (GO:0030323),0.4740865386302455,1.180863842152911,0.2584415584415584,0.6428564713993017,1.0,5/28,12.72%,STRA6;VEGFA;CCDC40;ABCA3;ITGA3
prerank,programmed necrotic cell death (GO:0097300),0.5047516239671269,1.180553033553392,0.25630252100840334,0.643173767079429,1.0,5/18,13.47%,RIPK1;LY96;PPIF;TICAM2;TRPM7
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.5015221763226825,1.1804990996311924,0.26379542395693134,0.6427565633814508,1.0,12/19,24.59%,FBXW7;HTRA2;CSNK2A2;FZD5;VDAC1;PRKN;USP36;HTT;FBXO7;SREBF1;HAX1;ATP13A2
prerank,positive regulation of heart rate (GO:0010460),0.4937011465371014,1.1804422075031757,0.2662162162162162,0.6423785850577745,1.0,2/17,1.52%,ADRA1D;ADRA1A
prerank,negative regulation of cell cycle process (GO:0010948),0.41436193243526365,1.1800956815989567,0.22435174746335965,0.6427992428858018,1.0,26/61,24.52%,TOM1L2;APAF1;FOXO4;E2F1;EED;CHMP2A;UXT;BRCA1;EPC1;ZFYVE19;TERF1;VPS4A;CBX3;RBBP7;CCP110;AURKAIP1;FBXO5;MGA;EHMT2;PPP1R10;CBX5;WAPL;TFDP1;PHC3;RNF2;PCGF6
prerank,regulation of cellular component movement (GO:0051270),0.42288353755395,1.1798621897875992,0.22695035460992907,0.642906334051801,1.0,13/49,13.76%,DIAPH1;VEGFA;ABL2;RAF1;ACTN1;ARAP1;ARHGAP18;ROCK1;ADAM17;PKN2;FES;NRG4;INPP5F
prerank,negative regulation of protein phosphorylation (GO:0001933),0.38671226738899617,1.1798066493867296,0.16305469556243551,0.6425131329562839,1.0,25/150,11.33%,PLPP3;XDH;DTNBP1;NCK2;CORO1C;GNAQ;PRKAG2;PDPK1;PRKCD;ENPP1;PTEN;PID1;TAF7;GPD1L;GSKIP;PPEF2;RB1;CNKSR3;SIRPA;DVL1;CEP85;NLRP2B;SNX25;PAK2;FBLN1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.42657557038769595,1.1797675364349514,0.21403508771929824,0.6420724292698162,1.0,18/52,24.34%,IDH1;MTHFS;D2HGDH;SDHAF3;FOLR2;SLC25A32;SDHA;MTHFD1L;ME2;ALDH18A1;OGDH;MTRR;SLC19A1;MDH1;IDH2;ACOT8;GOT1;SHMT2
prerank,neuromuscular process controlling balance (GO:0050885),-0.45540037759539254,-1.1796435736892004,0.2682926829268293,0.6404893173844542,1.0,4/12,3.63%,PCDH15;NRXN1;CDH23;MYO7A
prerank,RNA processing (GO:0006396),0.374735972141315,1.1795951508825622,0.15188583078491336,0.6419935465750066,1.0,42/176,15.35%,APOBEC1;RBMS1;DHX8;ATXN1;TFIP11;MBNL1;SRPK2;MPHOSPH10;SCAF11;CELF1;RBM39;TENT4B;RNPC3;NUFIP1;TCERG1;RNASEL;HNRNPUL1;CSTF3;THOC1;HNRNPU;PRPF8;RBPMS;PPP1R9B;SNRNP25;TENT2;HNRNPA0;DKC1;PRPF6;DDX23;NCBP2;DROSHA;ZMAT5;SF3A3;DEDD2;SNRNP35;DDX20;RSRC1;SNRPF;MRPL44;HNRNPD;ADARB1;ZRSR2
prerank,phospholipid translocation (GO:0045332),0.467967099884166,1.1794436876616932,0.27409261576971217,0.6418417599070307,1.0,4/28,4.27%,ABCA1;PLSCR4;ANO6;ATP8B4
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4112352736474417,1.1793454334849534,0.22297297297297297,0.6415505105409967,1.0,24/63,24.46%,LGALS3;FAS;BIRC6;RIPK1;IGF1;THBS1;SH3RF1;PAK2;TRAF1;DEDD2;RELA;PHIP;WWOX;BID;TRAF2;LTBR;HTT;TCF7L2;ITGAV;SIAH2;PSME3;BCL10;BCL2L12;CASP8
prerank,response to peptide hormone (GO:0043434),0.4342497234384089,1.1788000236217668,0.23990498812351543,0.6426068991361147,1.0,13/43,20.60%,ANXA1;STAT5B;EIF6;SLC27A1;ROCK1;SIRT1;CRY1;EIF2B2;CREB1;EPM2AIP1;ZBTB7B;STAT6;OGT
prerank,regulation of filopodium assembly (GO:0051489),-0.34369048558369575,-1.1783204224670354,0.17647058823529413,0.6415068837949303,1.0,9/38,8.61%,TENM2;GPM6A;NLGN1;PLPPR5;RIPOR2;ARHGAP44;FMR1;TRPM2;AGRN
prerank,epithelial cell migration (GO:0010631),0.44101215646618286,1.1781315280544173,0.25123762376237624,0.643947543257631,1.0,8/37,10.75%,PLXND1;ZEB2;PKN3;LPXN;PIK3CA;FSTL1;ROCK1;PKN2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.46567321532256334,-1.1780893504894208,0.284375,0.6397388035675935,1.0,3/11,7.31%,USP7;ATP9A;MAP2K1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.49919206978389286,1.177809777346037,0.2630098452883263,0.6443041189943036,1.0,6/18,12.72%,ABL2;CUL3;FLCN;DLC1;CCDC125;ITGA3
prerank,B cell mediated immunity (GO:0019724),0.5718870222258133,1.177189339117496,0.28593272171253825,0.6454857899307266,1.0,1/10,0.91%,TLR8
prerank,mitotic sister chromatid segregation (GO:0000070),0.3965744999215156,1.1770068570164995,0.2017075773745998,0.645431919605463,1.0,28/98,21.40%,NCAPG2;SPDL1;PIBF1;CUL3;NCAPG;CHMP2A;NIPBL;EML3;RB1;PDCD6IP;SMC1A;CSNK2A2;BOD1;SMC2;VPS4A;CHMP6;INO80;CHMP5;CSNK2A1;CHMP7;RAD21;PHF13;MCPH1;SGO1;NCAPD2;PDS5A;NCAPH;CHMP2B
prerank,protein O-linked glycosylation (GO:0006493),0.3915743466837732,1.1769038704263188,0.21753246753246752,0.6451762746085075,1.0,15/96,14.55%,B4GALT5;B3GNT8;GALNT3;DPM2;GALNT6;GALNT9;TET3;B3GALNT2;ST3GAL4;GXYLT2;TET2;OGA;TMTC4;POFUT2;FKTN
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.44490437270323063,1.1768578059331336,0.2628992628992629,0.6447538743794241,1.0,5/34,8.03%,NSMCE2;CD28;IGF1;CUL3;RB1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4049697596412028,1.1767999443441746,0.2224744608399546,0.6443595978696268,1.0,17/72,16.18%,ABCA1;APOE;SYNPO2L;ABL2;MYO9B;RAF1;CUL3;FLCN;AKAP13;DLC1;CCDC125;ARHGEF2;ITGA3;COL3A1;LPAR6;ARRB1;NRP1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4155416267555384,-1.176799649238777,0.256140350877193,0.6405686569359356,1.0,5/17,11.03%,SLC9A9;SLC12A2;TRPM4;SLC6A1;HCN2
prerank,cellular response to ATP (GO:0071318),-0.4322111278151018,-1.1767068138394503,0.2677966101694915,0.6384978123461585,1.0,3/14,6.69%,P2RY12;RYR3;HSP90B1
prerank,negative regulation of macroautophagy (GO:0016242),0.4718099349915081,1.1764709235114441,0.24518613607188702,0.6447687418005335,1.0,7/26,17.73%,MTM1;PIK3CA;QSOX1;USP36;RUBCN;TMEM39A;PHF23
prerank,carbohydrate transport (GO:0008643),0.5533130881021638,1.1764219882478704,0.302496328928047,0.6443786565369999,1.0,4/11,19.45%,AQP1;SLC23A2;SLC23A1;SLC50A1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.40851565548168894,1.1750569046996437,0.21585903083700442,0.6477245712053422,1.0,18/72,17.90%,SYK;SIGIRR;IRAK2;RIPK1;IFNGR2;IFNAR2;RNASEL;IRAK3;HIPK1;CBFB;BIRC3;TRAF1;TAX1BP1;GAS6;TNFAIP3;TRAF2;PTPN1;BIRC2
prerank,epidermal cell differentiation (GO:0009913),0.43773616370436574,1.1748304105905136,0.25555555555555554,0.6478188548216325,1.0,3/41,2.89%,ANXA1;CTNNB1;ADAM9
prerank,response to prostaglandin E (GO:0034695),0.5654415673347756,1.1746161633846015,0.2861491628614916,0.6478672126495947,1.0,2/10,9.83%,PTGER2;PTGER4
prerank,regulation of cell differentiation (GO:0045595),0.38259439958688385,1.1736760995227424,0.18442622950819673,0.6499740319486857,1.0,24/148,10.81%,LGALS3;SLC6A6;HOPX;TRPS1;CEBPB;RUNX2;ID2;TFAP2B;RUNX3;RAF1;DAG1;SMYD5;SIK1;DDX5;CREBBP;KLHL41;APC;ATF4;ANP32B;SNAI2;CBFB;ROCK1;MAFB;FES
prerank,organelle fission (GO:0048285),0.47642895910709887,1.173216021923096,0.27140974967061926,0.6506864465147055,1.0,6/24,13.63%,CORO1C;PEX11A;MTFR1L;MTFP1;GDAP1;PRKN
prerank,negative regulation of transport (GO:0051051),0.429483132451008,1.171673234514472,0.23826291079812206,0.6545262954591524,1.0,12/51,13.63%,LGALS3;LILRB1;RAB7A;NR1H3;PTEN;TRAT1;WWP2;SIRPA;SNX33;BST2;MCTP1;PRKN
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4961424134998148,1.1716325026630547,0.2833562585969739,0.6541030447732016,1.0,7/20,24.00%,IPO5;PTEN;APC;LATS1;CEBPA;MEN1;NR2F2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3809330307986779,1.170773461775811,0.16666666666666666,0.6560124950433756,1.0,24/151,16.18%,GPNMB;CD36;HTR2B;APOE;GCNT2;ADRA1A;FBXW7;CD44;PDGFA;NOTCH2;FGFR4;MFHAS1;PTK2B;MT3;APP;NOTCH1;ROR1;TREM2;GAS6;SHC1;CX3CL1;ARRB1;CCL7;NRP1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.5067872703138968,1.1703896333043036,0.2727272727272727,0.6565448690537236,1.0,5/18,17.17%,CD300A;B4GALT7;NLRC3;CDC73;FTH1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5413913063507079,1.1701640051155429,0.29154078549848944,0.6566240327977949,1.0,3/12,5.81%,ABCD1;MTLN;IRS2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3775040038486686,1.1698105665305951,0.17333333333333334,0.6570387272840256,1.0,40/163,19.69%,CD38;RFTN1;SYK;VAV3;TEC;PRAM1;CD28;PDPK1;PSMD1;SPG21;CD3D;MS4A1;TRAT1;PIK3CA;DENND1B;BLNK;PLEKHA1;SH2B2;PAK2;PSMF1;PSMD14;TAB2;PRKCB;PSMD12;BTK;RELA;PSME2;CUL1;CD247;PSMB10;PSMD5;EIF2B2;PSMD8;CARD11;PSMA3;TNFRSF21;PIK3CB;PSMA2;PSMD11;LAT2
prerank,cellular response to peptide (GO:1901653),0.4211280496414154,1.169744028376617,0.2540792540792541,0.6566815185675882,1.0,11/56,12.33%,CD36;VIM;LRP1;ITGA4;IGF1;RPL23;GSK3B;ARHGEF2;APP;TRIM41;TREM2
prerank,regulation of interferon-beta production (GO:0032648),0.4236169407664494,1.1695161670447667,0.25529411764705884,0.6567647290213537,1.0,10/46,13.14%,TLR8;LILRB1;FLOT1;RNF135;REL;SIRPA;MAVS;NLRC3;RELB;TRAF3
prerank,regulation of cytoskeleton organization (GO:0051493),0.3919721772942618,1.168937804360443,0.21868365180467092,0.6579385590444959,1.0,20/108,12.04%,IQGAP2;IQGAP1;DIAPH1;SPEF1;BAIAP2;LRP1;SORBS3;PRKCD;PDGFA;CLN3;CAPN2;DLC1;ARHGAP18;ARHGAP17;ROCK1;GSK3B;RHOD;PAK2;BST2;CDK2AP2
prerank,vesicle transport along microtubule (GO:0047496),0.4757464007015575,1.1688394507355502,0.27236315086782376,0.6576755822444849,1.0,9/23,19.76%,FYCO1;DYNC1H1;CLN3;KIF3A;NDE1;KIF5B;PAFAH1B1;HTT;RAB1A
prerank,cellular response to growth factor stimulus (GO:0071363),0.37939109389260345,1.1679653229340201,0.17628865979381445,0.6597597530721695,1.0,30/151,13.30%,IQGAP1;ANXA1;CTNNB1;ERN1;VEGFA;RUNX2;CD44;HGF;PDPK1;KIDINS220;APPL2;MAP2K5;HTRA2;MAPK7;EEF1A1;STAT5B;DUSP3;NR3C1;PTPN12;ZFP36L2;SOX9;ACVR2A;SNAI2;ACVRL1;BMPR2;NOTCH1;ACVR1B;APPL1;RAPGEF1;RELA
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.3891946169526598,-1.1678387525680416,0.25572519083969464,0.6593754441814873,1.0,5/22,6.14%,CASK;FGFR2;SRSF6;EPB41L4B;PRKD1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.45126528971872376,1.1676803906329623,0.25406758448060074,0.6599844584643452,1.0,11/35,19.22%,ARHGAP24;ABL2;CUL3;FLCN;DLC1;CCDC125;LZTR1;ITGA3;MAPKAP1;TNFAIP1;STAMBP
prerank,regulation of macromolecule metabolic process (GO:0060255),0.38166466717518643,1.167332241707358,0.18730808597748208,0.6604547044546996,1.0,31/170,15.47%,APLNR;APOE;AFF1;MTMR3;TFEB;FLOT1;TMPRSS4;C1D;AFF4;COQ7;KIF16B;HNRNPAB;TRIM17;IGF2BP3;SLC8A1;IGF1;SCARB2;SIRPA;FOXP1;MEFV;LAMTOR1;APP;TREM2;SOX2;GDNF;PRDM2;HNRNPD;ZNF513;ZFP64;TOB2;PCBP1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.4373316398369053,1.1669176780962216,0.2589395807644883,0.6610561314187914,1.0,6/39,5.58%,NFE2L2;ANO6;PDPK1;ITGA4;MAPK7;THBS1
prerank,central nervous system neuron development (GO:0021954),0.5132906613901054,1.1668862027421099,0.302158273381295,0.6605886409573244,1.0,3/15,5.70%,B4GALT5;PTEN;B4GALT6
prerank,negative regulation of neurogenesis (GO:0050768),0.4471795552197234,1.1668758560358543,0.2661596958174905,0.6600629950329161,1.0,6/34,5.04%,HOOK3;RUFY3;IL6;APPL2;PTEN;SORL1
prerank,pore complex assembly (GO:0046931),0.4971663587028,1.1667341532927933,0.2913165266106443,0.6599123671357869,1.0,11/19,24.83%,ANO6;PDZD11;TPR;RTN4;NUP98;TMEM170A;ADAM10;NDC1;GSDMD;AFDN;TSPAN33
prerank,cellular response to cadmium ion (GO:0071276),0.4734422816274887,1.1666398446974968,0.27225130890052357,0.6596321928524623,1.0,11/24,20.67%,JUN;MT3;NCF1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,aminoglycan biosynthetic process (GO:0006023),0.42004645065230073,1.1664999047132159,0.2557603686635945,0.6594614281324266,1.0,9/49,8.86%,B3GNT8;GCNT2;XYLT1;NDST1;EXT1;UGDH;B4GALT7;HEXA;HS2ST1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.36929445390853705,1.1663610985317485,0.12048192771084337,0.6593315517160119,1.0,112/314,24.76%,NFE2L2;CTNNB1;ZNRF1;WWP1;FBXW7;PSMD1;ZFAND2A;FBXL17;TRIM25;UBXN8;ANAPC1;SPSB4;CUL3;NPLOC4;FAM8A1;UBE2K;FBXL3;RPS27A;UBC;NHLRC1;BFAR;NEDD4L;RB1;KLHL20;WWP2;RAD23A;DCAF12;TMUB2;TOPORS;SPSB2;HUWE1;TBL1XR1;PCNP;DDIT3;DDB1;FAF2;UBXN4;SIRT1;FBXO9;NHLRC3;PSMF1;ERLIN1;PSMD14;STUB1;PSMD12;CUL4A;DNAJB14;RNF34;FBXO6;PRKN;DERL2;ZFAND2B;PSME2;CUL1;AMN1;UBQLN2;ARRB1;TMUB1;ANAPC10;DNAJC18;CDC34;KCTD5;TMEM129;PSMB10;PSMD5;SGTA;BIRC2;PSMD8;AMFR;PSMA3;PPP2R5C;TNFAIP1;AGAP3;CLOCK;FBXO5;FBXO31;UBE2S;MAN1B1;PSMA2;ATXN3;ANAPC15;PSMD11;WFS1;PLAA;PSMA6;SPOP;CUL4B;FOXRED2;FBXO45;FBXL4;JKAMP;TAF1;KCTD2;ECPAS;VCP;PSMB3;UBR3;KCTD10;HERPUD1;UBE4A;FAF1;SIAH2;PSME3;UBE2D3;UBE4B;CDK2;FBXO4;PTTG1;DMAC2;UBE2J2;UBE2E1;ANAPC7
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.4059933195376001,1.16617284872952,0.25,0.6593244606873834,1.0,28/69,23.40%,TRIM25;UBXN8;NPLOC4;FAM8A1;EDEM2;TMUB2;FAF2;UBXN4;ERLIN1;STUB1;DNAJB14;FBXO6;DERL2;UBQLN2;TMUB1;DNAJC18;TMEM129;SGTA;AMFR;MAN1B1;WFS1;FOXRED2;JKAMP;ECPAS;VCP;HERPUD1;UBE4A;UBE4B
prerank,negative regulation of hemostasis (GO:1900047),0.5352293463811666,1.1659775307437334,0.28046989720998533,0.6593165190832837,1.0,2/12,6.55%,APOE;PROC
prerank,establishment of protein localization to extracellular region (GO:0035592),0.42970863087326505,1.1659165448229758,0.25059665871121717,0.6589259902283205,1.0,6/39,10.39%,ABCA1;STEAP3;RAB8B;TANGO6;RAB12;RAB10
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5610001202386166,1.1656426750297089,0.2846270928462709,0.6591698046237016,1.0,3/10,17.48%,LRP1;PTPN12;APOD
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5445858415844574,1.1653703415428123,0.2997032640949555,0.6594183739758255,1.0,5/11,19.65%,IPPK;SIRT7;PWP1;SMARCB1;NCL
prerank,protein N-linked glycosylation (GO:0006487),0.407133521373412,1.165349744030986,0.23509561304836896,0.6589273086490315,1.0,21/66,19.82%,MAN1C1;DPM2;MGAT5;MCFD2;NUDT14;TMEM165;B4GALT7;DDOST;DAD1;GFPT1;ALG13;ALG12;MAGT1;MPDU1;MOGS;UGGT1;FUT8;ALG6;DPAGT1;ALG5;PMM2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.48516325781634373,1.1651787350189375,0.2857142857142857,0.6588630471605668,1.0,9/22,19.11%,MAN1C1;RPS27A;UBC;EDEM3;EDEM2;DERL2;UGGT1;AMFR;MAN1B1
prerank,nitric oxide metabolic process (GO:0046209),0.5243413632774852,1.165147923527305,0.28653295128939826,0.6584230323629596,1.0,2/14,6.12%,CYB5R3;ARG2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.485263175462026,1.1644663833160545,0.2608695652173913,0.6598366230459166,1.0,8/21,12.73%,HPSE;XYLT1;EXT1;UGDH;SULF2;HS2ST1;SULF1;SGSH
prerank,protein heterotetramerization (GO:0051290),-0.4407590658665944,-1.1640978117829626,0.277602523659306,0.6670102892133548,1.0,4/13,13.74%,GRIN2B;GRIN1;PKD2;PKD1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.5393079237473177,1.1638510782384155,0.2936046511627907,0.6610576775223854,1.0,6/12,25.33%,RAB10;CELSR1;LAMA3;VANGL2;ACTG1;ACTB
prerank,heart development (GO:0007507),0.377238724120876,1.163546777410603,0.20412371134020618,0.6613736338266294,1.0,26/150,13.59%,HTR2B;APLNR;ALPK3;SYNPO2L;STRA6;VEGFA;ID2;CDKN1A;ZDHHC16;MYL2;PTEN;CITED2;PDLIM5;NIPBL;SOX9;AKAP13;MYBPC3;DLC1;ACVRL1;BMPR2;TAB2;NOTCH1;MICAL2;COL3A1;SH3PXD2B;SMYD4
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5250683618147759,1.163428938382558,0.3108298171589311,0.661164778174541,1.0,4/14,12.40%,ABCD1;MTLN;IRS2;LONP2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.540878477918529,1.1630008828674245,0.29439252336448596,0.6618202424940859,1.0,4/11,15.85%,SIRT6;TPR;MPHOSPH8;DNMT1
prerank,amino sugar biosynthetic process (GO:0046349),0.5434552100433813,1.1627839127066357,0.31332357247437775,0.6618948464853622,1.0,4/12,14.52%,RENBP;GFPT1;NAGK;GNPDA1
prerank,regulation of response to stress (GO:0080134),-0.48534939851172,-1.1622829616559558,0.29393939393939394,0.6692982354684348,1.0,8/10,32.55%,OPRM1;EIF4G1;MLC1;STOX1;SLC38A2;DYRK3;CORO2B;CRHBP
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5499015208613721,1.1620437386981306,0.30906148867313915,0.6634222583745344,1.0,6/11,16.53%,CYBA;MFHAS1;TREM2;TNFAIP3;ACOD1;TLR1
prerank,cellular response to superoxide (GO:0071451),0.572637842702999,1.1608085597868587,0.2962962962962963,0.6664346792605989,1.0,3/10,15.41%,PRDX1;MT3;ATP7A
prerank,actin filament bundle organization (GO:0061572),0.44369326570848205,1.1602157152195751,0.2943396226415094,0.6676517446913693,1.0,4/33,3.00%,LIMA1;NEDD9;BAIAP2;LCP1
prerank,negative regulation of growth (GO:0045926),0.3867785281337299,1.1599302123810336,0.21294363256784968,0.6679229893987324,1.0,38/121,20.67%,TMPRSS4;CDKN1A;PPT1;ENPP1;MYL2;SESN2;NOTCH2;OSGIN1;APBB2;SPHK2;FLCN;HSPA1B;RB1;PPP1R9B;ACVRL1;BMPR2;NAIF1;SIRT1;ING4;MT3;DCUN1D3;BST2;NOTCH1;ACVR1B;RBBP7;HSPA1A;RTN4;NDUFS3;PPP2CA;PPP2R1A;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,intracellular lipid transport (GO:0032365),0.48616020653686826,1.1597283257278088,0.2924901185770751,0.667953989159751,1.0,5/21,9.93%,PRKAG2;CERT1;ABCD1;CPT1A;SLC25A20
prerank,ventricular septum development (GO:0003281),-0.3331394527597172,-1.1596819882762004,0.2331288343558282,0.6738193806000464,1.0,11/37,8.69%,ACVR1;SALL1;ROBO2;ROBO1;BMPR1A;TGFBR2;TGFBR1;MDM4;ZFPM2;SMAD7;TGFB2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3661566283100598,1.1596719643329778,0.12337011033099297,0.6675422722513089,1.0,98/336,22.19%,FNIP2;GRB2;TRIP12;VAV3;BCL2L11;IKBKE;TAOK3;CDKN1A;WAC;MUS81;MCM9;TANK;ZDHHC16;RFC3;MUTYH;UVRAG;TNFRSF1B;ZRANB3;PARP4;BACH1;E2F1;PARP2;HTRA2;FAM111A;GADD45A;BABAM2;APC;HELB;DOT1L;PARP3;NIPBL;ENDOV;XIAP;BRCA1;FOXP1;SMC1A;TOPORS;VCPIP1;RTEL1;SETD7;POLH;DDIT3;XRCC5;DDB1;XRCC2;DCUN1D5;FOXO1;SIRT1;MBD4;INIP;NBN;CBX3;CBX1;CUL4A;KMT5B;WRN;NSMCE3;SIRT7;FBXO6;DYRK2;USP16;POLA1;BAX;MCL1;INO80;NSMCE4A;MTREX;MNAT1;ALKBH8;FANCA;BID;RNF169;BAZ1B;ALKBH1;CRY1;POLI;ACER2;CASP2;NCOA6;FBXO31;ZBTB40;TLK2;BCL3;PDS5A;PHF1;MRE11;CUL4B;USP3;FBXO45;EPHA2;RAD51B;TAF1;XPC;MGMT;RPAIN;CBX5;VCP;PRKDC
prerank,telomere capping (GO:0016233),0.5022596206687064,1.15958151887071,0.2849083215796897,0.6672696113890627,1.0,7/16,14.75%,ACD;TFIP11;TERF1;NBN;DCLRE1B;TEN1;STN1
prerank,positive regulation of cellular process (GO:0048522),0.36247641386199053,1.1595674783075374,0.051,0.6667590411201915,1.0,104/565,15.00%,CD36;HTR2B;CDCA7L;SDCBP;NAMPT;SLC6A6;TIMP1;SLC35F6;GCNT2;ADRA1D;STX3;GAB2;VEGFA;FLOT1;KIF20B;TGM2;IER5;KDM4C;LRP1;IL6;PRKCD;ANKRD17;DYNC1H1;FASN;TFAP2B;PDGFA;P2RX4;TCIRG1;SRPK2;TNFRSF1B;LMNA;CELF1;RARA;MMP14;PTEN;CITED2;MTLN;CHTOP;IGF1;FGFR4;MVD;CUL3;THBS1;RNF10;MERTK;ADAM8;IRS2;COPS9;APC;DOT1L;FLCN;CACUL1;P2RX3;CYBA;RPL23;N6AMT1;PRODH;FOLR2;SOX9;SIRPA;RAD23A;CTSH;HPR;HP;TRPC3;PPP3CA;CNOT6L;EXOSC9;IL6R;FZD7;VIPR1;WDR77;CNOT7;ADAM17;RHOD;PTK2B;MTPN;POU3F3;SIRT1;MT3;CDC123;NOTCH1;TBX6;IL15;TREM2;DOCK2;MAZ;HCLS1;IL7R;DHPS;BCLAF1;POFUT2;RELA;GAS6;SLC11A1;DERL2;GDNF;SHC1;PHIP;LRP6;INO80;CX3CL1;CNOT6;NSMCE4A
prerank,glycerolipid metabolic process (GO:0046486),0.5474238044393918,1.159267138676602,0.3048048048048048,0.6670392280244032,1.0,5/11,17.19%,DGKZ;DGKA;PGP;DGKQ;DGKG
prerank,tyrosine metabolic process (GO:0006570),0.5530982597341904,1.1588716240012475,0.3066255778120185,0.6676145075133398,1.0,2/11,16.00%,DCT;FAH
prerank,response to zinc ion (GO:0010043),0.46700975089926716,1.1588169036232565,0.2696929238985314,0.6672487582200551,1.0,12/25,20.67%,P2RX4;D2HGDH;MT3;PAM;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5231670203013918,1.1581575921792582,0.29955947136563876,0.668562706923449,1.0,6/14,26.08%,VEGFA;PIK3CA;NRP1;GAB1;MYO1C;KDR
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.36128099076629455,1.1581529148980874,0.078,0.6680320490196776,1.0,106/572,14.84%,PPARG;FNIP2;SDCBP;TFEC;IRX3;FRK;TRPS1;ZNF3;MITF;VEGFA;CEBPB;FNIP1;ZEB2;ATXN1;FOXP3;DNMT3A;ATF3;WWC2;NR1H3;GATAD2A;ID2;FOXO3;LIN37;CBX8;ZNF692;TFAP2B;RUNX3;RXRA;JUN;NCOR1;RARA;MAP2K5;MZF1;CITED2;BACH1;E2F1;TAF7;SAP30;GADD45A;NR3C1;SIRT6;TCERG1;EED;NR1H4;DDX5;CREBBP;BHLHE40;RPS14;FLCN;HNRNPU;NIPBL;ATF4;TGIF1;RPS27A;UBC;RITA1;ETV6;ZNF177;RPL23;RREB1;UXT;SOX9;SNAI2;NEDD4L;RB1;LCOR;WWP2;EPC1;ZNF148;FOXP1;IRF2;CHD3;CBFB;TBL1XR1;DACH1;ARID5B;TPR;DDIT3;NR2C1;HCFC2;ESR1;VPS72;SIRT1;NFATC3;LARP7;PPARD;CUX1;NOTCH1;TBX6;SARS1;DDX20;MAZ;SIRT7;SOX2;RELA;KDM1B;PRKN;ZKSCAN3;DCAF1;HSPA1A;SUV39H2;PRDM2;ID4;EID1;PER3;RPL10
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.518890485289664,1.1578597528959809,0.3034188034188034,0.668307515503772,1.0,1/13,0.14%,MDFIC
prerank,nucleic acid-templated transcription (GO:0097659),0.4272067260840701,1.1572380871967352,0.26913875598086123,0.6694993003082911,1.0,10/42,10.93%,POLR2A;E2F1;NFKBIB;POLR2L;EPC1;TAF1B;TOPORS;PAX8;POLR2G;POLR2I
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.419598177558201,1.1572300654638645,0.26785714285714285,0.6689750767775366,1.0,20/46,26.10%,IPO5;PRKCD;ANP32B;GTSE1;TPR;MAVS;GSK3B;NCBP2;HCLS1;GAS6;CAMK1;RBM22;EFCAB7;TCF7L2;DMAP1;FLNA;CPSF6;UBR5;BAG3;ZIC1
prerank,cytoskeleton organization (GO:0007010),0.3832895614055322,1.157211818275391,0.20483193277310924,0.6684870738186521,1.0,30/114,16.84%,ARHGAP10;APOE;PALLD;FGD6;NEDD9;DIAPH1;ZMYM6;PLD2;SYNE3;WDPCP;SH3KBP1;KLHL20;CAPZB;EPB41L3;TNIK;RHOD;CFL1;SPRYD3;CFAP410;MICAL2;FGD5;LIMD1;TNFAIP3;MAST4;PHIP;FGD3;RND2;CCL7;SH3D19;BRWD1
prerank,regulation of vasoconstriction (GO:0019229),0.4567029285961224,1.1571887701745809,0.30256410256410254,0.6680082802473101,1.0,4/27,9.37%,ADRA1D;ADRA1A;ATP2B1;BMPR2
prerank,ESCRT complex disassembly (GO:1904896),0.5565060508660369,1.1568177051867286,0.2794561933534743,0.6679643885929272,1.0,5/10,21.40%,CHMP2A;VPS4A;CHMP5;CHMP7;CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),0.5565060508660369,1.1568177051867286,0.2794561933534743,0.6679643885929272,1.0,5/10,21.40%,CHMP2A;VPS4A;CHMP5;CHMP7;CHMP2B
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.5376570570605916,1.1566226291064297,0.30434782608695654,0.6679899154350717,1.0,1/12,0.35%,SOAT1
prerank,thymus development (GO:0048538),-0.44059939092070527,-1.1565776193654909,0.27070063694267515,0.6798174358271861,1.0,9/13,45.48%,TGFBR1;FGF10;FOXE1;EPHB3;HES1;SHH;FADD;RIPK3;TBX1
prerank,DNA biosynthetic process (GO:0071897),0.5109975007426282,1.1565756727958458,0.29069767441860467,0.6675793320165931,1.0,6/16,13.60%,RFC3;POLH;SIRT1;POLL;WRN;POLA1
prerank,aminoglycan catabolic process (GO:0006026),0.4546234739193127,1.156560986467111,0.2878787878787879,0.6670722178179436,1.0,8/28,14.88%,HPSE;GNS;IDUA;FUCA1;SGSH;SDC4;CTBS;GUSB
prerank,calcium ion transport into cytosol (GO:0060402),-0.38244310300278367,-1.1564919773659914,0.2857142857142857,0.6776221156500858,1.0,10/21,14.97%,GRIN2A;GRIN2B;CACNA1C;RYR2;GRIN1;JPH1;TRPM2;GRIN2D;ATP2B4;CACNA2D1
prerank,regulation of phospholipase activity (GO:0010517),0.5569498234381569,1.1561936224039728,0.30493273542600896,0.6675806525294896,1.0,2/10,3.02%,LRP1;PDPK1
prerank,melanosome localization (GO:0032400),0.4766707289682105,1.1560894210461379,0.2837653478854025,0.6673562783195154,1.0,4/21,12.95%,MYO5A;MREG;VPS33A;RAB11B
prerank,regulation of myotube differentiation (GO:0010830),0.4682803579001263,1.155655754634349,0.26790450928381965,0.6680141163761522,1.0,5/24,11.89%,MMP14;MAML1;SIK1;PIEZO1;NOTCH1
prerank,mRNA stabilization (GO:0048255),0.4257990072004654,1.1554220987372408,0.2869458128078818,0.6681163172107576,1.0,11/40,17.12%,E2F1;TENT5A;HNRNPU;HNRNPA0;SLC11A1;TENT5D;GDNF;MYD88;THRAP3;SYNCRIP;TAF15
prerank,translational termination (GO:0006415),0.3841255689027049,1.155253242184845,0.2303552206673843,0.6680339231079893,1.0,30/95,20.07%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;N6AMT1;MRPS23;ETF1;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;MRPS35;MRPS28;MRPL30;MRPL28;MRPL19;MRPS21;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;APEH;AURKAIP1;MRPS10;MRPL17;MRPS31
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5352167660182013,1.1550998536078418,0.31750741839762614,0.6679316498625395,1.0,1/13,0.52%,NAMPT
prerank,peptide biosynthetic process (GO:0043043),0.37139784705739415,1.1547440996225269,0.20351239669421486,0.66843276034798,1.0,40/153,18.07%,RPL3L;TNIP1;RHD;IGF2BP3;EEF1A1;AGO2;RPL18A;RPS14;MRPL11;RPS11;RPS27A;MRPL23;RPL17;RPL23;DARS1;RPL36A;EIF4EBP2;COPS5;MRPS7;RPL22;RPS21;RRBP1;MRPL32;MRPL36;GGTA1;SARS1;RPL10A;MRPL28;DHPS;RPS26;MRPS21;SRBD1;MRPL35;RPL15;RPL10;RPSA;MRPL43;RPL7;RPL26;MRPS18A
prerank,cellular response to amino acid stimulus (GO:0071230),0.4377417656310167,1.1546559491699855,0.27728983688833125,0.6681471797890894,1.0,8/33,13.39%,IPO5;CPEB4;SESN2;CAPN2;LAMTOR1;SLC38A9;LAMTOR3;CASTOR1
prerank,nitric oxide biosynthetic process (GO:0006809),0.524345202198685,1.1543314926099035,0.2922636103151863,0.6685050651327752,1.0,2/13,6.12%,CYB5R3;ARG2
prerank,regulation of protein ubiquitination (GO:0031396),0.38666552645136787,1.1539615184442558,0.2341101694915254,0.669057696451264,1.0,44/108,24.61%,SASH1;FBXW7;WASHC1;UBE2L3;CUL3;HSPA1B;XIAP;BRCA1;HUWE1;BIRC3;STUB1;NSMCE3;SIRT7;N4BP1;TNFAIP3;PRKN;HSPA1A;SQSTM1;ARRB1;PRKCG;CENPX;DCUN1D1;CRY1;PRR7;PHF23;BIRC2;MYCBP2;GNL3L;DNAJA1;HDAC8;WFS1;PAXIP1;OGT;GTPBP4;HSPBP1;FKBP1A;MALT1;SPRTN;BCL10;ISG15;TRAF6;FBXO4;NDFIP1;SOX4
prerank,GPI anchor metabolic process (GO:0006505),0.46311696654781165,1.1538358596734202,0.26718547341115434,0.6688653175683134,1.0,7/26,15.14%,PGAP3;DPM2;PIGH;PGAP1;PIGC;GPLD1;PIGQ
prerank,negative regulation of cellular process (GO:0048523),0.3637737052204782,1.153797456497726,0.083,0.6684218117750852,1.0,91/521,13.94%,GPNMB;HTR2B;PLXNA1;PLXNC1;ADAMTS8;FRK;PLXND1;HOPX;LILRB1;RPS6KA2;ADRA1A;CTNNB1;NCK2;FOXP3;SPEF1;ST18;CCN5;IFITM1;NR1H3;IL6;CDKN1A;NIBAN2;TFAP2B;RUNX3;PPT1;ENPP1;TNFRSF1B;LMNA;MYL2;SESN2;APPL2;CELF1;ABI1;PTEN;RAF1;FOXO4;OSGIN1;HTRA2;ACTN1;APBB2;SMYD5;LPXN;SPHK2;APC;CHMP2A;FLCN;NUDT6;HSPA1B;ANP32B;NF2;TES;RB1;PPP1R9B;SIRPA;BNIPL;P3H3;DLC1;STRN;ACVRL1;BRD7;DSCAM;BMPR2;NLRP2B;CNOT7;NAIF1;PTK2B;SIRT1;ATG5;CCN1;ING4;MT3;VPS13C;FBLN1;APP;DCUN1D3;BST2;NOTCH1;ACVR1B;LPCAT3;MYH9;TREM2;DUS2;SIRT7;ARID2;GPLD1;PODN;VAMP3;PRKN;RBBP7;TENM1;HSPA1A
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5278215652882912,1.153399234676102,0.3169642857142857,0.668988931273236,1.0,6/13,22.72%,ALG13;ALG12;MPDU1;ALG6;DPAGT1;SRD5A3
prerank,regulation of receptor binding (GO:1900120),-0.4796674807206175,-1.1533850386119198,0.29362880886426596,0.683398849734231,1.0,4/10,25.39%,ADAM15;HFE;ATP2A2;ATP2A3
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.43451303530790075,1.1531509822203432,0.2682619647355164,0.6691558074511597,1.0,9/35,12.58%,IQGAP2;BAIAP2;ABL2;NOTCH2;STAP1;PTK2B;FES;BCAS3;HCLS1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.40389887350444,1.152973443766193,0.2556818181818182,0.6691146316203282,1.0,20/67,23.47%,CD36;NEDD9;DOCK5;TRIOBP;RREB1;GSK3B;PTK2B;OLFM4;VIT;DOCK1;CX3CL1;UTRN;NRP1;RSU1;C1QBP;CCL25;ILK;JAK2;CDK6;FLNA
prerank,protein autoubiquitination (GO:0051865),0.40868587533365897,1.1528302486088433,0.27231638418079096,0.6689891513620126,1.0,23/61,23.92%,TRIM17;UHRF2;CUL3;RNF10;CNOT4;BFAR;SH3RF1;BRCA1;WWP2;RNF115;RNF146;ASB4;KLHL24;STUB1;PRKN;TRAF2;AMFR;NFX1;RNF19B;RNF141;OBI1;UBE2D3;TRAF6
prerank,cellular response to radiation (GO:0071478),0.43067467986561414,1.1526008765084625,0.30609756097560975,0.6690663643642288,1.0,11/40,20.59%,GRB2;CDKN1A;TANK;GADD45A;SIRT1;NSMCE3;INTS7;INO80;CLOCK;EEF1D;TNKS1BP1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.4628274567754386,1.1519353926974936,0.2837150127226463,0.6704218492886154,1.0,7/22,19.07%,LILRB1;TNFRSF1B;SPHK2;BTK;TRIL;TNFRSF14;SCIMP
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.44209544941101836,-1.151642424165735,0.2861635220125786,0.6858190637001008,1.0,7/13,22.48%,ARSB;HEXB;HYAL1;IDS;BCAN;CSPG4;NCAN
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5233404634935244,1.1515407397926254,0.30834512022630833,0.6709920731694751,1.0,4/13,14.52%,RENBP;GFPT1;NAGK;GNPDA1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3442320515334226,-1.151408474329438,0.23333333333333334,0.6840198725497657,1.0,12/31,14.97%,DLG2;OPHN1;PARD3B;PARD3;LIN7A;SYNJ2BP;SH3BP1;MARK2;DLG1;RHOA;DLG3;ANK1
prerank,cellular protein modification process (GO:0006464),0.35911931476146286,1.1509230305131737,0.035,0.6722259458360307,1.0,244/982,20.49%,EPAS1;CEL;MFGE8;FNIP2;FBXO32;B4GALT5;APOE;SGK1;MAP3K20;MAK;B3GNT8;SYK;MSRA;TLK1;MTM1;TIMP1;CCDC8;FRK;PRKCH;MTMR3;GCNT2;MAP3K1;ANXA1;ERN1;ATG7;TEC;NPC1;TIPARP;PDK4;GPS1;TGM2;PRKAG2;IKBKE;ITIH2;FBXW7;SPP1;PPM1H;PLK2;TAOK3;IL6;PDPK1;ABL2;PRKCD;APLP2;PPP4R1;RUNX3;PSMD1;BIRC6;SIK3;FAM20C;SRPK2;DAPK1;PPEF1;PARP4;B4GALT7;RARA;PTEN;MAPK6;GNMT;PTPRE;PIM1;PARP2;UBE2L3;MAML1;ATG10;PKN3;SPSB4;CUL3;THBS1;FBXW10;MERTK;SOCS6;SIRT6;RNASEL;MELK;FBXL3;DDOST;SIK1;MAN2A1;PPEF2;DCAF13;IRAK3;TRIOBP;STK24;STK3;MANBA;COG7;PIGH;KLHL41;PROC;PGAP1;PTPN12;PARP3;DYRK1A;NUB1;EIF2AK4;DAD1;B3GALNT2;PDP1;ST3GAL4;BTBD1;PPP4R2;RAB1B;WSB2;BRD2;ACVR2A;F13A1;KLHL20;WWP2;FBXO11;HIPK1;AGA;ZC3HAV1;MAP4K3;ACVRL1;LHPP;SPSB2;COPS5;HIPK2;QSOX1;PPP3CA;BMPR2;FSTL1;EGLN3;TNIK;DDB1;PIM3;ROCK1;GSK3B;PTK2B;SIRT1;FBXO9;ILKAP;PAK2;PKN2;PPP2R2A;ATG5;CDK7;OGA;CCN1;PSMF1;ASB4;MT3;MAN2A2;PSMD14;APP;DCUN1D3;ASB8;WDTC1;METAP1D;RHBDD1;PRKCB;ACVR1B;PSMD12;STK38;CUL4A;COPS7A;BTK;ATG4B;SIRT7;UBA3;FBXO6;RAB11B;COL3A1;FBXW2;DYRK2;GAS6;FGR;CTDP1;PPP6C;RBBP7;UBE2F;PPP1CA;SERPINC1;MCRS1;PSME2;JAK3;CUL1;NUCB1;TNKS;LATS1;CD247;CDK8;PRKCG;ATE1;SUMF1;CDC34;RNF7;CDKL4;MELTF;SIRT3;PGGT1B;RAB2A;LRRC41;PTPN1;CAMK1;DCUN1D1;UBE2M;CSNK2A1;PSMB10;KEAP1;PSMD5;ARF4;GAN;DCAF10;SRPK1;PTPRU;ICMT;CREB1;TNKS2;PSMD8;CLK3;STK4;PSMA3;PPP2R5C;CDK13;FBXO31;PPP2CA;UBE2S;FBXO7;PSMA2;PIGU;TLK2;ALG5;TBK1;PSMD11;CDC14B;MKNK2;RAB1A;PMM2;DCAF7;GMFB;DUSP10;JMJD4;SHISA5;RAB13;BRSK2;WFS1;NAGPA;PPP2R1A;DDA1;COQ8B;PSMA6;ANO8
prerank,protein secretion (GO:0009306),0.4065175054271056,1.1507032045539591,0.27387802071346373,0.6723209233043334,1.0,9/56,12.00%,ABCA1;ANXA1;STEAP3;RAB8B;TANGO6;RAB12;RAB10;WLS;CYB5R4
prerank,positive regulation of response to external stimulus (GO:0032103),0.3787875518152648,1.1506630566956064,0.23294858342077648,0.6719127736209816,1.0,19/128,12.33%,PLA2G7;SASH1;OPTN;TLR8;MGST2;STX3;TNIP1;ANKRD17;RIPK1;LY96;NINJ1;THBS1;ADAM8;CYBA;PTGER4;APP;PUM2;IL15;TREM2
prerank,epithelial to mesenchymal transition (GO:0001837),0.4209996131159034,1.1504010501997026,0.27995255041518385,0.6721304084218972,1.0,9/47,11.89%,CTNNB1;HGF;HNRNPAB;DDX5;SOX9;SNAI2;ROCK1;GSK3B;NOTCH1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5123214982312081,1.150281038741179,0.2971014492753623,0.6719301769338625,1.0,3/14,10.59%,LILRB1;MAVS;SIRT1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5566220296493292,1.149885255539854,0.29667149059334297,0.6725326102280903,1.0,5/11,19.08%,NEDD4L;PICALM;SNX33;LEPROTL1;GOPC
prerank,transepithelial transport (GO:0070633),-0.42460862357341167,-1.1495331111995717,0.27898550724637683,0.686669027727691,1.0,5/15,11.91%,SLC12A2;SLC1A3;SLC1A2;SLC1A1;ABCG2
prerank,mitochondrial translational elongation (GO:0070125),0.38587878459503355,1.1495167261181638,0.24427480916030533,0.6730963382706465,1.0,27/88,20.07%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;MRPS35;MRPS28;MRPL30;MRPL28;MRPL19;MRPS21;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31
prerank,renal filtration (GO:0097205),0.547639533385125,1.1490707911868951,0.31100478468899523,0.6737419828842112,1.0,4/10,12.72%,MYO1E;SULF2;SULF1;ITGA3
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.45209092810709345,1.1490247514840084,0.3040103492884864,0.6733379267034837,1.0,9/27,17.19%,ID2;FBXL17;FBXL3;CRTC1;SIK1;BHLHE40;PPP1CA;PER3;CRY1
prerank,keratan sulfate metabolic process (GO:0042339),0.43865335245192094,1.1483300343991576,0.2818181818181818,0.6747772417963819,1.0,8/31,10.88%,B4GALT5;GALNS;GNS;B4GALT6;HEXA;ST3GAL4;LUM;B4GALT3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5007745301332875,1.1482859656069804,0.3136427566807314,0.6743599178347778,1.0,5/16,15.14%,DPM2;PIGH;PIGX;PIGC;PIGQ
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.4109532167665345,-1.148224292118716,0.2785234899328859,0.6879723065287198,1.0,5/16,12.67%,SALL1;FGF2;PAX2;PKD2;NPNT
prerank,embryonic limb morphogenesis (GO:0030326),0.4425303030111487,1.1481481900274053,0.3017241379310345,0.6742129741060018,1.0,6/34,6.98%,MAP3K20;CTNNB1;MBNL1;CREBBP;WDPCP;NIPBL
prerank,protein deneddylation (GO:0000338),0.557224579739749,1.1476372031564124,0.29607250755287007,0.6750862998295577,1.0,3/10,12.64%,GPS1;COPS5;COPS7A
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.36666514292468844,1.14757514536161,0.18431771894093688,0.6747390849590378,1.0,37/214,16.55%,GPNMB;CD36;HTR2B;APOE;SYK;GCNT2;ADRA1A;FBXW7;CD44;TNIP1;PDGFA;NOTCH2;PTEN;FGFR4;DUSP3;FLCN;MFHAS1;CNKSR3;SIRPA;PTK2B;CCN1;MT3;FBLN1;APP;STYX;NOTCH1;ROR1;TREM2;GAS6;RRAS;SHC1;CX3CL1;ARRB1;CCL7;NRP1;ZDHHC17;PTPN1
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.4788620585193789,1.1474163104529111,0.2916666666666667,0.6746460058193868,1.0,5/20,20.34%,NCOR1;SIK1;PGP;CRY1;GCK
prerank,anterior/posterior axis specification (GO:0009948),0.5063239179079981,1.147027195794021,0.3170028818443804,0.6752521270696528,1.0,4/15,18.42%,DDIT3;FZD5;WLS;HOXD8
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4512346662953939,-1.146567294507639,0.3021148036253776,0.6900120190018522,1.0,5/12,22.67%,CSF1R;CSF1;PTK2;IL34;LYN
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3727831538642402,1.1464536174149742,0.22085889570552147,0.6763457541999942,1.0,37/166,14.32%,PPARG;POLR2A;NR1H3;E2F3;RXRA;NCOR1;NOTCH2;RARA;GTF2H5;GTF2B;TAF7;MAML1;NR3C1;MAML2;NR1H4;CREBBP;TAF5;POLR2L;TAF1B;TBL1XR1;NR5A1;POLR1A;NR2C1;ESR1;POLR2G;CDK7;MED26;POLR2I;PPARD;NOTCH1;RORA;GTF2F2;POLRMT;MAZ;NRBF2;GTF2A1;NAT14
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.34297910324485514,-1.1464017524733627,0.26865671641791045,0.6856570562490666,1.0,12/32,14.86%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,tRNA export from nucleus (GO:0006409),-0.34297910324485514,-1.1464017524733627,0.26865671641791045,0.6856570562490666,1.0,12/32,14.86%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,regulation of myoblast fusion (GO:1901739),0.5456814073162171,1.145802235561515,0.310126582278481,0.6776995912586303,1.0,2/11,5.60%,FLOT1;CD53
prerank,neurotransmitter secretion (GO:0007269),-0.31320569243190743,-1.145711116096964,0.21232876712328766,0.6851460399906397,1.0,8/44,5.23%,NRXN1;SYT1;RIMS1;RIMS2;SYN2;PTPRN2;LIN7A;SNAP25
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.463036016179894,-1.1453410426949777,0.29141104294478526,0.6838017620655481,1.0,1/11,0.13%,BIN1
prerank,neuromuscular junction development (GO:0007528),-0.37199647499889404,-1.144358834173726,0.270042194092827,0.6839138029128474,1.0,4/24,3.24%,CACNB2;UNC13C;ANK3;CACNB4
prerank,regulation of glucose transmembrane transport (GO:0010827),0.49787622009899285,1.143964674897229,0.3004418262150221,0.6824106853403356,1.0,4/18,12.33%,PRKAG2;PRKCB;APPL1;SLC2A1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.36146871382345797,1.1438562677600814,0.13913913913913914,0.6822047240849008,1.0,60/348,15.44%,GPNMB;FNIP2;IQGAP1;GDF15;SDCBP;APLNR;RAP2A;VEGFA;TEC;FLOT1;TXN;FNIP1;TFRC;PRKAG2;CD44;IL6;HGF;ITGA5;CDKN1A;FAS;PDGFA;SNX9;RIPK1;RAF1;IGF1;UBE2K;FLCN;CACUL1;RBPMS;SOX9;ACVR2A;ACVRL1;IL5;BMPR2;IL6R;TNIK;XRCC5;MAVS;ADAM17;PTK2B;SIRT1;PAK2;ARHGEF2;CCN1;MT3;NBN;APP;TAB2;IL15;TREM2;HCLS1;DGKQ;GAS6;TENM1;GDF10;PFN2;CX3CL1;LATS1;ARRB1;CDK2AP1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5011417945692737,1.1436491896038519,0.3084507042253521,0.68228961908234,1.0,5/15,16.33%,LRP1;IL6;FGFR4;CLASP1;MELTF
prerank,histone H4-K8 acetylation (GO:0043982),0.508506899058846,1.1435203999246146,0.31805555555555554,0.6815879715556306,1.0,6/15,22.41%,KANSL1;PHF20;ING4;MCRS1;OGT;KANSL3
prerank,histone H4-K5 acetylation (GO:0043981),0.508506899058846,1.1435203999246146,0.31805555555555554,0.6815879715556306,1.0,6/15,22.41%,KANSL1;PHF20;ING4;MCRS1;OGT;KANSL3
prerank,regulation of cell size (GO:0008361),0.4659524476424382,1.143199747501333,0.2770448548812665,0.6819257557270622,1.0,6/23,13.48%,VAV3;PTEN;MSN;VAV1;MTPN;RAP1GAP2
prerank,7-methylguanosine RNA capping (GO:0009452),0.44223168901452364,1.143084746599438,0.2950191570881226,0.6811818682329859,1.0,11/31,20.22%,POLR2A;GTF2H5;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;MNAT1;RAMAC;CMTR2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.44223168901452364,1.143084746599438,0.2950191570881226,0.6811818682329859,1.0,11/31,20.22%,POLR2A;GTF2H5;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;MNAT1;RAMAC;CMTR2
prerank,renal absorption (GO:0070293),0.544350040615054,1.1427208029854266,0.3238380809595202,0.6816532599408953,1.0,1/10,0.58%,SGK1
prerank,regulation of cell population proliferation (GO:0042127),0.3566579860183257,1.142394356711941,0.067,0.6820060777440541,1.0,114/691,14.86%,GPNMB;HTR2B;CDCA7L;SDCBP;NAMPT;SGK1;TIMP1;ADAMTS8;FRK;SLC35F6;GCNT2;RPS6KA2;ADRA1D;ADRA1A;CTNNB1;NCK2;STX3;GAB2;VEGFA;KIF20B;FOXP3;IER5;ST18;KDM4C;TFRC;IFITM1;ID2;IL6;CDKN1A;NIBAN2;TFAP2B;BIRC6;PDGFA;RAB33B;TCIRG1;JUN;SRPK2;LMNA;CELF1;ABI1;RARA;PTEN;RAF1;FOXO4;OSGIN1;CHTOP;IGF1;FGFR4;STAT5B;MVD;CUL3;THBS1;IRS2;COPS9;KLHL41;APC;DOT1L;NUDT6;HSPA1B;CACUL1;RPL23;NF2;FOLR2;XIAP;SOX9;TES;PPP1R9B;BNIPL;P3H3;CTSH;DLC1;STRN;ACVRL1;BRD7;BMPR2;CNOT6L;IL6R;EGLN3;XRCC5;VIPR1;WDR77;CNOT7;ADAM17;PTK2B;POU3F3;AGO3;SIRT1;ARHGEF2;FES;ING4;APP;CDC123;NOTCH1;TBX6;IL15;MAZ;HCLS1;IL7R;ARID2;DHPS;GPLD1;PODN;RELA;TENM1;DERL2;HSPA1A;JUNB;GDNF;SPEG;SHC1;PHIP;FKTN;CX3CL1;CNOT6
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3554370525228814,1.1421339598735838,0.044,0.6822220510438173,1.0,167/834,16.62%,EPAS1;PPARG;MMP12;NAMPT;TFEC;MRTFA;LITAF;MRTFB;ZMIZ1;ATP1B4;IRX3;PLXND1;TFEB;LPIN3;LILRB1;NFE2L2;CTNNB1;MITF;NCK2;VEGFA;CEBPB;ZEB2;GRHL1;FOXP3;IER5;ST18;ATF3;VEZF1;RUNX2;NR1H3;E2F3;LMO1;IL6;HGF;FOXO3;TNIP1;TFAP2B;RXRA;JUN;MED12;RIPK1;ASXL2;RARA;MAP2K5;MZF1;CITED2;PID1;FOXO4;E2F1;TAF7;IGF1;MAPK7;MAML1;STAT5B;RNF10;AGO2;NUFIP1;GLMP;NR3C1;TCERG1;RNASEL;CRTC1;MAML2;NR1H4;CREBBP;DOT1L;FLCN;MLLT10;HNRNPU;KLF5;TET3;ATF4;REL;RPS27A;UBC;RREB1;TCF20;SOX9;ACVR2A;BRCA1;ACTR3;EPC1;GABPB1;GABPB2;IRF2;NCOA3;DVL1;ACVRL1;COPS5;TBL1XR1;HIPK2;PPP3CA;TET2;NCOA1;BMPR2;NR5A1;DDIT3;PAXBP1;PAX8;MAVS;ESR1;PPP3R1;FOXO1;MED16;SIRT1;SALL2;ARHGEF2;CDK7;PRPF6;CCN1;NFATC3;LARP7;PPARD;BCAS3;APP;FZD5;SP3;NOTCH1;RORA;MEPCE;CAMTA2;MICAL2;HCLS1;SIRT7;PPRC1;RFX5;BCLAF1;SOX2;USP16;RELA;BCL11B;POU2F1;KDM1B;PRKN;SLC11A1;FOXJ3;SMARCD1;JUNB;GDNF;ATF1;PRDM2;ZNF513;MCRS1;PHIP;SQSTM1;LRP6;INO80;CX3CL1;TNKS;ZFP64;WASL;ARRB1;CDK8;ASXL1;PCBP1;CDC73;PPARGC1B;KLF6;NHLH2;WWOX;MTF1;THRAP3;NFATC2IP;TCF12;CAMK1;CREB3L4;CREB3
prerank,regulation of cell adhesion (GO:0030155),0.37576503416720053,1.1417535789555684,0.24739039665970772,0.6827970898252477,1.0,21/129,11.33%,PLXNA1;CXCR4;PLXNC1;PLXND1;STX3;VEGFA;CYTH1;TGM2;ABL2;ADAM8;LPXN;FLCN;ACVRL1;DSCAM;PPP3CA;PLAU;ROCK1;RHOD;PTK2B;FES;FBLN1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5331948095465099,1.1416332309979633,0.31130690161527164,0.6826038684244717,1.0,3/12,10.02%,IL6;NCOR1;ESR1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5147712993092991,1.1415904064412292,0.3142857142857143,0.6822057808075999,1.0,3/13,15.42%,CBLB;CHMP6;CBL
prerank,telomere maintenance (GO:0000723),0.41032991343548986,1.1414684574498715,0.2886473429951691,0.6820430677105601,1.0,12/50,14.75%,NSMCE2;ACD;TEP1;PARP3;RTEL1;TERF1;XRCC5;NBN;DCLRE1B;WRN;TEN1;STN1
prerank,cellular response to calcium ion (GO:0071277),-0.29186911457242304,-1.1406298375720663,0.20618556701030927,0.6918589872182643,1.0,20/67,12.14%,MEF2C;SYT1;NLGN1;MEF2A;RYR3;CAPN3;ADD1;PRKAA2;KCNH1;SYT7;SYT2;TRPM2;SYT4;SYT6;CPNE8;MCOLN1;ADGRV1;ADCY1;PKD2;CPNE4
prerank,cellular response to tumor necrosis factor (GO:0071356),0.36671240400419525,1.1404725106519662,0.2034764826175869,0.6843910011704449,1.0,49/175,22.89%,NFE2L2;ST18;FOXO3;PSMD1;TANK;RIPK1;TNFRSF1B;PID1;ZFP36L2;BRCA1;ADAM17;PTK2B;SIRT1;BIRC3;ARHGEF2;PSMF1;BAG4;PSMD14;TRAF1;PSMD12;ZFAND6;TRAF3;RELA;ERBIN;ACOD1;PSME2;CX3CL1;TRAF5;CCL7;TRAF2;LTB;LTBR;TNFRSF14;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;TNFRSF21;ASAH1;PSMA2;CCL25;PSMD11;PSMA6;TXNDC17;PSMB3;ILK;PSME3;JAK2
prerank,mesenchyme development (GO:0060485),-0.4109361775639482,-1.1404665821480102,0.2651006711409396,0.6899848808893717,1.0,10/15,37.44%,FGFR2;TGFBR1;PKD2;CRELD1;BMP2;BMP4;BMP7;HMGA2;ISL1;SFRP2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.4486950516862573,1.1400836385515916,0.3014888337468983,0.6849500740383752,1.0,9/30,21.02%,CD300A;PIBF1;PRKCD;NF2;INPP5F;SH3BP5;PPP2CA;PPP2R1A;PTPRC
prerank,positive regulation of embryonic development (GO:0040019),0.47690512680146935,1.1396945715667703,0.3178717598908595,0.6855251210361683,1.0,3/19,10.46%,B4GALT5;NIBAN2;CFL1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3718927589250575,1.1395922990184113,0.24220374220374222,0.6852890051835706,1.0,57/144,26.14%,MICALL2;IPO5;NPEPPS;KIF20B;RUFY3;FBXW7;PRKCD;SH3GLB1;E2F1;SORL1;HTRA2;UBE2L3;ANP32B;GTSE1;HUWE1;CSNK2A2;TPR;ARIH2;MAVS;MTCL1;PPP3R1;GSK3B;OAZ2;BCAS3;FZD5;HCLS1;ATG13;GAS6;TENM1;VPS11;USP36;BID;CAMK1;RAB29;OAZ1;BBC3;RBM22;TOMM7;EFCAB7;TCF7L2;VAMP2;TMEM30A;DMAP1;UBE2D3;FLNA;MYO1C;TM9SF4;HRAS;TFDP1;CASP8;UBE2J2;YWHAB;UBR5;BAG3;ABLIM3;ZIC1;CEMIP
prerank,photoperiodism (GO:0009648),0.4466846822059668,1.13919514653525,0.30512820512820515,0.6858909251907516,1.0,10/28,18.84%,ID2;FBXL17;FBXL3;CRTC1;SIK1;BHLHE40;PPP1CA;PER3;CRY1;CLOCK
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5548971802234153,1.1391626064699472,0.32972136222910214,0.6849306754396028,1.0,2/10,5.24%,MAP2K5;MAPK7
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5548971802234153,1.1391626064699472,0.32972136222910214,0.6849306754396028,1.0,2/10,5.24%,MAP2K5;MAPK7
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4359622715633428,-1.1387236043322908,0.29153605015673983,0.6924447409722038,1.0,5/13,13.63%,SPRED1;ATM;ATR;SPRED2;SPRED3
prerank,regulation of epithelial cell migration (GO:0010632),0.40997875796298267,1.138602871990293,0.2910360884749709,0.6859924799896944,1.0,16/51,15.40%,SASH1;CORO1C;RHOJ;DOCK5;RREB1;SOX9;MCC;CTSH;BMPR2;PFN1;DOCK1;MACF1;CAPN7;CLASP1;PFN2;RTN4
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.405385611233378,-1.1381912971184012,0.2827586206896552,0.6915642445819076,1.0,3/17,3.74%,SNTA1;ANK2;RYR2
prerank,regulation of cell motility (GO:2000145),0.37455653269477807,1.138173963827665,0.2358490566037736,0.6866989711022696,1.0,19/121,11.47%,PLXNA1;SGK1;PLXNC1;PLXND1;ADGRG3;DIAPH1;ABL2;LMNA;RAF1;OSGIN1;DOCK10;CFAP20;ARHGAP18;ROCK1;CCDC125;PKN2;FES;FBLN1;NRG4
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5214109039846109,1.1380511982968045,0.32116788321167883,0.6865348391428915,1.0,3/13,6.34%,ENPP1;ENTPD1;ITPA
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4539408869980869,1.1379727948391443,0.320109439124487,0.6862354508538079,1.0,9/25,22.54%,BCL2L11;PPIF;MLLT11;BAX;BNIP3;BID;BBC3;PDCD5;PLAUR
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5208836133932233,1.1379536826413115,0.32507739938080493,0.6857565154481597,1.0,3/12,15.85%,APOBEC1;MPHOSPH8;DNMT1
prerank,protein glycosylation (GO:0006486),0.372505839020354,1.13760311859465,0.2758985200845666,0.6861872227719175,1.0,21/125,10.99%,B4GALT5;B3GNT8;GCNT2;MAN1C1;NPC1;GALNT6;MGAT5;GALNT9;TMEM165;B4GALT7;DDOST;COG7;TET3;DAD1;B3GALNT2;ST3GAL4;GFPT1;TET2;ALG12;OGA;MAGT1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4248177945828894,1.1375707548113894,0.2971985383678441,0.6857432598587079,1.0,5/40,5.53%,SDCBP;GCNT2;CTNNB1;IL6;COL1A1
prerank,regulation of type I interferon production (GO:0032479),0.3873332547256886,1.1372698220116553,0.2560706401766004,0.6860803383792247,1.0,32/84,24.55%,CTNNB1;IKBKE;RNF26;TRIM25;NPLOC4;CREBBP;RNF135;POLR2L;XRCC5;MAVS;TAX1BP1;PQBP1;TRAF3;RELA;POLA1;TNFAIP3;ACOD1;MYD88;OTUD5;STAT6;TBK1;POLR3C;MRE11;TIRAP;PRKDC;RNF125;POLR3K;IRAK1;ISG15;LRRFIP1;DHX58;GPATCH3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4331802266349177,1.1359542475063542,0.28872366790582404,0.6892389498970732,1.0,10/34,20.64%,ANXA1;ERN1;VEGFA;PIK3CA;NOTCH1;RELA;NRP1;GAS1;GAB1;MT1G
prerank,response to peptide (GO:1901652),0.4358292153059924,1.135572649803155,0.31539424280350437,0.6897838755393494,1.0,3/33,5.39%,MMP12;ANXA1;STAT5B
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.38131368588379494,1.1354651059193461,0.278494623655914,0.6895636764770459,1.0,23/95,15.74%,LILRB1;VIM;IL36G;NR1H3;ADAM9;IL6;CD274;TNFRSF1B;LY96;SHPK;NFKBIB;STAP1;SIRPA;NFKBIL1;TICAM2;FZD5;TRIM41;RELA;TNFAIP3;ACOD1;LBP;CDC73;MYD88
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4072964852568235,1.1353782116250863,0.29698375870069604,0.6892812302893748,1.0,12/55,12.89%,HPSE;GALNS;CD44;STAB2;GNS;CEMIP2;HEXA;LUM;IDUA;FUCA1;SGSH;SDC4
prerank,cellular response to UV (GO:0034644),0.3879979453303819,1.1353612895868683,0.28634361233480177,0.6887910237010677,1.0,27/76,24.09%,TIMP1;AQP1;PRKCD;CDKN1A;COPS9;CREBBP;EIF2AK4;ATF4;DDB1;SIRT1;RHBDD1;NSMCE3;MFAP4;N4BP1;INO80;RPL26;CDC25A;NOC2L;CERS1;CUL4B;EIF2S1;TAF1;XPC;RUVBL2;POLD1;ERCC4;USP47
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.36404897191582153,-1.1352341788224118,0.26591760299625467,0.6973236412860739,1.0,8/22,20.32%,SPRED1;ATM;ATR;RPL37;SPRED2;SPRED3;CDK5RAP3;CHD5
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.34341121705881295,-1.1350872266495513,0.23577235772357724,0.6953932938147095,1.0,6/29,7.55%,P2RY12;IRS1;FGF2;FLT3;PRKD1;ATG14
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4678637424403707,-1.13496857967455,0.30844155844155846,0.6933830929535043,1.0,6/12,38.29%,FUT9;WNK1;LCK;PPARA;FUT4;ADTRP
prerank,metal ion transport (GO:0030001),-0.27974400970068214,-1.1348262802304245,0.15789473684210525,0.6915355291307236,1.0,20/86,15.95%,CACNA1E;RYR3;CCR5;CDH23;TRPC1;CACNA1C;GRIN3A;RYR2;ATP2C1;NDFIP2;RAMP1;TRPM2;NIPAL2;TRPC4;CAMK2A;PKD2;ATP2B2;CACNA2D1;CACNG3;CCR1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.4018310786736161,1.134812197083198,0.27816091954022987,0.6897641369260821,1.0,15/58,15.39%,NSMCE2;ERCC6;UVRAG;BABAM2;PIAS4;BRCA1;XRCC4;XRCC5;KDM2A;POLL;PSMD14;NBN;DCLRE1B;POLA1;BRCC3
prerank,epidermis development (GO:0008544),0.4041492317583133,1.1347398215728717,0.29770114942528736,0.6894371337037911,1.0,9/56,18.26%,FABP5;GRHL1;EMP1;DCT;SVEP1;ALDH3A2;LAMA3;PLOD1;CCN2
prerank,oligodendrocyte development (GO:0014003),0.5019408415589923,1.1343063388336996,0.3153961136023916,0.6901105098327546,1.0,3/15,8.05%,B4GALT5;B4GALT6;PRDM8
prerank,regulation of mitotic spindle organization (GO:0060236),0.43354154115139226,1.1342344406879243,0.2972636815920398,0.6897505960366755,1.0,8/35,9.43%,DYNC1H1;CHMP2A;PARP3;HSPA1B;HNRNPU;EML3;PDCD6IP;TPR
prerank,regulation of chemokine production (GO:0032642),0.42896257033741575,1.1340520731532893,0.3163771712158809,0.6897334788360663,1.0,9/36,12.33%,SIGIRR;IL6;HMOX1;SNAI2;FOXP1;IL6R;ADAM17;APP;TREM2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.48322649538804835,1.1336514690768784,0.3087621696801113,0.6903310148705406,1.0,5/19,17.58%,VEGFA;FLOT1;NOTCH1;ADAM19;PTPRU
prerank,cardiac ventricle development (GO:0003231),0.4742359923130365,1.1335112431529963,0.2948207171314741,0.6902000977381404,1.0,2/20,1.11%,TMEM65;STRA6
prerank,cellular glucose homeostasis (GO:0001678),0.4213830584525549,1.1328330490145373,0.29594272076372313,0.6916106849481971,1.0,10/41,14.56%,LRRC8D;ERN1;HK3;ZBTB20;SLC39A14;FOXK1;FOXO1;SIRT1;GAS6;ADCY8
prerank,histone H2A ubiquitination (GO:0033522),-0.3944487208156714,-1.1324944657261447,0.2937062937062937,0.6956153128489296,1.0,6/17,13.60%,RNF8;DDB2;TRIM37;RYBP;BCOR;UBE2B
prerank,mitochondrial translational termination (GO:0070126),0.3802675860883215,1.1322646095243003,0.27006507592190887,0.6927022906691122,1.0,27/88,20.07%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;MRPS35;MRPS28;MRPL30;MRPL28;MRPL19;MRPS21;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31
prerank,cytosolic calcium ion transport (GO:0060401),0.4546893471207992,1.1321587039157868,0.2994722955145119,0.6924975930386719,1.0,5/28,5.02%,ADRA1A;ATP2B1;MICU2;MICU1;SLC8A1
prerank,positive regulation of B cell proliferation (GO:0030890),0.4418857041642234,1.131689429215226,0.30125,0.6932540286411658,1.0,4/29,5.81%,CD38;VAV3;TFRC;IRS2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3851978502337312,1.131620165474094,0.2765726681127983,0.6929174455684238,1.0,16/87,11.67%,IQGAP2;IQGAP1;BAIAP2;LRP1;ABL2;PRKCD;PDGFA;NOTCH2;PIK3CA;DLC1;ARHGAP18;ARHGAP17;ROCK1;RHOD;PTK2B;BST2
prerank,protein K63-linked ubiquitination (GO:0070534),0.4179725319717167,1.1314920221551954,0.296028880866426,0.6927436189718044,1.0,16/41,19.11%,RNF135;BFAR;WWP2;RNF115;ARIH2;STUB1;TRAF1;TRAF3;PRKN;HECTD1;TRAF3IP2;TRAF5;TRAF2;UBE2O;UBE2V1;UBE2S
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3922397158286498,1.1312990432065364,0.2766439909297052,0.6927556740147086,1.0,11/69,9.32%,HTR2B;PIK3R5;GAB2;PTEN;IGF1;IRS2;PIK3CA;PTAFR;PIK3C2G;PLCB4;PLEKHA1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4342337581860606,1.131266700552004,0.30174563591022446,0.6923177142286153,1.0,13/36,21.45%,OPTN;RILPL2;RAB7A;RAB31;RAB10;MACF1;GOLPH3;GOLPH3L;GOLGA4;GGA2;BBS1;VAMP2;GGA3
prerank,glycerophospholipid metabolic process (GO:0006650),0.39610076111270254,1.1311771365490964,0.2717271727172717,0.6920376023986091,1.0,16/75,15.14%,PLA2G7;DPM2;PLA2G2D;GPCPD1;CLN3;PIGH;PIGX;ABCA3;PLAAT1;PLA2G4F;PGP;PIGC;GPLD1;GDE1;PRDX6;PIGQ
prerank,actin filament bundle assembly (GO:0051017),0.43438410688878604,1.131140023795738,0.32254047322540474,0.6916180413536133,1.0,4/33,3.00%,LIMA1;NEDD9;BAIAP2;LCP1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.41661137624892725,1.1310519856887986,0.28857479387514723,0.6913302941890156,1.0,6/45,9.37%,GDF15;SDCBP;RBPMS;ACVR2A;ACVRL1;BMPR2
prerank,regulation of neuron migration (GO:2001222),-0.3542116887595619,-1.1307882726911318,0.2602739726027397,0.6978777374759216,1.0,12/26,14.84%,CTNNA2;NTNG1;PHACTR1;SRGAP2;ADGRG1;ULK4;SEMA3A;DAB2IP;CAMK2A;SEMA6A;NEXMIF;RAPGEF2
prerank,microtubule depolymerization (GO:0007019),-0.3938542018865686,-1.1305305887949395,0.26644736842105265,0.6963379242387199,1.0,13/17,36.44%,STMN3;STMN4;STMN2;KIF18A;STMN1;NCKAP5;KATNB1;KIF14;CCSAP;KIF2C;KIF18B;KIF19;KIF2A
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.43779795947553457,-1.1301696336906293,0.31097560975609756,0.695014384692434,1.0,6/13,15.34%,SESN3;ATM;STK11;SZT2;DEPDC5;SESN1
prerank,RNA export from nucleus (GO:0006405),-0.2564381684529553,-1.1301654728880508,0.15942028985507245,0.6927457616136167,1.0,39/100,21.36%,NUP133;SLU7;SRSF6;SRSF5;FYTTD1;SMG6;RBM8A;NUP214;ZC3H11A;AAAS;THOC5;NUP85;POM121;SEH1L;NUP35;MCM3AP;SLBP;SRSF11;NUP37;NUP155;RAE1;DDX39B;NUP153;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;HNRNPA2B1;SYMPK;SRSF4
prerank,regulation of signal transduction (GO:0009966),0.3632671869964093,1.130120504108376,0.2163265306122449,0.6934624902615767,1.0,40/190,18.18%,MTCH1;CD36;MDFIC;DTNBP1;TIMP1;NCK2;MGLL;DHRS3;FOXP3;IRAK2;CD46;CD63;FBXL17;BRAP;CDC42SE2;GSKIP;CREBBP;LFNG;CBFB;ESR1;SIRT1;APP;RORA;TREM2;SULF1;ITGA3;TSPAN15;DGKQ;CASTOR1;RGS11;GDNF;ZFAND2B;CX3CL1;BST1;ZDHHC17;PTPN1;RIC8B;GAS1;SNX3;AMFR
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.26000578893877263,-1.1295272262718048,0.16417910447761194,0.6922032096742269,1.0,39/96,21.36%,NUP133;SLU7;SRSF6;SRSF5;FYTTD1;SMG6;RBM8A;NUP214;ZC3H11A;AAAS;THOC5;NUP85;POM121;SEH1L;NUP35;MCM3AP;SLBP;SRSF11;NUP37;NUP155;RAE1;DDX39B;NUP153;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;HNRNPA2B1;SYMPK;SRSF4
prerank,regulation of cell cycle process (GO:0010564),0.3787352266114842,1.1294675043383364,0.26545842217484006,0.6948328684850016,1.0,17/104,12.03%,CCDC8;CTNNB1;KIF20B;PLK2;DYNC1H1;BIRC6;UVRAG;SH3GLB1;APC;MYO19;FLCN;SOX9;CEP85;CSNK2A2;DBF4;DCUN1D3;SND1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.39332518135730643,1.1293959949855887,0.27946127946127947,0.6945137410652431,1.0,22/62,25.34%,NFE2L2;HTRA2;MAPK7;PPIF;SNAI2;SIRT1;ARHGEF2;PRKN;HSPA1A;MCL1;CREB3;NDUFS3;NOC2L;DNAJA1;CREB3L1;PLAUR;HERPUD1;CXCL12;NDUFA13;BCL2L1;PPIA;TXNDC12
prerank,peroxisomal membrane transport (GO:0015919),0.44763210875625603,1.1292692289403523,0.31725888324873097,0.6943539028532647,1.0,7/27,12.77%,RAB8B;ABCD1;PEX7;PEX14;ALDH3A2;PXMP2;GDAP1
prerank,midbody abscission (GO:0061952),0.4892326223053215,1.12911147315841,0.3185595567867036,0.6942697601899694,1.0,7/17,21.40%,CHMP2A;PDCD6IP;VPS4A;CHMP6;CHMP5;CHMP7;CHMP2B
prerank,regulation of protein import into nucleus (GO:0042306),0.4241263172287667,1.1287227815815668,0.3178391959798995,0.6948596590139164,1.0,14/36,26.10%,MDFIC;IPO5;PRKCD;TPR;MAVS;HCLS1;APOD;RBM22;EFCAB7;DMAP1;FLNA;UBR5;BAG3;ZIC1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3854261071893553,1.1286881177947818,0.2852422907488987,0.6944358401449893,1.0,30/78,23.38%,NFE2L2;RNF19A;SIRT6;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;PRKN;HSPA1A;HECTD1;UBQLN2;KEAP1;SGTA;BBS7;BCAP31;DDA1;RNF19B;PIAS1;CEBPA;TAF1;HSPBP1;VCP;HERPUD1;ARIH1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.42015165526583714,1.1285285176771689,0.29333333333333333,0.6943782140216561,1.0,14/40,21.48%,FBXW7;PTEN;GNA12;NUB1;RPL23;RAD23A;CSNK2A2;HIPK2;PTK2B;LATS1;CSNK2A1;SGTA;XPO1;TAF1
prerank,phospholipid metabolic process (GO:0006644),0.3925644245872413,1.1281027411583984,0.2828729281767956,0.6950256418637135,1.0,11/71,12.29%,PLPP3;LIPG;GPAT2;AGPAT4;PLA2G2D;GPX4;ABCA2;PLA2G4F;PLBD2;PLAAT3;PGP
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.548085915952373,1.1280619005761794,0.34894259818731116,0.6946065283481762,1.0,2/10,8.73%,PRKCH;NCOA3
prerank,positive regulation of calcium ion transport (GO:0051928),0.4369559997002264,1.1277786950457869,0.3269230769230769,0.6948656241102978,1.0,8/36,13.05%,LGALS3;ATP2B1;P2RX4;SPHK2;P2RX3;TRPC3;MYLK;CRACR2A
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.37398888178130946,-1.1276945342980877,0.29118773946360155,0.6949208846939285,1.0,4/21,3.74%,ANK2;CACNA1C;ATP1A2;RYR2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.5320322288457441,1.127662101346815,0.33088235294117646,0.6946639223986945,1.0,4/11,20.34%,SIK1;PGP;CRY1;GCK
prerank,JNK cascade (GO:0007254),0.41949411624918764,1.1272860413663275,0.3020457280385078,0.6951839337402005,1.0,8/40,11.55%,GPS1;IRAK2;RPS27A;UBC;MAP4K3;MAP2K4;PTGER4;TAB2
prerank,protein ADP-ribosylation (GO:0006471),0.445589153694965,1.1269941841927467,0.30670103092783507,0.6954257893754177,1.0,11/28,18.05%,TIPARP;PARP4;PARP2;SIRT6;PARP3;ZC3HAV1;SIRT1;TNKS;SIRT3;ARF4;TNKS2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.2661792201180876,-1.1265332293558863,0.1702127659574468,0.6958045653826189,1.0,29/94,18.66%,CEP83;CNTRL;CSNK1E;RPGRIP1L;RAB3IP;HSP90AA1;NINL;DYNC1I2;TUBB4A;AKAP9;CSNK1D;DCTN2;CEP57;SCLT1;TCTN3;TMEM67;RAB11A;PRKACA;MARK4;NPHP1;CEP164;YWHAG;MKS1;MAPRE1;CEP97;PRKAR2B;TCTN2;TMEM216;CEP290
prerank,protein homotrimerization (GO:0070207),0.5052708861110264,1.1256691349466441,0.3402061855670103,0.6980014436876347,1.0,2/14,7.20%,SLC1A5;P2RX3
prerank,protein trimerization (GO:0070206),0.5052708861110264,1.1256691349466441,0.3402061855670103,0.6980014436876347,1.0,2/14,7.20%,SLC1A5;P2RX3
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4207832515644066,1.1256322513440575,0.3066502463054187,0.6975738188262487,1.0,11/37,15.02%,RNASE3;ENTPD1;DFFB;ADPRM;DNASE1L1;SND1;SIDT2;RNASEH2A;HNRNPD;RNASEH1;MTREX
prerank,regulation of oxidoreductase activity (GO:0051341),0.5218916907211121,1.1255350069339563,0.3217391304347826,0.6973501995021648,1.0,5/13,15.41%,ABL2;HP;ECSIT;MT3;ATP7A
prerank,extracellular matrix organization (GO:0030198),0.3593768540317811,1.12532159604192,0.17334669338677355,0.6974047951217397,1.0,49/276,15.41%,MMP12;VWF;TIMP1;ICAM2;ADAMTS8;TLL2;CTSL;FLOT1;MMP27;SPP1;CD44;LCP1;ITGA5;ITGA4;KIF9;WASHC1;PDGFA;CD151;COL4A6;MMP14;HAS3;COL1A1;THBS1;DAG1;ADAM8;CAPG;CAPN2;TIMP2;LUM;COL4A1;CTSS;QSOX1;COL5A2;ITGB1;ITGA10;COL11A1;APP;VIT;COL5A3;ITGA3;COL3A1;SH3PXD2B;GAS6;ADAM19;ITGA8;LAMA4;LAMA3;COL6A2;ATP7A
prerank,base conversion or substitution editing (GO:0016553),0.5300887024067523,1.1250888694920016,0.3228346456692913,0.697524689612336,1.0,1/11,0.51%,APOBEC1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3752252694540148,1.124830507968843,0.27177334732423925,0.6977589278352996,1.0,38/101,24.61%,SAMD4A;ATG7;VIM;NR1H3;IL6;CD28;YTHDF3;FGFR4;ATG10;THBS1;TBC1D10A;EIF6;LARP4B;MSN;NAT10;CYFIP2;STUB1;HNRNPD;VPS11;EIF4A3;RPL26;AURKAIP1;BCL3;EIF3C;LARP4;OGT;PCIF1;NR1H2;VPS35;PRKDC;UPF3A;FAF1;ASPSCR1;EZR;ZCCHC4;PLXNB2;CASP8;SOX4
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.517781144873432,1.1247745871778392,0.3357664233576642,0.6974014306721427,1.0,8/13,22.89%,MGAT5;IL6;DOT1L;IL7R;JAK3;PIGU;PTPRC;JAK2
prerank,regulation of actin filament-based process (GO:0032970),0.39358299695535526,1.1245178313867876,0.29966703662597116,0.6975947364959136,1.0,12/70,11.67%,IQGAP2;IQGAP1;BAIAP2;LRP1;PRKCD;PDGFA;DLC1;ARHGAP18;ARHGAP17;ROCK1;RHOD;BST2
prerank,glial cell differentiation (GO:0010001),-0.3455548374600579,-1.1243629831789903,0.2796610169491525,0.6993995450444318,1.0,14/28,22.50%,NFIB;RELN;TPPP;CDH2;MYRF;PAX2;PICK1;ERBB3;EIF2B5;SOX10;FGF10;SOX11;GPC1;METRN
prerank,regulation of synapse organization (GO:0050807),-0.3504352376470913,-1.1234942764063707,0.2542372881355932,0.6994141594237542,1.0,3/26,0.68%,MEF2C;IL1RAPL1;CTNNA2
prerank,negative regulation of bone remodeling (GO:0046851),0.5350660302038098,1.1234937097636146,0.3328335832083958,0.6998706347211644,1.0,2/11,2.98%,GPR137B;IL6
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4611326248677731,1.1231309868758048,0.34914361001317523,0.7004081966885926,1.0,6/24,17.58%,IQSEC1;VEGFA;DUSP3;ROCK1;NRP1;TEK
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.40035124360506696,1.1228626698690005,0.31887456037514655,0.7006532083099121,1.0,7/52,5.48%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;STAC2
prerank,embryonic digit morphogenesis (GO:0042733),0.47946744296292604,1.122408796530657,0.3399734395750332,0.7014135915729693,1.0,3/18,6.44%,MAP3K20;CREBBP;WDPCP
prerank,sensory perception of light stimulus (GO:0050953),-0.2762544557354879,-1.122245223660037,0.20833333333333334,0.7004676159211903,1.0,12/87,10.33%,WHRN;PCDH15;RP2;ABLIM1;GRM8;CDH23;MYO7A;BBS2;PAX2;CABP1;SLC4A10;ADGRV1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3823210967665579,1.1220772405092125,0.28494041170097506,0.7018065952583762,1.0,12/88,10.98%,HTR2B;XDH;APOE;VEGFA;NRP2;THBS1;NRAS;ACVRL1;VASH2;BMPR2;SIRT1;ATP5F1A
prerank,negative regulation of B cell proliferation (GO:0030889),0.5316775612222352,1.1219453615989785,0.335423197492163,0.7016481351595171,1.0,4/11,19.77%,CD300A;TYROBP;TNFRSF21;FCGR2B
prerank,mRNA export from nucleus (GO:0006406),-0.2559826595911843,-1.1219338544469284,0.19672131147540983,0.6990500962027971,1.0,40/102,21.36%,IWS1;NUP133;SLU7;SRSF6;SRSF5;FYTTD1;SMG6;RBM8A;NUP214;ZC3H11A;AAAS;THOC5;NUP85;POM121;SEH1L;NUP35;MCM3AP;SLBP;SRSF11;NUP37;NUP155;RAE1;DDX39B;NUP153;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;HNRNPA2B1;SYMPK;SRSF4
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4343767923087814,1.1215702925784978,0.3278481012658228,0.7021801014783603,1.0,4/33,7.09%,PPARG;CDKN1A;PTEN;HMOX1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.3858209354687774,-1.1207537532061584,0.2737642585551331,0.6999263971326254,1.0,3/20,1.67%,ACVR1;PTCH1;BMPR1A
prerank,regulation of chromatin organization (GO:1902275),0.5042717931230513,1.1207458561023576,0.3428981348637016,0.7039449254719823,1.0,7/14,26.81%,TLK1;HNRNPU;MLLT3;TLK2;SETD5;IGF2;METTL4
prerank,response to tumor necrosis factor (GO:0034612),0.3754919173655516,1.120174899102833,0.2880085653104925,0.7050934425503544,1.0,24/91,19.46%,NFE2L2;ADAM9;TANK;RIPK1;PID1;NUB1;ZFP36L2;BRCA1;MAP4K3;SIRT1;ARHGEF2;BAG4;ZFAND6;RELA;ERBIN;ACOD1;CX3CL1;YTHDC2;CCL7;CASP3;GCH1;TNFRSF21;ASAH1;CCL25
prerank,regulation of monocyte chemotaxis (GO:0090025),0.4516177097010179,1.1201707853159248,0.3422103861517976,0.7045803120190833,1.0,8/24,24.08%,PLA2G7;ANO6;MOSPD2;CREB3;LGMN;CXCL12;SLAMF8;CCN3
prerank,cell cycle checkpoint signaling (GO:0000075),0.5227189505720942,1.1201112569105505,0.34977578475336324,0.7042255140468487,1.0,2/12,2.83%,WEE2;PLK2
prerank,positive regulation of signal transduction (GO:0009967),0.35858710214324974,1.120047597184592,0.2233502538071066,0.7038742820607706,1.0,45/238,15.64%,CCBE1;F7;SASH1;VWF;ZMIZ1;ERN1;LANCL2;MGAT5;IL6;ITGA5;FAS;CD63;SNX5;ASXL2;LY96;PTEN;CITED2;SORL1;IGF1;RWDD3;MAML1;MAML2;CREBBP;SULF2;SLC39A14;PTK2B;SIRT1;MT3;WLS;NOTCH1;PRKCB;TREM2;SULF1;IL7R;MACF1;ATP6V0C;GAS6;TNFAIP3;BAX;PHIP;ATP6AP2;DEPDC1B;ASXL1;NLGN2;CDC73
prerank,lung epithelium development (GO:0060428),0.5367843797015365,1.119564508158716,0.34049079754601225,0.7047017394346108,1.0,1/10,1.11%,STRA6
prerank,negative regulation of biomineral tissue development (GO:0070168),0.4607289325680009,1.1191677696336946,0.33464052287581697,0.705338849956714,1.0,6/21,13.37%,ENPP1;SOX9;ROCK1;PTK2B;NOTCH1;GAS6
prerank,transcription preinitiation complex assembly (GO:0070897),0.5240553245779689,1.1191366262556761,0.3597014925373134,0.704903325957704,1.0,3/12,8.40%,GTF2B;TAF7;TAF1B
prerank,GPI anchor biosynthetic process (GO:0006506),0.43364649093348395,1.1191247408237142,0.31155778894472363,0.7044183857872357,1.0,7/30,15.14%,PGAP3;DPM2;PIGH;PGAP1;PIGX;PIGC;PIGQ
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5441906410874144,1.119123113689732,0.3605546995377504,0.703909148305783,1.0,3/10,14.52%,RENBP;NAGK;GNPDA1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.4277890493755019,1.1190875179398316,0.31698564593301437,0.7034953236474425,1.0,8/36,13.24%,MAP3K20;ERCC6;BRIP1;E2F1;DOT1L;NBN;FBXO6;INTS7
prerank,multivesicular body organization (GO:0036257),0.43622388219558794,1.119066031216693,0.32540675844806005,0.7030435112143034,1.0,12/31,21.83%,STAM;CHMP2A;PDCD6IP;VPS4A;CHMP6;SNF8;STAM2;CHMP5;CHMP7;VPS36;CHMP2B;VPS37B
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4560638181967942,1.118754553980012,0.3411458333333333,0.7033931875602903,1.0,4/25,8.03%,NIBAN2;IGF1;DOT1L;RB1
prerank,axoneme assembly (GO:0035082),0.43876972045575036,1.1186212367524502,0.3201581027667984,0.7032277498833885,1.0,6/30,12.50%,DNAJB13;SPEF1;CCDC40;DNAAF3;TOGARAM1;SPAG17
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2560151439642644,-1.1179694147328332,0.2,0.7051666945773434,1.0,20/138,5.66%,PTPRD;ERBB4;PTPRT;LIFR;EPHA5;PTPRG;YES1;CSF1R;NTRK3;EPHA6;RYK;ACVR2B;EPHA3;FER;CSF1;HCK;FGFR2;NTRK2;IL6ST;FLT3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5425484357994547,1.1177792008594811,0.3483670295489891,0.7050620664416029,1.0,1/10,0.14%,HTR2B
prerank,actin filament organization (GO:0007015),0.3609469862576747,1.117603293404544,0.25737538148524924,0.7050292053874343,1.0,24/151,11.54%,MYO5A;GAS2L3;VILL;NEDD9;RUFY3;CORO1C;BAIAP2;MYO1E;LCP1;BIN3;ABI1;ACTN1;CAPG;TRIOBP;MYO19;SVIL;PPP1R9B;TPM3;MYO1F;ARHGAP17;RHOD;ARHGEF2;TPM4;PLS3
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5066527116533999,1.1175788484637912,0.3299565846599132,0.7045666130753564,1.0,2/13,11.08%,APOE;ERLIN1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.39376819722701145,-1.117516872151197,0.29,0.7040460870669395,1.0,7/16,16.85%,MEF2C;RIMS1;SNCAIP;FMR1;CAMK2A;CPLX1;CPLX2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3807215104880422,-1.1165416997712199,0.3,0.7043742141463245,1.0,5/20,15.88%,RPGRIP1L;BICD1;GRK2;STMN1;RGS2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.494020109632056,1.1163105403936562,0.33565459610027853,0.7075795987798892,1.0,4/15,13.63%,HGF;IGF1;PPIF;PRKN
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5075295021263339,1.1162471108666083,0.3442622950819672,0.7072641410987999,1.0,3/13,8.66%,SYK;PRKCD;TYROBP
prerank,mRNA transport (GO:0051028),-0.256725606120097,-1.1160359517694811,0.21666666666666667,0.703522950146497,1.0,40/101,21.36%,NUP133;SLU7;SRSF6;SRSF5;FYTTD1;FMR1;SMG6;RBM8A;NUP214;ZC3H11A;AAAS;THOC5;NUP85;POM121;SEH1L;NUP35;MCM3AP;SLBP;SRSF11;NUP37;NUP155;RAE1;DDX39B;NUP153;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;HNRNPA2B1;SYMPK;SRSF4
prerank,positive regulation of developmental process (GO:0051094),0.36062530874866483,1.1160075100226015,0.2934560327198364,0.7074366656812575,1.0,36/164,19.40%,DDHD1;B4GALT5;APOE;SLC6A6;VEGFA;CEBPB;CORO1C;TFRC;NIBAN2;LMNA;SORL1;DAG1;AGO2;RREB1;SOX9;NCOA3;DVL1;BMPR2;CFL1;SIRT1;ACVR1B;KMT5B;PRKN;CLASP1;LLPH;GDNF;RTN4;BNIP3;SHLD1;CAMK1;C1QBP;CCN2;SOX8;FBXO5;CORO1B;PPP1R13L
prerank,regulation of actin filament depolymerization (GO:0030834),0.5259808310844071,1.1157046375701511,0.33185840707964603,0.7077863636941626,1.0,4/12,11.02%,LIMA1;PIK3CA;MTPN;WDR1
prerank,fatty acid beta-oxidation (GO:0006635),0.40089728197696706,1.1154343799150563,0.32558139534883723,0.7079822967096205,1.0,22/51,25.81%,AMACR;ABCD1;HADHA;MTLN;ACADL;ACADVL;CRAT;PPARD;ECHDC1;EHHADH;ACAA2;GCDH;ACAD10;DECR2;SLC25A17;ETFA;IVD;SCP2;ABCD2;ACOT8;HSD17B4;CPT2
prerank,regulation of mitochondrial fission (GO:0090140),0.45021408119628803,1.1149492892680202,0.32443257676902537,0.7088062856148785,1.0,5/24,15.64%,DDHD1;MYO19;INF2;PRKN;BNIP3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5348412078693101,1.1148936917741499,0.35268505079825835,0.7084670777892805,1.0,3/10,11.91%,ITGA5;MT3;PRKCB
prerank,positive regulation of viral life cycle (GO:1903902),0.4550527643111308,1.114788861048549,0.33687002652519893,0.7082213152656057,1.0,5/22,9.99%,TMPRSS4;KPNA2;CHMP2A;VPS4A;DDB1
prerank,histone H2A monoubiquitination (GO:0035518),-0.3822487726946938,-1.114765726155902,0.30916030534351147,0.704737189974117,1.0,6/17,14.68%,PCGF3;DDB2;TRIM37;RYBP;BCOR;PCGF2
prerank,cellular response to sterol (GO:0036315),0.5147416589928202,1.1147442246217423,0.35502958579881655,0.7078410769737977,1.0,6/13,15.56%,GRAMD1B;GRAMD1C;RORA;GPLD1;LRP6;INSIG2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.46645475343185944,1.1144938907195743,0.3477088948787062,0.7080160491205896,1.0,5/22,20.89%,RBP1;PIAS4;ALDH1A2;LRP2;LGMN
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.41358173065025666,1.1139228398445202,0.3175182481751825,0.7091369676137766,1.0,15/40,25.29%,BCL2L11;HGF;IGF1;PPIF;MLLT11;PRKN;BAX;BNIP3;BID;BBC3;PDCD5;PLAUR;BCL2L1;GPX1;FXN
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5219392546518835,1.1137791707467921,0.3718518518518519,0.7089773878779112,1.0,1/12,0.55%,XDH
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4126840497345946,1.1136641794946813,0.33816425120772947,0.7087724782867925,1.0,12/43,18.21%,PRKCD;SNX5;ENPP1;PID1;SLC27A4;PTPRE;SORL1;SIRT1;PRKCB;PTPN1;PIP4K2A;ZBTB7B
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3774729639731413,-1.1135968279482371,0.31451612903225806,0.7056856834698328,1.0,7/22,15.79%,ORAI1;CACNA1C;GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,cellular response to BMP stimulus (GO:0071773),-0.2865241522173771,-1.1132544307226135,0.23711340206185566,0.7044551599192085,1.0,18/66,13.61%,ACVR1;SMAD3;BMPR1A;ACVR2B;HIVEP1;SMURF1;MEGF8;RGMB;ENG;SMAD1;SMAD7;PDCD4;VSTM2A;TGFB2;RGMA;SMAD2;TMEM100;ADAMTS12
prerank,leukotriene biosynthetic process (GO:0019370),0.5000012316484638,1.1131101394589171,0.34195402298850575,0.7097709984905481,1.0,3/14,11.96%,MGST2;LTA4H;GGTA1
prerank,regulation of cell division (GO:0051302),0.3867887663216163,1.1128228968111713,0.311529933481153,0.710083411105715,1.0,9/72,8.73%,HTR2B;PLK2;BIRC6;UVRAG;SH3GLB1;SMYD5;MYO19;FLCN;NCOA3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3644372443385101,1.1127284214280213,0.2928870292887029,0.7098505710981738,1.0,23/119,13.93%,PIK3R5;MTM1;PIKFYVE;MTMR3;PGAP3;DPM2;ITPKB;INPP4A;PTEN;TMEM150A;SOCS6;FIG4;PIK3CA;PIGH;PIK3C2G;SLC27A1;PLEKHA1;TTC7B;PI4K2A;PIGC;OCRL;INPP5F;EFR3A
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.47886928727722333,1.1124787252310002,0.3376251788268956,0.7100589557187942,1.0,7/17,17.58%,BAIAP2;STAP1;FES;BCAS3;HCLS1;NRP1;TEK
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4225196906290115,-1.1123301413499767,0.31962025316455694,0.7047936096876022,1.0,6/13,17.13%,HACD2;ELOVL7;ELOVL4;ELOVL6;HACD3;TECR
prerank,actin cytoskeleton reorganization (GO:0031532),0.39212051538124126,1.1119436416200803,0.3187571921749137,0.7110157114603463,1.0,6/63,1.74%,DTNBP1;GRB2;NEDD9;ANXA1;RAP2A;MICALL2
prerank,microvillus organization (GO:0032528),0.5082040593170556,1.1117696857520536,0.368575624082232,0.7109634147171549,1.0,3/13,10.17%,RAP2A;TNIK;RAP2B
prerank,regulation of protein phosphorylation (GO:0001932),0.3511902478509365,1.111548804895202,0.22590361445783133,0.7111096101707747,1.0,42/256,16.19%,GPNMB;FNIP2;PLPP3;XDH;RAP2A;VEGFA;FLOT1;CEBPB;FNIP1;CORO1C;ATF3;TFRC;HGF;FAS;PDGFA;RIPK1;SESN2;PTEN;PID1;FLCN;ATF4;SOX9;ACVR2A;SIRPA;TNIK;MAVS;ADAM17;SIRT1;CCN1;MT3;FBLN1;APP;TREM2;GAS6;FGR;PRKN;PHIP;LRP6;ARRB1;CDK2AP1;BST1;CCDC88C
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5107896131859272,1.1115303608570926,0.3541033434650456,0.7106481489552615,1.0,5/12,20.45%,STX3;SNAP29;STX11;SNAP47;SNAP23
prerank,transcription by RNA polymerase II (GO:0006366),0.3514975490076956,1.1114584772840626,0.21887550200803213,0.7103417012283698,1.0,90/305,21.95%,PPARG;TSC22D1;POLR2A;ERCC6;NR1H3;E2F3;AFF4;CPSF1;RXRA;NCOR1;NOTCH2;RARA;GTF2H5;GTF2B;TAF7;PCID2;MAML1;NR3C1;MAML2;NR1H4;INTS9;DDX5;CREBBP;CSTF3;ATF4;TAF5;POLR2L;RREB1;RPAP2;WDR33;CBFB;INTS6;TBL1XR1;SNAPC1;NR5A1;NR2C1;INTS1;ESR1;POLR2G;INTS13;INTS8;MED16;CDK7;MED26;POLR2I;PPARD;NCBP2;TRIP11;NOTCH1;RORA;GTF2F2;MAZ;NRBF2;INTS5;INTS7;ICE2;INTS2;CTDP1;POU2F1;SNRPF;GTF2A1;MLLT1;MNAT1;SSU72;CDC73;ELP4;TAF5L;TAF15;NELFE;MLLT3;ZBTB7B;CCN2;E2F2;TAF1A;CDK13;NFX1;NFIC;NR2F1;WWTR1;DTX1;NFE2L3;SNRPB;ABT1;HNF4G;TAF1;NR1H2;RARB;LSM11;SNAPC4;CCNT1
prerank,BMP signaling pathway (GO:0030509),-0.27974690364377497,-1.1114440518459026,0.24778761061946902,0.7048881499664308,1.0,16/62,13.55%,ACVR1;SMAD3;BMPR1A;ACVR2B;HIVEP1;SMURF1;MEGF8;RGMB;ENG;SMAD1;SMAD7;PDCD4;TGFB2;RGMA;SMAD2;TMEM100
prerank,regulation of osteoblast proliferation (GO:0033688),0.479936898087249,1.1112532408477742,0.3475177304964539,0.7104257396871442,1.0,5/17,18.62%,HPSE;TNN;CCN1;NELL1;SOX8
prerank,artery development (GO:0060840),0.4538801449880498,1.1109698771142804,0.3482849604221636,0.7107408490246626,1.0,5/23,9.37%,APLNR;STRA6;VEGFA;ACVRL1;BMPR2
prerank,muscle organ development (GO:0007517),-0.2857345403040818,-1.110849425507066,0.24647887323943662,0.7043226793541845,1.0,7/54,6.62%,MEF2C;SGCE;MEF2A;CAPN3;SGCD;VAMP5;POU6F1
prerank,endocardial cushion development (GO:0003197),-0.3557042184294249,-1.1107571077883054,0.2723735408560311,0.7024128005407729,1.0,6/21,12.54%,ACVR1;BMPR1A;ENG;MDM4;TGFB2;CRELD1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5338581441630305,1.1094080336642618,0.35266457680250785,0.7145445857372946,1.0,4/10,15.53%,NR1H3;NINJ1;TICAM2;LBP
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.44869245330086094,1.108683147806158,0.3468586387434555,0.7160372256110213,1.0,10/25,22.14%,FBXL17;LONP1;CUL3;ZER1;STUB1;OMA1;UGGT1;ATXN3;TOR1A;VCP
prerank,positive regulation of defense response to virus by host (GO:0002230),0.44781799437505043,1.1085299368012864,0.3416557161629435,0.715935046595125,1.0,5/24,14.43%,LILRB1;EIF2AK4;MAVS;PQBP1;TRAF3IP2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5243960922238978,1.1080846078883657,0.35046728971962615,0.7167056260369983,1.0,1/11,0.68%,SYK
prerank,positive regulation of signaling (GO:0023056),-0.3112296011621336,-1.107874650335391,0.2768361581920904,0.7082577913878971,1.0,8/37,11.48%,SYT1;RIMS1;RIMS2;GRIK2;CD80;HOMER1;ECE1;NMU
prerank,glycerophospholipid catabolic process (GO:0046475),0.4427158689000873,1.1074173886410184,0.33852140077821014,0.718107865397376,1.0,6/27,14.93%,PLA2G7;GPCPD1;PLA2G4F;INPP5F;GDE1;PRDX6
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3914513026458202,1.1073300306099085,0.3249138920780712,0.7178273480554701,1.0,17/57,22.54%,DDHD1;BCL2L11;HTRA2;PPIF;MLLT11;GSK3B;TREM2;PRKN;BAX;BNIP3;BID;BBC3;HTT;FBXO7;PDCD5;VPS35;PLAUR
prerank,endochondral bone morphogenesis (GO:0060350),-0.45289402933463846,-1.1067987593813178,0.3561253561253561,0.7089389435265602,1.0,8/11,30.99%,MEF2C;TMEM119;FGFR3;FOXC1;INPPL1;COL13A1;SCX;BMP4
prerank,regulation of activated T cell proliferation (GO:0046006),0.4299455567881607,1.1066979247416218,0.3328981723237598,0.7190262377889491,1.0,3/30,5.08%,FOXP3;CD274;IGF1
prerank,early endosome to Golgi transport (GO:0034498),0.5203776436302591,1.1065268196865503,0.3630862329803328,0.7190055430796002,1.0,3/11,13.84%,SNX8;STX5;TRAPPC10
prerank,negative regulation of kinase activity (GO:0033673),0.3863171527297762,1.106334632905515,0.3344370860927152,0.7189819329584987,1.0,12/62,10.74%,DTNBP1;GNAQ;PRKAG2;PDPK1;TAF7;IRS2;GSKIP;HNRNPU;RB1;DVL1;CEP85;PAK2
prerank,defense response to virus (GO:0051607),0.37278914784777406,1.106013984847943,0.30561555075593955,0.7193438703897568,1.0,22/100,16.48%,LYST;TLR8;LILRB1;ATG7;IFITM1;IL6;IFNAR2;RNASEL;RNF135;IRF2;AKAP1;IFITM2;MAVS;CNOT7;BST2;PQBP1;ATAD3A;RELA;ACOD1;BNIP3;MYD88;IFIT2
prerank,mitotic recombination (GO:0006312),0.4865572675499875,1.1057881953737652,0.3545994065281899,0.719470031358036,1.0,2/15,4.72%,NSMCE2;TEP1
prerank,regulation of TOR signaling (GO:0032006),0.38836074760806805,1.1056783584199927,0.3207762557077626,0.7192668824789422,1.0,23/67,21.88%,FNIP1;HTR6;GNA12;PIK3CA;FLCN;EPM2A;LAMTOR1;SIRT1;FBXO9;TREM2;MIOS;SLC38A9;LAMTOR3;DGKQ;GAS6;NPRL3;GOLPH3;GPAT3;NPRL2;RHEB;AKT1S1;RICTOR;TTI1
prerank,pharyngeal system development (GO:0060037),-0.40143272834151583,-1.1055137676198306,0.31186440677966104,0.7102809328718728,1.0,4/15,8.69%,PTCH1;BMPR1A;TGFBR1;TGFB2
prerank,stress-activated MAPK cascade (GO:0051403),0.38946678777491334,1.1054121459926318,0.3047830923248053,0.7194758767655411,1.0,22/61,26.53%,MAP3K20;GPS1;IRAK2;RPS27A;UBC;MAP3K8;MAP4K3;MAP2K4;PTGER4;TAB2;CUL1;SH2D3C;UBE2V1;CCM2;IRAK1;TRAF6;TAB1;ZFP36;MAP3K7;TAB3;MAP3K12;MAPK14
prerank,ureteric bud morphogenesis (GO:0060675),-0.40313030160081165,-1.104911347592194,0.3090277777777778,0.709775824970755,1.0,5/16,12.67%,SALL1;FGF2;PAX2;PKD2;NPNT
prerank,protein homotetramerization (GO:0051289),-0.2906283372737791,-1.1048568069161209,0.2751677852348993,0.7078267546353899,1.0,14/49,16.74%,HCN1;RYR3;ACACA;KCNJ2;TRPM4;TRPM2;SOD2;MCOLN1;APIP;PKD2;PKD2L1;ALDOA;GBP5;OSBPL2
prerank,microtubule anchoring at centrosome (GO:0034454),0.5503713071000771,1.10469218528576,0.37816455696202533,0.7209566715840847,1.0,2/10,7.51%,HOOK3;KIF3A
prerank,organophosphate catabolic process (GO:0046434),0.521278290492457,1.1044713392745162,0.38269794721407624,0.7210307437839124,1.0,2/11,10.93%,LIPG;PLBD2
prerank,Golgi ribbon formation (GO:0090161),0.5012973707618585,1.1044101346523736,0.3431952662721893,0.7206886062630823,1.0,5/13,14.72%,OPTN;VTI1A;TRIP11;STX6;GOLPH3
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.40706419098336033,-1.1041455925495691,0.33762057877813506,0.7076440265561614,1.0,3/14,4.38%,MEF2C;BMPR1A;AIF1
prerank,negative regulation of double-strand break repair (GO:2000780),0.42498771709642896,1.1034729109398091,0.3464968152866242,0.7228081348132234,1.0,8/30,20.00%,TRIP12;ERCC6;TFIP11;HELB;SHLD1;RNF169;RADX;SHLD2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.35716911129919304,1.103471226783848,0.28792569659442724,0.7222991626265507,1.0,13/152,6.49%,PSAP;ADGRE5;ABCA1;ADGRG3;ADRA1D;GNAQ;GNA13;LPAR2;ADCY7;CNR2;GNA12;ADGRE1;PTGER2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3967280243157636,-1.1034683974937984,0.3108108108108108,0.7072893806678949,1.0,8/15,22.62%,UST;B3GAT3;CSGALNACT1;DSEL;BCAN;CSPG4;NCAN;CHST12
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.34300712231891994,1.1034431168265715,0.085,0.7218603588487095,1.0,209/1082,16.62%,EPAS1;PPARG;MDFIC;MMP12;CD38;NAMPT;TFEC;APOE;MRTFA;LITAF;ELF2;MRTFB;ZMIZ1;ATP1B4;IRX3;TFEB;LPIN3;LILRB1;NFE2L2;CTNNB1;MITF;NCK2;VEGFA;CEBPB;ERCC6;ZEB2;GRHL1;FOXP3;IER5;ST18;ATF3;CXXC1;SPP1;ALYREF;VEZF1;RUNX2;NR1H3;E2F3;ID2;LMO1;IL6;HGF;FOXO3;TNIP1;NIBAN2;WAC;TFAP2B;RUNX3;RXRA;JUN;MED12;SNX5;RIPK1;ASXL2;HNRNPAB;RARA;MAP2K5;MZF1;CITED2;PID1;FOXO4;E2F1;TAF7;IGF1;HAS3;MAPK7;PCID2;MAML1;STAT5B;COL1A1;RNF10;AGO2;NUFIP1;GLMP;NR3C1;TCERG1;RNASEL;NSD3;CRTC1;MAML2;MLLT11;NR1H4;CREBBP;DOT1L;FLCN;THOC1;MLLT10;DYRK1A;HNRNPU;KLF5;TET3;ATF4;REL;RPS27A;UBC;KDM3A;RREB1;POU3F1;TCF20;SOX9;ACVR2A;BRCA1;ACTR3;EPC1;GABPB1;GABPB2;IRF2;NCOA3;DVL1;ACVRL1;COPS5;BRD7;TBL1XR1;PICALM;HIPK2;PPP3CA;TET2;NCOA1;BMPR2;NR5A1;DDIT3;PAXBP1;FZD7;PAX8;MAVS;ESR1;PPP3R1;FOXK1;POU3F3;MAFB;FOXO1;MED16;SIRT1;SALL2;KMT2E;ARHGEF2;CDK7;PRPF6;CCN1;NFATC3;PPARD;MT3;BCAS3;CAND2;APP;MYRFL;FZD5;SP3;NOTCH1;RORA;CAMTA2;MAZ;AFAP1L2;HCLS1;FZD2;SMARCC1;SIRT7;PPRC1;RFX5;BCLAF1;SOX2;USP21;USP16;RELA;BCL11B;ICE2;POU2F1;KDM1B;PRKN;SLC11A1;MSANTD1;ZKSCAN3;FOXJ3;SMARCD1;JUNB;GDNF;ATF1;NAT14;PRDM2;HNRNPD;ZNF513;SHC1;MCRS1;PHIP;SQSTM1;LRP6;MAP3K2;INO80;CX3CL1;TNKS;ZFP64;WASL;ARRB1;CDK8;QRICH1;ASXL1;PCBP1;PPARGC1B;KLF6;NHLH2;WWOX;BRPF1;MTF1;THRAP3;NFATC2IP;TCF12;CAMK1;CREB3L4;CREB3
prerank,regulation of superoxide anion generation (GO:0032928),0.4921204359155804,1.1032313638301907,0.3446244477172312,0.721933528748067,1.0,3/14,8.66%,SYK;PRKCD;TYROBP
prerank,megakaryocyte differentiation (GO:0030219),-0.43852569204687664,-1.1031315468239944,0.3125,0.7061309674582779,1.0,2/11,5.26%,SH2B3;TAL1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3615350319944003,1.1030581913788244,0.28335056876938985,0.7219029370583445,1.0,38/149,18.84%,CD36;RAB7B;PRKCH;FLOT1;IRAK2;TFRC;IL6;RIPK1;TRIM25;ADAM8;NFKBIB;IRAK3;HSPA1B;RPS27A;UBC;NLRC4;RIPK4;MTPN;ARHGEF2;APP;TAB2;TRAF1;PRKCB;ROR1;BTK;RELA;HSPA1A;CX3CL1;TRAF5;MYD88;TRAF2;SLCO3A1;ERC1;ZBTB7A;TRIM14;UBE2V1;CARD11;CLOCK
prerank,negative regulation of cellular protein localization (GO:1903828),0.4173176934747453,1.1025848027636798,0.3403205918618989,0.7227317040825055,1.0,13/34,20.52%,FLCN;MFHAS1;NEDD4L;PICALM;SNX33;GSK3B;LATS1;CTNNA1;CDT1;LEPROTL1;GOPC;DNAJA1;SIN3A
prerank,ion homeostasis (GO:0050801),-0.3298080063965957,-1.1025477279410292,0.30927835051546393,0.705578785667208,1.0,8/30,12.13%,SLC4A7;UNC80;WNK3;SLC4A10;SLC4A8;WNK2;SLC4A2;WNK1
prerank,embryonic digestive tract development (GO:0048566),0.47270491318365065,1.1025162853868427,0.3551532033426184,0.7224097387885392,1.0,5/18,10.80%,STRA6;ID2;NIPBL;PKDCC;RBPMS2
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4842254539630476,1.1025047868733522,0.3553370786516854,0.7219352559544551,1.0,1/16,0.07%,ARHGAP24
prerank,mitochondrion organization (GO:0007005),0.3554517099941487,1.102442873722917,0.31030927835051547,0.7215931973220335,1.0,49/165,20.54%,MTM1;MPV17;CHCHD4;TIMM22;PID1;LONP1;MTFR1L;IMMP2L;PITRM1;AIFM2;POLG2;TOMM20;TIMM17A;VPS13D;AFG1L;MTFP1;GABPB1;CYCS;VPS13C;ATP5F1D;TIMM17B;TMEM70;POLRMT;OMA1;GDAP1;PPRC1;ATAD3A;SSBP1;PRKN;BAX;ATP7A;NDUFS1;BNIP3;TWNK;HSPD1;BID;TOMM34;SIRT3;IFIT2;RAB29;TFB2M;GABPA;TOMM7;TOMM22;USP30;FBXO7;AFG3L2;BCAP31;FMC1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.45868586137563266,1.102407341522633,0.3486238532110092,0.7211846992310363,1.0,4/21,9.11%,XDH;AMPD3;NT5C2;NT5E
prerank,detection of visible light (GO:0009584),0.48434729809164145,1.1019064159252465,0.34375,0.7220335860456522,1.0,1/16,2.42%,GNAQ
prerank,positive regulation of cartilage development (GO:0061036),0.4762586484804302,1.1015619323868766,0.3640226628895184,0.7224737738295148,1.0,4/17,9.37%,SOX9;PKDCC;ACVRL1;BMPR2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4965490279746323,1.101388766505419,0.3522561863173217,0.7224632987178515,1.0,7/13,25.67%,IRAK2;UNC93B1;EPG5;MYD88;IRAK1;TRAF6;TLR9
prerank,negative regulation of intracellular protein transport (GO:0090317),0.44696345649850316,1.1013529436958511,0.3404539385847797,0.7220611407488906,1.0,1/22,0.14%,MDFIC
prerank,negative regulation of protein secretion (GO:0050709),0.4134501931415814,1.1007325428942314,0.3341375150784077,0.7232317610245036,1.0,4/38,3.76%,APOE;SERGEF;NR1H3;RHBDF2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5232089847969043,1.1006464870329056,0.375,0.7229556646352284,1.0,5/10,22.96%,MMGT1;EMC2;EMC4;EMC3;EMC10
prerank,skeletal muscle organ development (GO:0060538),0.44195897259548955,1.1005861561650139,0.35019455252918286,0.7226003334792702,1.0,3/26,7.27%,STRA6;IGSF8;SVIL
prerank,long-term synaptic potentiation (GO:0060291),-0.36141022522794636,-1.100452516437627,0.33458646616541354,0.7088450491493257,1.0,4/21,4.64%,GRIN2A;GRIN2B;SLC24A2;TSHZ3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4465139512301868,1.1003620081673775,0.3467741935483871,0.7227337492580508,1.0,5/23,13.76%,MTM1;MTMR3;PTEN;OCRL;INPP5F
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.4237454754606951,1.1001894593284667,0.35459183673469385,0.7227144621151264,1.0,11/31,16.75%,DDX6;EXOSC3;EXOSC9;POLR2G;PATL1;CNOT7;EXOSC8;NT5C3B;CNOT6;EDC3;EXOSC1
prerank,response to UV-A (GO:0070141),0.49624763490561175,1.0999971928972891,0.3670520231213873,0.7227457642556407,1.0,1/14,0.97%,TIMP1
prerank,positive regulation of defense response (GO:0031349),0.37043956676795425,1.0990293694912583,0.3329682365826944,0.7248868810524105,1.0,12/89,12.24%,PLA2G7;OPTN;TLR8;MGST2;TNIP1;RIPK1;NINJ1;ADAM8;CYBA;PTGER4;APP;IL15
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4344192517821313,1.0988383803652133,0.35611038107752957,0.7249166202396253,1.0,15/28,26.97%,IRAK2;RPS27A;UBC;TAB2;RELA;TNFAIP3;UBE2V1;AAMP;IRAK1;TRAF6;CASP8;TAB1;MAP3K7;TAB3;CYLD
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4495935498060611,1.0988237111820711,0.3617300131061599,0.7244374303388256,1.0,5/25,9.78%,CD200R1;ITGA5;ITGA4;NINJ1;ITGB1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.42991632246885503,1.098741583216293,0.3410553410553411,0.7241533908335929,1.0,9/29,16.46%,RIPK1;HTRA2;THBS1;PAK2;DEDD2;WWOX;BID;TRAF2;LTBR
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.537461961832422,1.0982570687313145,0.35096153846153844,0.7249487247338592,1.0,2/10,13.44%,LILRB1;FGR
prerank,synaptic vesicle membrane organization (GO:0048499),0.4739694453232788,1.0976860340533126,0.3688639551192146,0.726008369569008,1.0,7/17,20.73%,STX3;SNAP29;STX11;AP3D1;SNAP47;SNAP23;TOR1A
prerank,DNA metabolic process (GO:0006259),0.3471825995271284,1.09728537464565,0.24798387096774194,0.7265547557573483,1.0,63/270,17.54%,ACD;MUS81;RFC3;SRPK2;MUTYH;UVRAG;ZRANB3;PARP4;KPNA2;BACH1;UHRF2;LONP1;PARP2;GADD45A;HELB;DOT1L;PARP3;RPS27A;UBC;NEIL1;TOP1;ENDOV;BRCA1;DFFB;SMC1A;RTEL1;NT5E;TERF1;POLH;XRCC5;DDB1;XRCC2;POLL;DNASE1L1;DDX23;DBF4;MBD4;INIP;NBN;DCLRE1B;KMT5B;WRN;NSMCE3;SIRT7;FBXO6;POLA1;RNASEH2A;RNASEH1;NOC3L;STN1;INO80;NSMCE4A;ORC1;MNAT1;DNMT1;DNASE2;FANCA;CDC34;ORC4;ALKBH1;POLI;CDT1;SMARCB1
prerank,regulation of macrophage cytokine production (GO:0010935),0.49447038137160426,1.0971678799890727,0.3682678311499272,0.7263863966313583,1.0,3/13,10.59%,LILRB1;IRAK3;SIRT1
prerank,response to reactive oxygen species (GO:0000302),0.3948804416233954,1.096524896319806,0.3356242840778923,0.7276150994140503,1.0,10/54,13.10%,APOE;MPV17;ADAM9;JUN;STK24;HMOX1;CAT;HP;SIRT1;ERCC6L2
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3445021099493679,1.0963829231911209,0.206,0.7275000342022917,1.0,86/476,14.73%,PPARG;MDFIC;CD38;APOE;ELF2;ZMIZ1;TFEB;CTNNB1;MITF;CEBPB;FOXP3;CXXC1;SPP1;RUNX2;NR1H3;ID2;IL6;FOXO3;NIBAN2;WAC;TFAP2B;RUNX3;RXRA;JUN;MED12;SNX5;HNRNPAB;RARA;CITED2;E2F1;IGF1;HAS3;PCID2;COL1A1;RNF10;NSD3;MLLT11;NR1H4;CREBBP;DYRK1A;ATF4;KDM3A;RREB1;POU3F1;SOX9;BRCA1;EPC1;ACVRL1;BRD7;TBL1XR1;PICALM;HIPK2;NCOA1;DDIT3;FZD7;PAX8;ESR1;FOXK1;POU3F3;MAFB;FOXO1;MED16;KMT2E;PPARD;MT3;CAND2;MYRFL;SP3;NOTCH1;RORA;MAZ;AFAP1L2;FZD2;SMARCC1;SOX2;USP21;USP16;RELA;MSANTD1;ZKSCAN3;NAT14;HNRNPD;SHC1;PHIP;LRP6;MAP3K2
prerank,regulation of BMP signaling pathway (GO:0030510),0.3777190408288584,1.096370836793009,0.3367231638418079,0.7270303145927324,1.0,15/73,12.75%,PPARG;TFAP2B;SORL1;XIAP;ACVR2A;ACVRL1;HIPK2;BMPR2;FSTL1;RBPMS2;CCN1;NOTCH1;SULF1;ITGA3;LEMD3
prerank,cellular response to organonitrogen compound (GO:0071417),0.3672547229685183,1.0962764298717695,0.3351177730192719,0.7267854489065545,1.0,23/99,15.71%,HRH1;DIAPH1;CTNNB1;AQP1;IPO5;CPEB4;P2RX4;SESN2;SLC5A5;NR1H4;CAPN2;P2RX3;FOLR1;SOX9;BRCA1;LAMTOR1;RAPGEF1;SLC38A9;LAMTOR3;RELA;HTR1B;GOLPH3;CTNNA1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4054908809932003,1.096163783595075,0.3430913348946136,0.7265824395770636,1.0,11/47,18.05%,NEDD9;CORO1C;DOCK5;TRIOBP;RREB1;OLFM4;FBLN1;DOCK1;NRP1;MELTF;C1QBP
prerank,cellular response to interferon-beta (GO:0035458),0.49627436875589004,1.0961480833832495,0.37444279346210996,0.7261129029167498,1.0,5/14,16.15%,HTRA2;UBE2K;IFITM2;ACOD1;CDC34
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.47392202898637475,1.0959730012218893,0.3770718232044199,0.7260779064907558,1.0,6/17,16.35%,TFAP2B;XIAP;FSTL1;SULF1;ITGA3;ZDHHC17
prerank,peroxisome organization (GO:0007031),0.44509048965474757,1.0959118986809344,0.34748010610079577,0.725740089134553,1.0,6/25,12.40%,ABCD1;PEX11A;PEX7;PEX14;PLAAT3;LONP2
prerank,regulation of interferon-gamma production (GO:0032649),0.3744073843061777,1.0958438594198563,0.3396648044692737,0.725418443392034,1.0,11/71,13.66%,TLR8;LILRB1;FOXP3;CD274;RARA;NR1H4;SIRPA;DDIT3;FZD5;GAS6;SLC11A1
prerank,cAMP metabolic process (GO:0046058),0.4969959157263576,1.0958420224582965,0.3693181818181818,0.7249224774993476,1.0,7/13,23.07%,ADCY7;ADCY8;ADCY3;EPHA2;PDE4D;ADCY5;ADCY9
prerank,regulation of sodium ion transport (GO:0002028),-0.3117400710381016,-1.0957342331704103,0.281767955801105,0.7196457439748796,1.0,13/34,13.68%,SNTA1;ANK3;SCN1B;FGF12;WNK3;SPTBN4;WNK2;DLG1;NKAIN3;WNK1;ATP2B4;YWHAH;NKAIN2
prerank,artery morphogenesis (GO:0048844),0.4339718610075102,1.0953258028133888,0.36178343949044584,0.7258193612739423,1.0,7/30,11.89%,STRA6;VEGFA;LRP1;TFAP2B;FOLR1;BMPR2;NOTCH1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.4566141590560542,1.0951633803842151,0.376,0.7257590441243428,1.0,5/21,13.63%,ABCB7;ABCD1;BRCA1;MT3;PRKN
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.47554077957283736,1.094841150582813,0.359504132231405,0.7261195134440097,1.0,8/17,22.65%,NPLOC4;FAF2;HM13;RHBDD1;DERL2;TMEM129;VCP;HERPUD1
prerank,plasma membrane tubulation (GO:0097320),0.497812502685714,1.0946951600945019,0.3796711509715994,0.7260277726999332,1.0,5/13,14.26%,BIN3;SNX9;MICALL1;SNX33;WHAMM
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4107265260590197,1.0946809203492145,0.3503030303030303,0.7255572654502978,1.0,6/38,7.23%,SASH1;TLR8;ANKRD17;LY96;ADAM8;CYBA
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5390386859664298,1.0943922125283454,0.37444279346210996,0.7258304627255858,1.0,2/10,3.44%,NR1H3;ABCD1
prerank,diol metabolic process (GO:0034311),0.4618547639556249,1.0939820246200693,0.36575342465753424,0.7264170553809837,1.0,5/19,19.91%,PLPP3;SPHK2;PTS;GCH1;SGPP2
prerank,cell cycle G1/S phase transition (GO:0044843),0.38739724131838044,1.093904481003392,0.3463302752293578,0.7261217640447017,1.0,19/61,16.15%,PLK2;E2F3;CDKN1A;E2F1;CUL3;CACUL1;RB1;NASP;CDK7;USP26;CCNA2;DBF4;ACVR1B;CUL4A;PPP6C;CUL1;LATS1;MNAT1;CDC34
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.525103379045877,1.0938303238618399,0.3914327917282127,0.7258226251213041,1.0,5/10,19.33%,SPHK2;BRCA1;CAMK1;SMARCB1;KMT2A
prerank,negative regulation of MAPK cascade (GO:0043409),0.372342450976295,1.0938128839766215,0.32100108813928185,0.7253652093613402,1.0,16/87,12.18%,APOE;CD300A;PRKCD;TNIP1;PTEN;SORL1;DAG1;DUSP3;PPEF2;IRAK3;FLCN;CNKSR3;SIRPA;FOXO1;FBLN1;STK38
prerank,endoderm development (GO:0007492),0.49906276461518945,1.0936934876108688,0.3782991202346041,0.72519230590763,1.0,1/13,3.73%,KIF16B
prerank,regulation of platelet aggregation (GO:0090330),0.4675565891667533,1.0935437400417913,0.35962566844919786,0.7250889702854413,1.0,2/17,3.09%,SYK;PRKCD
prerank,positive regulation of gene expression (GO:0010628),0.34279146469224553,1.0934278292616149,0.22022022022022023,0.7249256838023652,1.0,73/442,13.94%,CD36;HTR2B;DTNBP1;HNRNPLL;SAMD4A;LILRB1;NFE2L2;MITF;ERN1;VEGFA;FLOT1;POLR2A;ERCC6;TFRC;VIM;IL36G;NAT8;ID2;IL6;CD28;CD46;SRPK2;RIPK1;CELF1;TENT4B;CITED2;PID1;YTHDF3;E2F1;IGF1;FGFR4;THBS1;AGO2;SPHK2;EIF6;DDX5;DYRK1A;HSPA1B;NWD1;ATF4;RPL23;LARP4B;POLR2L;STAP1;POU3F1;MSN;SOX9;BRCA1;TAF1B;CTSH;TYROBP;NAT10;TNRC6B;NR5A1;POLR1A;PTGER4;ROCK1;GSK3B;POU3F3;AGO3;MED26;MT3;APP;NOTCH1;IL15;TREM2;MAZ;DGKQ;GAS6;FGR;PRKN;SLC11A1;HSPA1A
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.26751716769044376,-1.0934213708943068,0.25,0.7238092571245994,1.0,12/80,5.49%,P2RY12;TENM2;GPM6A;TWF2;NLGN1;AUTS2;ABI2;PLPPR5;RIPOR2;ANLN;NCKAP1;FMR1
prerank,peptidyl-lysine modification (GO:0018205),0.36659059818293266,1.093205767880604,0.32802547770700635,0.7249865772266181,1.0,34/99,24.28%,EYA1;NSMCE2;SENP3;SUMO2;ETFBKMT;PIAS4;P3H3;TOPORS;NDUFAB1;TPR;SENP5;NUP50;SIRT1;SIRT7;USPL1;ATP7A;NUP98;SIRT3;SENP7;PLOD1;SENP1;NUP88;PIAS2;BCL11A;PIAS1;NUP188;NDC1;NUP43;NUP54;P3H4;RANBP2;GCSH;EGR2;METTL21A
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4972213065610709,1.0929062195675867,0.37349397590361444,0.7253290824723638,1.0,3/13,7.97%,CTNNB1;VEGFA;COL4A1
prerank,pulmonary valve development (GO:0003177),0.4663104591601254,1.0920424478636603,0.38620689655172413,0.7271809320931388,1.0,5/18,11.89%,STRA6;TNFRSF1B;NOTCH2;BMPR2;NOTCH1
prerank,DNA-dependent DNA replication (GO:0006261),0.35514453900133997,1.0920024532488108,0.3245798319327731,0.7268002155318674,1.0,44/128,25.69%,BAZ1A;PSMD1;RFC3;SRPK2;MCMBP;HELB;POLG2;RPS27A;UBC;DDX23;PSMF1;DBF4;PSMD14;PSMD12;WRN;SIRT7;SSBP1;POLA1;PSME2;NOC3L;ORC1;CDK2AP1;TWNK;CDC34;ORC4;CDT1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;RPAIN;PSMB3;PSME3;POLD1;CDK2;POLE3;PRIMPOL;PRIM2;PSMC5;ORC6;MCM3
prerank,hyaluronan metabolic process (GO:0030212),0.44175740587816803,1.0919844138631443,0.37549407114624506,0.7263474497834832,1.0,5/23,6.11%,CD44;STAB2;CEMIP2;HAS3;HEXA
prerank,histone H3-K4 trimethylation (GO:0080182),0.5160349278989608,1.0919633247868288,0.37537993920972645,0.725908679576119,1.0,6/11,26.40%,TET3;TET2;KMT2A;OGT;KMT2D;SETD1B
prerank,regulation of DNA repair (GO:0006282),0.3922069630219688,1.0919362501033492,0.3449519230769231,0.725483172674479,1.0,11/44,17.85%,EYA1;TRIP12;ERCC6;BABAM2;BRCA1;POLH;SIRT1;SIRT7;BRCC3;UBE2V1;RADX
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3750555980517425,1.0906661144122098,0.3348264277715566,0.7284866366648933,1.0,23/70,21.38%,SYK;GRB2;VAV3;ARPC2;BAIAP2;PRKCD;PLD2;ABI1;PIK3CA;VAV1;ACTR3;CYFIP2;DOCK1;FGR;WASL;CD247;ARPC1A;PIK3CB;FCGR2B;ARPC4;ACTG1;MYH2;WIPF1
prerank,regulation of neuron apoptotic process (GO:0043523),0.367057700282342,1.0906024100657112,0.3423618634886241,0.728175888387005,1.0,21/96,15.74%,APOE;CTNNB1;CPEB4;FOXO3;TFAP2B;SRPK2;PPT1;CLN3;ADAM8;ATF4;BACE1;DDIT3;EGLN3;PTK2B;MT3;TREM2;PRKN;GDNF;BAX;PRKCG;GRN
prerank,inorganic ion transmembrane transport (GO:0098660),0.507030867848121,1.0905664134102662,0.38002980625931443,0.7277806020476623,1.0,2/12,7.20%,ATP1B4;P2RX3
prerank,regulation of viral transcription (GO:0046782),0.4102562343182186,1.0902108838590334,0.3601953601953602,0.728271374291781,1.0,10/39,17.78%,MDFIC;POLR2A;POLR2L;POLR2G;POLR2I;LARP7;GTF2F2;CTDP1;NELFE;TRIM14
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4248457471517506,1.0901835517836524,0.36036036036036034,0.727848512339887,1.0,10/29,21.08%,FBXW7;ARRDC4;UBE2L3;TOPORS;DCUN1D5;DCUN1D3;DCUN1D4;DCUN1D1;FBXO5;ARRDC3
prerank,gluconeogenesis (GO:0006094),0.4062279010145289,1.0893648905907398,0.35391923990498814,0.7295536324656005,1.0,12/39,24.02%,TPI1;SLC25A1;ATF4;ENO3;SLC39A14;PGM1;CRY1;GAPDHS;MDH1;SLC37A4;SLC25A13;GOT1
prerank,cellular response to purine-containing compound (GO:0071415),-0.46379875597390263,-1.089336491496002,0.3598901098901099,0.7323955185224668,1.0,3/10,8.16%,RYR3;RYR2;TRPM2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4664919910241829,1.0891283988140354,0.3675675675675676,0.7296710682418024,1.0,5/18,20.76%,CXCR4;TNFRSF1B;NOTCH1;TNFRSF21;HES5
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.37437382625281795,1.0889863378754372,0.34606741573033706,0.7295630166944693,1.0,19/72,19.58%,PIK3R5;HGF;PDGFA;IGF1;IRS2;PIK3CA;SOX9;SIRT1;ROR1;TREM2;MAZ;HCLS1;FGR;CBL;NCF1;TEK;PIK3CB;GAB1;OSM
prerank,steroid catabolic process (GO:0006706),0.5297480275527684,1.0885973245556444,0.3746312684365782,0.7301075603420645,1.0,2/10,17.12%,SPP1;HSD17B11
prerank,regulation of defense response to virus by host (GO:0050691),0.4236789306262251,1.08839202866332,0.3670076726342711,0.7301929348718934,1.0,6/30,14.43%,LILRB1;EIF2AK4;MAVS;PQBP1;TNFAIP3;TRAF3IP2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.42810736620413886,1.0878366836184108,0.3503184713375796,0.7311727865391955,1.0,5/29,13.05%,APOE;SHISA9;CLN3;APP;MCTP1
prerank,regulation of lamellipodium organization (GO:1902743),-0.39161725809604675,-1.0878112156821809,0.3471337579617834,0.7342541724629547,1.0,4/14,7.80%,TWF2;FER;WAS;CARMIL1
prerank,anion transmembrane transport (GO:0098656),0.3748942384452342,1.0875447113462748,0.36251402918069586,0.7314255145007474,1.0,17/67,19.68%,LRRC8D;SLC7A2;SLC36A4;SLC25A1;MFSD12;SLC27A1;LRRC8C;SLC6A8;SLC23A2;SLC23A1;SLC25A42;SLC7A1;ABCC1;SLC35A2;SLC19A1;SLC35C2;SLC7A8
prerank,homotypic cell-cell adhesion (GO:0034109),0.40881451710472666,1.0872696652235059,0.3548387096774194,0.7316339638374573,1.0,16/39,25.45%,PLPP3;ACTN1;TLN1;RAP2B;STXBP3;MYH9;CLIC1;FIBP;PIK3CB;ACTG1;ILK;FLNA;PPIA;MYL12A;ACTB;ITGB3
prerank,cellular response to interleukin-12 (GO:0071349),0.3903648414988782,1.0872521174511978,0.33647058823529413,0.7311856145653921,1.0,17/48,24.51%,LCP1;TALDO1;ANXA2;MSN;SIRPA;PITPNA;CFL1;PAK2;PSME2;CAPZA1;HNRNPDL;GSTO1;CD47;JAK2;HSPA9;AIP;PPIA
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5090461016080071,1.0868074433443202,0.38724727838258166,0.7313806654262581,1.0,4/11,18.38%,AGO2;EIF6;AGO3;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5090461016080071,1.0868074433443202,0.38724727838258166,0.7313806654262581,1.0,4/11,18.38%,AGO2;EIF6;AGO3;AGO4
prerank,cellular response to heat (GO:0034605),0.4105053794029836,1.0864485612398416,0.37559808612440193,0.7318577527035791,1.0,9/35,13.94%,IER5;HTRA2;THBS1;HSPA1B;HMOX1;TPR;STUB1;RBBP7;HSPA1A
prerank,cytoplasmic microtubule organization (GO:0031122),-0.28196867159019745,-1.0858687927560036,0.25384615384615383,0.7374057567319984,1.0,19/54,23.03%,TUBGCP5;DST;MAPT;STMN3;TPPP;SPAST;RAB11A;DLG1;NUMA1;LIMK2;WDR73;RHOA;FIGNL2;TUBGCP6;KATNAL2;FSD1;CAMSAP1;CIB1;PLK3
prerank,ameboidal-type cell migration (GO:0001667),0.39207635487201503,1.0855845012547487,0.34201183431952664,0.7336958212370601,1.0,6/51,5.40%,HTR2B;SGPL1;CORO1C;ITGA4;SEMA4B;PKN3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5208387847368436,1.0855799985953314,0.3757861635220126,0.7327201438164554,1.0,3/10,10.97%,PPP3CA;PPP3R1;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),0.5208387847368436,1.0855799985953314,0.3757861635220126,0.7327201438164554,1.0,3/10,10.97%,PPP3CA;PPP3R1;NFATC3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3467620296427101,-1.0849764561876636,0.3333333333333333,0.7377754156422393,1.0,7/23,16.42%,ANK2;UBASH3B;ATP1A2;NOS1AP;PRNP;CACNA2D1;CACNB1
prerank,DNA double-strand break processing (GO:0000729),-0.38168123404154974,-1.0847982296000256,0.3467153284671533,0.7361591528523342,1.0,7/18,20.48%,EXD2;ATM;RAD50;UBE2V2;UBE2N;SMARCAD1;SETMAR
prerank,respiratory system development (GO:0060541),0.4273684886725559,1.0847001140205927,0.37343358395989973,0.7345754275370484,1.0,7/32,17.38%,STRA6;VEGFA;CCDC40;ABCA3;ITGA3;CHD7;NKX2-1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.5172176696302061,1.0836365136598214,0.3858858858858859,0.7369647485297895,1.0,2/10,6.26%,RARA;SPHK2
prerank,glucan catabolic process (GO:0009251),0.4727056929312415,1.0832649743640568,0.368575624082232,0.7374832685640316,1.0,5/15,21.74%,PYGL;AGL;PHKG2;MGAM;PYGB
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3675527424718176,1.0830812841901136,0.348302300109529,0.7374874342236452,1.0,35/87,24.48%,CHCHD4;LYRM7;UQCRFS1;IMMP2L;SDHAF3;NDUFS8;NDUFA10;SDHAF4;NDUFC1;ECSIT;NDUFAB1;TMEM126A;NDUFAF8;COA5;OMA1;NDUFB6;DMAC1;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFAF7;UQCC1;NDUFB8;COA3;NDUFAF4;SDHAF2;NDUFB9;NDUFAF2;AIFM1;NDUFA13;TMEM126B;PET100;COA8;DMAC2
prerank,response to interferon-gamma (GO:0034341),0.37358225054060534,1.0822727516836743,0.36302142051860203,0.7392141704853978,1.0,18/67,20.76%,KYNU;IFITM1;DAPK1;GBP6;NUB1;SIRPA;MEFV;IFITM2;BST2;EPRS1;SLC11A1;ACOD1;CX3CL1;CCL7;SYNCRIP;GCH1;CCL25;CD47
prerank,regulation of axonogenesis (GO:0050770),0.3924524339135126,1.0822369838713197,0.3438967136150235,0.7388168880558309,1.0,6/51,4.72%,PLXNA1;KIF13B;PLXNC1;PLXND1;RUFY3;PTEN
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.4412951824920631,1.0819516100709863,0.37218543046357616,0.7391027183134277,1.0,10/24,24.24%,DNMT3A;SMYD5;EED;EPC1;RBBP7;MPHOSPH8;DNMT1;PHF1;MTF2;AEBP2
prerank,regulation of lamellipodium assembly (GO:0010591),-0.31215441810434563,-1.0814070294361429,0.2983425414364641,0.7435341592757023,1.0,6/34,4.57%,TWF2;AUTS2;FER;ABI2;WAS;NCKAP1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4443846568709487,1.0812898804683702,0.37583892617449666,0.7403934007308333,1.0,10/22,21.35%,NOP14;EXOSC3;EXOSC9;RPS21;ERI1;EXOSC8;EXOSC10;WDR12;EXOSC7;ABT1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.4202722281423891,1.0809982092395722,0.37532133676092544,0.7406978025376717,1.0,6/29,10.19%,YTHDF3;IFNAR2;UBE2K;RNASEL;MAVS;CNOT7
prerank,histone H4-K16 acetylation (GO:0043984),0.4643512052681155,1.0809337353395692,0.37945205479452054,0.7403722971208339,1.0,7/19,22.41%,KANSL1;PHF20;ING4;MCRS1;KMT2A;OGT;KANSL3
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.41023653406680943,1.0802050753461359,0.37731196054254007,0.7417746120816832,1.0,13/37,21.81%,SDCBP;WAC;RPL23;CSNK2A2;HIPK2;N4BP1;CSNK2A1;EIF3H;SGTA;TLK2;OGT;TAF1;GIPC1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.33377158199525775,-1.0801201593482008,0.3118811881188119,0.7450748135245725,1.0,12/27,25.56%,CACNB2;ANK2;CACNB4;JPH1;PRKACA;SELENON;CACNB1;FKBP1B;JPH4;ADRA2A;NOS1;JPH3
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.4757422055843833,1.0799055335028944,0.3753501400560224,0.7420726622803655,1.0,4/16,8.74%,TBC1D25;CLN3;IRAK3;ETF1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4841890285390754,1.0798733945549697,0.3855072463768116,0.7416663827667693,1.0,4/14,16.10%,TIMP1;CD63;PHACTR4;BST1
prerank,sensory organ development (GO:0007423),0.39199644915640186,1.0796286592815265,0.35789473684210527,0.7418038859948793,1.0,10/51,13.34%,STRA6;ZDHHC16;HIPK1;HIPK2;PAX8;MAFB;SALL2;RAB18;SOX2;SH3PXD2B
prerank,positive regulation of histone modification (GO:0031058),0.4155134706621467,1.0794842480009914,0.37752525252525254,0.7416745767706404,1.0,6/33,9.03%,APLNR;FOXP3;CHTOP;NIPBL;BRCA1;BRD7
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.44856704587378654,1.0793406947909348,0.389945652173913,0.7415440662666456,1.0,7/21,20.59%,SAMD4A;CNOT4;CNOT6L;CNOT7;CNOT6;PAN3;TNKS1BP1
prerank,positive regulation of vacuole organization (GO:0044090),0.520468270774169,1.0792015271026019,0.3821656050955414,0.7414302000132896,1.0,7/10,24.92%,SH3GLB1;ANXA2;RAB3GAP2;GRN;PIP4K2A;RAB3GAP1;PIP4K2C
prerank,regulation of smooth muscle contraction (GO:0006940),-0.36602244430883446,-1.0784522091247692,0.33840304182509506,0.7475064489834901,1.0,5/20,11.48%,KCNB2;CHRM3;CHRM2;DAPK3;NMU
prerank,protein sumoylation (GO:0016925),0.3882286460878639,1.078348842450121,0.3680555555555556,0.7432292316705537,1.0,18/49,23.69%,EYA1;NSMCE2;SUMO2;PIAS4;TOPORS;TPR;NUP50;NUP98;NUP88;PIAS2;BCL11A;PIAS1;NUP188;NDC1;NUP43;NUP54;RANBP2;EGR2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3586229192820785,-1.078259885465525,0.32432432432432434,0.7458391961776928,1.0,6/21,10.05%,CYRIB;RASAL3;SH3BP1;TGFB2;DAB2IP;CD2AP
prerank,ERAD pathway (GO:0036503),0.3708336957383463,1.078123352484015,0.350109409190372,0.7433220618121105,1.0,33/83,23.40%,TRIM25;UBXN8;NPLOC4;FAM8A1;TMUB2;FAF2;UBXN4;ERLIN1;STUB1;RHBDD1;DNAJB14;FBXO6;PRKN;DERL2;UGGT1;UBQLN2;TMUB1;DNAJC18;TMEM129;SGTA;AMFR;MAN1B1;ATXN3;BRSK2;WFS1;TOR1A;FOXRED2;JKAMP;ECPAS;VCP;HERPUD1;UBE4A;UBE4B
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3707071028511164,1.0780482337939674,0.358659217877095,0.7430360149631255,1.0,23/71,21.38%,SYK;GRB2;VAV3;ARPC2;BAIAP2;PRKCD;PLD2;ABI1;PIK3CA;VAV1;ACTR3;CYFIP2;DOCK1;FGR;WASL;CD247;ARPC1A;PIK3CB;FCGR2B;ARPC4;ACTG1;MYH2;WIPF1
prerank,cell part morphogenesis (GO:0032990),0.4956324020267836,1.0779465595867959,0.4150664697193501,0.742825637542807,1.0,2/13,4.84%,MTM1;PID1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5121990440560229,1.0778996826363108,0.3831360946745562,0.7424650593825922,1.0,3/11,6.70%,TIPARP;PARP4;PARP3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3608714845604443,1.0776176913226565,0.36609071274298055,0.7427529603612505,1.0,32/84,26.51%,PSMD1;ANAPC1;CUL3;RPS27A;UBC;RB1;PSMF1;PSMD14;PSMD12;PSME2;ANAPC10;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;FBXO31;UBE2S;PSMA2;ANAPC15;PSMD11;PSMA6;PSMB3;PSME3;CDK2;PTTG1;UBE2E1;ANAPC7;PSMC5;FZR1;PSMC1;ANAPC2
prerank,negative regulation of chemotaxis (GO:0050922),-0.325316697161129,-1.0772497937711776,0.32057416267942584,0.7464753686370809,1.0,8/31,11.90%,SEMA5A;ROBO2;ROBO1;AIF1;SEMA4G;SEMA3E;SEMA3A;SEMA6A
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.367407951527351,1.077018764851277,0.3609271523178808,0.7438492620405843,1.0,23/73,21.38%,SYK;GRB2;VAV3;ARPC2;BAIAP2;PRKCD;PLD2;ABI1;PIK3CA;VAV1;ACTR3;CYFIP2;DOCK1;FGR;WASL;CD247;ARPC1A;PIK3CB;FCGR2B;ARPC4;ACTG1;MYH2;WIPF1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4093421855619042,1.0769367547133677,0.3683559950556242,0.7435856573387113,1.0,8/34,11.94%,IL6;ENPP1;E2F1;FLCN;ZFP36L2;FOXO1;SIRT1;RORA
prerank,cellular response to organic cyclic compound (GO:0071407),0.349723699882596,1.0765774853729768,0.3514344262295082,0.7440707630544711,1.0,30/141,15.71%,HRH1;DIAPH1;CTNNB1;AQP1;TIPARP;TGM2;SPP1;P2RX4;UBE2L3;NR3C1;SLC5A5;NR1H4;P2RX3;NCOA4;MSN;FOLR1;BRCA1;LCOR;NCOA3;ESR1;EPG5;FES;RORA;FAM210B;RAPGEF1;ADCY8;ADCY3;GOLPH3;CASP6;CTNNA1
prerank,osteoclast differentiation (GO:0030316),0.4321788546567826,1.0763817212099354,0.3620457604306864,0.7440964175227652,1.0,6/22,12.33%,GAB2;SNX10;ANXA2;FOXP1;TYROBP;TREM2
prerank,mitotic metaphase plate congression (GO:0007080),0.3914105101110138,1.0763172875335056,0.3744075829383886,0.7437670869539792,1.0,12/51,17.53%,SPDL1;PIBF1;CUL3;CHMP2A;EML3;PDCD6IP;BOD1;VPS4A;CHMP6;CHMP5;CDT1;CHMP7
prerank,calcium ion homeostasis (GO:0055074),0.36285695972472776,1.0760089196163811,0.3484358144552319,0.7441374122800642,1.0,8/95,5.02%,HTR2B;TPCN2;ATP2B1;TFAP2B;ATP13A3;SLC8B1;TMEM165;SLC8A1
prerank,actin filament polymerization (GO:0030041),0.42592252899419164,1.0757079521115736,0.3955901426718547,0.7444249219336662,1.0,7/29,16.31%,DIAPH1;MICALL2;MSRB1;PSTPIP1;PSTPIP2;WASL;WASHC3
prerank,response to cadmium ion (GO:0046686),0.4355224397478396,1.0754272703388543,0.3761348897535668,0.7446644566750914,1.0,11/26,20.67%,JUN;MT3;NCF1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.43111764194030217,1.0754244822753278,0.38114209827357237,0.7441806953091719,1.0,8/27,16.99%,PRKCD;ENPP1;PID1;SLC27A4;PTPRE;PRKCB;PTPN1;PIP4K2A
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.45692282965012354,-1.0753555030887465,0.39076923076923076,0.7494981345189304,1.0,2/10,3.32%,BIN1;ATP1A2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3569262877693957,1.07525201307188,0.32872340425531915,0.7441654333335425,1.0,34/114,22.89%,ST18;FOXO3;PSMD1;RIPK1;TNFRSF1B;ADAM17;PTK2B;BIRC3;PSMF1;BAG4;PSMD14;TRAF1;PSMD12;TRAF3;RELA;PSME2;TRAF5;TRAF2;LTB;LTBR;TNFRSF14;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;TXNDC17;PSMB3;ILK;PSME3;JAK2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.38335414195654016,1.0752514617092586,0.3798185941043084,0.7436778866082985,1.0,10/57,10.59%,CTSD;SYK;DAPK1;HTRA2;TBC1D10A;NLRC4;MEFV;CYFIP2;CYCS;SIRT1
prerank,homocysteine metabolic process (GO:0050667),0.5109622051622902,1.075025826212571,0.4200298953662182,0.7438033528963667,1.0,3/11,17.70%,TST;BLMH;MTRR
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.44177508592836034,1.0750233268842473,0.37753721244925575,0.7433227840993591,1.0,5/23,12.90%,WEE2;PLK2;ZFYVE19;VPS4A;CHFR
prerank,DNA alkylation (GO:0006305),0.4607072141912901,1.074918237500407,0.38227146814404434,0.7426112538217757,1.0,7/19,21.92%,DNMT3A;GATAD2A;KMT2E;DNMT1;MTRR;EHMT2;DMAP1
prerank,DNA methylation or demethylation (GO:0044728),0.4607072141912901,1.074918237500407,0.38227146814404434,0.7426112538217757,1.0,7/19,21.92%,DNMT3A;GATAD2A;KMT2E;DNMT1;MTRR;EHMT2;DMAP1
prerank,regulation of MAPK cascade (GO:0043408),0.3497900898232652,1.0748886390650614,0.34123711340206186,0.7422156061099747,1.0,27/157,15.12%,IQGAP1;GDF15;SYK;ADRA1D;ADRA1A;TAOK3;IL6;TMEM106A;FAS;PDGFA;IGF1;DAG1;DUSP3;PPEF2;STK3;LAMTOR1;TNIK;ROCK1;PAK2;CCN1;STYX;ROR1;SOX2;RRAS;SHC1;CX3CL1;ATP6AP2
prerank,endoplasmic reticulum organization (GO:0007029),0.3675302890256835,1.0747733379108104,0.37209302325581395,0.7420455618793612,1.0,22/72,20.29%,REEP4;GAK;STX5;HMOX1;RTN3;VAPA;CYB5A;VCPIP1;RAB10;RAB18;APP;ALDH3A2;LPCAT3;ATL2;ATL1;MOSPD3;RTN4;SGTA;TMEM170A;SEC31A;SHTN1;VAMP2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.33571642390072587,1.0746572456534131,0.222,0.7418595286512094,1.0,138/807,14.84%,PPARG;MDFIC;FNIP2;CD38;SDCBP;TFEC;IRX3;FRK;RCOR1;TRPS1;ZNF3;CTNNB1;MITF;VEGFA;WWP1;CEBPB;FNIP1;ZEB2;ATXN1;FOXP3;DNMT3A;ATF3;WWC2;LANCL2;RUNX2;ARID4A;NR1H3;GATAD2A;ID2;FOXO3;NIBAN2;LIN37;CBX8;ZNF692;TFAP2B;RUNX3;RXRA;JUN;NCOR1;RARA;MAP2K5;MZF1;CITED2;BACH1;E2F1;TAF7;SAP30;GADD45A;NR3C1;SIRT6;TCERG1;EED;NR1H4;DDX5;CREBBP;BHLHE40;RPS14;FLCN;HNRNPU;PEX14;NIPBL;ATF4;TGIF1;RPS27A;UBC;RITA1;ETV6;ZNF177;RPL23;RREB1;UXT;PIAS4;SOX9;BRCA1;SNAI2;NEDD4L;RB1;RBAK;LCOR;WWP2;EPC1;ZNF148;FOXP1;IRF2;CHD3;CBFB;BRD7;TBL1XR1;DACH1;ARID5B;TPR;DDIT3;XRCC5;NR2C1;HCFC2;RLIM;ESR1;PSPC1;CNOT7;FOXK1;KDM2A;VPS72;POU3F3;FOXO1;SIRT1;LARP7;PPARD;ING4;CUX1;MT3;CBX3;CIPC;SP3;NOTCH1;TBX6;SARS1;DEDD2;DDX20;MAZ;SIRT7;BCLAF1;SOX2;RELA;GAS6;ATP8B1;POU2F1;KDM1B;LIMD1;PRKN;ZKSCAN3;DCAF1;SUV39H2;PRDM2;SHC1;ID4;EID1;PER3;RPL10
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.43253466054130335,-1.0745460149822923,0.3698224852071006,0.7494387621111072,1.0,2/11,2.63%,PTPRT;SH2B3
prerank,substantia nigra development (GO:0021762),-0.30393828468436696,-1.0739441405819659,0.3128205128205128,0.7488875039141816,1.0,15/37,22.14%,MBP;PADI2;BASP1;GLUD1;INA;SIRT2;YWHAH;ATP5PF;RHOA;SUDS3;RAD1;TTBK1;CKB;COX6B1;GNB4
prerank,negative regulation of translation (GO:0017148),0.36085711443385526,1.0739298899027347,0.36373507057546145,0.7433168009384981,1.0,15/87,11.87%,SAMD4A;CPEB4;DAPK1;DDX6;CELF1;IGF2BP3;YTHDF3;AGO2;EIF2AK4;EIF4EBP2;TPR;ROCK1;CNOT7;FTO;EPRS1
prerank,rRNA processing (GO:0006364),0.3454841999735184,1.0737753654071371,0.360082304526749,0.743236767146647,1.0,68/172,27.29%,C1D;EBNA1BP2;MPHOSPH10;BYSL;SENP3;RPL18A;EIF6;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;EXOSC3;TEX10;SART1;NAT10;WDR18;EXOSC9;POP4;WDR74;RPL22;NOB1;DKC1;MRPL1;ERI1;EXOSC8;NOL8;RPL10A;KRR1;MRM2;TSR3;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;UTP15;RCL1;DHX37;EXOSC7;RPS27;WDR43;FBL;PRKDC;BOP1;NOLC1;RPL7A;LYAR;NOL6;XRN2;RPL32;SNU13;LSM6;RRP36;RPS9;WDR36;EXOSC4;DDX49;MPHOSPH6;RIOK3;RPL6
prerank,organic substance transport (GO:0071702),0.3564636859655473,1.0734994983239579,0.33195020746887965,0.7435390887401221,1.0,31/121,21.63%,ABCA1;FLVCR1;SLC18A1;ABCG1;RAB7A;ABCD1;ARRDC4;PPT1;PLTP;MFSD12;CHMP2A;KIF3A;ABCA3;ABCA2;ABCA6;GM2A;MYH9;SLC23A1;TOM1;ABCG4;SLC6A4;LRP2;SLC19A1;SLC50A1;SLC19A2;CALCRL;VAMP2;ARRDC3;CHMP2B;NDC1;SLC22A5
prerank,negative regulation of protein modification process (GO:0031400),0.36851659940834247,1.073371728396747,0.37024608501118567,0.743395010597712,1.0,14/79,14.61%,PLPP3;XDH;CORO1C;PTEN;PID1;ENSA;MFHAS1;SIRPA;CDYL;GSK3B;SIRT1;FBLN1;PRKN;LRP6
prerank,ribosomal small subunit assembly (GO:0000028),0.47434211922606684,1.0730865448648703,0.3955431754874652,0.7436611501979448,1.0,8/16,22.19%,RPS14;MRPS7;XRCC5;RPSA;PWP2;RPS27;ABT1;PRKDC
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.47843323172224184,1.0724263064349964,0.37926136363636365,0.7449294805998613,1.0,5/14,20.44%,TFRC;KMT5B;SHLD1;SHLD2;PAXIP1
prerank,embryonic axis specification (GO:0000578),-0.4025185454445306,-1.07237997138272,0.36363636363636365,0.7510465651945848,1.0,4/15,14.11%,PTCH1;CXXC4;SMAD2;TASOR
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4334927550550922,1.0723682254796656,0.3891102257636122,0.7445844009495836,1.0,5/25,8.86%,B3GNT8;NDST1;EXT1;HAS3;HS2ST1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3410492847716806,1.0723024301441315,0.312625250501002,0.7442827768431753,1.0,77/327,19.08%,ZMIZ1;ATP1B4;TFEB;MITF;POLR2A;CEBPB;ATXN1;FOXP3;CXXC1;WWC2;RUNX3;MYCBP;MZF1;FOXO4;BACH1;E2F1;UBE2L3;SAP30;APBB2;NR3C1;ASCC2;NSD3;CREBBP;BHLHE40;TESMIN;ATF4;TAF5;RREB1;JMJD1C;SNAI2;RB1;PRDM8;RBAK;IRF2;CHD3;DVL1;ZFAT;ACVRL1;DDIT3;FZD7;HCFC2;ESR1;ASCC1;PSPC1;ZFPL1;MAFB;GPBP1L1;SP3;NOTCH1;RORA;ACVR1B;PQBP1;APBB3;HCLS1;SOX2;RELA;LIMD1;PPIE;ZKSCAN5;PRDM2;HNRNPD;PPARGC1B;MYT1;CCAR1;ZBTB11;TAF5L;CHD7;ERC1;NFYC;HMGN5;UBE2V1;NAB1;ZNF431;CLOCK;NFX1;PPP2CA;NCOA2
prerank,mitochondrial translation (GO:0032543),0.3537854299565223,1.0719182400343104,0.3433799784714747,0.7448135713408307,1.0,38/104,26.09%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;MRPS35;MRPS28;MRPL30;MRPL28;IARS2;MRPL19;MRPS21;MRPL44;QRSL1;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31;MTIF2;MTIF3;MRPS2;MRPL16;MRPS18B;MRPL42;GATB;MRPL54;MRPS18C
prerank,positive regulation of cell division (GO:0051781),0.39970119892848993,1.0716613706295635,0.3709090909090909,0.7449987332204302,1.0,5/38,10.75%,HTR2B;KIF20B;CUL3;SVIL;PKN2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.46916867359925224,1.0714581639764835,0.3997233748271093,0.7450394630826315,1.0,6/16,17.81%,FASN;SLC25A1;PPT1;SCD;GCDH;CBR4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.33988898123712746,1.0712226747563078,0.2972972972972973,0.7451592261080198,1.0,87/366,19.08%,ATP1B4;TFEB;MITF;POLR2A;CEBPB;ATXN1;FOXP3;CXXC1;WWC2;FOXO3;ANKRD17;RUNX3;PDGFA;MYCBP;MZF1;ATXN2;FOXO4;BACH1;E2F1;UBE2L3;SAP30;APBB2;NR3C1;ASCC2;NSD3;CREBBP;BHLHE40;TESMIN;ATF4;TAF5;RREB1;JMJD1C;SNAI2;RB1;PRDM8;RBAK;IRF2;CHD3;PUM3;DVL1;ZFAT;ACVRL1;DDIT3;FZD7;HCFC2;ESR1;ASCC1;PSPC1;ZFPL1;MTPN;MAFB;CCNA2;GPBP1L1;APP;SP3;NOTCH1;RORA;ACVR1B;PQBP1;APBB3;HCLS1;SOX2;RELA;LIMD1;PPIE;ZKSCAN5;PRDM2;HNRNPD;RPL10;SMC3;PPARGC1B;MYT1;CCAR1;ZBTB11;TAF5L;CHD7;ERC1;NFYC;HMGN5;UBE2V1;NAB1;ZNF431;CLOCK;FBXO5;NFX1;PPP2CA;NCOA2
prerank,ncRNA 3'-end processing (GO:0043628),0.4847782910649116,1.071029782694737,0.4014388489208633,0.7452105154328981,1.0,7/14,13.46%,TOE1;INTS6;INTS8;ERI1;INTS5;INTS7;INTS2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.38340105669413416,1.0704998998835034,0.38739789964994165,0.7461318948541784,1.0,19/54,24.96%,RPL3L;MRPL20;EBNA1BP2;EIF6;WDR74;MRPL1;RPL10A;PAK1IP1;RPL10;WDR12;RPL7;RPL26;MALSU1;NOC2L;PPAN;GTF3A;BOP1;RPL7A;SNU13
prerank,negative chemotaxis (GO:0050919),-0.3204160772758403,-1.069486855576218,0.2978723404255319,0.75705252453444,1.0,9/33,14.48%,UNC5C;ROBO1;SLIT1;SEMA4G;SEMA3E;SEMA3A;EPHA7;SEMA6A;RHOA
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.36881775605170564,-1.0693905623550524,0.3559322033898305,0.7551879833459172,1.0,5/18,15.11%,IWS1;NUP133;ZC3H11A;MCM3AP;HHEX
prerank,neuron development (GO:0048666),0.3508988332504476,1.069280408438157,0.3433922996878252,0.7487912639483302,1.0,32/141,14.41%,LRP12;B4GALT5;APOE;DTNBP1;STX3;MICALL2;ERCC6;IL6;RUNX3;FRY;PPT1;CLN5;UGDH;ZFYVE27;B4GALT6;TBC1D23;MICALL1;RB1;PPP1R9B;VAPA;ROCK1;GSK3B;TBC1D24;APP;THOC2;PQBP1;TDP2;TENM1;ARL3;GDNF;UHMK1;UNC5A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.46659019388458356,1.0690717645811754,0.40331491712707185,0.748883551111864,1.0,3/17,9.25%,PLA2G2D;SERAC1;PLA2G4F
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3983467029520975,1.068629907223976,0.4034229828850856,0.7495482382046125,1.0,11/42,19.46%,CD36;VEGFA;ROCK1;GSK3B;PTK2B;RRAS;CX3CL1;UTRN;NRP1;TEK;CCL25
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4721896113546619,1.0685641787440419,0.3930131004366812,0.7492426830448227,1.0,5/15,18.62%,VEGFA;SOX9;PAX8;GDNF;SOX8
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3945124671675595,-1.068528980834363,0.35714285714285715,0.7554934723912516,1.0,10/15,30.50%,LIMK1;RPL5;SMAD7;BAG5;PARK7;BAG2;MAD2L2;ABL1;MAD2L1;DTX3L
prerank,necroptotic process (GO:0070266),0.46552087182636936,1.068443690324218,0.4147727272727273,0.7490836370122015,1.0,4/16,13.47%,RIPK1;LY96;TICAM2;TRPM7
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.43788985478305936,1.0683527853585215,0.3837981407702523,0.7488374516647929,1.0,6/22,22.15%,NFE2L2;PSMB10;PSMA3;PSMA2;PSMA6;PSMB3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3106237127428134,-1.0681749001561218,0.2912621359223301,0.754283336252923,1.0,15/33,20.66%,CCND3;RPTOR;PLCB1;AIF1;EGFR;PHB2;EZH2;PAF1;HYAL1;UBE2E2;FGF10;RGCC;PLCG2;STXBP4;EIF4G1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3387162974829832,1.0680733911692537,0.2984924623115578,0.7491159817652294,1.0,55/291,13.61%,LILRB1;AQP1;IPO5;PDK4;TGM2;MPV17;CPEB4;VIM;IL36G;NR1H3;ADAM9;IL6;ABL2;PRKCD;P2RX4;JUN;CD274;DAPK1;TNFRSF1B;LY96;SESN2;SHPK;PID1;HTRA2;NFKBIB;SLC5A5;NR1H4;CAPN2;P2RX3;STAP1;FOLR1;SOX9;LCOR;SIRPA;NFKBIL1;TICAM2;NCOA3;LAMTOR1;FZD7;ESR1;PTK2B;FOXO1;FES;MT3;TRIM41;RORA;KCNK4;FAM210B;RAPGEF1;GPLD1;ERCC6L2;SLC38A9;LAMTOR3;RELA;TNFAIP3
prerank,positive regulation of protein modification process (GO:0031401),0.33957255078221854,1.0678223876485837,0.3420787083753784,0.749285611463786,1.0,26/203,11.47%,GPNMB;RAP2A;ATG7;VEGFA;FLOT1;TXN;FNIP1;TFRC;HGF;PRKCD;FAS;RIPK1;ATG10;RAB3GAP2;FLCN;DYRK1A;SOX9;ACVR2A;DLC1;TNIK;MAVS;ADAM17;SIRT1;CCN1;MT3;APP
prerank,negative regulation of protein kinase activity (GO:0006469),0.3666925657941967,1.0677915846788453,0.3641304347826087,0.748888046341164,1.0,15/88,8.94%,DTNBP1;CORO1C;GNAQ;PRKAG2;PDPK1;CDKN1A;SLC8A1;SORL1;TAF7;GADD45A;DUSP3;GSKIP;RB1;DVL1;CEP85
prerank,arachidonate transport (GO:1903963),0.5218774081063836,1.0677890511648238,0.40735068912710565,0.7479283012831002,1.0,3/10,22.02%,ANXA1;ACE;DRD2
prerank,arachidonic acid secretion (GO:0050482),0.5218774081063836,1.0677890511648238,0.40735068912710565,0.7479283012831002,1.0,3/10,22.02%,ANXA1;ACE;DRD2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.34066053392456286,1.067788257782131,0.3604060913705584,0.7474480273870014,1.0,59/173,24.45%,F7;DYNC1H1;RANGRF;MCFD2;F10;CUL3;VTI1B;YIF1A;COG7;STX5;PROC;PGAP1;YIF1B;TRAPPC5;RAB1B;FOLR1;CTSZ;TICAM2;VAPA;CAPZB;VTI1A;BET1;TRIP11;KDELR2;ATL2;GAS6;WHAMM;COG5;TRAPPC6A;RAB2A;RAB29;CAPZA1;COG2;ARF4;BCAP29;ARFGAP2;GOPC;SEC31A;RAB1A;BCAP31;ERGIC2;SEC24C;SEC24B;PREB;COG6;PEF1;TRAPPC2L;TRAPPC8;DYNC1LI2;KLHL12;TRAPPC1;TMED3;TMED10;GOLT1A;TFG;SPTBN5;COPB1;DCTN4;STX17
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3466802300755584,1.0677621206598404,0.3591331269349845,0.7470387292964437,1.0,43/153,19.97%,SGK1;TLK1;PIKFYVE;PRKCH;RPS6KA2;ERN1;MAPKAPK3;IKBKE;PLK2;PDPK1;PRKCD;SRPK2;RIPK1;PKN3;DYRK1A;TOP1;HIPK1;CSNK2A2;HIPK2;ROCK1;GSK3B;PAK2;PKN2;DCLK3;PRKCB;STK38;DGKQ;DYRK2;GAS6;MAST4;UHMK1;TNKS;LATS1;PRKCG;CAMK1;CSNK2A1;CSNK1G1;STK4;STK32C;TLK2;TBK1;MKNK2;CAB39
prerank,smoothened signaling pathway (GO:0007224),-0.3089481603352699,-1.0674977154401484,0.31527093596059114,0.7539772389574589,1.0,16/32,26.41%,PTCH1;SMO;GLI3;TCTN3;MAP3K10;PKD2L1;ULK3;IFT27;TCTN2;TTBK2;GPC2;DISP2;CC2D2A;EVC2;STIL;GLI2
prerank,motile cilium assembly (GO:0044458),0.4922714132016375,1.06748120595057,0.41131498470948014,0.7473191522731684,1.0,2/12,5.72%,CCDC40;DNAAF3
prerank,lung development (GO:0030324),0.4122705873277105,1.0673799535619095,0.39012345679012345,0.7470987263178536,1.0,4/33,7.78%,STRA6;VEGFA;CCDC40;ABCA3
prerank,cellular response to interleukin-6 (GO:0071354),-0.33767288662286304,-1.0660434153190812,0.3333333333333333,0.7559321707970149,1.0,5/26,4.96%,SELPLG;ST3GAL6;PTPRT;FER;IL6ST
prerank,regulation of calcium ion transport (GO:0051924),0.38724708262032154,1.065529707976197,0.365296803652968,0.7515907533135118,1.0,8/54,5.19%,LILRB1;CTNNB1;CD84;ATP2B1;P2RX4;SLC8B1;HOMER3;GRIN3B
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5105635048045888,1.0652656164680432,0.3956723338485317,0.7518313019894675,1.0,1/10,0.78%,GALNT3
prerank,regulation of cell cycle phase transition (GO:1901987),0.35675480717844954,1.0647723995502154,0.37553648068669526,0.7526273054263127,1.0,33/91,26.51%,FBXW7;CDKN1A;PSMD1;ANAPC1;GTSE1;DDB1;PSMF1;DBF4;PSMD14;PSMD12;PSME2;CUL1;ANAPC10;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;UBE2S;PSMA2;ANAPC15;PSMD11;PSMA6;TAF1;XPC;PSMB3;PSME3;UBE2E1;ANAPC7;PSMC5;FZR1;PSMC1;ANAPC2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5223616066451331,1.0646747259542493,0.4375,0.7524040420034774,1.0,5/10,22.43%,RIC1;ANXA2;NELL1;EPHA4;FURIN
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.4648217350494074,1.06451397241538,0.41414141414141414,0.7523515446726632,1.0,7/16,19.90%,SNRNP200;SART1;DDX23;NCBP2;WBP11;RBM22;PRPF39
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5134962275879638,1.0644800340363343,0.40188383045525905,0.7519570520591483,1.0,3/11,8.74%,RUNX3;CD274;CBFB
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.42562009972720616,1.064462152462826,0.3937007874015748,0.7515267680941146,1.0,14/27,29.22%,NAT8;PHF20;CREBBP;PHF20L1;SGF29;KAT2A;RUVBL2;KAT6B;KAT6A;KAT2B;MRGBP;BRD8;EP300;MORF4L1
prerank,protein monoubiquitination (GO:0006513),0.4076168378685025,1.0643491151472566,0.391304347826087,0.7513423712948831,1.0,13/36,24.68%,WAC;TRIM25;CUL3;TOPORS;HUWE1;PRKN;CDC73;UBE2O;UBE2R2;KLHL12;OBI1;UBE2D3;UBE2E1
prerank,mitochondrial transport (GO:0006839),0.37867006636970385,1.0640803861643666,0.3822525597269625,0.7515543211132081,1.0,20/53,24.20%,FLVCR1;TIMM22;PPIF;PITRM1;TOMM20;TIMM17A;TIMM17B;GDAP1;BNIP3;TOMM34;TOMM7;TOMM22;FBXO7;BCAP31;SLC25A13;MFN2;SLC25A24;AIP;MTX2;BCL2L1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.4626893258116137,1.0632621261503097,0.4171270718232044,0.7532288965274095,1.0,7/17,22.72%,MVD;ALG13;ALG12;MPDU1;ALG6;DPAGT1;SRD5A3
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.4726420918617866,1.0630440337141924,0.4056737588652482,0.753302456906282,1.0,3/15,10.36%,TEC;DYRK1A;PTK2B
prerank,positive regulation of axonogenesis (GO:0050772),0.3956294496031591,1.0630177516878931,0.4050179211469534,0.7528766339341714,1.0,5/43,5.22%,PLXNA1;PLXNC1;PLXND1;RUFY3;ZFYVE27
prerank,iron-sulfur cluster assembly (GO:0016226),0.43107352028143064,1.0630098108941737,0.3959731543624161,0.7524204556662424,1.0,11/24,25.40%,ABCB7;NUBP2;NUBP1;GLRX3;CIAO2B;CIAO2A;GLRX5;NFS1;HSPA9;FXN;CIAO1
prerank,aminoglycan metabolic process (GO:0006022),0.5146438643329112,1.06258681515645,0.4113821138211382,0.7530653125219365,1.0,2/10,4.53%,XYLT1;B4GALT7
prerank,pre-replicative complex assembly (GO:0036388),0.3702311304299578,1.0625501875349896,0.38838268792710706,0.7526883832141978,1.0,23/64,26.26%,PSMD1;RPS27A;UBC;PSMF1;PSMD14;PSMD12;PSME2;ORC1;ORC4;CDT1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;PSMC5;ORC6;MCM3;PSMC1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4074956389698686,1.0621227472745598,0.39012345679012345,0.7533302807491402,1.0,11/35,18.11%,ACSS3;FASN;SLC25A1;PPT1;AACS;GGTA1;HMGCL;SCD;GCDH;CBR4;PAM
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5021381133194417,1.0620567205053015,0.42121684867394693,0.7530218586275202,1.0,4/10,22.39%,AGO2;DROSHA;MRPL44;TSNAX
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.39082688818346,-1.0618157218044166,0.3801369863013699,0.7656223868914712,1.0,4/15,7.55%,ACVR1;ACVR2B;MAGI2;SMAD7
prerank,regulation of mitotic nuclear division (GO:0007088),0.37743048003378155,1.0616712373737427,0.3761261261261261,0.7535310097806395,1.0,5/55,5.08%,CCDC8;KIF20B;CD28;TOM1L2;IGF1
prerank,cellular response to amyloid-beta (GO:1904646),0.40020669639495776,1.061637436919774,0.39775561097256856,0.753141644037062,1.0,7/35,12.33%,CD36;LRP1;ITGA4;IGF1;GSK3B;APP;TREM2
prerank,regulation of heart contraction (GO:0008016),-0.2581681992350499,-1.0615644568272562,0.33766233766233766,0.7641375360156044,1.0,17/90,12.40%,ATP1B1;RYR3;ANK2;ITPR2;TRPC1;ASPH;ATP1A2;RYR2;ATP1B2;SMAD7;ATP2B3;TGFB2;CELF2;PRKACA;ATP2B2;ATP2B4;AGT
prerank,cellular protein localization (GO:0034613),0.33524063767065204,1.0605176572599135,0.351460221550856,0.7556671996580627,1.0,99/285,25.11%,TLK1;CTNNB1;STX3;SNX8;RAP2A;ACD;TBC1D22A;SNX27;RIC1;TBC1D25;RAB20;TBC1D1;TBC1D2;CTSA;CD63;SNX9;TBC1D12;GRIN3B;RAB21;STX8;TBC1D10A;COG7;STX5;RAB3GAP2;NIPBL;TBC1D2B;RAB31;RAB1B;HPS6;TICAM2;RAB28;VPS33A;UNC93B1;STX11;LAMTOR1;EPB41L3;SIL1;TBC1D22B;ARHGEF2;RAB18;TBC1D15;WLS;STXBP3;RAB24;AP3D1;CPLANE2;PACS2;RAB43;ATG13;LAMTOR3;SH3PXD2B;ARL4C;STX6;CELSR1;AP3B1;SNX17;TBC1D9;RABGAP1;RAB29;GGA2;RAB22A;ARF4;PTPRU;VPS29;ITSN1;AP4M1;ARF5;STXBP2;CORO1B;PIGU;ARL5B;SEC31A;TM9SF1;RAB1A;SGSM2;CROCC;GGA3;RPGR;TBC1D4;DNAJC27;TM9SF3;VPS35;SNX13;TRAPPC8;VPS45;MFN2;TMED3;TMED10;FLNA;TM9SF4;ARMCX3;RRAGC;ARL11;STX17;CEP250;PRPF19;ARFGAP3;STX16;CLTC
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3588135113000153,1.0604535125125236,0.38209606986899564,0.7553731215991942,1.0,29/80,22.44%,SAMD4A;ABCG1;VIM;IL6;CD28;PRKCD;YTHDF3;THBS1;SPHK2;EIF6;LARP4B;ABCA2;NAT10;PICALM;RELA;HNRNPD;EIF4A3;SIRT3;RPL26;CASP3;NSMAF;BCL3;EIF3C;LARP4;PCIF1;GSAP;EPHA4;PRKDC;UPF3A
prerank,renal water homeostasis (GO:0003091),0.4412499970365433,1.0600210547645186,0.4178712220762155,0.7560677452395396,1.0,9/23,24.54%,AQP1;TFAP2B;ADCY7;ADCY8;ADCY3;WFS1;ADCY5;ADCY9;RAB11FIP2
prerank,regulation of establishment of protein localization (GO:0070201),0.48116156011175293,1.0600188427665342,0.4036144578313253,0.7555947974799758,1.0,5/13,22.99%,CTSD;TREM2;GAPVD1;DNAJA1;SPIDR
prerank,phospholipid catabolic process (GO:0009395),0.43191434261572587,1.059905204704858,0.40182054616384916,0.7554181800690823,1.0,6/24,14.93%,LIPG;GPCPD1;PLA2G4F;PLBD2;GDE1;PRDX6
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.44810033176806824,1.059665402303333,0.39313984168865435,0.7555732136119222,1.0,5/21,15.85%,ERN1;JUN;IGF1;HTR1B;DNMT1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.41993078315885757,1.0595348168663836,0.4034653465346535,0.7554268253119343,1.0,7/27,19.58%,MAP3K20;RPS27A;UBC;MAP3K8;CUL1;CCDC88C;CCM2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.49231192068577856,1.0591687227417659,0.4193061840120664,0.7559081051709184,1.0,5/12,18.62%,VEGFA;SOX9;PAX8;GDNF;SOX8
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.36291835429393243,1.058951012194062,0.3908174692049272,0.7560019759829653,1.0,14/72,15.80%,GALNT3;GRB2;POLR2A;KIF16B;FGFR4;POLR2L;POLR2G;POLR2I;NCBP2;HNRNPM;GTF2F2;CBL;FRS2;FLRT1
prerank,polyamine metabolic process (GO:0006595),0.47757048763143467,1.0589483766774328,0.39764359351988215,0.755530209286804,1.0,4/13,13.02%,PAOX;SAT1;OAZ2;DHPS
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3903743284076457,1.0589357569302902,0.3939038686987104,0.7550961080015414,1.0,8/47,11.47%,APOE;NR1H3;FOXO3;ATXN2;WDR91;PUM3;MTPN;APP
prerank,translational elongation (GO:0006414),0.3500964578540922,1.0587419087304075,0.3703308431163287,0.7551266179397901,1.0,30/101,20.33%,MRPS26;MRPL20;EEF1A1;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;GTPBP2;MRPS35;MRPS28;MRPL30;MRPL28;MRPL19;MRPS21;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31;EEF1D
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4933044093649909,1.058365048246709,0.42028985507246375,0.7556325531016169,1.0,5/12,22.13%,IDH1;IDH3G;IDH3B;IDH2;ACO1
prerank,DNA duplex unwinding (GO:0032508),0.3803115951723861,1.0581931399001072,0.3901869158878505,0.7555912825488156,1.0,12/50,15.71%,ANXA1;MCM9;GTF2H5;RPS27A;UBC;RTEL1;DDB1;NBN;CUL4A;WRN;SSBP1;TWNK
prerank,regulation of response to cytokine stimulus (GO:0060759),0.44681247006312685,1.0579189314037822,0.40405405405405403,0.7558471792589639,1.0,5/19,9.94%,IRAK2;MAP2K5;MAPK7;CBFB;MAVS
prerank,positive regulation of type 2 immune response (GO:0002830),0.4778747359622316,1.0567015221814153,0.3937677053824363,0.7585436629992003,1.0,3/14,8.01%,IL6;RARA;DENND1B
prerank,glycine transport (GO:0015816),0.5090960904102817,1.0562604900155774,0.4363354037267081,0.7591971432609451,1.0,4/10,23.01%,SLC36A2;SLC36A1;SLC7A8;SLC25A38
prerank,negative regulation of cell junction assembly (GO:1901889),0.4288612923250581,1.0562554403490285,0.40797940797940796,0.7587328625282626,1.0,9/25,17.48%,CORO1C;PTEN;THBS1;DLC1;ACVRL1;ROCK1;BCAS3;ACE;APOD
prerank,synaptic vesicle localization (GO:0097479),-0.40443480300328405,-1.056231588834667,0.3773006134969325,0.776870769832589,1.0,4/13,8.44%,NLGN1;RAB27A;KIF5A;SYNDIG1
prerank,DNA repair (GO:0006281),0.33396663925130726,1.0561401261060364,0.35943775100401604,0.7585635928103146,1.0,81/284,22.19%,EYA1;ERCC6;MUS81;RFC3;MUTYH;UVRAG;ZRANB3;PARP4;KPNA2;GTF2H5;BRIP1;BACH1;PARP2;FAM111A;GADD45A;BABAM2;ASCC2;DOT1L;PARP3;PMS1;RPS27A;UBC;NEIL1;PIAS4;EME1;ENDOV;BRCA1;WDR33;RAD23A;SMC1A;HUWE1;VCPIP1;POLH;XRCC4;XRCC5;DDB1;ASCC1;XRCC2;FTO;SIRT1;POLL;MBD4;INIP;NBN;DCLRE1B;KMT5B;TDP2;WRN;NSMCE3;FBXO6;ERCC6L2;POLA1;RNASEH2A;INO80;NSMCE4A;MNAT1;BRCC3;CENPX;FANCA;TEX264;BAZ1B;ALKBH1;POLI;UBE2V1;ALKBH5;RAD21;ATXN3;PDS5A;MRE11;TNKS1BP1;CUL4B;USP3;RAD51B;XPC;APEX2;MGMT;FANCM;RPAIN;XRCC1;VCP;PRKDC
prerank,gene silencing by miRNA (GO:0035195),0.40682124243278917,1.0560393108555033,0.4027603513174404,0.7583298663571588,1.0,9/32,14.86%,AGO2;EIF6;TNRC6B;CNOT7;AGO3;PUM2;SPOUT1;LIMD1;CNOT6
prerank,regulation of nervous system process (GO:0031644),-0.36347257259328225,-1.055390813217234,0.3694029850746269,0.7771273004388797,1.0,4/18,6.42%,HTR2C;DLGAP1;DLGAP2;AKAP9
prerank,positive regulation of protein import (GO:1904591),0.40930473719289984,1.05538032464659,0.39327296248382926,0.7595848263714223,1.0,13/30,26.10%,IPO5;PRKCD;TPR;MAVS;HCLS1;RBM22;EFCAB7;PDCD5;DMAP1;FLNA;UBR5;BAG3;ZIC1
prerank,activation of protein kinase activity (GO:0032147),0.35008515724950956,1.0553707781922932,0.39060832443970117,0.7591305080835196,1.0,21/106,16.20%,OSBPL8;VEGFA;TXN;PIBF1;TAOK3;PDPK1;PRKCD;IGF1;ADCY7;STK3;TNIK;PTK2B;PRRC1;PAK2;MT3;GAS6;SLC11A1;ADCY8;ADCY3;MAPKAP1;TRAF2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3481634911271349,1.0553679886891125,0.384375,0.7586619124609449,1.0,25/124,14.41%,LRP12;APOE;DTNBP1;LIMA1;STX3;MICALL2;ERCC6;IL6;FRY;ZFYVE27;TBC1D23;WDPCP;MICALL1;RB1;PPP1R9B;VAPA;PLEKHA1;ROCK1;GSK3B;TBC1D24;APP;PQBP1;GDNF;UHMK1;UNC5A
prerank,negative regulation of cell migration (GO:0030336),0.3432607501306891,1.055359738016012,0.4006276150627615,0.7582074494637516,1.0,32/137,15.31%,TIMP1;MITF;RAP2A;CORO1C;LRP1;IFITM1;FOXO3;PTEN;CITED2;ZMYND8;DAG1;DUSP3;TNN;STK24;FLCN;HMOX1;NF2;MCC;DLC1;ACVRL1;DACH1;RAP2B;BST2;SULF1;ARID2;COL3A1;MCTP1;PODN;CLASP1;PFN2;CX3CL1;ADARB1
prerank,positive regulation of T cell migration (GO:2000406),-0.3540018801258353,-1.0552214324372673,0.36496350364963503,0.7754766498775012,1.0,6/20,15.79%,DOCK8;AIF1;PYCARD;WNK1;RHOA;CCR2
prerank,positive regulation of cellular protein localization (GO:1903829),0.36698397812712474,1.0551420729256717,0.41394825646794153,0.7582860510984831,1.0,14/69,15.40%,GPR137B;STX3;TFRC;RANGRF;SESN2;GPD1L;APC;GTSE1;TYROBP;SNX33;GSK3B;PRKN;PARD6A;RTN4
prerank,protein localization to organelle (GO:0033365),0.3452103096656345,1.0551154662260085,0.38739669421487605,0.7578871532259841,1.0,20/133,8.95%,OPTN;PIKFYVE;LAMP1;SNX10;RAB33B;LMNA;SORL1;TSPAN17;COL1A1;GAK;COG7;STX5;LMBRD1;HMOX1;MICALL1;LAMP2;DVL1;VAPA;CYB5A;TOPORS
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3187494257304929,-1.0550341531140521,0.36792452830188677,0.7738277301104625,1.0,7/29,13.63%,LDLRAD4;SPRED1;SMAD7;DAB2IP;SPRED2;HPN;SPRED3
prerank,regulation of chemotaxis (GO:0050920),0.41527387502140234,1.054900486550683,0.41344956413449563,0.7579755146283702,1.0,5/30,5.64%,CXCR4;STX3;P2RX4;THBS1;DUSP3
prerank,regulation of protein transport (GO:0051223),0.42359919493910264,1.0548889359451854,0.41392904073587383,0.7575419177318937,1.0,12/27,25.12%,LCP1;RHBDF2;STXBP5;WWP2;GAPVD1;PTPN1;SNX3;DNAJA1;NDFIP1;DNAJC1;ATP13A2;DISP1
prerank,signal release from synapse (GO:0099643),-0.28515110415494554,-1.0544116374016526,0.36363636363636365,0.7734275812041003,1.0,7/43,5.23%,NRXN1;SYT1;RIMS1;SYN2;PTPRN2;LIN7A;SNAP25
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.46847955152704546,1.0543903948671092,0.4108983799705449,0.7583962701971935,1.0,1/15,0.68%,SYK
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5134504922191467,1.0542028135654153,0.4339339339339339,0.7584115285793657,1.0,5/10,22.11%,ACADL;ACADVL;GCDH;ETFA;IVD
prerank,hyaluronan catabolic process (GO:0030214),0.4465848032471856,1.053214110695629,0.42349726775956287,0.7604845705178804,1.0,4/18,6.11%,CD44;STAB2;CEMIP2;HEXA
prerank,microvillus assembly (GO:0030033),0.47583521867757045,1.0527719621283782,0.4127906976744186,0.7611705386753642,1.0,3/14,10.17%,RAP2A;TNIK;RAP2B
prerank,regulation of mononuclear cell migration (GO:0071675),0.4372735057575044,1.0526164868441703,0.41310160427807485,0.76111540690333,1.0,3/23,7.73%,LGALS3;THBS1;MSN
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.4615736051510908,1.0522198655475699,0.4090909090909091,0.7616680713573885,1.0,2/15,3.64%,ERN1;CPSF1
prerank,negative regulation of coagulation (GO:0050819),0.46955896549063275,1.0519923862378586,0.40638606676342526,0.761765817931667,1.0,2/14,6.55%,APOE;PROC
prerank,positive regulation of neuron death (GO:1901216),0.3883581901573312,1.0515106811649173,0.4090368608799049,0.7625357236268798,1.0,10/46,10.26%,CTNNB1;FOXO3;TFAP2B;SRPK2;ATF4;TYROBP;PICALM;BACE1;DDIT3;GSK3B
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3673786775733098,-1.0513464364519567,0.3591549295774648,0.7799629357778961,1.0,6/17,13.63%,SPRED1;PARD3;SMAD7;SPRED2;SIRT2;SPRED3
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.49659466663596896,1.0510688200592095,0.42313323572474376,0.7632624426889836,1.0,6/11,25.24%,NR1H3;SLC27A1;GPLD1;SREBF1;NR1H2;CTDNEP1
prerank,protein modification by small protein removal (GO:0070646),0.3338192053713276,1.050545057696567,0.3782696177062374,0.7641647552851554,1.0,78/252,22.15%,GPS1;TNIP1;PSMD1;RIPK1;ASXL2;PTEN;FOXO4;STAM;BABAM2;SENP3;APC;RNF128;TOMM20;RPS27A;UBC;USP42;BRCA1;RAD23A;USP12;VCPIP1;COPS5;SENP5;ESR1;FOXK1;USP40;BIRC3;USP26;CCNA2;PSMF1;USP48;PSMD14;PSMD12;COPS7A;TRAF3;USP21;USP16;KDM1B;TNFAIP3;PRKN;RNF123;USPL1;MCRS1;PSME2;INO80;STAM2;USP36;CCP110;BRCC3;ASXL1;USP8;TRAF2;NFRKB;OTUD5;SENP7;PSMB10;KEAP1;PSMD5;SNX3;USP32;BIRC2;SENP1;CDC25A;PSMD8;PSMA3;USP30;STAMBP;PSMA2;ATXN3;PSMD11;PSMA6;OGT;TOR1A;USP3;USP9X;KAT2A;USP2;VCP;PSMB3
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5047490933644312,1.0504473106147392,0.42966360856269115,0.7639584292869288,1.0,2/10,6.20%,ABCD1;MLLT11
prerank,T cell proliferation (GO:0042098),-0.3887960183131476,-1.0501827023479364,0.4,0.7809697064765789,1.0,2/13,0.25%,CADM1;DOCK8
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3612615547862361,1.0500302817854714,0.4140197152245345,0.7645781737388294,1.0,7/76,4.92%,HTR2B;HRH1;ADRA1D;ADRA1A;TGM2;GPR157;C3AR1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3536145117715816,1.0497134870187326,0.40261153427638735,0.7649341773113204,1.0,16/87,15.80%,GALNT3;GRB2;POLR2A;CD44;KIF16B;FGFR4;ZFP36L2;POLR2L;POLR2G;POLR2I;NCBP2;HNRNPM;GTF2F2;CBL;FRS2;FLRT1
prerank,defense response to symbiont (GO:0140546),0.35722899731369606,1.0495815636307007,0.4019607843137255,0.7648011157799306,1.0,19/92,16.48%,LYST;TLR8;LILRB1;ATG7;IFITM1;IL6;IFNAR2;RNASEL;IRF2;IFITM2;MAVS;CNOT7;BST2;PQBP1;RELA;ACOD1;BNIP3;MYD88;IFIT2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4444077908541886,1.0495678548051002,0.4214992927864215,0.7643603076218753,1.0,8/20,20.20%,FAS;GSK3B;APPL1;BAX;MCL1;CASP2;CASP3;ITGAV
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5025667275470169,1.0494004934301109,0.4218512898330804,0.7643016689132032,1.0,4/11,17.90%,RIPK1;BIRC3;ARHGEF2;BIRC2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4207448822988136,1.0489182400741524,0.4304461942257218,0.765063185174143,1.0,8/25,16.22%,FOXO3;STAT5B;HSPA1B;ACVR2A;ACVR1B;FAM210B;HSPA1A;BRD1
prerank,cellular response to interleukin-4 (GO:0071353),0.5109012905273485,1.0485914237206877,0.44049459041731065,0.7654553341628195,1.0,3/10,19.37%,SHPK;JAK3;STAT6
prerank,positive regulation of vascular permeability (GO:0043117),0.4860341044254032,1.0481600749838194,0.4182344428364689,0.766046680058274,1.0,1/12,1.73%,VEGFA
prerank,cell junction organization (GO:0034330),-0.2709861103326277,-1.0477699614679992,0.36893203883495146,0.7857033730681136,1.0,15/71,10.47%,GRM5;OPHN1;SDK1;SMAD3;CTNND2;VASP;MAPT;PPFIA4;SEMA3E;SH3BP1;AGRN;TGFB2;SLC6A1;FERMT2;NLGN3
prerank,cellular response to lipopolysaccharide (GO:0071222),0.34884657819527415,1.0477484752468735,0.4208289054197662,0.7665972586573581,1.0,22/101,15.74%,LILRB1;VIM;IL36G;NR1H3;ADAM9;IL6;CD274;TNFRSF1B;LY96;SHPK;NFKBIB;STAP1;SIRPA;NFKBIL1;TICAM2;TRIM41;RELA;TNFAIP3;ACOD1;LBP;CDC73;MYD88
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4407173983256093,1.0477447703445337,0.42587601078167114,0.7661347431377501,1.0,9/21,25.34%,BCL2L11;DDIT3;PRKN;HSPA1A;CREB3;CREB3L1;HERPUD1;BCL2L1;TXNDC12
prerank,regulation of insulin secretion (GO:0050796),-0.24695952928206405,-1.047742706991051,0.27941176470588236,0.7836492713255846,1.0,24/101,14.77%,EPHA5;CACNA1E;KCNC2;ITPR2;CACNA1C;IRS1;SNAP25;SYT7;LRP5;RAPGEF4;ACSL4;REST;CACNA2D2;PICK1;RFX3;GLUD1;LRRC8A;MYRIP;TM7SF3;PRKCA;DPP4;BAD;STX1A;RAPGEF3
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.37589288525222664,1.047686720027236,0.4257075471698113,0.7658048250690911,1.0,14/52,16.80%,SAMD4A;DDX6;CNOT4;EXOSC3;CNOT6L;EXOSC9;PATL1;CNOT7;EXOSC8;NT5C3B;CNOT6;EDC3;EXOSC1;PAN3
prerank,negative regulation of nuclear division (GO:0051784),0.5076078182931869,1.0476324862851085,0.413075780089153,0.7654803876884422,1.0,3/11,18.91%,TOM1L2;AURKAIP1;FBXO5
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.4024859766244522,-1.0476049611777687,0.38125,0.7819515595834421,1.0,3/12,8.88%,NFIB;SPTBN4;SZT2
prerank,T cell differentiation (GO:0030217),0.3891723336500136,1.0475812414422057,0.40803897685749085,0.7651366960329395,1.0,8/40,17.11%,ANXA1;CD28;ZFP36L2;LFNG;ADAM17;GPR89A;GPR89B;CHD7
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.49474442384670425,1.0473278646625224,0.41853512705530643,0.7649001451822109,1.0,5/12,25.42%,CORO1C;FBLN1;MELTF;RCC2;EFNA5
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.49474442384670425,1.0473278646625224,0.41853512705530643,0.7649001451822109,1.0,5/12,25.42%,CORO1C;FBLN1;MELTF;RCC2;EFNA5
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3817651484352588,1.0472372153490335,0.40375586854460094,0.7646586906854939,1.0,17/46,23.94%,CHCHD4;TIMM22;PITRM1;TOMM20;TIMM17A;TIMM17B;GDAP1;HSPD1;TOMM34;TOMM7;TOMM22;FBXO7;BCAP31;MFN2;AIFM1;AIP;HK1
prerank,regulation of stem cell proliferation (GO:0072091),0.4579838659103428,1.0470386812734758,0.4,0.7647248863941505,1.0,5/17,21.02%,HNRNPU;AGO3;FBLN1;ACE;PTPRC
prerank,positive regulation of protein import into nucleus (GO:0042307),0.4110342158989138,1.0470262386426457,0.39869281045751637,0.7643005469554683,1.0,12/28,26.10%,IPO5;PRKCD;TPR;MAVS;HCLS1;RBM22;EFCAB7;DMAP1;FLNA;UBR5;BAG3;ZIC1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3417947785758763,1.0467732700703827,0.3981191222570533,0.7644849978400747,1.0,42/122,24.61%,NAMPT;SAMD4A;VIM;IL6;HGF;CD28;TMEM106A;YTHDF3;IGF1;FGFR4;THBS1;IRS2;EIF6;LARP4B;NAT10;MTPN;SIRT1;NPM2;DYRK2;HNRNPD;STN1;EIF4A3;ATAD5;CDT1;RPL26;EPM2AIP1;BCAR3;BCL3;EIF3C;LARP4;GCK;PCIF1;PRKDC;UPF3A;FAF1;JAK2;NMD3;ZCCHC4;PDGFRB;PLXNB2;IGF2;SOX4
prerank,lymphocyte chemotaxis (GO:0048247),-0.30467494521305244,-1.0466170785652062,0.35714285714285715,0.7825274190988053,1.0,5/34,7.38%,SLC12A2;GPR183;CYP7B1;CCL4;CXCL16
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.38483514801557134,1.046533976474635,0.4043848964677223,0.7646755355064682,1.0,12/42,16.45%,FARS2;DARS1;TARS3;NARS2;EPRS1;SARS2;SARS1;TARS2;IARS2;PARS2;CARS2;AIMP1
prerank,regulation of intracellular signal transduction (GO:1902531),0.33058020240752334,1.0458974690957619,0.359,0.7657925862163534,1.0,107/420,20.40%,ARHGAP24;ARHGAP21;ARHGAP10;ABR;SGK1;ARHGAP19;VWF;OPTN;ARHGAP15;VAV3;VEGFA;PRKAG2;WWC2;TAOK3;SOS1;PDPK1;RHOJ;ARAP2;ARHGAP9;RFC3;ARHGAP31;MYO9B;PHF20;GNA13;PTEN;BRIP1;TAF7;GNA12;SPHK2;STK3;FLCN;ARAP1;TAF5;NF2;XIAP;BRCA1;AKAP13;VAV1;HIPK1;CHD3;TRIP10;DLC1;BRD7;ARHGAP18;CSNK2A2;STYXL1;HIPK2;TNIK;ARHGAP17;RHOD;FBXO9;FAM13B;BIRC3;PAK2;ARHGEF2;NBN;TRAF1;TREM2;ZFAND6;WRN;RNF34;TRAF3;DYRK2;RELA;CASTOR1;RBBP7;OCRL;MCF2;SOS2;RRAS;PAK1IP1;SQSTM1;FGD3;ATP6AP2;TRAF5;SMYD2;DEPDC1B;MAPKAP1;BST1;TMBIM4;GPAT3;TRAF2;BRPF1;ARHGAP25;MYO9A;PIP4K2A;TAF15;CSNK2A1;SGMS1;TEK;AKAP7;BIRC2;TTC5;ITSN1;STK4;PPP2R5C;NOC2L;CCNG1;RMI1;PPP1R13L;MOB3B;BCL3;FGD4;TOP3A;ITGAV;SYDE2;MRE11
prerank,regulation of neurogenesis (GO:0050767),0.3711679965605894,1.0458266980720121,0.41268075639599555,0.765528774356796,1.0,9/55,11.89%,CTNNB1;HOOK3;TGM2;IL6;APPL2;SORL1;BHLHE40;NUMBL;NOTCH1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.39447857305510015,1.045752592983858,0.42,0.7652539430457678,1.0,8/36,12.68%,CTNNB1;AGO2;PPP3CA;TNRC6B;PPP3R1;AGO3;FZD5;FZD2
prerank,positive regulation of synaptic transmission (GO:0050806),-0.2570493991417794,-1.0456201930551394,0.37142857142857144,0.7832403887642456,1.0,23/72,17.32%,GRIN2A;NRXN1;SYT1;NLGN1;RIMS1;GRIN2B;SLC24A2;RIMS2;GRIK2;RELN;TSHZ3;FMR1;CACNG4;NLGN3;NMU;ADCY1;GRIN2D;CACNG3;AKAP5;CCR2;CACNG2;SHISA7;TNF
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4089561366054183,1.045216021121572,0.42820838627700125,0.7661374899904215,1.0,6/27,11.54%,LPIN3;PLA2G2D;SLC27A1;ABHD4;PLAAT1;PLAAT3
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3236516060475081,1.045026982936816,0.246,0.7661584073052776,1.0,390/1668,21.95%,EPAS1;PPARG;FNIP2;MMP12;ANXA4;SDCBP;NAMPT;TFEC;APOE;MRTFA;LITAF;ELF2;MRTFB;ZMIZ1;ATP1B4;IRX3;FRK;RCOR1;TFEB;HOPX;LPIN3;LILRB1;TRPS1;NFE2L2;ZNF3;CTNNB1;MITF;NCK2;VEGFA;CEBPB;FNIP1;ZEB2;ATXN1;GRHL1;FOXP3;EN2;IER5;DNMT3A;ST18;ATF3;KDM4C;VEZF1;WWC2;RUNX2;ARID4A;NR1H3;GATAD2A;E2F3;ID2;LMO1;IL6;HGF;TOX4;CDKN1A;FOXO3;TNIP1;LIN37;CBX8;BAZ1A;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;MED12;RIPK1;ASXL2;NCOR1;PHF20;RARA;MAP2K5;ZFP28;MZF1;PTEN;CITED2;GTF2H5;PID1;FOXO4;BRIP1;BACH1;E2F1;TAF7;IGF1;ZBTB42;MAPK7;MAML1;STAT5B;SAP30;GADD45A;RNF10;AGO2;NUFIP1;GLMP;NR3C1;SIRT6;TCERG1;RNASEL;EED;CRTC1;MAML2;NR1H4;DDX5;CREBBP;BHLHE40;RPS14;DOT1L;FLCN;MLLT10;HNRNPU;KLF5;TET3;NIPBL;ATF4;REL;IFRD1;TGIF1;RPS27A;UBC;MED15;RITA1;KDM3A;ZBTB20;ETV6;ZNF177;RPL23;BAZ2B;RREB1;UXT;POU3F1;PIAS4;TCF20;JMJD1C;SOX9;BRD2;ACVR2A;BRCA1;SNAI2;RPAP2;NEDD4L;HOXA3;RB1;RBAK;ACTR3;LCOR;WWP2;ABCA2;EPC1;ZNF148;FOXP1;GABPB1;GABPB2;IRF2;CHD3;NCOA3;CBFB;DVL1;ACVRL1;COPS5;CARF;BRD7;TBL1XR1;DACH1;ARID5B;CHD2;HIPK2;PPP3CA;TET2;NCOA1;BMPR2;TNRC6B;TPR;NR5A1;DDIT3;PAXBP1;BRD3;PAX8;NR2C1;WDR77;HCFC2;MAVS;ESR1;PPP3R1;FOXK1;KDM2A;VPS72;POU3F3;AGO3;MAFB;FOXO1;MED16;SIRT1;MAFG;SALL2;ARHGEF2;CDK7;PRPF6;MED26;CCN1;NFATC3;LARP7;PPARD;ZNF691;CUX1;BCAS3;LCORL;APP;FZD5;ZKSCAN7;SP3;NOTCH1;PRKCB;RORA;TBX6;SARS1;CAMTA2;RELB;DDX20;MAZ;RFX1;HCLS1;SMARCC1;SIRT7;PPRC1;RFX5;BCLAF1;BUD31;DGKQ;SOX2;USP16;RELA;BBX;BCL11B;CTDP1;POU2F1;KDM1B;PRKN;HBP1;SLC11A1;ZKSCAN3;FOXJ3;SMARCD1;DCAF1;PGBD1;JUNB;SUV39H2;GDNF;ATF1;ZKSCAN5;KDM7A;PRDM2;BAX;ZNF513;CREG1;MCRS1;PHIP;ID4;SQSTM1;LRP6;EID1;PER3;INO80;CX3CL1;RPL10;SNF8;TNKS;ZFP64;ETV3;WASL;MNAT1;SSU72;ARRB1;CDK8;SMYD2;ASXL1;PCBP1;CDC73;PPARGC1B;PHF20L1;HSPD1;KLF6;NHLH2;ZNF32;WWOX;MTF1;MYT1;THRAP3;NFATC2IP;TCF12;CAMK1;CREB3L4;CREB3;ELP4;BRWD1;BAZ1B;PLAGL2;ZNF18;CRY1;NKX2-1;ARF4;SMARCB1;ZBTB41;ZBTB7A;GABPA;NFYC;CIR1;ZNF23;SENP1;CREB1;C1QBP;ZBTB7B;ZNF319;E2F2;AGO4;BBS7;HOXD8;NOC2L;NCOA6;RAD21;FLI1;KLF8;SOX8;CRTC3;ZNF431;CLOCK;CDK13;NFX1;ATAD2B;MCPH1;NCOA2;ZBTB40;METTL23;KMT2A;HDAC8;STAT6;PPP1R13L;NFIC;AKIRIN1;CREB3L1;NR2F1;OSM;TBK1;PURB;PIAS2;ZNF367;WWTR1;PRDM16;EFCAB7;TCF4;TCF7L2;PHF2;PFKM;HSF2;WFS1;NFE2L3;SREBF1;SPEN;SSBP4;BCL11A;SIN3A;OGT;HES5;ZFP62;JMJD6;SP8;ZBTB16;MGA;SAFB;MLXIP;FUBP3;NPAS2;PIAS1;MYPOP;EHMT2;HNF4G;CEBPA;TAF1;MBD2;USP9X;NR1H2;ZBTB24;HSBP1;KAT2A;RARB;TARBP1;USP2;MED31;DMAP1;CBX5;CCNT1
prerank,glycerolipid catabolic process (GO:0046503),0.4491273197377622,1.044866054969716,0.44182825484764543,0.7660893599307906,1.0,6/19,17.90%,MGLL;GPCPD1;PLA2G4F;GDE1;PRDX6;LYPLA2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.36405007983388094,1.0446293433567653,0.42342342342342343,0.7662611359735274,1.0,13/65,15.42%,GRB2;RHBDF2;DUSP3;STAM;MVB12B;PTPN12;ARAP1;SH3KBP1;RNF115;AFAP1L2;EPS15;STAM2;CBL
prerank,magnesium ion transport (GO:0015693),0.48132059506968156,1.0440478360118304,0.42378048780487804,0.7673134100904752,1.0,4/12,15.22%,NIPAL3;MMGT1;MAGT1;NIPA1
prerank,regulation of JUN kinase activity (GO:0043506),0.4052160360970609,1.0438595927058796,0.41604010025062654,0.7673366997499721,1.0,4/33,6.33%,SASH1;TAOK3;AIDA;PPEF2
prerank,copper ion transport (GO:0006825),0.49957491368063345,1.043803606618042,0.42011834319526625,0.7670086086557962,1.0,4/11,16.59%,STEAP3;SLC11A2;ATP7A;SLC31A2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.32060969571817255,-1.043758774514707,0.3684210526315789,0.7864885478165267,1.0,10/29,14.58%,SMAD3;DGCR8;METTL3;TUT4;PUM1;SMAD1;SNIP1;SMAD2;ADAR;DICER1
prerank,maturation of 5.8S rRNA (GO:0000460),0.4484115865288656,1.0435823207731985,0.44553072625698326,0.7670659151052299,1.0,5/17,16.12%,C1D;EIF6;MTREX;EXOSC10;WDR12
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.4051961299323318,1.0435488556238413,0.4300254452926209,0.7666857483487669,1.0,10/29,16.75%,DDX6;EXOSC3;EXOSC9;PATL1;CNOT7;EXOSC8;NT5C3B;CNOT6;EDC3;EXOSC1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4683352067233654,1.0434789773933115,0.40922619047619047,0.7664193985088799,1.0,3/14,11.89%,MAP2K5;THBS1;NOTCH1
prerank,ncRNA processing (GO:0034470),0.33344746513463364,1.043389847502918,0.39692307692307693,0.7661827888417861,1.0,54/200,18.99%,C1D;FARS2;EBNA1BP2;MPHOSPH10;BYSL;AGO2;SENP3;RPL18A;INTS9;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;INTS6;EXOSC3;TEX10;WDR18;EXOSC9;POP4;WDR74;RPL22;INTS1;NOB1;INTS8;DKC1;AGO3;DROSHA;EXOSC8;NOL8;SARS1;RPL10A;KRR1;INTS5;INTS7;INTS2;MRPL44;MRM2;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;AGO4;UTP15;RCL1;DHX37
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.3496997036058724,1.0432394786254038,0.4128342245989305,0.7660953381532944,1.0,34/94,26.33%,ST18;IRAK2;PSMD1;IRAK3;RPS27A;UBC;MAP3K8;PSMF1;PSMD14;TAB2;PSMD12;RELA;PSME2;SQSTM1;CUL1;MYD88;PSMB10;PSMD5;UBE2V1;PSMD8;PSMA3;PSMA2;PSMD11;PELI2;PSMA6;PSMB3;PSME3;IRAK1;TRAF6;PSMC5;TAB1;MAP3K7;PSMC1;TAB3
prerank,regulation of DNA replication (GO:0006275),0.37325072901637224,1.0432249852426676,0.4254079254079254,0.7656597940906333,1.0,20/49,22.80%,ANKRD17;ACVRL1;TERF1;CCNA2;NPM2;STN1;SMC3;ATAD5;CDT1;FBXO5;PPP2CA;BCAR3;PDS5A;PPP2R1A;EHMT2;GTPBP4;CDAN1;WAPL;FAF1;OBI1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.38050479493028944,1.0432050264765902,0.4208675263774912,0.7652428955321712,1.0,17/48,25.86%,ZMIZ1;ERCC6;SPHK2;POLR2L;TAF1B;POLR1A;SMARCD1;BAZ1B;TAF1A;ATAD2B;PHF2;KAT2A;MYO1C;ELOF1;ACTB;POLR2F;KAT2B
prerank,regulation of phosphorylation (GO:0042325),0.3453670298201368,1.0429017083774201,0.4069400630914827,0.7655495299208944,1.0,37/120,23.54%,FNIP2;SDCBP;FNIP1;CORO1C;PRKAG2;CDKN1A;SESN2;THBS1;EIF6;FLCN;STAP1;DSCAM;TPR;FZD7;ROCK1;NUP50;SIRT1;APP;PHIP;NUP98;NRP1;CCDC88C;ZBTB7A;PPP2CA;KCTD20;NUP88;GCK;OGT;NUP188;NDC1;NUP43;ILK;NUP54;RANBP2;CDH5;BCL10;SLAMF8
prerank,response to amino acid (GO:0043200),0.39927520683682016,1.0424687079495796,0.435,0.7661640488043306,1.0,7/31,13.12%,IPO5;CPEB4;SESN2;CAPN2;LAMTOR1;SLC38A9;LAMTOR3
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4682683947807598,1.042426039736365,0.4236526946107784,0.7658024802514327,1.0,8/14,25.45%,AMACR;ABCD1;CRAT;EHHADH;DECR2;SCP2;ACOT8;HSD17B4
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.34437393149316003,1.041608861547537,0.40083945435466944,0.7674725037909863,1.0,13/113,10.59%,HTR2B;MMP12;VEGFA;NOTCH2;IGF1;NRP2;NRAS;RREB1;SOX9;VASH2;BMPR2;FZD7;SIRT1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3771733155348018,1.041418221442098,0.4261704681872749,0.767494268812853,1.0,17/50,22.88%,PSMD1;OAZ2;PSMF1;PSMD14;PSMD12;PSME2;AZIN1;OAZ1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3
prerank,negative regulation of cell differentiation (GO:0045596),0.3368848193128897,1.041407287084812,0.40488301119023395,0.7670622104225292,1.0,25/181,11.94%,PPARG;ABCA1;XDH;HOPX;ABCG1;NR1H3;ID2;IL6;ENPP1;PTEN;E2F1;TNN;HNRNPU;EIF2AK4;ZFP36L2;ANP32B;SOX9;SNAI2;RB1;COL5A2;PTK2B;FOXO1;SIRT1;NOTCH1;RORA
prerank,neuron cell-cell adhesion (GO:0007158),-0.38792667207492026,-1.0413888014563681,0.40131578947368424,0.7910273794121897,1.0,8/14,11.72%,NRXN1;NRXN3;NLGN1;CNTN4;CDK5R1;ASTN2;NLGN3;NCAM2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.488221613604939,1.0412583959000101,0.4434108527131783,0.7669908790723727,1.0,5/12,9.94%,HNRNPU;BRCA1;CDYL;LRIF1;RLIM
prerank,DNA methylation (GO:0006306),0.42736019858847224,1.0411992608271667,0.4427994616419919,0.7666796412236162,1.0,8/23,21.92%,DNMT3A;GATAD2A;N6AMT1;KMT2E;DNMT1;MTRR;EHMT2;DMAP1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3285465769911886,1.0410874306050764,0.4006024096385542,0.7664700612893226,1.0,63/264,16.87%,DHX8;POLR2A;ALYREF;TFIP11;HNRNPH2;PLRG1;CPSF1;SRPK2;SCAF11;CLNS1A;RNPC3;RBM41;HNRNPUL1;DDX5;CSTF3;CTNNBL1;HNRNPU;PRPF8;SNRNP200;POLR2L;WDR33;ISY1;SNRNP25;SART1;HNRNPA0;SF1;PPIH;WDR77;PSPC1;POLR2G;PRPF6;DDX23;POLR2I;NCBP2;SRSF3;SYF2;ZMAT5;HNRNPM;CWC27;GTF2F2;SF3A3;PQBP1;SNRNP35;DDX20;CWF19L2;RSRC1;BUD31;SUGP1;RBM10;PPIE;WBP11;SNRPF;HNRNPD;MTREX;ZRSR2;PCBP1;DDX39A;EIF4A3;SMN1;PUF60;SYNCRIP;CCAR1;DHX38
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4190942713460697,1.0407283591484342,0.4119170984455959,0.7669239548424576,1.0,9/23,22.65%,RANGRF;NPLOC4;TECPR2;FAF2;DERL2;TMEM129;PREB;VCP;HERPUD1
prerank,RNA biosynthetic process (GO:0032774),0.4056489376557398,1.0405307876921401,0.4387755102040816,0.7669670724213211,1.0,10/31,18.52%,POLR2A;GTF2B;TAF7;HELB;TAF5;POLA1;NAT14;SMN1;TTF1;NCOA6
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3619532528359257,1.039684442821731,0.4230769230769231,0.7686792221099004,1.0,18/64,20.26%,CD36;CORO1C;THBS1;DUSP3;NF2;PLAU;ROCK1;GSK3B;PTK2B;MACF1;CLASP1;CX3CL1;UTRN;BST1;ACER2;PIK3CB;CCL25;ACTG1
prerank,ERBB2 signaling pathway (GO:0038128),0.40149738110187333,1.039548382429997,0.43844221105527637,0.7685594459049976,1.0,8/31,14.50%,GRB2;SOS1;PIK3CA;PTPN12;NRG4;STUB1;ERBIN;SHC1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.45712944012442874,1.0386090813713311,0.4431977559607293,0.7704717791325577,1.0,7/16,22.71%,PIBF1;NF2;INPP5F;PPP2CA;BCL3;PPP2R1A;ADIPOR1
prerank,regulation of phagocytosis (GO:0050764),0.37193520906391175,1.0385495271108809,0.41990846681922195,0.7701622361494462,1.0,17/53,21.02%,SYK;TGM2;MERTK;CYBA;SIRPA;OLFM4;IL15;TREM2;DOCK2;GAS6;FGR;SLC11A1;SNX3;FCGR2B;ITGAV;CD47;PTPRC
prerank,glycerol metabolic process (GO:0006071),0.5041968239298422,1.0384550491575189,0.442572741194487,0.7699601097539094,1.0,6/10,24.02%,TPI1;TKFC;PGP;GK5;GK;GOT1
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.43578434103702407,1.0383259798628341,0.43673469387755104,0.7698274851142087,1.0,4/19,10.12%,PRKCH;SNAI2;CBFB;ROCK1
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.33097659535599144,-1.0383218737256164,0.3956043956043956,0.7974388509217623,1.0,8/24,15.66%,AGBL4;TTLL7;TTLL3;AGBL5;PARP1;TTLL11;AGTPBP1;TTLL1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4722661365998766,1.0383217083022898,0.42592592592592593,0.7693755046287081,1.0,5/13,23.60%,SORL1;EDEM2;BCAP31;TMEM30A;TM9SF4
prerank,negative regulation of response to stimulus (GO:0048585),0.3673456569751855,1.0381972549181837,0.41713014460511677,0.7692643888784183,1.0,14/60,13.77%,FOXP3;NR1H3;FCRLB;APPL2;MAP2K5;BRAP;MAPK7;PIM3;SIRT1;VPS13C;LPCAT3;COL3A1;MCTP1;ZKSCAN3
prerank,positive regulation of JUN kinase activity (GO:0043507),0.43120175185510523,1.038084128236082,0.4264705882352941,0.7690910611168101,1.0,2/23,2.87%,SASH1;TAOK3
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.43404835470716246,1.0377002867722864,0.4427994616419919,0.76957926615398,1.0,5/21,13.11%,MITF;JUN;MED12;MED16;BCLAF1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3449965429087573,-1.037556838992607,0.39097744360902253,0.7973962090556682,1.0,5/20,11.90%,SEMA5A;SEMA4G;SEMA3E;SEMA3A;SEMA6A
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.37421137458654663,1.037300563162723,0.4195064629847238,0.7701334738119424,1.0,14/51,18.82%,CTNNB1;ACD;TENT4B;HNRNPU;TERF1;NAT10;XRCC5;TEN1;STN1;TNKS;EXOSC10;TNKS2;GNL3L;CCT2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3923837604945378,1.037248517932517,0.44471445929526127,0.7698139049704605,1.0,9/39,15.42%,GRB2;DUSP3;STAM;PTPN12;SH3KBP1;RNF115;EPS15;STAM2;CBL
prerank,vitamin D metabolic process (GO:0042359),0.4694480585462453,1.0371722930255165,0.44040697674418605,0.7695667666753856,1.0,3/13,20.89%,PIAS4;LRP2;LGMN
prerank,Golgi to endosome transport (GO:0006895),0.4499394672842368,1.0370645306583655,0.44752186588921283,0.7693623883616555,1.0,6/16,19.25%,KIF16B;KLHL20;VPS13C;EPS15;AP4M1;VPS13A
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.36890612198168055,1.0370280777690248,0.4180522565320665,0.7690075619429764,1.0,10/49,12.33%,TFIP11;RAF1;AIDA;SORL1;MEFV;NLRP2B;PTGER4;NLRC3;GSK3B;TREM2
prerank,morphogenesis of an epithelium (GO:0002009),0.41732781353195003,1.03609190503691,0.4267352185089974,0.7709373918803177,1.0,11/25,26.43%,DAG1;SOX9;RIPK4;LRP6;LAMA3;SOX8;ACTG1;ARHGAP12;ACTB;LIN7C;KDM2B
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.43706766979578693,1.0360826264951757,0.44798890429958393,0.7705003433631485,1.0,9/20,25.27%,AGO2;AGO3;DROSHA;PUM2;SPOUT1;MRPL44;AGO4;TSNAX;ZC3H7A
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.4487896663183474,1.0357084524627307,0.4442916093535076,0.7709829288742306,1.0,7/18,19.11%,RPS27A;UBC;EDEM2;DERL2;UGGT1;AMFR;MAN1B1
prerank,regulation of secretion (GO:0051046),0.46303302548962066,1.0350196798696074,0.4406528189910979,0.7723172378265654,1.0,3/13,13.26%,SGK1;GPLD1;POFUT2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.36103516979322015,1.0347852566612112,0.42427745664739885,0.7724529149808297,1.0,12/61,12.79%,EYA1;ERCC6;HGF;FGFR4;BABAM2;SIRT6;PARP3;BRCA1;RTEL1;SIRT1;NBN;WRN
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3697502520726178,1.0346946733384563,0.4384180790960452,0.7722298984380942,1.0,10/59,17.81%,BAAT;LIPG;AMACR;OSBPL1A;ACSM3;NDUFAB1;CYP46A1;ALDH1A2;CYP27A1;CBR4
prerank,positive regulation of cation channel activity (GO:2001259),-0.3022610363616799,-1.034159615575547,0.4024390243902439,0.8050779096390106,1.0,11/40,17.42%,ANK2;ANK3;RELN;TMSB4X;NLGN3;ACTN2;PKD2;ATPSCKMT;CCR2;STAC;ANTKMT
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.40338344767347467,1.0340293109530623,0.4259501965923984,0.7734459376061326,1.0,6/30,10.59%,CD44;THOC1;DYRK1A;SNAI2;RTEL1;SIRT1
prerank,ceramide catabolic process (GO:0046514),0.4587311527364968,1.0339572402179384,0.4228486646884273,0.7731717881101764,1.0,6/14,19.18%,GLA;HEXA;GM2A;NEU1;ACER2;ASAH1
prerank,regulation of cell morphogenesis (GO:0022604),0.40372531794917843,1.0338012787643849,0.44596273291925465,0.7731255480201377,1.0,10/30,21.12%,ZMYM6;CD44;CAPZB;CFL1;MACF1;PHIP;SH3D19;MYO9A;LARP4;FMNL2
prerank,regulation of defense response to virus (GO:0050688),0.46996012625124395,1.0337859130545188,0.43862275449101795,0.7727112862033544,1.0,4/14,18.05%,RNF26;TRAF3;TNFAIP3;C1QBP
prerank,positive regulation of macrophage migration (GO:1905523),-0.35752669030710227,-1.0337701885235926,0.4,0.804056348195629,1.0,3/19,2.94%,P2RY12;CSF1R;CSF1
prerank,protein-containing complex assembly (GO:0065003),0.32733841812664516,1.0333640395309074,0.4271356783919598,0.7733198196297847,1.0,86/259,24.83%,REPS2;CTNNB1;MITF;ANO6;SKAP2;FAS;PDZD11;MCFD2;SNX9;RIPK1;CUL3;CAPG;WDCP;LPXN;CREBBP;STX5;APC;DET1;PEX14;DARS1;TRAPPC5;RAB1B;FOLR1;SOX9;CTSZ;MEFV;PICALM;PPIH;GSK3B;PTK2B;BET1;CAND2;TUBGCP4;TRAF1;CDC123;EPRS1;SLC2A1;DNAJB14;SH3PXD2B;VAMP3;PPP6C;TRAPPC10;ADCY8;CUL1;CX3CL1;WASL;MNAT1;CD247;CDC73;FANCA;TRAF2;TRAPPC6A;KPNA3;CAPZA1;RANBP9;TAPBP;KMT2A;SEC31A;RAB1A;TCF7L2;AFG3L2;VAMP2;PPP2R1A;HES5;SEC24C;PPP6R1;ADAM10;SEC24B;WIPF1;PREB;PEF1;HGSNAT;TRAPPC2L;TLE3;KLHL12;TRAPPC1;CXCL12;TMED10;GSDMD;MEN1;TFG;ST13;CASP8;AFDN;TRAPPC9;TSPAN33
prerank,neural crest cell differentiation (GO:0014033),0.45194674254455613,1.0331573647940584,0.453804347826087,0.7733499113804009,1.0,8/18,23.00%,HTR2B;FBXL17;SNAI2;LRP6;SOX8;PEF1;KLHL12;NOLC1
prerank,regulation of cartilage development (GO:0061035),0.4419836898097068,1.0331083409988062,0.43319268635724334,0.7730107133513355,1.0,7/18,25.36%,TRPS1;SOX9;BMPR2;ZBTB16;KAT2A;BMPR1B;SOX5
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.48444091372654097,1.0329527131829994,0.44610778443113774,0.7724999452989892,1.0,3/12,13.27%,HOMER3;GSK3B;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.48444091372654097,1.0329527131829994,0.44610778443113774,0.7724999452989892,1.0,3/12,13.27%,HOMER3;GSK3B;DYRK2
prerank,peptidyl-lysine trimethylation (GO:0018023),0.413407593973248,1.03266128530198,0.4336283185840708,0.7727491731113546,1.0,12/26,26.40%,SMYD5;TET3;ETFBKMT;TET2;KMT5B;SUV39H2;KMT2A;OGT;SETD3;SETD5;KMT2D;SETD1B
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4261959145521343,1.032370782480761,0.4240422721268164,0.7725597081701852,1.0,10/24,23.94%,HK3;TPI1;ENO3;FOXK1;PFKP;GAPDHS;PFKM;GCK;PKM;HK1
prerank,canonical glycolysis (GO:0061621),0.4261959145521343,1.032370782480761,0.4240422721268164,0.7725597081701852,1.0,10/24,23.94%,HK3;TPI1;ENO3;FOXK1;PFKP;GAPDHS;PFKM;GCK;PKM;HK1
prerank,positive regulation of cell aging (GO:0090343),0.48392245932852923,1.031870913289694,0.4617691154422789,0.7733594693931942,1.0,3/11,10.59%,LMNA;ARG2;SIRT1
prerank,inorganic anion transport (GO:0015698),0.3703363433035947,1.031754195308926,0.4375,0.7731784824254074,1.0,9/53,17.01%,SLC26A11;ANO6;ENPP1;SLC26A1;SLC5A5;XPR1;SLC11A1;CLIC1;CLCN4
prerank,protein polymerization (GO:0051258),0.3709660264546784,1.0315775780927483,0.4295612009237875,0.7731811621306806,1.0,8/55,6.64%,DIAPH1;MICALL2;MSRB1;PSTPIP1;UBE2K;CHMP2A;RNF135;GPX4
prerank,protein destabilization (GO:0031648),0.3960052003317249,1.0311174782038561,0.43522012578616354,0.773861974260359,1.0,11/32,18.68%,CUL3;FBXL3;CREBBP;RAD23A;CTSH;SIRT1;PRKN;CDC73;CCDC88C;HTT;SERF2
prerank,regulation of transferase activity (GO:0051338),-0.3628462300513376,-1.0309815341612247,0.38283828382838286,0.8097385498141676,1.0,10/17,29.15%,ATM;SMG6;FEM1B;LDB1;LDB2;BAG5;PPP1R3F;SPTSSB;FEM1A;EMP2
prerank,negative regulation of cell adhesion (GO:0007162),0.3614972103005023,1.0309129058972746,0.44160177975528364,0.773899440099378,1.0,12/72,11.89%,PLXNA1;PLXNC1;PLXND1;GCNT2;LPXN;NF2;SNAI2;ACVRL1;DSCAM;FZD7;FBLN1;NOTCH1
prerank,canonical Wnt signaling pathway (GO:0060070),0.36203413245214233,1.0301972073097923,0.43381535038932145,0.7752587932799273,1.0,11/68,14.61%,PLPP3;CTNNB1;PTEN;APC;DVL1;FZD7;GSK3B;FZD5;FZD2;PPP1CA;LRP6
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3955212717735903,1.030088424282479,0.4194373401534527,0.7750596470710391,1.0,6/30,10.59%,KLK3;KDM4C;NCOR1;DDX5;FOXP1;SIRT1
prerank,phosphate ion transport (GO:0006817),0.44205332195653957,1.0300670537075571,0.43441466854724964,0.7746620722227814,1.0,6/16,28.56%,XPR1;SLC37A3;SLC20A2;SLC37A4;SLC25A30;SLC25A10
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3513703699037392,-1.0298273064501187,0.397212543554007,0.8109014021382841,1.0,2/19,3.76%,CAMK1D;RIPOR2
prerank,engulfment of apoptotic cell (GO:0043652),-0.3754451968851008,-1.0296559072264062,0.43902439024390244,0.8092565260176269,1.0,10/15,31.53%,RHOBTB1;ADGRB1;RHOBTB2;RHOG;RHOH;RAC1;XKR8;RAC2;XKR4;XKR6
prerank,protein stabilization (GO:0050821),0.33172258570358687,1.0295360611732904,0.430327868852459,0.7755724616015771,1.0,46/168,22.53%,PLPP3;LAMP1;FLOT1;GNAQ;FBXW7;PRKCD;CDKN1A;PTEN;IGF1;RAB21;GLMP;STK3;COG7;HSPA1B;RPL23;GTSE1;LAMP2;TYROBP;DVL1;CDK7;BAG4;IFT46;MT3;SUGT1;PFN1;PRKN;HSPA1A;PER3;PFN2;USP36;RTN4;GRN;HSPD1;TBRG1;CREB1;STK4;CCT2;BAG1;WFS1;TAF1;GTPBP4;USP9X;EPHA4;USP2;NAA15;AAK1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.34173676376923173,1.0290295085254135,0.4284176533907427,0.7763995074364409,1.0,19/95,14.94%,SDCBP;ZEB2;PDPK1;CITED2;THBS1;CREBBP;FLCN;RPS27A;UBC;FOLR1;HIPK2;SNX25;ADAM17;SIRT1;STUB1;ITGA3;LEMD3;HSPA1A;LATS1
prerank,mRNA processing (GO:0006397),0.3238146118442476,1.0289394628057607,0.418932527693857,0.7761789980443443,1.0,67/287,16.87%,DHX8;ERN1;POLR2A;ALYREF;TFIP11;HNRNPH2;PLRG1;CPSF1;SCAF11;CELF1;GTF2H5;CHTOP;RNPC3;TCERG1;RBM41;HNRNPUL1;DDX5;CSTF3;THOC1;CTNNBL1;HNRNPU;PRPF8;SNRNP200;POLR2L;WDR33;ISY1;SNRNP25;SART1;HNRNPA0;SF1;PPIH;PSPC1;POLR2G;CDK7;PRPF6;DDX23;POLR2I;NCBP2;SRSF3;SYF2;ZMAT5;THOC2;HNRNPM;CWC27;GTF2F2;SF3A3;PQBP1;SNRNP35;CWF19L2;RSRC1;BUD31;SUGP1;RBM10;PPIE;WBP11;SNRPF;HNRNPD;MTREX;MNAT1;ZRSR2;PCBP1;DDX39A;EIF4A3;PUF60;SYNCRIP;CCAR1;DHX38
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3881303508640329,1.0288648895986692,0.4488778054862843,0.7759297425733841,1.0,7/38,10.59%,XDH;PTEN;DAG1;FLCN;PLEKHA1;DDIT3;SIRT1
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.2776471424960871,-1.028855580173988,0.3419354838709677,0.8094846884849969,1.0,12/50,15.29%,PTCH1;SMO;FGFR2;MEGF8;INTU;RACK1;GLI3;ARMC9;TTC23;BTRC;ULK3;PDCL
prerank,Golgi to plasma membrane transport (GO:0006893),0.37797497661221896,1.028392499787891,0.4482338611449452,0.77664280017747,1.0,18/47,21.45%,OPTN;RABEP1;RAB31;RAB10;VPS35L;ARFGEF2;MACF1;ARL3;GOLPH3;EXOC4;GOLPH3L;GOLGA4;GGA2;EXOC1;GOPC;BBS1;VAMP2;GGA3
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3571135111680838,1.0283674371654519,0.4430523917995444,0.7762541445102982,1.0,23/66,26.10%,IPO5;TFRC;PRKCD;SESN2;GTSE1;TPR;MAVS;DKC1;LARP7;MEPCE;HCLS1;MCRS1;RBM22;CCT2;WWTR1;EFCAB7;DMAP1;NMD3;FLNA;UBR5;BAG3;CCT7;ZIC1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.46031153168240746,1.028043704912169,0.45454545454545453,0.776607878203404,1.0,2/14,5.73%,IL6;ADAM8
prerank,aorta morphogenesis (GO:0035909),0.44976063003178934,1.0279150524501504,0.45034965034965035,0.7764933895490957,1.0,4/17,12.20%,LRP1;TFAP2B;ACVRL1;MYLK
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3067760102903624,-1.0272745880583394,0.38235294117647056,0.8097196486161938,1.0,13/29,24.86%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;CENPQ;CENPN;CENPH
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3067760102903624,-1.0272745880583394,0.38235294117647056,0.8097196486161938,1.0,13/29,24.86%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;CENPQ;CENPN;CENPH
prerank,substrate-dependent cell migration (GO:0006929),-0.37939195208764864,-1.027109784049008,0.4368932038834951,0.808057721905797,1.0,5/14,10.05%,P2RY12;OPHN1;ITGB1BP1;ANKS1A;CD2AP
prerank,chromatin remodeling (GO:0006338),0.3438770502323004,1.0270472802581447,0.4387646432374867,0.7782395371847006,1.0,34/100,25.93%,ERCC6;FOXP3;KDM4C;BAZ1A;BAZ2B;TOP1;SOX9;RB1;CHD3;HCFC2;ESR1;SIRT1;CBX3;SMARCC1;NPM2;SMARCD1;SUV39H2;INO80;BAZ1B;PBRM1;SMARCB1;ZBTB7A;MBD2;KAT2A;KDM5C;RUVBL2;POLE3;SMARCE1;SMARCD2;ACTB;HDAC1;SMARCA1;KAT2B;CECR2
prerank,cellular response to metal ion (GO:0071248),-0.23398490690971335,-1.026898204262385,0.37777777777777777,0.8065256026342983,1.0,27/123,12.29%,DLG2;SLC12A2;MEF2C;SYT1;NLGN1;MEF2A;RYR3;CAPN3;ADD1;ANK3;PRKAA2;KCNH1;SYT7;EGFR;SYT2;TRPM2;SYT4;GLRA1;SYT6;CPNE8;MCOLN1;ADGRV1;ADCY1;PKD2;CPNE4;PRNP;HVCN1
prerank,manganese ion transport (GO:0006828),0.4653899612080705,1.0267718479855494,0.4370477568740955,0.7784752788371221,1.0,5/14,13.66%,SLC11A2;TMEM165;TRPC3;SLC39A14;SLC11A1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3250544408332508,1.0257119348108892,0.4248234106962664,0.7806533277898047,1.0,57/241,16.87%,DHX8;POLR2A;ALYREF;TFIP11;HNRNPH2;PLRG1;CPSF1;RNPC3;RBM41;HNRNPUL1;DDX5;CSTF3;CTNNBL1;HNRNPU;PRPF8;SNRNP200;POLR2L;WDR33;ISY1;SNRNP25;SART1;HNRNPA0;SF1;PPIH;PSPC1;POLR2G;PRPF6;DDX23;POLR2I;NCBP2;SRSF3;SYF2;ZMAT5;HNRNPM;CWC27;GTF2F2;SF3A3;PQBP1;SNRNP35;CWF19L2;RSRC1;BUD31;SUGP1;RBM10;PPIE;WBP11;SNRPF;HNRNPD;MTREX;ZRSR2;PCBP1;DDX39A;EIF4A3;PUF60;SYNCRIP;CCAR1;DHX38
prerank,regulation of Notch signaling pathway (GO:0008593),0.3521842870079602,1.0253236778840136,0.4552572706935123,0.7811141301052461,1.0,11/76,8.16%,ZMIZ1;FBXW7;CD46;NIBAN2;MMP14;MAML1;MAML2;CREBBP;RITA1;LFNG;WWP2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4402425280845086,1.0248051978244543,0.4625668449197861,0.781970513619324,1.0,8/18,23.13%,RIC1;WDR91;MSN;VPS11;NELL1;VPS35;FAF1;EZR
prerank,regulation of gene expression (GO:0010468),0.3208480800174159,1.0242602229209088,0.39,0.7828763617460575,1.0,152/903,15.12%,CD36;APLNR;XDH;APOE;DTNBP1;HNRNPLL;AFF1;ATP1B4;TFEB;LILRB1;NFE2L2;GCNT2;MITF;AHNAK;VEGFA;POLR2A;CEBPB;TIPARP;ATXN1;FOXP3;TMPRSS4;TFRC;FBXW7;C1D;CXXC1;WWC2;IL36G;NAT8;ID2;IL6;CD28;CD46;AFF4;COQ7;HNRNPH2;RUNX3;MBNL1;SRPK2;HNRNPAB;NOTCH2;CELF1;TRIM17;MYCBP;MZF1;IGF2BP3;CITED2;PID1;FOXO4;AHNAK2;BACH1;E2F1;SLC8A1;IGF1;UBE2L3;FGFR4;SAP30;APBB2;AGO2;NR3C1;ASCC2;NSD3;CREBBP;BHLHE40;TESMIN;FLCN;HSPA1B;NWD1;ATF4;REL;RPL23;TAF5;RREB1;STAP1;POU3F1;MSN;JMJD1C;SOX9;BRCA1;SNAI2;RB1;PRDM8;RBAK;WWP2;SIRPA;ZNF148;FOXP1;IRF2;CTSH;CHD3;MEFV;TYROBP;DVL1;ZFAT;ACVRL1;PICALM;TNRC6B;NR5A1;DDIT3;FZD7;HCFC2;RLIM;CNPY2;ESR1;ASCC1;ROCK1;PSPC1;CNOT7;GRSF1;GSK3B;ZFPL1;POU3F3;AGO3;MAFB;SIRT1;MED26;PTBP3;MT3;GPBP1L1;APP;SP3;NOTCH1;RORA;PUM2;ACVR1B;PTBP2;PQBP1;TREM2;APBB3;SPOUT1;MAZ;HCLS1;TRAF3;DGKQ;SOX2;RELA;GAS6;LIMD1;PPIE;PRKN;SLC11A1;HSPA1A;GDNF;ZKSCAN5;PRDM2;HNRNPD;ZNF513;ADAM19;SNF8;ZFP64;PRX;USP36;TOB2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.44085696809128183,1.024106919178092,0.44553072625698326,0.7827857084243914,1.0,5/17,11.89%,PLXND1;MAML1;MAML2;CREBBP;NOTCH1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.3663607940154733,1.0236193726632108,0.44970414201183434,0.7835640198097324,1.0,17/53,22.88%,PSMD1;OAZ2;PSMF1;PSMD14;PSMD12;PSME2;AZIN1;OAZ1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.31570315000892246,-1.0234617320696677,0.43621399176954734,0.8145155286703969,1.0,6/26,10.60%,VSIR;GRIN2B;MBP;GRIN1;PRELID1;PYCARD
prerank,ncRNA export from nucleus (GO:0097064),-0.2945508298443768,-1.0234375131218767,0.42473118279569894,0.8124555191801567,1.0,12/36,14.86%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,positive regulation of neurogenesis (GO:0050769),0.3583957643251778,1.023363985070422,0.45164835164835165,0.7837687202769016,1.0,7/68,2.56%,PLXNA1;PLXNC1;PLXND1;CTNNB1;VEGFA;TGM2;DCT
prerank,cognition (GO:0050890),0.37938940840295166,1.022400393333471,0.4594272076372315,0.7856333646069609,1.0,7/42,11.47%,CBR3;STRA6;NIPBL;ST3GAL4;JAKMIP1;MAGT1;APP
prerank,establishment of spindle localization (GO:0051293),0.45783999571999745,1.0221202420247335,0.4552023121387283,0.7858839462643865,1.0,3/14,13.75%,DYNC1H1;CFL1;CLASP1
prerank,positive regulation of neuron migration (GO:2001224),0.486582559314708,1.022120131572731,0.45852187028657615,0.7854278325404954,1.0,5/11,20.36%,KIF20B;NIPBL;ARHGEF2;SHTN1;PLAA
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.46773823803085407,1.0216964543001763,0.4519940915805022,0.7859923505594283,1.0,4/12,14.58%,UMPS;CTPS1;CRMP1;CTPS2
prerank,gas transport (GO:0015669),0.5011124328570168,1.0216813652303594,0.46615384615384614,0.7855815493556659,1.0,3/10,16.72%,AQP1;MB;CA2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3950638607659281,1.0216389176662455,0.454320987654321,0.7852369609779232,1.0,8/34,18.05%,NEDD9;DOCK5;TRIOBP;RREB1;OLFM4;DOCK1;NRP1;C1QBP
prerank,regulation of cell-cell adhesion (GO:0022407),-0.2875605660893031,-1.021569589152603,0.38372093023255816,0.8158539153095855,1.0,8/39,12.90%,PTPRG;TENM3;FLOT2;FUT9;SMAD7;EPHA7;DPP4;CELSR2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3487772843397462,1.0214380268776817,0.46078431372549017,0.7848187866039914,1.0,32/78,28.42%,CTSD;PIKFYVE;CTSL;OSBPL1A;RAB7A;DYNC1H1;KIF3A;CTSS;CAPZB;AP1G1;AP2B1;CAPZA1;ACTR1B;AP1M1;SEC31A;FCGR2B;LGMN;SEC24C;SEC24B;DYNC1LI2;AP2S1;DCTN4;CLTC;AP2A2;DYNC1LI1;KIF22;AP2A1;DCTN5;AP1B1;SEC24A;KIF3B;CANX
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3487772843397462,1.0214380268776817,0.46078431372549017,0.7848187866039914,1.0,32/78,28.42%,CTSD;PIKFYVE;CTSL;OSBPL1A;RAB7A;DYNC1H1;KIF3A;CTSS;CAPZB;AP1G1;AP2B1;CAPZA1;ACTR1B;AP1M1;SEC31A;FCGR2B;LGMN;SEC24C;SEC24B;DYNC1LI2;AP2S1;DCTN4;CLTC;AP2A2;DYNC1LI1;KIF22;AP2A1;DCTN5;AP1B1;SEC24A;KIF3B;CANX
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.35132001223295567,1.0213383873717963,0.4408839779005525,0.7846005170783479,1.0,27/73,25.86%,ERCC6;DNMT3A;SMYD5;EED;SPHK2;POLR2L;EPC1;TAF1B;POLR1A;KDM1B;RBBP7;MPHOSPH8;DNMT1;BAZ1B;TAF1A;PHF1;PHF2;KAT2A;MTF2;MYO1C;AEBP2;IGF2;TDG;GPX1;ACTB;POLR2F;KAT2B
prerank,sprouting angiogenesis (GO:0002040),0.36748422100051537,1.0211441025451673,0.44431418522860494,0.7846317221961717,1.0,5/51,10.36%,CCBE1;VEGFA;THBS1;ACVRL1;PTK2B
prerank,telomere organization (GO:0032200),0.37307612301468196,1.021047441684739,0.44417767106842737,0.7844090458772824,1.0,10/43,14.75%,ACD;DOT1L;PARP3;RTEL1;TERF1;XRCC5;NBN;DCLRE1B;WRN;STN1
prerank,lymphocyte mediated immunity (GO:0002449),0.4715013134067264,1.0207599143544883,0.44042232277526394,0.7846487635085532,1.0,2/12,15.18%,CD46;KLRD1
prerank,macrophage activation (GO:0042116),0.3907678786123363,1.020729273095046,0.44707347447073476,0.7842703936450837,1.0,11/34,18.65%,SYK;TMEM106A;CD93;FOXP1;APP;TREM2;SLC11A1;CX3CL1;LBP;TLR1;CRTC3
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.372703589816728,1.020660231669484,0.44069767441860463,0.7840001280883124,1.0,4/44,2.43%,BAAT;AMACR;OSBPL1A;PRKAG2
prerank,endothelial cell migration (GO:0043542),0.38505766185939877,1.0206071173544928,0.4382716049382716,0.7836826134856849,1.0,12/37,24.08%,PLXND1;VEGFA;LPXN;PIK3CA;FSTL1;MYH9;NRP1;CORO1B;RAB13;GIPC1;CDH5;CCN3
prerank,striated muscle cell differentiation (GO:0051146),0.4414395405327714,1.0204727543962022,0.45809248554913296,0.783564509935313,1.0,4/16,7.99%,PLD3;MTLN;SIK1;AKAP13
prerank,indolalkylamine catabolic process (GO:0046218),0.4927931961191708,1.0203717268352404,0.46367851622874806,0.7833533121804018,1.0,1/10,2.53%,KYNU
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4841031074145459,1.0201964320482493,0.44670846394984326,0.783331677962824,1.0,2/10,3.15%,XYLT1;DSE
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3659021317408224,-1.019973984138475,0.40863787375415284,0.8182872593707989,1.0,9/15,23.63%,COQ3;COQ10B;NDUFA9;COQ2;COQ9;COQ10A;COQ5;COQ8A;UBIAD1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3511152613985081,1.0195603888005942,0.458980044345898,0.7844423727337942,1.0,28/72,26.26%,PSMD1;REL;BIRC3;PSMF1;PSMD14;PSMD12;RELB;RELA;PSME2;CUL1;TRAF2;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;TIRAP;MALT1;PSME3;IRAK1;TRAF6;PSMC5;MAP3K7;PSMC1
prerank,axonal transport (GO:0098930),0.38722765870786585,1.0194279257173144,0.4593908629441624,0.7843163976551357,1.0,5/36,7.51%,DTNBP1;AP3S1;DYNC1H1;RAB21;KIF3A
prerank,DNA replication (GO:0006260),0.33725888355420436,1.0194270171896365,0.4380952380952381,0.7838682698456173,1.0,25/105,20.40%,RBMS1;BAZ1A;MCM9;RFC3;BRIP1;FAM111A;MCMBP;HELB;POLG2;TOP1;BRCA1;POLL;DBF4;ING4;NBN;WRN;POLA1;RNASEH2A;ORC1;CDK2AP1;ORC4;TBRG1;RMI1;TOP3A;MRE11
prerank,negative regulation of binding (GO:0051100),0.348719923774493,1.0192246796242128,0.45524017467248906,0.7839204044967658,1.0,18/81,16.60%,PRKCD;CDKN1A;TFIP11;JUN;E2F1;SORL1;PSME3IP1;PEX14;CTSZ;DVL1;ROCK1;GSK3B;STYX;PPP1CA;SLPI;BAX;IFIT2;CAMK1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.4163976328040686,1.0192173485141471,0.4486345903771131,0.7834878125488657,1.0,10/25,23.94%,HK3;TPI1;ENO3;FOXK1;PFKP;GAPDHS;PFKM;GCK;PKM;HK1
prerank,regulation of telomerase activity (GO:0051972),0.37017741523820336,1.0186269216078634,0.44630071599045346,0.7844858171720077,1.0,13/45,23.93%,CTNNB1;ACD;PARP4;TERF1;XRCC5;DKC1;TNKS;CCT2;CERS1;PKIB;ERCC4;NEK7;MEN1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.41060866352731,1.0186083837406694,0.46225165562913906,0.7840829520362951,1.0,5/25,11.47%,SDCBP;THBS1;DSCAM;FZD7;APP
prerank,mitochondrion transport along microtubule (GO:0047497),-0.39644756525289226,-1.017830144843855,0.4088050314465409,0.8221612718640894,1.0,3/13,9.71%,MAPT;NEFL;SPAST
prerank,embryonic organ morphogenesis (GO:0048562),-0.2840329839010601,-1.0177162211604598,0.42011834319526625,0.8203803004994589,1.0,14/42,21.98%,ACVR1;FGFR2;RYR2;MEGF8;RARG;FBN2;HOXD4;HOXD3;HOXC9;HOXA9;FOXE1;SOX11;HOXB9;DSCAML1
prerank,nuclear body organization (GO:0030575),0.47521315232307865,1.0176518763875562,0.4811320754716981,0.7859981074041723,1.0,4/12,13.97%,SRPK2;HIPK2;SERBP1;USPL1
prerank,positive regulation of inflammatory response (GO:0050729),0.3452448162985279,1.0175060562760505,0.4523281596452328,0.785907762423085,1.0,13/86,15.74%,PLA2G7;MGST2;IL6;TNIP1;RIPK1;NINJ1;ADAM8;PTGER4;APP;IL15;CX3CL1;LBP;GRN
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.49440235913637404,1.017269449791937,0.46021840873634945,0.786050014693947,1.0,3/10,2.56%,CTNNB1;VEGFA;DCT
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.42754908281526355,1.017171744700036,0.45657894736842103,0.7858388448797448,1.0,4/22,10.59%,CDKN1A;STAP1;ROCK1;SIRT1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.37801607254167024,1.0171286565935824,0.4603960396039604,0.7855023717291262,1.0,13/39,22.74%,ITPKB;TMEM150A;SOCS6;PIK3CA;PIK3C2G;TTC7B;PI4K2A;EFR3A;PIP4K2A;PIK3CB;PI4K2B;SOCS4;SOCS7
prerank,response to interleukin-4 (GO:0070670),0.49298974780998794,1.0168655794714867,0.49923195084485406,0.7856993957725339,1.0,2/10,14.65%,SHPK;JAK3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3198194506525545,1.0166323625944005,0.4494494494494494,0.7858167151690171,1.0,62/348,15.85%,CD36;DTNBP1;LILRB1;NFE2L2;MITF;VEGFA;TFRC;IL36G;NAT8;ID2;IL6;CD28;CD46;CD63;SRPK2;CELF1;MAP2K5;CITED2;PID1;E2F1;IGF1;MAPK7;FGFR4;AGO2;ANXA2;HSPA1B;NWD1;ATF4;RPL23;STAP1;POU3F1;MSN;SOX9;BRCA1;CTSH;TYROBP;TNRC6B;NR5A1;ROCK1;GSK3B;MTPN;POU3F3;AGO3;MED26;MT3;APP;NOTCH1;TREM2;MAZ;DGKQ;GAS6;VAMP3;PRKN;SLC11A1;INPP5F;HSPA1A;ADAM19;SNF8;ARRB1;MPHOSPH8;MYD88;DNMT1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3630271308724278,1.0161864268058174,0.45774647887323944,0.786479938626554,1.0,8/49,10.77%,RAB7B;THBS1;EIF6;CNOT4;CBFB;TNRC6B;AGO3;KMT2E
prerank,regulation of ERBB signaling pathway (GO:1901184),0.45471157365134596,1.0159811366391966,0.4519368723098996,0.7865167020679098,1.0,3/15,6.66%,RHBDF2;MVB12B;PTPN12
prerank,ribosome biogenesis (GO:0042254),0.3258152636204878,1.015254300436609,0.4624871531346352,0.7878905147703634,1.0,66/187,26.36%,C1D;EBNA1BP2;MPHOSPH10;BYSL;SENP3;RPL18A;EIF6;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;EXOSC3;TEX10;WDR18;EXOSC9;POP4;WDR74;RPL22;NOB1;DKC1;MRPL36;EXOSC8;NOL8;RPL10A;CUL4A;KRR1;MRM2;PAK1IP1;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;MALSU1;NOC2L;UTP15;RCL1;DHX37;XPO1;CUL4B;EXOSC7;RPS27;WDR43;FBL;GTF3A;BOP1;NOLC1;RPL7A;LYAR;NOL6;XRN2;RPL32;SNU13;RRP36;RPS9;LSG1;WDR36;EXOSC4
prerank,negative regulation of cell cycle (GO:0045786),0.34967549664393555,1.014962618147011,0.4624591947769314,0.7881490567701503,1.0,10/73,9.53%,LILRB1;RPS6KA2;IPO5;RUNX3;PTEN;HTRA2;APC;NUDT6;RB1;NLRP2B
prerank,positive regulation of translation (GO:0045727),0.339445102007995,1.014866924629219,0.4508108108108108,0.7879259125165737,1.0,29/94,22.44%,SAMD4A;VIM;IL6;CD28;YTHDF3;THBS1;AGO2;EIF6;LARP4B;NAT10;POLR2G;CDC123;RMND1;USP16;UHMK1;HNRNPD;EIF4A3;RPL26;C1QBP;TRMT10C;BCL3;JMJD4;EIF3C;LARP4;PCIF1;COA3;PKM;PRKDC;UPF3A
prerank,regulation of hormone secretion (GO:0046883),0.45263682180448567,1.0147695702126354,0.45375722543352603,0.7877171036305791,1.0,4/15,20.29%,ANXA1;VAMP3;OSM;VAMP2
prerank,mucosal immune response (GO:0002385),0.4462638144342487,1.014488250548922,0.4593437945791726,0.787976476060032,1.0,2/15,17.91%,RNASE3;DEFA6
prerank,mismatch repair (GO:0006298),0.39181538609450206,1.01412565212213,0.4411384217335058,0.7884254380571674,1.0,4/27,6.86%,MCM9;MSH4;MUTYH;PMS1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.48135922448344504,1.0139497049872837,0.4696969696969697,0.788419949501939,1.0,2/11,4.15%,ID2;RIPK1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4804045689454542,1.0137480142768838,0.4708588957055215,0.7880169972447495,1.0,5/11,19.54%,PTEN;OCRL;INPP5A;IMPA2;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4804045689454542,1.0137480142768838,0.4708588957055215,0.7880169972447495,1.0,5/11,19.54%,PTEN;OCRL;INPP5A;IMPA2;SYNJ2
prerank,protein hydroxylation (GO:0018126),-0.36712649278616605,-1.0135574866375672,0.4463667820069204,0.8302637510774776,1.0,3/15,8.03%,P3H2;ASPH;PLOD2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.28899323035764796,-1.0134176493776108,0.4166666666666667,0.8285076749732081,1.0,5/34,6.52%,PTPRT;UBASH3B;PTPRO;DUSP6;DUSP7
prerank,covalent chromatin modification (GO:0016569),0.4547565727125133,1.0133534777127033,0.47352941176470587,0.7885736786922927,1.0,7/14,25.53%,PARP2;SIRT1;MT3;SIRT7;MBD2;SETD5;HDAC1
prerank,B cell activation (GO:0042113),0.3517652880200236,1.013262004645916,0.44966442953020136,0.7883466300588514,1.0,15/68,15.90%,ADGRG3;TPD52;ITGA4;MS4A1;BLNK;CD22;ITGB1;ADAM17;CTPS1;PRKCB;BTK;DCAF1;JAK3;HSPD1;KLF6
prerank,histone lysine methylation (GO:0034968),0.39290944933306615,1.0128657546216067,0.4721878862793572,0.788862777544032,1.0,14/33,26.40%,SMYD3;CXXC1;DOT1L;N6AMT1;SUV39H2;SMYD2;KMT2A;PAXIP1;EHMT2;SETD3;MEN1;SETD6;KMT2D;SETD1B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4054546408220465,1.012495127167716,0.46613545816733065,0.7893158805361117,1.0,3/25,6.71%,ERCC6;ALYREF;THOC1
prerank,regulation of centrosome duplication (GO:0010824),0.3997162870837225,1.0124466859504095,0.4756554307116105,0.7889837834220649,1.0,8/29,17.04%,PLK2;CHMP2A;PDCD6IP;NAT10;SIRT1;CEP76;ALMS1;CHMP5
prerank,T-helper cell differentiation (GO:0042093),0.45181644913675556,1.012310860040903,0.4617691154422789,0.788863137099654,1.0,4/14,15.41%,IL6;FOXP1;PTGER4;ATP7A
prerank,cell-cell junction assembly (GO:0007043),-0.25876048183040856,-1.0118627440084986,0.4298245614035088,0.8307912164444414,1.0,13/63,9.00%,CTNND1;TLN2;CTNND2;CDH11;CDH9;JUP;CDH8;PATJ;CDH2;CDH6;SMAD7;CDH12;CLDN11
prerank,sulfur amino acid catabolic process (GO:0000098),0.4986335839958246,1.0117370326736825,0.4704968944099379,0.7897834214471984,1.0,4/10,20.74%,TST;BLMH;MTRR;TXN2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.41945732161500093,1.0116566703432794,0.4716981132075472,0.7895442280776229,1.0,3/22,7.99%,APOE;PIK3CA;AKAP13
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.39773451228348206,1.011624093868637,0.45525291828793774,0.7891725872777812,1.0,11/30,21.45%,OPTN;RAB31;RAB10;MACF1;GOLPH3;GOLPH3L;GOLGA4;GGA2;BBS1;VAMP2;GGA3
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.34225468730058156,-1.0115964493810141,0.4065934065934066,0.8294967611490967,1.0,3/19,6.10%,CX3CR1;CD33;NLRP3
prerank,positive regulation of glial cell differentiation (GO:0045687),0.43458071064215315,1.0112633022289244,0.44352617079889806,0.7896239821888194,1.0,3/17,4.33%,CXCR4;ID2;TNFRSF1B
prerank,vasculogenesis (GO:0001570),0.384780023784053,1.0112420407505616,0.4537712895377129,0.7892358537272985,1.0,2/32,1.73%,APLNR;VEGFA
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.45136960562504636,1.01121007613911,0.4866385372714487,0.7888760558755397,1.0,2/15,8.73%,PRKCH;NCOA3
prerank,neural crest cell migration (GO:0001755),0.3848400696929716,1.0111276941976475,0.4609571788413098,0.7886229464609616,1.0,8/36,16.18%,HTR2B;CORO1C;SEMA4B;FOLR1;PHACTR4;GDNF;SEMA3B;NRP1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.41213162654120783,-1.0107061605856498,0.4369747899159664,0.8299275328973708,1.0,2/10,4.66%,THRA;PSMC2
prerank,response to UV (GO:0009411),0.33876457919637065,1.0106166172785809,0.46949891067538124,0.7894056554320692,1.0,34/95,25.22%,AQP1;ERCC6;PRKCD;ZRANB3;COPS9;CREBBP;EIF2AK4;ATF4;CAT;MAP4K3;POLH;DCUN1D3;RHBDD1;WRN;NSMCE3;MFAP4;RELA;N4BP1;INO80;RPL26;CDC25A;NOC2L;BCL3;EIF2S1;TAF1;RUVBL2;POLD1;SPRTN;UBE4B;ERCC4;MEN1;USP47;PRIMPOL;GPX1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3545521117809741,1.0105568866605943,0.4639175257731959,0.789098580820318,1.0,17/62,17.21%,POLR2A;AFF4;GTF2H5;PCID2;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;CTDP1;MLLT1;MNAT1;CDC73;ELP4;NELFE;MLLT3
prerank,rRNA metabolic process (GO:0016072),0.3268644347852796,1.0104972464460957,0.48701973001038423,0.7887988090714533,1.0,69/160,29.25%,C1D;EBNA1BP2;MPHOSPH10;BYSL;SENP3;RPL18A;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;EXOSC3;TEX10;WDR18;EXOSC9;POP4;WDR74;RPL22;NOB1;DKC1;EXOSC8;NOL8;DEDD2;RPL10A;KRR1;MRM2;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;UTP15;RCL1;DHX37;EXOSC7;RPS27;WDR43;FBL;BOP1;NOLC1;RPL7A;LYAR;NOL6;XRN2;RPL32;SNU13;RRP36;RPS9;WDR36;EXOSC4;DDX49;MPHOSPH6;RPL6;DIS3L;PELP1;NOL11;RPL4;RPL14;MRTO4;EMG1;RPS7;ESF1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3241807847903487,1.0104747182434697,0.48577235772357724,0.788404339800603,1.0,34/199,15.88%,GPNMB;GDF15;TIMP1;FOXP3;CORO1C;WWC2;NR1H3;ATP2B1;PTEN;NR1H4;PROC;FLCN;PARP3;ATF4;SOX9;MCC;RB1;BMPR2;DDIT3;PTGER4;WDR77;ROCK1;ADAM17;GSK3B;NOTCH1;IL15;PLCL2;GAS6;N4BP1;SLC11A1;PFN2;LAMA4;GRN;LNPEP
prerank,cAMP biosynthetic process (GO:0006171),0.48611547078351236,1.010134502118846,0.4537177541729894,0.7887672656156558,1.0,5/10,23.07%,ADCY7;ADCY8;ADCY3;ADCY5;ADCY9
prerank,regulation of myelination (GO:0031641),-0.31598302685784435,-1.0099057491937284,0.41810344827586204,0.8300263625798863,1.0,15/25,26.68%,PARD3;JAM2;TPPP;MYRF;CST7;TENM4;SIRT2;DICER1;TMEM98;EIF2AK3;NSUN5;LGI4;KLK8;NKX6-2;KIF14
prerank,selective autophagy (GO:0061912),0.3600960791356602,1.009775116450543,0.4440639269406393,0.7891888244953014,1.0,22/56,23.39%,RAB7A;VIM;DYNC1H1;AMBRA1;RPS27A;UBC;ATG5;ATG13;UBA5;WDFY3;PRKN;SQSTM1;TEX264;UBE2V1;USP30;ARL13B;ACBD5;IFT88;RETREG1;ATG2B;DYNC1LI2;KLHL3
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4942993631193854,1.009600415600502,0.49251497005988026,0.7891592569039647,1.0,5/10,20.30%,PIBF1;NF2;INPP5F;PPP2CA;PPP2R1A
prerank,"phototransduction, visible light (GO:0007603)",0.4533896473204083,1.0093239297771905,0.4582723279648609,0.7893685101521603,1.0,1/14,2.42%,GNAQ
prerank,cell-matrix adhesion (GO:0007160),0.3429564680738293,1.0093162246771075,0.4851380042462845,0.788945933950905,1.0,17/95,14.97%,HPSE;CD44;ADAM9;ITGA4;CD63;ACTN1;TNN;DLC1;OTOA;ITGB1;RHOD;ITGA10;SIGLEC1;ITGA3;COL3A1;WHAMM;ITGA8
prerank,regulation of phospholipid metabolic process (GO:1903725),0.4878328632394408,1.0092295891922825,0.4743975903614458,0.788717881366802,1.0,2/10,7.78%,MTMR3;ABCA3
prerank,phosphatidylinositol metabolic process (GO:0046488),0.33606253861598395,1.0084697537649558,0.49092849519743864,0.7900872179730591,1.0,19/109,13.76%,PIK3R5;MTM1;PIKFYVE;MTMR3;PGAP3;PLA2G2D;INPP4A;PTEN;FIG4;PIK3CA;PGAP1;PIK3C2G;SLC27A1;PLA2G4F;PLEKHA1;PLAAT3;PI4K2A;OCRL;INPP5F
prerank,barbed-end actin filament capping (GO:0051016),0.4244940801780289,1.008380763674723,0.4455587392550143,0.7894109314494517,1.0,5/18,9.42%,VILL;CAPG;TRIOBP;SVIL;CAPZB
prerank,actin filament capping (GO:0051693),0.4244940801780289,1.008380763674723,0.4455587392550143,0.7894109314494517,1.0,5/18,9.42%,VILL;CAPG;TRIOBP;SVIL;CAPZB
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3003182519368953,-1.008201686846078,0.43283582089552236,0.8328687654776197,1.0,9/34,12.33%,P2RY12;IRS1;FGF2;FLT3;PRKD1;ATG14;DAB2IP;PIK3R2;PIK3R3
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.45173166302625495,1.00808959649063,0.47277936962750716,0.7896867628169287,1.0,7/15,24.79%,ADRA1A;CLN3;ZDHHC12;NLGN2;BAIAP3;DRD2;USP46
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.33641124227784214,-1.0078528895418242,0.4505928853754941,0.8275278236810355,1.0,12/20,32.24%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK;PLK1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.33641124227784214,-1.0078528895418242,0.4505928853754941,0.8275278236810355,1.0,12/20,32.24%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK;PLK1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.33641124227784214,-1.0078528895418242,0.4505928853754941,0.8275278236810355,1.0,12/20,32.24%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK;PLK1
prerank,regulation of peptide hormone secretion (GO:0090276),-0.2591664921429937,-1.0078113050282058,0.4537037037037037,0.8256062107619624,1.0,18/67,17.32%,CACNA1E;KCNC2;HTR2C;ITPR2;CACNA1C;SNAP25;SYT7;RAPGEF4;CACNA2D2;PICK1;RFX3;PRKCA;DPP4;STX1A;RAPGEF3;HFE;KCNG2;TNF
prerank,eye development (GO:0001654),0.35792862899055955,1.0074541407965316,0.4668192219679634,0.7907697241270104,1.0,10/54,13.34%,STRA6;ZDHHC16;NIPBL;HIPK1;HIPK2;COL5A2;SALL2;RAB18;SOX2;SH3PXD2B
prerank,negative regulation of viral process (GO:0048525),0.3584647901069915,1.007443363459025,0.46396396396396394,0.7903497434784318,1.0,14/57,17.78%,IFITM1;TNIP1;SRPK2;FAM111A;RNASEL;ZC3HAV1;IFITM2;MAVS;LARP7;BST2;N4BP1;SLPI;SRPK1;TRIM14
prerank,protein localization to membrane (GO:0072657),0.32414333158665,1.0073273298607806,0.4786150712830957,0.7902006111355604,1.0,38/187,14.61%,MYO5A;DENND4C;RFTN1;RAP2A;FLOT1;NPC1;RAB8B;PRAM1;ITGA4;PDZD11;SH3GLB1;SYNE3;TMEM150A;ZFYVE27;TSPAN17;GAK;RABEP1;HPS6;DVL1;TTC7B;EPB41L3;TNIK;RAB12;ROCK1;RAB10;RAB40C;CYP46A1;AP3D1;PACS2;RAB11B;TSPAN15;SH3PXD2B;GAS6;NRXN2;EFR3A;ARL3;CACNB3;LRP6
prerank,tRNA transport (GO:0051031),-0.2949353716340192,-1.0072145294653252,0.42487046632124353,0.8252982926935893,1.0,12/35,14.86%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,cellular response to misfolded protein (GO:0071218),0.42967699491363215,1.0069399368747847,0.45964432284541723,0.7906610979704307,1.0,12/20,28.86%,CUL3;STUB1;DNAJB14;UGGT1;DNAJC18;ATXN3;TOR1A;VCP;DNAJB12;KLHL15;RNF185;RNF5
prerank,chordate embryonic development (GO:0043009),0.35539220320638604,1.0069237688472252,0.47079439252336447,0.7902671637074917,1.0,15/55,21.31%,VEGFA;XYLT1;MBNL1;COL1A1;FLCN;SULF2;BRCA1;DVL1;SULF1;ALDH1A2;CHD7;FUT8;SOX8;HES5;ADAM10
prerank,protein localization to cell periphery (GO:1990778),0.3306336350721913,1.0068421559710257,0.4730848861283644,0.7900178212703205,1.0,26/133,14.61%,MYO5A;DENND4C;RAP2A;FLOT1;RAB8B;PRAM1;PDZD11;TMEM150A;ZFYVE27;TSPAN17;GAK;RABEP1;TTC7B;EPB41L3;TNIK;RAB12;ROCK1;RAB10;RAB40C;PACS2;TSPAN15;GAS6;EFR3A;ARL3;CACNB3;LRP6
prerank,peptidyl-lysine methylation (GO:0018022),0.40985432383141807,1.0067826650301264,0.46469833119383824,0.7897067648043311,1.0,10/26,25.52%,SMYD3;ETFBKMT;N6AMT1;SETD7;SUV39H2;SMYD2;EHMT2;SETD3;METTL21A;SETD6
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.32539686308639265,1.0059179855649147,0.5,0.7913551595390638,1.0,51/166,24.61%,CD36;SAMD4A;ZEB2;VIM;NR1H3;IL6;HGF;CD28;PAOX;P2RX4;YTHDF3;IGF1;FGFR4;THBS1;IRS2;EIF6;LARP4B;SLC27A1;NAT10;DDB1;SIRT1;APPL1;GPLD1;NPM2;DYRK2;HNRNPD;STN1;ATP7A;EIF4A3;ATAD5;CDT1;RPL26;EPM2AIP1;BCAR3;BCL3;EIF3C;LARP4;SREBF1;GCK;PCIF1;NR1H2;GIPC1;PRKDC;UPF3A;FAF1;NMD3;ZCCHC4;PDGFRB;PLXNB2;IGF2;SOX4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3383530865397679,1.0055887163948303,0.4829059829059829,0.7917185473990302,1.0,33/100,22.65%,SDCBP;WAC;RNF19A;GNA12;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;N4BP1;PRKN;HSPA1A;HECTD1;KEAP1;EIF3H;BBS7;TLK2;XPO1;DDA1;RNF19B;OGT;PIAS1;CEBPA;TAF1;GIPC1;HSPBP1;VCP;HERPUD1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4119645919164303,1.0053747923448717,0.4606141522029373,0.7917869894141766,1.0,4/23,6.20%,PDK4;TFAP2B;SLC12A3;SLC12A8
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.3634581109175027,1.0052182376529486,0.4609004739336493,0.7917368022008597,1.0,15/46,24.51%,LCP1;TALDO1;ANXA2;MSN;PITPNA;CFL1;PAK2;PSME2;CAPZA1;HNRNPDL;GSTO1;JAK2;HSPA9;AIP;PPIA
prerank,response to growth factor (GO:0070848),0.38045199947336805,1.0046987212733454,0.4721189591078067,0.7925212343562099,1.0,11/41,14.50%,CTNNB1;MAP2K5;HTRA2;MAPK7;STAT5B;ACVR2A;ACVRL1;BMPR2;ACVR1B;SOX2;SHC1
prerank,neuron projection development (GO:0031175),0.32541968578339603,1.004326718013662,0.4865424430641822,0.7929712704708441,1.0,27/168,12.11%,LRP12;APOE;SGK1;DTNBP1;STX3;MICALL2;ERCC6;KIF20B;TAOK3;IL6;FRY;PTEN;ZFYVE27;TBC1D23;DOCK10;MICALL1;RB1;PPP1R9B;VAPA;VASH2;EPB41L3;TNIK;ROCK1;GSK3B;TBC1D24;APP;PQBP1
prerank,protein deubiquitination (GO:0016579),0.3193837975512472,1.0043145946520868,0.5100806451612904,0.7925591525689227,1.0,85/242,26.02%,MINDY1;TNIP1;PSMD1;RIPK1;ASXL2;PTEN;FOXO4;STAM;BABAM2;APC;RNF128;TOMM20;RPS27A;UBC;USP42;BRCA1;RAD23A;USP12;VCPIP1;COPS5;ESR1;FOXK1;USP40;BIRC3;USP26;CCNA2;PSMF1;USP48;PSMD14;PSMD12;TRAF3;USP21;USP16;KDM1B;TNFAIP3;PRKN;RNF123;MCRS1;PSME2;INO80;STAM2;USP36;CCP110;BRCC3;ASXL1;USP8;TRAF2;NFRKB;OTUD5;PSMB10;KEAP1;PSMD5;SNX3;USP32;BIRC2;CDC25A;PSMD8;PSMA3;USP30;STAMBP;PSMA2;ATXN3;PSMD11;PSMA6;OGT;USP3;USP9X;KAT2A;USP2;VCP;PSMB3;SIAH2;PSME3;TRAF6;USP47;SHMT2;ATXN7;USP46;PSMC5;TAB1;RCE1;ACTB;WDR20;KAT2B;MAP3K7
prerank,external encapsulating structure organization (GO:0045229),0.3236328704191827,1.003985572718903,0.49798387096774194,0.7928932357775905,1.0,36/205,17.14%,MMP12;VWF;ICAM2;ADAMTS8;MMP27;SPP1;CD44;ITGA5;ITGA4;PDGFA;COL4A6;MMP14;COL1A1;THBS1;DAG1;LUM;COL4A1;HRNR;COL5A2;ITGB1;ITGA10;COL11A1;APP;VIT;COL5A3;ITGA3;COL3A1;ADAM19;ITGA8;LAMA4;LAMA3;COL6A2;ATP7A;ADAMTSL4;COL11A2;COL4A5
prerank,negative regulation of epithelial cell migration (GO:0010633),0.38416485503132825,1.0039509953206491,0.46740467404674046,0.7925393021353095,1.0,6/33,8.84%,APOE;CORO1C;PTEN;THBS1;MCC;ACVRL1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3765943715688247,1.0037579295983448,0.46384039900249374,0.7925328183117379,1.0,4/38,8.22%,CD36;GLA;P2RX4;SIRPA
prerank,regulation of cytokinesis (GO:0032465),0.34460261655140834,1.0037130616810626,0.49278579356270813,0.7922022956747599,1.0,12/78,10.75%,KIF20B;PLK2;BIRC6;UVRAG;SH3GLB1;CUL3;MYO19;FLCN;SVIL;ZFYVE19;VPS4A;PKN2
prerank,COPII-coated vesicle budding (GO:0090114),0.34847332671406656,1.0036710188838884,0.4943820224719101,0.7918590241311442,1.0,27/68,25.12%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;VAPA;SEC23B;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;PPP6R1;SEC24B;PREB;PEF1;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.41673021356876394,-1.0036108388717566,0.45544554455445546,0.8334363700820959,1.0,2/10,2.63%,SERPINE2;SH2B3
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.39929355271908956,1.0034478116634689,0.4729381443298969,0.7919976746672359,1.0,3/26,8.03%,NSMCE2;CUL3;RB1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.39575714369002957,1.0033848878999123,0.4897959183673469,0.7917118510508357,1.0,3/27,5.28%,SLC7A2;SLC36A4;SLC38A1
prerank,protein phosphorylation (GO:0006468),0.3160766106468844,1.0033382961498982,0.495,0.791396172975398,1.0,79/478,13.89%,FNIP2;SGK1;MAP3K20;MAK;SYK;TLK1;FRK;PRKCH;MAP3K1;RPS6KA2;ERN1;TEC;PDK4;MAPKAPK3;PRKAG2;IKBKE;PLK2;TAOK3;PDPK1;ABL2;PRKCD;PPP4R1;RUNX3;BIRC6;SIK3;FAM20C;SRPK2;DAPK1;RIPK1;ABI1;RARA;MAPK6;GTF2H5;PIM1;FGFR4;MAML1;PKN3;MERTK;RNASEL;MELK;SIK1;IRAK3;STK24;STK3;INCENP;DYRK1A;EIF2AK4;TOP1;BRD2;ACVR2A;PKDCC;HIPK1;MAP4K3;ACVRL1;CSNK2A2;HIPK2;BMPR2;TNIK;PIM3;ROCK1;GSK3B;PTK2B;PAK2;PKN2;FES;CDK7;CCNA2;APP;DCLK3;PRKCB;ACVR1B;STK38;BTK;DGKQ;DYRK2;GAS6;FGR;STK16;MAST4
prerank,triglyceride biosynthetic process (GO:0019432),0.43291487383114857,1.0030326375380938,0.47375690607734805,0.7917339749245466,1.0,2/18,1.54%,LPIN3;GPAT2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.36117117014494315,-1.0030156299807547,0.4243421052631579,0.8330529916637924,1.0,3/15,4.29%,TGFBR2;FGFR2;TGFBR1
prerank,negative regulation of developmental process (GO:0051093),0.34873672300024533,1.002794490858684,0.4791431792559188,0.7918758003608521,1.0,13/69,13.63%,VAT1;HOPX;TFRC;PARP3;ANP32B;SOX9;HUWE1;WDR77;ROCK1;NOTCH1;OMA1;GAS6;PRKN
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.33335271726986404,1.0027136936437875,0.4956989247311828,0.7916242036963564,1.0,19/95,14.70%,B4GALT5;GCNT2;XYLT1;DSE;NDST1;EXT1;UGDH;B4GALT7;HAS3;B4GALT6;HEXA;ST3GAL4;LUM;HS2ST1;B4GALT3;SDC4;B4GALT2;SLC10A7;HS3ST2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.30190009575579124,-1.0024964632980329,0.462882096069869,0.8324727623193924,1.0,8/28,10.71%,SMURF1;PSMC2;OSBPL7;FMR1;CLU;ECSCR;DAB2IP;RNF139
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4248339407943485,1.0024643203627626,0.4869684499314129,0.7917994448095841,1.0,4/18,15.53%,SYK;TYROBP;DOCK2;LBP
prerank,peptidyl-lysine acetylation (GO:0018394),0.4841516153881765,1.0022263485592415,0.47392638036809814,0.7919341879178515,1.0,5/10,29.18%,CREBBP;SIRT1;KAT2A;KAT2B;EP300
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3438411904698768,1.0021699545393,0.5,0.7916222662138054,1.0,25/76,22.14%,FBXW7;RNF19A;PTEN;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;PRKN;HSPA1A;HECTD1;KEAP1;BBS7;DDA1;RNF19B;PIAS1;CEBPA;TAF1;HSPBP1;VCP
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3882643273085116,1.002048844196485,0.4740740740740741,0.7914876081620614,1.0,5/36,8.84%,PPARG;APOE;THBS1;GADD45A;ACVRL1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3485321421707165,1.0016888900217027,0.49393605292171994,0.7919175730530353,1.0,11/64,12.82%,MGLL;ABCD1;SLC27A4;SLC27A3;ACADL;GPX4;CPT1A;AIG1;LTA4H;ELOVL1;ACSL5
prerank,regulation of myoblast differentiation (GO:0045661),-0.29757501901391314,-1.0015027471099593,0.4222222222222222,0.8330871497799849,1.0,4/32,3.76%,MEF2C;PLCB1;FLOT2;RIPOR2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4283503305423404,1.0014058451234333,0.46348314606741575,0.7917304636077066,1.0,5/17,16.84%,STAT5B;IRS2;IL7R;JAK3;BRWD1
prerank,cellular response to interleukin-7 (GO:0098761),0.4283503305423404,1.0014058451234333,0.46348314606741575,0.7917304636077066,1.0,5/17,16.84%,STAT5B;IRS2;IL7R;JAK3;BRWD1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3414017370990776,1.0010204481674094,0.49673202614379086,0.7921980627453644,1.0,32/79,28.42%,CTSD;PIKFYVE;CTSL;OSBPL1A;RAB7A;DYNC1H1;KIF3A;CTSS;CAPZB;AP1G1;AP2B1;CAPZA1;ACTR1B;AP1M1;SEC31A;FCGR2B;LGMN;SEC24C;SEC24B;DYNC1LI2;AP2S1;DCTN4;CLTC;AP2A2;DYNC1LI1;KIF22;AP2A1;DCTN5;AP1B1;SEC24A;KIF3B;CANX
prerank,RNA splicing (GO:0008380),0.33459639744337827,1.0008094801478395,0.5043010752688172,0.7922257563799324,1.0,33/95,25.39%,DHX8;MBNL1;SRPK2;MPHOSPH10;SCAF11;RNPC3;TCERG1;PRPF8;PPP1R9B;SNRNP25;PRPF6;DDX23;NCBP2;ZMAT5;SF3A3;SNRNP35;RSRC1;SNRPF;ZRSR2;SYNCRIP;SRPK1;PPP2CA;PPP2R1A;SNRNP40;YJU2;SNRPB;SNRNP48;WDR83;RRAGC;PPIG;SF3B2;PRPF3;LSM6
prerank,metanephros development (GO:0001656),-0.30850575999065877,-1.0007600255368032,0.4214876033057851,0.8331469527573044,1.0,7/26,16.28%,ROBO2;PTCH1;PAX2;BASP1;PKD2;PKD1;FGF10
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.4535298256869314,1.0007444885074521,0.47467438494934877,0.7919420004067744,1.0,1/14,0.68%,SYK
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.42345506084285245,1.0004532885941195,0.46354883081155435,0.7921991450957596,1.0,6/19,10.12%,APOE;SORL1;IGF1;RTN3;PICALM;ROCK1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.47381521385694736,1.0000435730535597,0.4893939393939394,0.7927241792828632,1.0,2/12,7.51%,HOOK3;KIF3A
prerank,nervous system development (GO:0007399),-0.2461582912569872,-1.0,1.0,0.8331845414336218,1.0,88/429,12.35%,NAV3;NAV2;RAPGEF5;RBFOX1;ADGRL3;MEF2C;OPHN1;ERBB4;SEMA5A;LSAMP;SDK1;GPM6A;SPOCK1;NRXN1;ADAM23;DCLK1;ROBO2;KIRREL3;ROBO1;NLGN1;CNTN6;MARCKS;RBFOX2;EVL;GRIK1;DNM3;SIAH1;RYK;MBP;SCN2A;SMO;BTBD3;GLRB;CHRM3;CNTN4;CHRM2;ANKLE2;FUT10;RBFOX3;FGF12;RELN;LIMK1;SRRM4;MYT1L;TGFBR1;NCKAP1;STMN3;TRIM3;ARNT2;FGF2;FGF13;TMOD2;IL1RAPL2;MOBP;INTU;ARHGAP26;FARP1;CDH2;VLDLR;EDNRB;ADORA1;GSS;MBD5;ATN1;MAL;DNER;SZT2;PPP2R5D;SERPINI1;IRF2BPL;EFNB3;ADGRV1;SOX6;ADAM22;NLGN3;SH3GL3;KCNQ2;MARK4;SREBF2;HAPLN2;SNTG2;PKD2;SEMA6A;RPS6KA6;LDB1;LDB2;ERBB3;GFRA2
prerank,establishment of vesicle localization (GO:0051650),-0.3379515304838551,-0.9998016475321773,0.4095940959409594,0.8317371967630726,1.0,6/18,12.85%,RAB27A;KIF5A;CCDC186;TESK1;RAB11A;LIMK2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4124073717488639,0.9992783560606614,0.46580645161290324,0.7941441222943307,1.0,11/24,25.34%,NR1H3;LPCAT3;PRKN;HSPA1A;CREB3;CREB3L1;WFS1;NR1H2;HERPUD1;BCL2L1;TXNDC12
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.33236265486762523,0.9992402962867007,0.4786680541103018,0.7938035427158614,1.0,23/112,16.06%,GDF15;ZMIZ1;GCNT2;ADAM9;JUN;APPL2;MAPK7;NR3C1;LPXN;RPS27A;UBC;ZFP36L2;SOX9;ACVRL1;ITGB1;SIRT1;APPL1;COL3A1;GDF10;PARD6A;NRROS;CBL;WWOX
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4842732886625416,0.9988997834406272,0.49242424242424243,0.7941836736452073,1.0,2/10,14.61%,CTNNB1;LRP6
prerank,circulatory system development (GO:0072359),0.33061886399623047,0.9988602188935807,0.4860813704496788,0.7938434444806134,1.0,21/118,13.59%,APLNR;ALPK3;STRA6;FBXW7;ID2;CDKN1A;ZDHHC16;MYL2;PTEN;CITED2;PIK3CA;PDLIM5;SOX9;AKAP13;ACVRL1;TAB2;NOTCH1;MICAL2;COL3A1;SH3PXD2B;SMYD4
prerank,histone methylation (GO:0016571),0.39897862335781387,0.9984460300627938,0.48284960422163586,0.7943785348231428,1.0,7/26,15.37%,SMYD3;NSD3;CREBBP;N6AMT1;SIRT7;SUV39H2;SMYD2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.37492046995306477,0.9984380995877148,0.46079613992762364,0.7939671048218843,1.0,18/35,28.45%,FOXO3;STAT5B;HSPA1B;ACVR2A;MAFB;ACVR1B;FAM210B;HSPA1A;BRD1;PRKDC;STAT3;CDK6;HSPA9;ZFP36;MAPK14;NCKAP1L;INHBA;ZFP36L1
prerank,vascular transport (GO:0010232),0.3382419625179783,0.9983446923060155,0.4861878453038674,0.7937349716701662,1.0,13/81,8.19%,SLC6A6;SLC7A2;TFRC;LRP1;SLC1A5;SLC16A1;SLC27A4;SLC38A1;SLC5A5;ABCC4;ABCC3;SLC27A1;ABCA2
prerank,DNA catabolic process (GO:0006308),0.4666238942671325,0.998032490046398,0.4534711964549483,0.7940455268704907,1.0,3/11,10.72%,MUS81;DFFB;DNASE1L1
prerank,translation (GO:0006412),0.315489991178973,0.997923162079058,0.5097037793667007,0.7938933799005953,1.0,47/208,17.36%,RPL3L;FARS2;TNIP1;IGF2BP3;EEF1A1;AGO2;RPL18A;RPS14;MRPL11;RPS11;RPS27A;MRPL23;RPL17;RPL23;N6AMT1;DARS1;RPL36A;ETF1;EIF4EBP2;COPS5;MRPS7;RPL22;RPS21;RRBP1;MRPL32;MRPL36;GTPBP2;EPRS1;MRPS28;SARS2;SARS1;RPL10A;MRPL28;DHPS;RPS26;IARS2;MRPS21;SRBD1;QRSL1;MRPL35;RPL15;RPL10;RPSA;AIMP1;MRPL43;RPL7;RPL26
prerank,regulation of intracellular pH (GO:0051453),0.3784306767055789,0.9978668606508788,0.4837905236907731,0.793594847813758,1.0,8/34,16.72%,SLC9B1;SLC9A3;TMEM165;CLN3;VPS33A;GPR89A;GPR89B;CA2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3721957178201082,0.9977044721150559,0.4619164619164619,0.7935474932555541,1.0,7/40,9.01%,ALYREF;MCM9;ZRANB3;FAM111A;THOC1;EME1;RTEL1
prerank,cellular response to retinoic acid (GO:0071300),-0.2797508672291305,-0.9976986770370575,0.480225988700565,0.8356869808100307,1.0,6/42,2.96%,BRINP3;TWF2;SETX;RORB;EPHA3;ATM
prerank,chromatin remodeling at centromere (GO:0031055),-0.29412925798364026,-0.9973197463347633,0.42857142857142855,0.8346801455637288,1.0,18/31,35.07%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;CENPQ;CENPN;CENPH;CENPI;CENPW;HELLS;SMARCA5;CENPL
prerank,presynapse organization (GO:0099172),-0.4133776222342462,-0.9968969318274363,0.4434782608695652,0.8338496957808418,1.0,3/10,10.47%,NLGN1;LRRTM3;NLGN3
prerank,camera-type eye development (GO:0043010),0.4042954516869297,0.9963782494806915,0.4844804318488529,0.796244607968374,1.0,2/25,1.73%,STRA6;VEGFA
prerank,mammary gland epithelium development (GO:0061180),-0.36762952675446836,-0.9958022163264763,0.4217687074829932,0.8348725634310066,1.0,2/14,1.05%,ERBB4;CSF1R
prerank,cellular response to light stimulus (GO:0071482),0.3434810488116809,0.9957490941105678,0.5011441647597255,0.7973310427301914,1.0,19/66,24.09%,AQP1;PRKCD;COPS9;CREBBP;EIF2AK4;ATF4;RHBDD1;NSMCE3;N4BP1;INO80;RPL26;CDC25A;NOC2L;EIF2S1;TAF1;RUVBL2;POLD1;ERCC4;USP47
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3486695548774567,0.9955401552299564,0.4840182648401826,0.7974201243686345,1.0,17/64,17.21%,POLR2A;AFF4;GTF2H5;PCID2;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;CTDP1;MLLT1;MNAT1;CDC73;ELP4;NELFE;MLLT3
prerank,positive regulation of histone methylation (GO:0031062),0.4066890525014317,0.9953861773637083,0.47780678851174935,0.7973383175102484,1.0,10/24,22.24%,CTNNB1;CHTOP;BRCA1;SIRT1;DNMT1;KMT2A;PHF1;PAXIP1;OGT;MTF2
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.40634578175219227,0.9949507994231634,0.48226018396846254,0.7979058156903821,1.0,2/23,1.57%,LILRB1;LAMP1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.45382040786157624,0.9946686911172292,0.5137481910274964,0.7981398757808672,1.0,7/14,25.34%,PRKN;HSPA1A;CREB3;CREB3L1;HERPUD1;BCL2L1;TXNDC12
prerank,protein modification process (GO:0036211),0.3444540854488212,0.9944456710501327,0.5039018952062431,0.7982367118340581,1.0,23/76,22.45%,MSRA;ABL2;PARP4;B4GALT7;GNMT;UBE2L3;MANBA;PIGH;PPP4R2;WWP2;FBXO11;STK38;UBA3;FBXW2;MCRS1;CDC34;UBE2M;ICMT;UBE2S;NAGPA;NTAQ1;PRKDC;DUSP12
prerank,microtubule nucleation (GO:0007020),-0.33172341083985313,-0.9942928013355123,0.4795539033457249,0.8371153095554364,1.0,7/19,19.74%,TUBGCP5;AKAP9;TPPP;CSNK1D;NDEL1;TPX2;TUBGCP6
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.34465144957938815,0.9942271172668985,0.48834628190899,0.798350205762396,1.0,18/70,18.54%,PDPK1;FAS;RIPK1;TNFRSF1B;MLLT11;HIPK1;IL6R;GSK3B;ACVR1B;DEDD2;APPL1;BAX;MCL1;BID;TRAF2;CASP2;CASP3;CRADD
prerank,"DNA-templated transcription, termination (GO:0006353)",0.34545543316594723,0.9940061956558853,0.49223946784922396,0.7984144325677786,1.0,17/68,18.55%,POLR2A;CPSF1;GTF2H5;CSTF3;POLR2L;WDR33;TAF1B;POLR1A;CDK7;NCBP2;MAZ;SNRPF;MNAT1;SSU72;SMN1;TTF1;TAF1A
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.35137507859256145,-0.9937328688109532,0.44224422442244227,0.8365608328441416,1.0,2/17,3.76%,CAMK1D;RIPOR2
prerank,supramolecular fiber organization (GO:0097435),0.3155337481179389,0.9932983478772206,0.5025075225677031,0.7996786229750997,1.0,66/333,19.16%,CD36;MFGE8;MYO5A;MTM1;TLL2;HOOK3;RUFY3;CORO1C;MYO1E;VIM;DNAJB6;NAT8;DYNC1H1;BIN3;CD151;COL4A6;RIPK1;B4GALT7;SORL1;ACTN1;COL1A1;TRIOBP;KLHL41;MYO19;RPS27A;UBC;NCKAP5L;LUM;COL4A1;PPP1R9B;CALB1;TPM3;BACE1;MYO1F;COL5A2;ARHGAP17;RHOD;ARHGEF2;TPM4;COL11A1;KLHL24;APP;TUBGCP4;COL5A3;MFAP4;COL3A1;TSPAN15;PRKN;WHAMM;LAMA3;NCSTN;COL6A2;ATP7A;RND2;CCDC88C;ARHGAP25;GGA2;COL11A2;COL4A5;PLOD1;COL12A1;PLEC;FLII;KATNA1;CALCA;CORO1B
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4757698967902888,0.9926009849122782,0.48992248062015503,0.800903511942379,1.0,2/10,13.37%,LILRB1;GAS6
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.27156821576003337,-0.9924370464551402,0.42011834319526625,0.8381265681495269,1.0,24/38,37.76%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;ATRX;ASF1B;CENPQ;CENPN;CENPH;ASF1A;CENPI;HIRA;HAT1;CENPW;SMARCA5;CENPL;CENPS;H3-3A
prerank,piRNA metabolic process (GO:0034587),0.42220318567839077,0.9924209510820382,0.4978601997146933,0.800882064150434,1.0,1/19,1.54%,GPAT2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.35464568371417193,0.9924110207977956,0.4936998854524628,0.8004716788174716,1.0,7/56,10.14%,GDF15;SDCBP;RBPMS;ACVR2A;ACVRL1;BMPR2;SNX25
prerank,inner dynein arm assembly (GO:0036159),0.47823431220996465,0.9920956755381227,0.4861111111111111,0.8007573664874811,1.0,1/10,3.81%,CCDC40
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4724568821677053,0.9918787699992665,0.4945904173106646,0.8008685147156178,1.0,2/10,15.41%,KYNU;ATP7A
prerank,negative regulation of protein binding (GO:0032091),0.3396490203785797,0.9916327178195746,0.48769574944071586,0.8009973461982386,1.0,17/71,16.60%,PRKCD;CDKN1A;ITGA4;TFIP11;SORL1;PSME3IP1;PEX14;CTSZ;DVL1;ROCK1;GSK3B;STYX;PPP1CA;SLPI;BAX;IFIT2;CAMK1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.42542391019489034,0.9914610010366788,0.4897119341563786,0.8009508834414754,1.0,2/19,2.98%,VIM;IL6
prerank,protein auto-ADP-ribosylation (GO:0070213),0.46051481280661016,0.9912985933689609,0.4890190336749634,0.8009072494978144,1.0,5/12,18.05%,TIPARP;PARP2;PARP3;TNKS;TNKS2
prerank,negative regulation of signaling (GO:0023057),0.3987900242102707,0.9911819140494754,0.5,0.8007342427394587,1.0,3/25,5.80%,OPTN;BRAP;TRAT1
prerank,import into nucleus (GO:0051170),0.3450494130690664,0.9908703924737612,0.503945885005637,0.801042738016496,1.0,19/73,22.67%,MMP12;SYK;IPO5;E2F3;APPL2;TPR;NUP50;TNPO1;APPL1;DDX20;SNRPF;SMN1;NUP88;CSE1L;NUP188;SNRPB;PPP1R10;RPAIN;STAT3
prerank,aortic valve development (GO:0003176),0.379704133762752,0.9905312284536687,0.4893350062735257,0.8014346840885339,1.0,7/34,11.89%,TNFRSF1B;SOX9;SNAI2;RB1;BMPR2;ROCK1;NOTCH1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.34684348415865385,0.9905275747817647,0.49146757679180886,0.8010093507654805,1.0,14/67,14.65%,SYK;TEC;PIBF1;ABL2;ABI1;FGFR4;DYRK1A;PKDCC;PTK2B;FES;IL15;BTK;FGR;JAK3
prerank,regulation of amyloid-beta formation (GO:1902003),0.3776335910175008,0.9904496446741586,0.4932014833127318,0.8007524140968534,1.0,16/34,23.25%,APOE;ABCG1;SORL1;IGF1;RTN3;ABCA2;PICALM;ROCK1;RELA;RTN4;CASP3;GSAP;GGA3;EPHA4;ABCA7;TMED10
prerank,regulation of sequestering of calcium ion (GO:0051282),0.462965705371469,0.9904096560918657,0.5,0.8003916092504618,1.0,3/12,10.36%,DIAPH1;MTLN;PTK2B
prerank,regulation of secretion by cell (GO:1903530),0.3527411069730977,0.990179535418441,0.505166475315729,0.8005073401451814,1.0,12/54,13.53%,ANXA1;RAB8B;RIC1;RHBDF2;RAB21;STXBP5;RAB12;RAB10;CPLANE2;SYN1;MCTP1;VAMP3
prerank,linoleic acid metabolic process (GO:0043651),0.4249976301170846,0.9901313391881261,0.4810126582278481,0.8001891095627571,1.0,2/17,11.41%,ABCD1;ELOVL1
prerank,protein deacylation (GO:0035601),0.4103165962396747,0.9898952107588187,0.4899598393574297,0.8003302660192254,1.0,9/23,21.03%,PPT1;SIRT6;ABHD10;SIRT1;SIRT7;SIRT3;LYPLA2;SIN3A;ABHD17C
prerank,regulation of microglial cell activation (GO:1903978),0.44078705682742114,0.9897269588979203,0.4956772334293948,0.8002645349017707,1.0,5/15,15.74%,IL6;STAP1;TREM2;CX3CL1;GRN
prerank,regulation of stress fiber assembly (GO:0051492),-0.24570634760438395,-0.9896761971616165,0.5,0.8439568566962721,1.0,23/74,18.10%,TMEFF2;F11R;EVL;ASAP3;PPM1E;LIMCH1;WAS;LIMK1;TGFBR1;PAK1;PPM1F;ITGB1BP1;CARMIL1;TESK1;FERMT2;ARHGAP6;ARHGEF18;RHOA;RAPGEF3;STMN1;RGCC;SLC9A1;TPM1
prerank,response to nutrient levels (GO:0031667),-0.3544341645184266,-0.9895114250494889,0.4639175257731959,0.8424250588018584,1.0,2/17,3.14%,RPTOR;PRKAA2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.3729074857071197,0.9894516471152839,0.4897713598074609,0.8004773214618642,1.0,8/40,10.92%,CEBPB;ANO6;ATP2B1;SLC8A1;ACVR2A;PKDCC;BMPR2;CCN1
prerank,regulation of osteoblast differentiation (GO:0045667),0.34274343775790456,0.9893401444874301,0.5077433628318584,0.8003083245289808,1.0,18/82,14.31%,PPARG;IFITM1;RUNX2;IL6;HGF;IGF1;TNN;DDX5;ATF4;SOX9;ACVR2A;SNAI2;BMPR2;IL6R;CCN1;NOTCH1;LIMD1;GDF10
prerank,I-kappaB phosphorylation (GO:0007252),-0.41655994636942817,-0.9892392295509755,0.45930232558139533,0.8411716534926498,1.0,4/10,18.57%,TLR3;DAB2IP;TLR2;CHUK
prerank,positive regulation of telomere capping (GO:1904355),0.42562060756269693,0.9892358660516676,0.49356223175965663,0.8001113623780656,1.0,6/17,23.86%,RTEL1;HNRNPD;TNKS;TNKS2;PKIB;NEK7
prerank,mesenchymal to epithelial transition (GO:0060231),-0.4095595229906798,-0.9891356197870256,0.49008498583569404,0.8393706224847125,1.0,3/10,8.49%,SALL1;PAX2;BASP1
prerank,histone H3-K9 demethylation (GO:0033169),0.4704989408530684,0.9890185758699102,0.4961948249619482,0.8001876471432792,1.0,4/11,14.31%,KDM4C;KDM3A;JMJD1C;KDM7A
prerank,ncRNA catabolic process (GO:0034661),0.3853391597522977,0.9889218223581727,0.4891994917407878,0.7999953703821314,1.0,9/28,17.20%,TENT4B;EXOSC3;EXOSC9;EXOSC8;SND1;DEDD2;MTREX;EXOSC10;RBM7
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.3384412847411091,0.988713037328905,0.5141304347826087,0.8000413306573955,1.0,18/87,15.42%,GDF15;ZMIZ1;GCNT2;ADAM9;JUN;APPL2;LPXN;RPS27A;UBC;ACVRL1;ITGB1;SIRT1;APPL1;COL3A1;GDF10;PARD6A;NRROS;CBL
prerank,UV-damage excision repair (GO:0070914),0.45829785957828195,0.98850646549052,0.4802342606149341,0.8001136756923253,1.0,6/12,21.49%,DDB1;SIRT1;POLA1;INO80;CUL4B;XPC
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.29718406032739786,-0.9884889759244362,0.4845814977973568,0.8390587309919671,1.0,14/30,22.62%,ARSB;HEXB;CHST11;CSGALNACT1;CHST7;HYAL1;CHST9;DSEL;CHSY1;IDS;BCAN;CSPG4;NCAN;CHST12
prerank,negative regulation of potassium ion transport (GO:0043267),-0.37630666219968645,-0.988139055320302,0.4745762711864407,0.8381062192189858,1.0,1/13,0.13%,BIN1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.2837929575764042,-0.9878026298355679,0.45652173913043476,0.8370165752328265,1.0,9/32,15.28%,PTPRD;IL1RAPL1;ADGRB3;KNDC1;CUX2;CDKL3;YWHAH;RAPGEF2;SS18L2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4730588982534804,0.9876086820174996,0.4921135646687697,0.8017094813239766,1.0,3/10,12.90%,RPS27A;UBC;CHFR
prerank,positive regulation of telomerase activity (GO:0051973),0.38093864557596485,0.9875982912522699,0.4879594423320659,0.8013017071640989,1.0,7/33,20.80%,CTNNB1;ACD;XRCC5;DKC1;TNKS;CCT2;PKIB
prerank,tRNA methylation (GO:0030488),0.3797075505311762,0.9875450691990307,0.5110565110565111,0.8009971848690044,1.0,19/34,28.33%,TRMT12;LCMT2;TRDMT1;TRMT44;GTPBP3;ALKBH8;PRORP;TRMT1L;TRMT10C;TARBP1;TRMT13;DALRD3;TRMT10A;FTSJ1;TRMO;THUMPD3;MTO1;METTL1;METTL6
prerank,purine nucleotide biosynthetic process (GO:0006164),0.45240445651646405,0.9872386315310867,0.48545176110260335,0.8012606529234612,1.0,2/12,5.01%,ADSL;PPAT
prerank,negative regulation of developmental growth (GO:0048640),0.38675201528779424,0.9871985073981643,0.47470817120622566,0.8009152838896879,1.0,4/30,4.72%,GDF15;WWC2;CDKN1A;PTEN
prerank,meiosis I (GO:0007127),0.40270380028275865,0.9871619655647174,0.4816326530612245,0.8005604014297788,1.0,6/23,26.62%,BCL2L11;FOXJ3;SGO1;PTTG1;MYBL1;FOXJ2
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4074426988338959,0.9870148864411477,0.48693259972489683,0.8004703479377456,1.0,10/22,25.40%,ABCB7;NUBP2;NUBP1;CIAO2B;CIAO2A;GLRX5;NFS1;HSPA9;FXN;CIAO1
prerank,heterocycle biosynthetic process (GO:0018130),0.441380185608896,0.9865281271560835,0.49550898203592814,0.801199644135478,1.0,4/14,19.00%,MOCOS;LIAS;GCH1;NFS1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4229220557487846,0.9862062265433913,0.48183041722745623,0.8015275251382088,1.0,11/18,30.62%,SETD7;SUV39H2;SMYD2;KMT2A;ASH1L;EHMT2;SETD3;KMT2D;SETD1B;EHMT1;SETD4
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.2471984230585011,-0.986008613824794,0.4803921568627451,0.8398951361226399,1.0,12/70,6.40%,MEF2C;OPHN1;TMEFF2;NTNG1;FER;ABI2;SRGAP2;RELN;METTL3;SIPA1L3;RILPL1;SRCIN1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.38533724412110726,0.9856882533920506,0.5012722646310432,0.8022779442852572,1.0,15/29,27.62%,ACD;RTEL1;TERF1;DKC1;PPP6C;SHQ1;MRE11;TNKS1BP1;CDK2;TERF2IP;PPIA;PPP6R3;TINF2;WRAP53;RFC1
prerank,negative regulation of translational initiation (GO:0045947),0.45342987742853963,0.985627246816014,0.5051395007342144,0.8019933590403071,1.0,4/13,9.43%,AGO2;EIF2AK4;EIF4EBP2;TPR
prerank,regulation of mitochondrial translation (GO:0070129),0.40803683234364757,0.9852369394611252,0.513550135501355,0.8024631161151062,1.0,9/21,24.34%,NSUN3;RMND1;ALKBH1;MTG1;C1QBP;MALSU1;TRMT10C;COA3;SHMT2
prerank,RNA methylation (GO:0001510),0.34766406929825705,0.9851417516405159,0.5095613048368954,0.8022684275463446,1.0,30/60,27.02%,TRMT12;WTAP;LCMT2;TRDMT1;NSUN3;TRMT44;MEPCE;MRM2;GTPBP3;ALKBH8;TFB2M;CBLL1;TRMT10C;RBM15;PCIF1;TARBP1;FBL;TRMT13;DIMT1;MTERF4;TRMT6;METTL8;ZCCHC4;TGS1;NSUN4;TRMT10A;FTSJ1;TRMO;THUMPD3;MTO1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3163975452785806,0.9850805122709454,0.5306122448979592,0.801999605121458,1.0,41/190,19.23%,APLNR;XDH;ADGRG3;FNIP1;WWC2;TNIP1;TANK;RIPK1;PTEN;PPIF;THBS1;DAG1;DUSP3;GPD1L;NR1H4;PPEF2;FLCN;EPM2A;CD22;PLEKHA1;DDIT3;ESR1;NLRC3;SIRT1;RORA;TREM2;RNF34;RELA;NPRL3;LIMD1;TNFAIP3;MCL1;CDC34;ARHGAP25;NPRL2;NDUFS3;DGKG;PPP2R5C;NOC2L;STAMBP;PIK3CB
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.35736666717432725,0.984949092137097,0.5017921146953405,0.8018911420444959,1.0,9/51,12.75%,PPARG;SORL1;ACVR2A;HIPK2;BMPR2;FSTL1;RBPMS2;NOTCH1;LEMD3
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.3361247414919096,-0.9848744773807757,0.4632352941176471,0.8410999410925605,1.0,3/19,2.94%,CAMK1D;CSF1R;CSF1
prerank,regulation of viral entry into host cell (GO:0046596),0.38118026373979286,0.9846761007447852,0.505521472392638,0.8020700110559198,1.0,4/30,8.89%,TMPRSS4;IFITM1;TRIM25;IFITM2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.31030243268169816,0.9839887325626694,0.564,0.8032605140551619,1.0,66/417,14.66%,PPARG;MDFIC;CD38;RCOR1;CTNNB1;WWP1;ATXN1;FOXP3;LANCL2;RUNX2;ARID4A;GATAD2A;ID2;NIBAN2;TFAP2B;JUN;NCOR1;RARA;CITED2;E2F1;TAF7;NR3C1;EED;BHLHE40;PEX14;NIPBL;PIAS4;SOX9;BRCA1;RB1;RBAK;WWP2;EPC1;ZNF148;FOXP1;BRD7;DACH1;ARID5B;DDIT3;XRCC5;RLIM;PSPC1;CNOT7;FOXK1;POU3F3;FOXO1;SIRT1;PPARD;ING4;MT3;CBX3;CIPC;SP3;NOTCH1;DEDD2;BCLAF1;RELA;GAS6;ATP8B1;POU2F1;LIMD1;ZKSCAN3;SUV39H2;SHC1;ID4;EID1
prerank,detection of mechanical stimulus (GO:0050982),0.41215703114424973,0.9836595139520864,0.510840108401084,0.8035781082342874,1.0,4/19,11.91%,CTNNB1;PKD1L2;PIEZO1;PIEZO2
prerank,peptide hormone secretion (GO:0030072),0.39049578635704807,0.9836222705165119,0.4928104575163399,0.8032411571843059,1.0,2/26,2.98%,ANXA1;IL6
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3927117029073882,0.9832908352136331,0.4801641586867305,0.8035758624140298,1.0,5/23,11.89%,PIBF1;IL6;IL10RB;PTK2B;NOTCH1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.30761219158483843,-0.9832711851274569,0.4935064935064935,0.8434935231404638,1.0,8/26,24.68%,THADA;ATP1A2;FMR1;PKD2;UBQLN1;FKBP1B;ADRA2A;CALM3
prerank,chondrocyte differentiation (GO:0002062),0.37491121837531854,0.9832420714687443,0.4863861386138614,0.8032812024742022,1.0,8/32,13.02%,RUNX2;RUNX3;SULF2;SOX9;BMPR2;SLC39A14;SULF1;GPLD1
prerank,positive regulation of peptidase activity (GO:0010952),0.41328267488155696,0.9831371909198273,0.4980026631158455,0.8030929942665437,1.0,9/20,23.52%,TANK;CTSH;PSME2;NCSTN;GRN;VCP;APH1B;PSME3;NDUFA13
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.34325708378709074,0.9831037205323967,0.5134831460674157,0.8027428653103509,1.0,21/72,20.59%,PLK2;CDKN1A;SESN2;E2F1;GADD45A;CNOT4;GTSE1;HIPK2;CNOT6L;CNOT7;ING4;NBN;BAX;CNOT6;RPL26;ACER2;CASP2;CRADD;BCL3;PAXIP1;TNKS1BP1
prerank,lipid phosphorylation (GO:0046834),0.4756585353867774,0.9829831964698208,0.5015673981191222,0.8026008132758801,1.0,4/10,17.19%,DGKZ;DGKA;DGKQ;DGKG
prerank,tRNA metabolic process (GO:0006399),-0.3505354295100007,-0.982863695981115,0.5034246575342466,0.8426485888344734,1.0,13/17,33.17%,ADAT1;AARS1;SSB;DTD2;KARS1;RPP30;YARS2;POP5;DTD1;POP7;THG1L;POP1;TRPT1
prerank,vesicle coating (GO:0006901),0.3462055298620543,0.9827985411604087,0.5199089874857793,0.8017439654457714,1.0,25/61,25.12%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;PPP6R1;SEC24B;PREB;PEF1;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,COPII vesicle coating (GO:0048208),0.3462055298620543,0.9827985411604087,0.5199089874857793,0.8017439654457714,1.0,25/61,25.12%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;PPP6R1;SEC24B;PREB;PEF1;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3462055298620543,0.9827985411604087,0.5199089874857793,0.8017439654457714,1.0,25/61,25.12%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;PPP6R1;SEC24B;PREB;PEF1;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3320025208699805,0.9826733372109835,0.5227272727272727,0.8015994822098682,1.0,30/88,26.26%,FBXW7;PSMD1;FBXL17;FBXL3;FBXO9;PSMF1;PSMD14;PSMD12;CUL4A;FBXO6;PSME2;CUL1;AMN1;PSMB10;PSMD5;PSMD8;PSMA3;FBXO31;PSMA2;PSMD11;PSMA6;CUL4B;FBXL4;PSMB3;PSME3;FBXO4;DMAC2;PSMC5;FBXL12;PSMC1
prerank,regulation of neutrophil migration (GO:1902622),0.47649793064080487,0.9825231410008594,0.4961948249619482,0.8015267355927,1.0,3/10,16.10%,MPP1;OLFM4;BST1
prerank,keratinocyte differentiation (GO:0030216),0.38630803367021194,0.9824424504916582,0.5,0.8012941685596416,1.0,2/29,2.89%,ANXA1;ADAM9
prerank,positive regulation of behavior (GO:0048520),-0.42132002439660005,-0.9823503399348086,0.4932975871313673,0.8421272858429502,1.0,3/10,1.91%,MEF2C;NLGN1;SGIP1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3016767171715278,-0.9823405473703856,0.48148148148148145,0.8401993040247454,1.0,14/28,32.84%,MAPT;STMN3;MAP2;STMN4;STMN2;MAPRE1;STMN1;CAMSAP1;GBA2;ABL1;MAP1S;CLASP2;CAMSAP3;SKA3
prerank,regulation of inclusion body assembly (GO:0090083),0.45757635431876775,0.9822605212085455,0.512937595129376,0.8012942516850623,1.0,3/11,13.94%,DNAJB6;HSPA1B;HSPA1A
prerank,regulation of regulated secretory pathway (GO:1903305),-0.2912598260475881,-0.981832663534565,0.4918032786885246,0.8395197702042393,1.0,8/34,8.86%,SYT1;RIMS1;RAB27A;RIMS2;SYT7;SYT2;SYT4;SYT6
prerank,cellular response to gamma radiation (GO:0071480),0.42067621766481045,0.9818194337749626,0.49584487534626037,0.8018791052988556,1.0,5/17,19.38%,MAP3K20;XRCC5;WRN;RPL26;TLK2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.41411807240903464,0.9817872468693685,0.5048409405255878,0.8015466029678021,1.0,6/19,18.76%,MTHFS;FOLR2;SLC25A32;MTHFD1L;MTRR;SLC19A1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3155712696411619,0.9814938053620793,0.5239551478083588,0.8017850844821814,1.0,39/168,17.36%,DHX34;SAMD4A;TENT4B;RPL18A;DDX5;RPS14;RPS11;CNOT4;RPS27A;RPL17;RPL23;RPL36A;ETF1;TENT2;CNOT6L;EXOSC9;RPL22;RPS21;POLR2G;PATL1;CNOT7;PPP2R2A;NBDY;ERI1;NCBP2;EXOSC8;RPL10A;RPS26;UPF2;RPL15;RPL10;CNOT6;RPSA;EXOSC10;EIF4A3;THRAP3;PAN3;RPL7;RPL26
prerank,regulation of neuron death (GO:1901214),0.33955932818374185,0.981474400453639,0.5204419889502763,0.8014129753490999,1.0,12/82,10.83%,GPNMB;CD200R1;TNFRSF1B;SORL1;HTRA2;CTSZ;TYROBP;PICALM;EGLN3;GSK3B;SNCG;NENF
prerank,negative regulation of cellular component movement (GO:0051271),-0.34452576597618195,-0.9810838528269891,0.4794952681388013,0.8395882480816503,1.0,3/15,5.16%,FRMD5;WAS;SPOCK3
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4858675803675856,0.9808676590357114,0.528,0.8023250556873588,1.0,2/10,9.53%,FOXP3;DDIT3
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3876864910528205,-0.980811278287855,0.45272206303724927,0.8383978602500238,1.0,5/12,15.79%,MAP2;TUBB4A;STMN2;MAPRE1;STMN1
prerank,positive regulation of immune response (GO:0050778),0.34225853942692724,0.9804679420458806,0.5172031076581576,0.8028376337965492,1.0,9/64,12.24%,TLR8;LILRB1;CD46;ADAM8;SPHK2;EIF2AK4;CYBA;SIRT1;IL15
prerank,metal ion export (GO:0070839),-0.2933942927887794,-0.9802665572126197,0.47317073170731705,0.8379977551236946,1.0,3/31,5.31%,ATP1B1;ATP1A2;ATP1B2
prerank,centromere complex assembly (GO:0034508),-0.2790341082997434,-0.9802430743952264,0.46835443037974683,0.8361180567499538,1.0,14/36,24.86%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPF;CENPT;CENPQ;CENPN;CENPH
prerank,Wnt signaling pathway (GO:0016055),0.33570124678872537,0.9801858137120428,0.5133976420150054,0.8030717020305457,1.0,20/92,17.98%,PLPP3;CTNNB1;PTEN;APC;RPS27A;UBC;DVL1;STRN;FZD7;GSK3B;FZD5;WLS;FZD2;LRP6;CUL1;CCDC88C;DIXDC1;CSNK1G1;SNX3;VPS29
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3285128151509354,0.9798610739412423,0.5222929936305732,0.8033945382909462,1.0,28/107,23.28%,BCL2L11;ERN1;FLOT1;CEBPB;ATF3;JUN;ATG10;THBS1;ATF4;DDIT3;GSK3B;RHBDD1;UBA5;PRKN;BAX;QRICH1;TRAF2;BBC3;CREB3L1;BCAP31;BRSK2;WFS1;EIF2S1;VCP;PPP1R15B;HERPUD1;TMCO1;AIFM1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.309117087250837,-0.979850902571048,0.45703125,0.8352604666578373,1.0,3/23,6.10%,CX3CR1;CD33;NLRP3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4409956414761043,0.979567570173305,0.48656716417910445,0.8036453247734043,1.0,1/13,0.65%,B3GNT8
prerank,actin filament network formation (GO:0051639),0.4586608570847394,0.9794809724479685,0.5085271317829457,0.8034383161276326,1.0,3/11,11.54%,LCP1;ACTN1;PLS3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3955965610020663,-0.9793512059295226,0.4657142857142857,0.8346919009852035,1.0,4/11,22.32%,REST;PARK7;UBQLN1;STK26
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3831081597435843,0.979192685732541,0.5094577553593947,0.8037071311427851,1.0,9/30,21.81%,SDCBP;WAC;STYX;N4BP1;EIF3H;SGTA;TLK2;OGT;GIPC1
prerank,positive regulation of cell differentiation (GO:0045597),0.3111265168835318,0.9789342723183194,0.5552178318135765,0.8038766099527805,1.0,30/237,11.51%,CD36;PPARG;SDCBP;SLC6A6;PRKCH;GCNT2;CTNNB1;CEBPB;IFITM1;RUNX2;ID2;IL6;HGF;ASXL2;ZC4H2;IGF1;COL1A1;SOX9;ACVR2A;PKDCC;ACVRL1;BMPR2;IL6R;PAX8;ARHGEF2;FES;CCN1;ASB4;PPARD;KCTD11
prerank,calcium ion transmembrane transport (GO:0070588),0.3336708774406122,0.9786250527347446,0.5081081081081081,0.8041675146025828,1.0,14/86,9.36%,MCOLN3;MCOLN2;ANO6;ATP2B1;P2RX4;SLC8B1;TMEM165;MICU2;MICU1;SLC8A1;PMPCA;LETM1;TRPC3;TRPV2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.32345359623233,0.9785820761246453,0.542827657378741,0.8038498818476572,1.0,24/128,15.42%,GDF15;ZMIZ1;GCNT2;RUNX2;ADAM9;JUN;APPL2;LPXN;DDX5;RPS27A;UBC;ACVR2A;ACVRL1;BMPR2;ITGB1;SIRT1;STUB1;ACVR1B;APPL1;COL3A1;GDF10;PARD6A;NRROS;CBL
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.38775779112595116,0.9784787246841112,0.5117493472584856,0.8036701811759349,1.0,11/25,21.62%,PSME3IP1;RPL23;CSNK2A2;HIPK2;PSMF1;PRKCG;CSNK2A1;SGTA;ALAD;TAF1;EPHA4
prerank,response to ATP (GO:0033198),-0.33210132354744115,-0.9775447226532248,0.4653846153846154,0.8377784851499747,1.0,3/18,6.69%,P2RY12;RYR3;HSP90B1
prerank,regulation of T cell cytokine production (GO:0002724),0.43941582726498823,0.9775394237412357,0.5128939828080229,0.8054133928375155,1.0,7/15,26.02%,FOXP3;TNFRSF1B;FZD5;TRAF2;MALT1;TRAF6;MAP3K7
prerank,regulation of cell growth (GO:0001558),0.31755314084895675,0.9772550646411524,0.5438775510204081,0.8056159067567222,1.0,36/204,13.94%,SDCBP;SGK1;TFRC;CDKN1A;RAB33B;PPT1;ENPP1;MYL2;SESN2;MMP14;OSGIN1;APBB2;NUBP1;SPHK2;FLCN;HSPA1B;N6AMT1;RB1;PPP1R9B;ACVRL1;BMPR2;EXOSC9;LAMTOR1;ADAM17;NAIF1;DCUN1D5;MTPN;SIRT1;MT3;DCUN1D3;BST2;ACVR1B;ATAD3A;RBBP7;DERL2;HSPA1A
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4212617259967435,0.9771218729483614,0.512396694214876,0.8055037241952308,1.0,8/18,19.81%,KIF20B;RUFY3;ROCK1;PTK2B;BCAS3;TEK;ARFGEF1;SHTN1
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.4323628006886643,0.9770541575945678,0.49640287769784175,0.8052462976962208,1.0,3/15,6.26%,SAMD8;PRKCD;SPHK2
prerank,endodermal cell differentiation (GO:0035987),0.38184503113616497,0.97702376409365,0.5056746532156369,0.8049006810984818,1.0,8/31,20.20%,ITGA5;ITGA4;MMP14;COL11A1;LAMA3;CDC73;COL12A1;ITGAV
prerank,metal ion homeostasis (GO:0055065),0.365261541018845,0.9769603637658305,0.5217391304347826,0.8046363337223816,1.0,9/40,14.16%,TFAP2B;SLC8A1;LETM2;SLC12A3;SLC12A8;TESMIN;LETM1;MT3;SLC12A7
prerank,regulation of cilium assembly (GO:1902017),0.3418832538088154,0.9767244050375158,0.5160575858250277,0.8047444684687097,1.0,17/62,21.61%,TBC1D22A;TBC1D1;TBC1D2;ODF2L;TBC1D10A;TBC1D2B;TBC1D22B;ATG5;TBC1D24;TBC1D15;IFT140;CCP110;RABGAP1;HTT;IFT88;CROCC;CDKL5
prerank,pre-miRNA processing (GO:0031054),0.42751077105234525,0.9766268885688956,0.501432664756447,0.804539356506561,1.0,5/14,18.38%,AGO2;AGO3;DROSHA;MRPL44;AGO4
prerank,positive regulation of T cell differentiation (GO:0045582),0.36591492834657896,0.9762044440264804,0.5194479297365119,0.8050866602576631,1.0,4/36,9.06%,ZMIZ1;CD46;ADAM8;SART1
prerank,establishment of epithelial cell polarity (GO:0090162),0.415668861254166,0.9761548556773106,0.4921985815602837,0.804781591365562,1.0,7/19,16.64%,RAP2A;CYTH1;FBF1;MSN;CLASP1;GOLPH3;MYO9A
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.4250602600956957,0.9758229002876743,0.4915014164305949,0.8051032029677153,1.0,5/17,10.12%,APOE;SORL1;IGF1;RTN3;ROCK1
prerank,negative regulation of protein catabolic process (GO:0042177),0.3680677672304224,0.9756939468742256,0.5196662693682956,0.8049731130450691,1.0,12/40,19.61%,TIMP1;RIC1;CTSA;IRAK3;TIMP2;ROCK1;AZIN1;PRKCG;NELL1;SNX3;HMGCR;AZIN2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3102514431504729,0.9748133481454698,0.5704225352112676,0.8064885985411302,1.0,49/259,15.50%,MTSS1;SDCBP;MAK;RILPL2;FGD6;RAP2A;RAB8B;PIBF1;SPEF1;SNX10;ANO6;EMP1;CFAP70;SNAP29;ATP6V0D1;KIF27;ASAP1;ABCC4;PARVB;WDPCP;CFAP20;FBF1;KIF3A;DYNC2I2;PPP1R9B;ACTR3;TNIK;ITGB1;RAP2B;RHOD;IFT46;CCDC66;NOTCH1;CFAP410;PMP22;MYLK;CPLANE2;FGD5;IFT52;OCRL;IFT140;SSX2IP;ARL3;WHAMM;GOLPH3;FGD3;EXOC4;OFD1;VSTM5
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3743930066891139,0.9747526366807487,0.5160493827160494,0.8061962423365548,1.0,4/33,4.71%,CEL;ABR;FABP5;BTBD9
prerank,peptidyl-serine modification (GO:0018209),0.31506421576580895,0.9743527102491195,0.5370370370370371,0.8066871245722741,1.0,43/166,19.97%,SGK1;GALNT3;TLK1;PRKCH;RPS6KA2;MAPKAPK3;IKBKE;PLK2;PDPK1;PRKCD;SRPK2;PARP2;PKN3;DYRK1A;TOP1;HIPK1;CSNK2A2;HIPK2;ROCK1;GSK3B;PAK2;PKN2;DCLK3;PRKCB;STK38;NAA10;DGKQ;DYRK2;GAS6;MAST4;UHMK1;TNKS;LATS1;PRKCG;CAMK1;CSNK2A1;CSNK1G1;STK4;STK32C;TLK2;TBK1;MKNK2;CAB39
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.4468043375314667,0.974168396054509,0.5249307479224377,0.8066940143813515,1.0,1/13,0.92%,ZMIZ1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.387499871259258,0.9741002182924405,0.5113636363636364,0.8064339721602622,1.0,8/25,18.60%,P2RX4;TRAT1;P2RX3;CD22;TREM2;BST1;TMBIM4;HTT
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.41526184224726026,0.9740884350142476,0.5013812154696132,0.8060453312126773,1.0,3/18,8.00%,SLC43A2;PPIF;NEDD4L
prerank,regulation of translation (GO:0006417),0.31295825740891614,0.973987812163234,0.5509164969450102,0.8058481634988942,1.0,44/173,20.72%,SAMD4A;EIF1;VIM;IL6;CD28;FOXO3;DAPK1;DDX6;ATXN2;IGF2BP3;YTHDF3;NSUN3;THBS1;EIF6;EIF2AK4;LARP4B;PUM3;ETF1;NAT10;EIF3B;EIF5;CNOT7;MTPN;NCBP2;APP;EPRS1;HNRNPD;RPL10;EIF4A3;SYNCRIP;ALKBH1;MTG1;CAPRIN1;RPL26;EIF3H;EIF2B2;MALSU1;EIF4G3;EIF4G2;NCL;BCL3;EIF3C;LARP4;PCIF1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4109563629927566,-0.9738415655222952,0.49719101123595505,0.846044670170647,1.0,2/10,3.32%,PRKCE;ATP1A2
prerank,regulation of vasculogenesis (GO:2001212),0.4336375493818333,0.9737594280113143,0.4935251798561151,0.8059772905979816,1.0,3/14,14.17%,XDH;ASB4;RRAS
prerank,positive regulation of GTPase activity (GO:0043547),0.31282921330596464,0.9735632871841844,0.5546558704453441,0.8060153663161016,1.0,25/188,11.46%,ARHGAP24;ABR;TBC1D22A;TGM2;RIC1;CORO1C;TBC1D25;TBC1D1;TBC1D2;SNX9;TBC1D12;RALGAPA2;SLC27A4;TBC1D10A;FLCN;DOCK10;ARAP1;TBC1D2B;PICALM;ITGB1;GSK3B;TBC1D22B;CCDC125;BCAS3;TBC1D15
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.40568235688634313,-0.9733571063899794,0.49560117302052786,0.8454451928227357,1.0,3/10,6.42%,DLGAP1;DLGAP2;AKAP9
prerank,extracellular structure organization (GO:0043062),0.31418256389948124,0.9728113928498898,0.5692618806875632,0.8072660845488633,1.0,35/204,17.14%,MMP12;VWF;ICAM2;ADAMTS8;MMP27;SPP1;CD44;ITGA5;ITGA4;PDGFA;COL4A6;MMP14;COL1A1;THBS1;DAG1;LUM;COL4A1;COL5A2;ITGB1;ITGA10;COL11A1;APP;VIT;COL5A3;ITGA3;COL3A1;ADAM19;ITGA8;LAMA4;LAMA3;COL6A2;ATP7A;ADAMTSL4;COL11A2;COL4A5
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3798751585957645,0.9725064541726658,0.5131233595800525,0.8075175060929083,1.0,6/31,11.77%,CHCHD4;PEX7;TOMM20;PEX14;TIMM17A;TIMM17B
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.386869638907401,0.9722707474671479,0.5226130653266332,0.8076518785820423,1.0,4/29,8.02%,APOE;NR1H3;ZBTB20;SLC27A1
prerank,C4-dicarboxylate transport (GO:0015740),0.44065533482279345,0.9722470847549318,0.5266106442577031,0.8072799283185311,1.0,1/14,0.63%,LRRC8D
prerank,folic acid metabolic process (GO:0046655),0.4132600022235199,0.9720488243863947,0.52,0.8072790534559734,1.0,6/18,18.76%,MTHFS;FOLR2;SLC25A32;MTHFD1L;MTRR;SLC19A1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.4503792767775751,0.9719125457370039,0.5,0.8071737603490696,1.0,3/13,17.73%,MTM1;TMEM39A;PHF23
prerank,cellular response to pH (GO:0071467),-0.33911980116455126,-0.9719117666617182,0.504950495049505,0.8474070599553615,1.0,7/17,17.94%,MCOLN1;HVCN1;RAB11FIP5;HYAL1;PKD2L1;GPR68;SLC9A1
prerank,hemidesmosome assembly (GO:0031581),-0.37969749275111,-0.9718725048113412,0.4831804281345566,0.8456048208390426,1.0,2/11,2.10%,DST;ITGA6
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3632149242511257,0.9705497631430035,0.5341463414634147,0.8098165140530866,1.0,16/36,24.52%,APAF1;FOXO4;E2F1;EED;UXT;BRCA1;EPC1;CBX3;RBBP7;MGA;EHMT2;CBX5;TFDP1;PHC3;RNF2;PCGF6
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.32101765350839884,-0.9703726780903923,0.5041666666666667,0.8478548157985433,1.0,7/23,20.41%,SMAD3;TRIM33;ENG;SMAD7;SMAD2;SMAD4;SOX11
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.39101481241674596,0.9699683821178549,0.508843537414966,0.8107356722486739,1.0,5/22,12.70%,MGAT5;IL6;IL10RB;NOTCH1;IL7R
prerank,histone H4 deacetylation (GO:0070933),0.4610278556583781,0.9699640048655298,0.5256609642301711,0.8103286939640189,1.0,1/10,1.19%,RCOR1
prerank,skin development (GO:0043588),0.33918698930544783,0.9699606414242594,0.5377677564825254,0.8099168435015995,1.0,12/65,19.18%,ANXA1;ADAM9;PDGFA;COL1A1;HRNR;COL5A2;COL5A3;ITGA3;COL3A1;ATP7A;CASP3;ASAH1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3050498929178055,0.9697174753352126,0.603,0.8100473204507002,1.0,77/497,14.66%,PPARG;MDFIC;CD38;RCOR1;SAMD4A;CTNNB1;WWP1;ATXN1;FOXP3;LANCL2;RUNX2;ARID4A;GATAD2A;ID2;CDKN1A;NIBAN2;TFAP2B;JUN;DAPK1;ENPP1;DDX6;NCOR1;RARA;IGF2BP3;CITED2;E2F1;TAF7;NR3C1;EED;BHLHE40;PEX14;NIPBL;PIAS4;SOX9;BRCA1;RB1;RBAK;WWP2;EPC1;ZNF148;FOXP1;ACVRL1;BRD7;DACH1;ARID5B;TERF1;BMPR2;DDIT3;XRCC5;RLIM;PSPC1;CNOT7;GSK3B;FOXK1;POU3F3;FOXO1;SIRT1;PPARD;ING4;MT3;CBX3;CIPC;SP3;EPRS1;NOTCH1;DEDD2;BCLAF1;RELA;GAS6;ATP8B1;POU2F1;LIMD1;ZKSCAN3;SUV39H2;SHC1;ID4;EID1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.2712657606434758,-0.9696776808577969,0.559322033898305,0.8477814690889792,1.0,15/44,18.10%,EVL;PPM1E;LIMCH1;LIMK1;TGFBR1;PAK1;PPM1F;ITGB1BP1;CARMIL1;TESK1;FERMT2;RHOA;RAPGEF3;RGCC;TPM1
prerank,prostanoid metabolic process (GO:0006692),-0.3643102374346956,-0.9693810200116919,0.5061728395061729,0.8467014992772806,1.0,3/13,3.77%,HPGD;PTGS1;ACOX1
prerank,mitotic cytokinesis (GO:0000281),-0.256944374475552,-0.9689917599313573,0.5466666666666666,0.84583938769506,1.0,21/47,22.71%,ANK3;CIT;ANLN;TRIM36;KLHDC8B;SPAST;SNX18;CENPA;RACGAP1;MYH10;KIF23;STMN1;ECT2;CUL7;CNTROB;EFHC2;EFHC1;NUSAP1;RTKN;KIF4A;CEP55
prerank,regulation of cellular localization (GO:0060341),-0.2631912700388731,-0.9687275448266053,0.5253164556962026,0.84464834447594,1.0,8/46,6.43%,EPHA5;CSNK1E;REEP5;FER;MAP2;HSP90AA1;LRP5;PPM1F
prerank,ATP transport (GO:0015867),0.4649580939803165,0.9687218370809906,0.5138036809815951,0.8118152285323083,1.0,5/10,23.40%,SLC25A42;SLC17A9;SLC25A17;CD47;SLC25A24
prerank,cranial nerve development (GO:0021545),-0.39130689503238797,-0.9684545692915489,0.4953560371517028,0.8435646607201833,1.0,3/11,12.21%,SALL1;PAX2;ERBB3
prerank,regulation of gene silencing by miRNA (GO:0060964),0.34138012787572036,0.9682915219020399,0.5252873563218391,0.8123808489254216,1.0,18/62,22.97%,PPARG;POLR2A;AGO2;POLR2L;TPR;POLR2G;NUP50;POLR2I;PUM2;LIMD1;NUP98;NUP88;NUP188;NDC1;NUP43;STAT3;NUP54;RANBP2
prerank,cellular component maintenance (GO:0043954),-0.3770795557814305,-0.9682897718427871,0.4938650306748466,0.8421285619018035,1.0,4/12,12.27%,PICK1;IGF1R;MTMR2;PRNP
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.34221273574692884,0.9682392258364834,0.5104166666666666,0.8120696156985117,1.0,8/60,10.49%,CTNNB1;ACD;HGF;RFC3;FGFR4;POLG2;XRCC5;DKC1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3144516780152298,-0.9679882653392872,0.4954545454545455,0.841027460489152,1.0,9/24,25.56%,JPH1;PRKACA;PKD2;SELENON;FKBP1B;JPH4;CALM3;NOS1;JPH3
prerank,regulation of macrophage differentiation (GO:0045649),0.4386565854834622,0.9678969861251465,0.5118343195266272,0.8124166259276886,1.0,2/15,4.15%,ID2;RIPK1
prerank,myofibril assembly (GO:0030239),0.36196213198905774,0.9678394949656703,0.535671100362757,0.812130477462811,1.0,4/42,11.02%,SYNPO2L;MYL2;KLHL41;WDR1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.39129392162709975,0.9677584381887083,0.5019973368841545,0.8118968010769838,1.0,6/24,17.58%,NFE2L2;PDPK1;MAPK7;GAS6;TNFAIP3;TEK
prerank,aerobic respiration (GO:0009060),0.4032361371943567,0.9676225886637978,0.522911051212938,0.8117892680821032,1.0,5/20,16.36%,MTFR1L;NDUFS8;SDHB;ATP5F1D;SIRT3
prerank,apical junction assembly (GO:0043297),0.3450950560743425,0.9673664609059485,0.5323325635103926,0.8119414236702784,1.0,10/53,15.71%,MICALL2;APC;FBF1;PDCD6IP;STRN;PAK2;PKN2;WDR1;PARD6A;CTNNA1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.3948981369843157,0.9669098754976218,0.5241935483870968,0.8124823304094684,1.0,5/23,12.13%,PLA2G2D;ABHD4;PLA2G4F;PLAAT3;LPCAT3
prerank,response to axon injury (GO:0048678),-0.3305980414180003,-0.9668227162466501,0.46715328467153283,0.8423395035902748,1.0,2/18,0.30%,P2RY12;RTN4RL1
prerank,ceramide biosynthetic process (GO:0046513),0.3563814225511532,0.966815402039085,0.5442260442260443,0.8122757768380032,1.0,6/40,7.34%,SPTLC2;SAMD8;SGMS2;B4GALT6;CERS6;SPTSSA
prerank,negative regulation of cell motility (GO:2000146),0.3187614335990443,0.9668122022031447,0.5582371458551941,0.8118680815612515,1.0,23/108,13.09%,MITF;RAP2A;IFITM1;FOXO3;PTEN;CITED2;ZMYND8;DAG1;DUSP3;STK24;FLCN;NF2;DLC1;ACVRL1;DACH1;RAP2B;CCDC125;FBLN1;BST2;SULF1;ARID2;MCTP1;PODN
prerank,response to interleukin-1 (GO:0070555),0.329684174933888,0.9667947660751518,0.5538461538461539,0.8114949563106911,1.0,13/73,15.84%,ANXA1;IRAK2;TANK;IRAK3;SOX9;SIRPA;APP;RELA;ACOD1;CX3CL1;YTHDC2;MYD88;CCL7
prerank,positive regulation of lamellipodium organization (GO:1902745),0.37005348834018753,0.9664287906268069,0.5161691542288557,0.8118963389539942,1.0,5/32,8.12%,ARPC2;CORO1C;PIK3CA;RREB1;ACTR3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.38392661198531725,0.9664212884399486,0.5271122320302648,0.8114968081089,1.0,2/32,3.02%,APLNR;PDPK1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3289442939444746,0.9663883555103094,0.5605726872246696,0.8111711353037957,1.0,17/76,14.82%,SYNPO2L;NCK2;BAIAP2;SORBS3;DYNC1H1;SNX9;STAP1;PTK2B;FES;WDR1;BCAS3;PFN1;HCLS1;SYNPO;TENM1;PFN2;CX3CL1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.4266543134369286,0.9660781012181457,0.5118343195266272,0.8114808269645039,1.0,5/15,14.19%,ZFAND2A;RAB3GAP2;RAB10;SPCS2;ZFAND2B
prerank,defense response to fungus (GO:0050832),-0.34374164304252397,-0.9658508331438614,0.5178571428571429,0.8431381746496939,1.0,1/17,0.09%,CX3CR1
prerank,regulation of B cell activation (GO:0050864),0.3870063061546394,0.9654674579109951,0.5197956577266922,0.8123824607386907,1.0,5/25,13.61%,IL6;SH3KBP1;ZFP36L2;CD22;TNFAIP3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.24218763953463815,-0.9654059415717295,0.5161290322580645,0.8425564871392058,1.0,14/65,13.63%,LDLRAD4;SMAD3;TGFBR2;SPRED1;SNX6;SMURF1;TGFBR1;SMAD7;HTRA3;LTBP1;SPRED2;FBN2;SMAD2;SPRED3
prerank,negative regulation of neuron differentiation (GO:0045665),0.39231032627309126,0.9653704964926293,0.5352862849533955,0.8121778448202901,1.0,7/22,22.27%,EIF2AK4;SOX9;GSK3B;SOX2;DTX1;HES5;DISP3
prerank,nucleotide biosynthetic process (GO:0009165),0.41075438096989936,0.9653579456206591,0.5073099415204678,0.8117954163753524,1.0,3/18,6.98%,ADSL;PPAT;NMNAT1
prerank,axon extension (GO:0048675),-0.31071365741115403,-0.9653342897180306,0.5081967213114754,0.8408858573504515,1.0,8/23,14.30%,SEMA5A;AUTS2;HSP90AA1;SLIT1;SEMA3A;NLGN3;ULK2;CYFIP1
prerank,ganglion development (GO:0061548),-0.3789362485434995,-0.9650085596531832,0.4695121951219512,0.8398882779623129,1.0,4/11,9.06%,UNC5C;FZD3;TUBB3;SEMA3A
prerank,cilium movement (GO:0003341),0.3511309795446991,0.9648300629955738,0.5310668229777257,0.8125898068742674,1.0,6/47,12.50%,SPEF1;CFAP70;CCDC40;CFAP53;ODAD1;SPAG17
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.46717080011495016,0.9645338437048724,0.5138461538461538,0.8128064587601093,1.0,1/10,2.06%,FOXP3
prerank,regulation of sister chromatid cohesion (GO:0007063),0.44977135694627607,0.9640252007113224,0.5335276967930029,0.813473015685255,1.0,5/12,22.54%,CTNNB1;RB1;RAD21;HDAC8;WAPL
prerank,negative regulation of defense response to virus (GO:0050687),0.45970302416550796,0.963694477601546,0.5238828967642527,0.8137590194000843,1.0,1/10,2.86%,RNF26
prerank,cellular response to interleukin-1 (GO:0071347),0.3126639646983994,0.9633546106994995,0.5817805383022774,0.814119939428222,1.0,45/143,26.38%,ST18;IRAK2;PSMD1;TANK;IRAK3;RPS27A;UBC;SOX9;SIRPA;MAP3K8;PSMF1;PSMD14;TAB2;PSMD12;RELA;ACOD1;PSME2;SQSTM1;CUL1;CX3CL1;MYD88;CCL7;PSMB10;PSMD5;UBE2V1;PSMD8;PSMA3;PSMA2;CCL25;PSMD11;PELI2;PSMA6;CD47;PSMB3;PSME3;IRAK1;TRAF6;PSMC5;TAB1;MAP3K7;GBP3;PSMC1;RC3H1;TAB3;CCL2
prerank,regulation of focal adhesion assembly (GO:0051893),0.34937163646215735,0.9631592370883361,0.5385514018691588,0.8141479806939677,1.0,14/54,17.58%,VEGFA;CORO1C;PTEN;THBS1;DUSP3;DLC1;ACVRL1;ROCK1;BCAS3;MACF1;CLASP1;NRP1;APOD;TEK
prerank,telomere maintenance via telomerase (GO:0007004),0.3776409057073051,0.9630557709642393,0.530690537084399,0.8139573865793389,1.0,14/28,27.62%,ACD;RTEL1;TERF1;DKC1;PPP6C;SHQ1;MRE11;TNKS1BP1;CDK2;TERF2IP;PPP6R3;TINF2;WRAP53;RFC1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.38618918009216086,0.9630452518437574,0.5006784260515604,0.8135745622522771,1.0,11/24,26.94%,FLVCR1;PGRMC1;FECH;COX15;RSAD1;ALAD;SLC25A38;NFE2L1;FXN;UROS;TSPO
prerank,positive regulation of chromosome organization (GO:2001252),0.42146749862874494,0.9626070368021382,0.5216178521617852,0.814115183901474,1.0,7/15,21.65%,SIRT6;RTEL1;SHCBP1L;NBN;RAD21;MRE11;PPP1R10
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.31971015725536145,0.9625087162703753,0.5611587982832618,0.813916560016139,1.0,24/100,19.58%,PIK3R5;HGF;PDGFA;PTEN;IGF1;IRS2;PIK3CA;SOX9;NLRC3;SIRT1;ROR1;TREM2;MAZ;HCLS1;FGR;CBL;NCF1;PIP4K2A;TEK;PPP2R5C;STAMBP;PIK3CB;GAB1;OSM
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3613775374959011,-0.9620807437585904,0.49854227405247814,0.8460343499530036,1.0,2/13,3.74%,TGFBR2;RYR2
prerank,mesoderm formation (GO:0001707),0.41600191028050815,0.9618540210517983,0.5310344827586206,0.8149453832757791,1.0,4/17,14.97%,BMPR2;ITGB1;ITGA3;ITGA8
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3628806906945363,0.961673364356875,0.5346534653465347,0.8149380551152159,1.0,6/35,10.02%,ZMIZ1;NR3C1;DDX5;KDM3A;NCOA4;ESR1
prerank,sarcomere organization (GO:0045214),0.38176253662964704,0.9615286694355897,0.531130876747141,0.8148475093071352,1.0,2/27,11.02%,SYNPO2L;WDR1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.25729989785861446,-0.9613392950563299,0.5432098765432098,0.8461553361506517,1.0,7/50,4.93%,PLCL1;CSF1R;PLCB1;ADAP2;KCNH1;IRS1;PLCH1
prerank,regulation of amyloid fibril formation (GO:1905906),0.42043509006075985,0.9610526450118937,0.5205278592375366,0.8154677503036528,1.0,3/15,12.33%,APOE;APP;TREM2
prerank,ncRNA transcription (GO:0098781),0.43569473397747527,0.9609264580253771,0.5242424242424243,0.8153401349759962,1.0,4/13,22.20%,RPAP2;SIRT7;USPL1;GTF3A
prerank,cation transmembrane transport (GO:0098655),0.35187955645729757,0.9606104939658735,0.5441527446300716,0.8156312609924095,1.0,6/44,9.93%,SLC7A2;ATP1B4;SLC36A4;MFSD12;P2RX3;SLC25A20
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.440996047389082,0.9605703136627749,0.5144157814871017,0.8153111022479951,1.0,1/12,0.65%,B3GNT8
prerank,regulation of neuroblast proliferation (GO:1902692),0.43046631053225454,0.9600656231968067,0.5200573065902578,0.8160191039780503,1.0,3/15,2.56%,CTNNB1;VEGFA;DCT
prerank,positive regulation of phospholipase activity (GO:0010518),0.3968836714933468,0.9598936121740285,0.5247933884297521,0.8159791093602343,1.0,4/22,10.02%,PDPK1;ABL2;GNA13;ESR1
prerank,kidney development (GO:0001822),0.33434462900214,0.9597957323662775,0.5451541850220264,0.8157909134748055,1.0,17/65,21.04%,STRA6;VEGFA;TFAP2B;NIPBL;SULF2;CTSH;PAX8;SULF1;ARL3;GDNF;ITGA8;VANGL2;ACE;IFT88;WFS1;ZBTB16;C1GALT1
prerank,regulation of mitotic cell cycle (GO:0007346),0.3079794216448738,0.9597451919564116,0.5848670756646217,0.8154977391446869,1.0,43/171,22.88%,IQGAP1;SDCBP;CCDC8;KIF20B;PSMD1;ANAPC1;DUSP3;SIK1;HNRNPU;RB1;DDB1;PIM3;INTS13;SIRT1;PKN2;PSMF1;PSMD14;APP;PSMD12;AFAP1L2;PSME2;CUL1;ANAPC10;GAS1;PSMB10;PSMD5;PSMD8;PSMA3;CDK13;FBXO5;UBE2S;PSMA2;ANAPC15;PSMD11;PSMA6;LGMN;TTL;XPC;CCDC57;USP2;PSMB3;BTG1;PSME3
prerank,clathrin-dependent endocytosis (GO:0072583),0.38766328784586124,0.9595919979659134,0.5128205128205128,0.8154228556548145,1.0,16/26,28.42%,GAK;LMBRD1;PICALM;FCHO1;SIGLEC1;AP2B1;INPP5F;ITSN1;FCHO2;AP2S1;GPR107;CLTC;AP2A2;AP2A1;DNAJC6;CANX
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.46543099743725214,0.9594430738755338,0.52,0.8153382139265488,1.0,5/10,26.29%,NOTCH1;PHACTR4;LRP6;ARHGAP12;LIN7C
prerank,phosphate ion transmembrane transport (GO:0035435),0.4421250125966856,0.9594245115476773,0.5176651305683564,0.8149686319458385,1.0,6/12,28.56%,XPR1;SLC37A3;SLC20A2;SLC37A4;SLC25A30;SLC25A10
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.32465591602849575,-0.9589404847722014,0.50199203187251,0.8508461626712264,1.0,10/17,29.14%,VPS9D1;ATP5PO;DMAC2L;ATP5F1E;ATP5PF;ATP5MC3;ATP5ME;ATP5F1B;ATP5MG;STOML2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.3048107283943533,-0.9587944105450819,0.548936170212766,0.8493650364592307,1.0,12/26,20.92%,CCND3;RPTOR;PLCB1;AIF1;EGFR;HYAL1;CDK10;UBE2E2;FGF10;RGCC;EIF4G1;MTBP
prerank,gland development (GO:0048732),0.3403461919671726,0.9585170865195249,0.5523255813953488,0.8165791196507379,1.0,7/59,9.86%,STRA6;ANXA1;CITED2;MSN;SOX9;ARID5B;PAX8
prerank,error-prone translesion synthesis (GO:0042276),0.3972576301177131,0.9582644030256015,0.5183175033921302,0.8167529269665471,1.0,4/21,9.33%,RFC3;RPS27A;UBC;POLH
prerank,regulation of microtubule nucleation (GO:0010968),0.4604438667831136,0.9582580939362934,0.5110410094637224,0.8163537507067228,1.0,6/10,27.03%,RANGRF;HSPA1B;HSPA1A;EML2;CKAP5;MECP2
prerank,positive regulation of tissue remodeling (GO:0034105),0.4666688616220881,0.9580993361673762,0.5195783132530121,0.816267306126919,1.0,2/10,12.24%,ROCK1;IL15
prerank,transition metal ion transport (GO:0000041),0.3702888409112992,0.957903640683456,0.5426452410383189,0.8162970464952733,1.0,11/35,19.26%,TFRC;SLC11A2;HEPH;TRPC3;MT3;SLC11A1;ATP7A;MELTF;SLC31A2;FTH1;SLC30A1
prerank,positive regulation of cell adhesion (GO:0045785),0.32934007196614806,0.9578908859039457,0.5405105438401776,0.8159244836980977,1.0,10/74,10.27%,SYK;STX3;VEGFA;TGM2;ADAM9;CITED2;ADAM8;FLCN;PPP3CA;RHOD
prerank,regulation of leukocyte activation (GO:0002694),0.4353072683400997,0.9574836793648976,0.5261627906976745,0.8163780881071786,1.0,3/14,7.28%,GPR137B;SHPK;MFHAS1
prerank,actin filament depolymerization (GO:0030042),0.45742109180486556,0.9571755706291494,0.5377643504531722,0.8166426688667704,1.0,6/11,19.63%,CFL1;WDR1;MICAL2;DSTN;CFL2;MICAL1
prerank,proteoglycan biosynthetic process (GO:0030166),0.3680867543493273,0.956741873731508,0.5235069885641678,0.8171613770237754,1.0,6/31,9.37%,XYLT1;EXT1;UGDH;B4GALT7;IGF1;BMPR2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.45857890685355035,0.9563977082035745,0.5563583815028902,0.817481405794617,1.0,1/11,0.92%,ZMIZ1
prerank,protein insertion into ER membrane (GO:0045048),0.3601745278895276,0.9562496619430202,0.5332512315270936,0.8174111629640604,1.0,13/37,20.29%,STX5;HMOX1;GET3;MMGT1;VAPA;CYB5A;APP;ALDH3A2;EMC2;EMC4;SGTA;EMC3;VAMP2
prerank,modulation by symbiont of host process (GO:0044003),0.46612543447643695,0.9561562759746569,0.5387045813586098,0.8172175839463841,1.0,2/10,7.16%,RPS27A;UBC
prerank,regulation of RNA export from nucleus (GO:0046831),-0.3756045970134229,-0.956043033965643,0.5014749262536873,0.8547608004336353,1.0,4/11,14.86%,IWS1;KHDRBS1;NSUN2;NUP153
prerank,regulation of protein polymerization (GO:0032271),-0.28311086199383945,-0.9556514045317309,0.5505050505050505,0.8540026019721835,1.0,18/35,30.93%,FCHSD2;MAPT;MAP2;HSP90AA1;TPPP;DBNL;TPPP3;TTBK1;ABITRAM;DBN1;CAMSAP1;PAK3;GBA2;ABL1;FCHSD1;ARHGAP28;ESAM;CAMSAP3
prerank,protein acetylation (GO:0006473),0.3765639880628577,0.955262411880263,0.533508541392904,0.8187397174794254,1.0,13/30,25.86%,GTF2B;CREBBP;NAT10;FOXO1;SIRT1;ING4;NAA10;NAT9;CLOCK;NAA80;NAA15;KAT6A;KAT2B
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4613477319832674,0.9547459112566409,0.5276461295418642,0.8194040296518833,1.0,3/10,13.94%,JUN;CITED2;HSPA1A
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.26598238866798424,-0.9545066847734914,0.5490196078431373,0.8551464523404936,1.0,10/41,12.40%,GRM5;CSF1R;TGFA;RELN;NTRK2;SRCIN1;LRP8;ERBB3;PRNP;AGT
prerank,tryptophan catabolic process (GO:0006569),0.45522734851122093,0.9544730501905665,0.5324074074074074,0.8195901954715253,1.0,1/11,2.53%,KYNU
prerank,regulation of establishment of cell polarity (GO:2000114),0.42279058852942664,0.9543869978992757,0.5434173669467787,0.8193692327856278,1.0,5/16,11.32%,KIF20B;RUFY3;ROCK1;PTK2B;BCAS3
prerank,response to UV-B (GO:0010224),0.44373157122484835,0.954270953675109,0.54337899543379,0.8191961908681131,1.0,3/12,13.30%,CDKN1A;MFAP4;RELA
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.338642813991471,0.9540035137484129,0.5463182897862233,0.8193555241254472,1.0,10/53,15.39%,EYA1;ERCC6;PRKCD;BABAM2;DDX5;BRCA1;SIRT1;BCLAF1;NSMCE4A;BRCC3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3970795717438661,-0.9536541438080139,0.5014577259475219,0.8555499359978235,1.0,1/10,1.82%,TGFBR2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3421678669473104,0.9532847106800815,0.5570934256055363,0.820503639823355,1.0,25/57,29.24%,EBNA1BP2;BYSL;NOP14;WDR74;MRPL36;CUL4A;PAK1IP1;WDR12;RPL7;RPL26;SHQ1;MALSU1;NOC2L;DHX37;XPO1;CUL4B;GTF3A;BOP1;TGS1;RRP36;RBIS;RPL14;MRTO4;EMG1;RPS7
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3569767009239125,0.9532080223666505,0.525609756097561,0.8202678100903297,1.0,7/39,8.16%,RANGRF;RIPK1;PPIF;GPD1L;SPHK2;NEDD4L;WWP2
prerank,positive regulation of protein transport (GO:0051222),0.3291782053591096,0.953154439966054,0.5586592178770949,0.819977953461745,1.0,18/67,17.95%,ABCG1;KIF20B;RUFY3;ADAM9;IGF1;CLN3;ADAM8;TPR;OAZ2;BCAS3;TREM2;APBB3;TENM1;GOLPH3;GOLPH3L;RAB29;OAZ1;EXOC1
prerank,nucleoside salvage (GO:0043174),-0.3949632216076754,-0.9531457812825795,0.5046728971962616,0.855026683065505,1.0,4/10,18.29%,UPP2;DCK;UCK1;UCKL1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.36867520733121034,-0.9531116229606679,0.4854368932038835,0.8532551228358989,1.0,3/13,9.19%,IL6ST;OAS2;STAT1
prerank,regulation of histone acetylation (GO:0035065),0.3699648109559558,0.9529786299201725,0.558282208588957,0.8199396006232558,1.0,13/33,23.59%,FOXP3;TAF7;FLCN;BRCA1;BRD7;ARRB1;CAMK1;NOC2L;KMT2A;PAXIP1;RUVBL2;CTBP1;SETD5
prerank,protein localization to synapse (GO:0035418),-0.3782578904462016,-0.9526054134985573,0.4954128440366973,0.8526717743606711,1.0,2/12,1.04%,NRXN1;NLGN1
prerank,ether lipid biosynthetic process (GO:0008611),-0.38828389327568347,-0.9519468908405702,0.5131964809384164,0.8526319876646978,1.0,4/10,7.09%,AGPS;LPCAT2;CHPT1;PLA2G4A
prerank,apoptotic nuclear changes (GO:0030262),0.39034770479830694,0.9519182989109436,0.5331599479843954,0.821854277958935,1.0,7/24,21.13%,DFFB;BLCAP;DEDD2;DNASE2;ACIN1;CASP3;DFFA
prerank,mitochondrial gene expression (GO:0140053),0.3437310187519406,0.9517502637547262,0.5327669902912622,0.8218181001467615,1.0,15/42,25.15%,FOXO3;MRPL23;MRPS7;MRPS28;POLRMT;IARS2;MRPS21;QRSL1;TWNK;TFB2M;MRPS18A;MRPS2;MRPL16;MRPS18B;GATB
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3235986477055035,0.9515679350698417,0.5621621621621622,0.8218018825615028,1.0,9/85,10.07%,MTSS1;VEGFA;RUNX3;RAB33B;IGF1;SOX9;MCC;ACVRL1;NLRC3
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.42379860156462235,0.9515262885210795,0.541029207232267,0.8214716442771351,1.0,2/17,2.89%,SYK;ADAM9
prerank,myelination (GO:0042552),0.3485499562899889,0.9514568854265818,0.5603345280764636,0.8211973638064984,1.0,11/46,19.14%,B4GALT5;CXCR4;ABCD1;B4GALT6;EPB41L3;PLLP;PMP22;DEGS1;ARHGEF10;EIF2B2;TNFRSF21
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.32390298922702987,0.9514313859769833,0.5759562841530055,0.8208447955670773,1.0,24/83,18.91%,PLK2;E2F3;CDKN1A;BACH1;E2F1;CUL3;CACUL1;RB1;NASP;CDK7;USP26;DBF4;ACVR1B;CUL4A;POLA1;PPP6C;CUL1;LATS1;ORC1;MNAT1;CDC34;CDT1;CDC25A;FBXO5
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.40107812505642004,0.9509368904307471,0.52400548696845,0.8215097698025594,1.0,7/18,22.89%,ST18;IL6;IL6R;CBL;CEBPA;STAT3;JAK2
prerank,regulation of telomere capping (GO:1904353),-0.3024008262807741,-0.9508779071116014,0.5019305019305019,0.8536683261002421,1.0,5/23,8.54%,ATM;USP7;SMG6;MAP2K7;RAD50
prerank,maturation of SSU-rRNA (GO:0030490),0.3571894344904917,0.9507770585701963,0.5253807106598984,0.821453994279177,1.0,10/34,18.99%,DCAF13;RPS14;HELB;NOP14;NAT10;NOB1;TSR3;PWP2;NGDN;DHX37
prerank,regulation of protein localization to membrane (GO:1905475),0.3843502531372986,0.9502585565436958,0.543450064850843,0.822196453592308,1.0,7/28,13.63%,MMP14;CLN3;STX8;VTI1B;VPS4A;APPL1;PRKN
prerank,response to sterol (GO:0036314),-0.38211935284458204,-0.949918274665743,0.521978021978022,0.8543276963116743,1.0,3/11,4.29%,CCR5;TGFBR2;TGFBR1
prerank,cellular metal ion homeostasis (GO:0006875),0.3187672274497442,0.9498858327670224,0.5702127659574469,0.8225894350730298,1.0,11/102,8.78%,HTR2B;TPCN2;ATP2B1;ATP13A3;SLC8B1;TMEM165;SLC8A1;LETM2;TESMIN;NEDD4L;LETM1
prerank,protein localization to plasma membrane (GO:0072659),0.3117235702242206,0.948640688291958,0.5956566701137539,0.8248892566128897,1.0,23/129,14.61%,MYO5A;DENND4C;RAP2A;FLOT1;RAB8B;PRAM1;TMEM150A;ZFYVE27;TSPAN17;GAK;TTC7B;EPB41L3;TNIK;RAB12;ROCK1;RAB10;RAB40C;PACS2;TSPAN15;GAS6;EFR3A;CACNB3;LRP6
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2456664935159878,-0.9485449391890975,0.6228070175438597,0.8561547340298361,1.0,21/59,19.19%,ACVR1;TGFBR2;CIT;CDC42BPA;TGFBR1;WNK3;CDK5R1;PRKD1;MAP2K1;MARK2;MAP3K10;PRKCA;CAMK2A;PRKD2;WNK1;CDK10;DYRK4;CSNK2B;TTBK1;SBK1;LMTK2
prerank,epithelial cell morphogenesis (GO:0003382),0.4080119175450157,0.9485391803923487,0.5457025920873124,0.8247078227349597,1.0,1/17,0.95%,RILPL2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4049677464205632,0.9485323911303358,0.5665760869565217,0.8243140715941456,1.0,6/20,17.81%,FASN;SLC25A1;PPT1;SCD;GCDH;CBR4
prerank,regulation of endocytic recycling (GO:2001135),0.4442212126285882,0.9482754486000244,0.5333333333333333,0.8244735358284302,1.0,4/11,13.76%,SORL1;EIPR1;RAB11B;INPP5F
prerank,positive regulation of histone acetylation (GO:0035066),0.3874495967413449,0.947829142437198,0.5349740932642487,0.8250401493827122,1.0,8/23,22.16%,FOXP3;SPHK2;BRCA1;BRD7;ARRB1;SMARCB1;PAXIP1;RUVBL2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23318221605023912,-0.9478079417417651,0.6285714285714286,0.8562695526874189,1.0,18/75,17.09%,GIT2;PLCB1;RGS6;RPGRIP1L;KCTD8;RGS20;FRMPD1;METAP2;ADCYAP1;NMT1;CAMK2A;USP20;RGS12;GIT1;RASGRP4;RGS2;SYP;SAG
prerank,base-excision repair (GO:0006284),0.3439318866925061,0.9471935169987168,0.5612366230677764,0.8259655954961026,1.0,8/48,12.79%,ERCC6;RFC3;MUTYH;NEIL1;HUWE1;POLL;MBD4;WRN
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.38546257700653674,0.9471702315672563,0.5623376623376624,0.8256085305800347,1.0,5/24,16.55%,ITGA5;NIBAN2;MT3;PRKCB;PTPN1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3926737629103863,0.9470152373700178,0.5607094133697135,0.8255393505222742,1.0,6/22,11.89%,P2RX4;IGF1;GLRX3;ROCK1;MTPN;NOTCH1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4002190353111026,0.9469358797090006,0.5420054200542005,0.8253039867273402,1.0,5/21,10.26%,ENSA;MFHAS1;STYXL1;BOD1;GSK3B
prerank,positive regulation of response to wounding (GO:1903036),0.38660743475391796,0.9468906687950742,0.535006605019815,0.8249938749560272,1.0,9/24,26.84%,ANXA1;ITGB1;MYLK;GRN;ARFGEF1;ACTG1;HRAS;HBEGF;VTN
prerank,regulation of stem cell differentiation (GO:2000736),0.31596239232066514,0.945748683097507,0.5910087719298246,0.8269905710076725,1.0,26/89,22.88%,LMO1;PSMD1;SMYD5;HNRNPU;ZFP36L2;CBFB;PSMF1;PSMD14;NOTCH1;PSMD12;GDNF;PSME2;TCF12;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;KMT2A;OSM;PSMD11;PSMA6;HES5;PSMB3;PRKDC;PSME3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.44362654346569813,0.9456667245591798,0.562406015037594,0.8267553477138277,1.0,1/12,7.85%,SOX9
prerank,modulation by host of viral genome replication (GO:0044827),0.4329719360087012,0.945318589213751,0.5295857988165681,0.8270682130929365,1.0,4/13,14.90%,EIF2AK4;VAPA;PRKN;YTHDC2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.29319619267826413,0.9447842821147139,0.795,0.8277721237159861,1.0,349/1646,21.55%,EPAS1;PPARG;MDFIC;ANXA4;CD38;TFEC;APOE;LITAF;ELF2;ZMIZ1;ATP1B4;IRX3;RCOR1;TFEB;HOPX;TRPS1;NFE2L2;ZNF3;CTNNB1;MITF;VEGFA;POLR2A;WWP1;CEBPB;ERCC6;ZEB2;ATXN1;GRHL1;FOXP3;EN2;ST18;ATF3;KDM4C;CXXC1;SPP1;VEZF1;WWC2;LANCL2;RUNX2;ARID4A;NR1H3;GATAD2A;E2F3;ID2;IL6;TOX4;CDKN1A;FOXO3;NIBAN2;WAC;BAZ1A;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;MED12;SNX5;NCOR1;PHF20;HNRNPAB;RARA;ZFP28;MYCBP;MZF1;CITED2;FOXO4;BRIP1;BACH1;E2F1;TAF7;IGF1;HAS3;ZBTB42;UBE2L3;PCID2;STAT5B;COL1A1;SAP30;APBB2;RNF10;NR3C1;ASCC2;EED;NSD3;MLLT11;NR1H4;DDX5;CREBBP;BHLHE40;TESMIN;THOC1;DYRK1A;KLF5;PEX14;NIPBL;ATF4;REL;IFRD1;TGIF1;KDM3A;ZBTB20;ETV6;ZNF177;TAF5;BAZ2B;POLR2L;RREB1;UXT;POU3F1;PIAS4;TCF20;JMJD1C;SOX9;BRD2;BRCA1;SNAI2;HOXA3;RB1;PRDM8;RBAK;LCOR;WWP2;ABCA2;EPC1;ZNF148;FOXP1;IRF2;CHD3;CBFB;DVL1;ZFAT;ACVRL1;CARF;BRD7;TBL1XR1;DACH1;ARID5B;CHD2;PICALM;HIPK2;NCOA1;NR5A1;DDIT3;BRD3;FZD7;XRCC5;PAX8;NR2C1;WDR77;HCFC2;RLIM;ESR1;ASCC1;PSPC1;CNOT7;FOXK1;ZFPL1;KDM2A;POU3F3;MAFB;FOXO1;MED16;SIRT1;MAFG;SALL2;KMT2E;MED26;NFATC3;PPARD;ZNF691;ING4;CUX1;MT3;GPBP1L1;CAND2;LCORL;CBX3;CIPC;MYRFL;ZKSCAN7;SP3;NOTCH1;PRKCB;RORA;ACVR1B;TBX6;PQBP1;DEDD2;CAMTA2;RELB;APBB3;MAZ;RFX1;AFAP1L2;HCLS1;FZD2;SMARCC1;RFX5;BCLAF1;DGKQ;SOX2;USP21;USP16;RELA;BBX;BCL11B;GAS6;ATP8B1;POU2F1;LIMD1;PPIE;POLA1;HBP1;MSANTD1;TENM1;ZKSCAN3;FOXJ3;SMARCD1;PGBD1;JUNB;SUV39H2;ATF1;ZKSCAN5;KDM7A;NAT14;PRDM2;HNRNPD;CREG1;SHC1;PHIP;ID4;LRP6;EID1;MAP3K2;SNF8;ETV3;ORC1;MNAT1;ARRB1;QRICH1;MPHOSPH8;PPARGC1B;PHF20L1;HSPD1;KLF6;NHLH2;ZNF32;BRPF1;MTF1;MYT1;THRAP3;RRP8;CCAR1;TCF12;CREB3L4;CREB3;NCF1;ELP4;ZBTB11;BRWD1;BAZ1B;PLAGL2;TAF5L;ZNF18;CHD7;TAF15;CRY1;MLLT3;ERC1;CDT1;NKX2-1;SMARCB1;ZBTB41;ZBTB7A;GABPA;NFYC;HMGN5;UBE2V1;CIR1;ZNF23;CREB1;NAB1;ZBTB7B;ZNF319;E2F2;BBS7;HOXD8;NCOA6;RAD21;FLI1;KLF8;SOX8;ZNF431;CLOCK;FBXO5;NFX1;PPP2CA;NCOA2;ZBTB40;CALCA;KMT2A;STAT6;PPP1R13L;NFIC;CREB3L1;NR2F1;PURB;PIAS2;ZNF367;WWTR1;PRDM16;BCL3;SAP30L;TCF4;TCF7L2;PHF1;PHF2;HSF2;SCMH1;SFMBT2;POLR3C;NFE2L3;PPP2R1A;SREBF1;RBM15;SPEN;BCL11A;SIN3A;OGT;HES5;ZFP62;JMJD6;SP8;ZBTB16;MGA;SAFB;MLXIP;FUBP3;NPAS2;PIAS1;MYPOP;HNF4G;CEBPA;XPC;MBD2;NR1H2;ZBTB24
prerank,cellular response to osmotic stress (GO:0071470),0.396240174438842,0.944387483200745,0.5546666666666666,0.8282519688304144,1.0,4/21,12.20%,LRRC8D;AQP1;ARHGEF2;MYLK
prerank,positive regulation of protein depolymerization (GO:1901881),-0.37926034776178463,-0.9442971893578772,0.5368731563421829,0.8636426602127995,1.0,4/11,24.66%,SEMA5A;STMN2;NES;KATNB1
prerank,replication fork processing (GO:0031297),0.3558746300630733,0.9440251509370857,0.5643564356435643,0.8286045569709047,1.0,8/38,15.89%,ALYREF;ZRANB3;FAM111A;THOC1;EME1;RTEL1;WRN;CENPX
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3643138464451234,0.9438117184812276,0.5493133583021224,0.8286336765936886,1.0,6/31,14.31%,PPARG;TNN;SOX9;NOTCH1;LIMD1;GDF10
prerank,cellular response to estradiol stimulus (GO:0071392),0.3994540352437255,0.943048114637365,0.5480631276901005,0.8298723735746015,1.0,4/18,12.68%,LCOR;NCOA3;ESR1;FAM210B
prerank,peptidyl-lysine monomethylation (GO:0018026),0.46095996607931566,0.9420667809696005,0.5480480480480481,0.8315532148186606,1.0,6/10,30.62%,SETD7;SMYD2;SETD3;SETD6;EHMT1;SETD4
prerank,respiratory chain complex IV assembly (GO:0008535),-0.31481130479713954,-0.9414969485718668,0.531496062992126,0.869192559772591,1.0,8/21,24.59%,COX16;COX10;COX19;COX17;SCO1;COX14;COX18;COA6
prerank,rRNA modification (GO:0000154),0.39406267693702196,0.9414480877668844,0.5532503457814661,0.8324580540610423,1.0,11/21,25.72%,NSUN3;NAT10;DKC1;MRM2;TSR3;TFB2M;FBL;DIMT1;MTERF4;ZCCHC4;NSUN4
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.33324288922809703,-0.9414408361069259,0.5291970802919708,0.8674928130551696,1.0,3/16,4.62%,ANK2;RYR2;GABARAPL2
prerank,"transcription, DNA-templated (GO:0006351)",0.30070627534407984,0.9409648142188999,0.6328600405679513,0.8330702548108485,1.0,59/207,22.66%,TSC22D1;POLR2A;ERCC6;AFF4;FOXO3;GTF2H5;GTF2B;E2F1;TAF7;NFKBIB;DDX5;ATF4;TAF5;POLR2L;RREB1;EPC1;TAF1B;CBFB;TOPORS;PAX8;POLR2G;MED16;GTF3C4;CDK7;POLR2I;NCBP2;TRIP11;GTF2F2;POLRMT;CTDP1;GTF2A1;NAT14;MLLT1;PWP1;MNAT1;CDC73;TWNK;SMN1;TAF5L;TAF15;NELFE;MLLT3;TFB2M;TTF1;ZBTB7B;NCOA6;TAF1A;NFX1;NFIC;BCL3;DTX1;NFE2L3;FUBP3;ABT1;TAF1;CCNT1;GTF3A;POLR3K;SUPT4H1
prerank,negative regulation of transmembrane transport (GO:0034763),0.4560267703891385,0.940630704400948,0.563165905631659,0.8333559976997469,1.0,3/10,11.91%,THBS1;IRS2;PRKCB
prerank,regulation of endothelial cell migration (GO:0010594),0.32282005385741186,0.940614846840796,0.599128540305011,0.83298301210375,1.0,19/85,19.23%,SASH1;APOE;VEGFA;RHOJ;NRP2;THBS1;FOXP1;ACVRL1;BMPR2;PTK2B;BCAS3;GPLD1;RRAS;GRN;NRP1;TEK;AAMP;PRCP;PIK3CB
prerank,protein autophosphorylation (GO:0046777),0.3067024923513693,0.9401670904014438,0.6143589743589744,0.8335200969035718,1.0,26/157,14.30%,MAK;PIKFYVE;ERN1;TEC;MAPKAPK3;TAOK3;PDPK1;DAPK1;RIPK1;PIM1;FGFR4;MELK;SIK1;STK24;DYRK1A;EIF2AK4;TNIK;PIM3;GSK3B;PTK2B;PAK2;FES;ACVR1B;FGR;STK16;UHMK1
prerank,negative regulation of signal transduction (GO:0009968),0.3010987242446944,0.9399667044367924,0.6572295247724975,0.8335296073172739,1.0,47/249,17.63%,GDF15;XDH;SIGIRR;FBXW7;LRP1;PRKCD;NIBAN2;ENPP1;MMP14;BRAP;PTEN;PID1;SLC27A4;PTPRE;PALM;THBS1;IRAK3;PTPN12;RITA1;SULF2;KCTD21;GPR108;SNAI2;RB1;WWP2;NFKBIL1;CSNK2A2;NLRP2B;PRKCB;APPL1;APCDD1;MAZ;SULF1;TSPAN15;TNFAIP3;PHACTR4;CX3CL1;ARRB1;ASXL1;WWOX;PTPN1;EGFL7;PIP4K2A;CRY1;CSNK2A1;APOD;ZBTB7A
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3034118337056173,0.9396749912343823,0.6274111675126903,0.8337421854643227,1.0,46/198,20.36%,HTR2B;PLPP3;CERK;HK3;ITPKB;NUDT14;PLA2G2D;ENPP1;SHPK;INPP4A;PTEN;DUSP3;SPHK2;PIK3CA;GPX4;IPPK;TOP1;GFPT1;LHPP;PLCB4;PLA2G4F;PPP3CA;HDHD2;ACYP1;PAK2;PLAAT3;PGP;LIMD1;OCRL;PPP1CA;GDE1;PANK2;PRKCG;INPP5A;IMPA2;PIP4K2A;GK5;PFKP;CERKL;PIK3CB;XYLB;PFKM;DUSP10;GCK;GK;PLAA
prerank,protein K11-linked ubiquitination (GO:0070979),0.3719437127709424,0.9394811608128212,0.5564102564102564,0.8337535881195713,1.0,11/27,26.51%,RNF26;UBE2L3;ANAPC1;PRKN;ANAPC10;UBE2S;UBE2H;UBE2D3;ANAPC7;FZR1;ANAPC2
prerank,macrophage activation involved in immune response (GO:0002281),0.4295248032046022,0.93916010952617,0.5455882352941176,0.8339954786384985,1.0,5/13,15.74%,SYK;TYROBP;TREM2;LBP;GRN
prerank,regulation of establishment of planar polarity (GO:0090175),0.3192603273318436,0.93913174645188,0.5989130434782609,0.8336443520138478,1.0,31/88,26.26%,SPEF1;PSMD1;DVL1;FZD7;PSMF1;PSMD14;FZD5;PFN1;PSMD12;FZD2;AP2B1;PARD6A;CELSR1;PSME2;DAAM1;VANGL2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;NPHP3;AP2S1;PSMC5;CLTC;AP2A2;PSMC1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4360794167433076,0.9389531657916388,0.5565476190476191,0.8336377248509699,1.0,5/13,24.87%,EDEM2;DERL2;BCAP31;BRSK2;SVIP
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3917858051030527,0.9387836432883047,0.5551128818061088,0.8336371214596899,1.0,7/20,26.02%,IL6;DENND1B;FZD5;TRAF2;MALT1;TRAF6;MAP3K7
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.45241952803235386,0.9379798291019832,0.5466666666666666,0.8349346275620854,1.0,1/11,1.59%,CTNNB1
prerank,positive regulation of phosphorylation (GO:0042327),0.2974400909876036,0.9379172529751639,0.6518668012108981,0.8346523580484313,1.0,30/240,12.33%,GPNMB;SDCBP;RAP2A;VEGFA;FLOT1;FNIP1;TFRC;HGF;FAS;RIPK1;IGF1;FGFR4;THBS1;MERTK;FLCN;ZBTB20;SOX9;ACVR2A;DSCAM;TNIK;FZD7;MAVS;ADAM17;SIRT1;CCN1;MT3;NBN;APP;ROR1;TREM2
prerank,negative regulation of locomotion (GO:0040013),-0.35538735548861106,-0.937538236853915,0.5377358490566038,0.8762251506021062,1.0,3/12,5.16%,FRMD5;WAS;SPOCK3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.40675043938288236,0.937331743471894,0.5421511627906976,0.8354458957136016,1.0,8/16,30.93%,ABCD1;PPIF;ATP7A;VCP;SHMT2;NUPR1;UQCC2;SLC25A33
prerank,regulation of GTPase activity (GO:0043087),0.30470021956076254,0.9370679185491207,0.6465163934426229,0.8355610258630681,1.0,26/177,12.80%,PLXNA1;GPR137B;PLXNC1;PLXND1;ARHGAP15;FGD6;VAV3;TGM2;RIC1;TBC1D2;ARHGAP9;SNX9;ADAP1;RASA4;RAB3GAP2;FLCN;DOCK10;ARAP1;VAV1;PICALM;ITGB1;GSK3B;BCAS3;TBC1D15;FGD5;RAPGEF1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3731982359776669,0.9370554460015711,0.5704874835309618,0.835190322869024,1.0,9/26,21.90%,CUL3;DUSP3;PKN2;APP;LGMN;TTL;PPP1R10;CCDC57;USP2
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3491549006201917,0.9366748695773839,0.5573170731707318,0.835574957534014,1.0,11/39,19.76%,MYO5A;MYO1E;CLN3;MYO19;MYO1F;NDE1;WASL;KIF5B;PAFAH1B1;HTT;RAB1A
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.38381658583237577,0.9363927258828745,0.561662198391421,0.8357628203455865,1.0,5/23,14.15%,VEGFA;SIRT6;SOX9;PAX8;GDNF
prerank,postreplication repair (GO:0006301),0.3416498604818006,0.9362891175189761,0.5580304806565064,0.8355663846571995,1.0,7/45,9.33%,RFC3;TRIM25;RPS27A;UBC;BRCA1;WDR33;POLH
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4300271011834454,0.9361854277137815,0.5544117647058824,0.835377628023116,1.0,2/13,5.15%,SHISA9;CLN3
prerank,T cell receptor signaling pathway (GO:0050852),0.3034383560543143,0.9361649203756993,0.6243550051599587,0.8350208849425474,1.0,37/138,23.92%,RFTN1;TEC;PRAM1;CD28;PDPK1;PSMD1;CD3D;TRAT1;PIK3CA;DENND1B;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELA;PSME2;CUL1;CD247;PSMB10;PSMD5;EIF2B2;PSMD8;CARD11;PSMA3;TNFRSF21;PIK3CB;PSMA2;PSMD11;PSMA6;PTPRC;PSMB3;PDE4D;MALT1;PSME3;BCL10;TRAF6
prerank,keratan sulfate biosynthetic process (GO:0018146),0.366742162391283,0.9359643502462477,0.5745257452574526,0.8350500413030999,1.0,6/26,14.18%,B4GALT5;B4GALT6;ST3GAL4;LUM;B4GALT3;B4GALT2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3039385383003877,0.9359128126986522,0.6138002059732235,0.834756118359311,1.0,46/161,23.83%,APOE;PSMD1;ZNRF3;CUL3;TNN;STK3;APC;SOX9;MCC;SNAI2;DVL1;DDIT3;GSK3B;PSMF1;PSMD14;PSMD12;SOX2;LIMD1;PRKN;PSME2;LRP6;KREMEN1;LATS1;CCDC88C;MLLT3;PSMB10;PSMD5;PTPRU;PSMD8;AMFR;STK4;PSMA3;PSMA2;PSMD11;WWTR1;TCF7L2;PSMA6;TLE3;PSMB3;RUVBL2;SDHAF2;KLHL12;SIAH2;PSME3;NPHP3;BICC1
prerank,nerve growth factor signaling pathway (GO:0038180),0.4497442984201488,0.9354558839840235,0.5572289156626506,0.8352861607712614,1.0,2/10,12.80%,KIDINS220;RAPGEF1
prerank,mesoderm development (GO:0007498),0.3951033625504055,0.9354486052252151,0.5591836734693878,0.8348967812484291,1.0,3/18,12.78%,VEGFA;TBX6;BTK
prerank,nucleotide-sugar metabolic process (GO:0009225),0.42750210154659773,0.935337500790272,0.5568862275449101,0.834720344093397,1.0,6/12,25.65%,GFPT1;UGP2;FUT8;EXTL2;GALT;SLC35A3
prerank,carbohydrate catabolic process (GO:0016052),0.35358377528823187,0.9353248746202427,0.58125,0.8343465403956258,1.0,14/38,26.55%,HK3;TPI1;MANBA;ENO3;DERA;PGM1;NEU1;GAPDHS;PFKM;GCK;PKM;HK1;PGK1;MAN2C1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.3855768491650403,-0.9352547714705107,0.525679758308157,0.8804880685237366,1.0,3/10,13.94%,PDE3B;WNK1;NEXMIF
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.35888471662154264,-0.9350330242774042,0.5488958990536278,0.8792561050988742,1.0,4/13,6.57%,TGFBR2;NKAP;PNP;GLI3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.4258315968207399,0.9348991288869348,0.5562043795620438,0.8348474100014156,1.0,6/13,22.75%,TCERG1;HNRNPU;LARP7;NELFE;SUPT4H1;RNF168
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4623933843610955,0.9348867738592693,0.5507462686567164,0.8344714198891301,1.0,5/10,23.94%,HK3;GFPT1;PFKP;PFKM;HK1
prerank,positive regulation of reproductive process (GO:2000243),0.3700850663618942,0.9348725376555252,0.5577689243027888,0.8341027479679417,1.0,4/31,11.99%,VEGFA;LHFPL2;AGO2;ACVR1B
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4286511203823848,0.9345572877921791,0.5609022556390978,0.8343725819236113,1.0,3/12,12.11%,FLOT1;MAVS;PQBP1
prerank,peptidyl-tyrosine modification (GO:0018212),0.3328094159808718,0.9343640946372854,0.5791907514450867,0.8343780838876327,1.0,12/56,14.65%,SYK;TEC;ABL2;ABI1;FGFR4;DYRK1A;PKDCC;PTK2B;FES;BTK;FGR;JAK3
prerank,T cell mediated immunity (GO:0002456),-0.36134297130595316,-0.9343268456416257,0.5261437908496732,0.879363811596374,1.0,1/13,0.11%,CADM1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.4236666987865717,0.9342898758869183,0.5666178623718887,0.8341389846625512,1.0,6/14,20.44%,CTNNB1;BRCA1;KMT2E;DNMT1;KMT2A;PAXIP1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.42337429588187364,0.9341213197710171,0.5597122302158274,0.8340786390499619,1.0,2/13,11.40%,CPSF1;NCBP2
prerank,glutamate metabolic process (GO:0006536),0.3954179899785295,0.9339573837127472,0.5667574931880109,0.8340064555726553,1.0,4/19,17.97%,MTHFS;PRODH;ALDH18A1;OAT
prerank,fibrinolysis (GO:0042730),0.41961516689355144,0.9338153629834052,0.5455861070911722,0.8339155153685278,1.0,2/13,22.54%,PLAU;PLAUR
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.27372407642813806,-0.9333351189911375,0.5215311004784688,0.8802622285395956,1.0,14/32,24.66%,NAV3;HDGFL3;MAP2;FGF13;TUBB4A;STMN2;MAPRE1;STMN1;MID1IP1;TPX2;TTBK2;CAMSAP1;CIB1;KATNB1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.32625758459758036,0.9331073780137691,0.5913140311804009,0.834958636093508,1.0,13/67,13.79%,TBC1D22A;TBC1D1;TBC1D2;P2RX4;TBC1D10A;TBC1D2B;CAPZB;TBC1D22B;ATG5;TBC1D24;TBC1D15;ATP8B1;IFT140
prerank,filopodium assembly (GO:0046847),0.40455782438976795,0.9330489035254469,0.5492371705963939,0.8346629129994307,1.0,6/16,15.50%,FGD6;SPEF1;PPP1R9B;FGD5;FGD3;VSTM5
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.39043886495339264,0.9328462778824155,0.5612382234185733,0.8346900244834986,1.0,3/21,2.56%,CTNNB1;VEGFA;DCT
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.34833239685876993,0.9325676185541241,0.5821256038647343,0.834862979458317,1.0,14/42,24.63%,RFC3;TRIM25;RPS27A;UBC;POLH;SIRT1;WRN;POLA1;POLI;VCP;POLD1;SPRTN;ISG15;PRIMPOL
prerank,positive regulation of protein sumoylation (GO:0033235),0.4481028908908587,0.9325503562063708,0.5522620904836193,0.8344970515583101,1.0,2/10,7.73%,RWDD3;PIAS4
prerank,sodium ion homeostasis (GO:0055078),0.38941298693123244,0.9318766905813755,0.5587467362924282,0.8354731759798731,1.0,4/21,8.00%,TFAP2B;SLC8A1;SLC12A3;NEDD4L
prerank,cellular response to alkaloid (GO:0071312),0.3999289602766127,0.9318099330206081,0.5444126074498568,0.8351966773701326,1.0,5/17,18.32%,TGM2;SLC8A1;HTR1B;CASP6;CASP3
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4467457203224983,0.9315459669146595,0.5914634146341463,0.8353256285836937,1.0,3/10,15.85%,BRCA1;SIRT1;DNMT1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.34002986216972664,0.9309398451394687,0.5828505214368482,0.836248654074761,1.0,5/45,7.16%,WEE2;CTNNB1;PLK2;TOM1L2;ZFP36L2
prerank,epithelial tube morphogenesis (GO:0060562),0.355676011658189,0.9308391681520274,0.5714285714285714,0.8360707922154601,1.0,4/32,8.84%,MTSS1;CTNNB1;COL4A1;ACVRL1
prerank,peptidyl-amino acid modification (GO:0018193),0.4448189045132032,0.930639352338367,0.5559006211180124,0.8360803715628818,1.0,4/10,22.17%,METAP1D;FKBP7;ATP7A;TTLL4
prerank,steroid biosynthetic process (GO:0006694),0.3309407250049046,0.9304763806660334,0.5885057471264368,0.8360303391302049,1.0,4/56,2.43%,BAAT;AMACR;OSBPL1A;PRKAG2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3719487851025746,0.9289990163317662,0.5650459921156373,0.8386769477536534,1.0,3/26,8.78%,HTR2B;SLC8B1;LETM1
prerank,negative regulation of innate immune response (GO:0045824),0.3536141772226546,0.9288861357337199,0.5825864276568502,0.8385036800390512,1.0,12/34,24.46%,YTHDF3;IRAK3;NLRC3;CNOT7;TRAFD1;TNFAIP3;ACOD1;GRN;SLAMF8;ISG15;LYAR;DHX58
prerank,regulation of TORC1 signaling (GO:1903432),0.3600022820078114,0.9284909734125705,0.5849297573435505,0.8389296862330415,1.0,6/33,13.39%,GPR137B;SIK3;SESN2;FLCN;DGKQ;CASTOR1
prerank,heart looping (GO:0001947),0.34895696038561197,0.9283840787350162,0.5916167664670658,0.8387397473106406,1.0,6/39,12.41%,APLNR;CCDC40;FOLR1;NOTCH1;TBX6;MICAL2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.4263534627611015,0.9282829224860603,0.573170731707317,0.8385494979582844,1.0,1/12,0.58%,APOE
prerank,regulation of interleukin-13 production (GO:0032656),0.42448099021515306,0.9275169577737016,0.5585185185185185,0.8397224441484411,1.0,2/13,6.26%,RARA;SPHK2
prerank,N-glycan processing (GO:0006491),-0.31899686121685167,-0.9273895953895614,0.5198675496688742,0.8945057122079857,1.0,6/18,10.94%,MGAT4A;ST8SIA6;MAN1A2;ST8SIA1;ST8SIA5;ST8SIA3
prerank,endothelial tube morphogenesis (GO:0061154),0.45593434675640787,0.9271618045251865,0.5795275590551181,0.8400341424115896,1.0,2/10,8.84%,CTNNB1;ACVRL1
prerank,pyroptosis (GO:0070269),-0.3391287110479448,-0.9270002700787968,0.5102739726027398,0.8937390351889707,1.0,4/15,11.18%,CASP4;GSDME;APIP;ZBP1
prerank,positive regulation of chemokine production (GO:0032722),0.33979737123432296,0.9268645028738883,0.5884476534296029,0.8402375881213934,1.0,7/44,11.47%,SYK;IL6;HMOX1;IL6R;MAVS;ADAM17;APP
prerank,arachidonic acid metabolic process (GO:0019369),0.3538587809419482,0.9265730154289715,0.5573170731707318,0.8404256356042032,1.0,4/35,8.67%,MGLL;GPX4;PTGES2;HPGDS
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3024723420498491,-0.9265115987764894,0.53515625,0.8930963661879439,1.0,5/22,8.09%,CACNB2;CACNB4;FMR1;NOS1AP;PDE4B
prerank,response to glucagon (GO:0033762),0.40231972411724964,0.9259427769820182,0.5832187070151307,0.8413067072974815,1.0,7/19,23.07%,ADCY7;ADCY8;ADCY3;CRY1;CREB1;ADCY5;ADCY9
prerank,mitochondrial genome maintenance (GO:0000002),-0.3787748021909559,-0.9255001120506852,0.5602409638554217,0.893891988880113,1.0,5/11,9.63%,MEF2A;AKT3;SLC25A36;SLC25A4;PARP1
prerank,RNA transport (GO:0050658),0.3196874705140005,0.9252668756163203,0.6104910714285714,0.8422967040304276,1.0,16/71,18.02%,RFTN1;FLOT1;ALYREF;TST;ATXN2;CHTOP;THOC1;TPR;NCBP2;SRSF3;THOC2;SIDT2;DDX39A;EIF4A3;DHX38;KIF5C
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.35418611693375585,0.9251489220882186,0.5850931677018634,0.8421543757705877,1.0,7/32,17.29%,LPIN3;SLC27A1;CSNK2A2;PCYT1A;LPCAT3;SLC44A2;CSNK2A1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.42291139945746603,0.9248150089111614,0.5845697329376854,0.8424547308646338,1.0,1/14,0.55%,XDH
prerank,homologous chromosome segregation (GO:0045143),-0.3046373220268793,-0.9244562394304406,0.5543478260869565,0.8947935167185063,1.0,5/20,19.63%,FMN2;FANCD2;ZCWPW1;IHO1;TERB1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.39977357610636777,0.9244153570836856,0.5836909871244635,0.8428712573183539,1.0,8/17,22.51%,AFG1L;COX6A1;CYCS;COX8A;COX7B;COX15;COX4I1;COX5A
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.36877829795188033,-0.9243535374556313,0.534375,0.8932124695491791,1.0,6/12,28.92%,CHEK2;STK33;SETMAR;NAE1;TOPBP1;TICRR
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.26408669803699947,-0.9236831003465424,0.5614973262032086,0.8932379476640764,1.0,7/35,9.06%,PLXNA4;SEMA5A;ARHGDIA;SEMA4G;SEMA3E;SH3BP1;SEMA3A
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.37716918457213855,-0.9233346860115416,0.5399449035812672,0.8922699863107103,1.0,4/10,9.19%,TGFBR2;FGFR2;LRP5;STAT1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.44879051056884867,0.9229013302357392,0.5793413173652695,0.8455327563612008,1.0,1/10,0.48%,APLNR
prerank,ribonucleoprotein complex assembly (GO:0022618),0.30473545481072495,0.9228537806164004,0.6462655601659751,0.8452268665440912,1.0,37/132,21.35%,RPL3L;MRPL20;SRPK2;SCAF11;CELF1;CLNS1A;EIF6;EIF3A;RPS14;SNRNP200;ISY1;SART1;MRPS7;SF1;EIF5;XRCC5;WDR77;PRPF6;DDX23;DDX20;SNRPF;RPL10;ZRSR2;RPSA;CDC73;SMN1;PUF60;LUC7L;SRPK1;SHQ1;PWP2;EIF2S2;RAMAC;PPAN;RPS27;SNRPB;ABT1
prerank,RNA destabilization (GO:0050779),0.3973324454864824,0.922639973990039,0.5826086956521739,0.8452564577406196,1.0,4/18,10.56%,CELF1;YTHDF3;ROCK1;FTO
prerank,nuclear pore complex assembly (GO:0051292),0.4464357117132848,0.9220489772169153,0.5793528505392912,0.8460552281857594,1.0,5/10,21.60%,TPR;RTN4;NUP98;TMEM170A;NDC1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3726688046091482,0.9218917793897383,0.5686015831134564,0.8459535739539665,1.0,6/25,12.02%,MPHOSPH10;SCAF11;PRPF8;PRPF6;DDX23;SF3A3
prerank,regulation of G0 to G1 transition (GO:0070316),0.344647433926732,0.9215873654097866,0.58679706601467,0.846195026129021,1.0,16/38,24.52%,APAF1;FOXO4;E2F1;EED;UXT;BRCA1;EPC1;CBX3;RBBP7;MGA;EHMT2;CBX5;TFDP1;PHC3;RNF2;PCGF6
prerank,positive regulation of glucose metabolic process (GO:0010907),0.41916111594980576,0.9213005029309502,0.5910987482614742,0.8463801653058453,1.0,4/14,13.02%,IRS2;DDB1;SIRT1;GPLD1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.4042675112969904,0.9211286950073968,0.576437587657784,0.846312623998457,1.0,6/16,25.24%,NR1H3;SLC27A1;GPLD1;SREBF1;NR1H2;CTDNEP1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.2967771176170937,-0.9203190535437938,0.5687022900763359,0.8984120926863307,1.0,7/22,23.87%,PDE3B;APOC1;TNF;PPP2R5A;CCDC3;IL1B;ADRA2A
prerank,response to metal ion (GO:0010038),0.32339576739031695,0.9201554299195794,0.623608017817372,0.847849601750789,1.0,20/67,21.58%,SLC11A2;ADAM9;D2HGDH;THBS1;TESMIN;NEDD4L;TRPC3;PPP3CA;MT3;ATP5F1D;PPP1CA;MTF1;ANXA11;PAM;PPP2CA;CALM2;SEC31A;MT1A;MT1X;PEF1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.20093255484131547,-0.9200300283032793,0.7209302325581395,0.8973660358112535,1.0,34/152,16.40%,GPC5;SEMA5A;SALL1;DISC1;CSNK1E;LGR4;CSNK1G3;FGFR2;JUP;PSMC2;TRPM4;LGR5;CSNK1D;EGFR;PSMD6;CSNK1G2;AMER1;PRDM15;DAPK3;WNK2;WNK1;PSMD7;RSPO3;RSPO2;UBE2B;SCEL;RNF220;PSMB5;DAAM2;HHEX;WNT5B;TLR2;FGF10;PSMB4
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.32081918285308253,0.9200152152145213,0.6138392857142857,0.8477380872553021,1.0,7/74,5.60%,SDCBP;GCNT2;CTNNB1;IL6;PTEN;COL1A1;DAG1
prerank,cartilage development (GO:0051216),0.32864559055169174,0.9198831334817633,0.6149358226371062,0.8475916304124271,1.0,11/49,16.93%,RUNX2;CD44;RUNX3;SULF2;SOX9;SLC39A14;TRIP11;SULF1;GPLD1;ATP7A;COL11A2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.2483962788954936,-0.9198607003205019,0.6791044776119403,0.8959202339200333,1.0,14/57,15.84%,P2RY12;GRM8;OPRM1;CHRM3;CHRM2;AKAP12;GPR37;GABBR1;GNAL;HTR1F;ADCY1;HTR4;AKAP5;GRM7
prerank,response to glucose (GO:0009749),0.33909152534882114,0.9196040994270672,0.5796568627450981,0.847777620335061,1.0,12/46,20.34%,ERN1;THBS1;IRS2;ZBTB20;SLC39A14;GPLD1;GAS6;ADCY8;EIF2B2;TCF7L2;VAMP2;GCK
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.44861771556106284,0.919262039601675,0.5872781065088757,0.8480806363621259,1.0,3/10,16.77%,FBXW7;ADAM17;NCF1
prerank,calcium ion import into cytosol (GO:1902656),0.406128551680351,0.9192309702641016,0.5659025787965616,0.8477315281043568,1.0,3/15,9.36%,SLC8A1;MS4A1;TRPV2
prerank,cellular response to inorganic substance (GO:0071241),0.3863227948893628,0.919106916539267,0.5779569892473119,0.847563486815924,1.0,8/21,23.84%,AQP1;FOXO1;MT3;NSMCE3;DDI2;RTF2;SPIDR;CDK2
prerank,glucose transmembrane transport (GO:1904659),-0.32318440234189383,-0.9189835185897484,0.5670498084291188,0.8963029819217716,1.0,5/18,16.88%,SLC2A3;SLC2A5;SLC2A9;SLC2A8;SLC2A6
prerank,positive regulation of ruffle assembly (GO:1900029),-0.36153149759132686,-0.918962167805655,0.541033434650456,0.8945138483913542,1.0,2/13,1.04%,P2RY12;NLGN1
prerank,relaxation of cardiac muscle (GO:0055119),0.4254447125388715,0.918653086759987,0.5829725829725829,0.8480521705540778,1.0,3/13,6.41%,P2RX4;SLC8A1;PIK3CA
prerank,regulation of sensory perception of pain (GO:0051930),0.4322600889286085,0.917848699746223,0.5823170731707317,0.8492437357640183,1.0,1/11,1.78%,MGLL
prerank,sulfur compound catabolic process (GO:0044273),0.345333585948626,0.9178112989416597,0.5847255369928401,0.8489165698853985,1.0,6/38,9.46%,GALNS;GNS;TST;HEXA;LUM;IDUA
prerank,translesion synthesis (GO:0019985),0.34039170015933506,0.9176171966596361,0.6002386634844868,0.8488937698850008,1.0,6/42,9.33%,RFC3;TRIM25;NPLOC4;RPS27A;UBC;POLH
prerank,cellular response to estrogen stimulus (GO:0071391),0.4073840327700725,0.9175940120133054,0.586764705882353,0.8485476874108918,1.0,3/14,11.32%,RARA;NCOA4;BCAS3
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3383349226937842,0.9175655495554585,0.5949214026602176,0.8481941782762913,1.0,5/40,5.78%,VEGFA;CD63;PPT1;RAB21;ANXA2
prerank,heme biosynthetic process (GO:0006783),0.37674252465767394,0.9175535137901764,0.5676429567642957,0.8478153353817188,1.0,10/22,26.94%,FLVCR1;PGRMC1;FECH;COX15;ALAD;SLC25A38;NFE2L1;FXN;UROS;TSPO
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.34843393392502237,0.9174854869066787,0.5877957658779577,0.8475573717906191,1.0,8/33,20.22%,NFE2L2;PDPK1;MAPK7;GAS6;TNFAIP3;TEK;TCF7L2;WFS1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.34913712848629147,0.917416169141491,0.5802005012531328,0.8473040044284451,1.0,11/33,26.56%,FBXW7;ARAP1;ADAM17;AFAP1L2;CBL;NCF1;BCAR3;PLAUR;HIP1;DOK1;HBEGF
prerank,endothelial cell proliferation (GO:0001935),0.3977044598740611,0.9172824489031023,0.6033287101248266,0.8471533930169329,1.0,4/17,9.37%,ERN1;HMOX1;ACVRL1;BMPR2
prerank,pulmonary valve morphogenesis (GO:0003184),0.3982635518551892,0.9171482724499778,0.5796269727403156,0.8470372406567838,1.0,3/17,11.89%,STRA6;NOTCH2;NOTCH1
prerank,fatty acid biosynthetic process (GO:0006633),0.32552378095009393,0.9171475617829885,0.6140939597315436,0.846641468150922,1.0,13/63,17.81%,LIPG;ABCD1;HACD4;ACSM3;GPX4;NDUFAB1;LTA4H;LIAS;ELOVL1;DEGS1;SCD;DECR2;CBR4
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.4147342922498854,0.9170736131519154,0.5740740740740741,0.8463938330342059,1.0,5/14,23.46%,TRAT1;RELA;RAB29;CARD11;BCL10
prerank,regulation of protein binding (GO:0043393),0.30176407252766285,0.9169605119868492,0.6391534391534391,0.8462111077411857,1.0,27/114,18.95%,FLOT1;LRP1;PRKCD;CDKN1A;TFIP11;SORL1;PSME3IP1;STK3;PEX14;BTBD1;CTSZ;DVL1;HIPK2;ROCK1;GSK3B;APP;STYX;PRKN;PPP1CA;SLPI;BAX;IFIT2;CAMK1;AMFR;STK4;GNL3L;PPP2CA
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3048083904583744,0.9167317611042751,0.6389776357827476,0.8462456542418992,1.0,22/107,20.67%,HTR2B;TPCN2;ATP2B1;ATP13A3;SLC8B1;TMEM165;SLC8A1;SLC39A14;MT3;SLC11A1;SLC39A12;SLC10A7;CCL7;SLC30A1;MT1E;MT1F;MT1M;MT1G;MT1B;MT1H;MT1A;MT1X
prerank,negative regulation of dephosphorylation (GO:0035305),0.39052171793929985,0.916432295295216,0.5819209039548022,0.8464513568300033,1.0,3/18,12.27%,ENSA;MFHAS1;GPATCH2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.270078620237644,-0.9159694656683561,0.6082474226804123,0.9006033741105263,1.0,7/33,12.13%,CHRM3;WNK3;KCNJ2;KCNJ3;AKAP9;KCNJ9;WNK1
prerank,sister chromatid segregation (GO:0000819),0.35689179744465804,0.9159136816980935,0.5994993742177722,0.8471171728532984,1.0,5/31,14.94%,NCAPG2;RB1;SMC1A;INO80;LATS1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.3257299370896072,0.9153946335632164,0.6033057851239669,0.8477838122203187,1.0,15/55,18.54%,BCL2L11;FAS;RIPK1;STYXL1;DDIT3;PAK2;DEDD2;BCLAF1;BAX;WWOX;BID;TRAF2;LTBR;BBC3;CRADD
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.44244136605128026,0.9153246312619573,0.6006339144215531,0.847543560633689,1.0,2/10,11.89%,VEGFA;NOTCH1
prerank,mRNA 3'-end processing (GO:0031124),0.3132179676809516,0.9146784677894101,0.6288546255506607,0.8483966126410857,1.0,18/78,16.87%,ALYREF;CPSF1;TENT4B;CHTOP;CSTF3;THOC1;WDR33;TENT2;GRSF1;NCBP2;APP;SRSF3;THOC2;SSU72;DDX39A;CDC73;EIF4A3;DHX38
prerank,kinetochore organization (GO:0051383),-0.34907756868003986,-0.9143335623641183,0.5627118644067797,0.9030106463605154,1.0,7/13,33.21%,CENPA;CENPF;CENPT;NDC80;CENPH;CENPW;NUF2
prerank,positive regulation of isotype switching (GO:0045830),0.39945767996344694,0.9139408732334724,0.5645390070921986,0.8494316854590876,1.0,5/15,20.44%,TFRC;KMT5B;SHLD1;SHLD2;PAXIP1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.37559136783414737,0.9136696204327995,0.5913838120104439,0.84958627838776,1.0,2/25,3.02%,APLNR;PDPK1
prerank,positive regulation of heart contraction (GO:0045823),-0.30489116952284784,-0.9131966880373348,0.5827338129496403,0.9040943410018448,1.0,4/19,8.69%,ATP1A2;RYR2;TRPM4;TGFB2
prerank,carnitine shuttle (GO:0006853),0.440262387864614,0.9129884313526021,0.5931952662721893,0.8505347575160197,1.0,3/11,9.93%,PRKAG2;CPT1A;SLC25A20
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.32584813632023235,0.9129669699367047,0.6111771700356718,0.8501784823782091,1.0,17/49,24.20%,BCL2L11;PPIF;STYXL1;DDIT3;BCLAF1;BAX;MCL1;BID;NDUFS3;SGMS1;BBC3;NOC2L;BCAP31;PLAUR;HERPUD1;NDUFA13;BCL2L1
prerank,apical protein localization (GO:0045176),0.44910890009366117,0.9128126167493563,0.5724852071005917,0.8500837679502964,1.0,5/10,25.33%,ATP8B1;CELSR1;VANGL2;GOPC;ACTB
prerank,photoreceptor cell development (GO:0042461),0.40916166175721996,0.912739137086626,0.5951008645533141,0.84982450959906,1.0,3/14,13.99%,VEGFA;TOPORS;ARL3
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.24379548806284645,-0.9123924114612408,0.6907894736842105,0.9043790104819847,1.0,14/51,14.77%,EVL;PPM1E;LIMCH1;LIMK1;TGFBR1;PAK1;PPM1F;ITGB1BP1;CARMIL1;TESK1;FERMT2;SYNPO2;RHOA;RAPGEF3
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3378620334277218,0.9120694044622241,0.6199756394640682,0.8507835869043521,1.0,18/42,25.93%,ERCC6;ZNHIT1;NASP;CHD3;VPS72;SMARCC1;INO80;PBRM1;SMARCB1;MBD2;DMAP1;SMARCE1;ANP32E;SMARCD2;ACTB;HDAC1;SMARCA1;CECR2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3904070530080884,0.9119887461737805,0.5880681818181818,0.8505520570404994,1.0,7/17,22.96%,GET3;MMGT1;EMC2;EMC4;SGTA;EMC3;EMC10
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3251347021824062,0.9114107795212613,0.5993031358885017,0.851314826667971,1.0,11/53,15.45%,APOE;FBXW7;PSME3IP1;GNA12;RAD23A;PSMF1;PSMD14;TREM2;PRKN;PSME2;PRKCG
prerank,prostaglandin metabolic process (GO:0006693),-0.28483391212204673,-0.9108138212989617,0.6056338028169014,0.9066937741463589,1.0,4/26,7.09%,HPGD;PTGS1;ACOX1;PLA2G4A
prerank,cardiac atrium morphogenesis (GO:0003209),0.3966717546158536,0.910643070318291,0.597457627118644,0.8523993120347503,1.0,3/16,11.89%,NOTCH2;BMPR2;NOTCH1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3527747537084409,0.9099958272365638,0.5760309278350515,0.8532696965363735,1.0,7/29,14.94%,BRCA1;CBFB;ESR1;STRN3;UBA5;VPS11;LATS1
prerank,spinal cord development (GO:0021510),-0.3526827904956644,-0.9094577800246242,0.6136363636363636,0.9083606611091793,1.0,5/12,26.41%,RELN;PKD2;PKD1;SOX11;GLI2
prerank,membrane lipid metabolic process (GO:0006643),0.3693368612748928,0.9094296457134335,0.5743519781718963,0.8539549966562984,1.0,3/22,6.26%,MGST2;CERK;SPHK2
prerank,rRNA catabolic process (GO:0016075),0.3929446960686619,0.9090305747476799,0.573632538569425,0.8543401710706849,1.0,6/16,21.01%,EXOSC3;EXOSC9;EXOSC8;DEDD2;EXOSC10;EXOSC7
prerank,embryonic appendage morphogenesis (GO:0035113),-0.3526974031191399,-0.909028853326761,0.5541795665634675,0.9076567021754313,1.0,3/12,8.69%,PTCH1;MEGF8;TGFB2
prerank,endoderm formation (GO:0001706),0.3507746971491236,0.9085137452105359,0.6084788029925187,0.8549248745742318,1.0,7/35,20.20%,ITGA5;ITGA4;MMP14;COL11A1;LAMA3;COL12A1;ITGAV
prerank,Ras protein signal transduction (GO:0007265),0.29640823633646557,0.9080064564687281,0.6551724137931034,0.8555281551889141,1.0,29/137,15.95%,GRB2;RAP2A;PLK2;SOS1;CDKN1A;JUN;RGL2;MYO9B;GNA13;BRAP;IGF1;NRAS;GNA12;RREB1;RB1;KSR2;ROCK1;RAP2B;RHOD;CFL1;CCNA2;RAPGEF1;RIT1;PHACTR4;RRAS;CELSR1;SHC1;DNMT1;USP8
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4261437517486583,0.9074749026078143,0.6042296072507553,0.856206839796092,1.0,3/12,12.33%,IL6;STAP1;TREM2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.3879573588664489,0.9074121122352725,0.5791610284167794,0.8559346062051869,1.0,2/18,3.06%,LILRB1;CD46
prerank,positive regulation of innate immune response (GO:0045089),0.3497574745607516,0.9073867847822639,0.5838587641866331,0.8555915051405955,1.0,4/30,9.94%,TLR8;ADAM8;UBE2K;MAVS
prerank,negative regulation of cell projection organization (GO:0031345),-0.24339558105714693,-0.907352798872844,0.648854961832061,0.9101050078126404,1.0,12/48,15.74%,RTN4RL1;SPOCK1;DCC;GRIN2B;PTPRO;MAG;SEMA3A;PRNP;STMN2;YWHAH;RAPGEF2;BAG5
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.37257067158364154,0.9071823369690072,0.6099195710455764,0.8555917497572599,1.0,6/23,22.73%,CBLB;CHMP6;CBL;SH3BP5;PTPRC;SOCS4
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.39197953383015915,0.9070551572279161,0.5836680053547524,0.8554465487256969,1.0,4/18,15.15%,CCDC40;CFAP53;SPAG17;OFD1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3407200711530929,0.9069740707617981,0.6071871127633209,0.8551966189193926,1.0,9/37,13.86%,KIF3A;DYNC2I2;DYNLRB1;IFT46;TRIP11;TNPO1;IFT52;IFT140;SSX2IP
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.320233225842656,-0.9065877692673867,0.5807692307692308,0.9103390214945476,1.0,6/18,22.12%,COX16;COX19;COX17;SCO1;COX14;COX18
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.40242676278524564,0.906239817688042,0.5881542699724518,0.8562437616642086,1.0,6/15,22.65%,NPLOC4;FAF2;DERL2;TMEM129;VCP;HERPUD1
prerank,autophagy of peroxisome (GO:0030242),-0.35747944682706145,-0.905450524193963,0.5826086956521739,0.9114285741188434,1.0,3/12,8.34%,ATM;NBR1;RB1CC1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.24411571160216286,-0.9053815934082277,0.6644295302013423,0.9097909930695914,1.0,15/50,20.81%,CD86;NR3C2;PTP4A3;TLR3;EGFR;IFI35;PDCD4;PHB2;LIMS1;RHOA;TLR2;TNF;CD14;TCIM;NOD1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3033638570647728,0.9052307795308802,0.644880174291939,0.8578261496979787,1.0,19/98,17.75%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;E2F1;STAC2;ITGB1;MTCL1;PPP3R1;TREM2;ITGA3;PRKN;SQSTM1;STAC3;BID;BBC3;KIF5B
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.32019429616530104,0.9052210024830287,0.6548974943052391,0.8574512343977584,1.0,21/63,24.90%,PLK2;CDKN1A;WAC;E2F1;GADD45A;CNOT4;GTSE1;CNOT6L;CNOT7;BAX;CNOT6;RPL26;CASP2;CRADD;FBXO31;TNKS1BP1;PRKDC;CDK2;TFDP1;SOX4;CARM1
prerank,tryptophan metabolic process (GO:0006568),0.43124797052226044,0.9048544476582182,0.6051829268292683,0.8577636774803884,1.0,2/11,15.41%,KYNU;ATP7A
prerank,mitochondrial fission (GO:0000266),0.39456431915107326,0.9047506087262998,0.5965909090909091,0.857564139488107,1.0,4/16,13.63%,MTFR1L;MTFP1;GDAP1;PRKN
prerank,negative regulation of organelle assembly (GO:1902116),0.3485244204393542,0.9045278307521395,0.6163522012578616,0.8575924694035254,1.0,8/35,17.73%,MTM1;ODF2L;BRCA1;STYXL1;NBDY;CCP110;TMEM39A;PHF23
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.360730037536449,0.9042987017422307,0.6018518518518519,0.8576402528534105,1.0,6/28,16.20%,ERCC6;TFIP11;PARP3;KMT5B;SIRT7;SHLD1
prerank,myeloid dendritic cell activation (GO:0001773),-0.3508008487568344,-0.9042289488755347,0.5520231213872833,0.9108879598211949,1.0,6/12,30.76%,TGFBR2;PYCARD;BATF3;BATF;CAMK4;BATF2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.4063639521068634,0.904085152401417,0.5843373493975904,0.8576443020323815,1.0,6/13,26.16%,EIF6;NUP88;XPO1;NMD3;NOP9;LSG1
prerank,relaxation of muscle (GO:0090075),0.41941635071937905,0.9038629502773191,0.6028985507246377,0.8576801507572083,1.0,3/13,6.41%,P2RX4;SLC8A1;PIK3CA
prerank,response to retinoic acid (GO:0032526),0.3161038102672553,0.9038137644219674,0.6206115515288788,0.8573715104523925,1.0,9/59,10.36%,AQP1;ABL2;RXRA;RARA;HTRA2;SOX9;CTSH;FZD7;PTK2B
prerank,negative regulation of vascular permeability (GO:0043116),0.41777137016727356,0.9037861799789234,0.5863570391872278,0.8570328026441608,1.0,1/12,1.73%,VEGFA
prerank,ribosome assembly (GO:0042255),0.3295164816728185,0.9037564953824481,0.6392111368909513,0.8566939321269657,1.0,15/47,23.29%,RPL3L;MRPL20;EIF6;RPS14;MRPS7;RPL10;RPSA;C1QBP;PWP2;DHX37;PPAN;RPS27;BOP1;MTERF3;MRPS2
prerank,activation of protein kinase A activity (GO:0034199),0.40162065289887133,0.9029313939350523,0.609375,0.8578506969216126,1.0,6/16,23.07%,ADCY7;PRRC1;ADCY8;ADCY3;ADCY5;ADCY9
prerank,presynapse assembly (GO:0099054),0.3915772456194329,0.9021343854588174,0.6045845272206304,0.858988403221409,1.0,3/16,8.75%,CEL;PTEN;DVL1
prerank,lipid translocation (GO:0034204),0.37819783648320926,0.9020423556986897,0.5937921727395412,0.8587754912111721,1.0,9/21,23.21%,ABCA1;ATP8B4;ATP8B1;RFT1;ABCC1;ATP11C;TMEM30A;ATP9B;ABCA7
prerank,cellular calcium ion homeostasis (GO:0006874),0.2952803028230341,0.9019240596619496,0.6830031282586028,0.8586200258673814,1.0,13/133,9.30%,HTR2B;TPCN2;ATP2B1;ATP13A3;SLC8B1;TMEM165;MICU2;MICU1;SLC8A1;CLN3;CALB1;LETM1;TRPC3
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2982195036925269,0.9012050427175693,0.6839323467230444,0.8595633301183639,1.0,31/124,20.47%,CTNNB1;PSMD1;AGO2;DVL1;PPP3CA;TNRC6B;FZD7;PPP3R1;AGO3;PSMF1;PSMD14;FZD5;PFN1;PSMD12;FZD2;AP2B1;PARD6A;CELSR1;PSME2;DAAM1;VANGL2;CCDC88C;PSMB10;PSMD5;PSMD8;AGO4;PSMA3;PSMA2;PSMD11;TCF7L2;PSMA6
prerank,quinone biosynthetic process (GO:1901663),-0.3315295428808576,-0.9012024194011894,0.5686274509803921,0.9170249131442774,1.0,8/14,23.63%,COQ3;COQ10B;COQ2;COQ9;COQ10A;COQ5;COQ8A;UBIAD1
prerank,endothelial cell differentiation (GO:0045446),0.424728491916174,0.901067179545462,0.6079295154185022,0.8594317548195539,1.0,3/12,9.48%,ACVRL1;BMPR2;FSTL1
prerank,cellular response to leucine starvation (GO:1990253),0.4361121169253891,0.9009630200826249,0.6101694915254238,0.8592421824071951,1.0,2/10,6.97%,SESN2;EIF2AK4
prerank,positive regulation of cell development (GO:0010720),-0.2677283052112409,-0.9009427974370761,0.6464646464646465,0.9158710000372527,1.0,6/31,12.91%,CX3CR1;NUMB;OPRM1;RFX3;NAP1L1;BAD
prerank,cellular response to organic substance (GO:0071310),0.3004672667245218,0.9008404401193781,0.6813417190775681,0.8590721472787113,1.0,16/116,9.37%,CXCR4;CTNNB1;SIGIRR;TIPARP;MAP2K5;PID1;HTRA2;MAPK7;STAT5B;NR1H4;PTPN12;ACVR2A;NCOA3;ACVRL1;NCOA1;BMPR2
prerank,mitotic nuclear division (GO:0140014),0.3125389248880671,0.9006712685242592,0.660377358490566,0.8590207570567766,1.0,21/71,23.75%,NCAPG2;PIBF1;CHMP2A;SMC1A;TOGARAM1;STAG2;CTDP1;CLASP1;CEP192;INO80;SMC3;NDE1;OFD1;CHMP7;ARHGEF10;UBE2S;SGO1;MZT1;FLNA;EPS8;BCCIP
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3334714951750628,0.9006607004703701,0.648235294117647,0.8586471383587441,1.0,3/48,3.02%,APLNR;DIAPH1;PDPK1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3086019413082892,0.9006098706625538,0.6524122807017544,0.8583460218081731,1.0,12/79,12.75%,PPARG;NIBAN2;SORL1;THBS1;SULF2;ACVR2A;HIPK2;BMPR2;RBPMS2;NOTCH1;SULF1;LEMD3
prerank,positive regulation of receptor internalization (GO:0002092),0.3712519721149503,0.9004379499570329,0.6034712950600801,0.8582846626415748,1.0,2/22,3.68%,VEGFA;CD63
prerank,tRNA wobble uridine modification (GO:0002098),0.40506749454579194,0.9003671462304847,0.6082474226804123,0.8580188560556299,1.0,5/14,16.82%,CTU2;ELP1;GTPBP3;ALKBH8;ELP4
prerank,hexose transmembrane transport (GO:0008645),-0.29356276833409345,-0.9001909578657384,0.6680327868852459,0.9159653829515472,1.0,6/21,19.92%,SLC2A3;SLC2A5;SLC2A9;SLC2A8;SLC2A6;SLC45A3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.33948107213677736,-0.9001816954675803,0.567741935483871,0.9141780958289537,1.0,2/14,2.94%,CSF1R;CSF1
prerank,histone H2A acetylation (GO:0043968),0.39208032820317323,0.9001692707045637,0.6036671368124118,0.8580019754708822,1.0,3/16,8.20%,SPHK2;ING3;EPC1
prerank,striated muscle tissue development (GO:0014706),-0.2783431197062151,-0.8999045012804103,0.6243386243386243,0.9129873543903457,1.0,5/29,13.08%,MEF2C;SGCD;SGCZ;ZBTB18;MYH14
prerank,protein complex oligomerization (GO:0051259),0.3064394680993712,0.8990813787582431,0.6579234972677596,0.8597232154639673,1.0,17/85,15.71%,LRRC8D;UGDH;MICU1;NINJ1;MS4A1;WDCP;CHMP2A;RNF135;NLRC4;PDCD6IP;LETM1;LRRC8C;ATL2;ATL1;ADCY8;VSTM5;TWNK
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3428734976604939,0.8990784384397816,0.6339622641509434,0.8593361821419172,1.0,11/35,25.64%,CTNNB1;ACD;RTEL1;XRCC5;TNKS;TNKS2;CCT2;PKIB;NEK7;FBXO4;CCT7
prerank,defense response to tumor cell (GO:0002357),0.43750500981931373,0.8987133585079826,0.5934065934065934,0.8596479666462332,1.0,2/10,8.30%,DAPK1;DLEC1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.35235325925891064,-0.8980054443273138,0.5816618911174785,0.9159495004327722,1.0,7/11,23.25%,TGFBR2;FGFR2;LRP5;STAT1;MYC;CTNNBIP1;WNT5A
prerank,histone H4 acetylation (GO:0043967),0.3284065376802909,0.8978085482264814,0.6322115384615384,0.860977773550786,1.0,12/47,22.41%,KANSL1;ZZZ3;PHF20;ING3;EPC1;ING4;MCRS1;KMT2A;OGT;DMAP1;RUVBL2;KANSL3
prerank,positive regulation of locomotion (GO:0040017),-0.2736172839308195,-0.8976620725322823,0.631336405529954,0.9149790542008237,1.0,4/27,6.43%,P2RY12;CSF1R;AIF1;PPM1F
prerank,miRNA metabolic process (GO:0010586),0.38337391050563063,0.89758374114165,0.6125874125874126,0.8609985865979587,1.0,4/20,12.03%,TENT4B;AGO2;DROSHA;SND1
prerank,negative regulation of protein depolymerization (GO:1901880),0.37030079913225994,0.8975532503057982,0.6190476190476191,0.8606652237580307,1.0,6/24,13.75%,LIMA1;SPEF1;PIK3CA;APC;ARHGEF2;CLASP1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.3713177781198844,-0.8971471120714205,0.5669515669515669,0.9144812357384674,1.0,4/10,13.84%,GABRA2;GABRA3;GABRG3;GABRA4
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3377833530858528,0.8968077399156694,0.6230110159118727,0.8617124660474632,1.0,5/39,11.89%,VEGFA;MAP2K5;MAPK7;NF2;NOTCH1
prerank,neuron projection morphogenesis (GO:0048812),0.29291126083047375,0.8962782661989339,0.7144340602284528,0.8623298364725164,1.0,18/137,10.39%,IQGAP1;SGK1;DTNBP1;CTNNB1;KIF20B;BAIAP2;ALCAM;TAOK3;SLITRK6;PTEN;TNN;DOCK10;EIF2AK4;DVL1;EPB41L3;TNIK;ROCK1;RAB10
prerank,negative regulation of stem cell differentiation (GO:2000737),0.40338491921653197,0.8961808200782403,0.5712074303405573,0.8621271917127082,1.0,3/12,11.89%,HNRNPU;ZFP36L2;NOTCH1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4000522871464054,0.8961249331648449,0.6292466765140325,0.8618492463019232,1.0,3/15,13.63%,CD44;SIRT1;PRKN
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.29847273402190494,-0.8959420404618036,0.6502057613168725,0.9156212860052082,1.0,12/21,32.24%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK;PLK1
prerank,muscle cell migration (GO:0014812),0.4360897921421804,0.895744048115918,0.6179941002949852,0.8621723462533595,1.0,5/10,28.65%,ROCK1;AAMP;CCN3;ITGB3;DDR1
prerank,embryonic organ development (GO:0048568),-0.23350263814707634,-0.8957006836728725,0.7314814814814815,0.9144376116673062,1.0,10/61,8.69%,SALL1;BMPR1A;TGFBR2;KITLG;SH2B3;FGFR2;PBX3;TAL1;GLI3;TGFB2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.4244391946052209,0.8953510468801048,0.6224328593996841,0.8625237266269912,1.0,2/11,10.59%,CD44;SIRT1
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3322091718556982,-0.8943788291349838,0.5813953488372093,0.9159072107117485,1.0,4/14,6.54%,PPP5C;NCK1;PPM1F;PPP2CB
prerank,double-strand break repair (GO:0006302),0.2875202128582735,0.8942941849809125,0.6768603465851172,0.8641291270773438,1.0,42/158,23.57%,EYA1;NSMCE2;SEM1;MCM9;KPNA2;BRIP1;PARP2;BABAM2;PARP3;PIAS4;EME1;BRCA1;XRCC4;XRCC5;XRCC2;KDM2A;POLL;AP5S1;PSMD14;NBN;DCLRE1B;TDP2;WRN;POLA1;INO80;AP5Z1;BRCC3;BAZ1B;RAD21;RMI1;MRE11;PAXIP1;TNKS1BP1;RAD51B;XRCC1;VCP;PRKDC;RNF168;SPIDR;RNF138;PALB2;ERCC4
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.19797845953660145,-0.8941845468258686,0.8113207547169812,0.9146199710309258,1.0,28/129,16.40%,GPC5;SEMA5A;CSNK1E;LGR4;CSNK1G3;FGFR2;JUP;PSMC2;TRPM4;LGR5;CSNK1D;EGFR;PSMD6;CSNK1G2;AMER1;PRDM15;DAPK3;WNK2;WNK1;PSMD7;UBE2B;SCEL;RNF220;PSMB5;DAAM2;HHEX;FGF10;PSMB4
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.39831925042038496,0.8941581447766433,0.5997171145685997,0.8640080255295851,1.0,2/14,4.62%,ANXA1;RARA
prerank,anion transport (GO:0006820),0.3438254958017474,0.8940609329098299,0.64375,0.863806106674604,1.0,4/33,8.81%,LRRC8D;VDAC2;SLC17A5;LRRC8C
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3244892358458314,-0.8939501470925177,0.6061643835616438,0.9133948979663898,1.0,5/15,18.38%,SNAP91;DGKD;TNK2;HIP1R;DAB2
prerank,androgen metabolic process (GO:0008209),0.3785887418370091,0.8937499351609469,0.6204081632653061,0.8640060177576947,1.0,5/18,25.45%,SPP1;HSD17B11;SRD5A1;SRD5A3;HSD17B4
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.31975587781511416,0.893491475818814,0.6436915887850467,0.8640832985524987,1.0,4/51,2.87%,SGK1;DTNBP1;KIF20B;TAOK3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.34426065299296493,-0.8934876612423664,0.6040955631399317,0.9127313096591116,1.0,9/13,36.80%,BMPR1A;TGFBR1;DAB2;SMAD4;TGFB1;BMP4;TGFB3;SH2B1;NUP93
prerank,regulation of feeding behavior (GO:0060259),0.4224339068335844,0.8933900354213498,0.6064,0.8638783498928506,1.0,2/11,6.97%,CFAP20;EIF2AK4
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.38128989550797043,0.8932821326868943,0.6115591397849462,0.8636801239501843,1.0,5/18,17.81%,RAB21;MSN;VPS11;DNAJC13;SNX3
prerank,mitotic cytokinetic process (GO:1902410),0.3781169584666843,0.8932418963140115,0.6124137931034482,0.8633709959783346,1.0,7/20,21.40%,CHMP2A;PDCD6IP;VPS4A;CHMP6;CHMP5;CHMP7;CHMP2B
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3663549501898254,-0.8930214716836434,0.5870206489675516,0.912111704043405,1.0,6/11,22.10%,FBH1;MSH3;DONSON;LIG3;TIMELESS;TIPIN
prerank,cellular copper ion homeostasis (GO:0006878),-0.33190232363622285,-0.8926872676207829,0.6299694189602446,0.9111982517885377,1.0,4/14,12.27%,SLC31A1;COX19;ATOX1;PRNP
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.30988543751908043,0.8925738150056773,0.6580717488789237,0.8642443031259659,1.0,22/65,26.26%,PSMD1;ZFYVE19;VPS4A;PSMF1;PSMD14;PSMD12;CHFR;PSME2;CUL1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;USP47;PSMC5;AVEN;PSMC1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3520039686565963,0.8923451644203159,0.6367088607594936,0.8642961209521115,1.0,11/29,22.89%,STAT5B;SOCS6;IFNAR2;IL15;JAK3;IFNAR1;STAMBP;STAT6;PIAS1;STAT3;JAK2
prerank,positive regulation of chromatin organization (GO:1905269),0.4164417484602246,0.8923439978709702,0.6085672082717873,0.8639092956659006,1.0,2/12,9.16%,ACD;TERF1
prerank,inositol phosphate catabolic process (GO:0071545),0.4165345942776552,0.8922049380624982,0.6127080181543116,0.8637958286717564,1.0,5/12,19.54%,PTEN;OCRL;INPP5A;IMPA2;SYNJ2
prerank,heart contraction (GO:0060047),-0.2524113285970767,-0.8921010545158531,0.68125,0.9109054408958536,1.0,5/41,3.96%,ATP1B1;ATP1A2;SGCD;RYR2;SCN1B
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.38124446132939,0.8920553436225265,0.5983493810178817,0.8636773417049071,1.0,5/19,8.86%,XYLT1;NDST1;EXT1;UGDH;HS2ST1
prerank,mitotic spindle organization (GO:0007052),-0.19615499945112652,-0.8919316047996728,0.7741935483870968,0.9095843391350688,1.0,49/153,20.30%,EML1;BUB3;NUP133;DYNC1I2;DYNLL2;ZW10;NUDC;DCTN2;AHCTF1;GPSM2;AAAS;LSM14A;NUP85;SPAST;RAB11A;CHEK2;SEH1L;ITGB3BP;CENPP;ZWILCH;EML4;KNL1;CENPA;NUP37;KIF18A;MAP9;NDEL1;RHOA;MAPRE1;KIF23;KIF11;PMF1;STMN1;RMDN1;CENPK;TPX2;CENPO;BUB1;DCTN6;PRC1;CENPF;CCDC61;CENPT;DYNC1I1;KIFC2;EFHC2;EFHC1;SEC13;NDC80
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.28933699013244696,0.8917693129308704,0.696652719665272,0.8638442916878151,1.0,19/121,13.37%,NEDD9;VEGFA;TEC;PIBF1;CD44;IL6;HGF;ITGA5;IGF1;IL5;IL6R;PTK2B;PAK2;ARHGEF2;IL15;TREM2;HCLS1;DGKQ;GAS6
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4238527990070937,0.8914983755290244,0.5972434915773354,0.863948746892658,1.0,2/10,11.13%,HIPK2;ING4
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3411520772232265,0.8913310150931382,0.6219974715549936,0.8638768557665536,1.0,8/32,18.91%,ID2;BACH1;E2F1;RB1;POLA1;ORC1;CDT1;FBXO5
prerank,spermatid development (GO:0007286),-0.2747179132899129,-0.8910764280325266,0.6280193236714976,0.9098950907065001,1.0,11/32,26.87%,JAM2;RNF8;CEP57;IQCG;TDRD5;ZMYND15;NME5;CIB1;RFX2;MKKS;SYCP3
prerank,cation transport (GO:0006812),0.28908958375666965,0.8904206229877369,0.7112244897959183,0.8652395122711988,1.0,15/167,8.00%,SGK1;SLC6A6;SLC36A2;SLC36A4;AQP1;ANO6;SLC11A2;SLC8B1;SLC8A1;TAF7;CLN3;SLC5A5;SLC12A3;SLC38A7;NEDD4L
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.40129721826174786,0.8903893268598017,0.6091445427728613,0.8649185294312104,1.0,6/13,20.34%,IGF1;IRS2;DYRK2;EPM2AIP1;PHKG2;GCK
prerank,response to iron ion (GO:0010039),0.4155872817107982,0.890223592005442,0.6321167883211679,0.8648300441716559,1.0,1/12,2.49%,SLC11A2
prerank,hepaticobiliary system development (GO:0061008),0.36958504303694106,0.8899799235309123,0.6206896551724138,0.864887864097345,1.0,3/20,9.12%,CITED2;NIPBL;ARID5B
prerank,positive regulation of cell cycle process (GO:0090068),0.30011355455901356,0.8898457606368116,0.6840390879478827,0.8647563203114778,1.0,15/91,16.08%,MAP3K20;KIF20B;CD28;DYNC1H1;IGF1;PCID2;CUL3;SVIL;TPR;PKN2;DBF4;NPM2;PHIP;INO80;RANBP1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3047610104090144,-0.889751113446705,0.6139705882352942,0.9112899438507117,1.0,5/19,11.95%,GMPR2;PNP;AMPD2;DCK;GMPR
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.39099498050213377,0.8895156496503815,0.6256906077348067,0.8649857239164617,1.0,2/15,9.43%,ANAPC1;TPR
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4149602379794559,0.8894587578528721,0.6146131805157593,0.8646980272000777,1.0,5/12,25.46%,PTEN;UBE2S;CDC14B;RAB1A;FZR1
prerank,regulation of bone mineralization (GO:0030500),0.3226757678878334,0.889354163509058,0.6685779816513762,0.8645116044834219,1.0,10/55,10.92%,ANO6;ATP2B1;ENPP1;SLC8A1;SGMS2;ACVR2A;PKDCC;BMPR2;PTK2B;CCN1
prerank,response to leucine (GO:0043201),-0.3614870600433746,-0.8891341090973574,0.5850144092219021,0.9091533853375405,1.0,2/10,2.76%,RPTOR;SESN3
prerank,cellular response to leucine (GO:0071233),-0.3614870600433746,-0.8891341090973574,0.5850144092219021,0.9091533853375405,1.0,2/10,2.76%,RPTOR;SESN3
prerank,neural tube closure (GO:0001843),0.338094370878946,0.8889064006838645,0.652605459057072,0.8649584968876195,1.0,13/34,26.43%,FOLR1;DLC1;DVL1;MTHFD1L;PHACTR4;CELSR1;LRP6;VANGL2;LRP2;BCL10;PLXNB2;SKI;KDM2B
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3380984380835444,0.888888162563294,0.6321695760598504,0.8645985153762592,1.0,16/33,27.62%,ACD;RTEL1;TERF1;DKC1;DCLRE1B;PPP6C;STN1;SHQ1;MRE11;TNKS1BP1;CDK2;TERF2IP;PPP6R3;TINF2;WRAP53;RFC1
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.323204360475124,0.8888616933739014,0.6378896882494005,0.8642578296236159,1.0,12/41,25.45%,MGLL;ABCD1;GPX4;ELOVL1;DEGS1;SCD;DECR2;SCP2;ACOT8;EPHX1;GPX1;HSD17B4
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3493666841074577,-0.8886940826347534,0.615606936416185,0.9085058531911837,1.0,6/11,31.82%,MEF2C;SOX6;TGFB1;GREM1;BMP2;EFNB2
prerank,determination of heart left/right asymmetry (GO:0061371),0.33059017143179426,0.8885123852343197,0.6548463356973995,0.8645663968897018,1.0,6/42,12.41%,APLNR;CCDC40;FOLR1;NOTCH1;TBX6;MICAL2
prerank,histone mRNA catabolic process (GO:0071044),-0.3248179458434064,-0.8884981430514637,0.596875,0.9072959737057927,1.0,6/15,13.12%,ATM;TUT4;SSB;MTPAP;LSM1;XRN1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.31644996115918866,0.8882496288732478,0.6567164179104478,0.8646541535427826,1.0,7/57,7.94%,TAOK3;CDKN1A;WAC;MUS81;BABAM2;EME1;BRCA1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.4316466796877585,0.8881399405669563,0.6268882175226587,0.8644885852634377,1.0,2/10,8.03%,SORL1;RB1
prerank,activation of adenylate cyclase activity (GO:0007190),0.3342512717363371,0.8881289864125678,0.6355828220858896,0.8641222294995229,1.0,6/35,14.57%,EDNRA;RAF1;ADCY7;CAP1;ADCY8;ADCY3
prerank,microtubule bundle formation (GO:0001578),0.32615919779800506,0.887803418895976,0.633495145631068,0.8643605860729497,1.0,8/42,13.75%,SPEF1;CCDC40;NCKAP5L;MTCL1;CCDC66;TOGARAM1;GAS2L1;CLASP1
prerank,erythrocyte development (GO:0048821),-0.37803478795690415,-0.8874909126316515,0.6325966850828729,0.9080527638327316,1.0,5/10,26.57%,SH2B3;ABCB10;ALAS2;MED1;ALAS1
prerank,polarized epithelial cell differentiation (GO:0030859),0.4074384357410104,0.887098948713685,0.623718887262079,0.8653403726654296,1.0,4/13,16.64%,RAP2A;MSN;RAB10;MYO9A
prerank,calcium-mediated signaling (GO:0019722),0.29711737641508157,0.8870070210996501,0.6641711229946524,0.8651139018689257,1.0,10/93,9.32%,HTR2B;TPCN2;CXCR4;PDPK1;P2RX4;XCR1;SLC8A1;PPP1R9B;KSR2;PPP3CA
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.3592664844375927,-0.8869647248295373,0.5922619047619048,0.9076103799243912,1.0,6/11,16.99%,IP6K2;PPIP5K1;FGF2;ITPKC;PPIP5K2;IP6K1
prerank,cellular biogenic amine metabolic process (GO:0006576),0.41316364950308226,0.886544716468552,0.6214953271028038,0.8656180086003347,1.0,4/12,15.41%,MAOA;TRH;OAZ2;ATP7A
prerank,glycolytic process (GO:0006096),0.35636485774442245,0.8864907816070006,0.6409921671018277,0.865340918308905,1.0,9/28,23.94%,HK3;TPI1;ENO3;PGM1;GAPDHS;PFKM;GCK;PKM;HK1
prerank,positive regulation of protein acetylation (GO:1901985),-0.3570669158753167,-0.8858968594597295,0.5994152046783626,0.9084025041288348,1.0,5/12,25.92%,PRKAA2;DIP2B;RAPGEF3;DIP2A;DDX3X
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.28899826481580293,-0.8858688369134361,0.6273764258555133,0.9067491367859349,1.0,6/23,14.15%,PTCH1;MEGF8;RACK1;GLI3;BTRC;ULK3
prerank,camera-type eye morphogenesis (GO:0048593),0.4280826992302471,0.8858420039608714,0.6389728096676737,0.8661466817176814,1.0,1/10,1.73%,VEGFA
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.30051566941590147,0.8856773991651108,0.7050053248136315,0.8660676082769052,1.0,7/88,5.15%,APOE;SAMD4A;RIC1;DAPK1;DDX6;IGF2BP3;CLN3
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.3515775200640061,-0.8855736258919762,0.6443148688046647,0.905817742163668,1.0,4/11,23.01%,HSP90AA1;QDPR;DHFR;SPR
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2899137821363209,0.8853974578249705,0.7073921971252567,0.8661791581559619,1.0,39/148,21.90%,SGK1;PRKAG2;PDPK1;RFC3;PHF20;BRIP1;TAF7;RPL23;TAF5;BRCA1;HIPK1;CHD3;BRD7;CSNK2A2;HIPK2;NBN;WRN;RNF34;DYRK2;RBBP7;PAK1IP1;SMYD2;MAPKAP1;BRPF1;PIP4K2A;TAF15;CSNK2A1;TTC5;PPP2R5C;NOC2L;CCNG1;RMI1;PPP1R13L;TOP3A;MRE11;RICTOR;EHMT2;TAF1;USP2
prerank,positive regulation of axon extension (GO:0045773),0.3603039741027114,0.8850145042706251,0.6193633952254642,0.866531683658751,1.0,10/22,21.76%,VEGFA;RUFY3;ZFYVE27;DSCAM;MACF1;GOLGA4;NRP1;SHTN1;CDKL5;NTN1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3635354176329223,0.8845022706425355,0.6069057104913679,0.8671064680043056,1.0,5/22,12.34%,GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,regulation of axon guidance (GO:1902667),0.4289509349136542,0.8844428207329013,0.5948012232415902,0.8668331325457244,1.0,3/10,18.10%,VEGFA;NRP1;MYCBP2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3310915215179231,0.8842147386656602,0.6578631452581032,0.8668687925110097,1.0,9/43,10.92%,IFITM1;RUNX2;IL6;HGF;IGF1;ACVR2A;BMPR2;IL6R;CCN1
prerank,cardiac muscle contraction (GO:0060048),-0.2646848816109464,-0.8841496172409691,0.6770833333333334,0.9074321737735894,1.0,4/34,3.96%,ATP1B1;ATP1A2;RYR2;SCN1B
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.32256464793818274,-0.8838926666666587,0.6041666666666666,0.906320543041803,1.0,7/15,15.96%,CSNK1E;TIAM1;CSNK1D;RNF213;RSPO3;DAAM2;WNT5B
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3051698186369677,0.8837028342007215,0.6611661166116611,0.8674330148179941,1.0,6/75,5.58%,PPARG;CTNNB1;KLK3;NIBAN2;FOXO4;THBS1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2847821711844971,0.8836741007048605,0.7410805300713558,0.8670951738606639,1.0,48/184,21.49%,ID2;DYNC1H1;PSMD1;APPL2;HAUS6;E2F1;ANAPC1;CUL3;RPS27A;UBC;ZFP36L2;PPP1R9B;DDB1;PSMF1;PSMD14;CEP76;PSMD12;APPL1;NPM2;CLASP1;CEP192;TUBA1A;PSME2;CUL1;INO80;NDE1;ALMS1;OFD1;ANAPC10;CCP110;SSNA1;HAUS7;PSMB10;PSMD5;PSMD8;PSMA3;PAFAH1B1;FBXO5;UBE2S;PSMA2;ANAPC15;PSMD11;CDC14B;PPP2R1A;PSMA6;HAUS5;CEP41;XPC
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3443077538563769,0.883248687751302,0.6060991105463787,0.8674725048081022,1.0,5/29,12.13%,NR1H3;PLA2G2D;PLA2G4F;PLAAT3;LPCAT3
prerank,positive regulation of response to stimulus (GO:0048584),0.3286451975256031,0.8827007626676918,0.6539877300613497,0.868122388080599,1.0,8/40,15.00%,IER5;PRKCD;ARG2;MAVS;SIRT1;IL15;BCLAF1;NSMCE4A
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4087777754167402,0.8817126935047119,0.6227544910179641,0.8695890766045036,1.0,4/12,17.18%,TCERG1;HNRNPU;LARP7;NELFE
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.32894181801040495,-0.8805480430434902,0.6301369863013698,0.9126577788014245,1.0,5/15,11.83%,SEMA5A;FGF2;PRKD1;TMSB4X;PRKD2
prerank,striated muscle contraction (GO:0006941),-0.2387068890520726,-0.8803010093909723,0.6764705882352942,0.9115905639576671,1.0,6/53,4.91%,ATP1B1;DTNA;ATP1A2;RYR2;SCN1B;RCSD1
prerank,cardiolipin metabolic process (GO:0032048),0.3942274764164682,0.8795013372247488,0.6095791001451378,0.8732292101599819,1.0,3/13,9.50%,HADHA;SLC27A1;TAMM41
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.33298195306928624,0.8790919259339243,0.6515892420537898,0.8735839100623188,1.0,10/39,17.41%,GCNT2;CORO1C;THBS1;NF2;FZD7;FBLN1;NOTCH1;CX3CL1;MELTF;ACER2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.3267786906048049,0.8786859879165616,0.680672268907563,0.8739630174202818,1.0,6/45,8.43%,CD44;PRKCD;IFNGR2;TRIM25;PTAFR;IRF2
prerank,eye morphogenesis (GO:0048592),0.37285364373618823,0.8779874544186586,0.6273972602739726,0.8748877263213459,1.0,3/19,9.58%,VEGFA;NIPBL;COL5A2
prerank,lymphocyte migration (GO:0072676),0.3362423906529892,0.8775272567014344,0.6579275905118602,0.8753564873788959,1.0,6/32,19.46%,ADAM8;CKLF;MSN;CX3CL1;CCL7;CCL25
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2986928632969867,0.8771947639112457,0.7033805888767721,0.8755719946201391,1.0,26/85,22.14%,FBXW7;RNF19A;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;TREM2;PRKN;HSPA1A;HECTD1;KEAP1;BBS7;ATXN3;DDA1;RNF19B;PIAS1;CEBPA;TAF1;HSPBP1;VCP
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3474162316100253,0.8771118988630597,0.648124191461837,0.8749490393933673,1.0,8/29,23.87%,BAAT;ACSM3;GLYAT;ACOT9;ACOT2;ACOT6;ACOT13;ACOT8
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3474162316100253,0.8771118988630597,0.648124191461837,0.8749490393933673,1.0,8/29,23.87%,BAAT;ACSM3;GLYAT;ACOT9;ACOT2;ACOT6;ACOT13;ACOT8
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3229343378110671,0.8770789844253644,0.6631578947368421,0.874621537654832,1.0,9/45,14.84%,GCNT2;FOXO3;ATXN2;PUM3;MTPN;APP;PUM2;SPOUT1;RPL10
prerank,regulation of microtubule-based movement (GO:0060632),0.40928128566877864,0.8769294039371184,0.6269592476489029,0.8745175067085131,1.0,1/11,1.57%,LAMP1
prerank,nuclear export (GO:0051168),-0.2172111007552838,-0.8764926813900266,0.8023255813953488,0.9188830225009281,1.0,35/80,26.24%,SLU7;SRSF6;SMURF1;SRSF5;WASHC4;RBM8A;NUP214;ZC3H11A;THOC5;STRADB;POM121;SRSF11;NUP155;RAE1;PKD1;DDX39B;NUP153;SRRM1;U2AF1;RANBP17;MAGOH;SRSF1;MAGOHB;STRADA;SRSF9;CCHCR1;THOC6;SRSF4;XPO6;EIF4E;PHAX;UPF3B;TGFB1;POLDIP3;XPO4
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3244766132038815,0.8764664062450218,0.66,0.8749413922695829,1.0,15/41,22.97%,PRKAG2;EIF6;SCARB2;TPR;NUP50;NUP98;ZBTB7A;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,ribosomal large subunit assembly (GO:0000027),0.358449225067101,0.8763715060167515,0.6596858638743456,0.8747333440704379,1.0,2/24,3.30%,RPL3L;MRPL20
prerank,regulation of T cell migration (GO:2000404),-0.3048850042883391,-0.8762549698309711,0.6594982078853047,0.917738411763063,1.0,6/18,14.48%,DOCK8;RIPOR2;AIF1;CD200;PYCARD;RHOA
prerank,leukotriene metabolic process (GO:0006691),0.37190712199440545,0.8757490056852736,0.6231493943472409,0.8754863014094777,1.0,4/19,21.50%,MGST2;LTA4H;ABCC1;DPEP2
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.28282117818373514,-0.8756213271829999,0.6751054852320675,0.915783043695053,1.0,7/23,13.58%,TFDP2;BCL2;PPP1R13B;NMT1;BAD;YWHAG;YWHAH
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.28282117818373514,-0.8756213271829999,0.6751054852320675,0.915783043695053,1.0,7/23,13.58%,TFDP2;BCL2;PPP1R13B;NMT1;BAD;YWHAG;YWHAH
prerank,limb morphogenesis (GO:0035108),0.37235660108065244,0.8755910642468988,0.6435643564356436,0.8753697711969779,1.0,3/20,6.98%,TFAP2B;MBNL1;NIPBL
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.39820199080358554,0.875473924989903,0.6317365269461078,0.8751832130069955,1.0,5/13,19.87%,GLRX3;CIAO2B;CIAO2A;GLRX5;YAE1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.2025655295613118,-0.8754112624728422,0.9310344827586207,0.9145580121600044,1.0,38/125,20.59%,EML1;BUB3;NUP133;DYNC1I2;DYNLL2;ZW10;NUDC;DCTN2;AHCTF1;GPSM2;NUP85;SEH1L;ITGB3BP;CENPP;ZWILCH;EML4;KNL1;CENPA;NUP37;KIF18A;NDEL1;MAPRE1;KIF11;PMF1;STMN1;RMDN1;CENPK;CENPO;BUB1;DCTN6;CENPF;CENPT;DYNC1I1;EFHC2;EFHC1;SEC13;NDC80;NUSAP1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.402141025674277,0.875258166214936,0.6356821589205397,0.8751952841975534,1.0,5/12,25.45%,ABCD1;ELOVL1;SCP2;ACOT8;HSD17B4
prerank,in utero embryonic development (GO:0001701),0.3482534753422882,0.8746093720615085,0.6498002663115846,0.8759803787374163,1.0,7/25,21.31%,VEGFA;MBNL1;FLCN;CHD7;FUT8;SOX8;ADAM10
prerank,sterol biosynthetic process (GO:0016126),0.34441744091618104,0.874172989712667,0.6392811296534018,0.8763836644950846,1.0,10/33,20.51%,PRKAG2;MVD;PLPP6;IDI1;INSIG2;PMVK;ACAA2;SC5D;HMGCR;ARV1
prerank,mitochondrial transcription (GO:0006390),0.42851421046190374,0.8734091718411147,0.625,0.8774221150553712,1.0,4/10,17.37%,FOXO3;POLRMT;TWNK;TFB2M
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3365429965288918,0.8733508962716117,0.639030612244898,0.8771478203655975,1.0,12/29,26.15%,DCAF13;RPS14;HELB;NOP14;RPS21;PWP2;NGDN;DHX37;ABT1;RRP36;NOP9;RPP40
prerank,regulation of ATP biosynthetic process (GO:2001169),0.37909364231647497,0.8733119619674937,0.6367461430575035,0.8768315273709066,1.0,4/16,12.33%,PID1;SPHK2;FLCN;TREM2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.34323975493611325,-0.8731478376110221,0.6080691642651297,0.9179516826861062,1.0,3/12,13.30%,TMEFF2;SELENOS;AR
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.29132188856313057,-0.8731185763042402,0.6433823529411765,0.9163090725798868,1.0,9/21,22.62%,CHST11;CSGALNACT1;CHST7;CHST9;CHSY1;BCAN;CSPG4;NCAN;CHST12
prerank,stem cell differentiation (GO:0048863),0.32420831682382256,0.8729289044220208,0.6537997587454765,0.8771597277615085,1.0,3/39,4.86%,HTR2B;FBXL17;FOXO4
prerank,platelet aggregation (GO:0070527),0.334648649786705,0.8725990613175294,0.6637055837563451,0.8773773677962957,1.0,15/33,25.45%,ACTN1;TLN1;RAP2B;STXBP3;MYH9;CLIC1;FIBP;PIK3CB;ACTG1;ILK;FLNA;PPIA;MYL12A;ACTB;ITGB3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.4015394085110892,0.872219012937003,0.632375189107413,0.8776900709301706,1.0,3/12,17.36%,CD44;SIRT1;RPL26
prerank,regulation of cell-substrate adhesion (GO:0010810),0.32399914073526737,0.8722102006106874,0.6643192488262911,0.8773237690193441,1.0,10/42,19.38%,GCNT2;CORO1C;FZD7;NOTCH1;VIT;CX3CL1;BST1;RSU1;PIK3CB;ATXN3
prerank,negative regulation of cell growth (GO:0030308),0.2917530584984161,0.8721934615364486,0.7277486910994765,0.8769704784322467,1.0,22/121,13.94%,CDKN1A;PPT1;ENPP1;MYL2;SESN2;OSGIN1;APBB2;SPHK2;FLCN;HSPA1B;RB1;PPP1R9B;ACVRL1;BMPR2;NAIF1;SIRT1;MT3;DCUN1D3;BST2;ACVR1B;RBBP7;HSPA1A
prerank,N-terminal protein amino acid modification (GO:0031365),-0.33380877362246786,-0.8721538712245804,0.6357615894039735,0.9168117284682374,1.0,5/14,15.58%,NAA35;METAP2;NTMT1;NAA60;NAA16
prerank,embryonic skeletal system development (GO:0048706),0.32900309480945683,0.8720547855226186,0.6608910891089109,0.8768267819907105,1.0,5/35,12.65%,XYLT1;COL1A1;SULF2;HOXA3;SULF1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3316434590009259,-0.8719452831535451,0.6114285714285714,0.9156102135801015,1.0,8/13,31.29%,TOX;CLPTM1;TESPA1;GLI2;FOXJ1;CAMK4;BMP4;ZC3H8
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.33518071520020626,-0.8711583720721031,0.6149068322981367,0.9157259767047188,1.0,5/13,15.79%,GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,histone H3-K4 methylation (GO:0051568),0.3478538273112236,0.8709485339778549,0.653997378768021,0.8784006686572337,1.0,10/26,26.71%,CXXC1;TET3;TET2;KMT2A;PAXIP1;OGT;MEN1;KMT2D;SETD1B;KMT2C
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3362196084430593,0.8709469541455311,0.6654040404040404,0.8780193095366682,1.0,10/32,25.64%,CTNNB1;ACD;XRCC5;TNKS;TNKS2;CCT2;PKIB;NEK7;FBXO4;CCT7
prerank,divalent inorganic cation homeostasis (GO:0072507),0.35417163992870254,0.8708687499973394,0.6534017971758665,0.8777758143177705,1.0,5/25,13.63%,TFAP2B;SLC8A1;MT3;TRPM7;PRKN
prerank,acylglycerol biosynthetic process (GO:0046463),0.3614077172021355,0.8705761267786659,0.631578947368421,0.8779169033878803,1.0,2/23,1.54%,LPIN3;GPAT2
prerank,protein-DNA complex assembly (GO:0065004),0.2880897310499313,0.8704313842174745,0.7247608926673751,0.8777957071975703,1.0,31/116,23.26%,PSMD1;GTF2H5;RPS27A;UBC;ANP32B;SOX9;BRD2;DDB1;CDK7;PSMF1;PSMD14;PSMD12;CUL4A;PSME2;ORC1;MNAT1;ORC4;CDT1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;TCF4;PSMA6;CUL4B;XPC;PSMB3;PSME3;KAT6B
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3430272616701913,0.8704054321429526,0.6692307692307692,0.8774563954695349,1.0,8/30,18.55%,GTF2H5;POLR2L;TAF1B;POLR1A;CDK7;MNAT1;TTF1;TAF1A
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3324885443407997,0.8701273978050106,0.6621951219512195,0.87757937479306,1.0,11/36,21.81%,SDCBP;WAC;PSME3IP1;PSMF1;N4BP1;PRKCG;EIF3H;ALAD;TLK2;OGT;GIPC1
prerank,homeostasis of number of cells (GO:0048872),-0.3314419600121369,-0.8699945159064452,0.643312101910828,0.9168200789969059,1.0,1/12,0.09%,CX3CR1
prerank,B cell activation involved in immune response (GO:0002312),-0.3288615038175545,-0.8699113919780844,0.6292834890965732,0.9153576531681148,1.0,2/13,5.04%,GPR183;RNF8
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.37615144074575974,0.8696865744257252,0.6359832635983264,0.8779961139504043,1.0,4/15,14.52%,RENBP;NAGK;OGA;GNPDA1
prerank,pancreas development (GO:0031016),0.4028995544980383,0.8684928572909728,0.6431718061674009,0.8797061129204272,1.0,3/12,23.77%,CCDC40;TCF7L2;NPHP3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3130088527705887,0.8684437646640857,0.7013888888888888,0.8794175239678417,1.0,13/54,18.54%,PLK2;CDKN1A;E2F1;GADD45A;CNOT4;GTSE1;CNOT6L;CNOT7;BAX;CNOT6;RPL26;CASP2;CRADD
prerank,histone ubiquitination (GO:0016574),-0.2859682535517541,-0.8682703470655234,0.6863468634686347,0.9173682725063118,1.0,7/21,15.58%,RNF8;PHC1;RNF20;PAF1;UBE2B;ATXN7L3;UBE2N
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.30520219303685564,0.8679545141870361,0.6762342135476463,0.8799298390658995,1.0,10/57,13.76%,VEGFA;PIBF1;IL6;IGF1;NF2;IL6R;CNOT7;IL15;HCLS1;INPP5F
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.35682204025318504,0.8677377533906802,0.6630581867388363,0.8799365609529676,1.0,1/24,0.14%,HTR2B
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3174990814588192,-0.8676307624170713,0.6765676567656765,0.9171257254147422,1.0,8/15,27.27%,ZC3H12B;DICER1;RPP30;NUDT16;ZC3H12C;NYNRIN;KHNYN;POP7
prerank,positive regulation of protein binding (GO:0032092),0.3065659155286532,0.8672422018674658,0.6875,0.8804450489945065,1.0,16/56,23.93%,APOE;FLOT1;LRP1;STK3;HIPK2;GSK3B;APP;PRKN;AMFR;STK4;PPP2CA;TCF7L2;TAF1;FKBP1A;NMD3;MEN1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.39097616828523674,0.8669267623544215,0.6494992846924177,0.8806230766600863,1.0,3/13,10.86%,RENBP;NAGK;OGA
prerank,histone modification (GO:0016570),0.2880072809946427,0.8668288371849213,0.7510593220338984,0.8804134725622939,1.0,33/109,25.77%,EYA1;RCOR1;PRKCD;PHF20;PARP2;NSD3;CREBBP;INCENP;HUWE1;TBL1XR1;SIRT1;CCNA2;MT3;SIRT7;USP21;USP16;USP36;PHF20L1;BAZ1B;SGF29;SIN3A;USP3;EHMT2;KAT2A;RUVBL2;KAT6B;CDK2;ATXN7;MIDEAS;CARM1;KAT6A;HDAC1;RCOR3
prerank,negative regulation of cell division (GO:0051782),0.415633716073543,0.8664764343244487,0.6251968503937008,0.8806714292458527,1.0,2/11,9.77%,ZFYVE19;VPS4A
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.330114856330237,0.8664421473368538,0.67375,0.8803401348248862,1.0,9/33,20.04%,KLK3;KDM4C;DDX5;CBFB;ESR1;UBA5;LATS1;NCOA2;UFSP2
prerank,renal system development (GO:0072001),0.3128983824267738,0.8660194907000521,0.6715741789354474,0.8806985737638953,1.0,12/52,21.04%,STRA6;VEGFA;TFAP2B;SULF2;PAX8;SULF1;ARL3;ITGA8;ACE;IFT88;WFS1;C1GALT1
prerank,regulation of cellular response to heat (GO:1900034),-0.21455707098955737,-0.8660024778804818,0.7857142857142857,0.9191112197274466,1.0,27/77,22.35%,RPTOR;MAPT;ATM;NUP133;CD34;HSP90AA1;HIKESHI;ATR;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;CAMK2A;NUP37;NUP155;RAE1;NUP153;BAG5;CRYAB;RPA3;MLST8;SEC13;DNAJB1;HSF1;RPA1
prerank,calcium ion import (GO:0070509),0.3459147908081129,0.8658933210927252,0.6632390745501285,0.8805450085332989,1.0,4/28,5.19%,MICU2;MICU1;SLC8A1;MS4A1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2785516470530365,0.8658278816246768,0.7548321464903357,0.8802829066517651,1.0,50/186,23.89%,APOE;LRP1;PSMD1;ZNRF3;CUL3;STK3;APC;SOX9;MCC;SNAI2;DVL1;DDIT3;GSK3B;PSMF1;PSMD14;PSMD12;APCDD1;SOX2;LIMD1;PRKN;PSME2;LRP6;KREMEN1;LATS1;WWOX;CCDC88C;MLLT3;PSMB10;PSMD5;PTPRU;PSMD8;AMFR;STK4;PSMA3;RNF43;PSMA2;PSMD11;WWTR1;TCF7L2;PSMA6;TLE3;PSMB3;RUVBL2;SDHAF2;KLHL12;SIAH2;PSME3;NPHP3;BICC1;HMGXB4
prerank,cell chemotaxis (GO:0060326),0.3026422223820573,0.8655661209270809,0.6939953810623557,0.8803446578186002,1.0,5/60,3.93%,CXCR4;VEGFA;HGF;PRKCD;XCR1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.4123952142646855,0.8649761973975489,0.6446043165467625,0.8810066629163038,1.0,2/12,6.92%,PHGDH;SEPHS2
prerank,protein-DNA complex disassembly (GO:0032986),0.37699023867634973,0.864781070014544,0.6488340192043895,0.8809581716973887,1.0,7/16,25.08%,RPL23;SMARCC1;ARID2;SMARCD1;SMARCB1;SMARCE1;SMARCD2
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.28276867220943736,-0.8639837368812479,0.6802973977695167,0.9219751919483904,1.0,10/21,24.66%,NAV3;HDGFL3;FGF13;STMN2;MID1IP1;TPX2;TTBK2;CAMSAP1;CIB1;KATNB1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.30547010621448073,0.863925127519586,0.6811926605504587,0.8821101909095385,1.0,19/55,26.26%,PSMD1;PSMF1;PSMD14;PSMD12;PSME2;CUL1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;USP47;PSMC5;AVEN;PSMC1
prerank,cellular response to virus (GO:0098586),-0.25921187030809184,-0.8637508645002773,0.7009345794392523,0.9207930498606387,1.0,12/30,25.92%,POU2F2;HSP90AA1;IRGM;FMR1;GSDME;IFIH1;RRP1B;CHUK;CCL5;GBF1;LGALS9;DDX3X
prerank,neuron apoptotic process (GO:0051402),-0.29836665874526824,-0.8636220564782504,0.652014652014652,0.919389319491566,1.0,6/19,12.21%,SIAH1;SCN2A;CIT;BCL2;ATN1;ERBB3
prerank,histone H3-K36 demethylation (GO:0070544),0.42007808296069016,0.8634623606270003,0.6533742331288344,0.8825478726806197,1.0,4/10,16.92%,KDM4C;KDM2A;KDM7A;RIOX2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.34823660565985703,0.8634600754598246,0.664,0.8821695827548054,1.0,5/27,10.59%,CD44;DDX5;DYRK1A;SNAI2;SIRT1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.32738916132971546,0.8633906652146963,0.6766541822721598,0.8819062290190991,1.0,5/35,11.06%,RFC3;MUTYH;NEIL1;POLL;MBD4
prerank,fatty acid oxidation (GO:0019395),0.3087212969767611,0.8632891728878865,0.6939704209328783,0.8817164925676026,1.0,18/57,25.81%,ABCD1;HADHA;MTLN;ACADL;ACADVL;PPARD;ALDH3A2;ECHDC1;EHHADH;ACAA2;ACAD10;SLC25A17;ADIPOR1;SCP2;ADIPOR2;ABCD2;HSD17B4;CPT2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3226386544836049,0.8632735756985874,0.6438356164383562,0.8813672351136481,1.0,12/35,22.89%,IL6;IL10RB;DOT1L;NF2;NOTCH1;JAK3;PIGU;BCL3;HES5;PTPRC;ADIPOR1;JAK2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.31624752296769504,-0.8630383544298912,0.6381578947368421,0.9190664037667139,1.0,4/15,11.45%,WHRN;ADGRV1;TMEM120A;HPN
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3908002438176076,0.8622565198943494,0.672463768115942,0.8827548347214139,1.0,3/15,15.74%,IL6;APPL1;MYD88
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.3511437194013633,0.8622033711109186,0.6679790026246719,0.8824617408000379,1.0,5/23,20.34%,NCOR1;SIK1;PGP;CRY1;GCK
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.40176672219407517,0.8612227415167698,0.6289592760180995,0.8834400411076817,1.0,4/11,18.82%,DKC1;LARP7;MEPCE;CCT2
prerank,regulation of protein localization to Cajal body (GO:1904869),0.40176672219407517,0.8612227415167698,0.6289592760180995,0.8834400411076817,1.0,4/11,18.82%,DKC1;LARP7;MEPCE;CCT2
prerank,regulation of lipase activity (GO:0060191),-0.3247345862062178,-0.8609140295155175,0.6529411764705882,0.9223872424368644,1.0,4/13,28.15%,RHOA;ANGPTL3;PCSK5;LPL
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.29654966980002795,0.8607366768910775,0.685290763968073,0.8839071324013279,1.0,20/70,22.88%,LMO1;PSMD1;CBFB;PSMF1;PSMD14;PSMD12;PSME2;TCF12;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;KMT2A;OSM;PSMD11;PSMA6;PSMB3;PRKDC;PSME3
prerank,regulation of T cell differentiation (GO:0045580),0.33142293643497334,0.8606527442415806,0.6708701134930644,0.8836961364977097,1.0,3/33,8.74%,ZMIZ1;FOXP3;CBFB
prerank,ion transport (GO:0006811),0.28715425630515123,0.860372602456374,0.7510638297872341,0.8838055114035307,1.0,11/111,6.03%,SLC26A11;SLC36A2;ANO6;SLC9A3;VDAC2;SLC8B1;SLC8A1;SLC26A1;SLC17A5;SLC5A5;SLC12A3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.37733201833683083,0.8603192866133496,0.6396526772793053,0.8835323364886226,1.0,3/16,14.52%,IGF1;ZFAND2B;PHIP
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.38549584006072496,0.8602919304412554,0.6440422322775264,0.8831988014813532,1.0,1/14,1.73%,CD84
prerank,anterograde axonal transport (GO:0008089),0.32427272888769887,0.8602432550750583,0.663727959697733,0.8828980663028587,1.0,8/37,18.02%,DTNBP1;AP3S1;RAB21;KIF3A;AP3D1;AP3B1;KIF5B;KIF5C
prerank,negative regulation of viral life cycle (GO:1903901),0.3850917779424304,0.8602237178855621,0.6543385490753911,0.8825410534979503,1.0,4/15,17.81%,IFITM1;IFITM2;BST2;SNX3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2915713865722474,0.8600389875659611,0.7118093174431203,0.882516305958366,1.0,16/84,18.13%,APOE;SAMD4A;DAPK1;DDX6;IGF2BP3;SORL1;IGF1;RTN3;ROCK1;CNOT7;EPRS1;RTN4;EIF4A3;SYNCRIP;CAPRIN1;MALSU1
prerank,negative regulation of cyclase activity (GO:0031280),-0.3261026702942643,-0.8598556307448804,0.6493506493506493,0.9231014862318204,1.0,5/14,15.79%,GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2911578567505402,-0.8586236127537662,0.6937269372693727,0.9241030778469287,1.0,7/19,21.01%,RPTOR;MAF1;AR;POLR3F;CHD8;POLR3G;BRF2
prerank,global genome nucleotide-excision repair (GO:0070911),0.3423693187921032,0.8582941556376766,0.6705426356589147,0.8851638840691521,1.0,5/26,12.34%,GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,positive regulation of bone mineralization (GO:0030501),0.3289510626488563,0.8578309399928726,0.6654456654456654,0.8856199729487028,1.0,7/35,10.92%,ANO6;ATP2B1;SLC8A1;ACVR2A;PKDCC;BMPR2;CCN1
prerank,histone lysine demethylation (GO:0070076),0.34499925826214883,0.8577600354378543,0.6697368421052632,0.8853583947555539,1.0,9/25,22.12%,KDM4C;KDM3A;JMJD1C;KDM2A;KDM1B;KDM7A;RIOX2;PHF2;KDM5C
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.33418858214150715,0.8576488371385101,0.6611039794608472,0.8851894388634985,1.0,7/29,15.09%,GTF2H5;RPS27A;UBC;DDB1;CDK7;CUL4A;MNAT1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.34531579151991776,0.8575794263380139,0.6807387862796834,0.8849264951125314,1.0,7/24,20.34%,ENPP1;IGF1;IRS2;GSK3B;DYRK2;EPM2AIP1;GCK
prerank,positive regulation of myelination (GO:0031643),-0.3418107311992365,-0.857369955115915,0.6385542168674698,0.925297738773462,1.0,6/11,14.58%,PARD3;TPPP;MYRF;CST7;TENM4;DICER1
prerank,regulation of pH (GO:0006885),0.4079613267352786,0.856589823426384,0.6464174454828661,0.886229624158351,1.0,1/11,1.98%,PDK4
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.35404586341472405,-0.8562817041053592,0.6523076923076923,0.9259710228960959,1.0,2/10,5.92%,CX3CR1;ARRB2
prerank,regulation of cell development (GO:0060284),0.32350125880420205,0.8561234156072848,0.6777367773677737,0.8866474514374182,1.0,9/36,20.76%,CTNNB1;NOTCH2;BHLHE40;FOXO1;CX3CL1;GRN;RHEB;CLOCK;HES5
prerank,organic anion transport (GO:0015711),0.2929114676875939,0.855465855598108,0.7195652173913043,0.887405934358031,1.0,18/76,19.80%,LRRC8D;AQP1;ABCC4;LRRC8C;CYB5R4;SLC23A1;MGST1;SLC52A1;SLC25A42;SLC17A9;CA2;SLCO3A1;CYB5R2;CYB5R1;SLC35A2;SLC19A1;SLC35C2;SLC25A17
prerank,apoptotic DNA fragmentation (GO:0006309),0.3803695519481651,0.8546610487907651,0.6416666666666667,0.8884390309887659,1.0,5/16,25.93%,DFFB;DNASE2;CASP3;DFFA;CECR2
prerank,protein targeting to ER (GO:0045047),0.28430456553041145,0.8546195245398638,0.7446120689655172,0.8881269613192628,1.0,22/99,17.78%,ZFAND2A;RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;GET3;RPL36A;RPL22;RPS21;RPL10A;RPS26;SPCS2;ZFAND2B;RPL15;RPL10;RPSA;RPL7;RPL26;SGTA;SEC63
prerank,cellular response to drug (GO:0035690),0.3407889034838839,0.8545365106120602,0.6706349206349206,0.8879001928266411,1.0,8/25,20.41%,RAP2A;TFRC;GPLD1;GAS6;HTR1B;ACER2;RBM22;CERS1
prerank,positive regulation of macrophage activation (GO:0043032),0.3703731327949354,0.8543351571996873,0.6623748211731044,0.8878639761687765,1.0,5/17,15.88%,THBS1;STAP1;TREM2;LBP;HSPD1
prerank,apoptotic process (GO:0006915),0.27568707134398274,0.85422618495255,0.7967644084934277,0.8876543301104454,1.0,52/203,20.92%,CXCR4;ADRA1A;BCL2L11;PRKCD;FAS;APAF1;DAPK1;RIPK1;NOTCH2;RAF1;GADD45A;AIFM2;MELK;STK3;PIK3CA;THOC1;BNIPL;AKAP1;DLC1;CYFIP2;EGLN3;PTK2B;FOXO1;PPARD;ING4;APP;BCLAF1;VDAC1;CASP12;BAX;KREMEN1;CASP6;RTN4;NDUFS1;BNIP3;MYD88;HSPD1;BID;IFIT2;BBC3;CASP2;CASP3;STK4;TNFAIP1;PPP2CA;TNFRSF21;NUDT2;PPP2R1A;OGT;PAWR;RELT;ZBTB16
prerank,positive regulation of lymphocyte activation (GO:0051251),0.33859527473560297,0.8541091029453416,0.6586666666666666,0.8874771525879394,1.0,4/28,8.66%,IL6;SH3KBP1;SIRPA;TYROBP
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.39307100667917494,0.8540059422206673,0.6618287373004355,0.8872731575195562,1.0,2/12,4.23%,FYCO1;UVRAG
prerank,skeletal system morphogenesis (GO:0048705),-0.23663675906031686,-0.8539202845631813,0.8,0.9295430203078545,1.0,13/42,21.98%,FGFR2;TGFBR1;MEGF8;LRP5;FBN2;HOXD4;HOXD3;HOXC9;FGFR3;HOXA9;SOX11;HOXB9;DSCAML1
prerank,regulation of centrosome cycle (GO:0046605),0.3611777596658627,0.8534388253842052,0.6662180349932705,0.8878564189343383,1.0,6/21,21.40%,CHMP2A;PDCD6IP;NAT10;SIRT1;CHMP5;CHMP2B
prerank,lipid biosynthetic process (GO:0008610),0.29421348242714457,0.8531575895347484,0.7373068432671082,0.887960772905697,1.0,15/77,21.36%,LIPG;GPAT2;AGPAT4;MVD;ACSM3;NDUFAB1;ACSL5;DHRS11;SCD;CBR4;PAM;HMGCR;PDSS1;SREBF1;SRD5A1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.36426816996260764,0.852884190558099,0.6716417910447762,0.8880460507076454,1.0,9/19,24.54%,LY96;NR1H4;TICAM2;LBP;TRIL;SCIMP;TIRAP;IRAK1;RAB11FIP2
prerank,autonomic nervous system development (GO:0048483),0.36819026780462516,0.8521860829322172,0.6853932584269663,0.8888595080020739,1.0,5/17,18.62%,TFAP2B;PHACTR4;GDNF;NRP1;SOX8
prerank,ncRNA metabolic process (GO:0034660),-0.23844869806391866,-0.8520191019260601,0.7591623036649214,0.9321671836187979,1.0,11/37,25.17%,MAPT;DGCR8;TDRKH;TUT4;DTD2;DICER1;BCDIN3D;PARN;DTD1;EXD1;DDX4
prerank,protein kinase A signaling (GO:0010737),0.39273457980212956,0.8519978608898383,0.6410998552821997,0.8888190343661079,1.0,1/12,3.00%,LCP1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.38332955548060305,0.8518699712766484,0.6533333333333333,0.8886392432123391,1.0,3/13,18.62%,SOX9;NOTCH1;SOX8
prerank,monoacylglycerol metabolic process (GO:0046462),0.3896601838217171,0.8517962480811566,0.6574344023323615,0.8883921634360086,1.0,1/13,1.78%,MGLL
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3713825484231529,0.8516803264988521,0.6519337016574586,0.8881981680672236,1.0,3/17,11.54%,PLA2G2D;PLA2G4F;PLAAT3
prerank,regulation of cellular component organization (GO:0051128),0.2787434176352552,0.8513392989588006,0.777319587628866,0.8883985168179805,1.0,23/135,17.21%,CD36;APOE;SGK1;TFRC;ABL2;RAB33B;NUBP1;IRAK3;HNRNPU;CD22;PICALM;LAMTOR1;ROCK1;DCUN1D5;RAPGEF1;ATAD3A;STON1;LATS1;SNX17;TRAF2;MELTF;PTPN1;MLLT3
prerank,aerobic electron transport chain (GO:0019646),0.293595801169553,0.8509202727148129,0.7181510710259301,0.888725482194826,1.0,23/68,23.52%,UQCRFS1;NDUFS8;NDUFA10;AFG1L;NDUFC1;COX6A1;NDUFAB1;CYCS;SDHA;COX8A;NDUFB6;NDUFS6;COX7B;NDUFS1;COX15;NDUFS3;NDUFB4;NDUFB8;COX4I1;SDHAF2;COX5A;NDUFB9;NDUFA13
prerank,sensory perception of mechanical stimulus (GO:0050954),0.2913928566472738,0.8508970445571259,0.7276688453159041,0.8883876975224594,1.0,11/85,11.94%,EYA1;LOXHD1;P2RX4;COL1A1;NIPBL;SNAI2;WDR1;COL11A1;LHFPL3;PIEZO2;ROR1
prerank,positive regulation of protein kinase activity (GO:0045860),0.27572256883153556,0.8497862354463527,0.7871900826446281,0.8898650608729027,1.0,19/148,11.55%,IQGAP1;NEDD9;VEGFA;PRKAG2;TAOK3;PRKCD;CDKN1A;SNX9;STK3;INCENP;CACUL1;SLC27A1;IL6R;TNIK;XRCC5;PTK2B;PAK2;CCN1;TAB2
prerank,glycolipid biosynthetic process (GO:0009247),0.31715332036097915,0.8497679552333652,0.6878824969400245,0.8895138882555399,1.0,8/38,15.14%,PGAP3;DPM2;B4GALT6;PIGH;ST3GAL4;A4GALT;PIGC;PIGQ
prerank,tetrahydrofolate metabolic process (GO:0046653),0.40433778895808714,0.8493777713952254,0.6676970633693973,0.8897980701157969,1.0,2/10,12.55%,MTHFS;MTHFD1L
prerank,response to gamma radiation (GO:0010332),0.3461769953260549,0.849269744046568,0.6778523489932886,0.8895996613559098,1.0,8/24,23.99%,MAP3K20;XRCC5;DCUN1D3;WRN;RPL26;TLK2;MEN1;HRAS
prerank,chromatin organization (GO:0006325),0.2787503361729077,0.8491569072303085,0.7700312174817898,0.8893996650848417,1.0,40/132,25.86%,FOXP3;KDM4C;BAZ1A;BAZ2B;TOP1;SOX9;RB1;SETD7;HCFC2;ESR1;SIRT1;CBX3;SMARCC1;NPM2;SOX2;SMARCD1;SUV39H2;INO80;BRWD1;BAZ1B;PBRM1;SMARCB1;ZBTB7A;HDAC8;PRDM16;PHF1;SAFB;CDAN1;KAT2A;HMG20A;KDM5C;RUVBL2;MTF2;SUPT4H1;SETD5;SMARCE1;SMARCD2;HDAC1;SMARCA1;KAT2B
prerank,acyl-CoA metabolic process (GO:0006637),0.3259061128397842,0.849155581071543,0.7008871989860583,0.889022513912875,1.0,10/35,23.87%,BAAT;ACSM3;GLYAT;MCEE;ACOT9;OGDH;ACOT2;ACOT6;ACOT13;ACOT8
prerank,receptor signaling pathway via STAT (GO:0097696),0.3394185558612727,0.8485405808847698,0.6743589743589744,0.8896960195893315,1.0,9/25,22.89%,STAT5B;SOCS6;IFNAR2;IFNAR1;STAMBP;STAT6;PIAS1;STAT3;JAK2
prerank,glycogen catabolic process (GO:0005980),0.37197930506576593,0.8484282217218905,0.6612184249628529,0.8895159722107048,1.0,4/15,21.74%,PYGL;AGL;PHKG2;PYGB
prerank,regulation of interferon-alpha production (GO:0032647),0.34757036242752015,0.8484186112163942,0.6878238341968912,0.8891524033829868,1.0,5/23,19.60%,TLR8;MAVS;NLRC3;HSPD1;TBK1
prerank,striated muscle cell development (GO:0055002),-0.31351584869119886,-0.8483784343304924,0.6870748299319728,0.9386030627595571,1.0,2/14,5.43%,CAPN3;TMOD2
prerank,protein localization to condensed chromosome (GO:1903083),-0.33439922545718825,-0.8482717477919264,0.6666666666666666,0.9371783694023739,1.0,10/12,31.47%,BUB3;ZW10;ZWILCH;KNL1;MTBP;IK;CDK1;CHAMP1;AURKB;TTK
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.30057408941512326,0.8479011046059843,0.7041284403669725,0.8892789617478533,1.0,21/56,24.48%,NDUFS8;NDUFA10;NDUFC1;ECSIT;NDUFAB1;TMEM126A;NDUFAF8;NDUFB6;DMAC1;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFAF7;NDUFB8;NDUFAF4;NDUFB9;NDUFAF2;NDUFA13;TMEM126B;DMAC2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.30057408941512326,0.8479011046059843,0.7041284403669725,0.8892789617478533,1.0,21/56,24.48%,NDUFS8;NDUFA10;NDUFC1;ECSIT;NDUFAB1;TMEM126A;NDUFAF8;NDUFB6;DMAC1;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFAF7;NDUFB8;NDUFAF4;NDUFB9;NDUFAF2;NDUFA13;TMEM126B;DMAC2
prerank,DNA strand elongation (GO:0022616),0.36480977320987745,0.8478333576155186,0.6514285714285715,0.8890144627584863,1.0,4/18,13.60%,RFC3;NBN;DCLRE1B;POLA1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.3873044272627103,0.8477641443424501,0.6637168141592921,0.8887633168058636,1.0,3/13,14.64%,CD46;FSTL1;NRROS
prerank,cell junction maintenance (GO:0034331),-0.31746230021431343,-0.8475737425215404,0.6508474576271186,0.9370590060150402,1.0,10/14,41.63%,CSF1R;CHCHD10;CBLN2;F2R;DCTN1;MYADM;CLDN1;CBLN1;PRTN3;CD177
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.2600310842188243,-0.8473607041390847,0.7167381974248928,0.9358473647510461,1.0,12/27,25.59%,SNTA1;SCN1B;FGF12;PTPN3;DLG1;ATP2B4;YWHAH;FXYD7;SCN4B;FXYD1;NOS1;SCN2B
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.2619059864947766,-0.846941191807741,0.6885245901639344,0.9351160345153866,1.0,12/27,22.62%,B3GAT3;CHST11;CSGALNACT1;B3GAT1;B3GAT2;CHST7;CHST9;CHSY1;BCAN;CSPG4;NCAN;CHST12
prerank,positive regulation of immunoglobulin production (GO:0002639),0.33008727961463946,0.8461948901251749,0.7058096415327565,0.891087122762012,1.0,8/31,21.02%,TFRC;IL6;KMT5B;VAMP3;SHLD1;SHLD2;PAXIP1;PTPRC
prerank,positive regulation of type I interferon production (GO:0032481),0.2937357806288219,0.8461563193331882,0.7192008879023307,0.8907780315019964,1.0,25/73,25.94%,TLR8;CTNNB1;FLOT1;CREBBP;RNF135;POLR2L;XRCC5;MAVS;PQBP1;RELA;MYD88;HSPD1;STAT6;TBK1;POLR3C;MRE11;PRKDC;POLR3K;IRAK1;ISG15;LRRFIP1;DHX58;TLR9;POLR2F;IRF7
prerank,protein localization to kinetochore (GO:0034501),-0.320423947227974,-0.8457554394832572,0.6719745222929936,0.935974922214293,1.0,11/14,31.47%,BUB3;ZW10;ZWILCH;KNL1;CENPT;MTBP;IK;CDK1;CHAMP1;AURKB;TTK
prerank,nuclear envelope organization (GO:0006998),0.36391940928275357,0.8455848477818303,0.6754874651810585,0.891376109351491,1.0,6/20,20.73%,REEP4;VPS4A;LEMD3;NEMP1;TMEM170A;TOR1A
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3971891921765823,0.844391948551667,0.6696296296296296,0.8930610713488418,1.0,2/11,9.88%,UQCRFS1;CYCS
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.39685269076937035,0.8443652559797085,0.6811594202898551,0.8927209684049687,1.0,1/12,1.99%,DHRS3
prerank,epithelial cell development (GO:0002064),0.3524932579710483,0.8442738872549306,0.7075471698113207,0.892497701170607,1.0,1/20,0.95%,RILPL2
prerank,positive regulation of growth (GO:0045927),0.29696168383872706,0.8439597922130561,0.7297605473204105,0.8926454983640189,1.0,7/64,10.43%,RFTN1;SDCBP;MMP14;N6AMT1;EXOSC9;ADAM17;MTPN
prerank,regulation of actin nucleation (GO:0051125),-0.33292576766239074,-0.8439357728536325,0.676923076923077,0.9381281894672563,1.0,3/12,8.24%,CORO1A;PICK1;ARFIP2
prerank,positive regulation of leukocyte activation (GO:0002696),0.36345454620536155,0.8438210178052833,0.6793785310734464,0.8924944148960261,1.0,4/18,15.88%,CLEC4D;THBS1;LBP;HSPD1
prerank,regulation of actomyosin structure organization (GO:0110020),0.3944044567020638,0.8435925430637682,0.6711309523809523,0.8925121738545485,1.0,5/13,20.26%,AKAP13;PTGER4;ROCK1;ALMS1;ACTG1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.33559227452900914,0.8428702821449988,0.6808236808236808,0.8933413236958968,1.0,9/26,27.36%,HOMER3;IGF1;GSK3B;DYRK2;STIMATE;HOMER2;EFHB;SPPL3;CHP1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.30271898134112696,0.8419995135776828,0.7124711316397229,0.89436491627546,1.0,18/54,21.51%,CTNNB1;COPS9;HSPA1B;DCUN1D3;SIRT7;N4BP1;TNFAIP3;HSPA1A;SQSTM1;ARRB1;PRKCG;CRY1;PRR7;GNL3L;DNAJA1;HDAC8;OGT;GTPBP4
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.348148835507426,0.8415531887930927,0.686141304347826,0.8947349752137277,1.0,3/22,8.74%,FOXP3;CD46;CBFB
prerank,spliceosomal complex assembly (GO:0000245),0.3089126920917492,0.8414583720206884,0.7148014440433214,0.8945237037738039,1.0,13/46,17.55%,SRPK2;SCAF11;CELF1;SNRNP200;SF1;PRPF6;DDX23;SF3A3;ZRSR2;SMN1;PUF60;LUC7L;SRPK1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.23761322591869188,-0.8412376374522141,0.718562874251497,0.9422040300365725,1.0,14/40,21.38%,SYT1;RIMS1;UNC13C;RIMS2;SNAP25;SYT7;SYT2;STX1A;CPLX1;CPLX2;BLOC1S6;UNC13A;STX4;OTOF
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3790816517915832,0.8411403679322705,0.6724890829694323,0.8946671648747638,1.0,4/14,19.53%,THBS1;SULF2;SULF1;CREB3L1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.2783540396769709,-0.8406025542357926,0.7182539682539683,0.9419018042574723,1.0,3/21,4.22%,CSF1R;CSF1;MTUS1
prerank,proteasome assembly (GO:0043248),-0.351318760911319,-0.840525411167945,0.6731301939058172,0.9404162966367229,1.0,5/11,22.96%,PSMG1;PSMG2;POMP;PSMD10;ADRM1
prerank,regulation of axon extension (GO:0030516),0.31595986821366073,0.840388919475478,0.6882640586797066,0.895532360297198,1.0,12/37,21.76%,APOE;RUFY3;ZFYVE27;GSK3B;MT3;MACF1;GOLGA4;RTN4;SHTN1;SIN3A;CDKL5;NTN1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.31353467929578166,-0.8403159528650093,0.6836734693877551,0.9392463679405403,1.0,5/15,12.40%,MEF2A;IL6ST;PARP1;PRKCA;AGT
prerank,tRNA wobble base modification (GO:0002097),0.37734507456080846,0.8399782663477461,0.6930983847283406,0.8958243670118758,1.0,5/14,17.02%,CTU2;GTPBP3;ALKBH8;ELP4;ALKBH1
prerank,zinc ion transport (GO:0006829),0.3496717439853839,0.8398401707824499,0.6815114709851552,0.8956772966256413,1.0,9/21,29.02%,SLC39A14;MT3;SLC39A3;SLC39A11;SLC30A1;SLC30A9;SLC39A1;SLC39A13;SLC30A5
prerank,negative regulation of TOR signaling (GO:0032007),0.3188260328106247,0.8394525102721435,0.6986301369863014,0.8959086282563753,1.0,7/36,13.44%,FNIP1;SESN2;FLCN;EPM2A;SIRT1;CASTOR1;NPRL3
prerank,protein localization to cell junction (GO:1902414),-0.28085656543098975,-0.8390099936650627,0.6958174904942965,0.940264994879994,1.0,12/22,33.21%,NLGN1;HEG1;FERMT2;ARHGEF18;NECTIN1;BSN;MPP4;JAM3;SHANK1;PCLO;TJP3;JAK1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.34460582705099324,0.838281828549352,0.6810810810810811,0.8974864069713915,1.0,5/21,13.75%,CORO1C;DUSP3;ROCK1;MACF1;CLASP1
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.2869255007338652,-0.8380991383652172,0.7040816326530612,0.9405464485428023,1.0,3/18,7.04%,NAV3;CD34;HDAC7
prerank,catecholamine metabolic process (GO:0006584),0.37882315929615784,0.8380820765923761,0.6782608695652174,0.8974338553783763,1.0,5/14,24.38%,PRKN;ATP7A;DRD2;COMT;RNF180
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.38747713915239945,0.8379093243040361,0.6661585365853658,0.8973652990340203,1.0,3/12,10.59%,SNX5;SORL1;SIRT1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.34657036018402887,0.8378534302105797,0.69140625,0.8970908531185204,1.0,6/23,21.13%,MUS81;DFFB;DNASE1L1;DNASE2;CASP3;DFFA
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.34736817040158136,0.8376902453644377,0.6804407713498623,0.8969960616587747,1.0,6/20,18.82%,HOPX;LONP1;HSPA1A;HSPD1;HSPA4;CCT2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.38367143161527045,0.837502762261466,0.6661742983751846,0.8968991837779096,1.0,3/13,12.38%,PRPF8;PRPF6;DDX20
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.28867896633986867,-0.837493751372138,0.6958174904942965,0.9402404240535407,1.0,9/18,28.28%,RAB11A;CDK4;CDC7;CDC25B;BRD4;DTL;CDK1;CCND1;STOX1
prerank,negative regulation of proteolysis (GO:0045861),0.32708268174329336,0.8374912925236195,0.7021013597033374,0.8965412719559204,1.0,4/34,10.12%,TIMP1;CLN3;TIMP2;ROCK1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3208929876635155,-0.8372489970158027,0.6563573883161512,0.9391052563506019,1.0,5/14,17.19%,PKIA;PKIG;ATP2B4;RAPGEF2;PRKAR2B
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.3051952845345612,-0.8371802710643995,0.6366666666666667,0.9376137571334762,1.0,2/14,4.75%,ZFP91;TLR3
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3109777929089328,0.8370856573639205,0.717049576783555,0.8968238387022466,1.0,8/43,15.39%,TAOK3;CDKN1A;BABAM2;BRCA1;NBN;CHFR;ORC1;BRCC3
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3263567369578648,0.8369539783907772,0.7110552763819096,0.8966696106971851,1.0,3/32,8.71%,CD300A;PRKCD;DLC1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.4044068535478215,0.8364682437598141,0.6792452830188679,0.8970976332195776,1.0,6/10,22.89%,STAT5B;JAK3;PTPN1;STAT6;STAT3;JAK2
prerank,mRNA metabolic process (GO:0016071),0.27893489350953526,0.8363929257278949,0.7780149413020278,0.8968275630583904,1.0,31/90,25.91%,ERN1;SCAF11;CELF1;TCERG1;DDX5;CSTF3;HSPA1B;PRPF8;ZFP36L2;HNRNPA0;AGO3;NCBP2;SF3A3;HSPA1A;SNRPF;RNH1;ALKBH5;AGO4;AURKAIP1;SNRPB;LSM11;HNRNPR;SUPT4H1;LSM5;ZC3H12D;SF3B2;CPSF6;PRPF3;LSM6;ZFP36;RIDA
prerank,regulation of lipid kinase activity (GO:0043550),0.39717737162337885,0.8363519357006745,0.6818897637795276,0.8965088896270138,1.0,2/11,8.03%,WDR91;RB1
prerank,regulation of ATP metabolic process (GO:1903578),0.29628249707409116,0.8361842312328174,0.7180974477958236,0.8964202746368415,1.0,17/54,22.97%,PRKAG2;ABCD1;SPHK2;EIF6;TPR;NUP50;ATP7A;NUP98;ZBTB7A;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,organelle fusion (GO:0048284),0.3451599201889639,0.8361106298530155,0.6978319783197832,0.8961845042890066,1.0,7/22,22.78%,EEA1;GDAP1;BAX;VPS11;USP30;AFG3L2;MFN2
prerank,neuron projection regeneration (GO:0031102),-0.34601290311442295,-0.8358875941877528,0.6899441340782123,0.938668072369476,1.0,1/10,0.30%,RTN4RL1
prerank,regulation of protein secretion (GO:0050708),0.27470835281425127,0.8358864995416779,0.7774294670846394,0.896179393644967,1.0,13/119,8.57%,APOE;ABCG1;SERGEF;ADAM9;IL6;TFAP2B;RHBDF2;SLC8B1;IGF1;ADAM8;ENSA;STXBP5;EIPR1
prerank,TOR signaling (GO:0031929),0.3359366403536627,0.8357242538955467,0.6578599735799208,0.8960897334561289,1.0,8/26,22.59%,FNIP1;FLCN;EIF4EBP2;NPRL3;MAPKAP1;CARD11;RICTOR;SYAP1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.24623127105866321,-0.8356705145300186,0.6887755102040817,0.9374921942835015,1.0,8/32,14.65%,ERBB4;HK2;BCL2;CLU;SOD2;CAMK2A;BAD;FIS1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.28857736468438294,0.8355453966664314,0.7372593431483578,0.8959854868665658,1.0,23/69,23.52%,UQCRFS1;NDUFS8;NDUFA10;AFG1L;NDUFC1;COX6A1;NDUFAB1;CYCS;SDHA;COX8A;NDUFB6;NDUFS6;COX7B;NDUFS1;COX15;NDUFS3;NDUFB4;NDUFB8;COX4I1;SDHAF2;COX5A;NDUFB9;NDUFA13
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.30202595573528984,-0.8354943247845233,0.6560283687943262,0.9362357694322319,1.0,6/17,20.37%,BCL2;CLU;SOD2;BAD;FIS1;TIMM50
prerank,regulation of protein acetylation (GO:1901983),0.3892610539231204,0.8352444616622394,0.6892307692307692,0.8960869318090803,1.0,5/12,26.21%,GSK3B;SIRT1;CAMK1;TERF2IP;CEP295
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3382027144434655,0.8346222308681466,0.7089452603471295,0.8967311711185466,1.0,9/25,22.75%,TCERG1;HNRNPU;LARP7;CDC73;NELFE;CDK13;WDR43;SUPT4H1;RNF168
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3394932444978556,-0.834445660329091,0.6436781609195402,0.9367219256775812,1.0,4/10,15.37%,CD34;TMEM100;RAPGEF2;RIN2
prerank,ganglioside biosynthetic process (GO:0001574),0.36514783340126117,0.8342649888119137,0.7023460410557185,0.8969549628115108,1.0,2/15,5.70%,B4GALT5;B4GALT6
prerank,positive regulation of interferon-beta production (GO:0032728),0.3202408405227447,0.8342250000735927,0.695273631840796,0.896642168693431,1.0,4/33,9.94%,TLR8;FLOT1;RNF135;MAVS
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3708691125827324,0.8340346767616964,0.6950354609929078,0.8965813711235278,1.0,2/15,7.77%,MUS81;EME1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.27169750685747623,-0.8338466475348361,0.7411764705882353,0.9363357107560613,1.0,3/22,7.99%,CYRIB;STX7;FBXO38
prerank,regulation of vesicle-mediated transport (GO:0060627),0.28300582012752346,0.8335157355505202,0.8054347826086956,0.8970871156753092,1.0,22/91,17.33%,SYK;RAB8B;ABL2;RAB33B;RAB21;STXBP5;CD22;PICALM;RAB12;RAB10;FES;OLFM4;CPLANE2;RAB11B;FGR;INPP5F;STON1;DNAJC13;SNX17;NRP1;PTPN1;GAS1
prerank,regulation of protein localization to centrosome (GO:1904779),0.4067104141209493,0.8332067089246922,0.6924342105263158,0.8972231042892918,1.0,3/10,14.33%,APC;GSK3B;PARD6A
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2886766014320711,-0.8330728353979404,0.698961937716263,0.9363456366326854,1.0,2/18,1.72%,FCHSD2;DTNA
prerank,zinc ion transmembrane transport (GO:0071577),0.3418157434138426,0.8330515765405158,0.7007978723404256,0.897099392881996,1.0,9/22,29.02%,SLC39A14;SLC39A12;SLC39A3;SLC39A11;SLC30A1;SLC39A10;SLC39A1;SLC39A13;SLC30A5
prerank,regulation of cytoplasmic translation (GO:2000765),0.37445788728167323,0.8329549484784616,0.6976047904191617,0.8968838500603463,1.0,4/14,23.41%,CPEB4;CPEB2;PKM;CPEB1
prerank,axon guidance (GO:0007411),0.26745288540768086,0.8327672096091673,0.8209562563580874,0.8968003190930547,1.0,20/201,7.14%,PLXNA1;CXCR4;PLXNC1;GRB2;PLXND1;PALLD;GAB2;VEGFA;ALCAM;SOS1;NIBAN2;SEMA4B;NTN3;NOTCH2;MAPK7;NRP2;DAG1;IRS2;PIK3CA;SH3KBP1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.2873270301554848,-0.8325452136019551,0.678082191780822,0.9357658464587782,1.0,2/18,3.76%,CAMK1D;RIPOR2
prerank,methylguanosine-cap decapping (GO:0110156),-0.33903275235064917,-0.8313787298037931,0.6492307692307693,0.9366383727367789,1.0,7/10,30.07%,DCPS;PNRC2;LSM1;DCP1B;DCP1A;PATL2;DCP2
prerank,maintenance of protein location in nucleus (GO:0051457),0.345808794735844,0.8306790524090912,0.7044817927170869,0.8998571975847048,1.0,5/20,23.44%,HNRNPU;TOPORS;SUPT7L;BCL3;TAF8
prerank,regulation of viral release from host cell (GO:1902186),0.3460307799133183,0.8305833624588229,0.6875,0.8996540775599399,1.0,4/21,9.99%,TRIM25;CHMP2A;VPS4A;DDB1
prerank,secretion (GO:0046903),0.36770035106543525,0.8305454371430422,0.6998577524893315,0.8993516249470647,1.0,1/14,2.59%,TPD52
prerank,negative regulation of secretion (GO:0051048),0.39857399297915697,0.8305300636920683,0.6815286624203821,0.8990009797984292,1.0,2/10,13.53%,NR1H3;VAMP3
prerank,alpha-amino acid metabolic process (GO:1901605),-0.22039216799201827,-0.8304876286660823,0.8406593406593407,0.9368669655245923,1.0,19/45,33.04%,NAALAD2;ASPA;NAT8L;FOLH1;GLUD1;ASNS;KMO;PYCR2;PYCR3;NOX4;DDAH1;MTHFD1;GLS;RIMKLB;DDAH2;KYAT1;CBS;SLC25A12;GPT
prerank,positive regulation of DNA repair (GO:0045739),0.29970460356314726,0.8303788520934786,0.7274881516587678,0.8988717471865181,1.0,14/46,23.97%,EYA1;ERCC6;BABAM2;BRCA1;SIRT1;BRCC3;PRKCG;NPAS2;MGMT;XRCC1;RNF168;SPIDR;SLF1;FOXM1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.39746264069519344,0.8300823588489754,0.6908809891808346,0.8989632229136855,1.0,2/11,5.58%,CD46;THBS1
prerank,protein K48-linked deubiquitination (GO:0071108),0.3412952372517616,0.8296541818203993,0.6821282401091405,0.8992914027238826,1.0,6/23,19.38%,MINDY1;VCPIP1;TNFAIP3;USP8;OTUD5;ATXN3
prerank,dendritic spine morphogenesis (GO:0060997),0.3652665024411339,0.829594442767667,0.6995827538247567,0.899000855989117,1.0,3/15,15.07%,PTEN;DOCK10;WASL
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3339316108698772,0.82939881868216,0.7104194857916103,0.898924887323308,1.0,3/25,5.51%,ADSL;PPAT;AMPD3
prerank,maturation of LSU-rRNA (GO:0000470),0.33442211994308096,0.8289287971118527,0.7256176853055917,0.8993121169555486,1.0,9/26,24.96%,EIF6;MRPL1;RPL10A;RPL7L1;WDR12;RPL7;BOP1;RPL7A;SNU13
prerank,positive regulation of cell cycle (GO:0045787),0.29268748667693445,0.8288235073687451,0.74364896073903,0.8991168198425064,1.0,9/62,11.47%,ANKRD17;SRPK2;RARA;CITED2;DUSP3;RAD23A;ADAM17;PKN2;APP
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.332031116773116,-0.8284767188413659,0.663768115942029,0.9392727477160031,1.0,3/11,12.75%,DCK;DCTD;ERH
prerank,intracellular protein transmembrane transport (GO:0065002),0.3069712894379775,0.8276229601174928,0.7250308261405672,0.9006774059701085,1.0,9/42,17.78%,CHCHD4;PEX7;TOMM20;PEX14;TIMM17A;TIMM17B;ZFAND2B;HSPD1;SEC63
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2732318933805211,0.8274878458512501,0.7960457856399584,0.900525270462841,1.0,34/128,22.33%,OPTN;CDKN1A;DYNC1H1;HAUS6;FBXL17;BACH1;MELK;FBXL3;ENSA;PPP2R2A;CDK7;CCNA2;CEP76;CLASP1;CEP192;TUBA1A;CUL1;NDE1;LATS1;MNAT1;ALMS1;OFD1;CCP110;SSNA1;HAUS7;CDC25A;PAFAH1B1;BRSK2;PPP2R1A;PHLDA1;HAUS5;CEP41;CCDC57;PPP1R12A
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4084983739927324,0.8267867940719114,0.6871165644171779,0.9013125136712418,1.0,4/10,21.42%,CD200R1;WASL;APOD;LRCH1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3277390596448395,0.826619198311477,0.7075098814229249,0.9012212674561572,1.0,8/25,26.02%,SPHK2;FZD5;TRAF2;TNFRSF14;SCIMP;MALT1;TRAF6;MAP3K7
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3127943626967615,0.8260274108285646,0.7201946472019465,0.9018075056753415,1.0,13/35,27.46%,FLOT1;PPT1;RAB21;PICALM;CBL;PIK3CB;MKLN1;AAK1;LDLRAP1;HIP1;C3;VTN;SMAP1
prerank,myotube cell development (GO:0014904),0.40240636930390333,0.825756919624766,0.685214626391097,0.9018743260123405,1.0,1/10,5.08%,IGF1
prerank,Golgi inheritance (GO:0048313),0.3905591727386768,0.8256117302197336,0.6955882352941176,0.9017284036506549,1.0,2/11,9.00%,STX5;VCPIP1
prerank,dopamine metabolic process (GO:0042417),0.3522132322390547,0.825169327882004,0.6906377204884667,0.9020329381142247,1.0,6/18,22.28%,MAOA;PRKN;ATP7A;GCH1;DRD2;COMT
prerank,cell projection organization (GO:0030030),0.3216086766468928,0.8251418962046537,0.7021546261089987,0.9016950009374621,1.0,5/30,9.78%,RHOJ;PDGFA;CAPG;PARVB;ITGB1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3171850060631497,0.8245743466881541,0.7093167701863354,0.9022189588510461,1.0,8/29,17.81%,FASN;SLC25A1;PPT1;ELOVL1;ACSL5;SCD;GCDH;CBR4
prerank,negative regulation of wound healing (GO:0061045),0.3238616991200293,0.8241819935068266,0.7130214917825537,0.9024561067638829,1.0,3/28,6.55%,APOE;PTEN;PROC
prerank,negative regulation of myotube differentiation (GO:0010832),-0.32274643536402653,-0.8239570897875873,0.7164634146341463,0.9468306209706672,1.0,1/12,1.90%,TMEM119
prerank,cardiocyte differentiation (GO:0035051),0.40668166334055644,0.8238948356251637,0.6980273141122914,0.9025539701032068,1.0,2/10,7.99%,SIK1;AKAP13
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3606924511435911,0.823729869937914,0.6896551724137931,0.9024663772238157,1.0,2/15,3.86%,VEGFA;P2RX4
prerank,termination of RNA polymerase II transcription (GO:0006369),0.31718040949106635,0.8237203135911585,0.7198492462311558,0.902108132754531,1.0,7/33,15.09%,CPSF1;CSTF3;WDR33;NCBP2;MAZ;SNRPF;SSU72
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.33924802989578007,-0.8234717335592749,0.699438202247191,0.9462727895064442,1.0,4/10,14.81%,WDR76;THOC5;FEM1B;DDX39B
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.3485746937143853,0.8234420080465163,0.7068965517241379,0.902211541191945,1.0,6/21,19.76%,PTEN;RPL23;FBXO5;UBE2S;CDC14B;RAB1A
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.29558830787715973,0.8233906702637267,0.748792270531401,0.9019220649592349,1.0,7/49,12.58%,VEGFA;PIBF1;IL6;IGF1;IL6R;IL15;HCLS1
prerank,regulation of lymphocyte migration (GO:2000401),0.3918863846986139,0.8233318748690718,0.6905829596412556,0.9016438632865287,1.0,3/10,15.07%,SLC8B1;MSN;WASL
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.3728412301676478,0.8229158566121798,0.6876876876876877,0.9019259648746079,1.0,3/13,10.59%,SNX5;SORL1;SIRT1
prerank,negative regulation of protein processing (GO:0010955),0.3919246617608859,0.8227010246834341,0.689807976366322,0.9019300330484668,1.0,3/12,17.33%,THBS1;CTSZ;GAS1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.38485420055168656,0.8225841412738965,0.6845238095238095,0.9017424724835642,1.0,3/11,9.94%,STAP1;TYROBP;MAVS
prerank,tRNA aminoacylation (GO:0043039),0.30968134908017764,0.8225661847317787,0.7342569269521411,0.9014029305201066,1.0,13/37,25.15%,FARS2;DARS1;EPRS1;SARS2;SARS1;IARS2;QRSL1;AIMP1;IARS1;FARSA;WARS2;LARS1;GATB
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3652460476466934,0.8224123246790136,0.7167381974248928,0.9012665726912078,1.0,4/14,17.37%,FOXO3;POLRMT;TWNK;TFB2M
prerank,muscle tissue development (GO:0060537),0.3840188099659787,0.8222312939541506,0.6903703703703704,0.9011879130065226,1.0,1/13,1.11%,STRA6
prerank,neural crest cell development (GO:0014032),0.30489234471793025,0.8218995369608647,0.7398568019093079,0.9013505727318896,1.0,12/44,23.00%,HTR2B;CORO1C;SEMA4B;SNAI2;PHACTR4;GDNF;SEMA3B;SOX8;SEMA4F;PEF1;KLHL12;NOLC1
prerank,RNA 3'-end processing (GO:0031123),0.28339194432996756,0.8218934114282511,0.7584269662921348,0.9009935561350463,1.0,14/69,16.87%,ALYREF;CPSF1;TENT4B;CHTOP;CSTF3;THOC1;WDR33;TENT2;NCBP2;SRSF3;THOC2;DDX39A;EIF4A3;DHX38
prerank,spindle assembly (GO:0051225),0.287530928715766,0.8215973039188075,0.7486157253599114,0.9010834221507871,1.0,20/67,23.86%,PIBF1;NCOR1;HAUS6;SMC1A;TOGARAM1;TUBGCP4;STAG2;CLASP1;CEP192;INO80;SMC3;TNKS;OFD1;HAUS7;ARHGEF10;MZT1;HAUS5;FLNA;BCCIP;NEK7
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.36865813313794127,0.821297573566193,0.7009873060648801,0.9011863192517398,1.0,2/14,8.02%,LPIN3;SLC27A1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3778075384317446,0.8209892751357155,0.6963746223564955,0.9013258948138637,1.0,5/12,20.34%,IGF1;IRS2;DYRK2;EPM2AIP1;GCK
prerank,regulation of phosphatase activity (GO:0010921),-0.2674255847644801,-0.8208791313850499,0.7786561264822134,0.9498071824483144,1.0,15/24,42.16%,PPP6R2;TIPRL;HSP90B1;MTMR9;CDK5RAP3;PPP1R35;BMP2;PTPA;PPP1R2;CHP2;SH2D4A;ZCCHC9;PPP1R26;PPP1R17;RIPK3
prerank,organelle assembly (GO:0070925),0.2589618423509749,0.81995267145166,0.9099099099099099,0.9026383262032155,1.0,90/384,21.87%,MAK;RILPL2;ATG7;RAB8B;PIBF1;SNX10;RAB7A;CFAP70;DYNC1H1;SNAP29;UBAP2L;ATP6V0D1;KIF27;DDX6;NCOR1;HAUS6;ATXN2;YTHDF3;ASAP1;STAM;ABCC4;WDPCP;KLHL41;CHMP2A;CFAP20;FBF1;AMBRA1;VMP1;KIF3A;RAB1B;ABCA3;DYNC2I2;ACTR3;PDCD6IP;VPS4A;PATL1;ATG5;IFT46;CCDC66;CHMP6;TUBGCP4;NOTCH1;CFAP410;CPLANE2;PACS2;RAB43;ATG13;SYNPO;SH3PXD2B;CDS2;IFT52;LIMD1;OCRL;IFT140;SSX2IP;ARL3;INO80;SNF8;TNKS;STAM2;UBQLN2;EXOC4;OFD1;PRRC2C;EDC3;HAUS7;TRAPPC6A;CHMP5;ARF4;CHMP7;EXOC7;EXOC1;BBS7;FLII;DHX37;ARL13B;TMEM231;CDC14B;RAB1A;BBS1;IFT88;TCTN1;VPS36;EIF2S1;HAUS5;CHMP2B;CEP41;RPGR;VPS37B;CCDC57
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.40200611969275835,0.819587984471332,0.7044025157232704,0.9028443252704362,1.0,4/10,17.33%,DBF4;SSBP1;INO80;CDT1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.282901733330876,-0.8188460861808258,0.7351778656126482,0.952034395500918,1.0,9/16,29.14%,ATP5PO;DMAC2L;ATP5F1E;ATP5PF;ATP5MC3;ATP5ME;ATP5F1B;ATP5MG;STOML2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.3730876411410032,0.8183944902989779,0.7032163742690059,0.9044053321945974,1.0,4/13,23.60%,SORL1;BRSK2;TMEM30A;TM9SF4
prerank,regulation of cellular pH (GO:0030641),0.3171589321071216,0.8182627903622872,0.7265725288831836,0.904246366889186,1.0,3/29,5.15%,SLC9B1;SLC9A3;CLN3
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3613989327440122,0.8179186419343399,0.7034965034965035,0.9044354314060867,1.0,6/16,23.96%,KLK3;BMPR2;ACE;PRCP;DRD2;KLK1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.22774286963691223,-0.8178101427942502,0.8170731707317073,0.9524471558321611,1.0,9/37,13.63%,RPTOR;SPRED1;PARD3;WNK3;IRGM;SMAD7;SPRED2;SIRT2;SPRED3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.34869532038662643,0.8173979585309276,0.7107093184979137,0.9048730408189061,1.0,4/18,12.86%,DTNBP1;RIMS4;GSK3B;SYN1
prerank,cellular response to dsRNA (GO:0071359),0.3600357363210613,0.8171647654719156,0.7097701149425287,0.9048821988163304,1.0,3/15,12.11%,FLOT1;MAVS;PQBP1
prerank,determination of bilateral symmetry (GO:0009855),0.33324166288342033,0.8166439489168061,0.730718954248366,0.9053390638922154,1.0,7/24,25.49%,CITED2;CFAP53;NOTCH1;BBS7;NPHP3;DNAH5;ARL6
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3303565288848787,0.8165250781676119,0.7116154873164219,0.905152255343395,1.0,2/23,3.04%,BCL2L11;TIMM22
prerank,brain morphogenesis (GO:0048854),-0.32240323638030105,-0.8165229886317419,0.6858789625360231,0.9533008435617255,1.0,3/12,7.94%,CTNNA2;BBS2;PAX2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.27455296204908125,-0.8163680249581318,0.7357142857142858,0.9520083666916023,1.0,8/18,27.74%,PTGS1;PLA2G4A;CD74;CBR1;PNPLA8;PTGDS;PTGIS;PRXL2B
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.3587545049697636,0.8161614869124134,0.7035460992907802,0.9053376187165646,1.0,1/16,1.46%,LILRB1
prerank,mitotic cell cycle phase transition (GO:0044772),0.26391777338053607,0.8161034369189394,0.848730964467005,0.9050546308687152,1.0,51/203,21.46%,OPTN;PLK2;E2F3;CDKN1A;DYNC1H1;HAUS6;FBXL17;E2F1;ANAPC1;CUL3;MELK;FBXL3;CHMP2A;ENSA;CACUL1;RB1;NASP;PPP2R2A;CDK7;USP26;CCNA2;DBF4;CEP76;ACVR1B;CUL4A;CTDP1;PPP6C;CLASP1;CEP192;TUBA1A;CUL1;NDE1;LATS1;MNAT1;ALMS1;OFD1;CCP110;SSNA1;CDC34;HAUS7;CHMP7;CDC25A;PAFAH1B1;CCNG1;UBE2S;BRSK2;PPP2R1A;CUL4B;PHLDA1;HAUS5;CEP41
prerank,double-strand break repair via homologous recombination (GO:0000724),0.27357287308738054,0.8159359166630196,0.787513691128149,0.9049585728203716,1.0,24/95,23.57%,NSMCE2;SEM1;MUS81;MCM9;NIPBL;BRCA1;XRCC2;POLL;AP5S1;PSMD14;NBN;WRN;INO80;AP5Z1;RAD21;RMI1;MRE11;RAD51B;FANCM;XRCC1;SPIDR;RNF138;PALB2;ERCC4
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.24787540077972925,-0.8151437710246511,0.7971014492753623,0.9527999451026259,1.0,10/30,18.68%,HACD2;ELOVL7;ACOX1;ACSL6;ELOVL4;ELOVL6;HACD3;ABCD4;TECR;ACSBG1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.34146288859647966,0.8150298852041957,0.7219973009446694,0.9060008251816315,1.0,6/21,17.90%,PCID2;MEFV;BIRC3;MT3;SOX2;BIRC2
prerank,macrophage differentiation (GO:0030225),0.3800898655995177,0.8149760769029248,0.7069219440353461,0.9057128711884573,1.0,3/13,12.24%,VEGFA;SIRT1;IL15
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.31714023389383134,0.81497269419707,0.7329974811083123,0.9053491353467076,1.0,8/32,20.40%,TAOK3;CDKN1A;BABAM2;BRCA1;NBN;BRCC3;CDC14B;MRE11
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.35745398105119536,0.8146695856000513,0.708843537414966,0.9054646974731553,1.0,1/17,0.63%,CD300A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.2722416329054,-0.814312691250263,0.7450199203187251,0.9527041903308947,1.0,3/22,3.74%,ATP1B1;ANK2;RYR2
prerank,protein localization to mitochondrion (GO:0070585),-0.32306628063166004,-0.814222630178092,0.6912181303116147,0.9512518340652009,1.0,1/11,1.24%,HK2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.3308403587197104,-0.814146258914641,0.7275204359673024,0.9498192542662037,1.0,2/11,17.98%,NFKBID;CARD9
prerank,regulation of exocytosis (GO:0017157),0.29663104513751526,0.8140978128347507,0.7520958083832335,0.9060044196363014,1.0,9/46,13.75%,ANXA1;RAB8B;RAB21;STXBP5;RAB12;RAB10;CHMP6;CPLANE2;CLASP1
prerank,regulation of intracellular transport (GO:0032386),0.30168655317510906,0.813853891368763,0.7264957264957265,0.905997975743387,1.0,8/38,17.33%,LAMP1;LCP1;DYNC1H1;MYBPC3;RAB11B;INPP5F;PTPN1;GAS1
prerank,transcription by RNA polymerase III (GO:0006383),-0.24769705458130864,-0.8133920970301094,0.7822222222222223,0.9497378916879343,1.0,7/27,16.29%,IVNS1ABP;CRCP;TBP;RO60;POLR2K;GTF3C6;POLR3H
prerank,synaptic vesicle recycling (GO:0036465),0.31566702168849015,0.8132801670914795,0.7329974811083123,0.9065294949844303,1.0,9/31,20.29%,CEL;PLD2;SNCG;TBC1D24;STON1;NLGN2;FCHO2;SYNJ2;VAMP2
prerank,plasma membrane invagination (GO:0099024),0.32031862789331483,0.8132607869307727,0.7209908735332464,0.9061955051718872,1.0,7/29,17.61%,CD36;SNX9;SNX33;MYH9;DOCK1;ARHGAP25;MSR1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.40014695861905236,0.8129838437236697,0.7164869029275809,0.9062459695688954,1.0,5/10,27.03%,DNMT3A;KDM1B;IGF2;PCGF5;MECP2
prerank,negative regulation of cilium assembly (GO:1902018),-0.31502787009162325,-0.8127907659240636,0.6990291262135923,0.9493400830016173,1.0,5/12,17.95%,TESK1;LIMK2;CDK10;CEP97;YAP1
prerank,pyruvate metabolic process (GO:0006090),0.2938654147097604,0.8127524190662143,0.7631578947368421,0.9062314811325549,1.0,11/52,20.34%,HK3;TPI1;SLC16A1;ENO3;PGM1;HAGH;VDAC1;ME2;GAPDHS;PFKM;GCK
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.31356226680006044,-0.8126732672035554,0.7317073170731707,0.9479757291380917,1.0,5/12,18.29%,UPP2;DCK;DHODH;UCK1;UCKL1
prerank,regulation of microtubule depolymerization (GO:0031114),-0.2567380754673325,-0.8125040548079964,0.7863247863247863,0.9467418776523571,1.0,10/25,24.66%,NAV3;HDGFL3;FGF13;STMN2;MID1IP1;TPX2;TTBK2;CAMSAP1;CIB1;KATNB1
prerank,cardiac muscle tissue development (GO:0048738),0.2938407592435707,0.8122750646612026,0.7337209302325581,0.9066243180205388,1.0,6/50,11.89%,NOTCH2;MAML1;SIK1;AKAP13;BMPR2;NOTCH1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.24874538612401018,-0.8121935621981968,0.7532467532467533,0.945782874009569,1.0,3/27,3.57%,GRM1;HTR2C;GNA15
prerank,Notch signaling pathway (GO:0007219),0.2872365263354772,0.8118672584686507,0.782051282051282,0.9068812595504063,1.0,17/59,24.58%,PLXND1;NOTCH2;MAML1;MAML2;CREBBP;SNAI2;ADAM17;NOTCH1;NCSTN;DTX1;HES5;DTX2;ADAM10;APH1B;PSEN2;MIB1;DLGAP5
prerank,negative regulation of viral transcription (GO:0032897),-0.3128084291841287,-0.8117692514312923,0.7275541795665634,0.9449998652302891,1.0,6/13,27.51%,TRIM11;TRIM13;TRIM62;IFITM3;TRIM32;TRIM27
prerank,response to cAMP (GO:0051591),-0.22800845652549426,-0.8115041175770678,0.7947368421052632,0.9439599070318699,1.0,11/37,19.70%,HCN1;AKAP9;STAT1;HCN2;NDUFS4;RAP1B;PKD2;RAPGEF3;RAPGEF2;AHR;SLC26A6
prerank,positive regulation of sodium ion transport (GO:0010765),-0.3216560854752778,-0.8108125461192874,0.7448275862068966,0.943587349382544,1.0,3/12,4.34%,ANK3;SCN1B;WNK3
prerank,heme catabolic process (GO:0042167),0.36356896218384416,0.810555704577147,0.7086956521739131,0.908155472701308,1.0,5/14,18.34%,BLVRB;HMOX1;HMOX2;BLVRA;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.36356896218384416,0.810555704577147,0.7086956521739131,0.908155472701308,1.0,5/14,18.34%,BLVRB;HMOX1;HMOX2;BLVRA;ABCC1
prerank,protein kinase B signaling (GO:0043491),-0.26123514494073174,-0.8098217399768202,0.7892561983471075,0.9438730146093808,1.0,13/23,24.88%,SETX;PAX2;PIK3R3;SIRT2;TSC2;TNF;TYRO3;PLK3;CCL3;IL1B;THEM4;CCL5;TGFB1
prerank,positive regulation of DNA recombination (GO:0045911),0.3192437005605499,0.8098170473675393,0.7309711286089239,0.9089359933533364,1.0,7/27,20.44%,ERCC6;TFRC;KMT5B;ARID2;SHLD1;SHLD2;PAXIP1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3208410628498356,-0.809620801654507,0.7057057057057057,0.9426830324792116,1.0,4/12,14.77%,CCT3;CCT5;CCT4;GNL3
prerank,negative regulation of cartilage development (GO:0061037),0.3733966204668788,0.8092522618998599,0.7201704545454546,0.9094468388623997,1.0,2/13,7.95%,SOX9;SNAI2
prerank,dephosphorylation (GO:0016311),0.26598177559767155,0.80802480767633,0.8516992790937178,0.9109816418638582,1.0,24/147,14.04%,PLPP3;MTM1;MTMR3;PPM1H;PPP4R1;PPEF1;PTEN;PTPRE;DUSP3;PPEF2;PTPN12;PLPP6;PDP1;PPP4R2;PLPP5;LHPP;PPP3CA;HDHD2;ILKAP;PPP2R2A;PGP;CTDP1;PPP6C;PPP1CA
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.34619956662724594,0.8079423894866372,0.7156862745098039,0.9107444631949907,1.0,3/17,10.12%,VEGFA;PROC;ROCK1
prerank,response to cholesterol (GO:0070723),0.3540445836844265,0.8074545988753568,0.7229254571026723,0.9111125055304442,1.0,6/17,15.73%,GRAMD1B;ABCA2;GRAMD1C;GPLD1;LRP6;PMVK
prerank,regulation of centriole replication (GO:0046599),0.35042903166932876,0.8074033197243256,0.723943661971831,0.9108270830024757,1.0,4/17,15.13%,PLK2;BRCA1;CEP76;ALMS1
prerank,endocrine system development (GO:0035270),0.3397503283450805,0.8065387367194926,0.7298013245033113,0.9117780712855844,1.0,4/21,17.38%,STRA6;PAX8;SOX2;NKX2-1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2823214937503974,0.8063279065873075,0.8,0.9117334952726853,1.0,12/69,15.74%,APOE;CPEB4;PPT1;CLN3;ADAM8;PTK2B;MT3;PRKN;GDNF;CX3CL1;PRKCG;GRN
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.32432113650364724,0.8061033137231948,0.7222222222222222,0.9117197827314237,1.0,8/25,26.47%,ARAP1;AFAP1L2;RTN4;CBL;BCAR3;PLAUR;HIP1;DOK1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3152242324574581,0.8058436292477519,0.7436868686868687,0.9117697933973419,1.0,9/32,21.48%,GTF2H5;POLR2L;TAF1B;POLR1A;CDK7;MNAT1;TAF1A;RRN3;TAF1
prerank,lipoxygenase pathway (GO:0019372),0.3678049869052754,0.805757654857053,0.7063953488372093,0.9115321341628998,1.0,2/14,6.64%,PON3;GPX4
prerank,oxoacid metabolic process (GO:0043436),0.31405734142732794,0.8052144040488655,0.7288135593220338,0.9119791235756519,1.0,4/27,11.07%,ENPP1;GNMT;GRHPR;LIAS
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2762714869853691,-0.8051141917232083,0.7323943661971831,0.9495102968595724,1.0,5/18,12.28%,PHF8;HEATR1;MAF1;POLR2K;UBTF
prerank,positive regulation of secretion by cell (GO:1903532),0.2753235725174216,0.8050898895389328,0.7667031763417306,0.9117931451105994,1.0,12/70,15.16%,DTNBP1;ABCG1;ADAM9;P2RX4;IGF1;ADAM8;STXBP5;TREM2;APBB3;CLASP1;GOLPH3;GOLPH3L
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3485823145873303,0.8049086691452867,0.7084507042253522,0.9117062645469215,1.0,6/16,25.02%,IL6;ST3GAL4;RELA;IRAK1;TRAF6;NFAT5
prerank,histone deubiquitination (GO:0016578),0.35001400271763594,0.8046673446490149,0.7364016736401674,0.9117270892911595,1.0,7/18,24.56%,USP21;USP16;USP36;BRCC3;USP3;KAT2A;ATXN7
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.37978121438671386,0.8046164709078998,0.7173252279635258,0.9114350913204776,1.0,2/11,11.13%,HIPK2;ING4
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.3514155028833733,0.8045006779478849,0.7146814404432132,0.9112500465979516,1.0,3/16,15.18%,LAMP1;AP1G1;KLRD1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.24654951777758638,-0.8034991628075195,0.7543103448275862,0.9508700667695192,1.0,10/26,25.67%,EPHA5;TRPM4;LRP5;PLA2G6;KLF7;C2CD2L;STXBP4;STX4;ADRA2A;CDK16
prerank,tube closure (GO:0060606),0.3108757448354445,0.8033766115950592,0.7620253164556962,0.9125536226642746,1.0,11/31,26.16%,FOLR1;DLC1;MTHFD1L;PHACTR4;CELSR1;LRP6;VANGL2;LRP2;BCL10;PLXNB2;SKI
prerank,transcription by RNA polymerase I (GO:0006360),0.3098115971673984,0.8033509378609224,0.7478260869565218,0.9122213981607725,1.0,10/34,21.48%,GTF2H5;POLR2L;TAF1B;POLR1A;CDK7;MNAT1;TTF1;TAF1A;RRN3;TAF1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.38840037483395307,0.8032045570847726,0.7223926380368099,0.911716533751813,1.0,7/10,30.55%,AP2B1;MYLIP;AP2S1;CLTC;AP2A2;AP2A1;AP2M1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.38840037483395307,0.8032045570847726,0.7223926380368099,0.911716533751813,1.0,7/10,30.55%,AP2B1;MYLIP;AP2S1;CLTC;AP2A2;AP2A1;AP2M1
prerank,neuron remodeling (GO:0016322),-0.3379894118142312,-0.8031561115350695,0.7228915662650602,0.9499022615317586,1.0,2/10,9.36%,ADGRB3;ANKS1A
prerank,anterior/posterior pattern specification (GO:0009952),-0.21775187136976068,-0.8027418349986162,0.8590604026845637,0.949138792717709,1.0,30/53,37.63%,ACVR2B;TGFBR1;LRP5;BASP1;SMAD2;CELSR2;HHEX;HOXD4;HOXA7;HOXD3;HOXC9;HOXC5;HOXA9;HOXB9;HOXC6;PCSK5;HOXA5;HOXB5;HOXB7;BHLHE41;BMP2;LHX1;HEY1;HEY2;HES1;HOXB6;CYP26C1;HEYL;HOXD9;HES7
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3159255317378045,0.8024592566969739,0.7283464566929134,0.9124828221621554,1.0,10/27,26.38%,CD44;IL6;SIRPA;RELA;HSPD1;CD47;IRAK1;TRAF6;NFAT5;CCL2
prerank,positive regulation of translational initiation (GO:0045948),0.3414534958033046,0.8023478832400206,0.7425320056899004,0.9122799900154099,1.0,4/18,14.30%,YTHDF3;POLR2G;CDC123;UHMK1
prerank,aortic valve morphogenesis (GO:0003180),0.31487744367432025,0.8020457360954804,0.7448717948717949,0.9123771137806055,1.0,5/30,11.89%,SOX9;SNAI2;RB1;ROCK1;NOTCH1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.2888771147701131,0.8018762679478767,0.7881656804733728,0.9122725841373652,1.0,2/48,1.46%,TLR8;LILRB1
prerank,cortical cytoskeleton organization (GO:0030865),-0.22132141534172076,-0.8018720431004682,0.8587570621468926,0.9492088493989629,1.0,16/41,27.34%,NLGN1;RHOBTB1;NCKAP1;RND3;DLG1;RHOA;TNF;LLGL2;RHOBTB3;RHOBTB2;STRIP1;RHOG;RHOH;RAC1;RAC3;FMNL1
prerank,myelin assembly (GO:0032288),0.3877934577724067,0.801758196916362,0.7042682926829268,0.912079596576198,1.0,3/10,11.93%,ABCA2;EPB41L3;PMP22
prerank,cellular response to cAMP (GO:0071320),-0.24004997088052304,-0.8015368089057132,0.8028169014084507,0.948261555702215,1.0,18/30,34.77%,HCN1;AKAP9;HCN2;RAP1B;PKD2;RAPGEF3;RAPGEF2;AHR;SLC26A6;HCN3;PDE2A;IGFBP5;HCN4;AANAT;CRHBP;DMTN;AKAP6;KCNQ1
prerank,response to hexose (GO:0009746),0.31988244626531787,0.8014324272551552,0.7369826435246996,0.9121899184458095,1.0,6/25,20.29%,THBS1;IRS2;GPLD1;EIF2B2;TCF7L2;VAMP2
prerank,protein insertion into membrane (GO:0051205),0.3105705159339191,0.8008610973459485,0.7525125628140703,0.9126891753568049,1.0,7/32,11.81%,GRIN3B;STX5;HMOX1;VAPA;CYB5A;APP;ALDH3A2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.3444084451254959,0.8002751229443954,0.7158469945355191,0.9132285306562734,1.0,3/17,15.18%,LAMP1;AP1G1;KLRD1
prerank,negative regulation of cation channel activity (GO:2001258),-0.24858736522075042,-0.8002686656559259,0.7901785714285714,0.9490291320943816,1.0,7/26,24.80%,KCNAB1;FMR1;PKD2;UBQLN1;FKBP1B;CALM3;SLC6A9
prerank,atrioventricular valve development (GO:0003171),0.36311167942352035,0.7996443280106984,0.728486646884273,0.9137856296415737,1.0,3/14,11.89%,APLNR;BMPR2;NOTCH1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.29302143642457135,0.7995731218556903,0.7689530685920578,0.9135292461369315,1.0,16/46,22.85%,NR1H3;FLCN;ATF4;RB1;DDIT3;ADAM17;NOTCH1;IL15;PLCL2;LAMA4;LNPEP;RHEB;ARRDC3;NR1H2;TLE3;ACOT13
prerank,dendrite self-avoidance (GO:0070593),0.3451165010453035,0.7993034619013675,0.7238493723849372,0.9135863475224827,1.0,3/16,9.16%,PALLD;TNN;DSCAM
prerank,cellular protein-containing complex assembly (GO:0034622),0.25828326192795925,0.799234268726785,0.8517382413087935,0.9133347873069042,1.0,36/159,20.29%,HOPX;NCK2;CHCHD4;CCDC40;SNX9;UVRAG;GTF2B;LONP1;IMMP2L;DNAAF3;CHMP2A;GPX4;CYBA;PICALM;TPR;FCHO1;DNAJB14;OMA1;EPS15;VAMP3;HSPA1A;TBCA;RTN4;NUP98;HSPD1;TRAF2;TBCEL;HSPA4;SHQ1;TMEM170A;FCHO2;CCT2;VBP1;PSMD11;TCF4;VAMP2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.25981507677005256,-0.7991667568252281,0.7362204724409449,0.9495060018592837,1.0,11/21,30.49%,RAB11A;CDK4;CDC7;CDC25B;NPM1;BRD4;DTL;CDK1;CCND1;STOX1;DYRK3
prerank,response to organonitrogen compound (GO:0010243),0.29833248128965306,0.7991545002948688,0.7593712212817413,0.9130887897600992,1.0,6/38,13.63%,KYNU;IL6;NR1H4;IRAK3;RHBDD1;PRKN
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.293172639830993,-0.7991041681225206,0.7654723127035831,0.9480683119079284,1.0,5/15,21.86%,GGT5;GGT7;SARDH;ABHD12;ALDH4A1
prerank,eye photoreceptor cell development (GO:0042462),0.3581239166281268,0.7989943051189062,0.7579250720461095,0.9129584211840991,1.0,2/15,8.95%,VEGFA;TOPORS
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.3691695466049988,0.7988514614658855,0.7484276729559748,0.9127984860376015,1.0,2/12,8.33%,MAP2K5;FOXP1
prerank,neuron projection organization (GO:0106027),0.35029400786969855,0.7988358601399878,0.7318116975748931,0.912459489501603,1.0,3/15,11.47%,ABCD1;GSK3B;APP
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.26467884558540455,0.7980421515793138,0.8299681190223167,0.9132802927327913,1.0,22/110,17.36%,DHX34;RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;ETF1;RPL22;RPS21;PPP2R2A;NCBP2;RPL10A;RPS26;UPF2;RPL15;RPL10;RPSA;EIF4A3;RPL7;RPL26
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.2531011765856658,0.7979960348230233,0.8694779116465864,0.9129891201168264,1.0,62/248,22.88%,APOE;CTNNB1;ZEB2;GNAQ;PSMD1;ZNRF3;COL1A1;CUL3;GSKIP;STK3;APC;FOLR1;XIAP;SOX9;MCC;SNAI2;RNF146;DVL1;TBL1XR1;DDIT3;FZD7;GSK3B;PSMF1;PSMD14;WLS;PSMD12;SOX2;LIMD1;PRKN;PPP1CA;PSME2;LRP6;KREMEN1;TNKS;LATS1;ATP6AP2;USP8;CCDC88C;MLLT3;PSMB10;PSMD5;CSNK1G1;PTPRU;TNKS2;PSMD8;AMFR;STK4;PSMA3;PSMA2;PSMD11;WWTR1;TCF7L2;PSMA6;TLE3;VCP;PSMB3;RUVBL2;SDHAF2;KLHL12;ILK;SIAH2;PSME3
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.34290621153623746,0.7976350010406891,0.7214484679665738,0.9131844972673425,1.0,2/17,5.08%,DOCK5;IGF1
prerank,nuclear membrane disassembly (GO:0051081),-0.2916513796046086,-0.7975128801050193,0.7601351351351351,0.9493478497146103,1.0,8/14,32.62%,PRKCA;VRK1;CNEP1R1;DCTN1;CDK1;CCNB2;PLK1;LPIN1
prerank,myeloid cell development (GO:0061515),0.33881936064875207,0.7974439420052294,0.7239884393063584,0.9131099241448009,1.0,4/18,14.64%,ANXA2;FOXP1;APP;NRROS
prerank,visual system development (GO:0150063),0.301788879215824,0.7970003023832607,0.754320987654321,0.9134078744407546,1.0,7/37,13.34%,ZDHHC16;HIPK1;HIPK2;SALL2;RAB18;SOX2;SH3PXD2B
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.34335643252901454,0.7964742951814441,0.7201704545454546,0.9138305144088078,1.0,4/16,10.43%,IGF1;TRPC3;ROCK1;MTPN
prerank,aspartate family amino acid metabolic process (GO:0009066),0.33807572634889776,0.7964656892817272,0.7341597796143251,0.9134764422356869,1.0,1/18,0.75%,MSRA
prerank,histone acetylation (GO:0016573),0.27563153201747026,0.7964171268436153,0.7912457912457912,0.9131883507137183,1.0,28/69,29.22%,ZZZ3;PHF20;CREBBP;TAF5;ING3;EPC1;ING4;SUPT7L;PHF20L1;BRPF1;BRD1;TAF5L;SGF29;KAT2A;DMAP1;RUVBL2;KAT6B;POLE3;MBIP;KAT6A;BRCA2;KAT2B;MAP3K7;MRGBP;PER1;BRD8;EP300;MORF4L1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.27439748377858786,0.7963929446178215,0.7956284153005464,0.9128639580872855,1.0,19/78,24.00%,IPO5;CDKN1A;PTEN;GADD45A;APC;ADAM17;CDK7;CCNA2;CNPPD1;LATS1;MNAT1;CDC25A;CCNG1;CEBPA;GTPBP4;CCNT1;BCCIP;MEN1;NR2F2
prerank,regulation of muscle contraction (GO:0006937),-0.2510236345495539,-0.7963498852396557,0.8060344827586207,0.949872338742875,1.0,3/26,3.60%,KCNB2;ATP1A2;CHRM2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3450945943090762,0.7961797720231057,0.7354196301564723,0.9128278474618645,1.0,3/17,14.38%,UBE2L3;NR3C1;ACOD1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.26690302048600234,0.796169356823035,0.8322649572649573,0.9124837599021431,1.0,9/101,10.59%,HTR2B;PIK3R5;VEGFA;PDGFA;ADAM8;INCENP;SLC27A1;ADAM17;SIRT1
prerank,positive regulation of telomere maintenance (GO:0032206),0.30507697580548315,0.7950881422814774,0.7628205128205128,0.9137269178859145,1.0,10/31,23.86%,SIRT6;RTEL1;NBN;HNRNPD;TNKS;TNKS2;MRE11;PKIB;PPP1R10;NEK7
prerank,mitochondrion disassembly (GO:0061726),0.3021153111677066,0.795017586499201,0.7509293680297398,0.9134704440541924,1.0,10/34,19.17%,ATG7;AMBRA1;ATG5;FUNDC1;PRKN;FUNDC2;SQSTM1;BNIP3;USP30;FBXO7
prerank,dendritic cell chemotaxis (GO:0002407),0.35958949445599403,0.7938711446214746,0.7365269461077845,0.9147880059336161,1.0,1/14,0.59%,CXCR4
prerank,autophagosome organization (GO:1905037),0.2836007331478063,0.793778177807476,0.7885514018691588,0.9145587493988838,1.0,10/50,15.04%,ATG7;RAB7A;AMBRA1;VMP1;RAB1B;ATG5;PACS2;RAB43;ATG13;UBQLN2
prerank,lymphocyte proliferation (GO:0046651),-0.25945644368073056,-0.7937322130748783,0.7732793522267206,0.9528615306040084,1.0,6/22,17.39%,MEF2C;FLT3;BCL2;CD40;PIK3CG;LMBR1L
prerank,skeletal muscle tissue development (GO:0007519),0.3047909463870906,0.7936088425913439,0.7576142131979695,0.9144459198816963,1.0,3/32,7.27%,IGSF8;KLHL41;SVIL
prerank,neuron fate commitment (GO:0048663),0.36067428570159993,0.7933582829797372,0.7436661698956781,0.9144375134469646,1.0,1/14,2.96%,ID2
prerank,regulation of actin filament-based movement (GO:1903115),-0.3277348964714735,-0.7932942097815565,0.7190332326283988,0.952084248086061,1.0,2/10,8.09%,ANK2;PDE4B
prerank,inorganic cation transmembrane transport (GO:0098662),0.2518687203038275,0.7926268797898433,0.9133064516129032,0.9151117163613591,1.0,31/268,13.91%,MCOLN3;SLC6A6;ATP1B4;SLC36A2;MCOLN2;ATP6V1A;ABCB7;ANO6;SLC9A3;SLC11A2;KCNK13;RHD;P2RX4;ATP6V0D1;TMEM165;SLC8A1;SLC12A3;P2RX3;KCNAB2;TRPC3;TRPV2;SLC39A14;SLC6A8;KCNK4;NNT;ATP6V0E1;ATP6V0C;GAS6;TRPM7;SLC11A1;ATP6V1H
prerank,sodium ion transport (GO:0006814),0.2685191456893891,0.792555404203021,0.8289183222958058,0.9148561212395682,1.0,8/85,8.00%,SGK1;SLC6A6;ANO6;SLC8A1;SLC5A5;SLC12A3;SLC38A7;NEDD4L
prerank,cellular response to hexose stimulus (GO:0071331),0.32775680448123595,0.7925193620693493,0.7473404255319149,0.9145500541964021,1.0,5/23,14.56%,ERN1;ZBTB20;SLC39A14;GAS6;ADCY8
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3071947503312722,-0.7922989362863305,0.7261538461538461,0.9523077677191508,1.0,4/12,9.56%,KHDRBS1;NUP214;AAAS;IFI27
prerank,MAPK cascade (GO:0000165),0.25044171416881245,0.7922431895567652,0.9216080402010051,0.9145714405635917,1.0,45/295,14.67%,HTR2B;MAP3K20;GRB2;TAOK3;SOS1;HGF;RASA3;PSMD1;PDGFA;RGL1;RGL2;BRAP;RAF1;IGF1;FGFR4;CUL3;IRS2;NRAS;RASA4;PIK3CA;CSF2RB;RPS27A;UBC;ZFP36L2;SOX9;MAP3K8;CTSH;IL5;TNIK;PTGER4;IL3RA;PSMF1;MT3;PSMD14;ARTN;NRG4;PSMD12;CSF2RA;RASGEF1A;LAMTOR3;GDNF;SHC1;PSME2;JAK3;CUL1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.3276635000381912,-0.7920057541920139,0.7232704402515723,0.9512660777144846,1.0,3/10,6.43%,MAPT;NDFIP2;PPM1F
prerank,negative regulation of endopeptidase activity (GO:0010951),0.29331159102426324,0.7918050321627044,0.7718040621266428,0.914845981652175,1.0,7/47,14.37%,TIMP1;SORL1;PCID2;TIMP2;MT3;SERPINB8;SERPINC1
prerank,regulation of chromosome segregation (GO:0051983),-0.28530960669126726,-0.7914940347749436,0.7558528428093646,0.95061804709654,1.0,11/16,35.49%,SMC6;PUM1;NUMA1;MKI67;BUB1;IHO1;RMI2;AURKB;KIF2C;RAD18;HORMAD1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.30614379153839966,0.7913850513154697,0.759493670886076,0.9150958146673779,1.0,5/30,15.15%,SYNPO2L;AKAP13;COL3A1;LPAR6;ARRB1
prerank,regulation of mRNA processing (GO:0050684),0.30169226284921835,0.791193865242282,0.7777777777777778,0.9149953703086148,1.0,8/32,21.06%,SRPK2;RBM39;SF1;LARP7;SRSF3;SRPK1;JMJD6;SAFB
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.23948037867300226,-0.7910759840403951,0.8115942028985508,0.9498450463853336,1.0,13/32,22.91%,FHIT;STK11;PML;PPP1R13B;PYCARD;AEN;JMY;MYBBP1A;CDIP1;HINT1;SNW1;RPS27L;PHLDA3
prerank,histone exchange (GO:0043486),-0.22801799949736246,-0.790944608036237,0.8620689655172413,0.9485571756951144,1.0,15/37,24.86%,RSF1;RNF8;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;ACTR6;CENPQ;CENPN;CENPH
prerank,negative regulation of complement activation (GO:0045916),0.3810666360228126,0.7908952598446582,0.7492307692307693,0.9150414260423508,1.0,1/10,3.06%,CD46
prerank,positive regulation of rRNA processing (GO:2000234),-0.3212725516859361,-0.7904065943304316,0.723463687150838,0.9479620990810673,1.0,4/10,17.09%,HEATR1;BUD23;RIOK2;TRMT112
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3116401121943848,0.7903680670061187,0.756687898089172,0.9154515176990593,1.0,7/29,14.81%,LIMA1;PRKCD;PIK3CA;PFN1;PRKN;CLASP1;PFN2
prerank,response to calcium ion (GO:0051592),0.26232162409520954,0.7902343966280257,0.8247863247863247,0.9152821784947047,1.0,12/102,9.97%,IQGAP1;CPNE2;ADAM9;ITPKB;D2HGDH;PPIF;THBS1;RASA4;CARF;TRPC3;PPP3CA;SYT17
prerank,axonemal dynein complex assembly (GO:0070286),0.31652053952319203,0.7897082832664563,0.7668393782383419,0.915684111039303,1.0,3/27,10.01%,CCDC40;DNAAF3;ODAD1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3000670638565459,-0.7894018210531714,0.7634069400630915,0.948114753227014,1.0,3/14,17.32%,CSF1;CCR1;TNF
prerank,mRNA modification (GO:0016556),-0.2556263266115981,-0.7893330644183206,0.7827715355805244,0.9466939377986325,1.0,5/22,8.59%,METTL3;VIRMA;PUS7;CMTR1;NSUN2
prerank,positive regulation of transferase activity (GO:0051347),0.25467826805607335,0.7874790693981374,0.8467153284671532,0.9185057925977901,1.0,21/142,14.89%,CTNNB1;ACD;FBXW7;ARRDC4;RFC3;SORL1;UBE2L3;FGFR4;MERTK;POLG2;TOPORS;XRCC5;DCUN1D5;DKC1;NBN;DCUN1D3;ROR1;TREM2;DCUN1D4;HNRNPD;TNKS
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.37234686350276935,0.7874170979128942,0.75,0.9182316502406643,1.0,4/12,23.84%,WAC;FBXO31;PRKDC;CDK2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.27714432659360577,-0.7873834958270421,0.7377622377622378,0.9484795012295477,1.0,9/17,26.63%,TGFB2;ARL6IP5;RNF13;CARD9;STK25;KLHDC10;TAOK2;LYN;MID1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.32620456587807123,-0.787365076235068,0.7675070028011205,0.9470088834993465,1.0,3/10,16.61%,HNMT;SARDH;CHDH
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.26971836520212333,0.7864483593912479,0.8090395480225989,0.9192711704005668,1.0,20/73,22.88%,LMO1;PSMD1;CBFB;PSMF1;PSMD14;PSMD12;PSME2;TCF12;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;KMT2A;OSM;PSMD11;PSMA6;PSMB3;PRKDC;PSME3
prerank,B cell homeostasis (GO:0001782),-0.3315006644917572,-0.7863394271283186,0.7307692307692307,0.9472411320131672,1.0,1/10,0.41%,MEF2C
prerank,negative regulation of viral entry into host cell (GO:0046597),0.36427913459701633,0.7859553300291583,0.7659259259259259,0.9196131402055531,1.0,2/12,8.89%,IFITM1;IFITM2
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.33688019898559673,0.7856939775205342,0.7372060857538036,0.919625518012289,1.0,3/17,9.37%,SPDL1;RB1;BOD1
prerank,positive regulation of ossification (GO:0045778),0.2970073465535212,0.7854590462617526,0.7699642431466031,0.9195948065323302,1.0,7/39,10.92%,ANO6;ATP2B1;SLC8A1;ACVR2A;PKDCC;BMPR2;CCN1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.35978598773342785,0.7854543879279889,0.746031746031746,0.9192395249998069,1.0,2/12,9.16%,VEGFA;DSCAM
prerank,cell cycle G2/M phase transition (GO:0044839),0.2592454242621264,0.7852969867820742,0.8407908428720083,0.9190952842781601,1.0,33/129,22.33%,OPTN;CDKN1A;DYNC1H1;HAUS6;FBXL17;MELK;FBXL3;ENSA;PPP2R2A;CDK7;CCNA2;CEP76;CLASP1;CEP192;TUBA1A;CUL1;NDE1;LATS1;MNAT1;ALMS1;OFD1;CCP110;SSNA1;HAUS7;CDC25A;PAFAH1B1;BRSK2;PPP2R1A;PHLDA1;HAUS5;CEP41;CCDC57;PPP1R12A
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3087675720326996,0.7850033338473913,0.7744845360824743,0.9191358556295023,1.0,5/27,14.47%,ERN1;TOE1;CSTF3;LACTB2;RNASEH1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.25845115736756813,0.7840818224745078,0.8252947481243301,0.9200536723353455,1.0,16/104,13.94%,PPARG;PDPK1;SORL1;RPS27A;UBC;ACVR2A;HIPK2;BMPR2;SNX25;ADAM17;SIRT1;RBPMS2;STUB1;NOTCH1;LEMD3;HSPA1A
prerank,cellular response to glucose stimulus (GO:0071333),0.3098628990117935,0.7839433396679812,0.7657657657657657,0.9198784551412013,1.0,6/30,14.56%,ERN1;ZBTB20;SLC39A14;RAB11B;GAS6;ADCY8
prerank,regulation of double-strand break repair (GO:2000779),0.2932418966002016,0.7835238832632887,0.7971188475390156,0.9201161260056624,1.0,13/39,25.28%,TRIP12;SIRT6;PPP4R2;RTEL1;SIRT7;RNF169;SHLD2;MGMT;SPIDR;SLF1;FOXM1;TERF2IP;UBR5
prerank,histone mRNA metabolic process (GO:0008334),-0.24594209347273122,-0.7832058255305759,0.8445378151260504,0.9508679341586803,1.0,8/27,13.12%,ATM;TUT4;SSB;SNRPE;MTPAP;LSM1;SLBP;XRN1
prerank,negative regulation of angiogenesis (GO:0016525),0.2678413875804432,0.7830623561735179,0.80931744312026,0.9204058928739234,1.0,6/84,5.58%,PPARG;CTNNB1;KLK3;NIBAN2;FOXO4;THBS1
prerank,dendritic cell migration (GO:0036336),0.34246330922217955,0.7830013680864965,0.7611510791366907,0.9201335117182792,1.0,1/16,0.59%,CXCR4
prerank,collagen fibril organization (GO:0030199),0.2673101317915114,0.7825719828961912,0.8394793926247288,0.9203683726529813,1.0,18/88,18.24%,TLL2;CD151;COL4A6;COL1A1;LUM;COL4A1;COL5A2;COL11A1;COL5A3;COL3A1;LAMA3;COL6A2;ATP7A;COL11A2;COL4A5;PLOD1;COL12A1;PLEC
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.26596226734559925,0.7823769324884201,0.8438864628820961,0.9202767678103928,1.0,29/85,26.26%,PSMD1;DVL1;FZD7;PSMF1;PSMD14;FZD5;PFN1;PSMD12;FZD2;AP2B1;PARD6A;CELSR1;PSME2;DAAM1;VANGL2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;AP2S1;PSMC5;CLTC;AP2A2;PSMC1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.3169401702619588,-0.7822949517946247,0.7246376811594203,0.9508879127668777,1.0,2/11,5.97%,JUP;PLEKHA7
prerank,histone monoubiquitination (GO:0010390),-0.24974297487183644,-0.7822525861146117,0.8169642857142857,0.9494550805057412,1.0,7/24,13.81%,DDB2;TRIM37;RYBP;RNF20;BCOR;PAF1;ATXN7L3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.31950164683546545,-0.7812603788529944,0.7514450867052023,0.9495501617744948,1.0,2/10,3.61%,PRKCE;IRS1
prerank,cAMP-mediated signaling (GO:0019933),0.31275903599734517,0.7812236785031531,0.7637075718015666,0.9215768497639414,1.0,5/24,13.22%,PDE7B;MAPK7;SOX9;CAP1;DGKQ
prerank,development of primary male sexual characteristics (GO:0046546),0.296390503120672,0.7807286784865143,0.7871536523929471,0.9219382852987384,1.0,4/34,9.48%,LHFPL2;NCOA4;SOX9;NR5A1
prerank,regulation of glycolytic process (GO:0006110),0.27111477291777764,0.7806488656047187,0.8035714285714286,0.9216852456126192,1.0,19/68,22.97%,PRKAG2;NCOR1;IGF1;EIF6;ZBTB20;TPR;NUP50;APP;NUP98;ZBTB7A;NUP88;GAPDHS;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,cell differentiation in spinal cord (GO:0021515),-0.32295058549399985,-0.7804692763254186,0.7272727272727273,0.9493494247864006,1.0,2/10,10.38%,MDGA2;SOX6
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.31936400350421723,0.7799882723333122,0.7750642673521851,0.9222266202133315,1.0,3/23,10.31%,GSTM1;GPX4;LTA4H
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.27678244145956443,0.7796175937641494,0.8131487889273357,0.9223942535975383,1.0,7/56,10.77%,NSMCE2;ANXA1;ANKRD17;CUL3;RB1;ADAM17;KMT2E
prerank,dicarboxylic acid catabolic process (GO:0043649),0.3602703949903211,0.7791892666564703,0.7453416149068323,0.9226352590771407,1.0,1/13,2.62%,MTHFS
prerank,rRNA transcription (GO:0009303),0.33708258372965594,0.7790510278227133,0.7623066104078763,0.9224731767323815,1.0,3/17,12.84%,TAF1B;GTF3C4;SIRT7
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.24903537965776143,-0.7789611301307383,0.7991803278688525,0.9502903887724838,1.0,9/24,21.46%,SAR1B;ERAP1;MFSD6;IDE;TAP2;PDIA3;HFE;SEC13;FCER1G
prerank,nucleocytoplasmic transport (GO:0006913),0.289886794729764,0.778742577450349,0.7990196078431373,0.9225408403881294,1.0,11/40,22.63%,ATXN1;RITA1;NCBP2;DDX20;RSRC1;SNRPF;NUP98;SMN1;XPO1;SNRPB;MALT1
prerank,regulation of monooxygenase activity (GO:0032768),0.32140392004073015,0.7777647501009514,0.7594594594594595,0.9235874806342486,1.0,4/23,15.07%,POR;NOSIP;GDNF;WASL
prerank,dermatan sulfate metabolic process (GO:0030205),0.36014669131998955,0.7777480518932268,0.7586206896551724,0.9232490032524415,1.0,2/13,9.46%,DSE;IDUA
prerank,recombinational repair (GO:0000725),0.2656826839697651,0.7773461090741982,0.8205128205128205,0.9234654223600285,1.0,20/77,23.57%,NSMCE2;SEM1;MCM9;BRCA1;XRCC2;POLL;AP5S1;PSMD14;NBN;WRN;INO80;AP5Z1;RMI1;MRE11;RAD51B;XRCC1;SPIDR;RNF138;PALB2;ERCC4
prerank,positive regulation of signaling receptor activity (GO:2000273),0.29335104678386487,0.7772476503451282,0.7826617826617827,0.9232469237666409,1.0,12/36,26.56%,FBXW7;NCOA3;ITGB1;ADAM17;BUD31;NRP1;NCF1;TAF1;JAK2;HDAC1;CCL2;HBEGF
prerank,mRNA methylation (GO:0080009),-0.2846836013815942,-0.7772215070883082,0.7737704918032787,0.9516305085819828,1.0,4/15,8.59%,METTL3;VIRMA;CMTR1;NSUN2
prerank,regulation of viral life cycle (GO:1903900),0.324200235473638,0.7770524890121875,0.7628726287262872,0.923154659928285,1.0,3/21,9.77%,KPNA2;TRIM25;VPS4A
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.29134907524052805,0.7770047356292019,0.792336217552534,0.9228591533169427,1.0,6/37,12.34%,RFC3;GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,protein dephosphorylation (GO:0006470),0.2557089888002849,0.7768245891396192,0.8720330237358102,0.9227337097132687,1.0,22/135,14.04%,EYA1;MTM1;MTMR3;PPM1H;PPP4R1;PPEF1;PTEN;PTPRE;DUSP3;PPEF2;PTPN12;PDP1;PPP4R2;RPAP2;LHPP;PPP3CA;ILKAP;PPP2R2A;PGP;CTDP1;PPP6C;PPP1CA
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3263768826864217,0.7767598320554518,0.784741144414169,0.922473596971411,1.0,3/20,9.23%,PID1;PKDCC;PICALM
prerank,synaptic vesicle endocytosis (GO:0048488),0.2976693248243807,0.7759777829640219,0.7684729064039408,0.923189663057769,1.0,10/33,20.29%,CEL;GAK;PICALM;SNCG;STON1;NLGN2;ITSN1;FCHO2;SYNJ2;VAMP2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.36663486150672175,0.775939615218871,0.7744360902255639,0.9228829461518081,1.0,3/12,17.33%,WDR18;NBN;CDT1
prerank,positive regulation of nuclear division (GO:0051785),0.31564320720535494,0.7757950691914975,0.7780713342140027,0.9227259450203689,1.0,4/25,14.52%,CD28;IGF1;NPM2;PHIP
prerank,autophagy of mitochondrion (GO:0000422),0.29013075979647784,0.775495115589756,0.7796817625458996,0.9227847591399423,1.0,11/38,19.17%,ATG7;AMBRA1;ATG5;FUNDC1;ATG13;PRKN;FUNDC2;SQSTM1;BNIP3;USP30;FBXO7
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.2916759682416644,-0.7754154912984642,0.7861635220125787,0.953174146855896,1.0,5/14,18.45%,TMSB4X;PKD2;NFKBIE;PKD1;PSMD10
prerank,gastrulation (GO:0007369),0.33972646812995233,0.7753782531147648,0.7785515320334262,0.9225905783469338,1.0,2/15,6.78%,UGDH;LMBRD1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3509656760945029,0.7749950152958184,0.7632311977715878,0.9227629815090197,1.0,5/13,21.55%,NR1H3;LPCAT3;FCGR2B;WFS1;NR1H2
prerank,positive regulation of kinase activity (GO:0033674),0.2560841933444992,0.7749604603110751,0.847872340425532,0.922451811531066,1.0,15/107,13.37%,IQGAP1;PRKAG2;CDKN1A;SNX9;FGFR4;MERTK;CACUL1;XRCC5;PTK2B;CCN1;NBN;TAB2;ROR1;TREM2;GAS6
prerank,regulation of cardiac muscle contraction (GO:0055117),0.2946102515221476,0.7743082421631163,0.7887667887667887,0.9229690274600605,1.0,3/34,5.02%,ADRA1A;P2RX4;SLC8A1
prerank,reticulophagy (GO:0061709),-0.3084609593501361,-0.7741225470976384,0.755223880597015,0.9537512159532404,1.0,5/12,17.24%,RB1CC1;UFM1;ULK2;UFL1;ATG2A
prerank,nucleus organization (GO:0006997),0.28344127646612416,0.7739062733916725,0.8002364066193853,0.9231943998775228,1.0,18/47,25.24%,REEP4;CHMP2A;PDCD6IP;TPR;VPS4A;CHMP6;LEMD3;USP36;NUP98;CHMP5;CHMP7;TMEM170A;TOR1A;CHMP2B;NDC1;NUP54;ATXN7;CTDNEP1
prerank,nuclear pore organization (GO:0006999),-0.2867571210365629,-0.7725440160411854,0.7641196013289037,0.9548225958003637,1.0,5/14,14.86%,NUP133;AHCTF1;SEH1L;NUP35;NUP153
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.270972492299952,-0.7723556972559131,0.8064516129032258,0.9536664833106479,1.0,6/18,20.94%,PTP4A3;CCT3;CCT5;CCT4;TNF;CEP135
prerank,retinoic acid metabolic process (GO:0042573),-0.28468897919756797,-0.7723283903866017,0.74,0.9522244243625712,1.0,9/14,43.92%,BCO2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1
prerank,histone H3 acetylation (GO:0043966),-0.217672960181377,-0.7715876400563746,0.8603351955307262,0.9518795617983805,1.0,17/40,26.67%,YEATS2;PHF14;BRPF3;TADA1;TAF12;LDB1;NAA60;TAF10;WDR5;MEAF6;DR1;ING5;KAT14;TAF6L;TAF9;JADE1;LEF1
prerank,polyol biosynthetic process (GO:0046173),-0.2783305898073539,-0.7715590983151317,0.8,0.9504557820005375,1.0,6/16,16.99%,IP6K2;PPIP5K1;FGF2;ITPKC;PPIP5K2;IP6K1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.33860504100920374,0.77024979435514,0.7443181818181818,0.9278568430482061,1.0,5/16,20.44%,CTNNB1;BRCA1;DNMT1;KMT2A;PAXIP1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.36243352090080155,0.7699698381880722,0.7587209302325582,0.927891873869063,1.0,4/12,20.34%,ABCA2;LPCAT3;DGKQ;SREBF1
prerank,regulation of coagulation (GO:0050818),0.36460065261294755,0.7697389768422738,0.7676923076923077,0.9278656139209979,1.0,1/11,6.55%,PROC
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.288515190140809,0.7696536525928516,0.7985166872682324,0.9276208323294208,1.0,6/39,12.34%,RFC3;GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,chromatin disassembly (GO:0031498),0.3450883721681845,0.769430327066991,0.7446504992867332,0.9272110286705371,1.0,6/14,25.08%,SMARCC1;ARID2;SMARCD1;SMARCB1;SMARCE1;SMARCD2
prerank,nucleosome disassembly (GO:0006337),0.3450883721681845,0.769430327066991,0.7446504992867332,0.9272110286705371,1.0,6/14,25.08%,SMARCC1;ARID2;SMARCD1;SMARCB1;SMARCE1;SMARCD2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.3777327046466669,0.7692708100539286,0.7636932707355243,0.9270535408734044,1.0,2/10,7.73%,RAP2A;MSN
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.32938514108678985,0.7686580912126515,0.7646239554317549,0.927502029047647,1.0,7/18,21.62%,ABCG1;ABCA2;PICALM;RELA;CASP3;GSAP;EPHA4
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.33673215561028974,0.7682587861370419,0.7565982404692082,0.9276925019882156,1.0,7/16,25.86%,CREBBP;NAA10;NAA30;NAA25;NAA80;NAA15;KAT2B
prerank,digestive tract development (GO:0048565),0.2972534276775339,0.7681243269539136,0.7936708860759494,0.9275058595866098,1.0,4/32,8.27%,STRA6;CCDC40;NIPBL;PKDCC
prerank,regulation of telomere maintenance (GO:0032204),0.30454882975487235,0.7677668696652653,0.7576923076923077,0.9276690396640811,1.0,10/26,24.25%,SIRT6;RTEL1;XRCC5;NBN;HNRNPD;HDAC8;MRE11;PPP1R10;ERCC4;TERF2IP
prerank,negative regulation of blood pressure (GO:0045776),0.3496937924413598,0.7675690224596076,0.752112676056338,0.9275878923927856,1.0,3/13,22.02%,BMPR2;PRCP;DRD2
prerank,cellular response to interferon-gamma (GO:0071346),0.2591342691211757,0.7674133039651845,0.841304347826087,0.9274230457893741,1.0,14/88,16.51%,CD44;PRKCD;DAPK1;IFNGR2;TRIM25;PTAFR;GBP6;SIRPA;IRF2;EPRS1;ACOD1;CX3CL1;CCL7;SYNCRIP
prerank,establishment of spindle orientation (GO:0051294),0.3008444192959139,0.7667423560688715,0.7873711340206185,0.9279939519634334,1.0,6/28,18.60%,SPDL1;ITGB1;CLASP1;NDE1;PAFAH1B1;HTT
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.24755953181253862,-0.766716674071469,0.8333333333333334,0.9563543335829567,1.0,6/24,15.79%,TMEFF2;F11R;WAS;ARHGAP6;ARHGEF18;STMN1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.26625695849684067,0.7664278890720176,0.8481152993348116,0.9280574500769955,1.0,13/72,14.81%,APOE;LIMA1;SPEF1;PRKCD;PIK3CA;APC;DYRK1A;ARHGEF2;PFN1;TREM2;PRKN;CLASP1;PFN2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.32186916840079366,0.7661573694905239,0.7552910052910053,0.9280734889536252,1.0,4/19,19.60%,TLR8;MAVS;HSPD1;TBK1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.257671786726373,0.766097828730814,0.8522975929978118,0.9277940131368645,1.0,18/87,17.78%,RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;RPL22;RPS21;RPL10A;RPS26;ZFAND2B;RPL15;RPL10;RPSA;RPL7;RPL26;SEC63
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.3666524156084466,0.7658485521739605,0.7446483180428135,0.9277683410816107,1.0,1/10,4.24%,ENPP1
prerank,negative regulation of telomere maintenance (GO:0032205),0.33567286138480323,0.7658088700380054,0.760806916426513,0.9274696993905368,1.0,7/15,24.25%,RTEL1;TERF1;NBN;TNKS;TNKS2;ERCC4;TERF2IP
prerank,synaptic vesicle transport (GO:0048489),0.362369541276954,0.7657299702555721,0.7670196671709532,0.9272226029963321,1.0,5/11,21.79%,SPG11;KIF5B;KIF5C;TOR1A;TMEM230
prerank,cyclooxygenase pathway (GO:0019371),0.36986836619070845,0.7656697769844575,0.7781201848998459,0.9269486578014201,1.0,2/10,8.67%,PTGES2;HPGDS
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.3461500313205607,0.765519591959619,0.7640449438202247,0.9267834368022703,1.0,2/14,7.95%,SOX9;SNAI2
prerank,regulation of histone modification (GO:0031056),-0.2890255341362915,-0.7653673554269673,0.8012232415902141,0.9569643185694403,1.0,4/13,16.23%,HPF1;UBE2N;CDK9;PARK7
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.3185705027321824,0.7649293399220384,0.7845528455284553,0.9272191070077584,1.0,7/20,24.51%,PPIF;PPIH;CWC27;PPIE;FKBP1A;PPIG;PPIA
prerank,bicellular tight junction assembly (GO:0070830),0.2771185880541681,0.7646737330847404,0.8266978922716628,0.9272159575849391,1.0,6/46,14.33%,MICALL2;APC;PDCD6IP;STRN;PAK2;PARD6A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.316715175462561,0.7646019453483461,0.7836021505376344,0.9269499801969128,1.0,2/23,7.56%,PPEF1;CAMKMT
prerank,acetyl-CoA metabolic process (GO:0006084),-0.2800811778651386,-0.7636348498446014,0.7473309608540926,0.9581814030239331,1.0,3/15,10.02%,ACSS1;ACACA;HMGCS1
prerank,cell-cell junction maintenance (GO:0045217),-0.30703704121792574,-0.7633880075339906,0.749271137026239,0.9570737502632393,1.0,2/11,10.44%,CSF1R;FERMT2
prerank,response to purine-containing compound (GO:0014074),0.32562253056887225,0.7629254349729886,0.7401894451962111,0.9288884345584842,1.0,3/17,13.22%,P2RX4;TRPC3;DGKQ
prerank,microtubule-based transport (GO:0099111),0.3552358094760912,0.7628011119621312,0.764179104477612,0.9286843034466841,1.0,3/12,18.60%,CCDC40;SPAG17;HTT
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3028338213083601,0.7623718559953354,0.8056300268096515,0.9288899828322853,1.0,6/29,16.90%,RAB33B;VTI1B;VTI1A;TRAPPC10;COG5;COG2
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3054427159367881,0.7618723335196573,0.7876447876447876,0.9291989682882135,1.0,3/24,8.12%,ARPC2;PIK3CA;ACTR3
prerank,insulin secretion (GO:0030073),0.32413500168894904,0.7617659526729017,0.7710674157303371,0.9289913867832965,1.0,3/19,12.95%,ANXA1;CYB5R4;RAB11B
prerank,negative regulation of protein metabolic process (GO:0051248),0.27747958314144655,0.7615806872909051,0.8211764705882353,0.92888972606897,1.0,12/48,20.20%,APOE;CD84;IRAK3;ROCK1;TREM2;AZIN1;PRKCG;SNX3;HMGCR;VBP1;AZIN2;ITGAV
prerank,positive regulation of cytokinesis (GO:0032467),0.2897337854129268,0.7613792516840642,0.8101736972704715,0.9287996261841005,1.0,4/32,10.75%,KIF20B;CUL3;SVIL;PKN2
prerank,potassium ion export across plasma membrane (GO:0097623),0.3478561114947578,0.761281219439159,0.789865871833085,0.9285781878699225,1.0,13/13,65.24%,KCNK5;KCND3;KCNH2;KCNK18;KCNE5;KCNE1;KCNE2;KCNA5;KCNE4;KCNE3;KCNT2;KCNIP2;KCNQ1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.3187935268167036,-0.7610701888944471,0.7834757834757835,0.9590968620902313,1.0,7/10,28.07%,CST3;TNFRSF1A;DPP4;FAP;TGFB1;EMILIN1;CHADL
prerank,negative regulation of ossification (GO:0030279),0.30413944082623584,0.7608777819710133,0.7755644090305445,0.9287755215067107,1.0,4/23,11.89%,ENPP1;SOX9;PTK2B;NOTCH1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.3029843939193227,0.7607152015722829,0.7802631578947369,0.9286286167054315,1.0,3/24,10.59%,CD44;SNAI2;SIRT1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3188210859661197,-0.7604782171916581,0.7616438356164383,0.9585960117984189,1.0,3/10,14.63%,CCT3;CCT5;CCT4
prerank,histone H3 deacetylation (GO:0070932),0.33627550765472064,0.7603691830338267,0.760806916426513,0.928731290893078,1.0,4/15,19.36%,SIRT6;SIRT1;SIRT7;HDAC8
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.3518718237636629,0.7603500118559108,0.7810650887573964,0.9283979815127715,1.0,5/13,20.89%,EIF2AK4;APP;ADCY8;SQSTM1;LGMN
prerank,regulation of astrocyte differentiation (GO:0048710),0.3478607608353365,0.76034140068016,0.7848484848484848,0.9280522859082179,1.0,2/12,2.98%,ID2;IL6
prerank,aromatic amino acid family catabolic process (GO:0009074),0.34059523265079,0.7603111279778504,0.7757142857142857,0.9277435803997804,1.0,1/15,2.53%,KYNU
prerank,cellular response to glucagon stimulus (GO:0071377),0.33485667763980653,0.7599040384802319,0.782246879334258,0.9279155166026268,1.0,5/17,23.07%,ADCY7;ADCY8;ADCY3;ADCY5;ADCY9
prerank,embryonic heart tube morphogenesis (GO:0003143),0.28058403187305636,0.7598835471197404,0.820543093270366,0.9275869752846848,1.0,6/43,12.41%,APLNR;CCDC40;FOLR1;NOTCH1;TBX6;MICAL2
prerank,mitochondrial membrane organization (GO:0007006),-0.2188314528908633,-0.7597450864320399,0.8717948717948718,0.9581745717723608,1.0,9/32,20.37%,SLC25A4;BCL2;MFN1;BAD;SAMM50;CHCHD6;RCC1L;CHCHD3;TIMM50
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3058839013491214,0.7595786837024497,0.8027210884353742,0.9276353789912632,1.0,10/25,23.73%,ACVR2A;ACVRL1;BMPR2;CCN1;NOTCH1;SULF1;UBE2O;HES5;CDH5;BMPR1B
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.33848703907368627,0.7595559847889533,0.7707736389684814,0.9273213904836426,1.0,2/15,7.94%,CELF1;BRCA1
prerank,positive regulation of protein secretion (GO:0050714),0.26201139585890526,0.7595094825124917,0.8466666666666667,0.9270285314769865,1.0,13/69,15.42%,ABCG1;ADAM9;IGF1;ADAM8;IRS2;TRH;AACS;WLS;TREM2;APBB3;GOLPH3;GOLPH3L;NLGN2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.31130715113374513,0.7593758549004084,0.7942779291553134,0.9268670954401095,1.0,8/22,21.62%,ABCG1;ABCA2;PICALM;RELA;RANBP9;CASP3;GSAP;EPHA4
prerank,T cell differentiation in thymus (GO:0033077),0.3435442502253465,0.7585276002924181,0.7722063037249284,0.927662423161005,1.0,2/14,10.25%,ZFP36L2;ADAM17
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2567806405470115,0.7575666756578348,0.8593406593406593,0.9285717078314988,1.0,22/84,20.81%,WTAP;MBNL1;SRPK2;CELF1;RBM39;DDX5;HNRNPU;SF1;LARP7;SRSF3;PRDX6;MBNL2;NUP98;PUF60;THRAP3;RBM7;SRPK1;ZBTB7A;C1QBP;NCL;RBM15;JMJD6
prerank,cytoplasmic translation (GO:0002181),0.25393422754139333,0.7573915928802812,0.8643326039387309,0.9284504024984799,1.0,18/91,17.36%,RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;ETF1;EIF4A1;RPL22;RPS21;RPL10A;RPS26;RPL15;RPL10;RPSA;RPL7;RPL26
prerank,nucleotide metabolic process (GO:0009117),0.30964562422236624,0.7564461831879588,0.7962466487935657,0.9293394169193918,1.0,2/23,6.98%,AK8;NMNAT1
prerank,DNA recombination (GO:0006310),-0.21407471869780306,-0.756376976990208,0.8905472636815921,0.9616518292354901,1.0,18/37,33.44%,RHNO1;FBH1;RAD50;MSH3;RECQL;GEN1;RAD54B;RAD54L;RPA1;TSN;SUPV3L1;RAD51;HMGB3;LIG4;EXO1;ENDOG;XRCC3;DMC1
prerank,protein O-linked mannosylation (GO:0035269),0.31883218007706426,0.7561075389419338,0.7921348314606742,0.92940627368523,1.0,5/18,23.16%,DPM2;TMTC4;FKTN;CRPPA;FKRP
prerank,cilium organization (GO:0044782),0.24115295946839857,0.7552048314314987,0.9295065458207452,0.930254544050333,1.0,42/209,20.24%,MAK;RILPL2;RAB8B;PIBF1;SNX10;CFAP70;SNAP29;ATP6V0D1;KIF27;ASAP1;ABCC4;WDPCP;CFAP20;FBF1;KIF3A;DYNC2I2;ACTR3;IFT46;CCDC66;NOTCH1;CFAP410;CPLANE2;IFT52;OCRL;IFT140;SSX2IP;ARL3;EXOC4;OFD1;CCP110;RTTN;ARF4;EXOC7;EXOC1;BBS7;ARL13B;TMEM231;CDC14B;RAB1A;BBS1;IFT88;TCTN1
prerank,protein export from nucleus (GO:0006611),-0.23241032729658911,-0.7547352454210123,0.8356807511737089,0.9625741063726929,1.0,11/27,28.91%,SMURF1;NUP214;STRADB;PKD1;RANBP17;STRADA;CCHCR1;XPO6;TGFB1;XPO4;DUSP16
prerank,cristae formation (GO:0042407),-0.22288442131373098,-0.7546769858716248,0.8812785388127854,0.9612019679511997,1.0,12/27,26.56%,ATP5PO;DMAC2L;ATP5F1E;SAMM50;ATP5PF;ATP5MC3;CHCHD6;CHCHD3;ATP5ME;UQCC3;ATP5F1B;ATP5MG
prerank,negative regulation of calcium ion transport (GO:0051926),0.335845579905762,0.7543492993402388,0.7824897400820794,0.9310306528386214,1.0,1/15,1.46%,LILRB1
prerank,cell proliferation in forebrain (GO:0021846),0.3716723843849349,0.7541908121957226,0.7856049004594181,0.930886252979085,1.0,2/10,11.36%,HOOK3;NUMBL
prerank,regulation of cellular response to stress (GO:0080135),0.24870203794236503,0.7541472677296908,0.8870292887029289,0.9305907959159558,1.0,30/115,22.97%,CEBPB;ATF3;DNAJB6;ABCD1;CLN3;AIFM2;CREBBP;HSPA1B;ATF4;TPR;GSK3B;NUP50;SIRT1;BAG4;PRKN;HSPA1A;ADCY8;MCL1;NUP98;AMFR;BAG1;NUP88;AKT1S1;NPAS2;NUP188;HSBP1;NDC1;NUP43;NUP54;RANBP2
prerank,stress fiber assembly (GO:0043149),-0.27208494733288685,-0.7537101902290123,0.7924528301886793,0.9596620113966076,1.0,4/15,14.48%,SORBS1;PHACTR1;FHDC1;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),-0.27208494733288685,-0.7537101902290123,0.7924528301886793,0.9596620113966076,1.0,4/15,14.48%,SORBS1;PHACTR1;FHDC1;RHOA
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3130108288771649,0.753491057075144,0.7965425531914894,0.9310860436246965,1.0,2/22,4.47%,ID2;APPL2
prerank,retina homeostasis (GO:0001895),0.31093793237075085,0.7533716771943106,0.8038709677419354,0.9308974526896667,1.0,6/23,25.33%,PRDX1;CCDC66;ACTG1;SLC28A2;POTEF;ACTB
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.26028275874649515,-0.7522476338437966,0.8115942028985508,0.9603299010961758,1.0,12/20,33.40%,TGFBR1;ENG;PDCD4;TGFB2;RBPJ;OLFM1;SPRY1;BMP2;HAS2;BMP4;HEY1;HEY2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.30363831122697893,0.7519669344899292,0.8047493403693932,0.9324123038784605,1.0,3/24,7.16%,RFC3;RPS27A;UBC
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.2938089711426456,0.7517597046845276,0.8234567901234567,0.932339005480979,1.0,6/30,14.94%,TFAP2B;FOLR1;XIAP;FSTL1;ITGA3;LATS1
prerank,sensory perception of smell (GO:0007608),0.354851689061083,0.7516485568240573,0.7702909647779479,0.932146626391717,1.0,3/11,22.21%,ADCY3;DRD2;UBR3
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.29403820089425575,0.7507181870060656,0.8109517601043025,0.9329408128270552,1.0,7/28,14.94%,ARHGAP18;COTL1;WDR1;PFN1;HCLS1;PFN2;LATS1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.32687323451561257,0.7501325438845988,0.7943262411347518,0.9333427977841101,1.0,6/16,18.86%,DDX5;HNRNPM;PQBP1;RSRC1;PUF60;CDK13
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3061673360021184,0.7501106440637907,0.790257104194858,0.9330105091845609,1.0,3/23,13.30%,ADGRG3;NLRC3;RELA
prerank,regulation of transposition (GO:0010528),0.34318359456796654,0.7498064911052281,0.7709580838323353,0.9330650784204727,1.0,2/13,12.84%,SMYD5;SIRT7
prerank,muscle tissue morphogenesis (GO:0060415),0.32942025333634706,0.7497098291484725,0.8008915304606241,0.9328348469236931,1.0,2/16,12.20%,NOTCH1;MYLK
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.27358749720989384,-0.7493619103291418,0.803076923076923,0.9629328386534534,1.0,8/14,27.35%,ENTPD5;NUDT5;ENTPD6;ENTPD7;NUDT16;NUDT1;ENTPD3;NUDT18
prerank,mitochondrion distribution (GO:0048311),0.3565077122501537,0.7491517109836778,0.7975077881619937,0.933223359365769,1.0,1/12,0.94%,MTM1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.2240593544472621,-0.7485671188371336,0.8765957446808511,0.9625544788412821,1.0,9/30,16.96%,FHIT;STK11;MDM4;PPP1R13B;PYCARD;USP10;JMY;MYBBP1A;HINT1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.2877350385775576,0.7481806028317634,0.7987654320987654,0.934116563975239,1.0,4/33,9.75%,SYK;ADAM9;SNAI2;PLAU
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.30204713746585043,0.7480619224230602,0.797634691195795,0.9339088569055616,1.0,5/24,16.18%,VEGFA;SEMA4B;DSCAM;SEMA3B;NRP1
prerank,smooth muscle tissue development (GO:0048745),0.3720386637535297,0.7472755927464871,0.7801857585139319,0.9345581969007282,1.0,1/10,1.11%,STRA6
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2215767769797691,-0.7470954695932973,0.8894472361809045,0.963100420111475,1.0,8/31,13.58%,TFDP2;BCL2;PPP1R13B;NMT1;HIP1R;BAD;YWHAG;YWHAH
prerank,autophagosome assembly (GO:0000045),0.26662179197073654,0.7470115682071446,0.8399532710280374,0.9345464670764403,1.0,10/52,15.04%,ATG7;RAB7A;AMBRA1;VMP1;RAB1B;ATG5;PACS2;RAB43;ATG13;UBQLN2
prerank,ruffle organization (GO:0031529),0.32784500275446693,0.745465210986265,0.8036984352773826,0.9361769811303627,1.0,2/16,9.32%,LIMA1;PLEKHA1
prerank,protein import into mitochondrial matrix (GO:0030150),0.31967189700779264,0.7453246608076575,0.7933425797503467,0.9359965073450683,1.0,3/18,11.77%,TOMM20;TIMM17A;TIMM17B
prerank,C-terminal protein amino acid modification (GO:0018410),0.34839231774213,0.7452975946412749,0.7921686746987951,0.9356660316217833,1.0,5/11,21.29%,ATG7;ATG5;GPLD1;ICMT;TTL
prerank,V(D)J recombination (GO:0033151),0.35830075869192685,0.7448295863681742,0.7822085889570553,0.9359049465334187,1.0,3/11,22.19%,XRCC4;DCAF1;PRKDC
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.27162637649113397,-0.7443105467876915,0.8303571428571429,0.9654694067072888,1.0,4/14,13.38%,FAM98B;DDX1;TSEN34;RTRAF
prerank,alpha-amino acid catabolic process (GO:1901606),0.2915258388850456,0.7440655680085918,0.8,0.9365091962887286,1.0,5/29,17.70%,KYNU;PRODH;FAH;BLMH;MTRR
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.28387222567388876,-0.7433616094742999,0.83125,0.96534959784951,1.0,5/13,17.32%,FUT9;ETS1;ITGB2;RHOA;TNF
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.2218452903849695,-0.7431338926748252,0.8571428571428571,0.9642172442081851,1.0,13/29,36.39%,FANCD2;ZCWPW1;IHO1;TERB1;STAG3;TRIP13;PRDM9;SYCE2;TEX11;MAJIN;REC8;HORMAD1;BAG6
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.3016415922598175,-0.7420847459909163,0.8115501519756839,0.9640487711535778,1.0,2/11,3.83%,NOVA1;PCBP3
prerank,cardiac conduction system development (GO:0003161),0.29988523886889773,0.7420371031527835,0.8031088082901554,0.9387283625551314,1.0,2/24,5.35%,NOTCH2;MAML1
prerank,cholesterol biosynthetic process (GO:0006695),0.29369500598035625,0.741629921288287,0.8158236057068742,0.9388782401327249,1.0,9/31,20.51%,MVD;PLPP6;IDI1;INSIG2;PMVK;ACAA2;SC5D;HMGCR;ARV1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24780787594230552,0.7415970783266382,0.8847780126849895,0.9385687083767906,1.0,26/104,22.59%,CDKN1A;UVRAG;SLC8A1;GADD45A;PPEF2;INCENP;SLC27A1;RB1;SIRT1;CDK7;CCNA2;CNPPD1;LRP6;SNF8;MNAT1;CAMK1;CDC25A;HTT;CCNG1;PPP2CA;CALM2;CAB39;KSR1;GTPBP4;CCNT1;SYAP1
prerank,peptidyl-threonine modification (GO:0018210),0.2616475809127865,0.7412848863316874,0.8681564245810056,0.9386014178413793,1.0,12/66,14.89%,GALNT3;PDPK1;PRKCD;DYRK1A;HIPK1;CSNK2A2;HIPK2;ROCK1;GSK3B;ACVR1B;DYRK2;TNKS
prerank,positive regulation of ATP metabolic process (GO:1903580),0.289036433546543,0.7408164493427009,0.8274111675126904,0.9388172936341082,1.0,5/32,12.33%,PID1;IGF1;ZBTB20;APP;TREM2
prerank,positive regulation of phosphatase activity (GO:0010922),0.30870974333630113,0.7405215797133143,0.794392523364486,0.9388351105708486,1.0,1/21,0.63%,CD300A
prerank,fatty acid elongation (GO:0030497),0.3383690514186663,0.7403287081000466,0.7865671641791044,0.9387161101802188,1.0,3/13,11.41%,ABCD1;HACD4;ELOVL1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.34547636101776324,0.7397664041649118,0.7910447761194029,0.9390455296581885,1.0,1/11,3.04%,TIMM22
prerank,bicarbonate transport (GO:0015701),0.29623038679248875,0.739683618356335,0.8129032258064516,0.9388003243456435,1.0,5/25,18.31%,AQP1;CYB5R4;CA2;CYB5R2;CYB5R1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.2776476432017198,0.7392433160025212,0.8476420798065296,0.9390164954545839,1.0,9/38,17.16%,NEDD9;NCK2;RAP2B;APP;GAS6;SHC1;PTPN1;ACE;SH3BP5
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.27229772154768384,0.739102388645855,0.8244365361803084,0.9388254262667332,1.0,9/42,20.00%,ERCC6;SIRT6;HELB;PPP4R2;RTEL1;ARID2;SHLD1;RADX;SHLD2
prerank,positive regulation of cilium assembly (GO:0045724),-0.2538425731020295,-0.738741476201049,0.8628158844765343,0.9668689422328766,1.0,5/18,21.31%,ENTR1;MARK4;TAPT1;CEP135;KCTD17
prerank,type I interferon signaling pathway (GO:0060337),0.27659509518208275,0.738396012456278,0.8299155609167672,0.9390098642382803,1.0,9/41,16.96%,IFITM1;IFNAR2;RNASEL;IRF2;IFITM2;BST2;MYD88;IFIT2;IFNAR1
prerank,cellular response to type I interferon (GO:0071357),0.27659509518208275,0.738396012456278,0.8299155609167672,0.9390098642382803,1.0,9/41,16.96%,IFITM1;IFNAR2;RNASEL;IRF2;IFITM2;BST2;MYD88;IFIT2;IFNAR1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.26729089645795895,0.7382657559646497,0.8444976076555024,0.9384702134377094,1.0,15/50,22.97%,POLR2A;AGO2;POLR2L;TPR;POLR2G;NUP50;POLR2I;PUM2;NUP98;NUP88;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,regulation of gene silencing by RNA (GO:0060966),0.26729089645795895,0.7382657559646497,0.8444976076555024,0.9384702134377094,1.0,15/50,22.97%,POLR2A;AGO2;POLR2L;TPR;POLR2G;NUP50;POLR2I;PUM2;NUP98;NUP88;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.25433463300745196,0.7379035354349288,0.884009009009009,0.93854232055686,1.0,17/68,23.87%,BAAT;ENPP1;AMPD3;ACSM3;GLYAT;NT5C2;ACOT9;BPNT2;ADSS1;ACOT2;ACOT6;PDE9A;EPHA2;HPRT1;ACOT13;GNAI3;ACOT8
prerank,spliceosomal snRNP assembly (GO:0000387),0.27786566816522085,0.7377966902795664,0.8394160583941606,0.9383282411965048,1.0,8/38,16.02%,CLNS1A;PRPF8;SART1;WDR77;PRPF6;DDX20;SNRPF;SMN1
prerank,establishment of mitotic spindle localization (GO:0040001),0.2921879247737762,0.7377682389840738,0.8272383354350568,0.9380129171587156,1.0,6/28,18.60%,SPDL1;ITGB1;CLASP1;NDE1;PAFAH1B1;HTT
prerank,negative regulation of lyase activity (GO:0051350),-0.2665078873076874,-0.7376973434349895,0.8166666666666667,0.9669160376315007,1.0,5/16,15.79%,GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.3340825194616362,0.7376571192528367,0.8214285714285714,0.9377941672987158,1.0,9/14,32.57%,SEC23B;SEC31A;RAB1A;SEC24C;SEC24B;SEC24A;SAR1A;SEC23A;SEC24D
prerank,positive regulation of hydrolase activity (GO:0051345),0.24304627062511538,0.7375917740665882,0.9033264033264033,0.937523369822066,1.0,16/137,12.80%,PSAP;TGM2;RIC1;TBC1D2;SNX9;FLCN;DOCK10;ARAP1;CTSH;PICALM;ITGB1;MTCL1;GSK3B;BCAS3;WRN;RAPGEF1
prerank,DNA packaging (GO:0006323),0.32540158734848107,0.7374096740249516,0.817923186344239,0.9374039390959543,1.0,8/16,30.45%,NAA10;NOC2L;PRM1;CDAN1;AIFM1;KAT6A;TP53;CHAF1B
prerank,interstrand cross-link repair (GO:0036297),0.26139459422347616,0.737377911556553,0.8522050059594756,0.9370932985731374,1.0,9/53,16.00%,MUS81;MCM9;RPS27A;UBC;EME1;DCLRE1B;ERCC6L2;CENPX;FANCA
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3189410395526271,0.7373455627390876,0.8008658008658008,0.9367859812876286,1.0,1/17,3.06%,CD46
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3063828429820581,0.7373350046345939,0.8149171270718232,0.9364472278614441,1.0,4/19,13.27%,HIPK1;HIPK2;SIRT1;DYRK2
prerank,peripheral nervous system development (GO:0007422),0.29994220360244406,0.7367114954655394,0.7997347480106101,0.9368568527993347,1.0,7/23,26.25%,ARTN;ALDH3A2;PMP22;GDNF;SOX8;EGR2;ADGRG6
prerank,regulation of dephosphorylation (GO:0035303),0.3259273572860243,0.7353831028508023,0.8014492753623188,0.9381606524300923,1.0,1/15,1.34%,MTMR3
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.28423952369140715,-0.7352067079085403,0.8252427184466019,0.9687673187674397,1.0,7/12,32.62%,PRKCA;VRK1;CNEP1R1;CDK1;CCNB2;PLK1;LPIN1
prerank,atrial septum morphogenesis (GO:0060413),0.3509126958035805,0.7347898132684495,0.7801857585139319,0.9385365422701059,1.0,2/10,9.37%,NOTCH2;BMPR2
prerank,negative regulation of macrophage activation (GO:0043031),0.3201658104415934,0.7345248264073521,0.7988826815642458,0.9385192283580804,1.0,5/16,21.02%,NR1H3;CX3CL1;GRN;FCGR2B;PTPRC
prerank,basement membrane organization (GO:0071711),-0.2785528673274933,-0.7338269191729505,0.823321554770318,0.9691243624864676,1.0,7/14,25.12%,NTNG1;HPN;NTN4;NID2;FLRT2;LAMB2;LAMB1
prerank,dicarboxylic acid transport (GO:0006835),0.28779433891827977,0.7335681917880105,0.822360248447205,0.939333347969995,1.0,4/28,8.91%,SLC26A1;FOLR2;FOLR1;SLC25A32
prerank,lipid droplet organization (GO:0034389),0.3052688644115293,0.7333296601715892,0.8344370860927153,0.9392556412496242,1.0,6/22,27.64%,FAF2;RAB18;CDS2;RAB3GAP1;PPIA;BSCL2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.20947241052878676,-0.7331776322714724,0.8961748633879781,0.9684605389570966,1.0,12/39,20.48%,FMN2;SPIRE1;WAS;FUS;KMT5C;PARP1;SMCHD1;KDM4D;ZCWPW1;TIMELESS;RAD51AP1;SETMAR
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.26683664657377887,0.7330854312337521,0.8464285714285714,0.9392072650586901,1.0,7/46,11.33%,TNIP1;PTEN;DUSP3;FLCN;CNKSR3;SIRPA;FBLN1
prerank,positive regulation of cellular senescence (GO:2000774),0.3525042547346281,0.7326755009365034,0.7712519319938176,0.9393433498741409,1.0,2/10,10.59%,ARG2;SIRT1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.30214420807089676,0.7325630169528952,0.8275401069518716,0.9391244765532017,1.0,5/23,18.60%,SPDL1;ITGB1;NDE1;PAFAH1B1;HTT
prerank,tight junction assembly (GO:0120192),0.26323236498989844,0.7322324279086571,0.8576429404900817,0.9391896997796277,1.0,12/49,25.41%,MICALL2;APC;PDCD6IP;STRN;PAK2;PARD6A;RAB13;ACTG1;FRMPD2;CDH5;AFDN;TBCD
prerank,lysine metabolic process (GO:0006553),0.3446084756036661,0.7322140311343548,0.8179012345679012,0.9385138157806189,1.0,3/12,16.77%,GCDH;OGDH;ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.3446084756036661,0.7322140311343548,0.8179012345679012,0.9385138157806189,1.0,3/12,16.77%,GCDH;OGDH;ALDH7A1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.2653251165860167,-0.7319225538721145,0.7985347985347986,0.9686138505179503,1.0,5/17,23.87%,PDE3B;APOC1;TNF;IL1B;ADRA2A
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.2523934377792797,-0.7317924843912548,0.8885245901639345,0.9673177726377981,1.0,6/17,22.27%,VIRMA;RNF20;CDK9;CPEB3;NUDT21;HSF1
prerank,regulation of interleukin-2 production (GO:0032663),0.26997295331959026,0.7306558574795559,0.8590203106332138,0.9400645262579674,1.0,4/43,4.59%,ANXA1;FOXP3;CD28;HOMER3
prerank,regulation of axon regeneration (GO:0048679),-0.28777672161565976,-0.7302705045418333,0.8595505617977528,0.9678111872784173,1.0,1/12,0.30%,RTN4RL1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3371811263843033,0.7297060245191855,0.7942446043165468,0.9408964702621516,1.0,3/13,9.33%,TBC1D10A;NLRC4;CYFIP2
prerank,hemopoiesis (GO:0030097),0.24648086904319463,0.729039819783115,0.8894907908992417,0.9413552980715081,1.0,25/87,22.19%,RUNX2;ZNF160;RUNX3;NOTCH2;MELK;FLCN;ATF4;ZFP36L2;ETV6;HIPK1;TET2;ARIH2;RRAS;PRRC2C;TEK;NCOA6;GLRX5;CDK13;KMT2A;MKNK2;ZBTB16;PTPRC;CEBPA;SNRK;TIRAP
prerank,cellular response to nitrogen compound (GO:1901699),0.3103487851517778,0.7287540705845885,0.8150134048257373,0.9413531351697624,1.0,6/20,22.99%,NR1H4;EPG5;NSMCE3;DDI2;RTF2;SPIDR
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.29006247963899656,-0.7284099586673574,0.8035190615835777,0.9687194819622181,1.0,2/11,9.19%,IL6ST;STAT1
prerank,regulation of microtubule-based process (GO:0032886),0.27379239250220444,0.7283419201567086,0.8341523341523341,0.9414764540837707,1.0,7/36,13.75%,DIAPH1;APC;ROCK1;GSK3B;CDK2AP2;MACF1;CLASP1
prerank,negative regulation of DNA replication (GO:0008156),0.33134742459886984,0.7282823541945188,0.7833827893175074,0.9411953786667692,1.0,5/13,22.54%,TERF1;PDS5A;GTPBP4;CDAN1;WAPL
prerank,growth hormone receptor signaling pathway (GO:0060396),0.32544136526052836,0.7279730269121883,0.8228404099560761,0.9412124499375724,1.0,6/14,22.89%,STAT5B;JAK3;PTPN1;STAT6;STAT3;JAK2
prerank,amino acid import (GO:0043090),0.30197678993797233,0.727947654433367,0.813986013986014,0.940892967851142,1.0,1/21,0.69%,SLC6A6
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.27025399982096643,0.727524605922548,0.8492822966507177,0.9410469273733734,1.0,14/41,22.97%,PRKAG2;EIF6;TPR;NUP50;NUP98;ZBTB7A;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,catecholamine biosynthetic process (GO:0042423),-0.2967276325950604,-0.7268928594863557,0.8302469135802469,0.9690932239006559,1.0,4/11,36.20%,TGFB2;MOXD1;GATA3;DAO
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.33015524446794164,0.7268049021445947,0.8075253256150506,0.941566938773719,1.0,1/13,3.19%,NIBAN2
prerank,body fluid secretion (GO:0007589),0.3202373901824745,0.7266524156312436,0.7977369165487977,0.9414115521790406,1.0,1/15,1.73%,VEGFA
prerank,regulation of dopamine secretion (GO:0014059),0.294151701460906,0.7264257333741998,0.8498727735368957,0.9413305314528034,1.0,4/25,14.15%,DTNBP1;SYT17;PRKN;GDNF
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.2202770755762939,-0.7255117969014928,0.9130434782608695,0.9692919100104668,1.0,4/30,12.72%,CSF1R;FLT3;PLD4;UFL1
prerank,tRNA processing (GO:0008033),0.254841819824994,0.7249992031903137,0.8789954337899544,0.9426154273019232,1.0,5/61,4.19%,DTWD1;FARS2;CPSF1;LCMT2;TRDMT1
prerank,regulation of catabolic process (GO:0009894),-0.24835653687618453,-0.7243545419594973,0.8647686832740213,0.9693478958114353,1.0,4/18,13.19%,HPGD;CENATAC;CHEK2;ODC1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.33524732611084523,0.7239676969573472,0.7864506627393225,0.9434893828559994,1.0,1/12,3.31%,MUS81
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.24191425953965479,-0.7237875348346782,0.8888888888888888,0.9686179839365731,1.0,11/21,38.35%,BMPR1A;TGFBR1;DAB2;SMAD4;TGFB1;FAM89B;BMP4;TGFB3;SH2B1;NUP93;VEPH1
prerank,cochlea morphogenesis (GO:0090103),-0.30026829459227555,-0.7234942853385576,0.8184523809523809,0.9675595943220148,1.0,3/10,19.45%,PAX2;HPN;MYO3B
prerank,regulation of transmembrane transport (GO:0034762),0.2818161260119094,0.723131353915238,0.8452685421994884,0.9441187772626111,1.0,5/31,12.33%,PIM1;NEDD4L;WWP2;PRKCB;SLC2A1
prerank,nucleosome organization (GO:0034728),0.2563908316004187,0.723072025405619,0.8775510204081632,0.9438392929209245,1.0,17/55,25.08%,ANP32B;SOX9;BRD2;ZNHIT1;NASP;VPS72;SMARCC1;ARID2;SMARCD1;INO80;SMARCB1;DMAP1;KAT6B;POLE3;SMARCE1;ANP32E;SMARCD2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.2812898377681828,0.7223782775955139,0.8571428571428571,0.9442671458135785,1.0,8/33,24.46%,ID2;RIPK1;FES;HCLS1;ACIN1;TRAF6;HAX1;CASP8
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.34373148136377374,0.7221298621572962,0.8074534161490683,0.9441947949461884,1.0,2/11,10.59%,ANXA1;SIRT1
prerank,limb development (GO:0060173),0.28292918727239835,0.7213392566460582,0.8542199488491049,0.9447668802754896,1.0,2/28,5.26%,MAP3K20;ZNRF3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.34609515045950884,0.7210093033577789,0.8190327613104524,0.9444571783401324,1.0,4/10,19.06%,PRKCD;SPHK2;SIRT3;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.34609515045950884,0.7210093033577789,0.8190327613104524,0.9444571783401324,1.0,4/10,19.06%,PRKCD;SPHK2;SIRT3;NSMAF
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3020411680613045,-0.7209970195046691,0.839541547277937,0.9691768671863132,1.0,2/10,12.46%,UPP2;NT5C
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3469748261097721,0.7206642215347282,0.802731411229135,0.9445141316537914,1.0,3/10,22.16%,NUFIP1;SHQ1;RUVBL2
prerank,L-serine metabolic process (GO:0006563),0.34998036053113907,0.7204013317863778,0.8011958146487295,0.9444856587817463,1.0,1/10,2.26%,PHGDH
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3153454775881033,0.7200519491677306,0.8222849083215797,0.9445349387324619,1.0,1/17,2.82%,NR1H3
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3410914249660606,0.7198422449814623,0.8081570996978852,0.9444295379187027,1.0,2/11,15.64%,NCBP2;CDC73
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.29492412382251715,0.7196273239810341,0.852437417654809,0.9443230726496701,1.0,1/24,0.48%,APLNR
prerank,dendritic cell differentiation (GO:0097028),0.2962851934660739,0.7194120887450847,0.8277310924369747,0.9442387617013578,1.0,3/22,13.37%,LILRB1;TREM2;GAS6
prerank,gonad development (GO:0008406),-0.19743959539786543,-0.7191011214228819,0.9485714285714286,0.9699377886530336,1.0,11/41,24.83%,SALL1;KITLG;BASP1;TGFB2;AR;WNT4;BIK;COL9A3;WNT5A;MKKS;WNT2B
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.29056492261496225,-0.719011367414559,0.8222222222222222,0.9657823581382442,1.0,2/11,5.59%,PANK3;ACOT7
prerank,coenzyme A biosynthetic process (GO:0015937),-0.29056492261496225,-0.719011367414559,0.8222222222222222,0.9657823581382442,1.0,2/11,5.59%,PANK3;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.29056492261496225,-0.719011367414559,0.8222222222222222,0.9657823581382442,1.0,2/11,5.59%,PANK3;ACOT7
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.31365321299379006,0.7183365470657074,0.8239339752407153,0.9451076052258669,1.0,4/16,15.66%,DDX5;NCOA4;ESR1;PPARGC1B
prerank,negative regulation of glycolytic process (GO:0045820),0.34427549460452883,0.7181539586457674,0.8194233687405159,0.9446268311498753,1.0,1/10,4.34%,NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.34427549460452883,0.7181539586457674,0.8194233687405159,0.9446268311498753,1.0,1/10,4.34%,NCOR1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.30644373978607037,0.7181381884853799,0.8155737704918032,0.9442954965378528,1.0,2/17,7.85%,VEZF1;SOX9
prerank,mRNA destabilization (GO:0061157),0.2687163705621189,0.7179281330071903,0.8619402985074627,0.9441950146529121,1.0,5/38,10.56%,CELF1;YTHDF3;ZFP36L2;ROCK1;FTO
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.30210182230018656,-0.7163499011636537,0.8265895953757225,0.9674593619485992,1.0,1/10,5.49%,FMR1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3175301064202196,0.7159199603717604,0.8152327221438646,0.9461408372793574,1.0,1/16,2.51%,VIM
prerank,cilium assembly (GO:0060271),0.22713965304681402,0.7158106886541535,0.9809045226130654,0.9459243409098625,1.0,60/296,20.30%,MAK;RILPL2;RAB8B;PIBF1;SNX10;CFAP70;DYNC1H1;SNAP29;CCDC40;ATP6V0D1;KIF27;HAUS6;ASAP1;DNAAF3;ABCC4;WDPCP;CFAP20;FBF1;KIF3A;DYNC2I2;ACTR3;DYNLRB1;IFT46;CCDC66;TRIP11;TOGARAM1;CEP76;TNPO1;NOTCH1;CFAP410;CPLANE2;IFT52;CLASP1;OCRL;IFT140;CEP192;TUBA1A;SSX2IP;ARL3;NDE1;ALMS1;EXOC4;OFD1;CCP110;SSNA1;VANGL2;HAUS7;ARF4;EXOC7;EXOC1;BBS7;PAFAH1B1;ARL13B;TMEM231;CDC14B;RAB1A;BBS1;IFT88;TCTN1;PPP2R1A
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.25663041438028167,0.7152199245902086,0.8917345750873108,0.9462643450860696,1.0,8/56,10.12%,BIN3;SNX9;APC;INCENP;PDCD6IP;VPS4A;SNX33;ROCK1
prerank,presynaptic endocytosis (GO:0140238),0.2892694614741399,0.7144449402975811,0.83841059602649,0.9468025026162644,1.0,7/24,20.29%,CEL;SNCG;STON1;NLGN2;FCHO2;SYNJ2;VAMP2
prerank,RNA modification (GO:0009451),0.25388114488664326,0.7141800992531584,0.8687572590011614,0.9467520988292466,1.0,11/54,17.02%,DTWD1;LCMT2;TRDMT1;NSUN3;NAT10;CTU2;MEPCE;MRM2;TSR3;ADARB1;ALKBH1
prerank,chromosome organization (GO:0051276),0.24140927877592508,0.7141669978358219,0.9208860759493671,0.9464215936972853,1.0,25/99,22.66%,GPS1;DOT1L;RPS27A;UBC;COPS5;SETD7;DDB1;SIRT1;CUL4A;COPS7A;SOX2;LATS1;BRWD1;CDT1;ZBTB7A;HDAC8;TCF7L2;PHF1;CUL4B;SAFB;XPC;CDAN1;HMG20A;MTF2;SUPT4H1
prerank,heterochromatin organization (GO:0070828),0.3172805297862912,0.7133887935416295,0.8316690442225392,0.9469511426316163,1.0,5/14,27.84%,SETD7;SIRT1;PRDM16;POLE3;HP1BP3
prerank,maintenance of protein localization in organelle (GO:0072595),0.2980072584169731,0.7131572119794992,0.8411602209944752,0.9468651326606756,1.0,6/19,23.94%,HNRNPU;TOPORS;SUPT7L;BCL3;TAF8;HK1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.27803650578531486,-0.7129541593081294,0.85,0.9699950751624088,1.0,4/13,13.30%,NR3C2;PLPP1;PGR;AR
prerank,regulation of proteolysis (GO:0030162),0.26100514044497086,0.7129145886942896,0.8827586206896552,0.946778807179317,1.0,14/48,24.55%,CLN3;FGFR4;TBC1D10A;CYFIP2;STUB1;TRAF3;PARL;AURKAIP1;SPOP;OGT;GSAP;PLAUR;CASP8;DNAJC1
prerank,ephrin receptor signaling pathway (GO:0048013),0.2451111001651282,0.7128652792549751,0.8934065934065935,0.9464820872585189,1.0,21/82,24.06%,SDCBP;VAV3;NCK2;ARPC2;ANKS1B;ACTR3;ROCK1;AP2B1;NCSTN;WASL;ARPC1A;ITSN1;ARPC4;ACTG1;EPHA2;EPHA4;ARPC5;APH1B;PSEN2;HRAS;AP2S1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3219730628389049,0.7128341577311423,0.8215339233038348,0.946170071357047,1.0,2/14,7.73%,RAP2A;MSN
prerank,regulation of spindle organization (GO:0090224),0.31130423447523725,0.712781242206243,0.852112676056338,0.9458817353938591,1.0,2/18,6.70%,DYNC1H1;PARP3
prerank,protein K63-linked deubiquitination (GO:0070536),0.27634882856016635,0.7127464722889884,0.8428390367553865,0.9455720588381615,1.0,9/31,19.38%,BABAM2;PSMD14;USP16;TNFAIP3;BRCC3;USP8;OTUD5;STAMBP;ATXN3
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3050085884376683,0.7120544896479775,0.840877914951989,0.9459875488008405,1.0,4/18,16.33%,IL6;RB1;CLASP1;MELTF
prerank,mitochondrion localization (GO:0051646),0.2995959319363898,0.7107610792528596,0.8184319119669876,0.9470782907612821,1.0,1/19,0.94%,MTM1
prerank,antibacterial humoral response (GO:0019731),0.3126690845271751,0.7100037826371033,0.8161244695898161,0.9475741281817242,1.0,3/16,17.91%,RNASE3;SLPI;DEFA6
prerank,establishment of endothelial barrier (GO:0061028),0.27695377806377813,0.7086902085194272,0.8606965174129353,0.948695582775393,1.0,9/29,24.83%,RAB1B;MSN;RAP2B;RAPGEF1;RAB1A;PDE4D;EZR;AFDN;RAP2C
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.25902408166078705,0.7082673247284654,0.8844807467911319,0.9488311681971604,1.0,14/48,23.47%,NEDD9;DOCK5;TRIOBP;RREB1;CUX1;OLFM4;DOCK1;NRP1;CAPRIN1;C1QBP;CDKL5;PRKDC;ILK;FLNA
prerank,toxin transport (GO:1901998),0.3459091350474634,0.7081570144136766,0.805993690851735,0.9486029611682266,1.0,3/10,21.31%,ANTXR2;RAB29;ADAM10
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.23295077475287962,-0.707804985298501,0.8980392156862745,0.9728612788135862,1.0,9/21,24.65%,GTF2H2;DDB2;PARP1;ERCC5;XPA;RPA3;GTF2H4;RPA1;ERCC2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.23295077475287962,-0.707804985298501,0.8980392156862745,0.9728612788135862,1.0,9/21,24.65%,GTF2H2;DDB2;PARP1;ERCC5;XPA;RPA3;GTF2H4;RPA1;ERCC2
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.27590657414261166,0.7072772239983416,0.8565989847715736,0.9492415823702062,1.0,11/29,30.22%,CTNNB1;CREBBP;CDC73;TCF7L2;TLE3;MEN1;HDAC1;KMT2D;SMARCA4;EP300;TLE4
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.33540237665259093,0.7072383057844974,0.8304552590266876,0.9489296982903364,1.0,1/11,2.99%,HGF
prerank,GTP metabolic process (GO:0046039),-0.26373655222137526,-0.7071215550434475,0.8390092879256966,0.9721534272069636,1.0,7/15,31.26%,GTPBP1;RAB23;MFN1;ENTPD7;EFL1;IMPDH1;AK4
prerank,protein import into peroxisome matrix (GO:0016558),0.32529858420974883,0.7071013716943128,0.8312883435582822,0.9487322311908832,1.0,2/12,6.94%,PEX7;PEX14
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.21164352691262467,-0.7060501460557157,0.9138755980861244,0.9718685283321074,1.0,8/28,25.92%,TNFRSF1A;BCL2;DAB2IP;DEDD;TNF;DIABLO;DELE1;DDX3X
prerank,nucleosome assembly (GO:0006334),0.27687057981893876,0.7059948797522153,0.8645320197044335,0.9495757967542936,1.0,4/31,8.39%,ANP32B;SOX9;BRD2;NASP
prerank,chromatin assembly or disassembly (GO:0006333),0.3366636565642326,0.705758937621565,0.8114374034003091,0.9495066539393133,1.0,4/11,21.67%,SUV39H2;NOC2L;HDAC8;CDAN1
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.20181893677641444,-0.7055806658922532,0.9570552147239264,0.9710197610762041,1.0,11/42,26.38%,SH2B3;CCL4;WNK1;CCR2;CCR1;CIB1;CCL3;CCL14;FOXC1;CCL5;GPR75
prerank,regulation of plasminogen activation (GO:0010755),0.33080059383861726,0.7055568508486589,0.8029850746268656,0.9493882467716281,1.0,3/12,16.33%,THBS1;CTSZ;MELTF
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3073649170738342,0.7053987068845149,0.8415841584158416,0.9492243922874538,1.0,6/16,28.45%,ZFP36L2;PLEKHN1;ZC3H12D;ZFP36;RC3H1;ZFP36L1
prerank,Rho protein signal transduction (GO:0007266),0.25425922444166227,0.7051400705613124,0.8869257950530035,0.9491547009284436,1.0,9/53,14.40%,RHOJ;MYO9B;GNA13;GNA12;ROCK1;RHOD;CFL1;PHACTR4;CELSR1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3034495866287402,0.704890884289229,0.8279132791327913,0.9490805479357719,1.0,4/19,17.58%,VEGFA;ROCK1;NRP1;TEK
prerank,cytoplasmic translational initiation (GO:0002183),0.30253226177250825,0.704773822382234,0.8365384615384616,0.9488673658932615,1.0,3/17,9.70%,EIF3A;EIF4A1;EIF5
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2724149079849678,0.7044349571657128,0.8521400778210116,0.9488963307544894,1.0,7/31,22.95%,MOCOS;LIAS;DHRS11;GCH1;NFS1;SRD5A1;SCP2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.28835534369741844,0.7033026654171938,0.8436268068331143,0.9497858347910713,1.0,6/23,18.02%,HOOK3;TUBA1A;TUBA1C;CCDC88C;KIF5B;KIF5C
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.25998999064282513,0.7030729917738029,0.8941736028537456,0.9496860267187802,1.0,5/47,10.58%,RAP2A;TAOK3;FAS;COPS5;FOXO1
prerank,negative regulation of metabolic process (GO:0009892),0.2523478231772828,0.7025420531581207,0.89728453364817,0.9499098456598747,1.0,16/54,22.85%,NR1H3;FLCN;ATF4;RB1;DDIT3;ADAM17;NOTCH1;IL15;PLCL2;LAMA4;LNPEP;RHEB;ARRDC3;NR1H2;TLE3;ACOT13
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.29694416489833086,0.7023258517788483,0.8449931412894376,0.949460178650797,1.0,3/20,11.47%,IGF1;ZBTB20;APP
prerank,positive regulation of glycolytic process (GO:0045821),0.29694416489833086,0.7023258517788483,0.8449931412894376,0.949460178650797,1.0,3/20,11.47%,IGF1;ZBTB20;APP
prerank,regulation of endopeptidase activity (GO:0052548),0.25137387289026436,0.7021611719674844,0.8915525114155252,0.9492987683558509,1.0,13/59,22.88%,TIMP1;TIMP2;PICALM;BIRC3;SERPINB8;SERPINC1;PSME2;NCSTN;BIRC2;PSMA3;APH1B;FURIN;PSME3
prerank,B cell proliferation (GO:0042100),-0.24434290523902488,-0.7020030790260156,0.8848920863309353,0.9734305407416509,1.0,2/17,7.48%,MEF2C;BCL2
prerank,lipid droplet formation (GO:0140042),-0.2882691361773327,-0.7016716651776618,0.8493975903614458,0.9724007082939619,1.0,2/10,12.01%,CDS1;SQLE
prerank,regulation of nervous system development (GO:0051960),0.2620080673815157,0.7015842827650319,0.8801897983392646,0.9496299724585386,1.0,3/37,6.45%,CTNNB1;TNFRSF1B;BHLHE40
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.269380102056639,-0.7015687533523285,0.8540372670807453,0.9711119675412488,1.0,4/12,21.07%,TRPM4;PLA2G6;C2CD2L;STX4
prerank,positive regulation of cellular respiration (GO:1901857),0.33779277528633145,0.7011320113180814,0.8381679389312977,0.9498028246238356,1.0,3/11,22.14%,IL10RB;IFNAR1;VCP
prerank,nucleoside catabolic process (GO:0009164),0.3264836340325588,0.7010245455704973,0.827433628318584,0.9495684313486176,1.0,2/11,9.82%,NT5E;DERA
prerank,ubiquinone metabolic process (GO:0006743),0.3058947982991982,0.7003287003239564,0.8328611898016998,0.9499399864457447,1.0,2/15,5.94%,COQ7;AIFM2
prerank,UV protection (GO:0009650),0.3366611165829437,0.700174129733533,0.8320373250388803,0.9497483795425565,1.0,2/10,12.81%,CAT;MFAP4
prerank,regulation of neuron projection arborization (GO:0150011),-0.25296632978293104,-0.6999113562705409,0.8821548821548821,0.9714471773072743,1.0,2/15,5.80%,NTNG1;MAP3K13
prerank,regulation of immunoglobulin production (GO:0002637),0.2899016250062141,0.6998389907284029,0.8595578673602081,0.9497387377426606,1.0,5/23,21.02%,IL6;CD22;VAMP3;FCGR2B;PTPRC
prerank,regulation of cilium movement (GO:0003352),0.33197092599001776,0.6992360481031843,0.8411497730711044,0.9500339065283904,1.0,1/10,3.81%,CCDC40
prerank,primary neural tube formation (GO:0014020),0.27243284980442456,0.6991919679686747,0.8782051282051282,0.9497422803626501,1.0,13/30,30.37%,DLC1;MTHFD1L;PHACTR4;CELSR1;LRP6;VANGL2;LRP2;BCL10;PLXNB2;SKI;DEAF1;MTHFR;LMO4
prerank,sensory perception of sound (GO:0007605),0.23707376168717575,0.6985016800233037,0.9219088937093276,0.9501231898344747,1.0,9/88,11.94%,EYA1;LOXHD1;COL1A1;NIPBL;SNAI2;WDR1;COL11A1;LHFPL3;ROR1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2502661748454096,0.6983630443571494,0.8981481481481481,0.949928127707787,1.0,17/50,21.51%,HSPA1B;SIRT7;N4BP1;TNFAIP3;HSPA1A;SQSTM1;ARRB1;PRKCG;CRY1;PRR7;GNL3L;FBXO5;DNAJA1;HDAC8;OGT;TAF1;GTPBP4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3105976919026841,0.6977697357038505,0.8460410557184751,0.9502104765855881,1.0,1/14,1.91%,ERCC6
prerank,endodermal cell fate commitment (GO:0001711),0.34133792989034145,0.697686008636799,0.8350824587706147,0.9499464607231534,1.0,2/10,15.64%,SOX2;CDC73
prerank,protein localization to cilium (GO:0061512),0.2712180657235379,0.6975688214643572,0.8684895833333334,0.9497225661906984,1.0,7/32,20.24%,SNX10;RABEP1;IFT140;ARL3;RAB29;BBS1;TCTN1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.26364964055539813,0.6975559701151813,0.8847117794486216,0.9493928887352494,1.0,4/39,6.44%,ZMIZ1;MAML1;MAML2;CREBBP
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.2892080519621433,0.6973794178995443,0.8380102040816326,0.9492204449602131,1.0,6/23,20.59%,PRKAG2;UBE2K;APP;CALM2;CAB39;TNKS1BP1
prerank,negative regulation of bone mineralization (GO:0030502),0.318095588241905,0.6970991441014011,0.8397058823529412,0.949162567963664,1.0,2/13,10.36%,ENPP1;PTK2B
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.2563264237978166,-0.6965892279576278,0.8918918918918919,0.9734723079670703,1.0,11/14,49.07%,ECE1;ENPEP;RASL10B;AVPR2;ACE2;OXTR;EDN3;EDN2;AVPR1A;AGTR1;EDN1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.28795455696284167,-0.6963442446812318,0.8689024390243902,0.9723332821548911,1.0,2/10,4.85%,WAS;TRPM4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3326450507186861,0.6960969571474904,0.8304821150855366,0.9498764723213902,1.0,5/11,27.57%,TERF1;DKC1;CCT2;CCT7;WRAP53
prerank,positive regulation by host of viral transcription (GO:0043923),0.3051490571657327,0.6958660328575017,0.8463810930576071,0.9497681118410227,1.0,4/15,21.95%,JUN;CTDP1;SMARCB1;CCNT1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.32961965893543455,0.695554523864614,0.823088455772114,0.9494150143213207,1.0,4/11,22.25%,SRI;CALM2;GSTO1;FKBP1A
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.32961965893543455,0.695554523864614,0.823088455772114,0.9494150143213207,1.0,4/11,22.25%,SRI;CALM2;GSTO1;FKBP1A
prerank,regulation of cellular senescence (GO:2000772),-0.2124410172097555,-0.6955065240977465,0.9619047619047619,0.9717220909775686,1.0,8/28,21.05%,NUAK1;AKT3;YPEL3;CGAS;RBL1;VASH1;ABI3;NEK4
prerank,atrial septum development (GO:0003283),0.31591045471153345,0.6953784309111443,0.8462643678160919,0.9492514941950742,1.0,2/13,9.37%,NOTCH2;BMPR2
prerank,response to light stimulus (GO:0009416),0.24566080337248583,0.6949359221474345,0.8978185993111366,0.9493666968638607,1.0,14/55,24.63%,ERCC6;DCT;ZRANB3;MAP4K3;FECH;CRY1;CLOCK;DRD2;POLD1;SPRTN;UBE4B;ERCC4;MEN1;PRIMPOL
prerank,tRNA modification (GO:0006400),0.24606632467876954,0.6948988104296747,0.9003436426116839,0.9490608992411452,1.0,11/62,17.02%,TRMT12;DTWD1;LCMT2;TRDMT1;OSGEP;TRMT44;CTU2;DUS2;GTPBP3;ALKBH8;ALKBH1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3151505848111094,0.6948554385860647,0.8450074515648286,0.9487664730436091,1.0,2/12,15.56%,KDELR2;INSIG2
prerank,negative regulation of transferase activity (GO:0051348),0.27337739468587824,0.6945919729261303,0.876,0.9487163785655415,1.0,13/28,29.73%,IRS2;HNRNPU;TERF1;GSK3B;NPRL2;FBXO5;CERS1;ERCC4;MEN1;ZFP36;SRC;TP53;GSK3A
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.2866798038141021,0.6940214539119428,0.8537234042553191,0.9489601239192381,1.0,8/22,24.19%,ATF4;IPPK;PWP1;SMARCB1;UTP15;NCL;WDR43;LYAR
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2676478788644391,0.6937803134922417,0.8789808917197452,0.9488624694472906,1.0,1/31,0.68%,SYK
prerank,mitotic nuclear membrane organization (GO:0101024),0.2538109765714309,0.6937563827976669,0.886986301369863,0.9482072909814109,1.0,14/51,21.70%,REEP4;LMNA;CHMP2A;VPS4A;PPP2R2A;CHMP6;NUP98;CHMP7;PPP2CA;PPP2R1A;NUP188;CHMP2B;NDC1;NUP43
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2538109765714309,0.6937563827976669,0.886986301369863,0.9482072909814109,1.0,14/51,21.70%,REEP4;LMNA;CHMP2A;VPS4A;PPP2R2A;CHMP6;NUP98;CHMP7;PPP2CA;PPP2R1A;NUP188;CHMP2B;NDC1;NUP43
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.2554287676252231,0.6932479407206581,0.8883435582822086,0.9483766889931383,1.0,8/39,17.38%,CTNNB1;VEGFA;COL4A1;PAX8;GDNF;LRP6;NRP1;NKX2-1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2648109723530588,0.692549426483339,0.8822815533980582,0.948748403323774,1.0,12/35,25.12%,CD300A;STYXL1;BOD1;GSK3B;HTT;CALM2;PPP6R1;FKBP1A;PPP1R12A;PPP1R15B;PDGFRB;PPP6R3
prerank,regulation of cell killing (GO:0031341),0.3073528418181042,0.6917369522830693,0.85,0.9492525369667456,1.0,2/16,9.80%,CYBA;FZD7
prerank,positive regulation of hormone secretion (GO:0046887),0.2979675365192584,0.6913092082987127,0.8522727272727273,0.9493428311178205,1.0,1/17,2.67%,SPP1
prerank,negative regulation of histone methylation (GO:0031061),0.3315416169012949,0.691062642222739,0.8453292496171516,0.9492575067696416,1.0,4/10,22.24%,BRCA1;DNMT1;PHF1;MTF2
prerank,positive regulation of ion transport (GO:0043270),0.2553093552032855,0.6910404536992122,0.9047058823529411,0.9489375156824924,1.0,9/48,14.15%,ANO6;ATP2B1;P2RX4;GPD1L;CNKSR3;MYLK;CRACR2A;PRSS8;GDNF
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.25091943285224394,0.6909039000263044,0.8997668997668997,0.9487321153062656,1.0,15/48,22.97%,PRKAG2;EIF6;TPR;NUP50;NUP98;ZBTB7A;NUP88;PRDM16;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,autophagy of nucleus (GO:0044804),0.3057718756171751,0.6898953555375857,0.8548850574712644,0.9493940668787495,1.0,3/16,12.98%,ATG7;ATG5;ATG13
prerank,cellular response to catecholamine stimulus (GO:0071870),0.28168933131081014,0.6898572302637174,0.8699731903485255,0.9490961913032845,1.0,4/23,17.65%,TGM2;ATF4;PRKN;GABPA
prerank,positive regulation of interleukin-2 production (GO:0032743),0.27779346175004416,0.6896138318862047,0.8604651162790697,0.9490281145881945,1.0,2/25,3.00%,ANXA1;CD28
prerank,regulation of neurotransmitter secretion (GO:0046928),0.26494839802074305,0.6891932805193874,0.8870765370138017,0.9491256540885132,1.0,5/32,13.05%,DTNBP1;RIMS4;GSK3B;SYN1;MCTP1
prerank,negative regulation of peptidase activity (GO:0010466),0.25526909183758706,0.6890920560841916,0.8803317535545023,0.9488873047633578,1.0,5/47,14.37%,TIMP1;LRP1;TIMP2;SERPINB8;SERPINC1
prerank,regulation of cellular protein localization (GO:1903827),0.25238364258812584,0.6887956211052239,0.8946135831381733,0.9488492897069432,1.0,8/45,12.95%,CTNNB1;LCP1;KCNAB2;ABCA2;DVL1;VCPIP1;CCDC66;RAB11B
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3268445212520802,0.6887348589378509,0.8482142857142857,0.9485628482024717,1.0,5/11,24.83%,RAB1B;RAP2B;RAB1A;AFDN;RAP2C
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2652016118857752,-0.6884474963113024,0.8523076923076923,0.9773960117390019,1.0,4/13,13.74%,GET4;PKD2;NFKBIE;PKD1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.3160093592742762,0.6882162560897155,0.8565022421524664,0.9487774006545322,1.0,2/13,9.43%,PCID2;TPR
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.22375891953224508,-0.6879466641916299,0.9099099099099099,0.9764777126984231,1.0,6/24,20.25%,NUMB;ITGB1BP1;GDI1;PPP2R5A;DAB2;ABI3
prerank,extracellular matrix assembly (GO:0085029),0.2823334672302314,0.6877446468447118,0.8506666666666667,0.9489349876079064,1.0,5/23,15.41%,HAS3;QSOX1;MFAP4;GAS6;ATP7A
prerank,cotranslational protein targeting to membrane (GO:0006613),0.22973044762673342,0.6869883017094323,0.9321663019693655,0.9493472870453185,1.0,18/91,17.78%,RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;RPL22;RPS21;SIL1;RPL10A;RPS26;RPL15;RPL10;RPSA;RPL7;RPL26;SEC63
prerank,sensory perception of pain (GO:0019233),0.28734457973270855,0.6869815982571836,0.8743386243386243,0.9490138904184741,1.0,7/21,29.73%,P2RX4;KCNK4;RETREG1;OPRK1;CCL2;PTGES;KCNA2
prerank,SNARE complex assembly (GO:0035493),0.3350720813269189,0.6868410373101329,0.8431061806656102,0.9488218728292035,1.0,3/10,20.29%,UVRAG;VAMP3;VAMP2
prerank,cortical actin cytoskeleton organization (GO:0030866),0.2878748915033739,0.6861679963966107,0.855944055944056,0.9491446224090447,1.0,4/20,21.12%,LCP1;ROCK1;RAB13;FMNL2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.27119546351336266,0.6832337477222266,0.8717616580310881,0.9517167853024827,1.0,8/30,20.51%,MVD;PLPP6;IDI1;INSIG2;PMVK;ACAA2;HMGCR;ARV1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.28187484411045566,0.6831616953396659,0.853625170998632,0.9514400774650722,1.0,6/21,23.07%,ADCY7;ADCY8;ADCY3;NPR2;ADCY5;ADCY9
prerank,positive regulation of dendritic spine development (GO:0060999),0.28774979702387815,0.6828438428958957,0.8629579375848032,0.9514130629181589,1.0,1/20,0.58%,APOE
prerank,regulation of chromosome organization (GO:0033044),0.28444815877537255,0.6821717246969684,0.8512064343163539,0.9517138280021442,1.0,8/22,24.25%,RB1;XRCC5;SHCBP1L;HNRNPD;CDT1;HDAC8;WAPL;TERF2IP
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3272178249777036,0.6817781304188444,0.8628048780487805,0.9517602802440874,1.0,3/10,14.82%,ATP5F1A;ATP5F1D;ATP5F1C
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2521803023259401,0.680606289286424,0.8933333333333333,0.9525871026167662,1.0,12/40,21.13%,PRKCD;POLH;SIRT7;BCLAF1;MCL1;NSMCE4A;SMYD2;CRY1;UBE2V1;RADX;FBXO5;NPAS2
prerank,negative regulation of synaptic transmission (GO:0050805),0.27902213925290265,0.680066632917238,0.892328398384926,0.9527787262402513,1.0,2/23,4.72%,PLK2;PTEN
prerank,regulation of membrane repolarization (GO:0060306),-0.2569660727439115,-0.6798878147374757,0.8647798742138365,0.9824451444842631,1.0,3/13,14.97%,KCNJ2;AKAP9;CACNA2D1
prerank,non-motile cilium assembly (GO:1905515),-0.2057481588474297,-0.6797375722637535,0.9158878504672897,0.9811783557010691,1.0,12/30,26.78%,DISC1;RPGRIP1L;CSNK1D;GORAB;IFT57;TMEM216;CEP290;TMEM80;BBS10;TTC8;DCTN1;C2CD3
prerank,dendritic spine organization (GO:0097061),0.2703035365227946,0.6788063943804372,0.881074168797954,0.9536508809383201,1.0,5/26,15.07%,PTEN;DOCK10;TREM2;ITGA3;WASL
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3004286352114829,0.6769910823690697,0.8619186046511628,0.9550838664698889,1.0,6/14,28.74%,HNRNPA0;MYD88;TIRAP;ZFP36;MAPK14;HNRNPC
prerank,ear morphogenesis (GO:0042471),0.2811402978986104,0.6769577389786955,0.8766756032171582,0.9547821543869375,1.0,3/20,17.11%,NIPBL;PAX8;CHD7
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.2787281427126292,-0.6764785643171802,0.8555555555555555,0.9827361194422075,1.0,4/10,26.76%,DPP4;WNK1;CCL5;PODXL
prerank,"phagocytosis, engulfment (GO:0006911)",0.25595670981430363,0.6761676088792218,0.8953771289537713,0.9552251796591361,1.0,2/36,5.58%,CD36;THBS1
prerank,negative regulation of DNA binding (GO:0043392),0.2659228513431486,0.6753784400499254,0.885143570536829,0.9556099338213593,1.0,2/28,4.96%,JUN;E2F1
prerank,regulation of lipid catabolic process (GO:0050994),-0.23732165681574763,-0.675312695993843,0.9016393442622951,0.9823279742709445,1.0,6/19,23.87%,PDE3B;APOC1;TNF;ANGPTL3;IL1B;ADRA2A
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.3191267781727666,0.6749107694744637,0.8707782672540382,0.9557040040153997,1.0,1/12,3.15%,DSE
prerank,regulation of adaptive immune response (GO:0002819),0.2882504682440795,0.674607396721846,0.8772169167803547,0.955637092115881,1.0,3/18,10.59%,ADCY7;EIF2AK4;SIRT1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.2579318834063205,0.6721354747638432,0.9155446756425949,0.9576137481750157,1.0,10/36,18.54%,FAS;RB1;CSNK2A2;STYXL1;TRAF1;MAZ;CX3CL1;CSNK2A1;SGMS1;CRADD
prerank,regulation of monocyte differentiation (GO:0045655),-0.2457175217258066,-0.6714754885762058,0.9117647058823529,0.984318195347702,1.0,6/14,20.73%,CSF1;CD74;HOXA7;MYC;CTNNBIP1;IL34
prerank,regulation of wound healing (GO:0061041),0.2471030274893864,0.6702707945671834,0.9169632265717675,0.9590033039659399,1.0,5/42,13.61%,ANXA1;PLAU;ITGB1;MYLK;TNFAIP3
prerank,regulation of peptidase activity (GO:0052547),-0.23258395881697425,-0.6700967126764175,0.9222222222222223,0.9841411561484583,1.0,3/19,12.19%,CST3;CST7;SVBP
prerank,outer dynein arm assembly (GO:0036158),-0.2439142616904942,-0.6699826589360398,0.8961937716262975,0.9828418545504857,1.0,9/14,39.44%,DNAH8;LRRC49;DNAAF5;ODAD2;ODAD4;DNAL1;ODAD3;DNAH17;DNAAF1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.26558056026700333,-0.6690766435827719,0.8825396825396825,0.9821753869875772,1.0,7/12,38.29%,PLCB1;NBL1;BMP5;GREM1;DUSP1;SLIT2;ADTRP
prerank,regulation of chromatin binding (GO:0035561),-0.27377798775868917,-0.6690326466000268,0.8662790697674418,0.9808234555078528,1.0,2/10,12.08%,MED25;KDM4D
prerank,protein methylation (GO:0006479),0.25250038983653905,0.6688527318337515,0.9069478908188585,0.9599865350295484,1.0,12/40,24.90%,NSD3;ETFBKMT;N6AMT1;CAMKMT;ETF1;ICMT;METTL22;SNRPB;EHMT2;SETD3;METTL21A;CARM1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.29347683426181886,0.6687049740836424,0.8864628820960698,0.9597900881776733,1.0,3/16,11.92%,NT5E;TET2;CRMP1
prerank,protein homooligomerization (GO:0051260),0.22168159427068138,0.6685582211747104,0.9483122362869199,0.959589024007434,1.0,23/114,19.15%,SLC1A5;MICU1;APPL2;GNMT;NINJ1;CHMP2A;RNF135;P2RX3;NLRC4;PDCD6IP;LETM1;ATL2;USP16;SSBP1;ATL1;ADCY8;VSTM5;ALDH1A2;TK1;ALDH9A1;CBR4;CARD11;ALAD
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.32183161290924894,0.6668792560146006,0.867579908675799,0.9608475232091237,1.0,1/10,3.47%,FAS
prerank,peptidyl-methionine modification (GO:0018206),0.30792004300680875,0.6664331201121757,0.8748137108792846,0.96091424083206,1.0,4/12,22.29%,METAP1D;NAA30;NAA25;NAA15
prerank,negative regulation of cell aging (GO:0090344),0.2928419131643481,0.6658237636753035,0.8677685950413223,0.9611198051193147,1.0,7/16,30.02%,SIRT1;ZKSCAN3;FBXO5;CDK6;FOXM1;YBX1;TERF2
prerank,positive regulation of cell growth (GO:0030307),0.22474139061635737,0.6656932627161037,0.9573560767590619,0.9608969973397254,1.0,15/96,15.29%,SDCBP;RUFY3;MMP14;IGF1;ZFYVE27;N6AMT1;NEDD4L;EXOSC9;SYT17;ADAM17;MTPN;MACF1;DERL2;INO80;GOLGA4
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.2498174049796072,-0.6656891775239309,0.8942307692307693,0.9821480469012809,1.0,4/13,23.01%,HSP90AA1;QDPR;FPGS;SPR
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.2649616744399616,-0.665667500405325,0.8942598187311178,0.9807786497731086,1.0,3/12,23.37%,IL18;CCR2;IL1B
prerank,icosanoid metabolic process (GO:0006690),0.251773678950402,0.6655409845906642,0.9207683073229291,0.9606874964110966,1.0,4/40,10.31%,MGLL;PON3;GPX4;LTA4H
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.26889757026730954,-0.6651913475068187,0.8968481375358166,0.9798285182794746,1.0,6/11,35.93%,NOS1AP;ALG10B;LRRC55;RNF207;AKAP6;KCNIP2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23061582938613523,0.6650113483633731,0.9339305711086227,0.9608020072263684,1.0,9/72,12.34%,MUS81;RFC3;ENPP1;GTF2H5;RPS27A;UBC;DDB1;DNASE1L1;CUL4A
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.31688056649329716,0.6648540384997926,0.8622754491017964,0.9606032729754741,1.0,2/11,10.24%,STAP1;RIN3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.27358929123781744,0.6645478691210412,0.8810160427807486,0.9605491654368502,1.0,7/22,24.99%,MED12;ESR1;MED16;PAXIP1;MED30;PSMC5;MED13
prerank,mitotic spindle assembly (GO:0090307),0.2450334748733615,0.6635377439531329,0.9133574007220217,0.96110055611174,1.0,9/42,17.73%,PIBF1;SMC1A;TOGARAM1;STAG2;CLASP1;CEP192;SMC3;OFD1;ARHGEF10
prerank,regulation of ossification (GO:0030278),0.25277119392576736,0.6631393597922725,0.9272271016311167,0.9611287119964002,1.0,6/36,14.61%,ENPP1;SGMS2;SOX9;BMPR2;NOTCH1;LRP6
prerank,positive regulation of insulin secretion (GO:0032024),0.24824360745568122,0.6631150585143737,0.909541511771995,0.9608171552835786,1.0,9/36,20.34%,IRS2;TRH;AACS;GPLD1;ADCY8;NLGN2;BAIAP3;TCF7L2;GCK
prerank,DNA replication initiation (GO:0006270),0.2476228720518954,0.662644509368038,0.9008674101610905,0.9608974932046045,1.0,15/37,29.44%,DBF4;POLA1;NOC3L;ORC1;CDC34;ORC4;CDT1;CDK2;POLE3;PRIM2;ORC6;MCM3;ORC2;POLE;POLA2
prerank,positive regulation of cellular component movement (GO:0051272),0.26872988035814815,0.6616355836195336,0.903183023872679,0.9614301353144543,1.0,3/24,10.25%,VEGFA;CFAP20;ADAM17
prerank,bone morphogenesis (GO:0060349),-0.2439457063174214,-0.6614648165861982,0.9093959731543624,0.9814075894828485,1.0,2/14,5.90%,FGFR2;LRP5
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.2801309926995203,0.6614554887161126,0.8835341365461847,0.9612600695057415,1.0,3/20,12.65%,THBS1;SULF2;SULF1
prerank,calcium ion import across plasma membrane (GO:0098703),0.29323097725301805,0.660198608811808,0.8760683760683761,0.9620102214468245,1.0,2/14,9.36%,SLC8A1;TRPV2
prerank,negative regulation of neuron projection development (GO:0010977),0.234601468931509,0.6597068353815383,0.9252013808975834,0.9620860230040488,1.0,11/56,18.04%,APOE;RUFY3;PTEN;GAK;MT3;CRMP1;ITM2C;MCF2;RTN4;RAB29;MYLIP
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.2636302207130876,0.6596132953485478,0.9164490861618799,0.9618355267894162,1.0,6/27,13.75%,ARAP1;DLC1;PAK2;PFN1;PRKN;CLASP1
prerank,stabilization of membrane potential (GO:0030322),0.29478323645246796,0.658669739783774,0.8865546218487395,0.9623065455938703,1.0,3/16,19.13%,KCNK13;KCNK4;KCNK5
prerank,diacylglycerol metabolic process (GO:0046339),0.2687653953243905,0.658608286491143,0.9055330634278003,0.962024164629977,1.0,4/23,17.19%,DGKZ;DGKA;DGKQ;DGKG
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.19988280093039906,-0.6583435501358701,0.9656862745098039,0.9825542557609288,1.0,10/32,31.90%,RPL30;RNASE7;ANG;ROMO1;HMGN2;RNASE6;CAMP;GAPDH;CXCL14;PGLYRP1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.25523265395578026,-0.6579985403730451,0.8975903614457831,0.9814797757777765,1.0,3/11,17.73%,FZD3;SIRT2;FAP
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.24663840726283776,0.6577562387238894,0.9152334152334153,0.9624253907233544,1.0,8/37,20.17%,BCL2L11;STYXL1;DDIT3;BCLAF1;BAX;BID;BBC3;BCAP31
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.28615305912273453,0.6576820044826945,0.9005602240896359,0.9621489778728178,1.0,3/17,11.89%,NOTCH2;SNAI2;NOTCH1
prerank,positive regulation of mRNA processing (GO:0050685),0.2715602257407075,0.6575526227104708,0.8958333333333334,0.961928671764669,1.0,6/21,19.65%,NCBP2;PRDX6;CDC73;NUP98;THRAP3;NCL
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.2541928779206428,-0.6572035355768577,0.9174311926605505,0.9807268331621701,1.0,6/13,23.81%,TPST1;TPST2;SULT1A1;ABHD14B;SULT4A1;BPNT1
prerank,blood vessel endothelial cell migration (GO:0043534),0.2766652235752055,0.6571043710735875,0.8865836791147994,0.9619774578873518,1.0,4/22,16.18%,VEGFA;MYH9;GPLD1;NRP1
prerank,negative regulation by host of viral transcription (GO:0043922),0.3038638007820863,0.6564359171633144,0.8564885496183207,0.9622315604466858,1.0,1/12,4.00%,JUN
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.30185693300995037,0.656015875409679,0.874439461883408,0.9622515538069633,1.0,6/13,26.15%,NOP14;RPS21;RCL1;ABT1;NOP9;RPP40
prerank,regulation of cellular respiration (GO:0043457),0.28350932334454343,0.6555257603922898,0.8859154929577465,0.9623212032119671,1.0,5/17,24.34%,IL10RB;IFNAR1;PRDM16;VCP;SHMT2
prerank,pseudouridine synthesis (GO:0001522),-0.25343162075777315,-0.6550106787804703,0.9056603773584906,0.9810756576401543,1.0,3/13,15.85%,PUS7;GAR1;TRUB2
prerank,modulation by host of symbiont process (GO:0051851),0.2543657837385366,0.6549587305104781,0.9229781771501926,0.9624828604042884,1.0,3/31,5.56%,AQP1;JUN;SAP30
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.30197335677683607,0.6531782993472415,0.8851251840942562,0.9636124717178366,1.0,2/13,10.19%,ZC3HAV1;CNOT7
prerank,negative regulation of ATPase activity (GO:0032780),0.2897935601056905,0.6525157499960762,0.8836265223274695,0.9638746084174079,1.0,2/16,10.59%,PPIF;SIRT1
prerank,modulation by symbiont of entry into host (GO:0052372),0.28417311321577376,0.6519552913135194,0.8767123287671232,0.9640073105160771,1.0,3/16,17.94%,TRIM25;TRIM14;EXOC7
prerank,copper ion homeostasis (GO:0055070),0.28538359427301424,0.6518288236111832,0.8944365192582026,0.9637823431125453,1.0,4/17,16.59%,XIAP;APP;ATP7A;SLC31A2
prerank,regulation of rRNA processing (GO:2000232),-0.23563210469518814,-0.6515226233382497,0.9,0.9823479350183673,1.0,6/16,19.80%,HEATR1;BUD23;RIOK2;YTHDF2;TRMT112;NUDT16
prerank,regulation of exit from mitosis (GO:0007096),0.24305874958831708,0.6514082773868767,0.9254278728606357,0.9638136825915189,1.0,9/38,19.70%,ANAPC1;RPS27A;UBC;PPP1R9B;NPM2;ANAPC10;UBE2S;ANAPC15;CDC14B
prerank,tRNA 5'-leader removal (GO:0001682),0.2957190531926931,0.6512226315706472,0.8881019830028328,0.9636337873768112,1.0,3/13,16.05%,RPP25L;POP4;PRORP
prerank,negative regulation of hormone secretion (GO:0046888),-0.2673974793015817,-0.6511504516899895,0.8690476190476191,0.9812474939835991,1.0,2/10,23.37%,RAB11FIP5;IL1B
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2722921569422226,0.6510047540813706,0.9087193460490464,0.9634829413791044,1.0,7/20,22.73%,TGM2;PACS2;BAX;BCAP31;WFS1;HERPUD1;TMCO1
prerank,nuclear membrane reassembly (GO:0031468),0.23555843554166492,0.6499778705054511,0.9261363636363636,0.9639831044003131,1.0,14/54,21.70%,REEP4;LMNA;CHMP2A;VPS4A;PPP2R2A;CHMP6;NUP98;CHMP7;PPP2CA;PPP2R1A;NUP188;CHMP2B;NDC1;NUP43
prerank,regulation of striated muscle contraction (GO:0006942),0.2662410924695424,0.6497217886166847,0.9250317662007624,0.9638550027126556,1.0,3/27,8.15%,P2RX4;MYL2;MYBPC3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.274839263471228,0.649660524019891,0.8917808219178082,0.9635659137841862,1.0,3/20,9.03%,FOXP3;BRCA1;BRD7
prerank,ribosomal small subunit biogenesis (GO:0042274),0.2406728182985306,0.6494802617627506,0.9383313180169287,0.9633708957207143,1.0,15/39,29.24%,RPS14;NOP14;MRPS7;NOB1;TSR3;RPSA;PWP2;RPS27;SNU13;LSM6;RRP36;RIOK3;NOL11;EMG1;RPS7
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.29467957458163235,0.6494761395106581,0.8669590643274854,0.9630392306259254,1.0,2/13,12.33%,PID1;TREM2
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.23895913734699392,-0.6493083760671086,0.9097222222222222,0.9812464370424389,1.0,10/15,34.34%,PHB2;EZH2;PAF1;NPM1;PLCG2;STXBP4;DDRGK1;DYRK3;CRNN;FAM83D
prerank,cellular amino acid catabolic process (GO:0009063),0.2198515403558269,0.648421440582347,0.9672131147540983,0.9636014498666126,1.0,19/87,24.34%,ARG1;KYNU;PRODH;MCCC1;HMGCL;HIBADH;FAH;GCDH;SLC25A44;BLMH;OGDH;ALDH7A1;MTRR;BCAT2;CARNMT1;IVD;GCSH;GOT1;SHMT2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.31329608248146523,0.6479617424283366,0.8763693270735524,0.9636129180065248,1.0,3/10,20.08%,AIDA;DNAJA1;DUSP10
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.30836429593738185,0.6476145589398382,0.8818316100443131,0.9635540751891281,1.0,3/11,19.19%,NASP;UBN1;CABIN1
prerank,regulation of phospholipase C activity (GO:1900274),0.2833980416103676,0.6475786155250849,0.9040697674418605,0.9632458753569003,1.0,2/15,10.02%,ABL2;ESR1
prerank,intraciliary retrograde transport (GO:0035721),-0.2578972465273956,-0.6473675308209765,0.9263803680981595,0.9813158168281987,1.0,6/12,29.73%,DYNC2H1;IFT43;TTC21B;DYNLT2B;DYNC2LI1;DYNC2I1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.2735123760130405,0.6446511217224233,0.9041487839771102,0.9653023825159085,1.0,5/18,25.53%,FZD7;NOTCH1;FRS2;CCN3;HDAC1
prerank,regulation of ion transport (GO:0043269),0.22296649966963414,0.6430408516846488,0.9654427645788337,0.966267278754608,1.0,10/76,14.15%,DTNBP1;P2RX4;SIK1;NEDD4L;WWP2;SYT17;RAB11B;VAMP3;PRKN;GDNF
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.30156676573545776,0.6426249615723986,0.8698830409356725,0.9662803165708411,1.0,4/11,19.53%,THBS1;E2F2;PIK3CB;CREB3L1
prerank,regulation of histone methylation (GO:0031060),0.2944440942072177,0.6424117044421098,0.8920454545454546,0.9660964805764741,1.0,1/13,4.99%,CHTOP
prerank,myelination in peripheral nervous system (GO:0022011),-0.24358258874274233,-0.6422762827247404,0.9145569620253164,0.9834901602145402,1.0,6/13,29.70%,PARD3;SIRT2;DICER1;LGI4;CNTNAP1;MYOC
prerank,negative regulation of phosphatase activity (GO:0010923),0.2580687383866079,0.641417738817343,0.9080157687253614,0.9665243875948608,1.0,4/25,12.27%,STYXL1;BOD1;GSK3B;GPATCH2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.23303626365498775,-0.6409829609117621,0.9294871794871795,0.9830534842592528,1.0,7/16,26.91%,RBMX;CIRBP;CELF4;TRA2B;SNW1;SF3B4;TRA2A
prerank,histone H2B ubiquitination (GO:0033523),0.3096621012552165,0.6402472417933148,0.8618012422360248,0.9670886624333015,1.0,1/10,3.25%,WAC
prerank,DNA replication checkpoint signaling (GO:0000076),-0.22959806653551362,-0.6395671007673426,0.9288256227758007,0.9827029220864874,1.0,6/16,28.92%,RAD9B;TIMELESS;NAE1;TIPIN;TOPBP1;TICRR
prerank,determination of left/right symmetry (GO:0007368),0.2423640717168402,0.63884934087854,0.916058394160584,0.967829788550425,1.0,6/36,18.40%,CCDC40;CITED2;CFAP53;NOTCH1;OFD1;BBS7
prerank,neural tube development (GO:0021915),-0.2409410346264456,-0.6367902282906506,0.9238410596026491,0.9832454871050644,1.0,7/15,26.40%,PTCH1;PKD2;PKD1;SOX11;TGFB1;DACT1;STIL
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.21018141503488796,-0.6359729518857546,0.929368029739777,0.9810724522328623,1.0,5/20,20.35%,BCAT1;DBT;ACADSB;AUH;ACAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.21018141503488796,-0.6359729518857546,0.929368029739777,0.9810724522328623,1.0,5/20,20.35%,BCAT1;DBT;ACADSB;AUH;ACAT1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.2615880436640831,0.6353665351469123,0.9040735873850198,0.9701898425469432,1.0,3/23,11.47%,IGF1;ZBTB20;APP
prerank,cGMP biosynthetic process (GO:0006182),-0.26687571629892914,-0.6352393546703433,0.9126760563380282,0.9801660235774858,1.0,6/10,40.67%,GUCY1A1;GUCY1B1;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,rRNA methylation (GO:0031167),0.260540599713265,0.6349450189379489,0.9057873485868102,0.9701713079850334,1.0,9/22,26.23%,NSUN3;MRM2;TFB2M;FBL;DIMT1;MTERF4;ZCCHC4;NSUN4;FDXACB1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.3050610533683086,0.6326401551302058,0.9105431309904153,0.9715678256980458,1.0,2/10,14.74%,DKC1;TSR3
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.2994043197685858,0.6318426237688428,0.898379970544919,0.9718320927961376,1.0,3/11,19.17%,ATF4;PRKN;FBXO7
prerank,mammary gland development (GO:0030879),0.2609463752663836,0.6296227241418496,0.9280868385345997,0.9731186738852262,1.0,1/21,1.73%,VEGFA
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.2638882296284438,-0.6293946272921948,0.9130434782608695,0.9825349664764698,1.0,1/10,2.17%,PRKCE
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.23407167836484916,0.6273124676382151,0.9467821782178217,0.9744456187742203,1.0,12/38,23.52%,NDUFS8;NDUFA10;NDUFC1;NDUFAB1;NDUFB6;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFB8;NDUFB9;NDUFA13
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.3072643402502357,0.6258213710235365,0.9031746031746032,0.9751633746666672,1.0,4/10,30.98%,APP;DRD2;RAB5A;DLG4
prerank,negative regulation of GTPase activity (GO:0034260),0.2571961229157273,0.6255594936378464,0.9209844559585493,0.9750108550949659,1.0,10/22,29.51%,RASA4;BCAS3;ARFGEF1;CPEB2;LRCH1;RCC2;HRAS;SH3BP4;GPSM1;LRRK2
prerank,protein localization to phagophore assembly site (GO:0034497),0.29830323221422705,0.6237991919982017,0.9133034379671151,0.9759035309697436,1.0,5/11,24.45%,PACS2;ATG13;TRAPPC8;MFN2;STX17
prerank,establishment of skin barrier (GO:0061436),-0.22755220856974753,-0.6235679022664329,0.9508771929824561,0.9834142153322495,1.0,6/15,33.49%,STMN1;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,regulation of water loss via skin (GO:0033561),-0.22755220856974753,-0.6235679022664329,0.9508771929824561,0.9834142153322495,1.0,6/15,33.49%,STMN1;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,focal adhesion assembly (GO:0048041),0.2616294495495469,0.6227242436374535,0.929144385026738,0.9763190825379627,1.0,4/21,14.26%,ACTN1;DLC1;RHOD;WHAMM
prerank,regulation of cell projection organization (GO:0031344),-0.23503640821591454,-0.6226799577848332,0.9143835616438356,0.9826446405282556,1.0,1/13,0.90%,NTNG1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.27465857500397106,0.6223493257145972,0.917963224893918,0.9762508438157692,1.0,3/16,16.55%,PDGFA;NRP1;PTPN1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.21832537712960232,-0.6222517737833048,0.9469964664310954,0.9815732929528391,1.0,6/18,22.97%,REST;CNOT2;CNOT1;MYC;ELAVL1;TAF6L
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.27197265797934134,0.6221540204994606,0.9151343705799151,0.9760476770014046,1.0,3/17,16.18%,VEGFA;GPLD1;NRP1
prerank,regulation of protein dephosphorylation (GO:0035304),0.23491202371305456,0.621997841025166,0.9344059405940595,0.9758221034220887,1.0,12/37,25.50%,PRKCD;ENSA;MFHAS1;DLC1;HTT;CALM2;PPP6R1;CDH5;PPIA;PPP6R3;YWHAB;SPPL3
prerank,nuclear membrane organization (GO:0071763),0.2642933964221556,0.6213152717620152,0.9231824417009602,0.9759609030421702,1.0,5/19,20.73%,CHMP2A;VPS4A;NEMP1;CHMP7;TOR1A
prerank,tRNA 5'-end processing (GO:0099116),0.2750764194745512,0.6200343236009739,0.9213793103448276,0.976526643703842,1.0,4/15,19.62%,RPP25L;POP4;PRORP;TRMT10C
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.27624072707390773,0.618367742354233,0.9081920903954802,0.9773208105437009,1.0,2/14,9.11%,UMPS;NT5E
prerank,regulation of cell aging (GO:0090342),0.29459936087179606,0.6179856147113292,0.9092307692307692,0.9772412870413199,1.0,1/11,4.39%,LMNA
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.2889159081076166,0.6170300173943978,0.9081481481481481,0.977545538451194,1.0,3/12,17.78%,GET3;SGTA;SEC63
prerank,clathrin coat assembly (GO:0048268),0.27231143104531425,0.614465959526573,0.9165487977369166,0.9789006931338066,1.0,7/15,25.11%,PICALM;FCHO1;EPS15;FCHO2;HIP1;AP2S1;CLTC
prerank,cell-substrate junction assembly (GO:0007044),0.23969334803094744,0.6137327287982098,0.9463840399002493,0.9790506350431922,1.0,6/33,15.01%,CD151;ACTN1;DLC1;RHOD;WHAMM;LAMA3
prerank,negative regulation of cellular senescence (GO:2000773),0.28318267863316265,0.6136427503171216,0.9002849002849003,0.9787700395508973,1.0,6/13,30.02%,SIRT1;ZKSCAN3;FBXO5;CDK6;YBX1;TERF2
prerank,regulation of complement activation (GO:0030449),0.22592771365283038,0.6127914322979491,0.944578313253012,0.9790023406487639,1.0,2/40,4.92%,CD46;C3AR1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.24468528398156608,-0.6126734923637256,0.9215116279069767,0.9855592283640119,1.0,2/11,6.49%,FMR1;PUM1
prerank,hippo signaling (GO:0035329),0.24322414119635577,0.6118761380441123,0.9310793237971391,0.9792519575984734,1.0,11/26,30.65%,STK3;LATS1;CASP3;STK4;WWTR1;MOB1A;YWHAB;MOB1B;TJP1;YWHAE;TEAD2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.2710213957782035,0.6117250680015106,0.9318181818181818,0.9790147248344033,1.0,8/16,30.10%,PARP3;KMT5B;SHLD1;SHLD2;PRKDC;WRAP53;PARP9;RIF1
prerank,vascular process in circulatory system (GO:0003018),0.28117141220490316,0.6109536114589458,0.9017094017094017,0.9788311303626152,1.0,2/13,16.74%,ROCK1;ACE
prerank,regulation of tube diameter (GO:0035296),0.28117141220490316,0.6109536114589458,0.9017094017094017,0.9788311303626152,1.0,2/13,16.74%,ROCK1;ACE
prerank,mitotic DNA replication (GO:1902969),-0.2513428582069296,-0.6097927600184999,0.9316939890710383,0.9856880983287402,1.0,6/10,37.40%,LIG1;MCM6;MCMDC2;MCM4;GINS3;CDC45
prerank,positive regulation of ATPase activity (GO:0032781),0.2265165430130311,0.6078316524171845,0.9606879606879607,0.9804876920569622,1.0,7/41,14.81%,CHTOP;HNRNPU;VMP1;MYBPC3;PFN1;SSBP1;PFN2
prerank,regulation of catecholamine secretion (GO:0050433),0.23930015274351318,0.6077609390011808,0.9408138101109741,0.9801998015127836,1.0,1/29,0.64%,DTNBP1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.23967198304847365,0.6076746850262595,0.9578005115089514,0.9799160248245811,1.0,3/29,11.89%,MYL2;MYBPC3;NOTCH1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.25998757060868366,0.6057034800271125,0.928169014084507,0.9808435942991285,1.0,6/18,25.64%,DKC1;EXOSC10;SHQ1;CCT2;RUVBL2;CCT7
prerank,regulation of gastrulation (GO:0010470),0.27319645441059215,0.60564880336465,0.9166666666666666,0.9805405846327397,1.0,2/14,13.75%,DAG1;CLASP1
prerank,organelle disassembly (GO:1903008),0.23227933635354323,0.6055354521535632,0.957124842370744,0.980272983991206,1.0,10/33,22.34%,KIF9;STX5;UBA5;TEX264;KIF5B;MTIF2;RETREG1;ATG2B;VCP;MTIF3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.1973796530424308,0.6045457212226888,0.9907120743034056,0.9805333877011058,1.0,45/145,27.03%,DYNC1H1;PSMD1;HAUS6;PSMF1;PSMD14;CEP76;PSMD12;CLASP1;CEP192;TUBA1A;PSME2;CUL1;NDE1;ALMS1;OFD1;CCP110;SSNA1;HAUS7;PSMB10;PSMD5;CDC25A;PSMD8;PSMA3;PAFAH1B1;FBXO5;PSMA2;PSMD11;PPP2R1A;PSMA6;HAUS5;CEP41;RAD51B;PSMB3;RCC2;PSME3;CDK2;USP47;CEP250;PSMC5;CEP152;CKAP5;AVEN;PSMC1;TUBA4A;MECP2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.23654690239591925,-0.6045097864856477,0.9436201780415431,0.9870852552205458,1.0,3/12,23.37%,CCR2;CARD9;IL1B
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.27380815554838245,0.6031991597748927,0.934876989869754,0.9810114181761824,1.0,4/14,21.31%,ADAM17;PTK2B;CCL7;ADAM10
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.26518558604914244,0.6024301368961947,0.9333333333333333,0.9811396129567885,1.0,2/15,10.19%,YTHDF3;CNOT7
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.20263636382095804,0.602087328616362,0.9845303867403314,0.9810163318761975,1.0,20/80,24.87%,PLPP3;UVRAG;COG7;KIF3A;RAB1B;KDELR2;GOLPH3;GOLPH3L;ARF4;ARF5;HTT;TAPBP;ARFGAP2;RAB1A;ERGIC2;ATP9B;TMED3;TMED10;COPB1;ARFGAP3
prerank,isotype switching (GO:0045190),0.28914927825805553,0.6017441581256203,0.9010819165378671,0.9808881664107711,1.0,3/10,22.75%,EXOSC3;HSPD1;RNF168
prerank,histone deacetylation (GO:0016575),0.22001425860875026,0.601123869610254,0.9629629629629629,0.9809162112212783,1.0,5/43,12.84%,RCOR1;SIRT6;TBL1XR1;SIRT1;SIRT7
prerank,protein alkylation (GO:0008213),0.2514375117237684,0.6005536951901145,0.9322493224932249,0.9809080572483068,1.0,3/22,8.74%,ETFBKMT;CAMKMT;ETF1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.2912016125143114,0.6003761141908313,0.9181102362204724,0.9806651775811078,1.0,2/10,10.59%,FLCN;SIRT1
prerank,glial cell development (GO:0021782),0.2418329050265377,0.6000431605895984,0.9522546419098143,0.9805117880445645,1.0,8/25,24.61%,PRDM8;MT3;APP;NRROS;EIF2B2;HES5;CDK6;SOX4
prerank,regulation of humoral immune response (GO:0002920),0.22036152237902343,0.5998186786872444,0.9576783555018138,0.980306770927196,1.0,2/44,4.92%,CD46;C3AR1
prerank,protein deacetylation (GO:0006476),0.22094111938876015,0.5997233166763002,0.9590854392298436,0.980023259174865,1.0,5/41,12.84%,RCOR1;SIRT6;TBL1XR1;SIRT1;SIRT7
prerank,hematopoietic stem cell proliferation (GO:0071425),0.28917489753965214,0.5995799836565451,0.9388059701492537,0.9797622498783262,1.0,2/11,9.68%,ETV6;ARIH2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.22482705587197543,0.5990516246161096,0.9546012269938651,0.9797378720824643,1.0,3/40,4.98%,ABCD1;PID1;MTLN
prerank,negative regulation of hydrolase activity (GO:0051346),0.21644856814784913,0.5988403792197604,0.9577960140679953,0.9795220786131789,1.0,6/49,12.27%,MAPK7;RASA4;NEIL1;SLC39A14;BCAS3;GPATCH2
prerank,regulation of mRNA metabolic process (GO:1903311),0.2800691571513724,0.598157369268347,0.9399075500770416,0.9795865855832324,1.0,3/11,21.06%,SRPK2;SRPK1;SAFB
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.24522972633693196,-0.5964051742951956,0.9455587392550143,0.9882686124822861,1.0,10/10,75.50%,CACNA2D4;REEP6;CNGB1;TULP1;GRM6;GNAT1;RPE65;GNAT2;CACNA1F;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.24522972633693196,-0.5964051742951956,0.9455587392550143,0.9882686124822861,1.0,10/10,75.50%,CACNA2D4;REEP6;CNGB1;TULP1;GRM6;GNAT1;RPE65;GNAT2;CACNA1F;CEP250
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.2653559033240675,0.5955655150204564,0.9186046511627907,0.9807256586456264,1.0,5/15,25.64%,DKC1;SHQ1;CCT2;RUVBL2;CCT7
prerank,female gamete generation (GO:0007292),-0.18399123717868204,-0.592959721836259,0.9823788546255506,0.9884630506908414,1.0,14/29,38.85%,FMN2;METTL3;IHO1;PARN;TRIP13;PRDM9;MCM8;GDF9;PIWIL2;PTN;DMC1;HORMAD1;NANOS1;M1AP
prerank,heart process (GO:0003015),0.2672898783787879,0.5886922671741345,0.9296987087517934,0.984186349892519,1.0,7/14,32.29%,MYL2;ACE;GPX1;FYN;SGCG;SOD1;PPCS
prerank,negative regulation of ion transport (GO:0043271),0.24264914302123286,0.5880157293415181,0.9662077596996246,0.9842184499731891,1.0,3/24,14.30%,LILRB1;PTK2B;HTR1B
prerank,positive regulation of DNA replication (GO:0045740),0.252317190574433,0.5878779504262238,0.9306930693069307,0.9839633412966416,1.0,6/16,22.70%,NPM2;STN1;ATAD5;CDT1;BCAR3;FAF1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.24211352645907086,0.5855815328921324,0.9478609625668449,0.9848260394612746,1.0,2/20,12.19%,TSPOAP1;CYP46A1
prerank,regulation of aerobic respiration (GO:1903715),0.25662952516296733,0.5853134867325442,0.9222873900293255,0.9846312607137976,1.0,4/15,24.34%,ABCD1;ATP7A;VCP;SHMT2
prerank,coenzyme A metabolic process (GO:0015936),0.26382514503808174,0.5852375055423178,0.9396067415730337,0.9843335740716181,1.0,3/14,18.41%,COASY;PANK2;NUDT7
prerank,embryonic eye morphogenesis (GO:0048048),-0.22901885723129434,-0.5840713340903607,0.9522388059701492,0.9911251570600019,1.0,2/11,11.98%,RARG;FBN2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.2552216287663105,0.5828614423160975,0.9456066945606695,0.9852167788581072,1.0,1/17,2.51%,VIM
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2508404778664423,0.5828178146589117,0.929676511954993,0.9849021688927604,1.0,3/16,15.71%,WRN;SSBP1;TWNK
prerank,response to acidic pH (GO:0010447),0.26302404082983977,0.5822098292735215,0.9335302806499262,0.9848711991727845,1.0,3/13,20.89%,CTSS;RAB11B;LGMN
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2530533282455899,0.5821741650340326,0.9444444444444444,0.9845530458613788,1.0,4/16,18.05%,RTEL1;TERF1;TNKS;TNKS2
prerank,regulation of immune effector process (GO:0002697),0.21422480634454602,0.5808369704073264,0.9699519230769231,0.9848868243806896,1.0,2/41,4.92%,CD46;C3AR1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.20990137276840604,0.5803501750317442,0.9730363423212193,0.9847935596818365,1.0,4/46,6.27%,MICALL2;ITGA4;LPXN;PARVB
prerank,male meiosis I (GO:0007141),0.2518523169659674,0.5799756425291381,0.9467625899280575,0.9846394561310641,1.0,16/16,74.84%,FOXJ3;MYBL1;FOXJ2;BRDT;CCNA1;BTBD18;MEIOC;DNMT3L;ZSCAN21;MOV10L1;TDRD9;SLC25A31;ING2;HSF2BP;SYCP3;DDX4
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.24037901038344378,-0.5796073047779949,0.9429429429429429,0.9916807430602355,1.0,4/10,24.81%,WNK1;CCR2;WNT5A;CCL5
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.1991413752453991,-0.5781512223372265,0.9738805970149254,0.9909212068476415,1.0,2/18,7.28%,IRS1;REST
prerank,regulation of hippo signaling (GO:0035330),0.25139849772394285,0.5776093192673759,0.9406077348066298,0.9854919419098562,1.0,3/17,13.58%,WWC2;NF2;LIMD1
prerank,peptidyl-proline modification (GO:0018208),0.23056527877303035,0.5770131046018793,0.9675324675324676,0.9854453553246629,1.0,5/25,15.17%,PPIF;PPIH;CWC27;PPIE;FKBP7
prerank,cellular response to hydroxyurea (GO:0072711),0.28620729557603236,0.5758010700856191,0.92018779342723,0.9856724056582734,1.0,4/10,22.99%,NSMCE3;DDI2;RTF2;SPIDR
prerank,negative regulation of insulin secretion (GO:0046676),0.24725434228442195,0.5745909881301501,0.9506849315068493,0.9859232071442888,1.0,3/17,13.63%,PIM3;MIDN;PRKN
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.21149178898106574,0.5742418188260375,0.9817739975698664,0.9857493007084465,1.0,8/39,22.02%,IRS2;TRH;AACS;NLGN2;AIMP1;TCF7L2;GCK;DRD2
prerank,epithelial structure maintenance (GO:0010669),0.27487288933525855,0.5741655505089014,0.943683409436834,0.9854507947661134,1.0,11/11,72.53%,TLR9;VSIG1;MUC13;MUC4;MUC2;RBP4;NOD2;MUC6;PIWIL4;CXADR;STRAP
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.21859080808370865,0.5736753473131528,0.9588875453446191,0.9853386273603741,1.0,6/34,21.02%,IL6;SPHK2;VAMP3;TNFRSF14;SCIMP;PTPRC
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.26308980088132794,0.5735427057863063,0.9340028694404591,0.9850664442529563,1.0,7/13,28.97%,BFAR;PTPN1;WFS1;PPP1R15B;ABCA7;ATF6B;DNAJB9
prerank,monosaccharide transmembrane transport (GO:0015749),0.2538021626877595,0.573196246088907,0.96398891966759,0.9848997342528856,1.0,3/16,19.45%,SLC23A2;SLC23A1;SLC50A1
prerank,mesenchymal cell development (GO:0014031),0.24665545043128617,0.573124379119096,0.9565217391304348,0.9846012217287777,1.0,6/18,23.00%,SNAI2;NOTCH1;SOX8;PEF1;KLHL12;NOLC1
prerank,protein prenylation (GO:0018342),-0.2385237632260926,-0.5714121828957354,0.9501466275659824,0.992091932318643,1.0,2/10,18.13%,CHML;PTAR1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2576464024203253,0.5704561015649439,0.9457142857142857,0.9854708129767664,1.0,2/14,11.97%,ANKRD17;PUM2
prerank,protein depolymerization (GO:0051261),0.22809415172703834,0.570258437259375,0.9647979139504563,0.9852280549486995,1.0,7/27,19.63%,NCKAP5L;CFL1;WDR1;MICAL2;DSTN;CFL2;MICAL1
prerank,protein localization to cell surface (GO:0034394),0.22817164308998014,0.5694435626858005,0.9656992084432717,0.9852476228860113,1.0,6/26,23.47%,CTNNB1;GGA2;PTPRU;PIGU;GGA3;FLNA
prerank,xenobiotic transport (GO:0042908),0.24565508921385854,0.5687821437377215,0.9491525423728814,0.9852069149975508,1.0,2/17,7.78%,ABCC3;ABCA3
prerank,negative regulation of hippo signaling (GO:0035331),0.2638559821677766,0.5686186995578693,0.9338235294117647,0.9849515348201422,1.0,1/12,2.73%,WWC2
prerank,protein localization to cell-cell junction (GO:0150105),-0.2102450552539495,-0.5678147583389876,0.9738562091503268,0.9921410198698863,1.0,1/15,1.34%,F11R
prerank,negative regulation of cholesterol transport (GO:0032375),0.2742571832454588,0.5676672562466,0.9374021909233177,0.9850681615134668,1.0,1/10,8.19%,ABCA2
prerank,DNA conformation change (GO:0071103),0.24460665702661577,0.5672980570046807,0.9550724637681159,0.9849054035547767,1.0,6/17,27.33%,TOP1;NAA10;PRM1;TOP3A;KAT6A;ERCC3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.19337588646733578,0.5662523016521166,0.9833518312985572,0.9850034227009065,1.0,2/76,1.43%,SASH1;ADGRG3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.26258048840084325,0.5630074960466984,0.9498525073746312,0.9857191926041289,1.0,2/12,16.61%,IGF1;STIMATE
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.26258048840084325,0.5630074960466984,0.9498525073746312,0.9857191926041289,1.0,2/12,16.61%,IGF1;STIMATE
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.23456914849940208,0.5620258527948295,0.9612817089452603,0.9857997092452727,1.0,2/20,9.23%,PID1;PICALM
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.25335166826291444,0.5616938390838931,0.9465081723625557,0.9856062307086085,1.0,2/14,13.37%,NLRP2B;GAS6
prerank,neurotransmitter biosynthetic process (GO:0042136),0.24880713209442484,0.5598315459019801,0.9556509298998569,0.9860147197710066,1.0,14/14,75.14%,ALDH9A1;SLC6A4;DAGLB;PAH;DBH;SLC6A3;SLC44A4;SLC22A2;DAGLA;SLC5A7;ACHE;MOXD1;NOS1;CHAT
prerank,negative regulation of RNA splicing (GO:0033119),0.23629198396185058,0.5591237241893008,0.9585561497326203,0.9859763342502664,1.0,4/19,18.05%,PTBP3;PTBP2;RPS26;C1QBP
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.1962721649719984,-0.5569695601937693,0.9671052631578947,0.9943868935046926,1.0,4/16,24.33%,TGFB2;SOX6;NUDT21;FOXC1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.2342662919820328,0.5560249006714291,0.9655172413793104,0.9868996331644484,1.0,7/20,25.71%,PTK2B;MAFB;CDC73;ZBTB16;CDK6;HSPA9;ZFP36
prerank,serine family amino acid catabolic process (GO:0009071),-0.23330404217926187,-0.5556737352592185,0.9673590504451038,0.9934546244719957,1.0,10/10,76.69%,SHMT1;CBS;THNSL2;DAO;GLDC;SDS;DLD;AMT;SHMT2;GCSH
prerank,regulation of transport (GO:0051049),0.20986302507083054,0.552655667483661,0.9769526248399488,0.9878865125729547,1.0,10/36,22.27%,TRAT1;FES;POFUT2;PRKN;GAPVD1;NRP1;DNAJA1;ACTG1;VAMP2;DISP3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.1995577657173031,0.550829806780718,0.9801864801864801,0.9882434473694321,1.0,10/50,21.95%,CDKN1A;GADD45A;CDK7;CCNA2;CNPPD1;MNAT1;CDC25A;CCNG1;GTPBP4;CCNT1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.2219087964895933,-0.5478504736752067,0.9721362229102167,0.9945811133096911,1.0,4/11,22.53%,UGGT2;DERL1;UFD1;POMT2
prerank,protein mannosylation (GO:0035268),0.22459231678220842,0.547661760076906,0.977961432506887,0.9890618266673681,1.0,3/22,14.55%,DPM2;TMTC4;FKTN
prerank,cGMP metabolic process (GO:0046068),-0.21102681707055054,-0.5458271686587556,0.9636363636363636,0.9938535675956409,1.0,7/12,40.67%,GUCY1A1;GUCY1B1;PDE2A;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,oligodendrocyte differentiation (GO:0048709),0.23156121234083765,0.5456781077352397,0.9668587896253602,0.9893972077622762,1.0,5/19,20.76%,SOX9;PRDM8;EIF2B2;SOX8;HES5
prerank,response to hydroxyurea (GO:0072710),0.2649963963528777,0.5444557974135504,0.9488372093023256,0.9894898273350375,1.0,4/11,22.99%,NSMCE3;DDI2;RTF2;SPIDR
prerank,cardiac myofibril assembly (GO:0055003),0.24490462141972005,0.5443801654462812,0.9701704545454546,0.9891842179932546,1.0,1/15,4.40%,MYL2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.19502992922505305,-0.5440836937335737,0.9964664310954063,0.9929994907539275,1.0,11/16,44.19%,FBH1;CLU;TRIM32;CDKN2D;TMEM161A;ACKR3;SFRP2;DDIAS;CCAR2;NACC2;RPS3
prerank,stem cell development (GO:0048864),0.23800313899445913,0.540307198032607,0.9558232931726908,0.990260957376132,1.0,6/16,23.00%,SNAI2;SOX8;PTPRC;PEF1;KLHL12;NOLC1
prerank,visual perception (GO:0007601),0.18430829332904047,0.5403042143004364,0.9967284623773174,0.9899284890650379,1.0,16/84,24.56%,DHRS3;RDH12;COL1A1;PITPNA;COL11A1;MYO9A;DRAM2;OAT;WFS1;RPGR;POU6F2;EML2;KIFC3;RGS16;CEP250;ATXN7
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.18401842514912461,0.5389453448256336,0.9956663055254604,0.990055952343204,1.0,18/82,21.46%,DYNC1H1;HAUS6;GTSE1;CEP76;CLASP1;CEP192;TUBA1A;NDE1;ALMS1;OFD1;CCP110;SSNA1;HAUS7;ATAD5;PAFAH1B1;PPP2R1A;HAUS5;CEP41
prerank,regulation of T cell chemotaxis (GO:0010819),-0.2160389098532154,-0.5367135059213267,0.978978978978979,0.9936338322002308,1.0,4/11,24.81%,WNK1;CCR2;WNT5A;CCL5
prerank,male gonad development (GO:0008584),0.20346539013593548,0.536640047350388,0.9874055415617129,0.9904605916480893,1.0,6/34,22.05%,NCOA4;SOX9;NR5A1;SOX8;LRP2;MAMLD1
prerank,inner ear morphogenesis (GO:0042472),0.2200754343648319,0.536601389700535,0.9764705882352941,0.9901370864282579,1.0,3/22,17.11%,SOX9;PAX8;CHD7
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.22810748875679315,0.5359912763216945,0.9630156472261735,0.9899841465834496,1.0,3/18,15.64%,PPIF;NAIF1;BNIP3
prerank,motor neuron axon guidance (GO:0008045),0.23740663090759465,0.5345506159440566,0.9726224783861671,0.9901228878299309,1.0,1/15,3.91%,NTN3
prerank,endothelial cell development (GO:0001885),-0.16470394449934728,-0.5344127336301591,0.9861751152073732,0.9929306171550532,1.0,13/25,38.51%,RAP1B;RAPGEF3;RAPGEF2;MARVELD2;PDE2A;PPP1R16B;COL22A1;MYADM;COL18A1;PECAM1;RAP1A;STC1;COL15A1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.25985084580402434,0.5343223071468931,0.9618208516886931,0.989861315404401,1.0,1/10,6.54%,APC
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.2542642471363289,0.5342573600923465,0.9646153846153847,0.9895509503289049,1.0,3/10,23.41%,NCBP2;CDC73;CPEB1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.2160948629975537,0.5335557675618949,0.9863760217983651,0.9894421582982722,1.0,4/23,18.05%,MPP1;MOSPD2;BST1;C1QBP
prerank,negative regulation of transposition (GO:0010529),0.23320889627654295,0.5284345559328888,0.9781021897810219,0.9906526247716451,1.0,2/16,12.84%,SMYD5;SIRT7
prerank,inner mitochondrial membrane organization (GO:0007007),0.19286333544160203,0.5266136027010785,0.9942462600690449,0.9908651542671199,1.0,11/47,23.65%,TIMM22;LETM1;ATP5F1A;ATP5F1D;ATP5F1C;AFG3L2;IMMT;MICOS13;HSPA9;NDUFA13;MTX2
prerank,regulation of response to interferon-gamma (GO:0060330),0.23811310847798392,0.5254074612142913,0.9613180515759312,0.9908680559438889,1.0,1/14,4.49%,IFNGR2
prerank,skeletal muscle contraction (GO:0003009),0.22080477591611725,0.5238769066018825,0.979253112033195,0.9909656082405772,1.0,2/19,16.08%,STAC2;STAC3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.23435726966075743,0.5210445561602494,0.9689265536723164,0.9914044922447655,1.0,4/14,22.84%,RPL7L1;WDR12;RPL7;BOP1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.20086116721745417,0.519246681865509,0.9899749373433584,0.9915565426166342,1.0,4/33,17.97%,MTHFS;PRODH;ALDH18A1;OAT
prerank,mitochondrial fusion (GO:0008053),0.2190431047108811,0.5129026743904325,0.981994459833795,0.9928379820468639,1.0,5/18,22.78%,GDAP1;BAX;USP30;AFG3L2;MFN2
prerank,amino sugar metabolic process (GO:0006040),0.24690211089693168,0.5124546769745972,0.9745627980922098,0.9926064997683495,1.0,5/10,31.25%,GFPT1;EXTL2;SLC35A3;GFPT2;ST3GAL1
prerank,chromatin assembly (GO:0031497),0.19399509414654226,0.511879822682015,0.9940047961630696,0.9924194776125317,1.0,4/38,10.59%,ANP32B;SOX9;BRD2;SIRT1
prerank,protein polyglutamylation (GO:0018095),0.24037811624223998,0.5109993768166307,0.9597523219814241,0.9922931335346991,1.0,3/11,22.17%,CFAP20;CEP41;TTLL4
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.21608958607284012,0.5093352424453367,0.9797979797979798,0.9923526218681654,1.0,1/18,5.08%,IGF1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.23612148913892816,0.5061585111285871,0.9729323308270676,0.9927443676611504,1.0,2/12,17.33%,BOD1;CDT1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.22837450006500595,0.4984238973077956,0.97953216374269,0.9940698431175263,1.0,3/13,21.48%,DDIT3;SIN3A;TAF1
prerank,estrogen metabolic process (GO:0008210),-0.18538882231719583,-0.4982882863577467,0.9867549668874173,0.9989779440483185,1.0,9/15,43.92%,HSD17B7;SULT1A1;HSD17B10;HSD17B1;CYP1A1;CYP1B1;HSD17B14;UGT1A7;UGT1A1
prerank,positive regulation of dephosphorylation (GO:0035306),0.19631202221761912,0.49314096605916896,0.9961290322580645,0.9947935169527953,1.0,2/27,8.71%,PRKCD;DLC1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.21263380098871137,0.49060917950140615,0.9901685393258427,0.9949495010309868,1.0,8/16,30.10%,HELB;SHLD1;RADX;SHLD2;UBQLN4;KLHL15;FANCB;RIF1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.22128474884084176,0.4905525656359373,0.9823269513991163,0.9946288393070237,1.0,4/14,20.98%,RMND1;C1QBP;TRMT10C;COA3
prerank,regulation of ERAD pathway (GO:1904292),-0.19514796141810023,-0.4891065334809187,0.9875776397515528,0.9990279621743724,1.0,2/11,12.59%,TMEM259;USP19
prerank,odontogenesis (GO:0042476),0.18506436343055319,0.48652728764987957,0.9950062421972534,0.9950315951351993,1.0,1/35,1.89%,AQP1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.21795789130869034,0.4841563355429058,0.9790419161676647,0.9951059020550916,1.0,2/13,13.37%,MAVS;GAS6
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.22039052160536055,0.4749038598521195,0.9790104947526237,0.9962230137128848,1.0,2/13,11.06%,NEIL1;MBD4
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.20278583546240941,0.4744332271467019,0.9842857142857143,0.9959589117571752,1.0,2/18,13.60%,RFC3;POLA1
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.16549545275363192,-0.47170483835442834,0.992619926199262,0.9998199370655849,1.0,6/18,28.39%,METTL3;PRELID1;CCR2;IL4I1;ABL1;CD2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.19201734697029701,0.459667643516106,0.9903047091412742,0.9976203746230864,1.0,1/17,6.84%,HNRNPU
prerank,synaptonemal complex assembly (GO:0007130),0.2012934011427134,0.45646576441413295,0.9914040114613181,0.9973291356218316,1.0,15/15,79.89%,RAD21;P3H4;SYCP2;SYCE3;SYCE1;SYCP1;RAD21L1;TEX12;BAG6;HORMAD1;REC8;TEX11;SYCE2;TRIP13;STAG3
prerank,synaptonemal complex organization (GO:0070193),0.2012934011427134,0.45646576441413295,0.9914040114613181,0.9973291356218316,1.0,15/15,79.89%,RAD21;P3H4;SYCP2;SYCE3;SYCE1;SYCP1;RAD21L1;TEX12;BAG6;HORMAD1;REC8;TEX11;SYCE2;TRIP13;STAG3
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.15795131903544612,-0.44283731089558903,1.0,1.0,1.0,9/15,45.80%,EDA;FOXC1;GLI2;BMP2;ROGDI;WNT6;MSX1;TBX1;AMELX
prerank,hematopoietic stem cell differentiation (GO:0060218),0.21291313326197733,0.44232692554461894,0.9908814589665653,0.9984484615676505,1.0,2/10,17.21%,ACE;MLLT3
prerank,heterochromatin assembly (GO:0031507),-0.14878123364617016,-0.43777700211294435,1.0,0.9997841763041615,1.0,11/20,37.76%,SMCHD1;SIRT2;BEND3;SUV39H1;ZNFX1;HELLS;EZH1;CDKN2A;HMGA1;HMGA2;H3-3A
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.14183333532045794,-0.43189098733222386,1.0,0.9987229615052341,1.0,1/20,2.17%,PRKCE
prerank,mesonephros development (GO:0001823),0.20017791631058446,0.4270483281956938,0.9970014992503748,0.9993773406514125,1.0,2/11,20.92%,PAX8;ZBTB16
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.20555412528379707,0.42421700759737546,0.9923076923076923,0.9992534794851774,1.0,3/10,30.32%,DERL2;SVIP;UBE2G2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.1817538008247115,0.41904942392983874,0.9900990099009901,0.9992600969626926,1.0,1/16,9.95%,SLC39A14
prerank,aspartate family amino acid catabolic process (GO:0009068),0.17797025059300015,0.4150537825365201,1.0,0.9991559619632844,1.0,3/19,16.77%,GCDH;OGDH;ALDH7A1
prerank,organic cation transport (GO:0015695),0.17395186832712578,0.41160736502834167,0.9972826086956522,0.9990123566915735,1.0,3/20,21.63%,SLC25A42;SLC44A2;SLC22A5
prerank,nuclear transport (GO:0051169),0.17901086067327399,0.40915531589997894,0.9971264367816092,0.9988111040345337,1.0,3/16,19.73%,RSRC1;NUP98;XPO1
prerank,steroid hormone biosynthetic process (GO:0120178),0.14782663311243469,0.3733781959190663,1.0,0.9997246056168014,1.0,7/29,29.00%,TSPOAP1;HSD17B11;SRD5A1;SRD5A3;HSD17B2;TSPO;FDXR
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.1646867503358896,0.35103363605643306,1.0,0.9997616249075181,1.0,1/12,11.25%,TSPOAP1
